Clustering O 0 0.08655688911676407
of O 0 0.03355378285050392
missense O 0 0.07869826257228851
mutations O 0 0.026300130411982536
in O 0 0.015324189327657223
the O 0 0.4889460802078247
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999983310699463
telangiectasia I-Disease 1 0.9999957084655762
gene O 0 0.019856374710798264
in O 0 0.010948603972792625
a O 0 0.02190769463777542
sporadic B-Disease 1 0.9982341527938843
T I-Disease 1 0.9999947547912598
- I-Disease 1 0.9999892711639404
cell I-Disease 1 0.9968693852424622
leukaemia I-Disease 1 0.999988317489624
. O 0 0.051487863063812256

Ataxia B-Disease 1 0.9999905824661255
- I-Disease 1 0.9999828338623047
telangiectasia I-Disease 1 0.9999947547912598
( O 1 0.8886445164680481
A B-Disease 1 0.9995273351669312
- I-Disease 1 0.999995231628418
T I-Disease 1 0.999927282333374
) O 0 0.011196942068636417
is O 0 0.007656050845980644
a O 0 0.01564013957977295
recessive B-Disease 1 0.9999227523803711
multi I-Disease 1 0.9999971389770508
- I-Disease 1 0.9999997615814209
system I-Disease 1 0.9998501539230347
disorder I-Disease 1 0.9999988079071045
caused O 1 0.9492773413658142
by O 0 0.013724147342145443
mutations O 0 0.012881246395409107
in O 0 0.0068327379412949085
the O 0 0.01121802069246769
ATM O 0 0.06613852828741074
gene O 0 0.014919293113052845
at O 0 0.017065998166799545
11q22 O 1 0.9900866150856018
- O 1 0.9994495511054993
q23 O 1 0.9973311424255371
( O 0 0.07626434415578842
ref O 1 0.9516711235046387
. O 0 0.01786573976278305
3 O 0 0.02731778845191002
) O 0 0.028313953429460526
. O 0 0.031937941908836365

The O 0 0.04057437181472778
risk O 0 0.3785923421382904
of O 1 0.7139047384262085
cancer B-Disease 1 0.9999971389770508
, O 1 0.8961432576179504
especially O 1 0.9894502758979797
lymphoid B-Disease 1 0.999997615814209
neoplasias I-Disease 1 0.9998964071273804
, O 0 0.01704498939216137
is O 0 0.009791908785700798
substantially O 0 0.015420961193740368
elevated O 1 0.7979635000228882
in O 0 0.014788173139095306
A B-Disease 1 0.9999716281890869
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999997615814209
patients O 1 0.9993494153022766
and O 0 0.014115369878709316
has O 0 0.01178633701056242
long O 0 0.01768694818019867
been O 0 0.012410897761583328
associated O 0 0.018832217901945114
with O 0 0.05656068027019501
chromosomal O 1 0.9999226331710815
instability O 1 0.9998847246170044
. O 0 0.13505223393440247

By O 0 0.040494807064533234
analysing O 1 0.8668746948242188
tumour B-Disease 1 0.9999885559082031
DNA O 0 0.029909029603004456
from O 0 0.01580393686890602
patients O 0 0.03602305427193642
with O 0 0.01450289785861969
sporadic B-Disease 1 0.9109169840812683
T I-Disease 1 0.9999469518661499
- I-Disease 1 0.9996438026428223
cell I-Disease 1 0.9574203491210938
prolymphocytic I-Disease 1 0.9999499320983887
leukaemia I-Disease 1 0.9999996423721313
( O 1 0.9969736337661743
T B-Disease 1 0.9999886751174927
- I-Disease 1 0.9999600648880005
PLL I-Disease 1 0.9999104738235474
) O 0 0.013089905492961407
, O 0 0.009268704801797867
a O 0 0.012605479918420315
rare O 0 0.1805274337530136
clonal B-Disease 1 0.9992189407348633
malignancy I-Disease 1 0.9999362230300903
with O 0 0.010854600928723812
similarities O 0 0.011093661189079285
to O 0 0.00790735986083746
a O 0 0.020982254296541214
mature B-Disease 1 0.9944400787353516
T I-Disease 1 0.9999740123748779
- I-Disease 1 0.9999544620513916
cell I-Disease 1 0.9421427249908447
leukaemia I-Disease 1 0.9999469518661499
seen O 0 0.014108167961239815
in O 0 0.011622510850429535
A B-Disease 1 0.9995174407958984
- I-Disease 1 0.9999980926513672
T I-Disease 1 0.9999510049819946
, O 0 0.010220701806247234
we O 0 0.00651604775339365
demonstrate O 0 0.009489092044532299
a O 0 0.00792828481644392
high O 0 0.010711802169680595
frequency O 0 0.009867334738373756
of O 0 0.010721847414970398
ATM O 1 0.6337398886680603
mutations O 0 0.02688051573932171
in O 0 0.023735906928777695
T B-Disease 1 0.9999241828918457
- I-Disease 1 0.9997764229774475
PLL I-Disease 1 0.9990112781524658
. O 0 0.055090729147195816

In O 0 0.030302036553621292
marked O 0 0.03356904909014702
contrast O 0 0.020272748544812202
to O 0 0.011908185668289661
the O 0 0.014554607681930065
ATM O 0 0.20284512639045715
mutation O 0 0.020099332556128502
pattern O 0 0.016218505799770355
in O 0 0.011546419933438301
A B-Disease 1 0.9997156262397766
- I-Disease 1 0.9999985694885254
T I-Disease 1 0.9999579191207886
, O 0 0.010087277740240097
the O 0 0.008812200278043747
most O 0 0.008254284039139748
frequent O 0 0.017444362863898277
nucleotide O 0 0.01718786731362343
changes O 0 0.008636834099888802
in O 0 0.01007133349776268
this O 0 0.015109865926206112
leukaemia B-Disease 1 0.9999821186065674
were O 0 0.030411824584007263
missense O 1 0.9018069505691528
mutations O 0 0.05832025036215782
. O 0 0.04147070646286011

These O 0 0.02146982215344906
clustered O 0 0.036213066428899765
in O 0 0.011272342875599861
the O 0 0.011841202154755592
region O 0 0.014903843402862549
corresponding O 0 0.011623441241681576
to O 0 0.009085003286600113
the O 0 0.017922496423125267
kinase O 1 0.9675530195236206
domain O 0 0.015033270232379436
, O 0 0.006910876836627722
which O 0 0.005561318714171648
is O 0 0.005499618593603373
highly O 0 0.009184807538986206
conserved O 0 0.011873841285705566
in O 0 0.009241417050361633
ATM O 1 0.6575508713722229
- O 1 0.8644196391105652
related O 0 0.012761530466377735
proteins O 0 0.010883663780987263
in O 0 0.010336772538721561
mouse O 0 0.032106366008520126
, O 0 0.018263816833496094
yeast O 0 0.047730740159749985
and O 0 0.026166964322328568
Drosophila O 0 0.06616700440645218
. O 0 0.04091627895832062

The O 0 0.03698405623435974
resulting O 0 0.05290447548031807
amino O 0 0.09050964564085007
- O 1 0.9984025359153748
acid O 0 0.18406200408935547
substitutions O 0 0.02168733812868595
are O 0 0.0065657044760882854
predicted O 0 0.011770728975534439
to O 0 0.009612148627638817
interfere O 0 0.023706959560513496
with O 0 0.01938156969845295
ATP O 1 0.9984763264656067
binding O 0 0.03294297680258751
or O 0 0.022077957168221474
substrate O 0 0.044223684817552567
recognition O 0 0.03984486684203148
. O 0 0.03730279952287674

Two O 0 0.02142482064664364
of O 0 0.022990258410573006
seventeen O 0 0.10690430551767349
mutated O 1 0.9979690909385681
T B-Disease 1 0.9999569654464722
- I-Disease 1 0.9998675584793091
PLL I-Disease 1 0.9992079138755798
samples O 0 0.017027512192726135
had O 0 0.011082890443503857
a O 0 0.010133099742233753
previously O 0 0.01305657159537077
reported O 0 0.02053743414580822
A B-Disease 1 0.9831142425537109
- I-Disease 1 0.999985933303833
T I-Disease 1 0.9999464750289917
allele O 0 0.4133772552013397
. O 0 0.04097428545355797

In O 0 0.027957534417510033
contrast O 0 0.025471171364188194
, O 0 0.014951128512620926
no O 0 0.01153656467795372
mutations O 0 0.012465533800423145
were O 0 0.006445341743528843
detected O 0 0.011345555074512959
in O 0 0.006373416632413864
the O 0 0.010978841222822666
p53 O 1 0.6954987049102783
gene O 0 0.01086097676306963
, O 0 0.007397403009235859
suggesting O 0 0.010402632877230644
that O 0 0.007023419253528118
this O 0 0.01627839170396328
tumour B-Disease 1 0.9999997615814209
suppressor O 1 0.9999014139175415
is O 0 0.013652545399963856
not O 0 0.00850033201277256
frequently O 0 0.013713846914470196
altered O 0 0.016468722373247147
in O 0 0.013728586956858635
this O 0 0.021389592438936234
leukaemia B-Disease 1 0.9999327659606934
. O 0 0.052087944000959396

Occasional O 0 0.11084125936031342
missense O 1 0.7080732583999634
mutations O 0 0.036026716232299805
in O 0 0.0156940259039402
ATM O 0 0.03898373246192932
were O 0 0.007730463519692421
also O 0 0.007522191386669874
found O 0 0.007644221186637878
in O 0 0.01009301096200943
tumour B-Disease 1 0.9999878406524658
DNA O 0 0.01454092189669609
from O 0 0.009156769141554832
patients O 0 0.0755370631814003
with O 0 0.013276898302137852
B B-Disease 1 0.9995695948600769
- I-Disease 1 0.998569130897522
cell I-Disease 0 0.30772024393081665
non I-Disease 1 0.984887957572937
- I-Disease 1 0.9999958276748657
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999991655349731
( O 1 0.9517247080802917
B B-Disease 1 0.9996193647384644
- I-Disease 1 0.9889658093452454
NHL I-Disease 0 0.037401389330625534
) O 0 0.011400596238672733
and O 0 0.010345694608986378
a O 0 0.020259004086256027
B B-Disease 1 0.9977983236312866
- I-Disease 1 0.9974617958068848
NHL I-Disease 1 0.527954638004303
cell O 0 0.053902145475149155
line O 0 0.05207154527306557
. O 0 0.04252147302031517

The O 0 0.025527087971568108
evidence O 0 0.013262663036584854
of O 0 0.01143962424248457
a O 0 0.011033298447728157
significant O 0 0.007773203309625387
proportion O 0 0.010257176123559475
of O 0 0.010586629621684551
loss O 1 0.9888805150985718
- O 1 0.9999599456787109
of O 1 0.9774288535118103
- O 1 0.9999841451644897
function O 0 0.026864228770136833
mutations O 0 0.010952586308121681
and O 0 0.006252833176404238
a O 0 0.008129812777042389
complete O 0 0.011356820352375507
absence O 0 0.01552283763885498
of O 0 0.009702317416667938
the O 0 0.011372468434274197
normal O 0 0.013290129601955414
copy O 0 0.015580127947032452
of O 0 0.011126948520541191
ATM O 0 0.02266700565814972
in O 0 0.005454350262880325
the O 0 0.0074941981583833694
majority O 0 0.009873849339783192
of O 0 0.01718924567103386
mutated O 1 0.9913456439971924
tumours B-Disease 1 0.9999957084655762
establishes O 1 0.9988996982574463
somatic O 1 0.9972991347312927
inactivation O 1 0.9972056746482849
of O 0 0.012525707483291626
this O 0 0.0072227176278829575
gene O 0 0.008569598197937012
in O 0 0.005575962830334902
the O 0 0.010358551517128944
pathogenesis O 1 0.9921807050704956
of O 0 0.0696626827120781
sporadic B-Disease 1 0.9999053478240967
T I-Disease 1 0.9999995231628418
- I-Disease 1 0.9999960660934448
PLL I-Disease 1 0.9999676942825317
and O 0 0.014060784131288528
suggests O 0 0.013860049657523632
that O 0 0.007796223741024733
ATM O 0 0.03157247230410576
acts O 0 0.01731555163860321
as O 0 0.017759207636117935
a O 1 0.6912493705749512
tumour B-Disease 1 0.9999990463256836
suppressor O 1 0.9999175071716309
. O 0 0.05651320517063141

As O 0 0.0328894667327404
constitutional O 0 0.03407040238380432
DNA O 0 0.022161463275551796
was O 0 0.01613677106797695
not O 0 0.006736331153661013
available O 0 0.007426973897963762
, O 0 0.008840140886604786
a O 0 0.0147069301456213
putative O 1 0.9431178569793701
hereditary O 1 0.9999579191207886
predisposition O 1 0.9999833106994629
to O 1 0.9900687336921692
T B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999933242797852
PLL I-Disease 1 0.999896764755249
will O 0 0.014513780362904072
require O 0 0.012440641410648823
further O 0 0.014035303145647049
investigation O 0 0.026884743943810463
. O 0 0.020481884479522705
. O 0 0.03083634003996849

Myotonic B-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999998807907104
protein O 1 0.9707099199295044
kinase O 1 0.9585496187210083
is O 0 0.015051605179905891
involved O 0 0.011297007091343403
in O 0 0.007686032447963953
the O 0 0.01079147681593895
modulation O 0 0.023002350702881813
of O 0 0.014183040708303452
the O 0 0.3330172598361969
Ca2 O 1 0.9999732971191406
+ O 1 0.999414324760437
homeostasis O 1 0.9987947940826416
in O 0 0.19203363358974457
skeletal O 1 0.9999821186065674
muscle O 1 0.9998962879180908
cells O 1 0.5891421437263489
. O 0 0.04694484546780586

Myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
( O 1 0.9999737739562988
DM B-Disease 1 0.9999998807907104
) O 0 0.024219732731580734
, O 0 0.011953559704124928
the O 0 0.013329674489796162
most O 0 0.02414889447391033
prevalent O 1 0.9999809265136719
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.983516275882721
adults O 1 0.9803772568702698
, O 0 0.0237627774477005
is O 0 0.009068580344319344
caused O 0 0.02172035537660122
by O 0 0.01192605309188366
( O 0 0.1858985722064972
CTG O 1 0.9997701048851013
) O 0 0.018208930268883705
n O 0 0.033871110528707504
- O 0 0.4656256437301636
repeat O 0 0.020397227257490158
expansion O 0 0.013360438868403435
in O 0 0.006823957897722721
a O 0 0.010377387516200542
gene O 0 0.010843655094504356
encoding O 0 0.013149140402674675
a O 0 0.01440907921642065
protein O 0 0.020915299654006958
kinase O 0 0.40741148591041565
( O 0 0.08398406207561493
DM B-Disease 1 0.9999957084655762
protein O 0 0.03678874298930168
kinase O 1 0.743403434753418
; O 0 0.021192306652665138
DMPK O 1 0.9918421506881714
) O 0 0.015105239115655422
and O 0 0.010205629281699657
involves O 0 0.016147326678037643
changes O 0 0.013044163584709167
in O 0 0.018042556941509247
cytoarchitecture O 1 0.9981589913368225
and O 0 0.08827036619186401
ion O 1 0.9940114617347717
homeostasis O 1 0.9910616874694824
. O 0 0.05128380283713341

To O 0 0.031950052827596664
obtain O 0 0.027444664388895035
clues O 0 0.02078859880566597
to O 0 0.00994187593460083
the O 0 0.010501887649297714
normal O 0 0.012834613211452961
biological O 0 0.013836359605193138
role O 0 0.014129525981843472
of O 0 0.01455339603126049
DMPK O 1 0.999458372592926
in O 0 0.016491787508130074
cellular O 1 0.9437270164489746
ion O 1 0.9923638105392456
homeostasis O 1 0.9916970729827881
, O 0 0.008434182032942772
we O 0 0.0056376890279352665
have O 0 0.004077942110598087
compared O 0 0.006908311974257231
the O 0 0.01174197718501091
resting O 1 0.9963884353637695
[ O 1 0.9891694784164429
Ca2 O 1 0.9997833371162415
+ O 1 0.9136145710945129
] O 0 0.027888664975762367
i O 0 0.012421820312738419
, O 0 0.00772523507475853
the O 0 0.008394642733037472
amplitude O 0 0.014715396799147129
and O 0 0.008133220486342907
shape O 0 0.012893511913716793
of O 0 0.02297634817659855
depolarization O 1 0.9999926090240479
- O 1 0.9999992847442627
induced O 1 0.999998927116394
Ca2 O 1 0.9999923706054688
+ O 1 0.9993709921836853
transients O 1 0.7920646667480469
, O 0 0.010379494167864323
and O 0 0.007368011865764856
the O 0 0.007476556580513716
content O 0 0.008396724238991737
of O 0 0.012401911430060863
ATP O 1 0.9994412064552307
- O 1 0.9990466237068176
driven O 0 0.09988024085760117
ion O 0 0.09009381383657455
pumps O 0 0.03437591344118118
in O 0 0.013983775861561298
cultured O 1 0.8039051294326782
skeletal O 1 0.9992613196372986
muscle O 1 0.8971852660179138
cells O 0 0.016488444060087204
of O 0 0.012249406427145004
wild O 0 0.04075285792350769
- O 1 0.992042601108551
type O 0 0.031084010377526283
and O 0 0.014420229010283947
DMPK O 1 0.9998457431793213
[ O 1 0.9883937835693359
- O 1 0.9999514818191528
/ O 1 0.999927282333374
- O 1 0.9997232556343079
] O 1 0.5611870288848877
knockout O 1 0.5687018632888794
mice O 0 0.05464155599474907
. O 0 0.03643065318465233

In O 0 0.035044219344854355
vitro O 0 0.07536657899618149
- O 1 0.957952082157135
differentiated O 1 0.6160996556282043
DMPK O 1 0.9996300935745239
[ O 1 0.9763546586036682
- O 1 0.9999456405639648
/ O 1 0.9998718500137329
- O 1 0.9992058873176575
] O 0 0.04765056073665619
myotubes O 0 0.12453818321228027
exhibit O 0 0.019245244562625885
a O 0 0.013117394410073757
higher O 0 0.015392893925309181
resting O 1 0.9983577132225037
[ O 1 0.994708776473999
Ca2 O 1 0.9999419450759888
+ O 1 0.9890235662460327
] O 0 0.026194512844085693
i O 0 0.010873282328248024
than O 0 0.005800370592623949
do O 0 0.007577890530228615
wild O 0 0.018921276554465294
- O 1 0.9924317598342896
type O 0 0.10179613530635834
myotubes O 1 0.8208318948745728
because O 0 0.007885826751589775
of O 0 0.007793711964040995
an O 0 0.009005875326693058
altered O 0 0.01121818833053112
open O 0 0.011035609990358353
probability O 0 0.009090633131563663
of O 0 0.011838234961032867
voltage O 0 0.27207523584365845
- O 1 0.996740996837616
dependent O 0 0.05020321160554886
l O 1 0.9531294703483582
- O 1 0.9971502423286438
type O 1 0.8424685001373291
Ca2 O 1 0.9971188306808472
+ O 1 0.6553451418876648
and O 0 0.033080607652664185
Na O 1 0.9993748068809509
+ O 0 0.12282328307628632
channels O 0 0.04360095039010048
. O 0 0.035860516130924225

The O 0 0.05363979563117027
mutant O 1 0.6736375689506531
myotubes O 1 0.9329794049263
exhibit O 0 0.04897115379571915
smaller O 0 0.02257886342704296
and O 0 0.021577319130301476
slower O 0 0.052665892988443375
Ca2 O 1 0.9951158761978149
+ O 0 0.12942376732826233
responses O 0 0.02088390290737152
upon O 0 0.01756191812455654
triggering O 0 0.1749192476272583
by O 0 0.018114199861884117
acetylcholine O 1 0.9814552664756775
or O 0 0.025181667879223824
high O 1 0.7441619038581848
external O 1 0.826835572719574
K O 1 0.99576735496521
+ O 0 0.23123876750469208
. O 0 0.04070347920060158

In O 0 0.025185665115714073
addition O 0 0.019111499190330505
, O 0 0.011696293950080872
we O 0 0.007860944606363773
observed O 0 0.009049028158187866
that O 0 0.00681348517537117
these O 0 0.010831018909811974
Ca2 O 1 0.9993231296539307
+ O 1 0.9871731996536255
transients O 1 0.9684241414070129
partially O 0 0.0253902655094862
result O 0 0.009425491094589233
from O 0 0.0077167595736682415
an O 0 0.009176778607070446
influx O 0 0.028205592185258865
of O 0 0.02214987762272358
extracellular O 1 0.9918636083602905
Ca2 O 1 0.9970472455024719
+ O 0 0.037613481283187866
through O 0 0.014847906306385994
the O 0 0.021622752770781517
l O 1 0.9981414079666138
- O 1 0.9998466968536377
type O 1 0.9938072562217712
Ca2 O 1 0.9990038275718689
+ O 0 0.2686883509159088
channel O 0 0.048352986574172974
. O 0 0.036647070199251175

Neither O 0 0.046097856014966965
the O 0 0.022364482283592224
content O 0 0.01668359898030758
nor O 0 0.015006555244326591
the O 0 0.011306987144052982
activity O 0 0.014548850245773792
of O 0 0.02553374320268631
Na O 1 0.9999911785125732
+ O 1 0.9990779161453247
/ O 1 0.9993993043899536
K O 1 0.9628737568855286
+ O 0 0.46099525690078735
ATPase O 0 0.2725445032119751
and O 0 0.033688899129629135
sarcoplasmic O 1 0.9996366500854492
reticulum O 1 0.9997722506523132
Ca2 O 1 0.9999390840530396
+ O 1 0.9992929697036743
- O 1 0.9997630715370178
ATPase O 1 0.9513432383537292
are O 0 0.013433189131319523
affected O 0 0.024938849732279778
by O 0 0.02470293827354908
DMPK O 1 0.9964465498924255
absence O 1 0.5658760070800781
. O 0 0.05169428512454033

In O 0 0.026912709698081017
conclusion O 0 0.026536917313933372
, O 0 0.01475039217621088
our O 0 0.014293819665908813
data O 0 0.009456362575292587
suggest O 0 0.011690838262438774
that O 0 0.00899824034422636
DMPK O 1 0.9598047137260437
is O 0 0.010210109874606133
involved O 0 0.01075463555753231
in O 0 0.009361879900097847
modulating O 0 0.17562255263328552
the O 0 0.011589881032705307
initial O 0 0.014506442472338676
events O 0 0.011261369101703167
of O 0 0.01627190411090851
excitation O 1 0.9943761825561523
- O 1 0.9999253749847412
contraction O 1 0.9885375499725342
coupling O 1 0.9687960147857666
in O 0 0.059410177171230316
skeletal O 1 0.9999603033065796
muscle O 1 0.9990850687026978
. O 0 0.0328274741768837
. O 0 0.03869371488690376

Constitutional O 1 0.5158723592758179
RB1 O 1 0.9999724626541138
- O 1 0.9998338222503662
gene O 0 0.09868276119232178
mutations O 0 0.029938247054815292
in O 0 0.015351706184446812
patients O 1 0.8200761079788208
with O 0 0.027831634506583214
isolated O 1 0.9888927340507507
unilateral B-Disease 1 0.9985237717628479
retinoblastoma I-Disease 1 0.9999847412109375
. O 0 0.08432654291391373

In O 0 0.02578715607523918
most O 0 0.017069390043616295
patients O 0 0.17387457191944122
with O 0 0.015528734773397446
isolated O 1 0.9879377484321594
unilateral B-Disease 1 0.9998583793640137
retinoblastoma I-Disease 1 0.9999997615814209
, O 1 0.9970718622207642
tumor B-Disease 1 0.9999960660934448
development O 0 0.395177960395813
is O 0 0.014247938990592957
initiated O 0 0.2418370097875595
by O 0 0.015093092806637287
somatic O 0 0.4919508695602417
inactivation O 1 0.973854660987854
of O 0 0.014970439486205578
both O 0 0.012330790981650352
alleles O 0 0.027006017044186592
of O 0 0.022933822125196457
the O 1 0.5873752236366272
RB1 O 1 0.9999682903289795
gene O 0 0.055922895669937134
. O 0 0.04063241183757782

However O 0 0.026345958933234215
, O 0 0.01589115709066391
some O 0 0.008682181127369404
of O 0 0.01333461795002222
these O 0 0.013989387080073357
patients O 1 0.9924607872962952
can O 0 0.028337784111499786
transmit O 1 0.9845743775367737
retinoblastoma B-Disease 1 0.9999896287918091
predisposition O 1 0.9994791150093079
to O 0 0.02431464195251465
their O 0 0.028137896209955215
offspring O 1 0.5218547582626343
. O 0 0.04670442268252373

To O 0 0.024139324203133583
determine O 0 0.014645090326666832
the O 0 0.012472262606024742
frequency O 0 0.010804200544953346
and O 0 0.007740231696516275
nature O 0 0.009801788255572319
of O 0 0.010540060698986053
constitutional O 1 0.898370087146759
RB1 O 1 0.9999982118606567
- O 1 0.9999265670776367
gene O 0 0.02441215142607689
mutations O 0 0.014371673576533794
in O 0 0.008878258988261223
patients O 0 0.2502760887145996
with O 0 0.012386991642415524
isolated O 1 0.9121143221855164
unilateral B-Disease 1 0.9936432838439941
retinoblastoma I-Disease 1 0.9999761581420898
, O 0 0.014549218118190765
we O 0 0.008976436220109463
analyzed O 0 0.011779219843447208
DNA O 0 0.013384999707341194
from O 0 0.013526802882552147
peripheral O 1 0.9967834949493408
blood O 1 0.9607884287834167
and O 0 0.09511640667915344
from O 1 0.8541854023933411
tumor B-Disease 1 0.9999960660934448
tissue O 1 0.9967880249023438
. O 0 0.050216227769851685

The O 0 0.029739975929260254
analysis O 0 0.0185127854347229
of O 0 0.020220927894115448
tumors B-Disease 1 0.9983388185501099
from O 0 0.015380455181002617
54 O 0 0.03502287343144417
( O 0 0.019105874001979828
71 O 0 0.025938965380191803
% O 0 0.013112159445881844
) O 0 0.009685182943940163
of O 0 0.012149224989116192
76 O 0 0.13489148020744324
informative O 0 0.0878862589597702
patients O 0 0.12957176566123962
showed O 0 0.015655862167477608
loss O 0 0.01924295909702778
of O 0 0.019772060215473175
constitutional O 1 0.932989239692688
heterozygosity O 1 0.9999901056289673
( O 1 0.9986489415168762
LOH O 1 0.9999979734420776
) O 0 0.04084708169102669
at O 0 0.043140631169080734
intragenic O 1 0.963799238204956
loci O 0 0.10141553729772568
. O 0 0.04793522134423256

Three O 0 0.03238711878657341
of O 0 0.033926744014024734
13 O 0 0.15657225251197815
uninformative O 1 0.9998284578323364
patients O 1 0.989355206489563
had O 0 0.045912403613328934
constitutional O 0 0.09358073770999908
deletions O 1 0.5168941020965576
. O 0 0.05266793817281723

For O 0 0.0262124203145504
39 O 0 0.03329704701900482
randomly O 0 0.0273445975035429
selected O 0 0.028233282268047333
tumors B-Disease 1 0.9904234409332275
, O 0 0.021662678569555283
SSCP O 1 0.9982489347457886
, O 0 0.03853069618344307
hetero O 1 0.9999496936798096
- O 1 0.9995965361595154
duplex O 1 0.9883480668067932
analysis O 0 0.011559892445802689
, O 0 0.010900580324232578
sequencing O 0 0.013485138304531574
, O 0 0.009492866694927216
and O 0 0.010870027355849743
Southern O 0 0.021904291585087776
blot O 0 0.2887468934059143
analysis O 0 0.012686116620898247
were O 0 0.009613901376724243
used O 0 0.011624426580965519
to O 0 0.0147080197930336
identify O 0 0.02837441675364971
mutations O 0 0.03706654906272888
. O 0 0.03350431099534035

Mutations O 0 0.04783022776246071
were O 0 0.01558300293982029
detected O 0 0.020979881286621094
in O 0 0.01172233372926712
21 O 0 0.019471298903226852
( O 0 0.016674060374498367
91 O 0 0.025368457660079002
% O 0 0.012700770050287247
) O 0 0.012702755630016327
of O 0 0.016909711062908173
23 O 0 0.3244595527648926
tumors B-Disease 1 0.9999628067016602
with O 1 0.8857141137123108
LOH O 1 0.999997615814209
. O 0 0.06710994988679886

In O 0 0.028933994472026825
6 O 0 0.028842782601714134
( O 0 0.019256841391324997
38 O 0 0.018957503139972687
% O 0 0.011158605106174946
) O 0 0.009057446382939816
of O 0 0.010378499515354633
16 O 0 0.027694063261151314
tumors B-Disease 1 0.9999619722366333
without O 0 0.25852254033088684
LOH O 1 0.9999998807907104
, O 0 0.01736631989479065
one O 0 0.011554477736353874
mutation O 0 0.023686757311224937
was O 0 0.012819360941648483
detected O 0 0.011655614711344242
, O 0 0.0058337547816336155
and O 0 0.005359336733818054
in O 0 0.00603026058524847
9 O 0 0.011574022471904755
( O 0 0.009990557096898556
56 O 0 0.012427015230059624
% O 0 0.008333984762430191
) O 0 0.007012405898422003
of O 0 0.009143098257482052
the O 0 0.07532871514558792
tumors B-Disease 1 0.9999947547912598
without O 1 0.8080465197563171
LOH O 1 0.9999997615814209
, O 0 0.022131195291876793
both O 0 0.014614392071962357
mutations O 0 0.021008817479014397
were O 0 0.01480915304273367
found O 0 0.019647939130663872
. O 0 0.030848313122987747

Thus O 0 0.027948088943958282
, O 0 0.013978411443531513
a O 0 0.012079625390470028
total O 0 0.0098958108574152
of O 0 0.011450759135186672
45 O 0 0.01571609638631344
mutations O 0 0.013196404092013836
were O 0 0.0076131317764520645
identified O 0 0.011998828500509262
in O 0 0.012436862103641033
tumors B-Disease 1 0.9995761513710022
of O 0 0.19155684113502502
36 O 1 0.8657872080802917
patients O 1 0.996644914150238
. O 0 0.046673160046339035

Thirty O 0 0.05911989510059357
- O 0 0.0610400065779686
nine O 0 0.016358554363250732
of O 0 0.012916618026793003
the O 0 0.016886897385120392
mutations O 0 0.026385195553302765
- O 1 0.6293991804122925
including O 0 0.00900832749903202
34 O 0 0.01403416320681572
small O 0 0.010506129823625088
mutations O 0 0.012635521590709686
, O 0 0.008275252766907215
2 O 0 0.011790919117629528
large O 0 0.010920694097876549
structural O 0 0.03703954815864563
alterations O 0 0.024007411673665047
, O 0 0.010764919221401215
and O 0 0.011417568661272526
hypermethylation O 1 0.9976361989974976
in O 0 0.015555663034319878
3 O 1 0.8280282616615295
tumors O 1 0.9999864101409912
- O 1 0.9913647174835205
were O 0 0.008000132627785206
not O 0 0.005778007674962282
detected O 0 0.011310907080769539
in O 0 0.007370184641331434
the O 0 0.014305206015706062
corresponding O 0 0.07705499976873398
peripheral O 1 0.9998252987861633
blood O 1 0.9956574440002441
DNA O 0 0.057269804179668427
. O 0 0.04210276156663895

In O 0 0.027674829587340355
6 O 0 0.03230007737874985
( O 0 0.020238805562257767
17 O 0 0.017932327464222908
% O 0 0.010555054992437363
) O 0 0.007790297269821167
of O 0 0.0075165401212871075
the O 0 0.01020977646112442
36 O 0 0.021216802299022675
patients O 1 0.5069685578346252
, O 0 0.00941593386232853
a O 0 0.012909749522805214
mutation O 0 0.05546480789780617
was O 0 0.013399189338088036
detected O 0 0.009564566425979137
in O 0 0.005533571820706129
constitutional O 0 0.010907527059316635
DNA O 0 0.008898346684873104
, O 0 0.005709370598196983
and O 0 0.005528745707124472
1 O 0 0.007797023747116327
of O 0 0.00668369559571147
these O 0 0.005661271512508392
mutations O 0 0.012227469123899937
is O 0 0.006991714239120483
known O 0 0.009022164158523083
to O 0 0.006791243329644203
be O 0 0.0068786186166107655
associated O 0 0.010722498409450054
with O 0 0.014044584706425667
reduced O 0 0.040892310440540314
expressivity O 1 0.9948050379753113
. O 0 0.046429943293333054

The O 0 0.028463803231716156
presence O 0 0.02191896177828312
of O 0 0.01430843397974968
a O 0 0.018792061135172844
constitutional O 0 0.19742703437805176
mutation O 1 0.5823649168014526
was O 0 0.025381911545991898
not O 0 0.006702070124447346
associated O 0 0.00723281130194664
with O 0 0.006640348117798567
an O 0 0.00950752105563879
early O 0 0.017959734424948692
age O 0 0.2523481845855713
at O 0 0.2923315167427063
treatment O 1 0.9982218146324158
. O 0 0.0405687540769577

In O 0 0.030340399593114853
1 O 0 0.03939279541373253
patient O 1 0.9852603673934937
, O 0 0.04939624294638634
somatic O 1 0.9981127977371216
mosaicism O 1 0.9998175501823425
was O 0 0.041147470474243164
demonstrated O 0 0.017177503556013107
by O 0 0.009778408333659172
molecular O 0 0.011164335533976555
analysis O 0 0.006603060755878687
of O 0 0.009162148460745811
DNA O 0 0.013594784773886204
and O 0 0.012753254733979702
RNA O 0 0.032136861234903336
from O 0 0.024404771625995636
peripheral O 1 0.994767427444458
blood O 1 0.824073076248169
. O 0 0.048036377876996994

In O 0 0.031317636370658875
2 O 0 0.032424457371234894
patients O 0 0.03568905219435692
without O 0 0.01408740971237421
a O 0 0.02044336497783661
detectable O 1 0.9390929937362671
mutation O 0 0.20117998123168945
in O 0 0.02070053480565548
peripheral O 1 0.9999297857284546
blood O 1 0.9982172846794128
, O 0 0.18481086194515228
mosaicism O 1 0.9996696710586548
was O 0 0.02320091240108013
suggested O 0 0.009710016660392284
because O 0 0.006001660600304604
1 O 0 0.008269756101071835
of O 0 0.008061141707003117
the O 0 0.020181730389595032
patients O 1 0.9994075298309326
showed O 1 0.9988603591918945
multifocal O 1 1.0
tumors B-Disease 1 0.9999982118606567
and O 0 0.031499721109867096
the O 0 0.018617156893014908
other O 0 0.010491546243429184
later O 0 0.019056690856814384
developed O 0 0.03923461213707924
bilateral B-Disease 1 0.9529100060462952
retinoblastoma I-Disease 1 0.9999737739562988
. O 0 0.06351117044687271

In O 0 0.029797442257404327
conclusion O 0 0.028236420825123787
, O 0 0.015784885734319687
our O 0 0.014342941343784332
results O 0 0.009484459646046162
emphasize O 0 0.01694127544760704
that O 0 0.007174469996243715
the O 0 0.01274070143699646
manifestation O 1 0.9982327222824097
and O 0 0.059812821447849274
transmissibility O 1 0.9999239444732666
of O 1 0.6827662587165833
retinoblastoma B-Disease 1 0.9999696016311646
depend O 0 0.011902553960680962
on O 0 0.007495624478906393
the O 0 0.007119308691471815
nature O 0 0.007380029186606407
of O 0 0.0066932570189237595
the O 0 0.008453737013041973
first O 0 0.012913900427520275
mutation O 0 0.013644609600305557
, O 0 0.0051859235391020775
its O 0 0.004560176748782396
time O 0 0.005228906404227018
in O 0 0.0050455741584300995
development O 0 0.007870988920331001
, O 0 0.006094519980251789
and O 0 0.005458966828882694
the O 0 0.006118581164628267
number O 0 0.006315381731837988
and O 0 0.0067517394199967384
types O 0 0.008993457071483135
of O 0 0.013702694326639175
cells O 0 0.02652178332209587
that O 0 0.0076597463339567184
are O 0 0.007513012737035751
affected O 0 0.01850631646811962
. O 0 0.017157994210720062
. O 0 0.027924468740820885

Hereditary B-Disease 1 0.9999891519546509
deficiency I-Disease 1 0.999997615814209
of I-Disease 1 0.724564254283905
the I-Disease 1 0.9828883409500122
fifth I-Disease 1 0.9999580383300781
component I-Disease 1 0.9979908466339111
of I-Disease 0 0.3662710189819336
complement I-Disease 1 0.9035868048667908
in O 0 0.02550019882619381
man O 1 0.5242235064506531
. O 0 0.0359671413898468

I O 0 0.1838802695274353
. O 0 0.09074118733406067

Clinical O 1 0.9839615821838379
, O 0 0.15969045460224152
immunochemical O 1 0.9992243051528931
, O 0 0.03063061647117138
and O 0 0.024470696225762367
family O 0 0.06621977686882019
studies O 0 0.030737536028027534
. O 0 0.034004922956228256

The O 0 0.030011119320988655
first O 0 0.024647993966937065
recognized O 0 0.027346909046173096
human O 0 0.03705713525414467
kindred O 1 0.9999227523803711
with O 1 0.983826220035553
hereditary B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
of I-Disease 1 0.9924888610839844
the I-Disease 1 0.9969155788421631
fifth I-Disease 1 0.9999306201934814
component I-Disease 1 0.9927361011505127
of I-Disease 1 0.8397307395935059
complement I-Disease 1 0.9996811151504517
( O 1 0.9963716268539429
C5 O 1 0.9999711513519287
) O 0 0.02328641340136528
is O 0 0.018260354176163673
described O 0 0.03265563026070595
. O 0 0.03240836411714554

The O 0 0.043499067425727844
proband O 0 0.3276325762271881
, O 0 0.016856210306286812
a O 0 0.015112875029444695
20 O 0 0.015494151972234249
- O 1 0.6679809093475342
year O 0 0.013136327266693115
- O 1 0.9740638732910156
old O 1 0.5709841847419739
black O 1 0.9012759923934937
female O 1 0.996961772441864
with O 1 0.9999105930328369
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9994924068450928
age O 1 0.9987081289291382
11 O 0 0.4613233506679535
, O 0 0.16173195838928223
lacked O 1 0.9957975149154663
serum O 1 0.9999960660934448
hemolytic O 1 0.9999998807907104
complement O 1 0.9977301955223083
activity O 0 0.07741452008485794
, O 0 0.02030906267464161
even O 0 0.018692621961236
during O 0 0.046072132885456085
remission O 1 0.9994124174118042
. O 0 0.05321399122476578

C5 O 1 0.9977909326553345
was O 0 0.08135227859020233
undetectable O 1 0.9689663052558899
in O 0 0.022721929475665092
her O 0 0.18628980219364166
serum O 1 0.9864176511764526
by O 0 0.01874893344938755
both O 0 0.028019098564982414
immunodiffusion O 1 0.9999123811721802
and O 1 0.9393142461776733
hemolytic O 1 0.9999997615814209
assays O 1 0.911579430103302
. O 0 0.05097685009241104

Other O 0 0.024659045040607452
complement O 0 0.03850238025188446
components O 0 0.018404407426714897
were O 0 0.008823699317872524
normal O 0 0.01418518926948309
during O 0 0.022253749892115593
remission O 1 0.9999706745147705
of O 1 0.9980021119117737
lupus O 1 1.0
, O 1 0.8701516389846802
but O 0 0.2579596936702728
C1 O 1 0.9999971389770508
, O 0 0.4323505759239197
C4 O 1 0.9998857975006104
, O 0 0.08760064840316772
C2 O 1 0.9999326467514038
, O 0 0.020916247740387917
and O 0 0.03360328823328018
C3 O 1 0.9999510049819946
levels O 0 0.0428282730281353
fell O 0 0.3899933695793152
during O 0 0.18663065135478973
exacerbations O 1 0.9998871088027954
. O 0 0.06503639370203018

A O 0 0.04432641342282295
younger O 0 0.05777375027537346
half O 0 0.031989067792892456
- O 1 0.9994982481002808
sister O 1 0.86318439245224
, O 0 0.012760087847709656
who O 0 0.01467620488256216
had O 0 0.017528975382447243
no O 0 0.21005186438560486
underlying O 1 0.9998713731765747
disease O 1 0.999996542930603
, O 0 0.2302725464105606
was O 0 0.1348487138748169
also O 0 0.008802875876426697
found O 0 0.00840616226196289
to O 0 0.012969178147614002
lack O 0 0.11319802701473236
immunochemically O 1 0.9997755885124207
detectable O 1 0.9991199374198914
C5 O 1 0.9997298121452332
. O 0 0.04770614206790924

By O 0 0.08105930685997009
hemolytic O 1 0.9999982118606567
assay O 1 0.975798487663269
, O 0 0.024375833570957184
she O 0 0.02185242809355259
exhibited O 0 0.0989885926246643
1 O 0 0.020044157281517982
- O 0 0.2569172978401184
2 O 0 0.011432104744017124
% O 0 0.006950791925191879
of O 0 0.008045587688684464
the O 0 0.012903353199362755
normal O 0 0.11069391667842865
serum O 1 0.9998929500579834
C5 O 1 0.9997621178627014
level O 0 0.021082011982798576
and O 0 0.013439206406474113
normal O 0 0.017292363569140434
concentrations O 0 0.02137281745672226
of O 0 0.014110169373452663
other O 0 0.013822370208799839
complement O 0 0.05670478940010071
components O 0 0.03921017423272133
. O 0 0.03547513857483864

C5 O 1 0.9962393045425415
levels O 0 0.02488710731267929
of O 0 0.014228744432330132
other O 0 0.008956415578722954
family O 0 0.014239462092518806
members O 0 0.009101033210754395
were O 0 0.006187701132148504
either O 0 0.006318015977740288
normal O 0 0.008123832754790783
or O 0 0.006160201504826546
approximately O 0 0.007923625409603119
half O 0 0.01261237170547247
- O 1 0.8802083134651184
normal O 0 0.013501862995326519
, O 0 0.009924174286425114
consistent O 0 0.015912536531686783
with O 0 0.014725997112691402
autosomal O 1 0.9950992465019226
codominant O 1 0.9989476799964905
inheritance O 1 0.8561199903488159
of O 0 0.08011043816804886
the O 1 0.8664072751998901
gene O 1 0.9669139385223389
determining O 1 0.9924545288085938
C5 B-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999996423721313
. O 0 0.26686227321624756

Normal O 1 0.9545032382011414
hemolytic O 1 0.999997615814209
titers O 1 0.9977116584777832
were O 0 0.02007746510207653
restored O 0 0.030176395550370216
to O 0 0.012056277133524418
both O 0 0.013161112554371357
homozygous O 1 0.9707909226417542
C5 B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999934434890747
deficient I-Disease 1 0.999990701675415
( O 1 0.8470736145973206
C5D B-Disease 1 0.9999691247940063
) O 0 0.022100601345300674
sera O 1 0.6751850843429565
by O 0 0.011350605636835098
addition O 0 0.013347841799259186
of O 0 0.01701737754046917
highly O 0 0.1663740873336792
purified O 1 0.9926962852478027
human O 0 0.27518171072006226
C5 O 1 0.9996028542518616
. O 0 0.0567391961812973

In O 0 0.0363805778324604
specific O 0 0.03691374510526657
C5 O 1 0.9999023675918579
titrations O 1 0.9890677332878113
, O 0 0.018268031999468803
however O 0 0.010731921531260014
, O 0 0.009126033633947372
it O 0 0.0059816231951117516
was O 0 0.010137022472918034
noted O 0 0.007672385312616825
that O 0 0.0046051545068621635
when O 0 0.00632952805608511
limited O 0 0.007721141912043095
amounts O 0 0.007976613938808441
of O 0 0.012840970419347286
C5 O 1 0.999024510383606
were O 0 0.010579908266663551
assayed O 0 0.02291710302233696
in O 0 0.007106864359229803
the O 0 0.008612925186753273
presence O 0 0.011650699190795422
of O 0 0.011244974099099636
low O 0 0.026489926502108574
dilutions O 1 0.9689140915870667
of O 0 0.025598883628845215
either O 0 0.18729154765605927
C5D B-Disease 1 0.9999970197677612
serum O 1 0.9992413520812988
, O 0 0.01776517555117607
curving O 0 0.05616256594657898
rather O 0 0.009078286588191986
than O 0 0.008028170093894005
linear O 0 0.02369234338402748
dose O 1 0.9920116066932678
- O 1 0.9980599284172058
response O 0 0.01795673929154873
plots O 0 0.015616314485669136
were O 0 0.00869344174861908
consistently O 0 0.015635691583156586
obtained O 0 0.011338476091623306
, O 0 0.011905599385499954
suggesting O 0 0.016682567074894905
some O 0 0.013019349426031113
inhibitory O 0 0.050408296287059784
effect O 0 0.03158799931406975
. O 0 0.035758838057518005

Further O 0 0.0342094860970974
studies O 0 0.019133228808641434
suggested O 0 0.016715185716748238
that O 0 0.010045195929706097
low O 0 0.022827256470918655
dilutions O 1 0.912259042263031
of O 0 0.23170506954193115
C5D B-Disease 1 0.9999985694885254
serum O 1 0.9999163150787354
contain O 0 0.027165967971086502
a O 0 0.1454310566186905
factor O 1 0.8586652278900146
( O 0 0.0290494654327631
or O 0 0.009756695479154587
factors O 0 0.009278111159801483
) O 0 0.00888779666274786
interfering O 0 0.012994044460356236
at O 0 0.0076084500178694725
some O 0 0.004570688586682081
step O 0 0.01042454969137907
in O 0 0.008105414919555187
the O 0 0.023522548377513885
hemolytic O 1 0.9999996423721313
assay O 1 0.9929506778717041
of O 1 0.584208607673645
C5 O 1 0.9999421834945679
, O 0 0.012219488620758057
rather O 0 0.008210237137973309
than O 0 0.006711211521178484
a O 0 0.01673191785812378
true O 0 0.4087701141834259
C5 O 1 0.9999805688858032
inhibitor O 1 0.9997639060020447
or O 0 0.04311201721429825
inactivator O 1 0.9742592573165894
. O 0 0.04952602460980415

Of O 0 0.044876907020807266
clinical O 1 0.8563360571861267
interest O 0 0.017445312812924385
are O 0 0.007294276263564825
( O 0 0.011248484253883362
a O 0 0.009349550120532513
) O 0 0.008365179412066936
the O 0 0.008857589215040207
documentation O 0 0.020853562280535698
of O 0 0.36627197265625
membranous O 1 0.9999998807907104
glomerulonephritis B-Disease 1 1.0
, O 1 0.9998825788497925
vasculitis B-Disease 1 1.0
, O 1 0.9980588555335999
and O 1 0.9984429478645325
arthritis B-Disease 1 1.0
in O 0 0.26553213596343994
an O 1 0.6032796502113342
individual O 1 0.5664812922477722
lacking O 1 0.9994077682495117
C5 O 1 0.9999924898147583
( O 0 0.017949039116501808
and O 0 0.008152330294251442
its O 0 0.010407754220068455
biologic O 1 0.9711651802062988
functions O 0 0.010654570534825325
) O 0 0.008889124728739262
, O 0 0.007916020229458809
and O 0 0.009225941263139248
( O 0 0.017053261399269104
b O 0 0.08368165791034698
) O 0 0.008742453530430794
a O 0 0.010258619673550129
remarkable O 0 0.019848454743623734
propensity O 1 0.9718843698501587
to O 0 0.09337194263935089
bacterial B-Disease 1 0.9999954700469971
infections I-Disease 1 0.9999980926513672
in O 0 0.12126000970602036
the O 1 0.9290867447853088
proband O 1 0.9999434947967529
, O 0 0.012109189294278622
even O 0 0.007018116302788258
during O 0 0.008773102425038815
periods O 0 0.012569030746817589
of O 0 0.013812839984893799
low O 1 0.7701241970062256
- O 1 0.9989244341850281
dose O 1 0.7908312678337097
or O 0 0.016202164813876152
alternate O 0 0.03487331047654152
- O 1 0.9984574317932129
day O 1 0.5349064469337463
corticosteroid O 1 0.9998553991317749
therapy O 1 0.9935821890830994
. O 0 0.04993005469441414

Other O 0 0.020936470478773117
observations O 0 0.01928914524614811
indicate O 0 0.011810543946921825
that O 0 0.006301607936620712
the O 0 0.011075492948293686
C5D B-Disease 1 0.9993075132369995
state O 0 0.008538838475942612
is O 0 0.00941778440028429
compatible O 0 0.020038200542330742
with O 0 0.012866546399891376
normal O 0 0.3789975345134735
coagulation O 1 0.9998780488967896
function O 0 0.014209508895874023
and O 0 0.009065153077244759
the O 0 0.011136963963508606
capacity O 0 0.015008507296442986
to O 0 0.013766628690063953
mount O 1 0.6242672204971313
a O 0 0.26294252276420593
neutrophilic O 1 0.9999932050704956
leukocytosis O 1 0.9999961853027344
during O 1 0.9996305704116821
pyogenic B-Disease 1 0.999998927116394
infection I-Disease 1 0.9999973773956299
. O 0 0.07579300552606583
. O 0 0.04826643317937851

Susceptibility O 1 0.9980069994926453
to O 1 0.8543858528137207
ankylosing B-Disease 1 0.9999998807907104
spondylitis I-Disease 1 1.0
in O 1 0.5325613617897034
twins O 1 0.9948946237564087
: O 0 0.01652640290558338
the O 0 0.01060833316296339
role O 0 0.01590615324676037
of O 0 0.017680667340755463
genes O 0 0.047067414969205856
, O 1 0.6012613773345947
HLA O 1 0.9999988079071045
, O 0 0.019057057797908783
and O 0 0.014523017220199108
the O 0 0.021689465269446373
environment O 0 0.033554743975400925
. O 0 0.0304388590157032

OBJECTIVE O 0 0.06146828830242157
To O 0 0.02015813998878002
determine O 0 0.013980784453451633
the O 0 0.014286485500633717
relative O 0 0.020526759326457977
effects O 0 0.019291292876005173
of O 0 0.015567000024020672
genetic O 0 0.0545901320874691
and O 0 0.013519857078790665
environmental O 0 0.08530580997467041
factors O 0 0.014721957966685295
in O 0 0.015006541274487972
susceptibility O 1 0.9999231100082397
to O 1 0.9985778331756592
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999470710754395
AS B-Disease 1 0.9988295435905457
) O 0 0.04421007260680199
. O 0 0.03579923138022423

METHODS O 0 0.04792589321732521
Twins O 0 0.1433558315038681
with O 0 0.01514569390565157
AS B-Disease 0 0.01900777406990528
were O 0 0.007758494932204485
identified O 0 0.007880248129367828
from O 0 0.0059280842542648315
the O 0 0.010091467760503292
Royal O 1 0.8001569509506226
National O 1 0.992520809173584
Hospital O 1 0.9999985694885254
for O 1 0.9998605251312256
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9991381168365479
. O 0 0.15500286221504211

Clinical O 1 0.9306259155273438
and O 0 0.044398147612810135
radiographic O 1 0.9945916533470154
examinations O 0 0.21651537716388702
were O 0 0.01288375724107027
performed O 0 0.01870388351380825
to O 0 0.01272185705602169
establish O 0 0.26738491654396057
diagnoses O 1 0.9999499320983887
, O 1 0.6559323072433472
and O 1 0.976646363735199
disease O 1 0.9999995231628418
severity O 1 0.9999830722808838
was O 1 0.9887142777442932
assessed O 0 0.036593496799468994
using O 0 0.009905028156936169
a O 0 0.013350662775337696
combination O 0 0.020294249057769775
of O 0 0.017965080216526985
validated O 0 0.05037928372621536
scoring O 0 0.03753673657774925
systems O 0 0.0433998741209507
. O 0 0.035644277930259705

HLA O 1 0.999502420425415
typing O 0 0.16951604187488556
for O 0 0.05276564508676529
HLA O 1 0.9999927282333374
- O 1 0.9993540644645691
B27 O 1 0.9908410310745239
, O 0 0.0693158507347107
HLA O 1 0.999990701675415
- O 1 0.9974983334541321
B60 O 1 0.8724595904350281
, O 0 0.016720455139875412
and O 0 0.025253169238567352
HLA O 1 0.9999979734420776
- O 1 0.9998766183853149
DR1 O 1 0.9992656111717224
was O 0 0.020190246403217316
performed O 0 0.017094722017645836
by O 0 0.012072929181158543
polymerase O 0 0.0536649189889431
chain O 0 0.02236837148666382
reaction O 0 0.013401130214333534
with O 0 0.009731080383062363
sequence O 0 0.013390474021434784
- O 0 0.47459331154823303
specific O 0 0.011013503186404705
primers O 0 0.03464331105351448
, O 0 0.013397801667451859
and O 0 0.015015623532235622
zygosity O 1 0.9514305591583252
was O 0 0.03368915989995003
assessed O 0 0.03793877735733986
using O 0 0.028007077053189278
microsatellite O 0 0.2217155247926712
markers O 0 0.07244840264320374
. O 0 0.043769270181655884

Genetic O 0 0.05493709072470665
and O 0 0.024225760251283646
environmental O 0 0.03004392422735691
variance O 0 0.022276131436228752
components O 0 0.015054629184305668
were O 0 0.007764818612486124
assessed O 0 0.011350316926836967
with O 0 0.007689204532653093
the O 0 0.013722235336899757
program O 0 0.333516001701355
Mx O 1 0.9978812336921692
, O 0 0.008725074119865894
using O 0 0.005778183229267597
data O 0 0.004872594028711319
from O 0 0.0051797423511743546
this O 0 0.004692395683377981
and O 0 0.006291127298027277
previous O 0 0.010013825260102749
studies O 0 0.00998641736805439
of O 0 0.013960528187453747
twins O 1 0.9688670635223389
with O 0 0.030632780864834785
AS B-Disease 1 0.8175804615020752
. O 0 0.038560040295124054

RESULTS O 0 0.025871308520436287
Six O 0 0.018457088619470596
of O 0 0.017802562564611435
8 O 0 0.04017585515975952
monozygotic O 1 0.9983750581741333
( O 1 0.8694148063659668
MZ O 1 0.9999918937683105
) O 0 0.03302496671676636
twin O 1 0.7814653515815735
pairs O 0 0.026433410122990608
were O 0 0.01976519264280796
disease O 1 0.9997329115867615
concordant O 1 0.9893476963043213
, O 0 0.013838181272149086
compared O 0 0.010463851504027843
with O 0 0.007223600056022406
4 O 0 0.010193893685936928
of O 0 0.009187293238937855
15 O 0 0.016592679545283318
B27 O 1 0.9847479462623596
- O 1 0.9601387977600098
positive O 0 0.0254257470369339
dizygotic O 1 0.9977317452430725
( O 0 0.29210352897644043
DZ O 1 0.9999351501464844
) O 0 0.021488364785909653
twin O 0 0.21739919483661652
pairs O 0 0.016379645094275475
( O 0 0.012494564056396484
27 O 0 0.013851580210030079
% O 0 0.009082396514713764
) O 0 0.0072535076178610325
and O 0 0.005766240879893303
4 O 0 0.010014682076871395
of O 0 0.010402028448879719
32 O 0 0.033049143850803375
DZ O 1 0.9999115467071533
twin O 1 0.9315328598022461
pairs O 0 0.019539471715688705
overall O 0 0.04201909527182579
( O 0 0.016689162701368332
12 O 0 0.015447881072759628
. O 0 0.011376828886568546
5 O 0 0.018782896921038628
% O 0 0.018717098981142044
) O 0 0.024790529161691666
. O 0 0.02883732132613659

Nonsignificant O 1 0.9262802600860596
increases O 0 0.03557579591870308
in O 0 0.014964352361857891
similarity O 0 0.015764646232128143
with O 0 0.009160646237432957
regard O 0 0.01490786112844944
to O 0 0.010545830242335796
age O 1 0.9281979203224182
at O 1 0.9982306361198425
disease O 1 0.9999995231628418
onset O 1 0.9999978542327881
and O 0 0.04987085610628128
all O 0 0.010235696099698544
of O 0 0.44407975673675537
the O 1 0.9992081522941589
disease O 1 0.9999997615814209
severity O 1 0.9999421834945679
scores O 0 0.06986269354820251
assessed O 0 0.01691066473722458
were O 0 0.008054673671722412
noted O 0 0.011600959114730358
in O 0 0.013907680287957191
disease O 1 0.9999794960021973
- O 1 0.9999833106994629
concordant O 1 0.9999301433563232
MZ O 1 0.9999945163726807
twins O 1 0.9088438749313354
compared O 0 0.031038304790854454
with O 0 0.033372145146131516
concordant O 1 0.9986380934715271
DZ O 1 0.9999657869338989
twins O 1 0.978882372379303
. O 0 0.06324727088212967

HLA O 1 0.9999791383743286
- O 1 0.9994433522224426
B27 O 1 0.9813071489334106
and O 0 0.02423880621790886
B60 O 0 0.47893568873405457
were O 0 0.011150762438774109
associated O 0 0.010988031513988972
with O 0 0.010561714880168438
the O 0 0.14763352274894714
disease O 1 0.9999840259552002
in O 0 0.12704065442085266
probands O 1 0.9999287128448486
, O 0 0.011569289490580559
and O 0 0.007287435233592987
the O 0 0.009156950749456882
rate O 0 0.013728653080761433
of O 0 0.12516102194786072
disease O 1 0.9999880790710449
concordance O 1 0.9978892207145691
was O 0 0.04870258644223213
significantly O 0 0.013047178275883198
increased O 0 0.013485176488757133
among O 0 0.050834912806749344
DZ O 1 0.9999938011169434
twin O 1 0.8445814847946167
pairs O 0 0.012012001127004623
in O 0 0.006600458640605211
which O 0 0.006451508961617947
the O 0 0.012258335016667843
co O 1 0.9974802136421204
- O 1 0.9997753500938416
twin O 1 0.9575502276420593
was O 0 0.02210979163646698
positive O 0 0.014360511675477028
for O 0 0.011415540240705013
both O 0 0.016580980271100998
B27 O 1 0.9892416596412659
and O 0 0.0428764633834362
DR1 O 1 0.9966687560081482
. O 0 0.05038554221391678

Additive O 1 0.8484400510787964
genetic O 0 0.05080302432179451
effects O 0 0.02927338518202305
were O 0 0.011702409014105797
estimated O 0 0.01340418215841055
to O 0 0.01107314694672823
contribute O 0 0.0183419119566679
97 O 0 0.02731691673398018
% O 0 0.012247913517057896
of O 0 0.011871514841914177
the O 0 0.01685020513832569
population O 0 0.01920802891254425
variance O 0 0.03823487088084221
. O 0 0.03428894281387329

CONCLUSION O 0 0.08884359896183014
Susceptibility O 1 0.8223258852958679
to O 0 0.016939034685492516
AS B-Disease 0 0.07458999752998352
is O 0 0.0100185452029109
largely O 0 0.012262198142707348
genetically O 0 0.011343779973685741
determined O 0 0.010258749127388
, O 0 0.007657564710825682
and O 0 0.007277872413396835
the O 0 0.010647711344063282
environmental O 0 0.1137588769197464
trigger O 1 0.544923722743988
for O 0 0.014550224877893925
the O 1 0.8499788641929626
disease O 1 0.9999873638153076
is O 0 0.19412638247013092
probably O 0 0.06744279712438583
ubiquitous O 1 0.7190971374511719
. O 0 0.03494906798005104

HLA O 1 0.9999884366989136
- O 1 0.9978607296943665
B27 O 1 0.6355000138282776
accounts O 0 0.021183595061302185
for O 0 0.011565526947379112
a O 0 0.013444323092699051
minority O 0 0.01911161281168461
of O 0 0.015349161811172962
the O 0 0.03553633764386177
overall O 1 0.9954348206520081
genetic O 1 0.9798523187637329
susceptibility O 1 0.9993571639060974
to O 0 0.0287126824259758
AS B-Disease 0 0.3726802468299866
. O 0 0.03496547043323517

Cell O 0 0.25616422295570374
cycle O 0 0.12634898722171783
- O 1 0.9177135825157166
dependent O 0 0.03490346670150757
colocalization O 1 0.6544188857078552
of O 0 0.03249911218881607
BARD1 O 1 0.9999165534973145
and O 0 0.37739869952201843
BRCA1 O 1 0.9995591044425964
proteins O 0 0.020472809672355652
in O 0 0.014900637790560722
discrete O 0 0.029990728944540024
nuclear O 0 0.04114602506160736
domains O 0 0.05064528062939644
. O 0 0.039724621921777725

Germ O 1 0.999607264995575
- O 1 0.997605562210083
line O 0 0.035750776529312134
mutations O 0 0.0195706058293581
of O 0 0.014526237733662128
the O 0 0.06477352231740952
BRCA1 O 1 0.9997391104698181
gene O 0 0.02359471097588539
predispose O 0 0.11860472708940506
women O 0 0.01448381319642067
to O 0 0.01182581391185522
early O 0 0.28706789016723633
- O 1 0.9999980926513672
onset O 1 0.9999998807907104
breast B-Disease 1 1.0
and I-Disease 1 0.9999819993972778
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
by O 0 0.33175185322761536
compromising O 1 0.9978042244911194
the O 0 0.14502108097076416
genes O 0 0.02750726416707039
presumptive O 1 0.9996488094329834
function O 0 0.022508295252919197
as O 0 0.019508428871631622
a O 1 0.8748304843902588
tumor B-Disease 1 0.9999805688858032
suppressor O 1 0.9996306896209717
. O 0 0.052264194935560226

Although O 0 0.027880031615495682
the O 0 0.023533089086413383
biochemical O 0 0.03749704360961914
properties O 0 0.020866846665740013
of O 0 0.06592760980129242
BRCA1 O 1 0.9999325275421143
polypeptides O 0 0.17820870876312256
are O 0 0.0076744467951357365
not O 0 0.006813530810177326
understood O 0 0.011240871623158455
, O 0 0.008244464173913002
their O 0 0.007816976867616177
expression O 0 0.014903297647833824
pattern O 0 0.018679842352867126
and O 0 0.013576459139585495
subcellular O 0 0.04783274605870247
localization O 0 0.02958839014172554
suggest O 0 0.011575338430702686
a O 0 0.010998835787177086
role O 0 0.018308795988559723
in O 0 0.016200415790081024
cell O 1 0.8830232620239258
- O 1 0.998778760433197
cycle O 0 0.07737851142883301
regulation O 0 0.041911229491233826
. O 0 0.03600246086716652

When O 0 0.062003184109926224
resting O 1 0.9975335597991943
cells O 0 0.043083738535642624
are O 0 0.012902691960334778
induced O 1 0.7011976838111877
to O 0 0.013911533169448376
proliferate O 0 0.053155068308115005
, O 0 0.009992471896111965
the O 0 0.011152276769280434
steady O 0 0.08462002128362656
- O 1 0.6422879099845886
state O 0 0.007790175266563892
levels O 0 0.009950144216418266
of O 0 0.01108983252197504
BRCA1 O 1 0.8882135152816772
increase O 0 0.010026109404861927
in O 0 0.009935377165675163
late O 0 0.050066132098436356
G1 O 1 0.9972896575927734
and O 0 0.011382750235497952
reach O 0 0.01597479358315468
a O 0 0.015547589398920536
maximum O 0 0.024269400164484978
during O 0 0.03370508924126625
S O 1 0.9912624359130859
phase O 0 0.25071096420288086
. O 0 0.04407115280628204

Moreover O 0 0.04648002237081528
, O 0 0.022314859554171562
in O 0 0.019059594720602036
S O 1 0.98886638879776
phase O 1 0.9045961499214172
cells O 0 0.044384900480508804
, O 0 0.024870669469237328
BRCA1 O 1 0.9787686467170715
polypeptides O 0 0.04433433711528778
are O 0 0.01204914040863514
hyperphosphorylated O 0 0.16594862937927246
and O 0 0.01566266268491745
accumulate O 0 0.027218705043196678
into O 0 0.015007316134870052
discrete O 0 0.02984200231730938
subnuclear O 1 0.885405421257019
foci O 1 0.9805757403373718
termed O 1 0.9112787842750549
" O 0 0.4266951084136963
BRCA1 O 1 0.9954460859298706
nuclear O 0 0.08304024487733841
dots O 0 0.08554574847221375
. O 0 0.04385284334421158

" O 0 0.15851041674613953
BRCA1 O 1 0.9929521679878235
associates O 0 0.1270110160112381
in O 0 0.018836181610822678
vivo O 0 0.05537296086549759
with O 0 0.016950583085417747
a O 0 0.029382985085248947
structurally O 1 0.5826224684715271
related O 0 0.03329581767320633
protein O 0 0.037372540682554245
termed O 0 0.46760454773902893
BARD1 O 1 0.9975712895393372
. O 0 0.05570954829454422

Here O 0 0.029993608593940735
we O 0 0.015058604069054127
show O 0 0.01292912382632494
that O 0 0.006681922823190689
the O 0 0.01058134064078331
steady O 0 0.028531379997730255
- O 0 0.32115310430526733
state O 0 0.009166299365460873
levels O 0 0.011123108677566051
of O 0 0.012046785093843937
BARD1 O 1 0.9989573955535889
, O 0 0.012180276215076447
unlike O 0 0.01130147185176611
those O 0 0.007936093956232071
of O 0 0.01596316695213318
BRCA1 O 1 0.9996813535690308
, O 0 0.015149128623306751
remain O 0 0.018572773784399033
relatively O 0 0.013864626176655293
constant O 0 0.03293473273515701
during O 0 0.17887794971466064
cell O 1 0.9488200545310974
cycle O 1 0.8732869029045105
progression O 1 0.9944962859153748
. O 0 0.049859777092933655

However O 0 0.038436345756053925
, O 0 0.03136417269706726
immunostaining O 1 0.6528686285018921
revealed O 0 0.029197776690125465
that O 0 0.01658625528216362
BARD1 O 1 0.9849613904953003
resides O 0 0.10555674135684967
within O 0 0.021952645853161812
BRCA1 O 1 0.9812720417976379
nuclear O 0 0.030277784913778305
dots O 0 0.03181745857000351
during O 0 0.019171029329299927
S O 1 0.9027803540229797
phase O 0 0.02428383380174637
of O 0 0.01255597174167633
the O 0 0.031173493713140488
cell O 1 0.8438363671302795
cycle O 0 0.04724960774183273
, O 0 0.010048440657556057
but O 0 0.006805442739278078
not O 0 0.007238336373120546
during O 0 0.015551559627056122
the O 0 0.030189864337444305
G1 O 1 0.9992501139640808
phase O 0 0.35473206639289856
. O 0 0.04514264687895775

Nevertheless O 0 0.07677149027585983
, O 0 0.042059265077114105
BARD1 O 1 0.9977474808692932
polypeptides O 0 0.05804150924086571
are O 0 0.010055586695671082
found O 0 0.010030560195446014
exclusively O 0 0.011467893607914448
in O 0 0.007307643536478281
the O 0 0.009976239874958992
nuclear O 0 0.015125706791877747
fractions O 0 0.015094934962689877
of O 0 0.012381253764033318
both O 0 0.015044515021145344
G1 O 1 0.9996223449707031
- O 1 0.9966018199920654
and O 0 0.03385474905371666
S O 1 0.9997058510780334
- O 1 0.999583899974823
phase O 1 0.9013339877128601
cells O 0 0.044552285224199295
. O 0 0.03453324735164642

Therefore O 0 0.04034977778792381
, O 0 0.028945324942469597
progression O 1 0.7887929677963257
to O 0 0.023940008133649826
S O 1 0.997933030128479
phase O 0 0.17625080049037933
is O 0 0.01271655224263668
accompanied O 0 0.02199043519794941
by O 0 0.010473296046257019
the O 0 0.012082920409739017
aggregation O 0 0.023825909942388535
of O 0 0.01723817177116871
nuclear O 0 0.04311579838395119
BARD1 O 1 0.9984885454177856
polypeptides O 0 0.0725187137722969
into O 0 0.03314740210771561
BRCA1 O 1 0.978670060634613
nuclear O 0 0.060242198407649994
dots O 0 0.07473574578762054
. O 0 0.04384646192193031

This O 0 0.031802356243133545
cell O 0 0.04727483168244362
cycle O 0 0.052974216639995575
- O 1 0.824702799320221
dependent O 0 0.028545770794153214
colocalization O 1 0.8498876690864563
of O 0 0.034064728766679764
BARD1 O 1 0.9999462366104126
and O 0 0.07624272257089615
BRCA1 O 1 0.9993483424186707
indicates O 0 0.020363502204418182
a O 0 0.012666971422731876
role O 0 0.0176094938069582
for O 0 0.01465851441025734
BARD1 O 1 0.9986855387687683
in O 0 0.030621442943811417
BRCA1 O 1 0.9999589920043945
- O 1 0.9999874830245972
mediated O 1 0.9998433589935303
tumor B-Disease 1 0.9999872446060181
suppression O 1 0.999907374382019
. O 0 0.07816999405622482

Ethnic O 0 0.053526829928159714
differences O 0 0.028689052909612656
in O 0 0.020030563697218895
the O 0 0.03320876881480217
HFE O 1 0.9999161958694458
codon O 1 0.9314709901809692
282 O 1 0.9907938838005066
( O 1 0.9411540031433105
Cys O 1 0.9999585151672363
/ O 1 0.9997182488441467
Tyr O 1 0.999649167060852
) O 0 0.05683667212724686
polymorphism O 0 0.08856509625911713
. O 0 0.04691527038812637

Recent O 0 0.031003719195723534
studies O 0 0.014939418993890285
have O 0 0.008749340660870075
shown O 0 0.013668877072632313
that O 0 0.017523573711514473
hereditary B-Disease 1 0.9999996423721313
hemochromatosis I-Disease 1 1.0
( O 1 0.9999996423721313
HH B-Disease 1 1.0
) O 1 0.6341643333435059
is O 0 0.011090449057519436
likely O 0 0.007686843629926443
to O 0 0.006185516715049744
be O 0 0.0056992182508111
caused O 0 0.011097365990281105
by O 0 0.01001660991460085
homozygosity O 1 0.690433919429779
for O 0 0.012172646820545197
a O 0 0.020676806569099426
Cys282Tyr O 1 0.9957270622253418
mutation O 0 0.02445516176521778
in O 0 0.011400558054447174
the O 0 0.022402996197342873
HFE O 1 0.9999110698699951
gene O 0 0.036917101591825485
located O 0 0.03476335108280182
4 O 0 0.037513863295316696
. O 0 0.035711489617824554

5 O 0 0.08211351186037064
Mb O 1 0.9897253513336182
telomeric O 1 0.9887978434562683
to O 0 0.10689522325992584
HLA O 1 0.9999967813491821
- O 1 0.9995023012161255
A O 0 0.4679127633571625
. O 0 0.051741208881139755

Population O 0 0.02930590696632862
studies O 0 0.016477297991514206
of O 0 0.012558217160403728
this O 0 0.010715734213590622
polymorphism O 0 0.04280634596943855
are O 0 0.00678016385063529
facilitated O 0 0.01869615726172924
by O 0 0.007387773599475622
the O 0 0.009359193034470081
fact O 0 0.008338231593370438
that O 0 0.006220236420631409
the O 0 0.014837440103292465
Cys282Tyr O 1 0.9980777502059937
mutation O 0 0.10702335089445114
creates O 0 0.03780040889978409
a O 0 0.03307700902223587
Rsal O 1 0.9947474598884583
restriction O 0 0.05914393439888954
site O 0 0.04442639276385307
. O 0 0.03532837703824043

We O 0 0.024854309856891632
have O 0 0.010791466571390629
studied O 0 0.01531726773828268
the O 0 0.017276180908083916
codon O 0 0.049058038741350174
282 O 0 0.457337886095047
( O 1 0.7496395707130432
Cys O 1 0.9999934434890747
/ O 1 0.9999531507492065
Tyr O 1 0.9998655319213867
) O 0 0.024929622188210487
polymorphism O 0 0.028448469936847687
in O 0 0.011680832132697105
different O 0 0.009482362307608128
ethnic O 0 0.022992029786109924
groups O 0 0.026716917753219604
. O 0 0.03318372368812561

In O 0 0.02514773979783058
agreement O 0 0.01834912970662117
with O 0 0.012144400738179684
previous O 0 0.016889257356524467
observations O 0 0.019789015874266624
the O 0 0.024710308760404587
Tyr O 1 0.9999585151672363
allele O 0 0.32533299922943115
appeared O 0 0.014849795959889889
to O 0 0.008660095743834972
be O 0 0.007077316287904978
rare O 0 0.011008008383214474
or O 0 0.009504001587629318
absent O 0 0.02403777465224266
in O 0 0.011439986526966095
Asiatic O 1 0.9985658526420593
( O 0 0.028125159442424774
Indian O 0 0.023284299299120903
, O 0 0.01585775427520275
Chinese O 0 0.026832185685634613
) O 0 0.021360037848353386
populations O 0 0.024509837850928307
. O 0 0.0299769788980484

The O 0 0.04027862474322319
highest O 0 0.0711321234703064
allele O 0 0.07025604695081711
frequency O 0 0.024278756231069565
( O 0 0.018134791404008865
7 O 0 0.017005087807774544
. O 0 0.009851056151092052
5 O 0 0.013830491341650486
% O 0 0.01322725135833025
) O 0 0.01085228193551302
was O 0 0.013937297277152538
found O 0 0.012455417774617672
in O 0 0.017354784533381462
Swedes O 0 0.06483616679906845
. O 0 0.03713309392333031

Saamis O 1 0.9717006087303162
( O 0 0.039990220218896866
2 O 0 0.025317423045635223
% O 0 0.017571743577718735
) O 0 0.013061118312180042
and O 0 0.012994974851608276
Mordvinians O 1 0.9720436930656433
( O 0 0.01677168533205986
1 O 0 0.013598738238215446
. O 0 0.008741000667214394
8 O 0 0.014880484901368618
% O 0 0.010931514203548431
) O 0 0.009331081062555313
had O 0 0.009307511150836945
significantly O 0 0.0105147585272789
lower O 0 0.013111400417983532
frequencies O 0 0.011950564570724964
of O 0 0.015336827374994755
the O 0 0.03150523081421852
Tyr O 1 0.9997751116752625
allele O 1 0.5746342539787292
. O 0 0.04653250426054001

Comparisons O 0 0.054299645125865936
with O 0 0.025133078917860985
allele O 0 0.04101916775107384
frequencies O 0 0.01545285526663065
based O 0 0.012629253789782524
on O 0 0.012108299881219864
prevalence O 1 0.5088725686073303
estimates O 0 0.0161990188062191
of O 0 0.03627775236964226
HH B-Disease 1 0.9999979734420776
showed O 0 0.021096428856253624
some O 0 0.008854181505739689
disagreements O 0 0.029471447691321373
with O 0 0.01216303650289774
the O 0 0.0215937327593565
RFLP O 1 0.9827466011047363
data O 0 0.013837022706866264
, O 0 0.014016404747962952
particularly O 0 0.018050676211714745
in O 0 0.019633473828434944
Finns O 0 0.09850093722343445
. O 0 0.04110070317983627

The O 0 0.04557434469461441
newly O 0 0.28804197907447815
described O 0 0.3125169575214386
HFE O 1 0.9999020099639893
marker O 1 0.8990383148193359
provides O 0 0.021540001034736633
a O 0 0.013195541687309742
new O 0 0.01030394621193409
approach O 0 0.00964492280036211
to O 0 0.0069914585910737514
the O 0 0.009309783577919006
screening O 0 0.2688809037208557
of O 0 0.4075014591217041
HH B-Disease 1 0.9999998807907104
as O 0 0.01356672402471304
well O 0 0.007301391568034887
as O 0 0.0058494508266448975
studies O 0 0.005424452014267445
of O 0 0.006358390208333731
the O 0 0.009346419014036655
relationship O 0 0.015660973265767097
between O 0 0.014663034118711948
the O 0 0.18225546181201935
HFE O 1 0.9999972581863403
Tyr O 1 0.9999899864196777
allele O 1 0.9076768755912781
and O 0 0.02773354947566986
different O 0 0.022526714950799942
disorders O 1 0.9999914169311523
including O 1 0.9804127812385559
cancer B-Disease 1 0.9999980926513672

Autosomal B-Disease 1 0.9998860359191895
dominant I-Disease 1 0.9999399185180664
neurohypophyseal I-Disease 1 0.9999994039535522
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999990463256836
associated O 0 0.20786118507385254
with O 0 0.019152821972966194
a O 0 0.026955774053931236
missense O 1 0.5025177597999573
mutation O 0 0.03481332212686539
encoding O 0 0.027833156287670135
Gly23 O 1 0.9952213168144226
- O 1 0.9997634291648865
- O 1 0.999784529209137
> O 1 0.98763507604599
Val O 1 0.9963223934173584
in O 0 0.03091481886804104
neurophysin O 1 0.9972845315933228
II O 1 0.9995699524879456
. O 0 0.056640349328517914

Autosomal B-Disease 1 0.9993425011634827
dominant I-Disease 1 0.9996727705001831
neurohypophyseal I-Disease 1 0.9999984502792358
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 1 0.9996898174285889
ADNDI B-Disease 1 0.9999935626983643
) O 0 0.03143615275621414
is O 0 0.016222402453422546
an O 1 0.7417206764221191
inherited B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
caused O 1 0.9999784231185913
by O 1 0.9987700581550598
progressive O 1 0.9999997615814209
degeneration O 1 1.0
of O 1 0.9982530474662781
the O 1 0.9996695518493652
magnocellular O 1 0.9999985694885254
neurons O 1 0.5119207501411438
of O 0 0.020709998905658722
the O 1 0.5820688605308533
hypothalamus O 1 0.9997361302375793
leading O 0 0.32877233624458313
to O 0 0.012035326100885868
decreased O 0 0.019313782453536987
ability O 0 0.010453547351062298
to O 0 0.008469035848975182
produce O 0 0.0112478481605649
the O 0 0.023121412843465805
hormone O 1 0.9984918832778931
arginine O 1 0.9980170726776123
vasopressin O 1 0.9993438124656677
( O 1 0.6429809331893921
AVP O 1 0.9996267557144165
) O 0 0.04347681999206543
. O 0 0.03947603702545166

Affected O 0 0.043935444205999374
individuals O 0 0.017376478761434555
are O 0 0.009489781223237514
not O 0 0.010493313893675804
symptomatic O 1 0.9999383687973022
at O 0 0.33259767293930054
birth O 1 0.9741544723510742
, O 0 0.013813541270792484
but O 0 0.009335851296782494
usually O 0 0.013150223530828953
develop O 1 0.8907787799835205
diabetes B-Disease 1 0.9999990463256836
insipidus I-Disease 1 0.9999936819076538
at O 1 0.575343132019043
1 O 0 0.4128788411617279
- O 1 0.9973284006118774
6 O 0 0.048109155148267746
yr O 1 0.9723170399665833
of O 0 0.027057060971856117
age O 0 0.04702600836753845
. O 0 0.04073542729020119

The O 0 0.03932680934667587
genetic O 0 0.03379686176776886
locus O 0 0.08130312711000443
of O 0 0.01977003552019596
the O 0 0.4723077714443207
disease O 1 0.9999712705612183
is O 0 0.04729519784450531
the O 1 0.6392536163330078
AVP O 1 0.9999979734420776
- O 1 0.9999841451644897
neurophysin O 1 0.9999483823776245
II O 1 0.9999891519546509
( O 1 0.6420406699180603
NPII O 1 0.9994667172431946
) O 0 0.013082501478493214
gene O 0 0.009536121971905231
, O 0 0.007135194726288319
and O 0 0.0070739793591201305
mutations O 0 0.012577307410538197
that O 0 0.0076743015088140965
cause O 1 0.9110177755355835
ADNDI B-Disease 1 0.9998898506164551
have O 0 0.005612521432340145
been O 0 0.005203803535550833
found O 0 0.004554372746497393
in O 0 0.004350578412413597
both O 0 0.00519754970446229
the O 0 0.008690286427736282
signal O 0 0.01492844894528389
peptide O 0 0.015638774260878563
of O 0 0.009790003299713135
the O 0 0.018447209149599075
prepro O 1 0.9993636012077332
- O 1 0.9999449253082275
AVP O 1 0.9999836683273315
- O 1 0.9998026490211487
NPII O 1 0.9995653033256531
precursor O 0 0.16303345561027527
and O 0 0.021062467247247696
within O 0 0.028764257207512856
NPII O 1 0.9909142255783081
itself O 0 0.05259247124195099
. O 0 0.03999534621834755

An O 0 0.040375933051109314
affected O 0 0.06191065534949303
girl O 1 0.91483473777771
who O 0 0.021445466205477715
presented O 0 0.016685087233781815
at O 0 0.012443703599274158
9 O 0 0.01285201869904995
months O 0 0.010123733431100845
of O 0 0.009195944294333458
age O 0 0.015841733664274216
and O 0 0.010344218462705612
her O 0 0.23625609278678894
similarly O 0 0.1295464038848877
affected O 0 0.18010032176971436
younger O 1 0.8196650743484497
brother O 1 0.9761238098144531
and O 0 0.016478758305311203
father O 0 0.4937846064567566
were O 0 0.007123020011931658
all O 0 0.005857597105205059
found O 0 0.005893353372812271
to O 0 0.005517849698662758
have O 0 0.004622450564056635
a O 0 0.009726325049996376
novel O 0 0.020344465970993042
missense O 0 0.05019894614815712
mutation O 0 0.030733374878764153
( O 0 0.024993162602186203
G1758 O 1 0.9986445307731628
- O 1 0.9999397993087769
- O 1 0.9999415874481201
> O 1 0.9962384700775146
T O 1 0.6106889247894287
) O 0 0.01250444632023573
encoding O 0 0.011228783056139946
the O 0 0.011026746593415737
amino O 0 0.017128823325037956
acid O 0 0.02560313418507576
substitution O 0 0.03800118714570999
Gly23 O 1 0.998540997505188
- O 1 0.9998517036437988
- O 1 0.9996310472488403
> O 1 0.9814931750297546
Val O 1 0.9771032333374023
within O 0 0.048168282955884933
NPII O 1 0.993232011795044
. O 0 0.06029188632965088

The O 0 0.05275046452879906
mutation O 0 0.055327896028757095
was O 0 0.03081478737294674
confirmed O 0 0.02586379647254944
by O 0 0.022170905023813248
restriction O 0 0.053114280104637146
endonuclease O 1 0.7960609793663025
analysis O 0 0.03161457180976868
. O 0 0.03335316851735115

A O 1 0.8497911691665649
T1 O 1 0.9999229907989502
- O 1 0.9947080612182617
weighted O 0 0.04660383239388466
magnetic O 0 0.029459252953529358
resonance O 0 0.02707410790026188
imaging O 0 0.023951703682541847
of O 0 0.014818199910223484
the O 0 0.027325673028826714
fathers O 1 0.9974567294120789
pituitary O 1 0.9999903440475464
gland O 1 0.999903678894043
demonstrates O 1 0.8704725503921509
an O 1 0.6435633301734924
attenuated O 1 0.9999802112579346
posterior O 1 0.9999610185623169
pituitary O 1 0.9999827146530151
bright O 1 0.9973625540733337
spot O 1 0.7037646174430847
. O 0 0.05439198017120361

This O 0 0.029505066573619843
mutation O 0 0.05873797461390495
may O 0 0.012578267604112625
be O 0 0.006698390934616327
valuable O 0 0.009993594139814377
for O 0 0.007203991059213877
developing O 0 0.01212777104228735
models O 0 0.013201137073338032
of O 0 0.038650598376989365
dominantly B-Disease 1 0.9999970197677612
inherited I-Disease 1 0.9999990463256836
neurodegeneration I-Disease 1 0.9999998807907104
, O 0 0.04046972468495369
as O 0 0.009941997937858105
the O 0 0.009344039484858513
early O 0 0.009765811264514923
age O 0 0.0172546599060297
of O 0 0.2940255403518677
onset O 1 0.9999992847442627
of O 1 0.9998143315315247
symptoms O 1 0.9999996423721313
suggests O 1 0.9336637854576111
that O 0 0.008553028106689453
this O 0 0.008674271404743195
mutation O 0 0.19563066959381104
may O 0 0.008713213726878166
be O 0 0.006890453863888979
particularly O 0 0.011947963386774063
deleterious O 0 0.036395538598299026
to O 0 0.016525324434041977
the O 0 0.049059487879276276
magnocellular O 1 0.9998948574066162
neuron O 1 0.9495224356651306
. O 0 0.030502235516905785
. O 0 0.03582010790705681

Frequent O 0 0.10422319918870926
inactivation O 1 0.9870549440383911
of O 1 0.7016152143478394
PTEN O 1 0.9999918937683105
/ O 1 0.99997878074646
MMAC1 O 1 0.9999765157699585
in O 1 0.9488201141357422
primary O 1 0.9999786615371704
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 1 0.8513374328613281

Sporadic B-Disease 1 0.9999434947967529
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.09872022271156311
the O 0 0.033895835280418396
most O 0 0.013586077839136124
common O 1 0.7498223781585693
male B-Disease 1 0.9992409944534302
cancer I-Disease 1 0.9999727010726929
in O 0 0.009104043245315552
the O 0 0.028864236548542976
Western O 0 0.027792826294898987
world O 0 0.029734231531620026
, O 0 0.006220605690032244
yet O 0 0.005221072118729353
many O 0 0.0035244280006736517
of O 0 0.005636507645249367
the O 0 0.009875668212771416
major O 0 0.049693264067173004
genetic O 0 0.014428447000682354
events O 0 0.0073995040729641914
involved O 0 0.007894978858530521
in O 0 0.007049752399325371
the O 0 0.01272386871278286
progression O 1 0.9695782661437988
of O 0 0.02172977477312088
this O 0 0.016956480219960213
often O 0 0.1639283001422882
fatal O 1 0.9999929666519165
cancer B-Disease 1 0.9999933242797852
remain O 0 0.20294076204299927
to O 0 0.01850784383714199
be O 0 0.018317097797989845
elucidated O 1 0.5933133959770203
. O 0 0.03412984311580658

Numerous O 0 0.0676349550485611
cytogenetic O 1 0.9738300442695618
and O 0 0.036898817867040634
allelotype O 1 0.9961093068122864
studies O 0 0.017338724806904793
have O 0 0.008829392492771149
reported O 0 0.012828191742300987
frequent O 0 0.01759232021868229
loss O 0 0.02403332106769085
of O 0 0.027482379227876663
heterozygosity O 1 0.9996615648269653
on O 0 0.1339872181415558
chromosomal O 1 0.9993341565132141
arm O 1 0.9989525079727173
10q O 1 0.9992610812187195
in O 0 0.276614248752594
sporadic B-Disease 1 0.9999792575836182
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 1 0.7408640384674072

Deletion O 0 0.11961890757083893
mapping O 0 0.0517948716878891
studies O 0 0.02231428027153015
have O 0 0.01220744289457798
unambiguously O 0 0.03259965032339096
identified O 0 0.015044290572404861
a O 0 0.012144778855144978
region O 0 0.015347222797572613
of O 0 0.017864251509308815
chromosome O 1 0.7885133028030396
10q23 O 1 0.9592763781547546
to O 0 0.011658817529678345
be O 0 0.008224740624427795
the O 0 0.012396621517837048
minimal O 0 0.02106371708214283
area O 0 0.019365327432751656
of O 0 0.020010851323604584
loss O 1 0.5982077121734619
. O 0 0.04553448408842087

A O 0 0.055105071514844894
new O 0 0.06487949937582016
tumor B-Disease 1 0.9999645948410034
suppressor O 1 0.9999090433120728
gene O 0 0.1374800056219101
, O 0 0.20955947041511536
PTEN O 1 0.9999920129776001
/ O 1 0.9999568462371826
MMAC1 O 1 0.999755322933197
, O 0 0.014233909547328949
was O 0 0.017253931611776352
isolated O 0 0.018749000504612923
recently O 0 0.01131370011717081
at O 0 0.007568876259028912
this O 0 0.005434942431747913
region O 0 0.010469391942024231
of O 0 0.013948651030659676
chromosome O 1 0.5491870641708374
10q23 O 1 0.7601320147514343
and O 0 0.009591869078576565
found O 0 0.0076694670133292675
to O 0 0.006853471510112286
be O 0 0.006803409196436405
inactivated O 0 0.03067651018500328
by O 0 0.010326709598302841
mutation O 0 0.018307607620954514
in O 0 0.01258634589612484
three O 1 0.8431611061096191
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9994930028915405
lines O 0 0.09641747176647186
. O 0 0.03951144218444824

We O 0 0.03760320320725441
screened O 0 0.23599547147750854
80 O 1 0.8173031210899353
prostate B-Disease 1 0.9999961853027344
tumors I-Disease 1 0.9997884631156921
by O 0 0.029232999309897423
microsatellite O 1 0.8704303503036499
analysis O 0 0.012446822598576546
and O 0 0.012196188792586327
found O 0 0.013717280700802803
chromosome O 0 0.0352664440870285
10q23 O 0 0.4164058268070221
to O 0 0.011879896745085716
be O 0 0.009906318970024586
deleted O 0 0.022021805867552757
in O 0 0.013022009283304214
23 O 0 0.03039984405040741
cases O 0 0.02941889502108097
. O 0 0.03793825954198837

We O 0 0.028275620192289352
then O 0 0.02070555090904236
proceeded O 0 0.02564523182809353
with O 0 0.01051249634474516
sequence O 0 0.008997675031423569
analysis O 0 0.006187064573168755
of O 0 0.008009719662368298
the O 0 0.013571823947131634
entire O 1 0.9111896753311157
PTEN O 1 0.9999973773956299
/ O 1 0.9999717473983765
MMAC1 O 1 0.9997836947441101
coding O 0 0.04238535836338997
region O 0 0.018941562622785568
and O 0 0.011865687556564808
tested O 0 0.017376435920596123
for O 0 0.01033560186624527
homozygous O 0 0.028494294732809067
deletion O 0 0.027501560747623444
with O 0 0.012971228919923306
new O 0 0.020917236804962158
intragenic O 1 0.9868457317352295
markers O 0 0.02308223396539688
in O 0 0.007674026302993298
these O 0 0.0061861504800617695
23 O 0 0.012571906670928001
cases O 0 0.01119740679860115
with O 0 0.016499292105436325
10q23 O 1 0.9987534284591675
loss O 1 0.7354880571365356
of O 0 0.32248514890670776
heterozygosity O 1 0.9996445178985596
. O 0 0.05760808289051056

The O 0 0.030139660462737083
identification O 0 0.02357630804181099
of O 0 0.014209921471774578
the O 0 0.017326973378658295
second O 0 0.2964164614677429
mutational O 1 0.9976494908332825
event O 0 0.019779199734330177
in O 0 0.009729371406137943
10 O 0 0.011873159557580948
( O 0 0.013148962520062923
43 O 0 0.018281985074281693
% O 0 0.015466349199414253
) O 0 0.022423582151532173
tumors B-Disease 1 0.9996811151504517
establishes O 1 0.9996311664581299
PTEN O 1 0.9999980926513672
/ O 1 0.9998792409896851
MMAC1 O 1 0.9969547986984253
as O 0 0.013851541094481945
a O 0 0.014341781847178936
main O 0 0.022369427606463432
inactivation O 0 0.4406684339046478
target O 0 0.013420525006949902
of O 0 0.013137316331267357
10q O 1 0.6873806118965149
loss O 0 0.16378265619277954
in O 0 0.21665596961975098
sporadic B-Disease 1 0.9999914169311523
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7554019093513489
. O 0 0.05465979874134064

Risk O 0 0.10434410721063614
reversals O 0 0.10262395441532135
in O 0 0.03006625734269619
predictive O 0 0.2683446705341339
testing O 0 0.39717260003089905
for O 1 0.921440064907074
Huntington B-Disease 1 0.999998927116394
disease I-Disease 1 0.9999983310699463
. O 0 0.40025410056114197

The O 0 0.026746731251478195
first O 0 0.02060697041451931
predictive O 0 0.03458404913544655
testing O 0 0.02815130352973938
for O 1 0.6171513199806213
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 1 0.999729573726654
HD B-Disease 1 0.9998704195022583
) O 0 0.013448832556605339
was O 0 0.011003026738762856
based O 0 0.007442273199558258
on O 0 0.006694505922496319
analysis O 0 0.007048012688755989
of O 0 0.009866980835795403
linked O 0 0.1602689027786255
polymorphic O 1 0.8970953822135925
DNA O 0 0.020197389647364616
markers O 0 0.017100876197218895
to O 0 0.008776100352406502
estimate O 0 0.009573567658662796
the O 0 0.00895167700946331
likelihood O 0 0.015238557942211628
of O 0 0.015054361894726753
inheriting O 1 0.947096586227417
the O 0 0.03222212195396423
mutation O 0 0.35921353101730347
for O 0 0.027735376730561256
HD B-Disease 1 0.9745392799377441
. O 0 0.043592505156993866

Limits O 0 0.03579658269882202
to O 0 0.01867006905376911
accuracy O 0 0.018096284940838814
included O 0 0.01651080697774887
recombination O 0 0.022767795249819756
between O 0 0.011267310939729214
the O 0 0.013048357330262661
DNA O 0 0.015621811151504517
markers O 0 0.01677059754729271
and O 0 0.009301813319325447
the O 0 0.01211924385279417
mutation O 0 0.09259756654500961
, O 0 0.01348025444895029
pedigree O 1 0.5104051232337952
structure O 0 0.015953483060002327
, O 0 0.007911257445812225
and O 0 0.0073906974866986275
whether O 0 0.007066086865961552
DNA O 0 0.01064376998692751
samples O 0 0.009373457171022892
were O 0 0.0071776024997234344
available O 0 0.009178008884191513
from O 0 0.012774032540619373
family O 0 0.024639200419187546
members O 0 0.026516703888773918
. O 0 0.037339210510253906

With O 0 0.0239422470331192
direct O 0 0.020460760220885277
tests O 0 0.012681029736995697
for O 0 0.009878112003207207
the O 0 0.025132641196250916
HD B-Disease 1 0.999686598777771
mutation O 0 0.11608155816793442
, O 0 0.009236494079232216
we O 0 0.005792961455881596
have O 0 0.004557445645332336
assessed O 0 0.0083096232265234
the O 0 0.0065193939954042435
accuracy O 0 0.007907216437160969
of O 0 0.007225125562399626
results O 0 0.006819612812250853
obtained O 0 0.008192344568669796
by O 0 0.009409433230757713
linkage O 0 0.08805998414754868
approaches O 0 0.0173525158315897
when O 0 0.010415375232696533
requested O 0 0.015365717001259327
to O 0 0.007971808314323425
do O 0 0.0069876667112112045
so O 0 0.0065584550611674786
by O 0 0.008658957667648792
the O 0 0.014069008640944958
test O 0 0.02510250359773636
individuals O 0 0.021704545244574547
. O 0 0.030558671802282333

For O 0 0.02368718944489956
six O 0 0.020329385995864868
such O 0 0.01237365324050188
individuals O 0 0.012312738224864006
, O 0 0.011021691374480724
there O 0 0.009061675518751144
was O 0 0.016189858317375183
significant O 0 0.014067959040403366
disparity O 0 0.38394656777381897
between O 0 0.017825298011302948
the O 0 0.03865279629826546
tests O 0 0.03058144636452198
. O 0 0.03116793744266033

Three O 0 0.026148635894060135
went O 0 0.02461572177708149
from O 0 0.014516357332468033
a O 0 0.02460186555981636
decreased O 1 0.6436833739280701
risk O 0 0.18116717040538788
to O 0 0.00971872266381979
an O 0 0.015565200708806515
increased O 0 0.10455352813005447
risk O 1 0.6091011762619019
, O 0 0.00793194305151701
while O 0 0.00640582712367177
in O 0 0.0056205750443041325
another O 0 0.00845037680119276
three O 0 0.00899528432637453
the O 0 0.0174337737262249
risk O 1 0.7220516204833984
was O 1 0.5412695407867432
decreased O 0 0.47633129358291626
. O 0 0.04087004065513611

Knowledge O 0 0.03546145185828209
of O 0 0.018891507759690285
the O 0 0.018481219187378883
potential O 0 0.018110420554876328
reasons O 0 0.01085583958774805
for O 0 0.006353691685944796
these O 0 0.004768517334014177
changes O 0 0.0055641597136855125
in O 0 0.005499307997524738
results O 0 0.005787564907222986
and O 0 0.006174182984977961
impact O 0 0.008926219306886196
of O 0 0.007624853402376175
these O 0 0.006743484642356634
risk O 0 0.1403464376926422
reversals O 1 0.631201446056366
on O 0 0.011016557924449444
both O 0 0.010554791428148746
patients O 1 0.8590465784072876
and O 0 0.010914597660303116
the O 0 0.03302132338285446
counseling O 1 0.9988054037094116
team O 0 0.020186133682727814
can O 0 0.007423304487019777
assist O 0 0.01305325236171484
in O 0 0.005826894659548998
the O 0 0.007946906611323357
development O 0 0.008626420982182026
of O 0 0.008525632321834564
strategies O 0 0.014343716204166412
for O 0 0.008229588158428669
the O 0 0.1908256560564041
prevention O 1 0.9999698400497437
and O 0 0.020017925649881363
, O 0 0.009030744433403015
where O 0 0.00803240854293108
necessary O 0 0.009455867111682892
, O 0 0.007759926375001669
management O 0 0.013630806468427181
of O 0 0.009524652734398842
a O 0 0.09662002325057983
risk O 0 0.4947023093700409
reversal O 0 0.47026437520980835
in O 0 0.011528671719133854
any O 0 0.013501426205039024
predictive O 0 0.14176931977272034
testing O 0 0.026023471727967262
program O 0 0.02556382305920124
. O 0 0.01894395984709263
. O 0 0.026921918615698814

A O 0 0.0628892034292221
novel O 0 0.05831550434231758
common O 0 0.035610131919384
missense O 1 0.5081461071968079
mutation O 0 0.04504130780696869
G301C O 0 0.19593581557273865
in O 0 0.012429450638592243
the O 0 0.018161345273256302
N O 1 0.8021280169487
- O 1 0.9952710270881653
acetylgalactosamine O 1 0.9958091974258423
- O 1 0.9956508278846741
6 O 0 0.1464879810810089
- O 1 0.9992256164550781
sulfate O 1 0.9987877011299133
sulfatase O 1 0.9991581439971924
gene O 0 0.0371667854487896
in O 0 0.03139830380678177
mucopolysaccharidosis B-Disease 1 0.9983285069465637
IVA I-Disease 1 0.999940037727356
. O 0 0.06896728277206421

Mucopolysaccharidosis B-Disease 1 0.9996041655540466
IVA I-Disease 1 0.999993085861206
( O 1 0.9772306084632874
MPS B-Disease 1 0.9993581175804138
IVA I-Disease 1 0.999997615814209
) O 0 0.02533183991909027
is O 0 0.01781386509537697
an O 0 0.14398528635501862
autosomal B-Disease 1 0.999993085861206
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 1.0
storage I-Disease 1 0.9999994039535522
disorder I-Disease 1 1.0
caused O 1 0.9995037317276001
by O 0 0.10976092517375946
a O 1 0.9182637929916382
genetic B-Disease 1 0.9902521371841431
defect I-Disease 1 0.9999332427978516
in O 0 0.019864730536937714
N O 1 0.9901525378227234
- O 1 0.9987022876739502
acetylgalactosamine O 1 0.9993689656257629
- O 1 0.9991160035133362
6 O 1 0.6729456186294556
- O 1 0.9998831748962402
sulfate O 1 0.9998854398727417
sulfatase O 1 0.9999785423278809
( O 1 0.7903967499732971
GALNS O 1 0.9991176724433899
) O 0 0.042074378579854965
. O 0 0.04065309837460518

In O 0 0.02503029629588127
previous O 0 0.022874852642416954
studies O 0 0.015687545761466026
, O 0 0.01074720174074173
we O 0 0.007030504755675793
have O 0 0.00490142684429884
found O 0 0.006152810994535685
two O 0 0.006910674273967743
common O 0 0.013243530876934528
mutations O 0 0.016905179247260094
in O 0 0.013013303279876709
Caucasians O 1 0.9000056385993958
and O 0 0.01886739954352379
Japanese O 0 0.046394091099500656
, O 0 0.023835627362132072
respectively O 0 0.0364655926823616
. O 0 0.03424452245235443

To O 0 0.03887145221233368
characterize O 0 0.05822549760341644
the O 0 0.032399632036685944
mutational O 1 0.9953029155731201
spectrum O 0 0.02980249561369419
in O 0 0.009277045726776123
various O 0 0.0076150777749717236
ethnic O 0 0.011598149314522743
groups O 0 0.007659558206796646
, O 0 0.008018742315471172
mutations O 0 0.008773409761488438
in O 0 0.006099110934883356
the O 0 0.011120612733066082
GALNS O 1 0.999249279499054
gene O 0 0.011913741007447243
in O 0 0.009752585552632809
Colombian O 1 0.6643235087394714
MPS B-Disease 1 0.9997490048408508
IVA I-Disease 1 0.9999998807907104
patients O 1 0.9991639852523804
were O 0 0.01348375529050827
investigated O 0 0.10117223858833313
, O 0 0.013201896101236343
and O 0 0.01202998124063015
genetic O 0 0.016961408779025078
backgrounds O 0 0.013853136450052261
were O 0 0.007967201992869377
extensively O 0 0.013557097874581814
analyzed O 0 0.010301991365849972
to O 0 0.007777187041938305
identify O 0 0.011484013870358467
racial O 0 0.016042569652199745
origin O 0 0.008659014478325844
, O 0 0.008405240252614021
based O 0 0.010266905650496483
on O 0 0.012691834010183811
mitochondrial O 0 0.03016987256705761
DNA O 0 0.025057978928089142
( O 0 0.028927549719810486
mtDNA O 0 0.04047146439552307
) O 0 0.02865012176334858
lineages O 0 0.05221244692802429
. O 0 0.03988651558756828

Three O 0 0.03395341336727142
novel O 0 0.0640796422958374
missense O 1 0.8389487266540527
mutations O 0 0.0322328582406044
never O 0 0.018797626718878746
identified O 0 0.012870168313384056
previously O 0 0.010094336234033108
in O 0 0.006260164547711611
other O 0 0.005774376913905144
populations O 0 0.006872810423374176
and O 0 0.00550560187548399
found O 0 0.005329118575900793
in O 0 0.00504307122901082
16 O 0 0.008731096982955933
out O 0 0.00786901917308569
of O 0 0.01023613940924406
19 O 0 0.02347431890666485
Colombian O 0 0.4198439419269562
MPS B-Disease 1 0.9943311214447021
IVA I-Disease 1 0.999993085861206
unrelated O 0 0.3985710144042969
alleles O 0 0.054475460201501846
account O 0 0.024443482980132103
for O 0 0.020251672714948654
84 O 0 0.0687631368637085
. O 0 0.041484199464321136

2 O 0 0.04250092804431915
% O 0 0.021050771698355675
of O 0 0.01738293655216694
the O 0 0.023121260106563568
alleles O 0 0.044501613825559616
in O 0 0.01626637764275074
this O 0 0.017186211422085762
study O 0 0.029075918719172478
. O 0 0.033639468252658844

The O 0 0.0660577192902565
G301C O 1 0.9128437042236328
and O 0 0.04523696005344391
S162F O 1 0.9759587049484253
mutations O 0 0.04109978303313255
account O 0 0.025991937145590782
for O 0 0.023561928421258926
68 O 0 0.06549772620201111
. O 0 0.04250726476311684

4 O 0 0.06897993385791779
% O 0 0.04003295302391052
and O 0 0.03214556723833084
10 O 0 0.041502323001623154
. O 0 0.046032100915908813

5 O 0 0.03375234827399254
% O 0 0.020627513527870178
of O 0 0.017375338822603226
mutations O 0 0.026295756921172142
, O 0 0.013302159495651722
respectively O 0 0.01459821593016386
, O 0 0.009605632163584232
whereas O 0 0.01163347065448761
the O 0 0.011470749042928219
remaining O 0 0.02024899609386921
F69V O 1 0.9959986209869385
is O 0 0.012937037274241447
limited O 0 0.011991238221526146
to O 0 0.011148826219141483
a O 0 0.019130010157823563
single O 0 0.039935413748025894
allele O 0 0.06271001696586609
. O 0 0.03722560033202171

The O 0 0.04785427451133728
skewed O 0 0.06760158389806747
prevalence O 1 0.872524619102478
of O 0 0.03039529360830784
G301C O 1 0.9902353882789612
in O 0 0.01518898457288742
only O 0 0.01361056324094534
Colombian O 1 0.5669304728507996
patients O 1 0.9062131643295288
and O 0 0.015414880588650703
haplotype O 0 0.23530037701129913
analysis O 0 0.009925780817866325
by O 0 0.008979239501059055
restriction O 0 0.017927400767803192
fragment O 0 0.02099323831498623
length O 0 0.012440458871424198
polymorphisms O 0 0.018422618508338928
in O 0 0.00781816802918911
the O 0 0.014383078552782536
GALNS O 1 0.9977365732192993
gene O 0 0.015546079725027084
suggest O 0 0.011239228770136833
that O 0 0.009402154944837093
G301C O 0 0.16781719028949738
originated O 0 0.018150918185710907
from O 0 0.011601676233112812
a O 0 0.01877729594707489
common O 0 0.02645917795598507
ancestor O 0 0.2650659680366516
. O 0 0.041192229837179184

Investigation O 0 0.04244101792573929
of O 0 0.021449139341711998
the O 0 0.021101973950862885
genetic O 0 0.022351719439029694
background O 0 0.015800807625055313
by O 0 0.009125481359660625
means O 0 0.01123715192079544
of O 0 0.013282135128974915
mtDNA O 0 0.024508444592356682
lineages O 0 0.01863359846174717
indicate O 0 0.009359178133308887
that O 0 0.005157894920557737
all O 0 0.007300887256860733
our O 0 0.015199337154626846
patients O 0 0.2506091892719269
are O 0 0.007467432878911495
probably O 0 0.014193073846399784
of O 0 0.014529186300933361
native O 0 0.030248193070292473
American O 0 0.05227963998913765
descent O 0 0.3113844096660614

Low O 0 0.04990275204181671
frequency O 0 0.028353797271847725
of O 0 0.02565290592610836
BRCA1 O 1 0.9863719344139099
germline O 0 0.3040311932563782
mutations O 0 0.0221833698451519
in O 0 0.014280403032898903
45 O 0 0.03493557125329971
German O 1 0.9997393488883972
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 1 0.9779242873191833
. O 0 0.08470448851585388

In O 0 0.02222825214266777
this O 0 0.011678630486130714
study O 0 0.011282498016953468
we O 0 0.008317953906953335
investigated O 0 0.01713653653860092
45 O 0 0.023719310760498047
German O 1 0.9985748529434204
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 1 0.6028141975402832
for O 0 0.11103615909814835
germline O 1 0.9994377493858337
mutations O 0 0.032016366720199585
in O 0 0.014188816770911217
the O 0 0.1224922314286232
BRCA1 O 1 0.9998125433921814
gene O 0 0.04787791892886162
. O 0 0.03964299336075783

We O 0 0.02126479148864746
identified O 0 0.019979629665613174
four O 0 0.0154868820682168
germline O 0 0.13502086699008942
mutations O 0 0.01857421174645424
in O 0 0.011243914254009724
three O 0 0.17341195046901703
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999819993972778
families O 0 0.016720429062843323
and O 0 0.009335163049399853
in O 0 0.010838224552571774
one O 1 0.9727745056152344
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9959740042686462
. O 0 0.009301964193582535
among O 0 0.006853263825178146
these O 0 0.0038976429495960474
were O 0 0.00558222783729434
one O 0 0.009517467580735683
frameshift O 1 0.9771596789360046
mutation O 0 0.024669311940670013
, O 0 0.009351078420877457
one O 0 0.010511226952075958
nonsense O 1 0.6846730709075928
mutation O 0 0.019337451085448265
, O 0 0.008897829800844193
one O 0 0.010075674392282963
novel O 0 0.023975107818841934
splice O 0 0.058703064918518066
site O 0 0.021885031834244728
mutation O 0 0.02007840946316719
, O 0 0.01221571397036314
and O 0 0.013226144947111607
one O 0 0.021863121539354324
missense O 1 0.5845736265182495
mutation O 0 0.0667840912938118
. O 0 0.03962627798318863

The O 0 0.058400221168994904
missense O 1 0.9369655847549438
mutation O 0 0.3336804509162903
was O 0 0.03494101017713547
also O 0 0.014384714886546135
found O 0 0.012810306623578072
in O 0 0.014606180600821972
2 O 0 0.035391613841056824
. O 0 0.03365685045719147

8 O 0 0.03770601749420166
% O 0 0.017058705911040306
of O 0 0.011666204780340195
the O 0 0.012431181967258453
general O 0 0.028106942772865295
population O 0 0.011170266196131706
, O 0 0.008415536023676395
suggesting O 0 0.009342971257865429
that O 0 0.005313443019986153
it O 0 0.006329932250082493
is O 0 0.011695797555148602
not O 0 0.015073180198669434
disease O 1 0.9996349811553955
associated O 0 0.04016566276550293
. O 0 0.03663283959031105

The O 0 0.033332306891679764
average O 0 0.03137151896953583
age O 0 0.08032125234603882
of O 1 0.9508126974105835
disease O 1 0.9999994039535522
onset O 1 0.9999984502792358
in O 0 0.1631769835948944
those O 0 0.031203454360365868
families O 1 0.9589511156082153
harbouring O 1 0.9999991655349731
causative O 1 0.9999958276748657
mutations O 1 0.6982268691062927
was O 0 0.04488040879368782
between O 0 0.023203883320093155
32 O 0 0.0421033576130867
. O 0 0.03417820483446121

3 O 0 0.07645649462938309
and O 0 0.05026289075613022
37 O 0 0.08075575530529022
. O 0 0.06294989585876465

4 O 0 0.04012969136238098
years O 0 0.021018056198954582
, O 0 0.014991492964327335
whereas O 0 0.016152994707226753
the O 0 0.013718480244278908
family O 0 0.0906648114323616
harbouring O 1 0.9996843338012695
the O 0 0.14892326295375824
missense O 1 0.9969934225082397
mutation O 0 0.2542046308517456
had O 0 0.013324858620762825
an O 0 0.010475429706275463
average O 0 0.013676541857421398
age O 0 0.016879631206393242
of O 0 0.019833054393529892
onset O 1 0.9998263716697693
of O 0 0.36645862460136414
51 O 1 0.8837619423866272
. O 0 0.04576574265956879

2 O 0 0.07943909615278244
years O 0 0.06312578916549683
. O 0 0.06132626160979271

These O 0 0.01793648488819599
findings O 0 0.019749188795685768
show O 0 0.018302563577890396
that O 0 0.011552768759429455
BRCA1 O 1 0.9847715497016907
is O 0 0.010582013987004757
implicated O 0 0.022840246558189392
in O 0 0.00676542054861784
a O 0 0.008471116423606873
small O 0 0.008385772816836834
fraction O 0 0.018561003729701042
of O 1 0.9882014393806458
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.6472927331924438
suggesting O 0 0.019694607704877853
the O 0 0.013399012386798859
involvement O 0 0.23002319037914276
of O 0 0.07963447272777557
another O 1 0.9860625863075256
susceptibility O 1 0.999975323677063
gene O 1 0.7964506149291992
( O 0 0.17065951228141785
s O 1 0.7272965908050537
) O 0 0.057536520063877106

Paternal O 1 0.991114616394043
transmission O 1 0.9991129040718079
of O 1 0.9999531507492065
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9996691942214966

We O 0 0.024785444140434265
report O 0 0.017191091552376747
a O 0 0.01473847683519125
rare O 0 0.016840806230902672
case O 0 0.02060253731906414
of O 0 0.27135151624679565
paternally O 1 0.99998939037323
transmitted O 1 0.9999983310699463
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999996423721313
DM B-Disease 1 1.0
) O 1 0.656938374042511
. O 0 0.049856144934892654

The O 0 0.0428602434694767
proband O 1 0.672843873500824
is O 0 0.015940731391310692
a O 0 0.013890127651393414
23 O 0 0.01667933724820614
year O 0 0.01391715370118618
old O 1 0.7066721320152283
, O 1 0.5049587488174438
mentally B-Disease 1 0.9999988079071045
retarded I-Disease 1 0.9999992847442627
male O 1 0.9999747276306152
who O 1 0.999974250793457
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999997615814209
. O 1 0.9966885447502136

He O 0 0.038417793810367584
presented O 0 0.05395853519439697
with O 1 0.7269347310066223
respiratory O 1 0.9999996423721313
and O 1 0.9834660887718201
feeding O 1 0.9996905326843262
difficulties O 1 0.9998748302459717
at O 1 0.9915313720703125
birth O 1 0.9986044764518738
. O 0 0.05308689922094345

His O 0 0.06146944314241409
two O 0 0.04717247560620308
sibs O 1 0.9996188879013062
suffer O 1 0.9979876279830933
from O 1 0.915160596370697
childhood O 1 0.9999984502792358
onset O 1 0.9999998807907104
DM B-Disease 1 1.0
. O 1 0.9656877517700195

Their O 0 0.023942960426211357
late O 0 0.02691924013197422
father O 0 0.03068847581744194
had O 0 0.012972449883818626
the O 0 0.012948465533554554
adult O 0 0.030813321471214294
type O 1 0.6094492077827454
of O 1 0.9215413928031921
DM B-Disease 1 1.0
, O 0 0.21197181940078735
with O 0 0.09168817847967148
onset O 1 0.9999206066131592
around O 0 0.024349752813577652
30 O 0 0.0244823656976223
years O 0 0.0256650410592556
. O 0 0.03295251354575157

Only O 0 0.02042406052350998
six O 0 0.016318920999765396
other O 0 0.00895147304981947
cases O 0 0.012057378888130188
of O 0 0.018225982785224915
paternal O 1 0.9996850490570068
transmission O 1 0.999901533126831
of O 1 0.9999912977218628
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.4034197926521301
been O 0 0.02393268048763275
reported O 0 0.026523495092988014
recently O 0 0.036352816969156265
. O 0 0.02987348474562168

We O 0 0.025083724409341812
review O 0 0.027389276772737503
the O 0 0.017768310382962227
sex O 0 0.026504797860980034
related O 0 0.017899127677083015
effects O 0 0.031160635873675346
on O 0 0.02681868150830269
transmission O 1 0.9978220462799072
of O 1 0.9996930360794067
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9823254942893982

Decreased O 0 0.085701584815979
fertility O 0 0.3389022946357727
of O 0 0.02190851978957653
males O 0 0.024782933294773102
with O 0 0.05939691141247749
adult O 1 0.9996405839920044
onset O 1 1.0
DM B-Disease 1 1.0
and O 1 0.8730035424232483
contraction O 1 0.9220288395881653
of O 0 0.01843911036849022
the O 0 0.14133106172084808
repeat O 1 0.9813882112503052
upon O 0 0.06686437129974365
male O 1 0.9845539927482605
transmission O 1 0.5413095951080322
contribute O 0 0.01325279287993908
to O 0 0.007411533500999212
the O 0 0.009082396514713764
almost O 0 0.008136056363582611
absent O 0 0.021685604006052017
occurrence O 0 0.022256581112742424
of O 0 0.02333877980709076
paternal O 1 0.9998002648353577
transmission O 1 0.9998561143875122
of O 1 0.9999412298202515
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9928699135780334

Also O 0 0.025461740791797638
the O 0 0.019286610186100006
fathers O 0 0.02945803664624691
of O 0 0.01575244404375553
the O 0 0.02290273830294609
reported O 0 0.4840796887874603
congenitally O 1 0.9999344348907471
affected O 0 0.20652316510677338
children O 0 0.0477951243519783
showed O 0 0.01495780237019062
, O 0 0.009157591499388218
on O 0 0.008140590973198414
average O 0 0.011148571036756039
, O 0 0.011638329364359379
shorter O 0 0.023361237719655037
CTG O 1 0.9959163069725037
repeat O 0 0.03847649320960045
lengths O 0 0.027746492996811867
and O 0 0.014347034506499767
hence O 0 0.021144498139619827
less O 0 0.02207360602915287
severe O 1 0.9999760389328003
clinical O 1 0.9999853372573853
symptoms O 1 0.9999854564666748
than O 0 0.014639209024608135
the O 0 0.12608052790164948
mothers O 1 0.9958720803260803
of O 0 0.45904576778411865
children O 1 0.9997027516365051
with O 1 0.9999697208404541
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9965029954910278

We O 0 0.024239810183644295
conclude O 0 0.030707649886608124
that O 0 0.013714803382754326
paternal O 0 0.42802202701568604
transmission O 1 0.9824642539024353
of O 1 0.9998522996902466
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9968390464782715
rare O 1 0.9851175546646118
and O 0 0.12185038626194
preferentially O 1 0.5386975407600403
occurs O 0 0.013879523612558842
with O 0 0.01455903984606266
onset O 1 0.9999722242355347
of O 1 0.9940443634986877
DM B-Disease 1 0.9999998807907104
past O 0 0.05065010115504265
30 O 0 0.017715517431497574
years O 0 0.012181618250906467
in O 0 0.010652469471096992
the O 0 0.017047714442014694
father O 1 0.5354083180427551
. O 0 0.02337770350277424
. O 0 0.03570811450481415

The O 0 0.08276685327291489
RB1 O 1 0.9997113347053528
gene O 0 0.04255973920226097
mutation O 0 0.02976817823946476
in O 0 0.013907968997955322
a O 0 0.02520965225994587
child O 1 0.9983320832252502
with O 1 0.9906519651412964
ectopic B-Disease 1 0.9999995231628418
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999982118606567
. O 1 0.7283447980880737

The O 0 0.07615815103054047
RB1 O 1 0.9998080134391785
gene O 0 0.04513430595397949
mutation O 0 0.032264627516269684
was O 0 0.01691090315580368
investigated O 0 0.016906416043639183
in O 0 0.009254169650375843
a O 0 0.016701197251677513
child O 1 0.9931526184082031
with O 1 0.9734569787979126
ectopic B-Disease 1 0.9999997615814209
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999980926513672
using O 0 0.013638836331665516
DNA O 0 0.010795626789331436
obtained O 0 0.006964418105781078
from O 0 0.005791989155113697
both O 0 0.007254081312566996
the O 0 0.0215311236679554
pineal B-Disease 1 0.999976396560669
and I-Disease 1 0.9040473103523254
retinal I-Disease 1 0.9999982118606567
tumours I-Disease 1 0.9999983310699463
of O 1 0.9306060671806335
the O 1 0.995307981967926
patient O 1 0.9999524354934692
. O 0 0.09383361786603928

A O 0 0.0634680986404419
nonsense O 0 0.16893236339092255
mutation O 0 0.038979820907115936
in O 0 0.01753191649913788
exon O 0 0.05665340647101402
17 O 0 0.026002291589975357
( O 0 0.020380746573209763
codon O 0 0.03525669500231743
556 O 0 0.04325932264328003
) O 0 0.012880802154541016
of O 0 0.012354082427918911
the O 0 0.038846615701913834
RB1 O 1 0.9999834299087524
gene O 0 0.018983524292707443
was O 0 0.012666434049606323
found O 0 0.006726689636707306
to O 0 0.006197960581630468
be O 0 0.005998675245791674
present O 0 0.00932383257895708
homozygously O 0 0.2939944267272949
in O 0 0.008992055431008339
both O 0 0.009396100416779518
the O 0 0.028625978156924248
retinal B-Disease 1 0.9998464584350586
and I-Disease 0 0.07063308358192444
the I-Disease 1 0.9684777855873108
pineal I-Disease 1 0.9999945163726807
tumours I-Disease 1 0.9999953508377075
. O 0 0.07014817744493484

The O 0 0.03276994451880455
same O 0 0.021101273596286774
mutation O 0 0.02992863953113556
was O 0 0.018428534269332886
present O 0 0.014793675392866135
heterozygously O 1 0.6690115332603455
in O 0 0.006962315179407597
the O 0 0.008141975849866867
DNA O 0 0.007448330521583557
from O 0 0.00531274126842618
the O 0 0.006461104843765497
constitutional O 0 0.014902975410223007
cells O 0 0.010584451258182526
of O 0 0.010438572615385056
the O 1 0.6748671531677246
patient O 1 0.9999339580535889
, O 0 0.06460820138454437
proving O 0 0.24132202565670013
it O 0 0.006132497452199459
to O 0 0.007867839187383652
be O 0 0.008357730694115162
of O 0 0.017434777691960335
germline O 0 0.3290572762489319
origin O 0 0.027670808136463165
. O 0 0.03275419399142265

The O 0 0.04404061287641525
initial O 0 0.04527107998728752
mutation O 0 0.05048158019781113
was O 0 0.021135598421096802
shown O 0 0.011875106953084469
to O 0 0.008870994672179222
have O 0 0.007654637563973665
occurred O 0 0.013160611502826214
in O 0 0.009323334321379662
the O 0 0.021482352167367935
paternally O 1 0.9448639750480652
derived O 0 0.05071309581398964
RB1 O 1 0.9994572997093201
allele O 0 0.10517960786819458
. O 0 0.04517976567149162

The O 0 0.03780679777264595
mutation O 0 0.057133808732032776
is O 0 0.01113829854875803
in O 0 0.007073778659105301
an O 0 0.006867786403745413
area O 0 0.008455627597868443
of O 0 0.00644110469147563
the O 0 0.008252992294728756
gene O 0 0.0077991490252316
that O 0 0.00463114632293582
encodes O 0 0.010633701458573341
the O 0 0.008539875969290733
protein O 0 0.011868248693645
- O 0 0.03935474902391434
binding O 0 0.009688299149274826
region O 0 0.00936416257172823
known O 0 0.008584308438003063
as O 0 0.007262687664479017
the O 0 0.011763633228838444
pocket O 1 0.9600889086723328
region O 0 0.014434020966291428
and O 0 0.00836778711527586
has O 0 0.0069580827839672565
been O 0 0.007028055377304554
detected O 0 0.010642473585903645
in O 0 0.005422718822956085
other O 0 0.006092604715377092
cases O 0 0.012925034388899803
of O 0 0.2203553020954132
retinoblastoma B-Disease 1 0.9999889135360718
. O 0 0.036137983202934265
. O 0 0.039799414575099945

Low O 0 0.045621030032634735
levels O 0 0.023464640602469444
of O 0 0.01992178149521351
beta O 1 0.601682186126709
hexosaminidase O 1 0.97798752784729
A O 0 0.030887844040989876
in O 0 0.013808852061629295
healthy O 0 0.24808700382709503
individuals O 0 0.014674956910312176
with O 0 0.09982547163963318
apparent O 1 0.9999744892120361
deficiency O 1 1.0
of O 1 0.9953794479370117
this O 1 0.8771876692771912
enzyme O 1 0.9616571068763733
. O 0 0.03525862842798233

Appreciable O 0 0.45626112818717957
beta O 0 0.28464576601982117
hexosaminidase O 1 0.9339199066162109
A O 0 0.2701665461063385
( O 0 0.051922380924224854
hex O 1 0.7172539830207825
A O 0 0.030494539067149162
) O 0 0.014341060072183609
activity O 0 0.009753736667335033
has O 0 0.0066238464787602425
been O 0 0.007627914194017649
detected O 0 0.014142417348921299
in O 0 0.011563337408006191
cultured O 1 0.9751784801483154
skin O 1 0.9999765157699585
fibroblasts O 1 0.9999663829803467
and O 1 0.9995561242103577
melanoma B-Disease 1 1.0
tissue O 1 0.9999812841415405
from O 0 0.44140976667404175
healthy O 1 0.9809150695800781
individuals O 0 0.01049123890697956
previously O 0 0.012498177587985992
reported O 0 0.012026620097458363
as O 0 0.012529070489108562
having O 1 0.716220498085022
deficiency B-Disease 1 0.999998927116394
of I-Disease 1 0.8196967840194702
hex I-Disease 1 0.9997424483299255
A I-Disease 0 0.273065984249115
activity O 0 0.014836298301815987
indistinguishable O 0 0.015965286642313004
from O 0 0.0061884718015789986
that O 0 0.00475127249956131
of O 0 0.009946245700120926
patients O 1 0.9489350914955139
with O 1 0.990140974521637
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999997615814209
( O 1 0.9997304081916809
TSD B-Disease 1 0.9999916553497314
) O 0 0.05135659873485565
. O 0 0.03975662216544151

Identification O 0 0.0591561421751976
and O 0 0.03188304975628853
quantitation O 1 0.7032725811004639
of O 0 0.036006271839141846
hex O 1 0.9676336646080017
A O 0 0.07492225617170334
, O 0 0.02453761175274849
amounting O 0 0.04125617817044258
to O 0 0.022791575640439987
3 O 0 0.03825794905424118
. O 0 0.035068247467279434

5 O 0 0.07472875714302063
% O 0 0.06015956029295921
- O 1 0.9100233316421509
6 O 0 0.06416124850511551
. O 0 0.048310525715351105

9 O 0 0.03846286982297897
% O 0 0.01750112697482109
of O 0 0.013622923754155636
total O 0 0.01893029734492302
beta O 1 0.5635551810264587
hexosaminidase O 1 0.9717247486114502
activity O 0 0.018779003992676735
, O 0 0.011018719524145126
has O 0 0.008884617127478123
been O 0 0.008028906770050526
obtained O 0 0.010465781204402447
by O 0 0.014392105862498283
cellulose O 1 0.8881235718727112
acetate O 1 0.9977073669433594
gel O 1 0.9504888653755188
electrophoresis O 0 0.08110133558511734
, O 0 0.023753231391310692
DEAE O 1 0.9987143278121948
- O 1 0.998877227306366
cellulose O 1 0.9653255939483643
ion O 1 0.8367027640342712
- O 1 0.984953761100769
exchange O 0 0.040149495005607605
chromatography O 1 0.9575862884521484
, O 0 0.028851551935076714
radial O 1 0.8046862483024597
immunodiffusion O 1 0.942434549331665
, O 0 0.033875200897455215
and O 0 0.03623625636100769
radioimmunoassay O 1 0.9441699385643005
. O 0 0.05069253593683243

Previous O 0 0.04405514523386955
family O 0 0.04247688502073288
studies O 0 0.016900859773159027
suggested O 0 0.013752573169767857
that O 0 0.006406410131603479
these O 0 0.005280287005007267
individuals O 0 0.007865305058658123
may O 0 0.007506963796913624
be O 0 0.006788645405322313
compound O 0 0.034867387264966965
heterozygotes O 0 0.06131761148571968
for O 0 0.008551119826734066
the O 0 0.0117759108543396
common O 0 0.03177374228835106
mutant O 1 0.9970663189888
TSD B-Disease 1 0.9999788999557495
gene O 0 0.018085326999425888
and O 0 0.010686632245779037
a O 0 0.01611424796283245
rare O 0 0.2527395188808441
( O 0 0.47874385118484497
allelic O 1 0.9981541037559509
) O 0 0.03834766522049904
mutant O 1 0.6873157024383545
gene O 0 0.04011203721165657
. O 0 0.03250305354595184

Thus O 0 0.028334418311715126
, O 0 0.017545104026794434
the O 0 0.016583213582634926
postulated O 0 0.05354111269116402
rate O 0 0.0239444300532341
mutant O 1 0.7586976289749146
gene O 0 0.016895821318030357
appears O 0 0.012332987040281296
to O 0 0.007090194150805473
code O 0 0.00935826450586319
for O 0 0.005977314431220293
the O 0 0.008302710019052029
expression O 0 0.011472241021692753
of O 0 0.011009888723492622
low O 0 0.024934072047472
amounts O 0 0.013888833113014698
of O 0 0.0217530969530344
hex O 1 0.8449753522872925
A O 0 0.059328921139240265
. O 0 0.0418432392179966

Heterozygotes O 0 0.4550994634628296
for O 0 0.023815924301743507
the O 0 0.02465292625129223
rare O 1 0.5478118062019348
mutant O 1 0.9581968188285828
may O 0 0.016474487259984016
be O 0 0.009341763332486153
indistinguishable O 0 0.02400491200387478
from O 0 0.013983795419335365
heterozygotes O 0 0.1753225475549698
for O 0 0.014766456559300423
the O 0 0.026889950037002563
common O 0 0.43230894207954407
TSD B-Disease 1 0.9999595880508423
mutant O 1 0.9818938970565796
. O 0 0.055154118686914444

However O 0 0.033119965344667435
, O 0 0.02368231862783432
direct O 0 0.02306734211742878
visualization O 0 0.05326222628355026
and O 0 0.017814548686146736
quantitation O 1 0.9340102672576904
of O 0 0.021689586341381073
hex O 1 0.7953885197639465
A O 0 0.018951846286654472
by O 0 0.009129648096859455
the O 0 0.01028850581496954
methods O 0 0.009131589904427528
described O 0 0.012612104415893555
may O 0 0.0096451910212636
prevent O 0 0.01894601806998253
false O 0 0.15572769939899445
- O 1 0.9996483325958252
positive O 0 0.43172645568847656
prenatal O 1 0.9999692440032959
diagnosis O 1 0.9999103546142578
of O 1 0.940453290939331
TSD B-Disease 1 0.9999986886978149
in O 0 0.02372053638100624
fetuses O 1 0.6977857351303101
having O 0 0.01388406753540039
the O 0 0.014559607952833176
incomplete O 0 0.22923187911510468
hex B-Disease 1 0.9931299090385437
A I-Disease 1 0.9795976281166077
deficiency I-Disease 1 0.9999973773956299
of O 0 0.20243270695209503
the O 1 0.8040868639945984
type O 1 0.9849051833152771
described O 0 0.03518485650420189
in O 0 0.009708257392048836
the O 0 0.015117188915610313
four O 0 0.02139212377369404
healthy O 1 0.7749552130699158
individuals O 0 0.04644504934549332

The O 0 0.08226054161787033
tumor B-Disease 1 0.9999456405639648
suppressor O 1 0.9998623132705688
gene O 1 0.7174023985862732
Smad4 O 1 0.9999102354049683
/ O 1 0.9997212290763855
Dpc4 O 1 0.9766154289245605
is O 0 0.013032903894782066
required O 0 0.010553545318543911
for O 0 0.011049272492527962
gastrulation O 1 0.9883706569671631
and O 0 0.011763948015868664
later O 0 0.012014231644570827
for O 0 0.012427084147930145
anterior O 1 0.9914831519126892
development O 0 0.024462660774588585
of O 0 0.02637847699224949
the O 1 0.5468893647193909
mouse O 1 0.9829059839248657
embryo O 0 0.31651774048805237
. O 0 0.042755890637636185

Mutations O 0 0.04221709072589874
in O 0 0.019650891423225403
the O 0 0.0321626141667366
SMAD4 O 1 0.999984622001648
/ O 1 0.9999957084655762
DPC4 O 1 0.9999970197677612
tumor B-Disease 1 0.999998927116394
suppressor O 1 0.9999580383300781
gene O 0 0.024115625768899918
, O 0 0.01148039847612381
a O 0 0.01322360523045063
key O 0 0.01634354144334793
signal O 0 0.018130488693714142
transducer O 0 0.03010256215929985
in O 0 0.008258625864982605
most O 0 0.011711412109434605
TGFbeta O 1 0.9998644590377808
- O 1 0.9999020099639893
related O 0 0.14285500347614288
pathways O 0 0.25490161776542664
, O 0 0.007495443802326918
are O 0 0.004115247167646885
involved O 0 0.0063791656866669655
in O 0 0.006070492323487997
50 O 0 0.014048797078430653
% O 0 0.019475243985652924
of O 1 0.6682987809181213
pancreatic B-Disease 1 0.9999996423721313
cancers I-Disease 1 0.9999672174453735
. O 0 0.0901113897562027

Homozygous O 1 0.5981158018112183
Smad4 O 1 0.9976488947868347
mutant O 1 0.9876863956451416
mice O 1 0.5155089497566223
die O 0 0.3652650713920593
before O 0 0.030077971518039703
day O 0 0.039437245577573776
7 O 0 0.048939649015665054
. O 0 0.04215342923998833

5 O 0 0.07658109068870544
of O 0 0.06726746261119843
embryogenesis O 1 0.7406610250473022
. O 0 0.07632311433553696

Mutant O 0 0.10613583028316498
embryos O 0 0.03534768521785736
have O 0 0.013849768787622452
reduced O 0 0.0189434252679348
size O 0 0.014692847616970539
, O 0 0.01295449398458004
fail O 0 0.02171388268470764
to O 0 0.0128970080986619
gastrulate O 1 0.8139232993125916
or O 0 0.013355129398405552
express O 0 0.0272871945053339
a O 0 0.024390675127506256
mesodermal O 1 0.9995313882827759
marker O 1 0.9286107420921326
, O 0 0.01839357800781727
and O 0 0.018044104799628258
show O 0 0.03800303116440773
abnormal O 1 0.9930636286735535
visceral O 1 0.9996780157089233
endoderm O 1 0.9997784495353699
development O 0 0.24162738025188446
. O 0 0.05210258439183235

Growth B-Disease 1 0.5476806163787842
retardation I-Disease 1 0.9983105659484863
of O 0 0.03553413599729538
the O 1 0.8613389134407043
Smad4 O 1 0.9999985694885254
- O 1 0.9999948740005493
deficient O 1 0.9995587468147278
embryos O 0 0.016850538551807404
results O 0 0.008705745451152325
from O 0 0.009694521315395832
reduced O 0 0.02046598680317402
cell O 0 0.14034654200077057
proliferation O 1 0.5815281271934509
rather O 0 0.014730213209986687
than O 0 0.014376307837665081
increased O 0 0.034958310425281525
apoptosis O 1 0.9579232931137085
. O 0 0.04584120959043503

Aggregation O 0 0.07737382501363754
of O 0 0.03746882826089859
mutant O 1 0.9112548828125
Smad4 O 1 0.9995836615562439
ES O 1 0.9995212554931641
cells O 0 0.02895723469555378
with O 0 0.01783580146729946
wild O 0 0.04078326001763344
- O 1 0.9982227683067322
type O 1 0.5807149410247803
tetraploid O 1 0.9708774089813232
morulae O 1 0.9971669316291809
rescues O 1 0.988716185092926
the O 0 0.4324323832988739
gastrulation B-Disease 1 0.9998958110809326
defect I-Disease 1 0.9993576407432556
. O 0 0.06835382431745529

These O 0 0.02229679562151432
results O 0 0.015623415820300579
indicate O 0 0.014969203621149063
that O 0 0.010488131083548069
Smad4 O 1 0.8476966023445129
is O 0 0.010016455315053463
initially O 0 0.011268462985754013
required O 0 0.006990095600485802
for O 0 0.006974365562200546
the O 0 0.010520704090595245
differentiation O 0 0.026241721585392952
of O 0 0.015612165443599224
the O 0 0.14493787288665771
visceral O 1 0.9996811151504517
endoderm O 1 0.9994366765022278
and O 0 0.013298604637384415
that O 0 0.008810809813439846
the O 0 0.021591495722532272
gastrulation B-Disease 1 0.9999344348907471
defect I-Disease 1 0.9976014494895935
in O 0 0.013832548633217812
the O 0 0.040214959532022476
epiblast O 1 0.9999322891235352
is O 0 0.01785079389810562
secondary O 0 0.07492175698280334
and O 0 0.021473711356520653
non O 1 0.9641669392585754
- O 1 0.9997580647468567
cell O 0 0.1553547978401184
autonomous O 0 0.053031932562589645
. O 0 0.04141399264335632

Rescued O 0 0.15868473052978516
embryos O 0 0.0605841800570488
show O 0 0.06077878549695015
severe O 1 0.9996548891067505
anterior O 1 0.999983549118042
truncations O 1 0.9999668598175049
, O 0 0.20444896817207336
indicating O 0 0.030010800808668137
a O 0 0.01580211892724037
second O 0 0.019809117540717125
important O 0 0.011285616084933281
role O 0 0.01783914305269718
for O 0 0.014838275499641895
Smad4 O 1 0.9986862540245056
in O 0 0.02978440374135971
anterior O 1 0.9998373985290527
patterning O 1 0.9994714856147766
during O 1 0.717527449131012
embryogenesis O 1 0.9899091720581055
. O 0 0.061724282801151276

Prevalence O 1 0.9235186576843262
of O 0 0.0536080077290535
p16 O 1 0.9674295783042908
and O 0 0.0373079776763916
CDK4 O 1 0.9994125366210938
germline O 1 0.9872798919677734
mutations O 0 0.02904317155480385
in O 0 0.018331481143832207
48 O 1 0.9608920812606812
melanoma B-Disease 1 1.0
- O 1 0.9999957084655762
prone O 1 0.999651312828064
families O 0 0.0366586372256279
in O 0 0.024104425683617592
France O 0 0.18418866395950317
. O 0 0.03896728903055191

The O 0 0.06803170591592789
French O 1 0.9952566027641296
Familial B-Disease 1 0.9999985694885254
Melanoma I-Disease 1 1.0
Study O 1 0.9901222586631775
Group O 1 0.9740239381790161
. O 0 0.05093026161193848

Germline O 1 0.550656795501709
mutations O 0 0.04081214964389801
in O 0 0.018960315734148026
the O 0 0.023612096905708313
p16 O 1 0.9786185026168823
and O 0 0.02522466331720352
CDK4 O 1 0.9995530247688293
genes O 0 0.013546745292842388
have O 0 0.005541483871638775
been O 0 0.0054438067600131035
reported O 0 0.006629364565014839
in O 0 0.005833516363054514
a O 0 0.01078785490244627
subset O 0 0.18946948647499084
of O 1 0.7701520919799805
melanoma B-Disease 1 1.0
pedigrees O 1 0.9980872273445129
, O 0 0.01722046546638012
but O 0 0.009035923518240452
their O 0 0.011030739173293114
prevalence O 1 0.9996486902236938
is O 0 0.014631637372076511
not O 0 0.010166959837079048
well O 0 0.013877044431865215
known O 0 0.023689990863204002
. O 0 0.028707748278975487

We O 0 0.027658771723508835
searched O 0 0.03188629448413849
for O 0 0.012449288740754128
such O 0 0.011509533040225506
germline O 0 0.06684691458940506
mutations O 0 0.0164785198867321
in O 0 0.010113507509231567
48 O 0 0.026408350095152855
French O 1 0.9987547397613525
melanoma B-Disease 1 1.0
- O 1 0.9999985694885254
prone O 1 0.9993997812271118
families O 0 0.01657518930733204
selected O 0 0.010984129272401333
according O 0 0.006443399004638195
to O 0 0.005652800668030977
two O 0 0.005921198055148125
major O 0 0.010865465737879276
criteria O 0 0.011062411591410637
families O 0 0.008650930598378181
with O 0 0.00631960853934288
at O 0 0.007258268538862467
least O 0 0.005302599165588617
three O 0 0.006020048167556524
affected O 0 0.010216747410595417
members O 0 0.01105966791510582
( O 0 0.016736436635255814
n O 0 0.028083648532629013
= O 0 0.019815431907773018
20 O 0 0.011103447526693344
) O 0 0.008845163509249687
or O 0 0.006321956403553486
families O 0 0.006970172747969627
with O 0 0.005785353947430849
two O 0 0.006291117984801531
affected O 0 0.011301993392407894
members O 0 0.008629030548036098
, O 0 0.006398783531039953
one O 0 0.005342358257621527
of O 0 0.006101617589592934
them O 0 0.005396631546318531
affected O 0 0.007948567159473896
before O 0 0.006504682824015617
the O 0 0.007082599215209484
age O 0 0.008826088160276413
of O 0 0.0086637232452631
50 O 0 0.015196510590612888
( O 0 0.019313694909214973
n O 0 0.030284272506833076
= O 0 0.0221105869859457
28 O 0 0.014713654294610023
) O 0 0.010314017534255981
, O 0 0.008604135364294052
and O 0 0.008807561360299587
one O 0 0.011933033354580402
additional O 0 0.017850803211331367
minor O 0 0.18411073088645935
criterion O 1 0.9697753190994263
. O 0 0.04734182357788086

Sixteen O 0 0.07537751644849777
different O 0 0.0254671610891819
p16 O 1 0.9769080877304077
germline O 1 0.9391716718673706
mutations O 0 0.023186467587947845
were O 0 0.010213319212198257
found O 0 0.008664547465741634
in O 0 0.007026637904345989
21 O 0 0.012469641864299774
families O 0 0.010238227434456348
, O 0 0.007073256652802229
while O 0 0.007693684194236994
one O 0 0.011523901484906673
germline O 1 0.9863588213920593
mutation O 0 0.1611092984676361
, O 0 0.01679128408432007
Arg24His O 1 0.9936854243278503
, O 0 0.0134032117202878
was O 0 0.017164476215839386
detected O 0 0.016878968104720116
in O 0 0.010842201299965382
the O 0 0.022470686584711075
CDK4 O 1 0.9992796778678894
gene O 0 0.046998877078294754
. O 0 0.03667367622256279

The O 0 0.03691503405570984
frequency O 0 0.027883701026439667
of O 0 0.024335838854312897
p16 O 1 0.9397814869880676
gene O 0 0.022684315219521523
mutation O 0 0.017432842403650284
in O 0 0.00797325000166893
our O 0 0.011305371299386024
sample O 0 0.012593998573720455
( O 0 0.011486412025988102
44 O 0 0.014254181645810604
% O 0 0.010321779176592827
) O 0 0.007561194244772196
is O 0 0.005752223543822765
among O 0 0.006522409617900848
the O 0 0.007797222584486008
highest O 0 0.021654948592185974
rates O 0 0.009201820939779282
yet O 0 0.00720062293112278
reported O 0 0.007912177592515945
and O 0 0.007499016355723143
the O 0 0.012697857804596424
CDK4 O 1 0.9997217059135437
mutation O 0 0.022601068019866943
is O 0 0.008173046633601189
the O 0 0.009534618817269802
second O 0 0.025646507740020752
mutation O 0 0.05223706737160683
detected O 0 0.015850039198994637
in O 0 0.00961760152131319
this O 0 0.010902795940637589
gene O 0 0.022602679207921028
worldwide O 0 0.029218140989542007
. O 0 0.031839918345212936

In O 0 0.0290011465549469
summary O 0 0.029887868091464043
, O 0 0.016320832073688507
our O 0 0.014642477035522461
results O 0 0.010462157428264618
show O 0 0.01214112900197506
frequent O 0 0.015522495843470097
involvement O 0 0.017280714586377144
of O 0 0.011101844720542431
the O 0 0.026401203125715256
p16 O 1 0.9985765218734741
gene O 0 0.03396500274538994
in O 0 0.024720298126339912
familial B-Disease 1 0.9999988079071045
melanoma I-Disease 1 0.9999998807907104
and O 0 0.07019490003585815
confirm O 0 0.014174271374940872
the O 0 0.008834055624902248
role O 0 0.009973254054784775
of O 0 0.008717398159205914
the O 0 0.014824236743152142
CDK4 O 1 0.9993960857391357
gene O 0 0.015876546502113342
as O 0 0.014182842336595058
a O 1 0.5798332095146179
melanoma B-Disease 1 0.9999998807907104
- O 1 0.9999948740005493
predisposing O 1 0.9997205138206482
gene O 0 0.03972678631544113
. O 0 0.022060927003622055
. O 0 0.03034057281911373

Progression O 1 0.8893982768058777
of O 0 0.0907968208193779
somatic O 1 0.9990334510803223
CTG O 1 0.9998857975006104
repeat O 1 0.5237170457839966
length O 0 0.02584224008023739
heterogeneity O 0 0.04223064333200455
in O 0 0.013398470357060432
the O 0 0.02516287751495838
blood O 1 0.9988042116165161
cells O 1 0.9673076272010803
of O 1 0.9997157454490662
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999943971633911
. O 1 0.8129660487174988

The O 0 0.03154982626438141
genetic O 0 0.024312231689691544
basis O 0 0.021109795197844505
of O 1 0.9906043410301208
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999988079071045
DM B-Disease 1 1.0
) O 0 0.02467115968465805
is O 0 0.007949012331664562
the O 0 0.007798975333571434
expansion O 0 0.012391718104481697
of O 0 0.011014283634722233
an O 0 0.10440279543399811
unstable O 1 0.9999176263809204
CTG O 1 0.9999071359634399
repeat O 0 0.03212031349539757
in O 0 0.009738614782691002
the O 0 0.010784312151372433
34 O 0 0.020941413938999176
UTR O 0 0.0764644518494606
of O 0 0.01708991639316082
the O 0 0.14610853791236877
DM B-Disease 1 0.9999991655349731
protein O 0 0.04675954580307007
kinase O 0 0.12021087110042572
gene O 0 0.02684411220252514
on O 0 0.02263232134282589
chromosome O 0 0.04666467383503914
19 O 0 0.04097021371126175
. O 0 0.037963125854730606

One O 0 0.021746451035141945
of O 0 0.016252467408776283
the O 0 0.016438959166407585
principal O 0 0.026950234547257423
features O 0 0.013871114701032639
of O 0 0.01695716381072998
the O 1 0.986903190612793
DM B-Disease 1 1.0
mutation O 1 0.9497488141059875
is O 0 0.010897325351834297
an O 0 0.009657146409153938
extraordinarily O 1 0.5622792840003967
high O 0 0.024464787915349007
level O 0 0.01790628768503666
of O 0 0.294808030128479
somatic O 1 0.9998626708984375
mosaicism O 1 0.9999279975891113
, O 0 0.01500024925917387
due O 0 0.010226858779788017
to O 0 0.008711861446499825
an O 0 0.008781872689723969
extremely O 0 0.013866685330867767
high O 0 0.016395356506109238
degree O 0 0.018235964700579643
of O 0 0.24087534844875336
somatic O 1 0.9995964169502258
instability O 1 0.9843230843544006
both O 0 0.013528426177799702
within O 0 0.014288687147200108
and O 0 0.014186031185090542
between O 0 0.017920279875397682
different O 0 0.013356291688978672
tissues O 0 0.11203981935977936
. O 0 0.03582620993256569

This O 0 0.0384863056242466
instability O 1 0.9224374294281006
appears O 0 0.02823026105761528
to O 0 0.012319901958107948
be O 0 0.008729025721549988
biased O 0 0.018619973212480545
towards O 0 0.01384567841887474
further O 0 0.009570304304361343
expansion O 0 0.013549957424402237
and O 0 0.007856654934585094
continuous O 0 0.013821701519191265
throughout O 0 0.00830213725566864
the O 0 0.0078624552115798
life O 0 0.010527962818741798
of O 0 0.009447679854929447
an O 0 0.01681460067629814
individual O 0 0.012647997587919235
, O 0 0.008842773735523224
features O 0 0.009039906784892082
that O 0 0.004060099367052317
could O 0 0.004611445125192404
be O 0 0.00391178485006094
associated O 0 0.0054413024336099625
with O 0 0.006081088911741972
the O 0 0.011520647443830967
progressive O 1 0.9837446212768555
nature O 0 0.03156915679574013
of O 0 0.24013207852840424
the O 1 0.9910181760787964
disease O 1 0.9999942779541016
. O 0 0.3366832435131073

Although O 0 0.02675568126142025
increasing O 0 0.02605319395661354
measured O 0 0.024781806394457817
allele O 0 0.03518594056367874
size O 0 0.01564687117934227
between O 0 0.01598801463842392
patients O 1 0.8807743191719055
clearly O 0 0.01537950150668621
correlates O 0 0.025847001001238823
with O 0 0.009336689487099648
an O 0 0.012209461070597172
increased O 0 0.15945065021514893
severity O 1 0.9998027682304382
of O 1 0.9900688529014587
symptoms O 1 0.9999946355819702
and O 0 0.037072088569402695
an O 0 0.013915386982262135
earlier O 0 0.013009623624384403
age O 0 0.3130263090133667
of O 1 0.7764512896537781
onset O 1 0.9999988079071045
, O 0 0.05923666059970856
this O 0 0.007677403744310141
correlation O 0 0.013506240211427212
is O 0 0.006726429332047701
not O 0 0.005395245272666216
precise O 0 0.008749481290578842
and O 0 0.007854076102375984
measured O 0 0.01253980677574873
allele O 0 0.02086517959833145
length O 0 0.00980215985327959
cannot O 0 0.00757976621389389
be O 0 0.004994847346097231
used O 0 0.005602037999778986
as O 0 0.0063219228759408
an O 0 0.008480221964418888
accurate O 0 0.01607566885650158
predictor O 0 0.36734873056411743
of O 0 0.017529156059026718
age O 0 0.15767833590507507
of O 1 0.6075893044471741
onset O 1 0.9999891519546509
. O 0 0.19673550128936768

In O 0 0.025000831112265587
order O 0 0.019477244466543198
to O 0 0.011456051841378212
further O 0 0.01085360161960125
characterize O 0 0.022383373230695724
the O 0 0.015019156038761139
dynamics O 0 0.04203278198838234
of O 1 0.851582944393158
DM B-Disease 1 1.0
CTG O 1 0.9999979734420776
repeat O 1 0.9994931221008301
somatic O 1 0.9983843564987183
instability O 1 0.9817425012588501
, O 0 0.01398890558630228
we O 0 0.007764418609440327
have O 0 0.006060827523469925
studied O 0 0.010499588213860989
repeat O 0 0.0155381690710783
length O 0 0.008754643611609936
changes O 0 0.005961492192000151
over O 0 0.006911950651556253
time O 0 0.008747885003685951
in O 0 0.013818919658660889
111 O 1 0.9998668432235718
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999723434448242
with O 0 0.4627113938331604
varying O 0 0.3401319086551666
clinical O 1 0.9998002648353577
severity O 1 0.9999135732650757
and O 1 0.9375423789024353
CTG O 1 0.9999920129776001
repeat O 0 0.37848639488220215
size O 0 0.011875375173985958
over O 0 0.008760372176766396
time O 0 0.007847226224839687
intervals O 0 0.011341908946633339
of O 0 0.011807316914200783
1 O 0 0.024814041331410408
- O 1 0.8669216632843018
7 O 0 0.027521934360265732
years O 0 0.02532687783241272
. O 0 0.03241022676229477

We O 0 0.02267114445567131
have O 0 0.009868083521723747
found O 0 0.00914070662111044
a O 0 0.012330989353358746
direct O 0 0.014838797971606255
progression O 1 0.7961679697036743
of O 0 0.012646757997572422
the O 0 0.015718169510364532
size O 0 0.014469261281192303
heterogeneity O 0 0.06936965137720108
over O 0 0.01075340248644352
time O 0 0.008463751524686813
related O 0 0.008966273628175259
to O 0 0.010126142762601376
initial O 0 0.029074734076857567
CTG O 1 0.9994577765464783
repeat O 0 0.038981299847364426
size O 0 0.013067611493170261
and O 0 0.009384417906403542
the O 0 0.011735963635146618
time O 0 0.01288522407412529
interval O 0 0.025011667981743813
and O 0 0.013937374576926231
always O 0 0.019679011777043343
biased O 0 0.029072122648358345
towards O 0 0.02421989105641842
further O 0 0.022179996594786644
expansion O 0 0.0433369018137455
. O 0 0.03874420002102852

Attempts O 0 0.052834611386060715
to O 0 0.022057194262742996
mathematically O 0 0.029294563457369804
model O 0 0.02101169154047966
the O 0 0.015454372391104698
dynamics O 0 0.02246658131480217
have O 0 0.008532357402145863
proved O 0 0.015607848763465881
only O 0 0.008856282569468021
partially O 0 0.020558778196573257
successful O 0 0.01531887985765934
suggesting O 0 0.011612543836236
that O 0 0.005429935175925493
individual O 0 0.007354958914220333
specific O 0 0.007634658832103014
genetic O 0 0.018939580768346786
and O 0 0.10459806025028229
/ O 1 0.9999055862426758
or O 0 0.014910208992660046
environmental O 0 0.030255412682890892
factors O 0 0.009029422886669636
also O 0 0.00723066134378314
play O 0 0.008550150319933891
a O 0 0.011812502518296242
role O 0 0.022884422913193703
in O 0 0.02246994338929653
somatic O 1 0.9943866729736328
mosaicism O 1 0.9995737671852112
. O 0 0.031321898102760315
. O 0 0.03959561511874199

Aspartylglucosaminuria B-Disease 1 0.9967179894447327
among O 0 0.07323217391967773
Palestinian O 0 0.10205497592687607
Arabs O 0 0.11153525114059448
. O 0 0.06276412308216095

Aspartylglucosaminuria B-Disease 1 0.9999451637268066
( O 1 0.9950947761535645
AGU B-Disease 1 0.9999879598617554
) O 0 0.023959871381521225
is O 0 0.01358106266707182
a O 0 0.020089101046323776
rare O 1 0.9774697422981262
disorder B-Disease 1 0.999998927116394
of I-Disease 1 0.9997038245201111
glycoprotein I-Disease 1 0.9999988079071045
metabolism I-Disease 1 0.9992572665214539
caused O 1 0.7517233490943909
by O 0 0.0173021387308836
the O 1 0.7571592330932617
deficiency B-Disease 1 0.999998927116394
of I-Disease 1 0.8932972550392151
the I-Disease 1 0.9996917247772217
lysosomal I-Disease 1 0.9999998807907104
enzyme I-Disease 1 0.9999467134475708
aspartylglucosaminidase I-Disease 1 0.99998939037323
( O 1 0.9828041791915894
AGA O 1 0.9999246597290039
) O 0 0.042730748653411865
. O 0 0.03772066533565521

AGU B-Disease 1 0.9998726844787598
is O 0 0.04148811101913452
inherited O 1 0.9742037057876587
as O 0 0.04017291218042374
an O 1 0.9938615560531616
autosomal O 1 0.9999998807907104
recessive O 1 0.9999998807907104
trait O 1 0.9999856948852539
and O 1 0.7287763953208923
occurs O 0 0.02307060919702053
with O 0 0.009640933945775032
a O 0 0.01616511680185795
high O 0 0.03455499932169914
frequency O 0 0.009859269484877586
in O 0 0.006969541776925325
Finland O 0 0.019710464403033257
because O 0 0.008552608080208302
of O 0 0.011950801126658916
a O 0 0.029124822467565536
founder O 1 0.9965178966522217
effect O 0 0.03776552900671959
. O 0 0.03270500898361206

While O 0 0.031900398433208466
very O 0 0.02155209518969059
few O 0 0.01960674673318863
patients O 1 0.9852764010429382
with O 0 0.4410066604614258
AGU B-Disease 1 0.9999978542327881
have O 0 0.008776797913014889
been O 0 0.007434467785060406
reported O 0 0.008816090412437916
from O 0 0.008122565224766731
non O 0 0.03900177776813507
- O 1 0.9626304507255554
Finnish O 0 0.176434725522995
origin O 0 0.010132419876754284
, O 0 0.009608975611627102
we O 0 0.01048901118338108
diagnosed O 1 0.999894380569458
the O 0 0.2826871871948242
disorder O 1 0.9999934434890747
in O 0 0.047736406326293945
8 O 1 0.6044700145721436
patients O 1 0.8821109533309937
originating O 0 0.019762272015213966
from O 0 0.00973123125731945
3 O 0 0.013612529262900352
unrelated O 0 0.016442498192191124
families O 0 0.011075815185904503
, O 0 0.008405311033129692
all O 0 0.007202859036624432
Palestinian O 0 0.020878365263342857
Arabs O 0 0.018737033009529114
from O 0 0.010495472699403763
the O 0 0.014235374517738819
region O 0 0.021414725109934807
of O 0 0.024539940059185028
Jerusalem O 1 0.7681484222412109
. O 0 0.04303104802966118

The O 0 0.05686904117465019
clinical O 1 0.9990469813346863
diagnosis O 1 0.999994158744812
of O 1 0.9998326301574707
AGU B-Disease 1 1.0
is O 1 0.7980265617370605
often O 0 0.01163930632174015
difficult O 0 0.011646542698144913
, O 0 0.007780764251947403
in O 0 0.005364300683140755
particular O 0 0.0052018905989825726
early O 0 0.005171630531549454
in O 0 0.004357025492936373
the O 0 0.0065528531558811665
course O 0 0.012724786065518856
of O 0 0.02629866637289524
the O 1 0.986713171005249
disease O 1 0.9999980926513672
, O 0 0.022612422704696655
and O 0 0.006719659082591534
most O 0 0.005656793247908354
of O 0 0.02706601470708847
the O 1 0.9815550446510315
patients O 1 0.9999704360961914
are O 0 0.013267893344163895
diagnosed O 1 0.9999667406082153
after O 0 0.03302857652306557
the O 0 0.021853836253285408
age O 0 0.03907841444015503
of O 0 0.019500361755490303
5 O 0 0.0263228602707386
years O 0 0.02586418390274048
. O 0 0.03303990885615349

However O 0 0.028619060292840004
, O 0 0.02003053016960621
since O 0 0.017216358333826065
these O 0 0.013587228953838348
patients O 1 0.8801190257072449
excrete O 1 0.6668102741241455
early O 0 0.013274948112666607
large O 0 0.010196361690759659
amounts O 0 0.008920940570533276
of O 0 0.012654847465455532
aspartylglucosamine O 1 0.9870453476905823
in O 0 0.015288138762116432
urine O 1 0.5187819004058838
, O 0 0.01705693081021309
biochemical O 0 0.06558242440223694
screening O 0 0.07377957552671432
is O 0 0.013885869644582272
easy O 0 0.024334311485290527
by O 0 0.021241137757897377
urine O 0 0.4806753993034363
chromatography O 1 0.7849971055984497
. O 0 0.028253629803657532
. O 0 0.034915436059236526

Detection O 0 0.06085578352212906
of O 0 0.028591042384505272
heterozygous O 0 0.03956139460206032
carriers O 0 0.025973068550229073
of O 0 0.01762966811656952
the O 1 0.6327622532844543
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999995231628418
telangiectasia I-Disease 1 0.9999996423721313
( O 1 0.7928209900856018
ATM O 1 0.7061014175415039
) O 0 0.014550989493727684
gene O 0 0.01323423720896244
by O 0 0.016105661168694496
G2 O 1 0.9996520280838013
phase O 1 0.8360700011253357
chromosomal O 1 0.9923279881477356
radiosensitivity O 1 0.9987550973892212
of O 1 0.9724358320236206
peripheral O 1 0.9999969005584717
blood O 1 0.9999626874923706
lymphocytes O 1 0.9999350309371948
. O 0 0.06037139147520065

In O 0 0.05335674434900284
ataxia B-Disease 1 0.9999899864196777
- I-Disease 1 0.9999842643737793
telangiectasia I-Disease 1 0.999995231628418
( O 1 0.9572871923446655
A B-Disease 1 0.9999076128005981
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.9999986886978149
) O 0 0.03649837523698807
patients O 0 0.46533384919166565
, O 0 0.008949396200478077
mutations O 0 0.009440979920327663
in O 0 0.005697084590792656
a O 0 0.008576997555792332
single O 0 0.02100987546145916
gene O 0 0.01202723290771246
, O 0 0.00904194638133049
ATM O 0 0.021796293556690216
, O 0 0.006499098148196936
result O 0 0.006780034862458706
in O 0 0.009060810320079327
an O 1 0.8984478116035461
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.7123660445213318
embraces O 1 0.9973598122596741
a O 0 0.029962243512272835
variety O 0 0.012285090051591396
of O 0 0.01716924086213112
clinical O 1 0.9774273633956909
features O 0 0.06278079003095627
and O 0 0.038714323192834854
manifests O 1 0.9936816692352295
extreme O 1 0.9923778772354126
radiosensitivity O 1 0.999482274055481
and O 0 0.014113658107817173
a O 0 0.017887767404317856
strong O 0 0.08543570339679718
pre O 1 0.9991746544837952
- O 1 0.9999600648880005
disposition O 1 0.9986339211463928
to O 0 0.04890332370996475
malignancy B-Disease 1 0.9998397827148438
. O 0 0.04913933202624321

Heterozygotes O 0 0.2853383421897888
for O 0 0.023019840940833092
the O 0 0.02558247745037079
ATM O 1 0.7448351979255676
gene O 0 0.014869061298668385
have O 0 0.006928453221917152
no O 0 0.007304219529032707
clinical O 0 0.014074249193072319
expression O 0 0.01000596396625042
of O 0 0.015703553333878517
A B-Disease 1 0.9999634027481079
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.999994158744812
but O 0 0.009819946251809597
may O 0 0.011116020381450653
be O 0 0.010676458477973938
cancer B-Disease 1 0.9999277591705322
prone O 1 0.9839950799942017
with O 0 0.014339111745357513
a O 0 0.08157902210950851
moderate O 1 0.8457698822021484
increase O 0 0.015128652565181255
in O 0 0.012368752621114254
in O 0 0.017993396148085594
vitro O 0 0.19041556119918823
radiosensitivity O 1 0.9647302031517029
. O 0 0.04289457947015762

We O 0 0.030846601352095604
performed O 0 0.03488164767622948
a O 0 0.025747019797563553
blind O 1 0.8283420205116272
chromosomal O 0 0.23979635536670685
analysis O 0 0.015785226598381996
on O 0 0.020201852545142174
G2 O 1 0.9999923706054688
- O 1 0.9993558526039124
phase O 1 0.763136088848114
lymphocytes O 1 0.7008318901062012
from O 0 0.010743362829089165
7 O 0 0.017225800082087517
unrelated O 0 0.028890859335660934
A B-Disease 1 0.9991649389266968
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999929666519165
patients O 1 0.7682810425758362
, O 0 0.011119643226265907
13 O 0 0.016060644760727882
obligate O 0 0.38836219906806946
A B-Disease 1 0.9991540908813477
- I-Disease 1 0.9999985694885254
T I-Disease 1 0.9999961853027344
heterozygotes O 1 0.9949986934661865
( O 0 0.01547328382730484
parents O 0 0.01278392132371664
of O 0 0.010905212722718716
the O 0 0.2433198094367981
patients O 1 0.99868243932724
) O 0 0.011313864961266518
, O 0 0.0068074059672653675
and O 0 0.0062804133631289005
14 O 0 0.00972596276551485
normal O 0 0.008871757425367832
controls O 0 0.013724417425692081
following O 0 0.014783080667257309
X O 1 0.9645285606384277
- O 1 0.9918124675750732
irradiation O 0 0.03328613564372063
with O 0 0.010602008551359177
1 O 0 0.02043132111430168
Gy O 0 0.44049832224845886
in O 0 0.010309234261512756
order O 0 0.011497586965560913
to O 0 0.008909872733056545
evaluate O 0 0.01699170283973217
this O 0 0.009621494449675083
cytogenetic O 0 0.1781572550535202
method O 0 0.012766961939632893
as O 0 0.009594714269042015
a O 0 0.013972898945212364
tool O 0 0.025171762332320213
for O 0 0.013935893774032593
detection O 0 0.03938231244683266
of O 0 0.03209752216935158
ATM O 1 0.9227423071861267
carriers O 0 0.062100257724523544
. O 0 0.04202784597873688

Both O 0 0.03853001445531845
A B-Disease 1 0.9944165945053101
- I-Disease 1 0.9999961853027344
T I-Disease 1 0.9999924898147583
homozygotes O 1 0.9987576007843018
and O 0 0.027473390102386475
heterozygotes O 1 0.9472935199737549
showed O 0 0.016941102221608162
significantly O 0 0.011214043945074081
increased O 0 0.009999456815421581
levels O 0 0.012317475862801075
of O 0 0.024931976571679115
radiation O 1 0.9999529123306274
- O 1 0.9999963045120239
induced O 1 0.9999899864196777
chromatid O 1 0.9999889135360718
damage O 1 0.685386598110199
relative O 0 0.020300118252635002
to O 0 0.009402617812156677
that O 0 0.007259683683514595
of O 0 0.01341811940073967
normal O 0 0.028649484738707542
controls O 0 0.04859944432973862
. O 0 0.03464340418577194

These O 0 0.01967542991042137
results O 0 0.014642477035522461
show O 0 0.01419685035943985
that O 0 0.008717460557818413
the O 0 0.019871454685926437
G2 O 1 0.9999728202819824
- O 1 0.9996079802513123
phase O 1 0.985002338886261
chromosomal O 1 0.9983391761779785
radiosensitivity O 1 0.999448835849762
assay O 0 0.17179135978221893
can O 0 0.008512848056852818
be O 0 0.005352559499442577
used O 0 0.004942921921610832
for O 0 0.005729322787374258
the O 0 0.009097352623939514
detection O 0 0.023620860651135445
of O 0 0.02187090925872326
A B-Disease 1 0.9998660087585449
- I-Disease 1 0.9999955892562866
T I-Disease 1 0.9999699592590332
heterozygotes O 1 0.9863016605377197
. O 0 0.05097132548689842

In O 0 0.027669096365571022
combination O 0 0.03143491595983505
with O 0 0.016793878749012947
molecular O 0 0.025800080969929695
genetic O 0 0.021434035152196884
analyses O 0 0.011898494325578213
, O 0 0.0075654322281479836
this O 0 0.005463177803903818
test O 0 0.00919981300830841
may O 0 0.005456813145428896
be O 0 0.00293864612467587
of O 0 0.004434308502823114
value O 0 0.005060744937509298
in O 0 0.0047738216817379
studies O 0 0.006041784305125475
of O 0 0.013162742368876934
familial B-Disease 1 0.9999843835830688
and I-Disease 1 0.8977442979812622
sporadic I-Disease 1 0.9998520612716675
cancers I-Disease 1 0.9999841451644897
aimed O 0 0.3794940710067749
at O 0 0.015083136968314648
determination O 0 0.019349684938788414
of O 0 0.008053705096244812
the O 0 0.009567438624799252
potential O 0 0.01092478446662426
involvement O 0 0.027412842959165573
of O 0 0.03340262547135353
ATM O 1 0.999704897403717
mutations O 1 0.5266609191894531
in O 0 0.15622186660766602
tumor B-Disease 1 0.9999955892562866
risk O 1 0.9867520332336426
or O 0 0.022952890023589134
development O 0 0.031126422807574272
. O 0 0.020182456821203232
. O 0 0.02855542302131653

Ataxia B-Disease 1 0.9999979734420776
- I-Disease 1 0.9999924898147583
telangiectasia I-Disease 1 0.9999850988388062
: O 0 0.03192485496401787
identification O 0 0.01793309859931469
and O 0 0.011725632473826408
detection O 0 0.022952262312173843
of O 0 0.018174143508076668
founder O 1 0.9998102784156799
- O 1 0.9993466734886169
effect O 0 0.01585274003446102
mutations O 0 0.011763714253902435
in O 0 0.00683005154132843
the O 0 0.013979063369333744
ATM O 1 0.6991273164749146
gene O 0 0.016586909070611
in O 0 0.012008516117930412
ethnic O 0 0.02662447839975357
populations O 0 0.030368633568286896
. O 0 0.035675499588251114

To O 0 0.029038546606898308
facilitate O 0 0.02870693802833557
the O 0 0.019164854660630226
evaluation O 0 0.0378054715692997
of O 0 0.02664944715797901
ATM O 1 0.9944372177124023
heterozygotes O 1 0.9551581740379333
for O 0 0.014987901784479618
susceptibility O 1 0.6870378255844116
to O 0 0.01120805460959673
other O 0 0.010807962156832218
diseases O 1 0.999790370464325
, O 0 0.02097930759191513
such O 0 0.024973740801215172
as O 1 0.9990884065628052
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.3141918182373047
we O 0 0.00778241315856576
have O 0 0.005232993047684431
attempted O 0 0.011146536096930504
to O 0 0.007281545549631119
define O 0 0.01163677591830492
the O 0 0.008020813576877117
most O 0 0.007293384987860918
common O 0 0.009043009020388126
mutations O 0 0.00837685540318489
and O 0 0.005280316807329655
their O 0 0.0054087513126432896
frequencies O 0 0.009560014121234417
in O 0 0.012364880181849003
ataxia B-Disease 1 0.9999973773956299
- I-Disease 1 0.9999973773956299
telangiectasia I-Disease 1 0.9999991655349731
( O 1 0.9123032093048096
A B-Disease 1 0.9997298121452332
- I-Disease 1 0.9999967813491821
T I-Disease 1 0.9999685287475586
) O 0 0.022250814363360405
homozygotes O 0 0.25548067688941956
from O 0 0.014793871901929379
10 O 0 0.018552476540207863
ethnic O 0 0.02814936637878418
populations O 0 0.03287317976355553
. O 0 0.03654914349317551

Both O 0 0.04110376909375191
genomic O 0 0.06508651375770569
mutations O 0 0.029859760776162148
and O 0 0.014753823168575764
their O 0 0.014658420346677303
effects O 0 0.02532961592078209
on O 0 0.02095596119761467
cDNA O 0 0.0641157254576683
were O 0 0.02417507953941822
characterized O 0 0.053627390414476395
. O 0 0.04097378998994827

Protein O 0 0.07169487327337265
- O 0 0.44561144709587097
truncation O 0 0.06535719335079193
testing O 0 0.020244700834155083
of O 0 0.013166174292564392
the O 0 0.01645221747457981
entire O 0 0.03230976685881615
ATM O 0 0.13386328518390656
cDNA O 0 0.04992678016424179
detected O 0 0.026475166901946068
92 O 0 0.038542382419109344
( O 0 0.024269212037324905
66 O 0 0.03149266168475151
% O 0 0.019803209230303764
) O 0 0.01993226259946823
truncating O 0 0.0659099817276001
mutations O 0 0.02377261221408844
in O 0 0.01705923117697239
140 O 0 0.0438520647585392
mutant O 1 0.7519179582595825
alleles O 0 0.08466977626085281
screened O 0 0.09650968760251999
. O 0 0.052144650369882584

The O 0 0.043452225625514984
haplotyping O 1 0.9747673273086548
of O 0 0.04966328293085098
patients O 1 0.9832215309143066
with O 0 0.026909785345196724
identical O 0 0.21682539582252502
mutations O 0 0.14597412943840027
indicates O 0 0.012634200975298882
that O 0 0.003889459650963545
almost O 0 0.004512392450124025
all O 0 0.00417308509349823
of O 0 0.005632627289742231
these O 0 0.0043313042260706425
represent O 0 0.007798067294061184
common O 0 0.010664287023246288
ancestry O 0 0.01475351769477129
and O 0 0.007980939000844955
that O 0 0.00627922872081399
very O 0 0.009100465103983879
few O 0 0.013943222351372242
spontaneously O 1 0.878521203994751
recurring O 1 0.998680055141449
ATM O 1 0.993540346622467
mutations O 0 0.0460243746638298
exist O 0 0.028042655438184738
. O 0 0.033339958637952805

Assays O 0 0.07020119577646255
requiring O 0 0.03901439905166626
minimal O 0 0.030875451862812042
amounts O 0 0.018384234979748726
of O 0 0.01498777512460947
genomic O 0 0.028006678447127342
DNA O 0 0.015791302546858788
were O 0 0.009459446184337139
designed O 0 0.01593930646777153
to O 0 0.011214560829102993
allow O 0 0.015248585492372513
rapid O 0 0.10916246473789215
screening O 0 0.06042727828025818
for O 0 0.017748475074768066
common O 0 0.026156747713685036
ethnic O 0 0.04641591012477875
mutations O 0 0.05707154795527458
. O 0 0.039140671491622925

These O 0 0.025921525433659554
rapid O 0 0.05662389099597931
assays O 0 0.03369685634970665
detected O 0 0.023663876578211784
mutations O 0 0.013146642595529556
in O 0 0.007216269616037607
76 O 0 0.017153862863779068
% O 0 0.009661588817834854
of O 0 0.011335333809256554
Costa O 1 0.640633761882782
Rican O 1 0.9867521524429321
patients O 1 0.9883650541305542
( O 0 0.01895107701420784
3 O 0 0.013388250023126602
) O 0 0.009290510788559914
, O 0 0.006205404177308083
50 O 0 0.00743893114849925
% O 0 0.007183965761214495
of O 0 0.00935276597738266
Norwegian O 0 0.16544091701507568
patients O 1 0.9710124731063843
( O 0 0.016743091866374016
1 O 0 0.012578149326145649
) O 0 0.007436058018356562
, O 0 0.006208752281963825
25 O 0 0.0077033634297549725
% O 0 0.0076880548149347305
of O 0 0.010973894037306309
Polish O 1 0.9976820945739746
patients O 1 0.9989532232284546
( O 0 0.05734425410628319
4 O 0 0.014963029883801937
) O 0 0.008029567077755928
, O 0 0.005807518493384123
and O 0 0.0050905984826385975
14 O 0 0.007992643862962723
% O 0 0.007953803986310959
of O 0 0.010095136240124702
Italian O 1 0.9879862666130066
patients O 1 0.9981643557548523
( O 0 0.11307457089424133
1 O 0 0.01815808191895485
) O 0 0.008364926092326641
, O 0 0.0060011884197592735
as O 0 0.004596380982547998
well O 0 0.00480511924251914
as O 0 0.005258217919617891
in O 0 0.006647791247814894
patients O 0 0.0807715430855751
of O 0 0.03879513591527939
Amish O 1 0.9997336268424988
/ O 1 0.9997798800468445
Mennonite O 1 0.9023728966712952
and O 0 0.02372765727341175
Irish O 0 0.05595531687140465
English O 0 0.033619098365306854
backgrounds O 0 0.04677242785692215
. O 0 0.035826798528432846

Additional O 0 0.037567589432001114
mutations O 0 0.026391517370939255
were O 0 0.011699817143380642
observed O 0 0.012517265975475311
in O 0 0.009381846524775028
Japanese O 0 0.019196314737200737
, O 0 0.013871322385966778
Utah O 0 0.03005300648510456
Mormon O 0 0.0444612018764019
, O 0 0.015585379675030708
and O 0 0.01496930792927742
African O 0 0.04097716137766838
American O 0 0.29809242486953735
patients O 1 0.9860665202140808
. O 0 0.046223707497119904

These O 0 0.023673027753829956
assays O 0 0.03012005239725113
should O 0 0.015727393329143524
facilitate O 0 0.023943061009049416
screening O 0 0.028085459023714066
for O 0 0.01606498658657074
A B-Disease 1 0.9990849494934082
- I-Disease 1 0.9999942779541016
T I-Disease 1 0.999967098236084
heterozygotes O 1 0.5555213093757629
in O 0 0.012209351174533367
the O 0 0.016022533178329468
populations O 0 0.019247183576226234
studied O 0 0.02427947334945202
. O 0 0.01991857960820198
. O 0 0.031777963042259216

The O 0 0.058158572763204575
von B-Disease 1 0.9679102301597595
Hippel I-Disease 1 0.9999139308929443
- I-Disease 1 0.9999958276748657
Lindau I-Disease 1 0.9999972581863403
tumor I-Disease 1 0.9999988079071045
suppressor O 1 0.999966025352478
gene O 0 0.030763395130634308
is O 0 0.013100034557282925
required O 0 0.012596852146089077
for O 0 0.01320512592792511
cell O 0 0.040642086416482925
cycle O 0 0.05235220119357109
exit O 0 0.058834243565797806
upon O 0 0.03840602561831474
serum O 1 0.9948523640632629
withdrawal O 1 0.6021631360054016
. O 0 0.04473467543721199

The O 0 0.04529441520571709
inactivation O 0 0.3391033113002777
of O 0 0.028038347139954567
the O 0 0.03550255671143532
von B-Disease 1 0.9977351427078247
Hippel I-Disease 1 0.9999630451202393
- I-Disease 1 0.9999860525131226
Lindau I-Disease 1 0.9999854564666748
( I-Disease 1 0.98501056432724
VHL I-Disease 1 0.9999890327453613
) I-Disease 1 0.9097403883934021
tumor I-Disease 1 0.999991774559021
suppressor O 1 0.9999550580978394
gene O 0 0.18755003809928894
predisposes O 1 0.941435694694519
affected O 0 0.015490414574742317
individuals O 0 0.008327695541083813
to O 0 0.0077005717903375626
the O 0 0.03223010525107384
human O 1 0.9998217225074768
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.7833197712898254
is O 0 0.025204814970493317
associated O 0 0.013892341405153275
with O 0 0.030105391517281532
sporadic B-Disease 1 0.9999094009399414
renal I-Disease 1 1.0
cell I-Disease 1 0.9999995231628418
carcinomas I-Disease 1 1.0
( O 1 0.9999866485595703
RCC B-Disease 1 0.9999998807907104
) O 0 0.4137260913848877
and O 0 0.048640090972185135
brain B-Disease 1 0.9904413223266602
hemangioblastomas I-Disease 1 0.995422899723053
. O 0 0.045720260590314865

VHL O 1 0.9986844658851624
- O 1 0.9710736274719238
negative O 0 0.05675625801086426
786 O 1 0.9996060729026794
- O 1 0.9999551773071289
0 O 1 0.9314000606536865
RCC B-Disease 1 0.9999874830245972
cells O 0 0.02200731262564659
are O 0 0.009256631135940552
tumorigenic O 1 0.6400495171546936
in O 0 0.015413809567689896
nude O 1 0.98362135887146
mice O 0 0.04799996316432953
which O 0 0.009727941825985909
is O 0 0.01110935490578413
suppressed O 0 0.030438225716352463
by O 0 0.01421978510916233
the O 0 0.022027218714356422
reintroduction O 0 0.4457945227622986
of O 0 0.07086782902479172
VHL B-Disease 1 0.9995303153991699
. O 0 0.063600093126297

Remarkably O 0 0.19685505330562592
, O 0 0.021775277331471443
this O 0 0.011276887729763985
occurs O 0 0.011936047114431858
without O 0 0.009404710493981838
affecting O 0 0.014089873060584068
the O 0 0.011180730536580086
growth O 0 0.016429772600531578
rate O 0 0.013541127555072308
and O 0 0.012693608179688454
cell O 0 0.18540576100349426
cycle O 0 0.042294736951589584
profile O 0 0.02117527648806572
of O 0 0.012720191851258278
these O 0 0.010031303390860558
cells O 0 0.018853772431612015
in O 0 0.015309386886656284
culture O 0 0.03459462150931358
. O 0 0.031857382506132126

The O 0 0.051042210310697556
786 O 1 0.9878228902816772
- O 1 0.9734162092208862
0 O 0 0.03595134615898132
cell O 0 0.02810860425233841
line O 0 0.020080329850316048
, O 0 0.011796738021075726
like O 0 0.013701308518648148
many O 0 0.014435473829507828
cancer B-Disease 1 0.9999839067459106
cells O 0 0.20570434629917145
, O 0 0.013431844301521778
fails O 0 0.0283567626029253
to O 0 0.01076151616871357
exit O 0 0.026330173015594482
the O 0 0.01667516864836216
cell O 0 0.04421406239271164
cycle O 0 0.048132676631212234
upon O 0 0.035073041915893555
serum O 1 0.9944532513618469
withdrawal O 1 0.6825792789459229
. O 0 0.043622616678476334

Here O 0 0.03370612859725952
, O 0 0.017617415636777878
it O 0 0.008643008768558502
is O 0 0.0072707622312009335
shown O 0 0.006474234163761139
that O 0 0.0047208648175001144
reintroduction O 0 0.01702410914003849
of O 0 0.008544371463358402
the O 0 0.013263973407447338
wild O 0 0.4552743434906006
- O 1 0.9999258518218994
type O 1 0.9801162481307983
VHL B-Disease 1 0.9996258020401001
gene O 0 0.018458468839526176
restores O 0 0.03151331841945648
the O 0 0.010232537053525448
ability O 0 0.012127782218158245
of O 0 0.018913106992840767
VHL O 1 0.999993085861206
- O 1 0.9999927282333374
negative O 1 0.9996016621589661
RCC B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999916553497314
cells O 0 0.020235249772667885
to O 0 0.010684357956051826
exit O 0 0.02303054742515087
the O 0 0.01391904428601265
cell O 0 0.026108121499419212
cycle O 0 0.023736746981739998
and O 0 0.01838928833603859
enter O 0 0.3148939311504364
G0 O 1 0.9999872446060181
/ O 1 0.9994484782218933
quiescence O 1 0.9934415817260742
in O 0 0.0372193306684494
low O 1 0.5213964581489563
serum O 1 0.9874057173728943
. O 0 0.053723257035017014

Both O 0 0.05351310968399048
VHL O 1 0.9998369216918945
- O 1 0.9964519739151001
positive O 0 0.031397826969623566
and O 0 0.0542578361928463
VHL O 1 0.999992847442627
- O 1 0.9999467134475708
negative O 1 0.9053909182548523
RCC B-Disease 1 0.9999947547912598
cells O 0 0.03443583473563194
exit O 0 0.0352606400847435
the O 0 0.020398637279868126
cell O 0 0.04143943637609482
cycle O 0 0.04003704711794853
by O 0 0.025614280253648758
contact O 0 0.3084781765937805
inhibition O 1 0.7894222736358643
. O 0 0.043738801032304764

The O 0 0.06883309036493301
cyclin O 1 0.9995918869972229
- O 1 0.9993559718132019
dependent O 1 0.6875656247138977
kinase O 1 0.9950737357139587
inhibitor O 1 0.9984172582626343
, O 0 0.035654984414577484
p27 O 1 0.9900112748146057
, O 0 0.02532307058572769
accumulates O 0 0.21132342517375946
upon O 0 0.025562556460499763
serum O 1 0.9935153722763062
withdrawal O 0 0.1114194244146347
, O 0 0.009643930941820145
only O 0 0.005495178978890181
in O 0 0.005129580851644278
the O 0 0.007582542486488819
presence O 0 0.013248001225292683
of O 0 0.10062618553638458
VHL B-Disease 1 0.9999853372573853
, O 0 0.011184358038008213
as O 0 0.007637227885425091
a O 0 0.007765295449644327
result O 0 0.006995273754000664
of O 0 0.008521956391632557
the O 0 0.016756750643253326
stabilization O 1 0.9721605181694031
of O 0 0.02742950990796089
the O 0 0.11531493812799454
protein O 0 0.02800283394753933
. O 0 0.02870798297226429

We O 0 0.024454977363348007
propose O 0 0.023230306804180145
that O 0 0.007727141957730055
the O 0 0.008797559887170792
loss O 0 0.012784415856003761
of O 0 0.013544942252337933
wild O 1 0.9527755975723267
- O 1 0.9999971389770508
type O 1 0.9992532134056091
VHL B-Disease 1 0.9999841451644897
gene O 0 0.01299181766808033
results O 0 0.006171725690364838
in O 0 0.005882604978978634
a O 0 0.009044650010764599
specific O 0 0.008327895775437355
cellular O 0 0.030449584126472473
defect O 1 0.9869367480278015
in O 0 0.017270710319280624
serum O 1 0.999968409538269
- O 1 0.9999116659164429
dependent O 0 0.03350038826465607
growth O 0 0.017400570213794708
control O 0 0.016827674582600594
, O 0 0.012435538694262505
which O 0 0.01196108665317297
may O 0 0.020364543423056602
initiate O 1 0.8467695713043213
tumor B-Disease 1 0.9997028708457947
formation O 1 0.7791159749031067
. O 0 0.04903697595000267

This O 0 0.024797722697257996
is O 0 0.019430696964263916
corrected O 0 0.02702648751437664
by O 0 0.010055865161120892
the O 0 0.012540219351649284
reintroduction O 0 0.04018028452992439
of O 0 0.01656665839254856
wild O 1 0.5383118987083435
- O 1 0.9999657869338989
type O 1 0.9976072311401367
VHL B-Disease 1 0.9999762773513794
, O 0 0.03622443228960037
implicating O 1 0.9994168281555176
VHL B-Disease 1 0.9996588230133057
as O 0 0.010852004401385784
the O 0 0.013780619017779827
first O 1 0.5195329189300537
tumor B-Disease 1 0.9999867677688599
suppressor O 1 0.9955710768699646
involved O 0 0.010329067707061768
in O 0 0.005855708848685026
the O 0 0.007892267778515816
regulation O 0 0.011764496564865112
of O 0 0.014391348697245121
cell O 1 0.760217010974884
cycle O 1 0.530925989151001
exit O 0 0.17023931443691254
, O 0 0.008556886576116085
which O 0 0.006070698611438274
is O 0 0.005829895380884409
consistent O 0 0.008809264749288559
with O 0 0.006713204551488161
its O 0 0.011741512455046177
gatekeeper O 1 0.9997792840003967
function O 0 0.015929801389575005
in O 0 0.012924768030643463
the O 0 0.267356812953949
kidney O 1 0.9999938011169434
. O 0 0.03509275242686272
. O 0 0.039594221860170364

Piebaldism B-Disease 1 0.9997001886367798
with O 1 0.8699659109115601
deafness B-Disease 1 0.9999995231628418
: O 0 0.2503551244735718
molecular O 0 0.022142015397548676
evidence O 0 0.011899761855602264
for O 0 0.0123782679438591
an O 0 0.11954692751169205
expanded O 1 0.9829540848731995
syndrome O 1 0.9999996423721313
. O 0 0.23469607532024384

In O 0 0.028861617669463158
a O 0 0.02668645791709423
South O 0 0.032144203782081604
African O 0 0.03853835538029671
girl O 1 0.8560047149658203
of O 0 0.034993622452020645
Xhosa O 1 0.9998548030853271
stock O 0 0.18078845739364624
with O 0 0.027140801772475243
severe O 1 0.999972939491272
piebaldism B-Disease 1 0.9999953508377075
and O 1 0.9994588494300842
profound O 1 0.9999998807907104
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.7854716181755066
identified O 0 0.034798167645931244
a O 0 0.01836967095732689
novel O 0 0.0337456613779068
missense O 0 0.20576702058315277
substitution O 0 0.02079474925994873
at O 0 0.011950564570724964
a O 0 0.011742142960429192
highly O 0 0.015703031793236732
conserved O 0 0.01705309748649597
residue O 0 0.019461801275610924
in O 0 0.009020458906888962
the O 0 0.013091222383081913
intracellular O 0 0.2001124918460846
kinase O 0 0.05069485306739807
domain O 0 0.016812313348054886
of O 0 0.012834818102419376
the O 0 0.027521871030330658
KIT O 1 0.9999681711196899
proto O 1 0.9999423027038574
- O 1 0.9998844861984253
oncogene O 1 0.9993922710418701
, O 0 0.04416218400001526
R796G O 1 0.7522048354148865
. O 0 0.04590606316924095

Though O 0 0.061047572642564774
auditory B-Disease 1 0.9785798788070679
anomalies I-Disease 1 0.7124509215354919
have O 0 0.010846990160644054
been O 0 0.009004623629152775
observed O 0 0.009394582360982895
in O 0 0.007026976905763149
mice O 0 0.013501273468136787
with O 0 0.009917611256241798
dominant O 1 0.7666364312171936
white O 1 0.9970092177391052
spotting O 1 0.9999079704284668
( O 1 0.870670735836029
W O 1 0.9976544976234436
) O 0 0.010432659648358822
due O 0 0.009952662512660027
to O 0 0.013474879786372185
KIT O 1 0.9997753500938416
mutations O 1 0.6475464701652527
, O 1 0.5088385939598083
deafness B-Disease 1 0.9999990463256836
is O 0 0.019595041871070862
not O 0 0.009471793659031391
typical O 0 0.02216680534183979
in O 0 0.015270188450813293
human O 0 0.038076095283031464
piebaldism B-Disease 1 0.9962892532348633
. O 0 0.044288232922554016

Thus O 0 0.026822606101632118
, O 0 0.01580917462706566
the O 0 0.015317368321120739
occurrence O 0 0.4998246133327484
of O 1 0.9937286376953125
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.972421407699585
this O 0 0.446896493434906
patient O 1 0.9997714161872864
extends O 0 0.39968302845954895
considerably O 0 0.01762961782515049
the O 0 0.011999874375760555
phenotypic O 0 0.01881447434425354
range O 0 0.013071713037788868
of O 0 0.012451617047190666
piebaldism B-Disease 1 0.8596185445785522
due O 0 0.015394874848425388
to O 0 0.015068388544023037
KIT O 1 0.9998791217803955
gene O 0 0.022593392059206963
mutation O 0 0.017766090109944344
in O 0 0.008406099863350391
humans O 0 0.01094047911465168
and O 0 0.012410581111907959
tightens O 1 0.9364895820617676
the O 0 0.017256876453757286
clinical O 0 0.44364866614341736
similarity O 0 0.02115117572247982
between O 0 0.015066689811646938
piebaldism B-Disease 1 0.9546984434127808
and O 0 0.009813820011913776
the O 0 0.010145225562155247
various O 0 0.01033575925976038
forms O 0 0.12192528694868088
of O 1 0.9997710585594177
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.782806396484375
. O 0 0.0691559836268425

Cycloheximide O 1 0.9027196168899536
facilitates O 0 0.07210087776184082
the O 0 0.023920254781842232
identification O 0 0.02299562841653824
of O 0 0.018203286454081535
aberrant O 1 0.8842207789421082
transcripts O 0 0.02448630891740322
resulting O 0 0.01365883368998766
from O 0 0.009556501172482967
a O 0 0.015240682289004326
novel O 0 0.04212263226509094
splice O 1 0.8349606990814209
- O 1 0.9480654001235962
site O 0 0.02015312761068344
mutation O 0 0.018261563032865524
in O 0 0.011143934912979603
COL17A1 O 1 0.9494152665138245
in O 0 0.013330922462046146
a O 0 0.03181220591068268
patient O 1 0.9991974234580994
with O 1 0.8398842215538025
generalized O 1 0.9999908208847046
atrophic B-Disease 1 0.9999997615814209
benign I-Disease 1 0.9999995231628418
epidermolysis I-Disease 1 0.9999996423721313
bullosa I-Disease 1 0.9999949932098389
. O 1 0.6895784735679626

Patients O 1 0.9923989176750183
with O 1 0.5854583382606506
generalized O 1 0.9999935626983643
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999991655349731
often O 0 0.05066787451505661
show O 0 0.02465912327170372
decreased O 0 0.027284372597932816
expression O 0 0.02027737908065319
of O 0 0.12058078497648239
type O 1 0.9999386072158813
XVII O 1 0.9999998807907104
collagen O 1 0.9999943971633911
, O 0 0.03373628109693527
a O 0 0.05568412318825722
transmembrane O 1 0.9945544004440308
hemidesmosomal O 1 0.9962840676307678
protein O 0 0.0240190327167511
encoded O 0 0.02038172446191311
by O 0 0.022631188854575157
COL17A1 O 1 0.9151092767715454
. O 0 0.04343781992793083

This O 0 0.021865101531147957
report O 0 0.017659347504377365
documents O 0 0.014512810856103897
a O 0 0.016618851572275162
novel O 0 0.031817350536584854
splice O 0 0.39490339159965515
- O 1 0.8669022917747498
site O 0 0.022591322660446167
mutation O 0 0.01878696121275425
in O 0 0.009595697745680809
COL17A1 O 1 0.9023370742797852
in O 0 0.01157416496425867
a O 0 0.021204615011811256
patient O 1 0.9966310858726501
with O 1 0.6315425634384155
generalized O 1 0.9999923706054688
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
, O 0 0.47159823775291443
and O 0 0.01914108544588089
applies O 0 0.01976214535534382
a O 0 0.014256714843213558
new O 0 0.015727872028946877
methodology O 0 0.017843730747699738
to O 0 0.011666104197502136
define O 0 0.019028879702091217
and O 0 0.013161281123757362
characterize O 0 0.030888190492987633
the O 0 0.019981645047664642
resulting O 0 0.03219292685389519
mRNA O 0 0.04653789848089218
splice O 0 0.07787391543388367
variants O 0 0.044965069741010666
. O 0 0.03934406861662865

Mutational O 0 0.4774385392665863
analysis O 0 0.028226254507899284
of O 0 0.024569623172283173
COL17A1 O 1 0.9589402675628662
identified O 0 0.02245468832552433
a O 0 0.020852064713835716
maternally O 1 0.8296779990196228
inherited O 1 0.9987720847129822
G O 1 0.9988515377044678
- O 1 0.9959088563919067
to O 0 0.02181500382721424
- O 1 0.9998376369476318
T O 1 0.9976717829704285
transversion O 1 0.9239747524261475
at O 0 0.012982160784304142
the O 0 0.0145568223670125
- O 1 0.589150607585907
1 O 0 0.015688899904489517
position O 0 0.018612582236528397
of O 0 0.022312259301543236
exon O 0 0.07373719662427902
32 O 0 0.050818219780921936
. O 0 0.03884878009557724

This O 0 0.04126759618520737
acceptor O 1 0.6942376494407654
splice O 1 0.5922077298164368
- O 1 0.9514107704162598
site O 0 0.028868764638900757
mutation O 0 0.02173861302435398
led O 0 0.01466545183211565
to O 0 0.00911061093211174
the O 0 0.0100453095510602
formation O 0 0.022914249449968338
of O 0 0.01804601214826107
aberrant O 1 0.9871149063110352
transcripts O 0 0.03073081560432911
present O 0 0.015406358055770397
at O 0 0.022286470979452133
extremely O 0 0.040928274393081665
low O 0 0.04707995057106018
levels O 0 0.033187925815582275
. O 0 0.033251456916332245

Based O 0 0.030749348923563957
on O 0 0.01746901497244835
our O 0 0.01661108434200287
recent O 0 0.013991464860737324
finding O 0 0.019904587417840958
that O 0 0.012825789861381054
cycloheximide O 1 0.9243366122245789
stabilized O 1 0.9030343294143677
mutant O 0 0.4377564489841461
COL17A1 O 1 0.9879344701766968
transcripts O 0 0.030484631657600403
in O 0 0.015423482283949852
keratinocytes O 0 0.13376620411872864
homozygous O 0 0.028562139719724655
for O 0 0.01253044418990612
a O 0 0.022716758772730827
frameshift O 1 0.9979596138000488
mutation O 0 0.03571352735161781
, O 0 0.010558576323091984
the O 0 0.009197517298161983
effects O 0 0.01180231012403965
of O 0 0.010412272997200489
the O 0 0.02527090348303318
splice O 1 0.9633432626724243
- O 1 0.954901933670044
site O 0 0.01611367240548134
mutation O 0 0.012862015515565872
on O 0 0.007726265583187342
splicing O 0 0.014903262257575989
of O 0 0.012620950117707253
COL17A1 O 1 0.8639733791351318
transcripts O 0 0.019163988530635834
were O 0 0.007894008420407772
determined O 0 0.011597459204494953
using O 0 0.010276047512888908
reverse O 0 0.026349321007728577
transcriptase O 1 0.7106728553771973
polymerase O 0 0.09198600798845291
chain O 0 0.030426310375332832
reaction O 0 0.01638711616396904
of O 0 0.012692071497440338
total O 0 0.016694875434041023
RNA O 0 0.0272727832198143
from O 0 0.01788325421512127
keratinocytes O 1 0.5203765034675598
incubated O 0 0.06588374823331833
for O 0 0.0233613234013319
2 O 0 0.042446546256542206
. O 0 0.04031974822282791

5 O 0 0.05690547078847885
h O 0 0.05941883847117424
in O 0 0.01411669235676527
the O 0 0.016723807901144028
presence O 0 0.021079452708363533
or O 0 0.01244964636862278
absence O 0 0.026155740022659302
of O 0 0.022717304527759552
10 O 0 0.03673980385065079
microg O 1 0.9980280995368958
cycloheximide O 1 0.994141161441803
per O 0 0.048092227429151535
ml O 1 0.9349584579467773
. O 0 0.049578819423913956

Using O 0 0.02085578441619873
this O 0 0.011992075480520725
approach O 0 0.015660090371966362
, O 0 0.011167178861796856
an O 0 0.012426582165062428
abnormally O 1 0.9208858609199524
spliced O 0 0.03371669724583626
transcript O 0 0.021660374477505684
was O 0 0.01341045182198286
identified O 0 0.010567775927484035
that O 0 0.0058499546721577644
contains O 0 0.008440549485385418
an O 0 0.007377102039754391
extra O 0 0.01284413319081068
264 O 0 0.023990556597709656
bases O 0 0.014844787307083607
upstream O 0 0.017332520335912704
from O 0 0.010926144197583199
exon O 0 0.03401118889451027
32 O 0 0.015970800071954727
, O 0 0.00984693132340908
resulting O 0 0.010913129895925522
in O 0 0.00888896081596613
a O 0 0.0182215366512537
premature O 1 0.8955892324447632
termination O 1 0.984666109085083
codon O 0 0.1381291002035141
27 O 0 0.03190449997782707
bp O 0 0.03956717997789383
downstream O 0 0.02723717875778675
from O 0 0.013769063167273998
the O 0 0.024019591510295868
cryptic O 1 0.5361095666885376
splice O 0 0.15827834606170654
site O 0 0.044230204075574875
. O 0 0.03791750222444534

Three O 0 0.025987857952713966
other O 0 0.018349124118685722
splice O 0 0.07438185065984726
variants O 0 0.0189896859228611
, O 0 0.010216062888503075
including O 0 0.007315970025956631
one O 0 0.008159458637237549
derived O 0 0.008182281628251076
from O 0 0.006679236423224211
the O 0 0.00992713961750269
skipping O 0 0.028432447463274002
of O 0 0.016063997521996498
exon O 1 0.7231097221374512
32 O 0 0.022878708317875862
, O 0 0.013556236401200294
were O 0 0.01242930255830288
also O 0 0.015393313951790333
identified O 0 0.029272664338350296
. O 0 0.031852882355451584

These O 0 0.02035953849554062
results O 0 0.016222761943936348
indicate O 0 0.014336558058857918
the O 0 0.013712262734770775
usefulness O 0 0.04100208356976509
of O 0 0.03829263895750046
cycloheximide O 1 0.9999045133590698
treatment O 1 0.9971359968185425
in O 0 0.013561905361711979
evaluating O 0 0.024411633610725403
the O 0 0.015751244500279427
abnormal O 0 0.09218526631593704
processing O 0 0.01114258449524641
of O 0 0.009251458570361137
mRNA O 0 0.015256536193192005
due O 0 0.009550058282911777
to O 0 0.01033972017467022
splice O 0 0.159394308924675
- O 1 0.943760097026825
site O 0 0.018193615600466728
mutations O 0 0.014052866958081722
, O 0 0.00894919317215681
because O 0 0.008997512049973011
( O 0 0.01458117924630642
i O 0 0.016205614432692528
) O 0 0.014751826412975788
aberrant O 0 0.07109358161687851
splicing O 0 0.019273752346634865
often O 0 0.008456172421574593
generates O 0 0.013455318287014961
a O 0 0.01365503016859293
premature O 1 0.6971253752708435
termination O 1 0.9802025556564331
codon O 0 0.464168518781662
, O 0 0.01645484007894993
( O 0 0.01915835216641426
ii O 1 0.8749363422393799
) O 0 0.01234652753919363
transcripts O 0 0.017328280955553055
with O 0 0.011704922653734684
premature O 1 0.9359198808670044
termination O 1 0.9915146827697754
codons O 0 0.12974923849105835
can O 0 0.009128526784479618
occur O 0 0.008283399976789951
at O 0 0.01306894514709711
low O 0 0.03295261412858963
or O 0 0.017022281885147095
undetectable O 1 0.9808372855186462
levels O 0 0.012686731293797493
due O 0 0.0110440943390131
to O 0 0.011265796609222889
nonsense O 1 0.5459437370300293
- O 1 0.9694846868515015
mediated O 0 0.1080525815486908
mRNA O 0 0.02007938176393509
decay O 0 0.023747539147734642
, O 0 0.01173671055585146
and O 0 0.011465359479188919
( O 0 0.02022743411362171
iii O 1 0.6324466466903687
) O 0 0.010769874788820744
the O 0 0.009365218691527843
levels O 0 0.009601346217095852
of O 0 0.00841059535741806
these O 0 0.007035380229353905
transcripts O 0 0.016839899122714996
can O 0 0.00736897112801671
be O 0 0.007859126664698124
increased O 0 0.016500351950526237
by O 0 0.024670401588082314
cycloheximide O 1 0.9635284543037415
. O 0 0.04934142157435417

A O 0 0.0712587833404541
deletion O 0 0.3274674415588379
mutation O 0 0.04138266295194626
in O 0 0.016886726021766663
COL17A1 O 1 0.9736324548721313
in O 0 0.012740467675030231
five O 0 0.01471333485096693
Austrian O 0 0.4200366735458374
families O 0 0.03283383697271347
with O 0 0.3162745237350464
generalized O 1 0.9999741315841675
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999990463256836
represents O 1 0.9540525078773499
propagation O 1 0.5240103006362915
of O 0 0.03306490182876587
an O 0 0.0488508865237236
ancestral O 1 0.9722723364830017
allele O 0 0.3625069260597229
. O 0 0.04934265464544296

Patients O 1 0.979251503944397
with O 0 0.40364372730255127
generalized O 1 0.999972939491272
atrophic B-Disease 1 0.9999997615814209
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999995231628418
, O 0 0.23556318879127502
a O 0 0.03215476870536804
usually O 0 0.018595097586512566
nonlethal O 0 0.04336527734994888
form O 0 0.02126426063477993
of O 0 0.15137909352779388
junctional B-Disease 1 0.9999988079071045
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999985694885254
, O 0 0.04283306002616882
have O 0 0.013991161249577999
generalized O 1 0.9642453789710999
blistering B-Disease 1 0.9997555613517761
, O 1 0.9838618636131287
nail B-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999998807907104
, O 1 0.9989079236984253
patchy B-Disease 1 0.9999990463256836
alopecia I-Disease 1 1.0
, O 1 0.9979233741760254
and O 1 0.9975787997245789
dental B-Disease 1 0.9999992847442627
abnormalities I-Disease 1 0.9999911785125732
. O 0 0.44136443734169006

Skin B-Disease 1 0.9999675750732422
fragility I-Disease 1 0.9998418092727661
in O 0 0.024894144386053085
most O 0 0.01673106476664543
cases O 0 0.024422943592071533
is O 0 0.010136988013982773
due O 0 0.011162824928760529
to O 0 0.008219864219427109
mutations O 0 0.009837831370532513
in O 0 0.006287268362939358
the O 0 0.011461008340120316
gene O 0 0.020509885624051094
encoding O 0 0.03064979426562786
type O 1 0.9941766262054443
XVII O 1 0.9999995231628418
collagen O 1 0.9999984502792358
( O 1 0.976823091506958
COL17A1 O 1 0.9997848868370056
) O 0 0.0404103584587574
. O 0 0.03750127926468849

Recently O 0 0.04716363921761513
, O 0 0.020392270758748055
we O 0 0.011403830721974373
reported O 0 0.01331718172878027
five O 0 0.012313601560890675
Austrian O 0 0.05467092990875244
families O 0 0.02662268653512001
with O 0 0.11607559770345688
generalized O 1 0.999976396560669
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999986886978149
who O 1 0.5688536763191223
share O 0 0.025924578309059143
the O 0 0.02350536920130253
same O 0 0.029101485386490822
COL17A1 O 1 0.9998231530189514
mutation O 0 0.48172280192375183
. O 0 0.04073137044906616

Affected O 0 0.04189937934279442
individuals O 0 0.015812868252396584
in O 0 0.010965300723910332
three O 0 0.010013253428041935
families O 0 0.013647755607962608
are O 0 0.00740421237424016
homozygous O 0 0.029447199776768684
for O 0 0.015023129060864449
4003delTC O 1 0.9980974793434143
, O 0 0.01412089355289936
whereas O 0 0.01226801611483097
those O 0 0.007291462272405624
in O 0 0.007037166506052017
two O 0 0.008845055475831032
others O 0 0.013684006407856941
are O 0 0.011967952363193035
compound O 0 0.09011109173297882
heterozygotes O 1 0.78365159034729
. O 0 0.04549548402428627

To O 0 0.024583570659160614
determine O 0 0.016224343329668045
if O 0 0.010665242560207844
the O 0 0.012349970638751984
occurrence O 0 0.0237566065043211
of O 0 0.01640111580491066
4003delTC O 1 0.9913608431816101
in O 0 0.010182357393205166
these O 0 0.007149013690650463
unrelated O 0 0.017086533829569817
families O 0 0.016732923686504364
signifies O 1 0.7481146454811096
propagation O 0 0.035755839198827744
of O 0 0.013177869841456413
an O 0 0.020418677479028702
ancestral O 1 0.988929808139801
allele O 0 0.3925139307975769
or O 0 0.014459691941738129
a O 0 0.022912072017788887
mutational O 1 0.9989878535270691
hot O 1 0.9774075150489807
spot O 0 0.27705734968185425
, O 0 0.01641256734728813
haplotypes O 0 0.040742307901382446
were O 0 0.009246941655874252
determined O 0 0.013624909333884716
for O 0 0.011075845919549465
polymorphisms O 0 0.027083108201622963
both O 0 0.011559586971998215
within O 0 0.01802009530365467
and O 0 0.02997814118862152
flanking O 1 0.9895457625389099
COL17A1 O 1 0.99898761510849
. O 0 0.06346166133880615

Five O 0 0.062128372490406036
intragenic O 1 0.9243056178092957
polymorphisms O 0 0.06384485960006714
were O 0 0.016425296664237976
chosen O 0 0.022518940269947052
based O 0 0.016615143045783043
on O 0 0.015603139996528625
their O 0 0.021727053448557854
informativeness O 1 0.9345758557319641
. O 0 0.040822554379701614

One O 0 0.023439958691596985
of O 0 0.016603723168373108
these O 0 0.009384062141180038
, O 0 0.008720885030925274
not O 0 0.005775217432528734
previously O 0 0.008766718208789825
reported O 0 0.009400326758623123
, O 0 0.008919330313801765
was O 0 0.016154516488313675
2988 O 1 0.8462568521499634
A O 0 0.031117701902985573
or O 0 0.012882011011242867
C O 0 0.11771636456251144
that O 0 0.007841570302844048
introduces O 0 0.02109348401427269
a O 0 0.011886168271303177
new O 0 0.015136491507291794
restriction O 0 0.024298932403326035
site O 0 0.025221368297934532
for O 0 0.020841067656874657
Eco0109 O 1 0.9187731146812439
I O 0 0.06665536016225815
. O 0 0.039102982729673386

All O 0 0.032647449523210526
the O 0 0.03684408962726593
4003delTC O 1 0.9287213683128357
alleles O 0 0.045546434819698334
showed O 0 0.023324966430664062
the O 0 0.017775511369109154
same O 0 0.01684354618191719
haplotype O 0 0.04290572181344032
for O 0 0.012448398396372795
these O 0 0.011708365753293037
five O 0 0.025741860270500183
polymorphic O 1 0.9720255732536316
markers O 0 0.20418766140937805
. O 0 0.044298168271780014

Fourteen O 0 0.11364805698394775
microsatellite O 1 0.7498316168785095
polymorphisms O 0 0.056349195539951324
were O 0 0.013699703849852085
selected O 0 0.016222219914197922
based O 0 0.010612791404128075
on O 0 0.008891906589269638
their O 0 0.008769296109676361
high O 0 0.041703563183546066
heterozygosity O 1 0.993519127368927
and O 0 0.011288817971944809
their O 0 0.009419367648661137
location O 0 0.01602313108742237
within O 0 0.019242288544774055
10q23 O 1 0.9943152070045471
- O 1 0.9978572726249695
q25 O 1 0.9762434363365173
near O 0 0.08408136665821075
COL17A1 O 1 0.9895992279052734
. O 0 0.051590751856565475

Three O 0 0.032134223729372025
families O 0 0.037798840552568436
shared O 0 0.04598716273903847
microsatellite O 1 0.955486536026001
polymorphisms O 0 0.3380992114543915
covering O 0 0.04418380185961723
at O 0 0.01682412624359131
most O 0 0.010969619266688824
19 O 0 0.020634282380342484
cM O 0 0.026036277413368225
, O 0 0.010529275052249432
whereas O 0 0.010103249922394753
the O 0 0.008902535773813725
others O 0 0.008871853351593018
shared O 0 0.012668080627918243
smaller O 0 0.00960069801658392
regions O 0 0.009922593832015991
consistent O 0 0.013882538303732872
with O 0 0.009958264417946339
cross O 0 0.2559674084186554
- O 1 0.9831795692443848
over O 0 0.011202365159988403
events O 0 0.009536806493997574
during O 0 0.011032086797058582
passage O 0 0.015197239816188812
of O 0 0.01093975268304348
this O 0 0.010904657654464245
mutation O 0 0.023173771798610687
through O 0 0.01621781289577484
several O 0 0.017326071858406067
generations O 0 0.045592498034238815
. O 0 0.041546780616045

These O 0 0.024618400260806084
results O 0 0.01933985762298107
indicate O 0 0.01933242566883564
that O 0 0.012261921539902687
4003delTC O 0 0.345011442899704
occurs O 0 0.014231793582439423
on O 0 0.011983783915638924
a O 0 0.01850302331149578
single O 0 0.03401483595371246
ancestral O 1 0.8447566032409668
allele O 0 0.23190973699092865
. O 0 0.0257246196269989
. O 0 0.032482098788022995

The O 0 0.07035516202449799
haptoglobin O 1 0.9984422326087952
- O 1 0.99934321641922
gene O 0 0.051838550716638565
deletion O 0 0.10598708689212799
responsible O 0 0.05032354220747948
for O 0 0.040376871824264526
anhaptoglobinemia B-Disease 1 0.9967458248138428
. O 0 0.05550491437315941

We O 0 0.024810267612338066
have O 0 0.011880372650921345
found O 0 0.010499043390154839
an O 0 0.011711979284882545
allelic O 0 0.09726914018392563
deletion O 0 0.03152710944414139
of O 0 0.01701914705336094
the O 0 0.18679764866828918
haptoglobin O 1 0.999921441078186
( O 1 0.6513601541519165
Hp O 1 0.927408754825592
) O 0 0.015748674049973488
gene O 0 0.01313660480082035
from O 0 0.009089889004826546
an O 0 0.011000553146004677
individual O 0 0.015678873285651207
with O 0 0.02219568006694317
anhaptoglobinemia B-Disease 1 0.989617109298706
. O 0 0.04678371548652649

The O 0 0.04735739529132843
Hp O 1 0.6425229907035828
gene O 0 0.02983502857387066
cluster O 0 0.03093935362994671
consists O 0 0.018674660474061966
of O 0 0.012855599634349346
coding O 0 0.018532533198595047
regions O 0 0.008973700925707817
of O 0 0.008858551271259785
the O 0 0.014334605075418949
alpha O 0 0.329725056886673
chain O 0 0.023689892143011093
and O 0 0.009892836213111877
beta O 0 0.02012922428548336
chain O 0 0.017290150746703148
of O 0 0.011407831683754921
the O 0 0.01824498362839222
haptoglobin O 1 0.9998281002044678
gene O 0 0.0585651621222496
( O 0 0.01809100992977619
Hp O 0 0.040048953145742416
) O 0 0.00773989874869585
and O 0 0.005522673949599266
of O 0 0.006551648490130901
the O 0 0.010753615759313107
alpha O 0 0.15468625724315643
chain O 0 0.020099177956581116
and O 0 0.009140102192759514
beta O 0 0.0193307027220726
chain O 0 0.01550302840769291
of O 0 0.010743124410510063
the O 0 0.0176312867552042
haptoglobin O 1 0.9995063543319702
- O 1 0.9994580149650574
related O 0 0.030266493558883667
gene O 0 0.041215699166059494
( O 0 0.06028454005718231
Hpr O 1 0.9970442652702332
) O 0 0.012508150190114975
, O 0 0.009458440355956554
in O 0 0.009056131355464458
tandem O 0 0.03146658465266228
from O 0 0.011979754082858562
the O 0 0.01757870428264141
5 O 0 0.029841069132089615
side O 0 0.036627620458602905
. O 0 0.03546616807579994

Southern O 0 0.07635471224784851
blot O 1 0.8727788329124451
and O 0 0.031098052859306335
PCR O 0 0.198049396276474
analyses O 0 0.016280928626656532
have O 0 0.0068750688806176186
indicated O 0 0.00975633505731821
that O 0 0.004630332812666893
the O 0 0.007535367272794247
individual O 0 0.007543238811194897
with O 0 0.009859883226454258
anhaptoglobinemia B-Disease 1 0.9302830696105957
was O 0 0.01705312356352806
homozygous O 0 0.017576880753040314
for O 0 0.007549223490059376
the O 0 0.01186355110257864
gene O 0 0.013283496722579002
deletion O 0 0.01671648770570755
and O 0 0.007243453525006771
that O 0 0.005611206404864788
the O 0 0.009159521199762821
gene O 0 0.013181757181882858
deletion O 0 0.020917411893606186
was O 0 0.010797291994094849
included O 0 0.008068803697824478
at O 0 0.007295276969671249
least O 0 0.005760639905929565
from O 0 0.006304702255874872
the O 0 0.010275383479893208
promoter O 0 0.4121229946613312
region O 0 0.013513835147023201
of O 0 0.014556207694113255
Hp O 0 0.40800172090530396
to O 0 0.0171890277415514
Hpr O 1 0.9921931624412537
alpha O 0 0.02829841338098049
but O 0 0.009947739541530609
not O 0 0.009255805984139442
to O 0 0.016159294173121452
Hpr O 1 0.9967189431190491
beta O 1 0.6589803695678711
( O 0 0.05209079012274742
Hpdel O 1 0.8797293305397034
) O 0 0.041420828551054
. O 0 0.04179088771343231

In O 0 0.02775242179632187
addition O 0 0.020453907549381256
, O 0 0.013049432076513767
we O 0 0.008308883756399155
found O 0 0.006581111811101437
seven O 0 0.00893727969378233
individuals O 0 0.007560828700661659
with O 0 0.008831914514303207
hypohaptoglobinemia B-Disease 1 0.969546914100647
in O 0 0.007457014173269272
three O 0 0.007261285558342934
families O 0 0.009797782637178898
, O 0 0.007154951803386211
and O 0 0.006870206445455551
the O 0 0.009727239608764648
genotypes O 0 0.16848519444465637
of O 0 0.00892449077218771
six O 0 0.008901387453079224
of O 0 0.00886248704046011
the O 0 0.010968274436891079
seven O 0 0.011809714138507843
individuals O 0 0.008774736896157265
were O 0 0.007814044132828712
found O 0 0.008336137980222702
to O 0 0.012295394204556942
be O 0 0.017078887671232224
Hp2 O 1 0.998083233833313
/ O 1 0.9975631237030029
Hpdel O 1 0.9507738351821899
. O 0 0.05030960217118263

The O 0 0.049404628574848175
phenotypes O 0 0.294592946767807
and O 0 0.024712014943361282
genotypes O 0 0.3336590528488159
in O 0 0.010614835657179356
one O 0 0.008468355052173138
of O 0 0.007796948775649071
these O 0 0.005300220102071762
three O 0 0.006968528963625431
families O 0 0.010319198481738567
showed O 0 0.0096302954480052
the O 0 0.009403256699442863
father O 0 0.022982550784945488
to O 0 0.009242972359061241
be O 0 0.009324374608695507
hypohaptoglobinemic B-Disease 1 0.8837874531745911
( O 0 0.020759260281920433
Hp2 O 1 0.612557590007782
) O 0 0.014840702526271343
and O 0 0.015674568712711334
Hp2 O 1 0.9990098476409912
/ O 1 0.9991266131401062
Hpdel O 1 0.8400651216506958
, O 0 0.01164079736918211
the O 0 0.009822987951338291
mother O 0 0.03555445373058319
to O 0 0.008846832439303398
be O 0 0.008698192425072193
Hp2 O 1 0.8889614939689636
- O 1 0.8497848510742188
1 O 0 0.016656596213579178
and O 0 0.014916226267814636
Hp1 O 1 0.9986847043037415
/ O 1 0.9981371164321899
Hp2 O 1 0.6467926502227783
, O 0 0.009485946968197823
one O 0 0.007187446113675833
of O 0 0.006950195878744125
the O 0 0.007331931497901678
two O 0 0.006615267135202885
children O 0 0.010917255654931068
to O 0 0.008166118524968624
be O 0 0.00956782791763544
hypohaptoglobinemic B-Disease 1 0.9652125239372253
( O 0 0.02089216373860836
Hp2 O 1 0.8496363162994385
) O 0 0.014815730042755604
and O 0 0.016041215509176254
Hp2 O 1 0.9997047781944275
/ O 1 0.9995918869972229
Hpdel O 1 0.9732004404067993
, O 0 0.011007346212863922
and O 0 0.008016496896743774
the O 0 0.007823620922863483
other O 0 0.006928732618689537
child O 0 0.027717165648937225
to O 0 0.009123275056481361
be O 0 0.009493495337665081
Hp1 O 1 0.8152734041213989
and O 0 0.025282301008701324
Hp1 O 1 0.9999226331710815
/ O 1 0.9998421669006348
Hpdel O 1 0.9756727814674377
, O 0 0.014124425128102303
showing O 0 0.015397608280181885
an O 0 0.013218852691352367
anomalous O 1 0.6902212500572205
inheritance O 1 0.6133679747581482
of O 0 0.14292678236961365
Hp O 1 0.9963082671165466
phenotypes O 0 0.3238619267940521
in O 0 0.013352534733712673
the O 0 0.021898915991187096
child O 1 0.9817401170730591
with O 0 0.08408466726541519
Hp1 O 1 0.9984526634216309
. O 0 0.047087620943784714

The O 0 0.08685250580310822
Hp2 O 1 0.9998733997344971
/ O 1 0.999927282333374
Hpdel O 1 0.9969243407249451
individuals O 0 0.019955605268478394
had O 0 0.014046559110283852
an O 0 0.010599412024021149
extremely O 0 0.016056057065725327
low O 0 0.014629733748733997
level O 0 0.01138372253626585
of O 0 0.01375448890030384
Hp O 1 0.8685855269432068
( O 0 0.018712861463427544
mean O 0 0.02137908525764942
+ O 1 0.6489693522453308
/ O 1 0.9878425598144531
- O 1 0.9825347065925598
SD O 1 0.9554663896560669
= O 0 0.02994927577674389
0 O 0 0.022443322464823723
. O 0 0.01561728771775961
049 O 1 0.9014412760734558
+ O 0 0.2860032320022583
/ O 1 0.7426105737686157
- O 0 0.0628943219780922
0 O 0 0.022733308374881744
. O 0 0.014719316735863686
043 O 1 0.9465219974517822
mg O 1 0.996466875076294
/ O 1 0.9990859031677246
ml O 1 0.9781824350357056
; O 0 0.020216092467308044
n O 0 0.03626367449760437
= O 0 0.02839547209441662
6 O 0 0.016531510278582573
) O 0 0.010003913193941116
, O 0 0.006257717963308096
compared O 0 0.006961131002753973
with O 0 0.005453998688608408
the O 0 0.007423048373311758
level O 0 0.010296120308339596
( O 0 0.0096310218796134
1 O 0 0.008659076876938343
. O 0 0.0067580523900687695
64 O 0 0.019231533631682396
+ O 0 0.181780144572258
/ O 1 0.636799156665802
- O 0 0.07543676346540451
1 O 0 0.014755860902369022
. O 0 0.012187030166387558
07 O 1 0.9705721139907837
mg O 1 0.9996336698532104
/ O 1 0.9993767142295837
ml O 1 0.8077113032341003
) O 0 0.011569654569029808
obtained O 0 0.008437220938503742
from O 0 0.00898929312825203
52 O 0 0.021659202873706818
healthy O 0 0.14126288890838623
volunteers O 0 0.0900198444724083
having O 0 0.02907661907374859
phenotype O 1 0.9718846082687378
Hp2 O 1 0.9934350252151489
, O 0 0.015324813313782215
whereas O 0 0.017031176015734673
the O 0 0.017772721126675606
serum O 1 0.979629635810852
Hp O 0 0.07224306464195251
level O 0 0.013278784230351448
of O 0 0.010660337284207344
an O 0 0.01126866601407528
individual O 0 0.013346643187105656
with O 0 0.025746027007699013
Hp1 O 1 0.9999147653579712
/ O 1 0.9998065829277039
Hpdel O 1 0.997021496295929
was O 0 0.0553472675383091
0 O 0 0.05451439321041107
. O 0 0.040919288992881775

50 O 0 0.07609760761260986
mg O 1 0.9989700317382812
/ O 1 0.9997518658638
ml O 1 0.9923921823501587
, O 0 0.015234657563269138
which O 0 0.007779225707054138
was O 0 0.009465641342103481
approximately O 0 0.007102555595338345
half O 0 0.007149338722229004
the O 0 0.00784380454570055
level O 0 0.009263434447348118
of O 0 0.010524372570216656
Hp O 0 0.11233673989772797
in O 0 0.008163291960954666
control O 0 0.01770286075770855
sera O 1 0.9003280997276306
from O 0 0.010373926721513271
the O 0 0.016501272097229958
Hp1 O 1 0.9996285438537598
phenotype O 1 0.9108818769454956
( O 0 0.013575589284300804
1 O 0 0.012120140716433525
. O 0 0.007891722954809666
26 O 0 0.020229090005159378
+ O 0 0.3310515582561493
/ O 1 0.5040410757064819
- O 0 0.042188484221696854
0 O 0 0.015615996904671192
. O 0 0.00943827349692583
33 O 0 0.025491781532764435
mg O 1 0.9487641453742981
/ O 1 0.9943512678146362
ml O 1 0.9647030234336853
; O 0 0.019362986087799072
n O 0 0.03284449875354767
= O 0 0.02576388418674469
9 O 0 0.017095033079385757
) O 0 0.01013420894742012
, O 0 0.008543971925973892
showing O 0 0.014624695293605328
a O 0 0.020380591973662376
gene O 0 0.04062967374920845
- O 1 0.994415283203125
dosage O 1 0.8269280791282654
effect O 0 0.03231855109333992
. O 0 0.030858542770147324

The O 0 0.032243236899375916
other O 0 0.019322127103805542
allele O 0 0.20310476422309875
( O 0 0.03149868920445442
Hp2 O 1 0.8592936992645264
) O 0 0.011792875826358795
of O 0 0.010044741444289684
individuals O 0 0.010574319399893284
with O 0 0.016349663957953453
Hp2 O 1 0.9999748468399048
/ O 1 0.9999654293060303
Hpdel O 1 0.998066246509552
was O 0 0.018406501039862633
found O 0 0.006906748283654451
to O 0 0.005097697023302317
have O 0 0.003928689751774073
, O 0 0.005078463349491358
in O 0 0.0045172953978180885
all O 0 0.006345502100884914
exons O 0 0.020464006811380386
, O 0 0.010185672901570797
no O 0 0.01114171277731657
mutation O 0 0.018987976014614105
, O 0 0.011733414605259895
by O 0 0.015069372951984406
DNA O 0 0.027546003460884094
sequencing O 0 0.04107929766178131
. O 0 0.034977987408638

On O 0 0.02036258392035961
the O 0 0.013389712199568748
basis O 0 0.008687123656272888
of O 0 0.008172574453055859
the O 0 0.009841670282185078
present O 0 0.009460401721298695
study O 0 0.00795682892203331
, O 0 0.007453337777405977
the O 0 0.008153657428920269
mechanism O 0 0.022753959521651268
of O 0 0.017599210143089294
anhaptoglobinemia B-Disease 1 0.9975777268409729
and O 0 0.010875873267650604
the O 0 0.013281509280204773
mechanism O 0 0.023938899859786034
of O 0 0.01680782251060009
anomalous O 1 0.9705113172531128
inheritance O 1 0.9061573147773743
of O 1 0.7951635122299194
Hp O 1 0.9996473789215088
phenotypes O 1 0.8099634051322937
were O 0 0.017121141776442528
well O 0 0.02153128571808338
explained O 0 0.03841212019324303
. O 0 0.03445170819759369

However O 0 0.032415177673101425
, O 0 0.024703696370124817
the O 0 0.02477320469915867
mechanism O 0 0.042615167796611786
of O 0 0.0411597304046154
hypohaptoglobinemia B-Disease 1 0.999103307723999
remains O 1 0.8076077699661255
unknown O 0 0.0918070450425148

ATM O 0 0.18994154036045074
mutations O 0 0.042338211089372635
and O 0 0.02454197034239769
phenotypes O 0 0.17978358268737793
in O 0 0.058669306337833405
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999983310699463
telangiectasia I-Disease 1 0.9999884366989136
families O 0 0.023044025525450706
in O 0 0.010229687206447124
the O 0 0.01179145835340023
British O 0 0.02263244241476059
Isles O 0 0.35766661167144775
: O 0 0.011846392415463924
expression O 0 0.010486116632819176
of O 0 0.010394571349024773
mutant O 1 0.7604495286941528
ATM O 0 0.06960514187812805
and O 0 0.007385025732219219
the O 0 0.009138953872025013
risk O 0 0.4273093044757843
of O 1 0.9888478517532349
leukemia B-Disease 1 1.0
, O 1 0.9999969005584717
lymphoma B-Disease 1 1.0
, O 1 0.9999217987060547
and O 1 0.9999303817749023
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 1 0.5679420232772827

We O 0 0.023146094754338264
report O 0 0.015464918687939644
the O 0 0.01352644618600607
spectrum O 0 0.017668448388576508
of O 0 0.013299173675477505
59 O 0 0.03431249409914017
ATM O 0 0.06394753605127335
mutations O 0 0.014731284230947495
observed O 0 0.011586046777665615
in O 0 0.014867894351482391
ataxia B-Disease 1 0.999998927116394
- I-Disease 1 0.9999969005584717
telangiectasia I-Disease 1 0.9999978542327881
( O 1 0.8762030005455017
A B-Disease 1 0.9998308420181274
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999958276748657
) O 0 0.026539625599980354
patients O 0 0.08983924239873886
in O 0 0.010400783270597458
the O 0 0.01870614103972912
British O 0 0.054226282984018326
Isles O 1 0.6503226161003113
. O 0 0.0413939505815506

Of O 0 0.04362351447343826
51 O 0 0.12271470576524734
ATM O 1 0.8918869495391846
mutations O 0 0.027284806594252586
identified O 0 0.014695572666823864
in O 0 0.00865755882114172
families O 0 0.010375404730439186
native O 0 0.009973240084946156
to O 0 0.007327151019126177
the O 0 0.008773275651037693
British O 0 0.014630372636020184
Isles O 0 0.0903046503663063
, O 0 0.00895974226295948
11 O 0 0.00996650941669941
were O 0 0.008330888114869595
founder O 1 0.9576775431632996
mutations O 0 0.014764098450541496
, O 0 0.0074655283242464066
and O 0 0.006050741765648127
2 O 0 0.00784230511635542
of O 0 0.0059271398931741714
these O 0 0.005311937537044287
11 O 0 0.012630680575966835
conferred O 0 0.14817002415657043
a O 0 0.040994808077812195
milder O 1 0.982796311378479
clinical O 1 0.9965097308158875
phenotype O 1 0.7770730257034302
with O 0 0.011755929328501225
respect O 0 0.0202482957392931
to O 0 0.016437087208032608
both O 0 0.16241709887981415
cerebellar B-Disease 1 0.9999986886978149
degeneration I-Disease 1 1.0
and O 1 0.9970442652702332
cellular O 1 0.9957005381584167
features O 0 0.06287863850593567
. O 0 0.036706067621707916

We O 0 0.02050546184182167
report O 0 0.014006813056766987
, O 0 0.00819296482950449
in O 0 0.006376225501298904
two O 0 0.007779188919812441
A B-Disease 1 0.9859486818313599
- I-Disease 1 0.999987006187439
T I-Disease 1 0.9998742341995239
families O 0 0.01280705165117979
, O 0 0.007780123967677355
an O 0 0.00876630935817957
ATM O 0 0.04631375893950462
mutation O 0 0.020055430009961128
( O 0 0.018210142850875854
7271T O 1 0.9959191679954529
- O 1 0.9998983144760132
- O 1 0.9999682903289795
> O 1 0.9994877576828003
G O 1 0.9695596694946289
) O 0 0.009713465347886086
that O 0 0.0049935681745409966
may O 0 0.006086204666644335
be O 0 0.003976191859692335
associated O 0 0.005165760405361652
with O 0 0.004629509057849646
an O 0 0.006887602154165506
increased O 0 0.014708097092807293
risk O 1 0.9144271612167358
of O 1 0.9960744380950928
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
in O 0 0.12415273487567902
both O 0 0.16002385318279266
homozygotes O 1 0.9999243021011353
and O 0 0.21594710648059845
heterozygotes O 1 0.9991946816444397
( O 0 0.02310655266046524
relative O 0 0.017766103148460388
risk O 0 0.015083717182278633
12 O 0 0.010688845068216324
. O 0 0.00791081227362156
7 O 0 0.014261922799050808
; O 0 0.01399687398225069
P O 1 0.8925756216049194
= O 0 0.03386758640408516
. O 0 0.011135231703519821
0025 O 1 0.9280915260314941
) O 0 0.010094893164932728
, O 0 0.0064506386406719685
although O 0 0.005534308962523937
there O 0 0.00462157279253006
is O 0 0.005202759522944689
a O 0 0.007321285083889961
less O 0 0.008503064513206482
severe O 1 0.9993895292282104
A B-Disease 1 0.9999932050704956
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999957084655762
phenotype O 0 0.2634390592575073
in O 0 0.007872556336224079
terms O 0 0.007132387720048428
of O 0 0.009051294066011906
the O 0 0.013482240028679371
degree O 0 0.0897633507847786
of O 1 0.982143223285675
cerebellar B-Disease 1 0.9999994039535522
degeneration I-Disease 1 0.9999998807907104
. O 1 0.9657824039459229

This O 0 0.02717564068734646
mutation O 0 0.042413339018821716
( O 0 0.03654090315103531
7271T O 1 0.9985540509223938
- O 1 0.9999806880950928
- O 1 0.9999812841415405
> O 1 0.9996427297592163
G O 1 0.9456385970115662
) O 0 0.011579959653317928
also O 0 0.0069410111755132675
allows O 0 0.007221894338726997
expression O 0 0.007338736671954393
of O 0 0.008073645643889904
full O 0 0.01601104810833931
- O 1 0.9703384637832642
length O 0 0.015888530761003494
ATM O 0 0.11951515823602676
protein O 0 0.010711832903325558
at O 0 0.008840036578476429
a O 0 0.010596532374620438
level O 0 0.012827672064304352
comparable O 0 0.01590622030198574
with O 0 0.009962968528270721
that O 0 0.010289213620126247
in O 0 0.01645302027463913
unaffected O 1 0.6045526266098022
individuals O 0 0.029804086312651634
. O 0 0.038054872304201126

In O 0 0.021560117602348328
addition O 0 0.017929421737790108
, O 0 0.01035642996430397
we O 0 0.006179592106491327
have O 0 0.0048149870708584785
studied O 0 0.008636187762022018
18 O 0 0.016489166766405106
A B-Disease 1 0.999505877494812
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.9999960660934448
patients O 1 0.8766003847122192
, O 0 0.007526450324803591
in O 0 0.005610499065369368
15 O 0 0.007852357812225819
families O 0 0.008248141966760159
, O 0 0.008015602827072144
who O 0 0.014941947534680367
developed O 1 0.7438260316848755
leukemia B-Disease 1 0.9999998807907104
, O 1 0.9989835619926453
lymphoma B-Disease 1 1.0
, O 1 0.9988279938697815
preleukemic O 1 0.9999992847442627
T O 1 0.9999978542327881
- O 1 0.9999285936355591
cell O 1 0.7895692586898804
proliferation O 1 0.9807652831077576
, O 0 0.2264164537191391
or O 1 0.998754620552063
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.939720094203949
mostly O 0 0.03212845325469971
in O 0 0.02720734477043152
childhood O 1 0.9978679418563843
. O 0 0.053248099982738495

A O 0 0.03783578425645828
wide O 0 0.026739580556750298
variety O 0 0.0173924770206213
of O 0 0.025086289271712303
ATM O 1 0.9969633221626282
mutation O 0 0.07098289579153061
types O 0 0.012204050086438656
, O 0 0.010171644389629364
including O 0 0.010440878570079803
missense O 0 0.4430277645587921
mutations O 0 0.01628968119621277
and O 0 0.010404592379927635
in O 0 0.013419209979474545
- O 1 0.9982080459594727
frame O 0 0.21378813683986664
deletions O 0 0.034230347722768784
, O 0 0.01089207362383604
were O 0 0.008766312152147293
seen O 0 0.012821672484278679
in O 0 0.012709052301943302
these O 0 0.014763917773962021
patients O 1 0.7255012392997742
. O 0 0.03726820647716522

We O 0 0.023294972255825996
also O 0 0.012619659304618835
show O 0 0.011213799938559532
that O 0 0.005308517720550299
25 O 0 0.008238080888986588
% O 0 0.006687438581138849
of O 0 0.006798938382416964
all O 0 0.009094911627471447
A B-Disease 1 0.9989097118377686
- I-Disease 1 0.9999980926513672
T I-Disease 1 0.9999812841415405
patients O 1 0.7403731346130371
carried O 0 0.0138825923204422
in O 0 0.010994904674589634
- O 1 0.9914129972457886
frame O 0 0.16617794334888458
deletions O 0 0.03809649869799614
or O 0 0.0145128658041358
missense O 1 0.5527657866477966
mutations O 0 0.01600622572004795
, O 0 0.007670344784855843
many O 0 0.005218748934566975
of O 0 0.006527664605528116
which O 0 0.005771801806986332
were O 0 0.005609131883829832
also O 0 0.0061496831476688385
associated O 0 0.007474985904991627
with O 0 0.007363434415310621
expression O 0 0.014514883980154991
of O 0 0.01995636522769928
mutant O 1 0.9969028830528259
ATM O 1 0.9877082109451294
protein O 0 0.03619988635182381
. O 0 0.02987578697502613

The O 0 0.046351514756679535
DMPK O 1 0.9767239093780518
gene O 0 0.03424545004963875
of O 0 0.040389832109212875
severely O 1 0.999910831451416
affected O 1 0.9999663829803467
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999994039535522
is O 1 0.9989309906959534
hypermethylated O 1 0.9999871253967285
proximal O 1 0.9997425675392151
to O 0 0.020074233412742615
the O 0 0.022016366943717003
largely O 0 0.0297235120087862
expanded O 0 0.05759598687291145
CTG O 1 0.9983702301979065
repeat O 0 0.38979586958885193
. O 0 0.05368705093860626

Using O 0 0.038562171161174774
methylation O 0 0.07673405855894089
- O 1 0.9899897575378418
sensitive O 0 0.0633692592382431
restriction O 0 0.032885633409023285
enzymes O 0 0.022368580102920532
, O 0 0.010700969025492668
we O 0 0.008668475784361362
characterized O 0 0.01539509929716587
the O 0 0.012937390245497227
methylation O 0 0.02087343856692314
pattern O 0 0.013313522562384605
on O 0 0.007709008175879717
the O 0 0.00855961348861456
5 O 0 0.010445027612149715
side O 0 0.010387798771262169
of O 0 0.009267366491258144
the O 0 0.01691039465367794
CTG O 1 0.9996761083602905
repeat O 0 0.02899947762489319
in O 0 0.008692150935530663
the O 0 0.012816737405955791
DMPK O 1 0.9989815354347229
gene O 0 0.013295351527631283
of O 0 0.009287088178098202
normal O 0 0.010536828078329563
individuals O 0 0.006990916561335325
and O 0 0.008455815725028515
of O 0 0.17129084467887878
patients O 1 0.9999349117279053
affected O 1 0.995270311832428
with O 1 0.9997153878211975
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.8485737442970276
showing O 0 0.3667343854904175
expansions O 0 0.23100848495960236
of O 0 0.02168484590947628
the O 0 0.0890636295080185
repetitive O 1 0.9873329997062683
sequence O 0 0.04061804339289665
. O 0 0.03771015629172325

The O 0 0.04807059466838837
gene O 0 0.03736533597111702
segment O 0 0.034706756472587585
analyzed O 0 0.020191384479403496
corresponds O 0 0.020319761708378792
to O 0 0.01138116791844368
the O 0 0.016824742779135704
genomic O 0 0.04199322685599327
SacI O 1 0.9942203760147095
- O 1 0.954100489616394
HindIII O 1 0.8340889811515808
fragment O 0 0.03827870264649391
carrying O 0 0.02890920825302601
exons O 0 0.04542454332113266
11 O 0 0.03750752657651901
- O 0 0.26495397090911865
15 O 0 0.037957243621349335
. O 0 0.037193283438682556

There O 0 0.02936992049217224
is O 0 0.024553904309868813
constitutive O 0 0.05685311183333397
methylation O 0 0.03602863848209381
in O 0 0.017552921548485756
intron O 1 0.9568545818328857
12 O 0 0.015516368672251701
at O 0 0.013047701679170132
restriction O 0 0.014549094252288342
sites O 0 0.010601443238556385
of O 0 0.011347856372594833
SacII O 1 0.971814751625061
and O 0 0.016254905611276627
HhaI O 1 0.89809250831604
, O 0 0.014008301310241222
localized O 0 0.024048559367656708
1 O 0 0.014697506092488766
, O 0 0.011670569889247417
159 O 0 0.03870048746466637
- O 1 0.5566049814224243
1 O 0 0.014345765113830566
, O 0 0.0106800002977252
232 O 0 0.025725621730089188
bp O 0 0.021826455369591713
upstream O 0 0.015249093063175678
of O 0 0.010521894320845604
the O 0 0.019278891384601593
CTG O 1 0.9999343156814575
repeat O 1 0.7545281648635864
, O 0 0.012002050876617432
whereas O 0 0.01161085907369852
most O 0 0.007091134786605835
, O 0 0.007101133465766907
if O 0 0.005259846802800894
not O 0 0.003940836992114782
all O 0 0.004210670944303274
, O 0 0.005072403233498335
of O 0 0.005536716431379318
the O 0 0.006420654710382223
other O 0 0.005117636173963547
sites O 0 0.008161033503711224
of O 0 0.010442272759974003
SacII O 1 0.9913272261619568
, O 0 0.017587853595614433
HhaI O 1 0.9951527118682861
, O 0 0.011348502710461617
and O 0 0.0101660480722785
HpaII O 1 0.848951518535614
in O 0 0.007756248116493225
this O 0 0.0065611121244728565
region O 0 0.011093477718532085
are O 0 0.006303211208432913
unmethylated O 1 0.9839078187942505
, O 0 0.010446248576045036
in O 0 0.007651614490896463
normal O 0 0.012139379046857357
individuals O 0 0.007913855835795403
and O 0 0.007497007958590984
most O 0 0.00823538564145565
of O 0 0.019250303506851196
the O 1 0.6817904710769653
patients O 1 0.9991108775138855
. O 0 0.05011279135942459

In O 0 0.020085930824279785
a O 0 0.014976194128394127
number O 0 0.010120470076799393
of O 0 0.014826111495494843
young O 1 0.9881894588470459
and O 1 0.9116005301475525
severely O 1 0.9999792575836182
affected O 1 0.9949826002120972
patients O 1 0.9991453886032104
, O 0 0.01332589890807867
however O 0 0.00748415058478713
, O 0 0.00814557820558548
complete O 0 0.012215310707688332
methylation O 0 0.015517068095505238
of O 0 0.008652377873659134
these O 0 0.006460357923060656
restriction O 0 0.015011502429842949
sites O 0 0.010460622608661652
was O 0 0.011888290755450726
found O 0 0.00892666820436716
in O 0 0.009643866680562496
the O 0 0.02107023075222969
mutated O 0 0.22935788333415985
allele O 0 0.07422962784767151
. O 0 0.04160592332482338

In O 0 0.020351795479655266
most O 0 0.012390206567943096
of O 0 0.012862402014434338
these O 0 0.008331352844834328
patients O 1 0.7264106869697571
, O 0 0.011979048140347004
the O 0 0.03615188971161842
onset O 1 0.9999805688858032
of O 1 0.9858566522598267
the O 1 0.9999651908874512
disease O 1 1.0
was O 1 0.9999986886978149
congenital O 1 1.0
. O 1 0.9958490133285522

Preliminary O 0 0.04729435592889786
in O 0 0.031067103147506714
vivo O 1 0.5110407471656799
footprinting O 1 0.7535074949264526
data O 0 0.01280888356268406
gave O 0 0.01284791063517332
evidence O 0 0.007822977378964424
for O 0 0.008463159203529358
protein O 0 0.014672172255814075
- O 1 0.6487904787063599
DNA O 0 0.011960061267018318
contact O 0 0.01172326784580946
in O 0 0.006613199133425951
normal O 0 0.0105544812977314
genes O 0 0.009373350068926811
at O 0 0.010387873277068138
an O 0 0.013691396452486515
Sp1 O 1 0.9923595786094666
consensus O 0 0.018238363787531853
binding O 0 0.012349959462881088
site O 0 0.012595465406775475
upstream O 0 0.01345930714160204
of O 0 0.008889267221093178
the O 0 0.01682952232658863
CTG O 1 0.9999294281005859
repeat O 0 0.28920978307724
and O 0 0.009612814523279667
for O 0 0.007557244040071964
a O 0 0.009441344998776913
significant O 0 0.0077425651252269745
reduction O 0 0.016233058646321297
of O 0 0.009206541813910007
this O 0 0.007037805393338203
interaction O 0 0.0114844786003232
in O 0 0.007930757477879524
cells O 0 0.011741180904209614
with O 0 0.011034091003239155
a O 0 0.03130197525024414
hypermethylated O 1 0.999357283115387
DMPK O 1 0.9998005032539368
gene O 0 0.04142078757286072
. O 0 0.023948604241013527
. O 0 0.033667080104351044

The O 0 0.42307382822036743
hemochromatosis B-Disease 1 0.9999978542327881
gene O 0 0.12190131098031998
product O 0 0.03288742154836655
complexes O 0 0.046730153262615204
with O 0 0.015572196803987026
the O 0 0.12173484265804291
transferrin O 1 0.9999257326126099
receptor O 1 0.5193009376525879
and O 0 0.02054479904472828
lowers O 1 0.7185689210891724
its O 0 0.01783364824950695
affinity O 0 0.03275485709309578
for O 0 0.021788233891129494
ligand O 0 0.08265047520399094
binding O 0 0.04221993312239647
. O 0 0.03697739541530609

We O 0 0.028905637562274933
recently O 0 0.02859325334429741
reported O 0 0.0176229290664196
the O 0 0.013705749996006489
positional O 0 0.028831154108047485
cloning O 0 0.017008652910590172
of O 0 0.011819906532764435
a O 0 0.01646626554429531
candidate O 0 0.026565132662653923
gene O 0 0.02679673582315445
for O 0 0.05272642895579338
hereditary B-Disease 1 0.9999996423721313
hemochromatosis I-Disease 1 1.0
called O 1 0.9999771118164062
HFE O 1 0.9999947547912598
. O 0 0.17887409031391144

The O 0 0.034671131521463394
gene O 0 0.02527914196252823
product O 0 0.014966939575970173
, O 0 0.00920331571251154
a O 0 0.008883093483746052
member O 0 0.010571995750069618
of O 0 0.0087737450376153
the O 0 0.012580890208482742
major O 0 0.4812459945678711
histocompatibility O 1 0.9999948740005493
complex O 1 0.8952327370643616
class O 1 0.9870645999908447
I O 1 0.9813975095748901
- O 1 0.9990893602371216
like O 0 0.01326547097414732
family O 0 0.01690874621272087
, O 0 0.007641891948878765
was O 0 0.008864766918122768
found O 0 0.004300784319639206
to O 0 0.004679587669670582
have O 0 0.003978821448981762
a O 0 0.0083773797377944
mutation O 0 0.015005744993686676
, O 0 0.013557389378547668
Cys O 1 0.9993851184844971
- O 1 0.9817283749580383
282 O 1 0.8997779488563538
- O 1 0.9997422099113464
- O 1 0.9995914101600647
> O 1 0.9913402199745178
Tyr O 1 0.9998288154602051
( O 0 0.06395357847213745
C282Y O 1 0.8394433856010437
) O 0 0.012245669029653072
, O 0 0.009448546916246414
in O 0 0.008356419391930103
85 O 0 0.021603116765618324
% O 0 0.01771043986082077
of O 0 0.023790236562490463
patient O 1 0.9946861267089844
chromosomes O 0 0.06516211479902267
. O 0 0.04544946178793907

This O 0 0.037309449166059494
mutation O 0 0.04845023527741432
eliminates O 0 0.04611712694168091
the O 0 0.01635861024260521
ability O 0 0.016784176230430603
of O 0 0.0186301376670599
HFE O 1 0.9990562796592712
to O 0 0.014144464395940304
associate O 0 0.024308988824486732
with O 0 0.01618923991918564
beta2 O 1 0.9997898936271667
- O 1 0.9999234676361084
microglobulin O 1 0.9996170997619629
( O 0 0.04328915849328041
beta2m O 1 0.9061896204948425
) O 0 0.015934733673930168
and O 0 0.0159697737544775
prevents O 1 0.8519848585128784
cell O 1 0.7964529991149902
- O 1 0.9962550401687622
surface O 0 0.036851007491350174
expression O 0 0.036993928253650665
. O 0 0.03402557224035263

A O 0 0.04998878762125969
second O 0 0.0658276155591011
mutation O 0 0.03528926149010658
that O 0 0.007758751977235079
has O 0 0.007397116161882877
no O 0 0.007061504293233156
effect O 0 0.00849264394491911
on O 0 0.011483981274068356
beta2m O 1 0.9972442388534546
association O 0 0.20835238695144653
, O 0 0.020407747477293015
H63D O 1 0.9991492033004761
, O 0 0.010807426646351814
was O 0 0.01152530126273632
found O 0 0.0059666880406439304
in O 0 0.0051506259478628635
eight O 0 0.007632322143763304
out O 0 0.008387011475861073
of O 0 0.011095324531197548
nine O 0 0.0211300328373909
patients O 1 0.8326197862625122
heterozygous O 0 0.03550055995583534
for O 0 0.01728716306388378
the O 0 0.039188265800476074
C282Y O 1 0.9989805817604065
mutant O 1 0.7770694494247437
. O 0 0.049220409244298935

In O 0 0.023677704855799675
this O 0 0.013324734754860401
report O 0 0.0145625164732337
, O 0 0.009600666351616383
we O 0 0.007730712182819843
demonstrate O 0 0.012289969250559807
in O 0 0.01000493299216032
cultured O 0 0.03532405197620392
293 O 0 0.4135117828845978
cells O 0 0.03073524869978428
overexpressing O 1 0.920107901096344
wild O 0 0.05830603092908859
- O 1 0.9986774325370789
type O 0 0.13117501139640808
or O 0 0.017800530418753624
mutant O 1 0.9310204386711121
HFE O 1 0.9988596439361572
proteins O 0 0.01206672191619873
that O 0 0.005361798219382763
both O 0 0.006236904300749302
the O 0 0.010222699493169785
wild O 0 0.021486179903149605
- O 1 0.9955796599388123
type O 0 0.04216047376394272
and O 0 0.02163253352046013
H63D O 1 0.9999710321426392
HFE O 1 0.9999560117721558
proteins O 0 0.023316940292716026
form O 0 0.018136613070964813
stable O 0 0.24324142932891846
complexes O 0 0.03387109562754631
with O 0 0.015281607396900654
the O 0 0.07331204414367676
transferrin O 1 0.9999521970748901
receptor O 1 0.9945547580718994
( O 0 0.21519166231155396
TfR O 1 0.9966431856155396
) O 0 0.04236438125371933
. O 0 0.03840324655175209

The O 0 0.05232659727334976
C282Y O 1 0.9919992089271545
mutation O 0 0.054041411727666855
nearly O 0 0.021468447521328926
completely O 0 0.028924942016601562
prevents O 0 0.02798391878604889
the O 0 0.012461964972317219
association O 0 0.015661846846342087
of O 0 0.014155480079352856
the O 0 0.03548986464738846
mutant O 1 0.9988884329795837
HFE O 1 0.9999698400497437
protein O 0 0.026724781841039658
with O 0 0.018853330984711647
the O 0 0.03627223148941994
TfR O 1 0.9988589286804199
. O 0 0.050851378589868546

Studies O 0 0.03175172209739685
on O 0 0.024887509644031525
cell O 0 0.23198889195919037
- O 1 0.9723687767982483
associated O 0 0.021494191139936447
transferrin O 1 0.8741261959075928
at O 0 0.016666462644934654
37 O 0 0.02285897172987461
degrees O 0 0.018365995958447456
C O 0 0.02958313189446926
suggest O 0 0.01035548746585846
that O 0 0.005728953517973423
the O 0 0.011515929363667965
overexpressed O 1 0.6301506161689758
wild O 0 0.05018698424100876
- O 1 0.9998444318771362
type O 1 0.991305410861969
HFE O 1 0.9999771118164062
protein O 0 0.020665040239691734
decreases O 0 0.018154827877879143
the O 0 0.012101497501134872
affinity O 0 0.01907327026128769
of O 0 0.015886636450886726
the O 0 0.045057982206344604
TfR O 1 0.9999151229858398
for O 0 0.0935792624950409
transferrin O 1 0.9985352754592896
. O 0 0.053860943764448166

The O 0 0.06631933897733688
overexpressed O 1 0.9993757605552673
H63D O 1 0.9998772144317627
protein O 0 0.02777310647070408
does O 0 0.010881097055971622
not O 0 0.005839143879711628
have O 0 0.004671962931752205
this O 0 0.0046331449411809444
effect O 0 0.007277100812643766
, O 0 0.007177071645855904
providing O 0 0.009223398752510548
the O 0 0.00736064650118351
first O 0 0.008769329637289047
direct O 0 0.008612396195530891
evidence O 0 0.006939518731087446
for O 0 0.007327275816351175
a O 0 0.012953060679137707
functional O 0 0.01931355707347393
consequence O 0 0.023824535310268402
of O 0 0.019621500745415688
the O 1 0.683520495891571
H63D O 1 0.9999792575836182
mutation O 1 0.9109083414077759
. O 0 0.042365625500679016

Addition O 0 0.030430559068918228
of O 0 0.026306673884391785
soluble O 1 0.5674493908882141
wild O 0 0.15487127006053925
- O 1 0.9999064207077026
type O 1 0.9992246627807617
HFE O 1 0.9999964237213135
/ O 1 0.9999827146530151
beta2m O 1 0.9996857643127441
heterodimers O 1 0.999479353427887
to O 0 0.022620590403676033
cultured O 1 0.8779347538948059
cells O 0 0.0197038222104311
also O 0 0.009311195462942123
decreased O 0 0.016814852133393288
the O 0 0.011224468238651752
apparent O 0 0.08245264738798141
affinity O 0 0.02073211595416069
of O 0 0.012449730187654495
the O 0 0.02118314988911152
TfR O 1 0.9985525012016296
for O 0 0.008477559313178062
its O 0 0.009791150689125061
ligand O 0 0.028678426519036293
under O 0 0.014976777136325836
steady O 0 0.49554067850112915
- O 1 0.9717464447021484
state O 0 0.008185037411749363
conditions O 0 0.011688116006553173
, O 0 0.0070313639007508755
both O 0 0.006701786536723375
in O 0 0.009465014562010765
293 O 1 0.9450972676277161
cells O 0 0.023338880389928818
and O 0 0.015480970963835716
in O 0 0.024138467386364937
HeLa O 1 0.9998637437820435
cells O 0 0.061595965176820755
. O 0 0.04096533730626106

Furthermore O 0 0.039688240736722946
, O 0 0.019237730652093887
at O 0 0.01597338542342186
4 O 0 0.018546590581536293
degrees O 0 0.018315663561224937
C O 0 0.06194616109132767
, O 0 0.010321984067559242
the O 0 0.011527215130627155
added O 0 0.017296966165304184
soluble O 0 0.03835277259349823
complex O 0 0.01775371842086315
of O 0 0.03245942294597626
HFE O 1 0.9999973773956299
/ O 1 0.9999496936798096
beta2m O 1 0.9977669715881348
inhibited O 0 0.14295458793640137
binding O 0 0.01892814226448536
of O 0 0.01657921075820923
transferrin O 1 0.9357277154922485
to O 0 0.02337169088423252
HeLa O 1 0.9998795986175537
cell O 0 0.2601688802242279
TfR O 1 0.9907280206680298
in O 0 0.01509831752628088
a O 0 0.02778702601790428
concentration O 1 0.9979775547981262
- O 1 0.999672532081604
dependent O 0 0.04044916480779648
manner O 0 0.0407804474234581
. O 0 0.03613996133208275

Scatchard O 0 0.2570485472679138
plots O 0 0.04423137381672859
of O 0 0.019074877724051476
these O 0 0.01050916314125061
data O 0 0.009671717882156372
indicate O 0 0.009793262928724289
that O 0 0.006389355752617121
the O 0 0.011066668666899204
added O 0 0.020284252241253853
heterodimer O 1 0.9776262640953064
substantially O 0 0.020005708560347557
reduced O 0 0.017308341339230537
the O 0 0.015748022124171257
affinity O 0 0.030985744670033455
of O 0 0.0346532016992569
TfR O 1 0.9998728036880493
for O 0 0.0884125605225563
transferrin O 1 0.998685896396637
. O 0 0.05682266876101494

These O 0 0.019752629101276398
results O 0 0.014546724036335945
establish O 0 0.019550390541553497
a O 0 0.016074642539024353
molecular O 0 0.018997155129909515
link O 0 0.0253364909440279
between O 0 0.018366754055023193
HFE O 1 0.9999417066574097
and O 0 0.012142094783484936
a O 0 0.014441241510212421
key O 0 0.019800016656517982
protein O 0 0.009533163160085678
involved O 0 0.006672087591141462
in O 0 0.007345604244619608
iron O 1 0.9905299544334412
transport O 0 0.07174748182296753
, O 0 0.011313412338495255
the O 0 0.023603931069374084
TfR O 1 0.9998501539230347
, O 0 0.009858346544206142
and O 0 0.007029000669717789
raise O 0 0.01010066457092762
the O 0 0.007446532603353262
possibility O 0 0.009971266612410545
that O 0 0.005863605998456478
alterations O 0 0.017648523673415184
in O 0 0.006904481444507837
this O 0 0.00760124996304512
regulatory O 0 0.11401575058698654
mechanism O 0 0.11798252910375595
may O 0 0.007595204748213291
play O 0 0.007132880389690399
a O 0 0.008180420845746994
role O 0 0.010938117280602455
in O 0 0.007926305755972862
the O 0 0.020558500662446022
pathogenesis O 1 0.999983549118042
of O 1 0.9992932081222534
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9955763816833496
. O 0 0.22050458192825317

Genomic O 0 0.06521008908748627
organization O 0 0.03345083072781563
of O 0 0.023036343976855278
the O 0 0.04988173767924309
UBE3A O 1 0.9999949932098389
/ O 1 0.9999849796295166
E6 O 1 0.9999796152114868
- O 1 0.9999327659606934
AP O 1 0.7367550730705261
gene O 0 0.02956622838973999
and O 0 0.022236524149775505
related O 0 0.036165978759527206
pseudogenes O 0 0.11597421020269394
. O 0 0.04621661454439163

The O 0 0.05334991216659546
UBE3A O 1 0.9950847029685974
gene O 0 0.03188096731901169
encodes O 0 0.030130112543702126
the O 0 0.022519947960972786
E6 O 1 0.997424840927124
- O 1 0.997819185256958
AP O 1 0.821914792060852
ubiquitin O 1 0.9884090423583984
- O 1 0.9983313679695129
protein O 0 0.02196338027715683
ligase O 0 0.02810484729707241
and O 0 0.00995905976742506
has O 0 0.00931335985660553
recently O 0 0.011665143072605133
been O 0 0.006849393248558044
shown O 0 0.006703637074679136
to O 0 0.0069486889988183975
be O 0 0.009428617544472218
mutated O 0 0.20429623126983643
in O 1 0.9195718765258789
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.999996542930603
who O 1 0.9930118918418884
lack O 1 0.9992454051971436
15q11 O 1 0.9999940395355225
- O 1 0.9999788999557495
q13 O 1 0.9992778897285461
deletions O 0 0.2685357630252838
or O 0 0.02753555215895176
chromosome O 0 0.0563884973526001
15 O 0 0.04799782484769821
paternal O 1 0.9869715571403503
uniparental B-Disease 1 0.9999021291732788
disomy I-Disease 1 0.998040497303009
. O 0 0.07562422007322311

Previous O 0 0.08223969489336014
UBE3A O 1 0.9958475828170776
cDNA O 0 0.09111785143613815
analysis O 0 0.020712707191705704
has O 0 0.015595759265124798
shown O 0 0.013312296010553837
a O 0 0.01759609580039978
coding O 0 0.02664540708065033
region O 0 0.016806986182928085
of O 0 0.01718149334192276
approximately O 0 0.022175448015332222
2 O 0 0.03766409307718277
. O 0 0.03607366234064102

6 O 0 0.06089678779244423
kb O 0 0.07797488570213318
and O 0 0.01872198097407818
a O 0 0.021009676158428192
3 O 0 0.027626287192106247
- O 1 0.9825870394706726
untranslated O 0 0.4845610558986664
region O 0 0.024209612980484962
( O 0 0.02124323695898056
UTR O 0 0.30348464846611023
) O 0 0.01253563817590475
of O 0 0.013172011822462082
< O 0 0.15379276871681213
50 O 0 0.016996413469314575
bp O 0 0.02879849262535572
, O 0 0.011030437424778938
whereas O 0 0.012446447275578976
Northern O 0 0.012271454557776451
analysis O 0 0.007523772306740284
has O 0 0.007546623237431049
indicated O 0 0.012113535776734352
mRNA O 0 0.014513724483549595
sizes O 0 0.00967870932072401
of O 0 0.01244383305311203
5 O 0 0.026514708995819092
- O 1 0.9524818062782288
8 O 0 0.046912577003240585
kb O 0 0.3297919034957886
. O 0 0.04734121635556221

We O 0 0.026181623339653015
have O 0 0.013340904377400875
analyzed O 0 0.019657758995890617
additional O 0 0.01711425743997097
cDNA O 0 0.058551158756017685
clones O 0 0.05771094560623169
and O 0 0.014461548067629337
provide O 0 0.014434712007641792
evidence O 0 0.011087468825280666
for O 0 0.011175627820193768
an O 0 0.014960823580622673
additional O 0 0.021395038813352585
0 O 0 0.04137633740901947
. O 0 0.03385472670197487

5 O 0 0.04746917262673378
kb O 0 0.06903152167797089
of O 0 0.025328753516077995
5 O 0 0.03785587474703789
- O 1 0.9800050258636475
UTR O 1 0.7366767525672913
and O 0 0.01911246031522751
> O 0 0.051131851971149445
2 O 0 0.023304715752601624
kb O 0 0.05124162137508392
of O 0 0.025335749611258507
3 O 0 0.05149669200181961
- O 1 0.9899499416351318
UTR O 1 0.7513148784637451
. O 0 0.047370992600917816

We O 0 0.022735897451639175
have O 0 0.010910408571362495
established O 0 0.017095530405640602
the O 0 0.013141117990016937
genomic O 0 0.02270618826150894
organization O 0 0.02035050094127655
of O 0 0.01903177984058857
UBE3A O 1 0.9996901750564575
and O 0 0.013983705081045628
the O 0 0.014847202226519585
sequence O 0 0.01634380780160427
of O 0 0.026984738186001778
intron O 1 0.9999334812164307
- O 1 0.9993281364440918
exon O 1 0.6373475790023804
borders O 0 0.047458063811063766
. O 0 0.037497520446777344

We O 0 0.026237908750772476
have O 0 0.012883489951491356
also O 0 0.011529909446835518
mapped O 0 0.019011259078979492
two O 0 0.010391535237431526
highly O 0 0.019452689215540886
homologous O 0 0.03134709969162941
processed O 0 0.024026736617088318
pseudogenes O 0 0.046246279031038284
, O 0 0.02104375511407852
UBE3AP1 O 1 0.992638111114502
and O 0 0.01910039223730564
UBE3AP2 O 1 0.9794948101043701
, O 0 0.011556101031601429
to O 0 0.00928301177918911
chromosomes O 0 0.014871618710458279
2 O 0 0.011049909517168999
and O 0 0.00833771750330925
21 O 0 0.013959595933556557
, O 0 0.010582124814391136
respectively O 0 0.011788958683609962
, O 0 0.009789577685296535
and O 0 0.008785028010606766
determined O 0 0.014132382348179817
their O 0 0.011747944168746471
genomic O 0 0.03457555174827576
organization O 0 0.03913208097219467
. O 0 0.032847028225660324

These O 0 0.022441444918513298
results O 0 0.015539984218776226
will O 0 0.01065504364669323
form O 0 0.010209796950221062
the O 0 0.008998967707157135
basis O 0 0.008797110989689827
for O 0 0.007637451868504286
studies O 0 0.00941114965826273
of O 0 0.014492378570139408
mutation O 0 0.16274158656597137
and O 0 0.023567715659737587
imprinting O 1 0.9942504167556763
of O 0 0.26242783665657043
UBE3A O 1 0.9998311996459961
. O 0 0.06180892139673233

Mutation O 0 0.08909636735916138
spectrum O 0 0.054187972098588943
and O 0 0.03307825326919556
genotype O 1 0.9918873906135559
- O 1 0.9988828301429749
phenotype O 1 0.8263527750968933
analyses O 0 0.024305520579218864
in O 0 0.02020339109003544
Cowden B-Disease 1 0.9999909400939941
disease I-Disease 1 0.9999630451202393
and O 1 0.9499222040176392
Bannayan B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999998807907104
Zonana I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
, O 0 0.29029014706611633
two O 0 0.15182887017726898
hamartoma B-Disease 1 0.9999992847442627
syndromes I-Disease 1 0.999998927116394
with O 1 0.995762288570404
germline O 1 0.9999951124191284
PTEN O 1 0.9999873638153076
mutation O 1 0.933369517326355
. O 0 0.05437440052628517

The O 1 0.859916090965271
tumour B-Disease 1 0.9999994039535522
suppressor O 1 0.9999949932098389
gene O 1 0.9902623891830444
PTEN O 1 0.9997376799583435
, O 0 0.02829689159989357
which O 0 0.0195644311606884
maps O 0 0.028027141466736794
to O 0 0.026470759883522987
10q23 O 0 0.24094857275485992
. O 0 0.050605129450559616

3 O 0 0.040679775178432465
and O 0 0.021978992968797684
encodes O 0 0.03158167377114296
a O 0 0.023158740252256393
403 O 0 0.053889937698841095
amino O 0 0.026275448501110077
acid O 0 0.031897880136966705
dual O 0 0.035790689289569855
specificity O 0 0.12254849076271057
phosphatase O 1 0.9958513975143433
( O 0 0.025122467428445816
protein O 0 0.020613521337509155
tyrosine O 0 0.29144996404647827
phosphatase O 1 0.9744696617126465
; O 0 0.020655237138271332
PTPase O 1 0.9830145835876465
) O 0 0.013383918441832066
, O 0 0.009700209833681583
was O 0 0.011945577338337898
shown O 0 0.009574188850820065
recently O 0 0.011616638861596584
to O 0 0.007561451755464077
play O 0 0.009323595091700554
a O 0 0.013411512598395348
broad O 0 0.029875705018639565
role O 0 0.06531648337841034
in O 0 0.021044880151748657
human O 1 0.7326657176017761
malignancy B-Disease 1 0.9999929666519165
. O 0 0.07973401248455048

Somatic O 1 0.9942517280578613
PTEN O 1 0.9991024732589722
deletions O 0 0.09697134792804718
and O 0 0.022844132035970688
mutations O 0 0.018962891772389412
were O 0 0.008681582286953926
observed O 0 0.010020000860095024
in O 0 0.009038789197802544
sporadic B-Disease 1 0.8500486016273499
breast I-Disease 1 0.9999971389770508
, I-Disease 1 0.8323580026626587
brain I-Disease 1 0.9998593330383301
, I-Disease 1 0.9981967806816101
prostate I-Disease 1 1.0
and I-Disease 1 0.9999916553497314
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9998626708984375
lines O 0 0.02312670461833477
and O 0 0.00843404233455658
in O 0 0.006415169220417738
several O 0 0.008022869937121868
primary O 0 0.09398633241653442
tumours B-Disease 1 0.9999109506607056
such O 0 0.015385156497359276
as O 1 0.9425700902938843
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.999997615814209
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999998807907104
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9980092644691467

In O 0 0.02756670117378235
addition O 0 0.026658406481146812
, O 0 0.026822345331311226
PTEN O 1 0.9994200468063354
was O 0 0.023315615952014923
identified O 0 0.012605882249772549
as O 0 0.00952010229229927
the O 0 0.012528805062174797
susceptibility O 0 0.4081539511680603
gene O 0 0.014295190572738647
for O 0 0.010772527195513248
two O 0 0.027201643213629723
hamartoma B-Disease 1 0.9999996423721313
syndromes I-Disease 1 0.9999998807907104
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997594952583313
CD B-Disease 1 0.999868631362915
; O 0 0.08805805444717407
MIM O 1 0.9998929500579834
158350 O 1 0.9078086018562317
) O 0 0.016077207401394844
and O 0 0.015063726343214512
Bannayan B-Disease 1 0.9981545805931091
- I-Disease 1 0.999724805355072
Zonana I-Disease 1 0.9996808767318726
( I-Disease 0 0.047158416360616684
BZS I-Disease 1 0.9892486333847046
) I-Disease 0 0.018829304724931717
or I-Disease 0 0.01732492633163929
Ruvalcaba I-Disease 1 0.9967746138572693
- I-Disease 1 0.9993264675140381
Riley I-Disease 1 0.9994342923164368
- I-Disease 1 0.9999920129776001
Smith I-Disease 1 0.999891996383667
syndrome I-Disease 1 1.0
( O 1 0.999194324016571
MIM O 1 0.9999971389770508
153480 O 1 0.999257504940033
) O 0 0.054633475840091705
. O 0 0.042128078639507294

Constitutive O 0 0.11985968798398972
DNA O 0 0.036739759147167206
from O 0 0.019822167232632637
37 O 0 0.033891960978507996
CD B-Disease 0 0.05010605975985527
families O 0 0.019374480471014977
and O 0 0.014391807839274406
seven O 0 0.025177380070090294
BZS B-Disease 1 0.9975304007530212
families O 0 0.02824719250202179
was O 0 0.03382555767893791
screened O 0 0.13851167261600494
for O 0 0.03745555877685547
germline O 1 0.9991902709007263
PTEN O 1 0.9997062087059021
mutations O 0 0.08380097895860672
. O 0 0.04816489666700363

PTEN O 1 0.9989966750144958
mutations O 0 0.03981989994645119
were O 0 0.014326831325888634
identified O 0 0.01271965354681015
in O 0 0.007359656505286694
30 O 0 0.009532362222671509
of O 0 0.009832185693085194
37 O 0 0.021619530394673347
( O 0 0.01716574840247631
81 O 0 0.026159392669796944
% O 0 0.01326138898730278
) O 0 0.013416750356554985
CD B-Disease 0 0.025707334280014038
families O 0 0.011433888226747513
, O 0 0.009671065956354141
including O 0 0.009627061896026134
missense O 0 0.03692181408405304
and O 0 0.012807642109692097
nonsense O 0 0.28701144456863403
point O 0 0.01702098175883293
mutations O 0 0.016286199912428856
, O 0 0.01118807028979063
deletions O 0 0.023779431357979774
, O 0 0.01247401349246502
insertions O 0 0.033466484397649765
, O 0 0.012057754211127758
a O 0 0.0210738405585289
deletion O 1 0.960992693901062
/ O 1 0.9987406134605408
insertion O 1 0.5030471682548523
and O 0 0.026580730453133583
splice O 0 0.48020488023757935
site O 0 0.04253193736076355
mutations O 0 0.04214753583073616
. O 0 0.03613843396306038

These O 0 0.024079222232103348
mutations O 0 0.021874604746699333
were O 0 0.009273374453186989
scattered O 0 0.013703159056603909
over O 0 0.010226448997855186
the O 0 0.010989326983690262
entire O 0 0.017437441274523735
length O 0 0.01439571101218462
of O 0 0.02766808122396469
PTEN O 1 0.9998564720153809
, O 0 0.00988718681037426
with O 0 0.006808727513998747
the O 0 0.008370916359126568
exception O 0 0.011324096471071243
of O 0 0.007985742762684822
the O 0 0.01028348132967949
first O 0 0.013260522857308388
, O 0 0.011729948222637177
fourth O 0 0.02957795187830925
and O 0 0.0171327143907547
last O 0 0.028917204588651657
exons O 0 0.06595682352781296
. O 0 0.035529542714357376

A O 0 0.06503043323755264
hot O 0 0.25975877046585083
spot O 0 0.05174996331334114
for O 0 0.027659296989440918
PTEN O 1 0.9997230172157288
mutation O 0 0.036237701773643494
in O 0 0.012641341425478458
CD B-Disease 0 0.2772960066795349
was O 0 0.015714427456259727
identified O 0 0.009698853828012943
in O 0 0.007145292591303587
exon O 0 0.02487746998667717
5 O 0 0.010152622126042843
that O 0 0.005460191052407026
contains O 0 0.0094890296459198
the O 0 0.012501861900091171
PTPase O 1 0.991672933101654
core O 0 0.27511024475097656
motif O 0 0.027535684406757355
, O 0 0.007561278995126486
with O 0 0.0063844965770840645
13 O 0 0.008875533007085323
of O 0 0.008561248891055584
30 O 0 0.012454625219106674
( O 0 0.012579462490975857
43 O 0 0.018072737380862236
% O 0 0.012879433110356331
) O 0 0.015764083713293076
CD B-Disease 0 0.05302188917994499
mutations O 0 0.017970165237784386
identified O 0 0.013279633596539497
in O 0 0.011212109588086605
this O 0 0.017608391121029854
exon O 0 0.07947393506765366
. O 0 0.03767018765211105

Seven O 0 0.03163544461131096
of O 0 0.02102234587073326
30 O 0 0.022930646315217018
( O 0 0.01742585375905037
23 O 0 0.016820892691612244
% O 0 0.01085930597037077
) O 0 0.0070589566603302956
were O 0 0.005097697023302317
within O 0 0.006494047585874796
the O 0 0.0103802140802145
core O 0 0.08231600373983383
motif O 0 0.08698254823684692
, O 0 0.007497405633330345
the O 0 0.007267344743013382
majority O 0 0.008993304334580898
( O 0 0.007960963994264603
five O 0 0.005506453104317188
of O 0 0.0065272506326437
seven O 0 0.008427872322499752
) O 0 0.00648281816393137
of O 0 0.005966993980109692
which O 0 0.005969183053821325
were O 0 0.008105249144136906
missense O 1 0.7525784373283386
mutations O 0 0.023117223754525185
, O 0 0.010283994488418102
possibly O 0 0.010325940325856209
pointing O 0 0.013450522907078266
to O 0 0.008128962479531765
the O 0 0.010711969807744026
functional O 0 0.017883578315377235
significance O 0 0.015513136051595211
of O 0 0.014606374315917492
this O 0 0.015902388840913773
region O 0 0.03697400167584419
. O 0 0.032314617186784744

Germline O 1 0.9991864562034607
PTEN O 1 0.9996500015258789
mutations O 0 0.03695221245288849
were O 0 0.012117303907871246
identified O 0 0.011523955501616001
in O 0 0.006586039438843727
four O 0 0.007869265042245388
of O 0 0.010395876131951809
seven O 0 0.016775459051132202
( O 0 0.02343982458114624
57 O 0 0.039937328547239304
% O 0 0.029347989708185196
) O 0 0.03413699194788933
BZS B-Disease 1 0.9358855485916138
families O 0 0.03972742334008217
studied O 0 0.04687424376606941
. O 0 0.040831059217453

Interestingly O 0 0.07528591901063919
, O 0 0.02111741155385971
none O 0 0.015991227701306343
of O 0 0.01284800749272108
these O 0 0.009893101640045643
mutations O 0 0.01652010902762413
was O 0 0.014794176444411278
observed O 0 0.013479863293468952
in O 0 0.011221203953027725
the O 0 0.022910604253411293
PTPase O 1 0.9975982308387756
core O 0 0.46127334237098694
motif O 0 0.15887613594532013
. O 0 0.04484418407082558

It O 0 0.02066832035779953
is O 0 0.014575015753507614
also O 0 0.011344470083713531
worthy O 0 0.0252029187977314
of O 0 0.012972614727914333
note O 0 0.013983329758048058
that O 0 0.005741411354392767
a O 0 0.00933657493442297
single O 0 0.015357472002506256
nonsense O 0 0.03663419187068939
point O 0 0.01625470072031021
mutation O 0 0.022448234260082245
, O 0 0.012879002839326859
R233X O 0 0.4994621276855469
, O 0 0.009967680089175701
was O 0 0.010721741244196892
observed O 0 0.007695573847740889
in O 0 0.007284489925950766
the O 0 0.012182376347482204
germline O 0 0.31278786063194275
DNA O 0 0.012387679889798164
from O 0 0.00846506841480732
two O 0 0.009096415713429451
unrelated O 0 0.02430681511759758
CD B-Disease 0 0.3197886347770691
families O 0 0.020880021154880524
and O 0 0.017435824498534203
one O 0 0.031809091567993164
BZS B-Disease 1 0.9989427924156189
family O 0 0.0798325389623642
. O 0 0.04714202880859375

Genotype O 1 0.9995336532592773
- O 1 0.9996399879455566
phenotype O 1 0.7242979407310486
studies O 0 0.01350152213126421
were O 0 0.007881700992584229
not O 0 0.006124630104750395
performed O 0 0.011702087707817554
on O 0 0.007235105615109205
this O 0 0.006090993992984295
small O 0 0.010441606864333153
group O 0 0.020298436284065247
of O 0 0.02731640823185444
BZS B-Disease 1 0.9991927742958069
families O 0 0.05166931822896004
. O 0 0.04273684322834015

However O 0 0.032058995217084885
, O 0 0.029880650341510773
genotype O 1 0.9508320093154907
- O 1 0.9975473284721375
phenotype O 0 0.2894393503665924
analysis O 0 0.015231810510158539
inthe O 1 0.5957422256469727
group O 0 0.01794188842177391
of O 0 0.016577234491705894
CD B-Disease 1 0.8705766201019287
families O 0 0.013426259160041809
revealed O 0 0.013517415151000023
two O 0 0.006685130298137665
possible O 0 0.008885298855602741
associations O 0 0.013132092542946339
worthy O 0 0.043688926845788956
of O 0 0.014673123136162758
follow O 0 0.02568277157843113
- O 1 0.9700266122817993
up O 0 0.015219412744045258
in O 0 0.012359384447336197
independent O 0 0.023116717115044594
analyses O 0 0.030868947505950928
. O 0 0.029459550976753235

The O 0 0.029830336570739746
first O 0 0.02338353544473648
was O 0 0.021820280700922012
an O 0 0.012690531089901924
association O 0 0.017020775005221367
noted O 0 0.010254882276058197
in O 0 0.005845574662089348
the O 0 0.008489537052810192
group O 0 0.01303883083164692
of O 0 0.014512701891362667
CD B-Disease 1 0.9919209480285645
families O 0 0.4537716507911682
with O 1 0.9792018532752991
breast B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999986886978149
. O 1 0.6511595249176025

A O 0 0.0500878170132637
correlation O 0 0.03730696812272072
was O 0 0.020203707739710808
observed O 0 0.012457212433218956
between O 0 0.010704832151532173
the O 0 0.013423656113445759
presence O 0 0.10824979096651077
/ O 1 0.9937193393707275
absence O 0 0.025959298014640808
of O 0 0.016930755227804184
a O 1 0.739597737789154
PTEN O 1 0.9999738931655884
mutation O 0 0.023897163569927216
and O 0 0.008357936516404152
the O 0 0.012064117938280106
type O 1 0.6143916845321655
of O 1 0.6854402422904968
breast O 1 0.9999990463256836
involvement O 1 0.9997101426124573
( O 1 0.9567419290542603
unaffected O 1 0.9984022974967957
versus O 1 0.9986022114753723
benign O 1 0.9999876022338867
versus O 1 0.9998422861099243
malignant O 1 0.9999985694885254
) O 0 0.1172291710972786
. O 0 0.044767919927835464

Specifically O 0 0.03192131966352463
and O 0 0.016053728759288788
more O 0 0.0086861876770854
directly O 0 0.010403129272162914
, O 0 0.009578949771821499
an O 0 0.009694082662463188
association O 0 0.026912754401564598
was O 0 0.013879446312785149
also O 0 0.0070165242068469524
observed O 0 0.006978497840464115
between O 0 0.005985521711409092
the O 0 0.006864625960588455
presence O 0 0.010302858427166939
of O 0 0.012283905409276485
a O 1 0.6934541463851929
PTEN O 1 0.9999964237213135
mutation O 1 0.9994331002235413
and O 1 0.9994888305664062
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 1 0.983238697052002

Secondly O 1 0.5877336859703064
, O 0 0.023805977776646614
there O 0 0.013137667439877987
appeared O 0 0.014296763576567173
to O 0 0.007988696917891502
be O 0 0.007342617958784103
an O 0 0.010706032626330853
interdependent O 1 0.8514022827148438
association O 0 0.02249676175415516
between O 0 0.014362793415784836
mutations O 0 0.01795140840113163
upstream O 0 0.015830988064408302
and O 0 0.007688771467655897
within O 0 0.008996721357107162
the O 0 0.012947526760399342
PTPase O 1 0.9984570741653442
core O 1 0.5664086937904358
motif O 0 0.12338418513536453
, O 0 0.009393571875989437
the O 0 0.010223953984677792
core O 0 0.026131045073270798
motif O 0 0.021368324756622314
containing O 0 0.007729921955615282
the O 0 0.006314150057733059
majority O 0 0.008849074132740498
of O 0 0.012550183571875095
missense O 1 0.9767324328422546
mutations O 0 0.020345749333500862
, O 0 0.00708897365257144
and O 0 0.005695437081158161
the O 0 0.006512770429253578
involvement O 0 0.014083873480558395
of O 0 0.007246505934745073
all O 0 0.007650639861822128
major O 0 0.272445946931839
organ O 1 0.9997206330299377
systems O 0 0.3167835474014282
( O 0 0.018858527764678
central O 0 0.01801290735602379
nervous O 1 0.912055253982544
system O 0 0.05635162442922592
, O 1 0.613804817199707
thyroid O 1 0.9999998807907104
, O 1 0.9941871166229248
breast O 1 0.9999998807907104
, O 1 0.9995517134666443
skin O 1 0.9999997615814209
and O 1 0.9999369382858276
gastrointestinal O 1 1.0
tract O 1 0.9999998807907104
) O 1 0.9766483902931213
. O 0 0.05179326981306076

However O 0 0.03131218999624252
, O 0 0.019623123109340668
these O 0 0.010320078581571579
observations O 0 0.014651119709014893
would O 0 0.008554325439035892
need O 0 0.009104770608246326
to O 0 0.006787179969251156
be O 0 0.005853971466422081
confirmed O 0 0.007736522704362869
by O 0 0.006567490287125111
studying O 0 0.009278431534767151
a O 0 0.009772835299372673
larger O 0 0.010813908651471138
number O 0 0.010334441438317299
of O 0 0.01980520226061344
CD B-Disease 1 0.8438341021537781
families O 0 0.04179801046848297
. O 0 0.03863222897052765

Molecular O 0 0.11485224217176437
defects O 1 0.9486038088798523
leading O 0 0.03786999359726906
to O 0 0.018246429041028023
human O 0 0.07076576352119446
complement B-Disease 1 0.9995500445365906
component I-Disease 1 0.9999947547912598
C6 I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 0.023335691541433334
an O 0 0.17636607587337494
African O 1 0.9872887134552002
- O 1 0.9997454285621643
American O 0 0.09164197742938995
family O 0 0.04976212978363037
. O 0 0.037443630397319794

Complement B-Disease 1 0.9755538702011108
component I-Disease 1 0.999884843826294
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
( O 1 0.999488353729248
C6D B-Disease 1 0.999993085861206
) O 0 0.13422462344169617
was O 0 0.37280306220054626
diagnosed O 1 0.9995457530021667
in O 0 0.008560256101191044
a O 0 0.011728775687515736
16 O 0 0.017110848799347878
- O 1 0.9669193029403687
year O 0 0.014128051698207855
- O 1 0.9819559454917908
old O 0 0.27232053875923157
African O 0 0.24237871170043945
- O 1 0.994210958480835
American O 0 0.031889066100120544
male O 1 0.8837664723396301
with O 1 0.9806278347969055
meningococcal B-Disease 1 0.9999998807907104
meningitis I-Disease 1 0.9999998807907104
. O 1 0.9700933694839478

The O 0 0.06410029530525208
patients O 1 0.9827326536178589
father O 1 0.5855058431625366
and O 0 0.01543789729475975
two O 0 0.011748778633773327
brothers O 1 0.751403272151947
also O 0 0.013768856413662434
had O 0 0.017942549660801888
C6D B-Disease 1 0.9926908612251282
, O 0 0.010945206508040428
but O 0 0.006527457386255264
gave O 0 0.010376241989433765
no O 0 0.008385851979255676
history O 0 0.013897483237087727
of O 1 0.741306483745575
meningitis B-Disease 1 0.9999997615814209
or O 1 0.9687661528587341
other O 1 0.5481210350990295
neisserial B-Disease 1 0.9999868869781494
infection I-Disease 1 0.9999908208847046
. O 0 0.11069050431251526

By O 0 0.027852529659867287
using O 0 0.021734656766057014
exon O 0 0.08493910729885101
- O 0 0.26638883352279663
specific O 0 0.015959525480866432
polymerase O 0 0.06022677570581436
chain O 0 0.032677728682756424
reaction O 0 0.0236875731498003
( O 0 0.019539782777428627
PCR O 0 0.042257897555828094
) O 0 0.017963113263249397
/ O 0 0.3983577489852905
single O 0 0.02510831132531166
- O 1 0.9566510319709778
strand O 0 0.040392231196165085
conformation O 0 0.026055119931697845
polymorphism O 0 0.020999537780880928
as O 0 0.009511562995612621
a O 0 0.01278790645301342
screening O 0 0.021582361310720444
step O 0 0.01521581131964922
and O 0 0.00932699628174305
nucleotide O 0 0.015212004072964191
sequencing O 0 0.011218094266951084
of O 0 0.008574599400162697
target O 0 0.013068213127553463
exons O 0 0.019617900252342224
, O 0 0.007748736068606377
we O 0 0.005655949003994465
determined O 0 0.007443087175488472
that O 0 0.004932742100208998
the O 0 0.008906280621886253
proband O 1 0.5385280847549438
was O 0 0.01647971011698246
a O 0 0.01600794494152069
compound O 0 0.042979005724191666
heterozygote O 0 0.4736711382865906
for O 0 0.014870164915919304
two O 0 0.021212192252278328
C6 O 1 0.9999864101409912
gene O 0 0.06613176316022873
mutations O 0 0.04819871485233307
. O 0 0.03561489284038544

The O 0 0.030103975906968117
first O 0 0.02074420265853405
, O 0 0.018116919323801994
1195delC O 0 0.28308048844337463
located O 0 0.018795832991600037
in O 0 0.010560224764049053
exon O 0 0.040980469435453415
7 O 0 0.014326644130051136
, O 0 0.008779357187449932
is O 0 0.00709151104092598
a O 0 0.01036863587796688
novel O 0 0.020627034828066826
mutation O 0 0.015674300491809845
, O 0 0.007157561369240284
while O 0 0.006358040496706963
the O 0 0.0077807423658668995
second O 0 0.012229346670210361
, O 0 0.010201058350503445
1936delG O 0 0.07566069066524506
in O 0 0.0094240577891469
exon O 0 0.0355740450322628
12 O 0 0.013237426988780499
, O 0 0.008751706220209599
has O 0 0.007335812319070101
been O 0 0.006726276129484177
described O 0 0.009537464939057827
before O 0 0.008339042775332928
to O 0 0.010981017723679543
cause O 0 0.25481969118118286
C6D B-Disease 1 0.9963143467903137
in O 0 0.010459388606250286
an O 0 0.012847770936787128
unrelated O 0 0.042964376509189606
African O 1 0.6267609000205994
- O 1 0.9984644651412964
American O 0 0.04216959327459335
individual O 0 0.02771528996527195
. O 0 0.03182809799909592

Both O 0 0.035790566354990005
mutations O 0 0.03268851712346077
result O 0 0.01973801478743553
in O 0 0.022294947877526283
premature O 1 0.9986857771873474
termination O 1 0.9997367262840271
codons O 1 0.9682619571685791
and O 0 0.35245171189308167
C6 O 1 0.999974250793457
null O 1 0.8814823031425476
alleles O 0 0.11849978566169739
. O 0 0.04605744406580925

Allele O 1 0.9048293828964233
- O 1 0.942380428314209
specific O 0 0.02209203504025936
PCR O 0 0.03799054026603699
indicated O 0 0.014300702139735222
that O 0 0.006784695200622082
the O 0 0.009463266469538212
probands O 0 0.18872901797294617
two O 0 0.009399909526109695
brothers O 0 0.05611402913928032
also O 0 0.010778982192277908
inherited O 1 0.8420628309249878
the O 0 0.024121973663568497
1195delC O 1 0.9984182119369507
mutation O 0 0.024025985971093178
from O 0 0.008541559800505638
their O 0 0.008888805285096169
heterozygous O 0 0.02590140327811241
mother O 0 0.0576668456196785
and O 0 0.011834542267024517
the O 0 0.018540190532803535
1936delG O 1 0.9946250319480896
mutation O 0 0.031444888561964035
from O 0 0.01087249256670475
their O 0 0.012744756415486336
homozygous O 0 0.08725542575120926
father O 0 0.24074052274227142
. O 0 0.02567831613123417
. O 0 0.03297921642661095

PAX6 O 1 0.9983736276626587
mutations O 0 0.148797869682312
reviewed O 0 0.09578222036361694
. O 0 0.06588511168956757

Mutations O 0 0.060596074908971786
in O 0 0.02619181200861931
PAX6 O 1 0.9993723034858704
are O 0 0.010732803493738174
responsible O 0 0.0185598973184824
for O 0 0.013194975443184376
human O 1 0.7079064846038818
aniridia B-Disease 1 0.9999890327453613
and O 0 0.017442641779780388
have O 0 0.00599905289709568
also O 0 0.005797816440463066
been O 0 0.005318477749824524
found O 0 0.005441140383481979
in O 0 0.00627373019233346
patients O 0 0.046349044889211655
with O 0 0.014995761215686798
Peters B-Disease 1 0.999932050704956
anomaly I-Disease 1 0.9999481439590454
, O 1 0.5347888469696045
with O 1 0.9985902905464172
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9996792078018188
with O 1 0.9997876286506653
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999992847442627
keratitis I-Disease 1 0.9999998807907104
, O 1 0.8475050330162048
and O 0 0.043698690831661224
with O 0 0.36914530396461487
isolated B-Disease 1 0.9993435740470886
foveal I-Disease 1 0.9999880790710449
hypoplasia I-Disease 1 0.9999923706054688
. O 0 0.07943280786275864

No O 0 0.03734728321433067
locus O 0 0.049416664987802505
other O 0 0.012324427254498005
than O 0 0.012974788434803486
chromosome O 0 0.0627695694565773
11p13 O 1 0.8029327988624573
has O 0 0.011456958018243313
been O 0 0.009193901903927326
implicated O 0 0.05026348680257797
in O 0 0.01257961057126522
aniridia B-Disease 1 0.9997240900993347
, O 0 0.018329225480556488
and O 0 0.021177517250180244
PAX6 O 1 0.9999392032623291
is O 0 0.011902240104973316
clearly O 0 0.011994651518762112
the O 0 0.010002609342336655
major O 0 0.014434639364480972
, O 0 0.008116266690194607
if O 0 0.0069490154273808
not O 0 0.006049135234206915
only O 0 0.007851875387132168
, O 0 0.01354145910590887
gene O 0 0.020036766305565834
responsible O 0 0.02865120954811573
. O 0 0.02925656922161579

Twenty O 0 0.0656982883810997
- O 0 0.054934121668338776
eight O 0 0.017552541568875313
percent O 0 0.014570619910955429
of O 0 0.015386412851512432
identified O 0 0.02616283856332302
PAX6 O 1 0.9998067021369934
mutations O 0 0.024047566577792168
are O 0 0.009968806058168411
C O 1 0.9934499859809875
- O 1 0.9995778203010559
T O 1 0.9025044441223145
changes O 0 0.010444652289152145
at O 0 0.01462105568498373
CpG O 1 0.8862848281860352
dinucleotides O 1 0.6222565174102783
, O 0 0.010344776324927807
20 O 0 0.010467030107975006
% O 0 0.00808191392570734
are O 0 0.005171350669115782
splicing O 0 0.013702308759093285
errors O 0 0.011915202252566814
, O 0 0.007357804104685783
and O 0 0.005937859881669283
more O 0 0.004466798156499863
than O 0 0.0055692619644105434
30 O 0 0.011227380484342575
% O 0 0.012351332232356071
are O 0 0.008416601456701756
deletion O 0 0.03804566338658333
or O 0 0.019813280552625656
insertion O 0 0.1255231499671936
events O 0 0.03487015143036842
. O 0 0.0378643274307251

There O 0 0.02425464615225792
is O 0 0.016750050708651543
a O 0 0.021243682131171227
noticeably O 0 0.22306083142757416
elevated O 1 0.9913823008537292
level O 0 0.016956431791186333
of O 0 0.016359645873308182
mutation O 0 0.094364233314991
in O 0 0.008469379507005215
the O 0 0.013984262943267822
paired O 0 0.4759531617164612
domain O 0 0.014101044274866581
compared O 0 0.007823862135410309
with O 0 0.0067065623588860035
the O 0 0.00913592241704464
rest O 0 0.015024552121758461
of O 0 0.015018682926893234
the O 0 0.02790750563144684
gene O 0 0.03641355037689209
. O 0 0.03218431398272514

Increased O 0 0.04778054356575012
mutation O 0 0.04050352796912193
in O 0 0.01570414938032627
the O 0 0.02665543183684349
homeodomain O 1 0.9986248016357422
is O 0 0.015091766603291035
accounted O 0 0.019835226237773895
for O 0 0.010451368056237698
by O 0 0.013607222586870193
the O 0 0.024891041219234467
hypermutable O 1 0.9979026317596436
CpG O 1 0.9953521490097046
dinucleotide O 1 0.9717475771903992
in O 0 0.031864311546087265
codon O 0 0.08530639111995697
240 O 0 0.07225380092859268
. O 0 0.04911945015192032

Very O 0 0.029885517433285713
nearly O 0 0.02157733589410782
all O 0 0.01713726855814457
mutations O 0 0.021419262513518333
appear O 0 0.012898745015263557
to O 0 0.010903103277087212
cause O 0 0.021334288641810417
loss O 0 0.01842528022825718
of O 0 0.01125054806470871
function O 0 0.009853769093751907
of O 0 0.010752311907708645
the O 1 0.5749093294143677
mutant O 1 0.9992528557777405
allele O 0 0.46983617544174194
, O 0 0.009168336167931557
and O 0 0.006737872492522001
more O 0 0.00498223677277565
than O 0 0.005914849694818258
80 O 0 0.011899661272764206
% O 0 0.010624034330248833
of O 0 0.015209490433335304
exonic O 1 0.8800502419471741
substitutions O 0 0.033144403249025345
result O 0 0.01989310048520565
in O 0 0.021607346832752228
nonsense O 0 0.48541074991226196
codons O 0 0.08662572503089905
. O 0 0.04521845653653145

In O 0 0.025009330362081528
a O 0 0.022923780605196953
gene O 0 0.017515717074275017
with O 0 0.011415637098252773
such O 0 0.009923606179654598
extraordinarily O 1 0.768889307975769
high O 0 0.11098778247833252
sequence O 0 0.012573440559208393
conservation O 0 0.01664513349533081
throughout O 0 0.00929210800677538
evolution O 0 0.009550148621201515
, O 0 0.007065264042466879
there O 0 0.0056425235234200954
are O 0 0.006009830627590418
presumed O 0 0.029890384525060654
undiscovered O 1 0.9845198392868042
missense O 1 0.8919293284416199
mutations O 0 0.02147941291332245
, O 0 0.008734292350709438
these O 0 0.005314568988978863
are O 0 0.004822443705052137
hypothesized O 0 0.012083598412573338
to O 0 0.005947939120233059
exist O 0 0.006707318592816591
in O 0 0.0069308290258049965
as O 0 0.011558562517166138
- O 1 0.9856890439987183
yet O 0 0.020286669954657555
unidentified O 0 0.10121317207813263
phenotypes O 0 0.09335268288850784
. O 0 0.020793290808796883
. O 0 0.030596736818552017

Genetic O 0 0.06933603435754776
heterogeneity O 0 0.10768294334411621
and O 0 0.02525198645889759
penetrance O 1 0.5769217014312744
analysis O 0 0.01343807578086853
of O 0 0.012815759517252445
the O 0 0.026606010273098946
BRCA1 O 1 0.999332845211029
and O 0 0.1194576621055603
BRCA2 O 1 0.9998435974121094
genes O 0 0.08531242609024048
in O 0 0.3943076729774475
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999983310699463
families O 1 0.8832616806030273
. O 0 0.06380811333656311

The O 1 0.9881553649902344
Breast B-Disease 1 0.9999996423721313
Cancer I-Disease 1 0.9999997615814209
Linkage O 1 0.9999417066574097
Consortium O 1 0.9862369298934937
. O 0 0.061926983296871185

The O 0 0.03145807608962059
contribution O 0 0.03408857807517052
of O 0 0.02740177884697914
BRCA1 O 1 0.9988718628883362
and O 0 0.03435353562235832
BRCA2 O 1 0.999847412109375
to O 1 0.9177616834640503
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9992294311523438
assessed O 0 0.3397417664527893
by O 0 0.014439163729548454
linkage O 1 0.8595406413078308
and O 0 0.010928252711892128
mutation O 0 0.015335417352616787
analysis O 0 0.006223226431757212
in O 0 0.006673661060631275
237 O 0 0.03825132176280022
families O 0 0.01014187466353178
, O 0 0.006187328137457371
each O 0 0.004155401140451431
with O 0 0.004400595556944609
at O 0 0.005742408335208893
least O 0 0.00497535802423954
four O 0 0.006067210342735052
cases O 0 0.010754848830401897
of O 1 0.9340111017227173
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
, O 0 0.020879464223980904
collected O 0 0.011999868787825108
by O 0 0.01442764513194561
the O 1 0.9668241143226624
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Linkage O 1 0.9999483823776245
Consortium O 1 0.934249758720398
. O 0 0.049733519554138184

Families O 0 0.033405207097530365
were O 0 0.015434346161782742
included O 0 0.014454521238803864
without O 0 0.009964397177100182
regard O 0 0.012867925688624382
to O 0 0.00859865453094244
the O 0 0.013110024854540825
occurrence O 1 0.9431045055389404
of O 1 0.9990065693855286
ovarian B-Disease 1 1.0
or I-Disease 1 0.9867163896560669
other I-Disease 0 0.20071616768836975
cancers I-Disease 1 0.9999533891677856
. O 0 0.05396087467670441

Overall O 1 0.7618282437324524
, O 0 0.32586660981178284
disease O 1 0.9998289346694946
was O 1 0.6533508896827698
linked O 0 0.40091878175735474
to O 0 0.016958586871623993
BRCA1 O 1 0.9508047699928284
in O 0 0.00822715274989605
an O 0 0.00818547885864973
estimated O 0 0.009715544991195202
52 O 0 0.013189191929996014
% O 0 0.00761853763833642
of O 0 0.00786137580871582
families O 0 0.010155229829251766
, O 0 0.00871630571782589
to O 0 0.00836377963423729
BRCA2 O 0 0.3944431245326996
in O 0 0.006883701775223017
32 O 0 0.0112032201141119
% O 0 0.008575823158025742
of O 0 0.00765843503177166
families O 0 0.010294906795024872
, O 0 0.00704166479408741
and O 0 0.00582323269918561
to O 0 0.006028700154274702
neither O 0 0.010531395673751831
gene O 0 0.007916131988167763
in O 0 0.006141723599284887
16 O 0 0.010459162294864655
% O 0 0.009705277159810066
( O 0 0.011469321325421333
95 O 0 0.015661515295505524
% O 0 0.012296725064516068
confidence O 0 0.024528035894036293
interval O 0 0.06353593617677689
[ O 0 0.31171831488609314
CI O 1 0.999355137348175
] O 0 0.0297610554844141
6 O 0 0.020105283707380295
% O 0 0.016291042789816856
- O 0 0.09931428730487823
28 O 0 0.01955583691596985
% O 0 0.014936184510588646
) O 0 0.014222713187336922
, O 0 0.013031709007918835
suggesting O 0 0.022181859239935875
other O 0 0.018512025475502014
predisposition O 1 0.9931954145431519
genes O 0 0.03727065771818161
. O 0 0.03659576550126076

The O 0 0.031129758805036545
majority O 0 0.02570008486509323
( O 0 0.02207818068563938
81 O 0 0.024476217105984688
% O 0 0.01137524750083685
) O 0 0.008257610723376274
of O 0 0.010803761892020702
the O 1 0.9328547716140747
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.6838642358779907
were O 0 0.010328395292162895
due O 0 0.014887911267578602
to O 0 0.014387262985110283
BRCA1 O 1 0.9979547262191772
, O 0 0.009043642319738865
with O 0 0.007059712894260883
most O 0 0.007191601675003767
others O 0 0.010238908231258392
( O 0 0.013711545616388321
14 O 0 0.016374729573726654
% O 0 0.014812451787292957
) O 0 0.015391645021736622
due O 0 0.019489677622914314
to O 0 0.025775713846087456
BRCA2 O 1 0.9713686108589172
. O 0 0.04110198840498924

Conversely O 0 0.06602182239294052
, O 0 0.018249446526169777
the O 0 0.01187250018119812
majority O 0 0.011505089700222015
of O 0 0.009963014163076878
families O 0 0.012553328648209572
with O 0 0.010825340636074543
male B-Disease 1 0.8371338844299316
and I-Disease 1 0.8617578148841858
female I-Disease 1 0.9999978542327881
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
were O 0 0.024421704933047295
due O 0 0.11746562272310257
to O 0 0.06274643540382385
BRCA2 O 1 0.9997559189796448
( O 0 0.05019427463412285
76 O 0 0.23515349626541138
% O 0 0.0291290320456028
) O 0 0.028179096058011055
. O 0 0.030573993921279907

The O 0 0.03445535525679588
largest O 0 0.03851189836859703
proportion O 0 0.031765520572662354
( O 0 0.021579386666417122
67 O 0 0.02623419649899006
% O 0 0.013860956765711308
) O 0 0.009188380092382431
of O 0 0.008230457082390785
families O 0 0.01046675443649292
due O 0 0.009486524388194084
to O 0 0.007081958465278149
other O 0 0.005925007630139589
genes O 0 0.007440902292728424
was O 0 0.009550681337714195
found O 0 0.005464380141347647
in O 0 0.005593931768089533
families O 0 0.007992309518158436
with O 0 0.005851916037499905
four O 0 0.006344357039779425
or O 0 0.005967229139059782
five O 0 0.007305959239602089
cases O 0 0.010945846326649189
of O 1 0.7090368866920471
female O 1 0.9999979734420776
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
only O 1 0.5009578466415405
. O 0 0.04973538964986801

These O 0 0.02196582593023777
estimates O 0 0.017374085262417793
were O 0 0.0099569633603096
not O 0 0.008459949865937233
substantially O 0 0.014381218701601028
affected O 0 0.010905490256845951
either O 0 0.007725666277110577
by O 0 0.007492386735975742
changing O 0 0.009820680133998394
the O 0 0.010437332093715668
assumed O 0 0.06202148273587227
penetrance O 1 0.9981521964073181
model O 0 0.02360832877457142
for O 0 0.014469637535512447
BRCA1 O 1 0.9944859147071838
or O 0 0.010169661603868008
by O 0 0.008822736330330372
including O 0 0.01180996559560299
or O 0 0.019669612869620323
excluding O 0 0.4615000784397125
BRCA1 O 1 0.998931348323822
mutation O 0 0.07808688282966614
data O 0 0.024596374481916428
. O 0 0.03126906231045723

Among O 0 0.03188145533204079
those O 0 0.017730841413140297
families O 0 0.02727632410824299
with O 0 0.14312323927879333
disease O 1 0.999987006187439
due O 1 0.8672202825546265
to O 1 0.5958484411239624
BRCA1 O 1 0.9998842477798462
that O 0 0.008083481341600418
were O 0 0.006899569649249315
tested O 0 0.010893707163631916
by O 0 0.005547038745135069
one O 0 0.005957294721156359
of O 0 0.007034667767584324
the O 0 0.009993642568588257
standard O 0 0.0198445376008749
screening O 0 0.04386569559574127
methods O 0 0.00851766299456358
, O 0 0.007562575396150351
mutations O 0 0.008612066507339478
were O 0 0.005831674672663212
detected O 0 0.011071743443608284
in O 0 0.006375464145094156
the O 0 0.009513292461633682
coding O 0 0.017433740198612213
sequence O 0 0.010047847405076027
or O 0 0.009211327880620956
splice O 0 0.022790631279349327
sites O 0 0.009312910959124565
in O 0 0.0060173384845256805
an O 0 0.0074928835965693
estimated O 0 0.010576475411653519
63 O 0 0.01904098130762577
% O 0 0.012087248265743256
( O 0 0.013055304996669292
95 O 0 0.019532183185219765
% O 0 0.020047428086400032
CI O 1 0.9981598258018494
51 O 0 0.0347578339278698
% O 0 0.028050297871232033
- O 1 0.9782698154449463
77 O 0 0.07495787739753723
% O 0 0.026340287178754807
) O 0 0.0265992172062397
. O 0 0.03137664124369621

The O 0 0.03694469481706619
estimated O 0 0.028877628967165947
sensitivity O 0 0.037119459360837936
was O 0 0.019926471635699272
identical O 0 0.015520084649324417
for O 0 0.011093461886048317
direct O 0 0.01608302630484104
sequencing O 0 0.019829919561743736
and O 0 0.01349832583218813
other O 0 0.013064966537058353
techniques O 0 0.02758134715259075
. O 0 0.02975228615105152

The O 0 0.05092809349298477
penetrance O 1 0.9847205877304077
of O 0 0.11818017810583115
BRCA2 O 1 0.9990682005882263
was O 0 0.03194889798760414
estimated O 0 0.01419028453528881
by O 0 0.012155596166849136
maximizing O 0 0.031444206833839417
the O 0 0.016555793583393097
LOD O 1 0.9912853837013245
score O 0 0.019046256318688393
in O 0 0.016607454046607018
BRCA2 O 1 0.9996235370635986
- O 1 0.9991360306739807
mutation O 0 0.043199993669986725
families O 0 0.011914494447410107
, O 0 0.009130523540079594
over O 0 0.010062086395919323
all O 0 0.011118201538920403
possible O 0 0.023095950484275818
penetrance O 1 0.9710982441902161
functions O 0 0.033647116273641586
. O 0 0.039738740772008896

The O 0 0.03469815477728844
estimated O 0 0.030996374785900116
cumulative O 0 0.07158200442790985
risk O 1 0.6103522181510925
of O 1 0.9790911078453064
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
reached O 1 0.9113532900810242
28 O 0 0.0364314503967762
% O 0 0.014417465776205063
( O 0 0.013318647630512714
95 O 0 0.01789580099284649
% O 0 0.018193216994404793
CI O 1 0.9815410375595093
9 O 0 0.021559985354542732
% O 0 0.01584368199110031
- O 0 0.31474047899246216
44 O 0 0.017515186220407486
% O 0 0.01011127419769764
) O 0 0.007771375589072704
by O 0 0.0069669815711677074
age O 0 0.010357348248362541
50 O 0 0.009719998575747013
years O 0 0.007839375175535679
and O 0 0.008330213837325573
84 O 0 0.02102612517774105
% O 0 0.013326108455657959
( O 0 0.013482702895998955
95 O 0 0.018652739003300667
% O 0 0.015940971672534943
CI O 1 0.923454999923706
43 O 0 0.025789055973291397
% O 0 0.018876640126109123
- O 0 0.09064088016748428
95 O 0 0.02207360602915287
% O 0 0.014138534665107727
) O 0 0.011471321806311607
by O 0 0.011283072642982006
age O 0 0.0188226867467165
70 O 0 0.026552999392151833
years O 0 0.0271146260201931
. O 0 0.0358719527721405

The O 0 0.31383320689201355
corresponding O 1 0.9995589852333069
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risks O 1 0.9997972846031189
were O 0 0.04955532029271126
0 O 0 0.07215419411659241
. O 0 0.043886683881282806

4 O 0 0.04678826779127121
% O 0 0.025651633739471436
( O 0 0.022180655971169472
95 O 0 0.027509598061442375
% O 0 0.022783303633332253
CI O 1 0.9868351817131042
0 O 0 0.02507183328270912
% O 0 0.018566081300377846
- O 0 0.18016362190246582
1 O 0 0.014658805914223194
% O 0 0.010099770501255989
) O 0 0.0074872043915092945
by O 0 0.0064984397031366825
age O 0 0.010030437260866165
50 O 0 0.00852632150053978
years O 0 0.007658256683498621
and O 0 0.008230054751038551
27 O 0 0.015236089006066322
% O 0 0.011460911482572556
( O 0 0.012173839844763279
95 O 0 0.017682142555713654
% O 0 0.016819410026073456
CI O 1 0.99115389585495
0 O 0 0.022910576313734055
% O 0 0.0173784326761961
- O 0 0.1396128237247467
47 O 0 0.02206435240805149
% O 0 0.013947798870503902
) O 0 0.011581155471503735
by O 0 0.011054432950913906
age O 0 0.02113770879805088
70 O 0 0.026125486940145493
years O 0 0.03041824884712696
. O 0 0.0339079350233078

The O 0 0.03922606259584427
lifetime O 1 0.8038434982299805
risk O 1 0.9942637085914612
of O 1 0.9998670816421509
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 1 0.9862251281738281
similar O 0 0.010215725749731064
to O 0 0.008386113680899143
the O 0 0.015167593955993652
risk O 1 0.8978052139282227
in O 0 0.07348587363958359
BRCA1 O 1 0.9999676942825317
carriers O 0 0.19337084889411926
, O 0 0.008322237990796566
but O 0 0.005595133174210787
there O 0 0.0052730487659573555
was O 0 0.007908212020993233
some O 0 0.004799599759280682
suggestion O 0 0.012873397208750248
of O 0 0.007877623662352562
a O 0 0.016314219683408737
lower O 0 0.04200592637062073
risk O 0 0.11215872317552567
in O 0 0.016420751810073853
BRCA2 O 1 0.9990542531013489
carriers O 0 0.3925726115703583
< O 1 0.6198094487190247
50 O 0 0.016464145854115486
years O 0 0.013931216672062874
of O 0 0.021528562530875206
age O 0 0.07283447682857513
. O 0 0.03611782565712929

Eye B-Disease 1 0.9973419308662415
movement I-Disease 1 0.7564229369163513
abnormalities I-Disease 1 0.9974014759063721
correlate O 0 0.07613576203584671
with O 0 0.025832807645201683
genotype O 1 0.9931471943855286
in O 0 0.07845811545848846
autosomal O 1 0.9999970197677612
dominant O 1 0.9999974966049194
cerebellar B-Disease 1 0.9999998807907104
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999904632568359
I I-Disease 1 0.9992454051971436
. O 0 0.05420693755149841

We O 0 0.02982913702726364
compared O 0 0.03283211216330528
horizontal O 0 0.07501146197319031
eye O 1 0.9614182710647583
movements O 0 0.03797771409153938
( O 0 0.034388210624456406
visually O 0 0.10668089985847473
guided O 0 0.2088000625371933
saccades O 1 0.9990666508674622
, O 0 0.023995378986001015
antisaccades O 1 0.8966323733329773
, O 0 0.014056581072509289
and O 0 0.012287323363125324
smooth O 0 0.1153041198849678
pursuit O 1 0.6843089461326599
) O 0 0.010647515766322613
in O 0 0.007226117420941591
control O 0 0.012194843962788582
subjects O 0 0.01639322005212307
( O 0 0.025785882025957108
n O 0 0.04592924937605858
= O 0 0.026619793847203255
14 O 0 0.01436259038746357
) O 0 0.010878654196858406
and O 0 0.009149633347988129
patients O 0 0.01550332736223936
with O 0 0.006480251904577017
three O 0 0.007555992808192968
forms O 0 0.012198790907859802
of O 0 0.04101318493485451
autosomal O 1 0.9999681711196899
dominant O 1 0.9999103546142578
cerebellar B-Disease 1 0.9999988079071045
ataxias I-Disease 1 0.9999972581863403
type I-Disease 1 0.9998652935028076
I I-Disease 1 0.9994825124740601
spinocerebellar B-Disease 1 0.9999973773956299
ataxias I-Disease 1 0.9964373111724854
1 I-Disease 0 0.018937861546874046
and I-Disease 0 0.011656652204692364
2 I-Disease 0 0.01724007911980152
( O 0 0.01864069513976574
SCA1 B-Disease 1 0.8460245132446289
, O 0 0.015217147767543793
n O 0 0.026804499328136444
= O 0 0.022693954408168793
11 O 0 0.01672685332596302
; O 0 0.014747163280844688
SCA2 B-Disease 1 0.6435711979866028
, O 0 0.014462735503911972
n O 0 0.024949904531240463
= O 0 0.02018771879374981
10 O 0 0.009547965601086617
) O 0 0.009755331091582775
and O 0 0.012468843720853329
SCA3 B-Disease 1 0.999575674533844
/ O 1 0.997637152671814
Machado B-Disease 1 0.9983270764350891
- I-Disease 1 0.9997691512107849
Joseph I-Disease 1 0.999468982219696
disease I-Disease 1 0.9999943971633911
( O 1 0.9944310784339905
MJD B-Disease 1 0.9999971389770508
) O 0 0.07487458735704422
( O 0 0.034707847982645035
n O 0 0.05169549211859703
= O 0 0.04558113217353821
16 O 0 0.032609712332487106
) O 0 0.03236357495188713
. O 0 0.034564245492219925

In O 0 0.04452335089445114
SCA1 B-Disease 1 0.9972577691078186
, O 0 0.046347443014383316
saccade O 1 0.9973397850990295
amplitude O 0 0.15192556381225586
was O 0 0.032398540526628494
significantly O 0 0.021868474781513214
increased O 0 0.018381590023636818
, O 0 0.017182618379592896
resulting O 0 0.024335814639925957
in O 0 0.023850813508033752
hypermetria B-Disease 1 0.9942057728767395
. O 0 0.04610200598835945

The O 0 0.06024419143795967
smooth O 1 0.7103737592697144
pursuit O 1 0.9348157048225403
gain O 0 0.08450302481651306
was O 0 0.2557252049446106
decreased O 0 0.4878906309604645
. O 0 0.048224810510873795

In O 0 0.0601329542696476
SCA2 B-Disease 1 0.9977321624755859
, O 0 0.06210712343454361
saccade O 1 0.9940775632858276
velocity O 0 0.0809575691819191
was O 0 0.06125452369451523
markedly O 0 0.09981310367584229
decreased O 0 0.10740537941455841
. O 0 0.04811793565750122

The O 0 0.029017554596066475
percentage O 0 0.020415952429175377
of O 0 0.015107622370123863
errors O 0 0.023438993841409683
in O 0 0.015332241542637348
antisaccades O 1 0.9996551275253296
was O 0 0.36419549584388733
greatly O 0 0.018696270883083344
increased O 0 0.010995395481586456
and O 0 0.009318781085312366
was O 0 0.015257395803928375
significantly O 0 0.012924729846417904
correlated O 0 0.018926002085208893
with O 0 0.014269614592194557
age O 1 0.6547510623931885
at O 1 0.9930167198181152
disease O 1 0.9999974966049194
onset O 1 0.999997615814209
. O 1 0.708850085735321

In O 0 0.02797864004969597
addition O 0 0.02127983793616295
, O 0 0.015534983016550541
a O 0 0.017530051991343498
correlation O 0 0.02254403755068779
between O 0 0.015337440185248852
smooth O 0 0.27327626943588257
pursuit O 0 0.30353835225105286
gain O 0 0.014414403587579727
and O 0 0.008565127849578857
the O 0 0.009513949044048786
number O 0 0.010086305439472198
of O 0 0.021984117105603218
trinucleotide O 1 0.9994612336158752
repeats O 0 0.12061886489391327
was O 0 0.03850788623094559
found O 0 0.025664709508419037
. O 0 0.03342205658555031

In O 0 0.04759949818253517
SCA3 B-Disease 1 0.9995473027229309
, O 0 0.055200058966875076
gaze B-Disease 1 0.9988019466400146
- I-Disease 1 0.9999221563339233
evoked I-Disease 1 0.9991661310195923
nystagmus I-Disease 1 0.9999376535415649
was O 0 0.08820763975381851
often O 0 0.011176608502864838
present O 0 0.01280409749597311
as O 0 0.012607627548277378
was O 0 0.06824032217264175
saccade O 1 0.9987205862998962
hypometria O 1 0.9946894645690918
and O 0 0.022152289748191833
smooth O 1 0.6697289943695068
pursuit O 1 0.9509190917015076
gain O 0 0.09093817323446274
was O 0 0.239803746342659
markedly O 0 0.1363154798746109
decreased O 0 0.08653488755226135
. O 0 0.04624694213271141

Three O 0 0.03563863784074783
major O 0 0.0388835109770298
criteria O 0 0.03808176890015602
, O 0 0.030182285234332085
saccade O 1 0.9978240728378296
amplitude O 0 0.2922026216983795
, O 0 0.025683993473649025
saccade O 1 0.9459304809570312
velocity O 0 0.025060871616005898
, O 0 0.011269505135715008
and O 0 0.008496588096022606
presence O 0 0.013635384850203991
of O 0 0.01868923008441925
gaze B-Disease 1 0.9996253252029419
- I-Disease 1 0.999977707862854
evoked I-Disease 1 0.999087929725647
nystagmus I-Disease 1 0.9998430013656616
, O 0 0.013471316546201706
permitted O 0 0.012275172397494316
the O 0 0.010011566802859306
correct O 0 0.015923328697681427
assignment O 0 0.01619873009622097
of O 0 0.008025648072361946
90 O 0 0.009694916196167469
% O 0 0.00745801767334342
of O 0 0.008451228030025959
the O 0 0.014408719725906849
SCA1 B-Disease 1 0.9989228844642639
, O 0 0.008876262232661247
90 O 0 0.009204898029565811
% O 0 0.007504760753363371
of O 0 0.007704653311520815
the O 0 0.012454818934202194
SCA2 B-Disease 1 0.9991101622581482
, O 0 0.00994871649891138
and O 0 0.008234049193561077
93 O 0 0.018294185400009155
% O 0 0.008455212228000164
of O 0 0.007607499603182077
the O 0 0.014322873204946518
patients O 1 0.8672287464141846
with O 0 0.014931072480976582
SCA3 B-Disease 1 0.999963641166687
to O 0 0.008474558591842651
their O 0 0.0067460183054208755
genetically O 0 0.012376905418932438
confirmed O 0 0.01802780292928219
patient O 1 0.9845775961875916
group O 0 0.04788237437605858
and O 0 0.008995085023343563
, O 0 0.008977173827588558
therefore O 0 0.008215988986194134
, O 0 0.007892115041613579
may O 0 0.00889662280678749
help O 0 0.014905635267496109
orient O 1 0.7315164804458618
diagnoses O 1 0.9857248067855835
of O 0 0.04898892343044281
SCA1 B-Disease 1 0.9999164342880249
, O 0 0.048802465200424194
SCA2 B-Disease 1 0.9995546936988831
, O 0 0.014716213569045067
and O 0 0.014444254338741302
SCA3 B-Disease 1 0.9998469352722168
at O 0 0.015646351501345634
early O 0 0.013635564595460892
clinical O 0 0.27091649174690247
stages O 0 0.08649946004152298
of O 0 0.48917800188064575
the O 1 0.9955695271492004
diseases O 1 0.9999982118606567
. O 0 0.1964755356311798
. O 0 0.04113147035241127

Genetic O 0 0.050289735198020935
basis O 0 0.025392578914761543
and O 0 0.0263165682554245
molecular O 0 0.04930992051959038
mechanism O 1 0.9672126173973083
for O 1 0.9979739785194397
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9953511953353882

Ventricular B-Disease 1 0.9999996423721313
fibrillation I-Disease 1 0.9999995231628418
causes O 1 0.9954444169998169
more O 0 0.01326074730604887
than O 0 0.010713893920183182
300 O 0 0.01696653850376606
, O 0 0.012805122882127762
000 O 0 0.02977469190955162
sudden O 1 0.646074652671814
deaths O 0 0.021499527618288994
each O 0 0.00884801521897316
year O 0 0.01129881665110588
in O 0 0.010365172289311886
the O 0 0.020276924595236778
USA O 0 0.3529164493083954
alone O 0 0.04044220596551895
. O 0 0.03477731719613075

In O 0 0.022258691489696503
approximately O 0 0.021197985857725143
5 O 0 0.022526266053318977
- O 0 0.16969971358776093
12 O 0 0.012833180837333202
% O 0 0.008534339256584644
of O 0 0.0068375831469893456
these O 0 0.005215492099523544
cases O 0 0.007293494883924723
, O 0 0.006245916243642569
there O 0 0.0047548250295221806
are O 0 0.0037960419431328773
no O 0 0.01018514484167099
demonstrable O 1 0.9999078512191772
cardiac O 1 0.9999994039535522
or O 1 0.9973561763763428
non O 1 0.999997615814209
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.9882855415344238
to O 0 0.009452723897993565
account O 0 0.008489027619361877
for O 0 0.005722772795706987
the O 0 0.008268066681921482
episode O 0 0.023637495934963226
, O 0 0.006658271886408329
which O 0 0.004694081377238035
is O 0 0.005829475354403257
therefore O 0 0.00881319958716631
classified O 0 0.03186912089586258
as O 1 0.9259306192398071
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999865293502808
IVF B-Disease 1 0.9999980926513672
) O 0 0.08465849608182907
. O 0 0.04185287654399872

A O 0 0.035926491022109985
distinct O 0 0.024568267166614532
group O 0 0.033567626029253006
of O 1 0.9169480204582214
IVF B-Disease 1 0.9999997615814209
patients O 1 0.9998890161514282
has O 0 0.024012068286538124
been O 0 0.008585996925830841
found O 0 0.006892186589539051
to O 0 0.006977912969887257
present O 0 0.009845593012869358
with O 0 0.01000411156564951
a O 0 0.03371043503284454
characteristic O 1 0.9878858327865601
electrocardiographic O 1 0.9999058246612549
pattern O 1 0.8465129137039185
. O 0 0.04377804696559906

Because O 0 0.0227359626442194
of O 0 0.014957030303776264
the O 0 0.012146838009357452
small O 0 0.010230652987957
size O 0 0.008754072710871696
of O 0 0.007999655790627003
most O 0 0.007824813015758991
pedigrees O 0 0.028629451990127563
and O 0 0.007605336140841246
the O 0 0.011445904150605202
high O 1 0.7828143239021301
incidence O 1 0.999789297580719
of O 1 0.8437634110450745
sudden B-Disease 1 0.9999666213989258
death I-Disease 1 0.9991816878318787
, O 0 0.01802317053079605
however O 0 0.007055836729705334
, O 0 0.00797194056212902
molecular O 0 0.009155431762337685
genetic O 0 0.008282655850052834
studies O 0 0.0076473793014883995
of O 0 0.04764653742313385
IVF B-Disease 1 0.9999818801879883
have O 0 0.00945376418530941
not O 0 0.009276870638132095
yet O 0 0.013407372869551182
been O 0 0.014453312382102013
done O 0 0.025342827662825584
. O 0 0.030661219730973244

Because O 0 0.4846351146697998
IVF B-Disease 1 0.9999938011169434
causes O 1 0.9999889135360718
cardiac O 1 0.9999998807907104
rhythm O 1 0.9999947547912598
disturbance O 1 0.9999872446060181
, O 0 0.0325896330177784
we O 0 0.010179789736866951
investigated O 0 0.016678204759955406
whether O 0 0.009746305644512177
malfunction O 1 0.8724551200866699
of O 0 0.01364146638661623
ion O 0 0.3677438199520111
channels O 0 0.012101410888135433
could O 0 0.008832322433590889
cause O 0 0.022301899269223213
the O 0 0.024750327691435814
disorder O 1 0.9998883008956909
by O 0 0.013301946222782135
studying O 0 0.016472570598125458
mutations O 0 0.015326807275414467
in O 0 0.010340778157114983
the O 0 0.13582904636859894
cardiac O 1 0.9999966621398926
sodium O 1 0.9935717582702637
channel O 0 0.0586245134472847
gene O 0 0.04543618485331535
SCN5A O 1 0.954615592956543
. O 0 0.046155523508787155

We O 0 0.021992933005094528
have O 0 0.010842937976121902
now O 0 0.013075620867311954
identified O 0 0.012995915487408638
a O 0 0.01455218717455864
missense O 0 0.0451236218214035
mutation O 0 0.02080397494137287
, O 0 0.012020827271044254
a O 0 0.01886054314672947
splice O 1 0.9457992911338806
- O 1 0.9993011951446533
donor O 1 0.6823141574859619
mutation O 0 0.02201012149453163
, O 0 0.009658031165599823
and O 0 0.009242444299161434
a O 0 0.016947008669376373
frameshift O 1 0.9620669484138489
mutation O 0 0.018201423808932304
in O 0 0.00796051137149334
the O 0 0.011824352666735649
coding O 0 0.020337264984846115
region O 0 0.015157156623899937
of O 0 0.01721169427037239
SCN5A O 1 0.9985631108283997
in O 0 0.01845923811197281
three O 0 0.02723231539130211
IVF B-Disease 1 0.9991477727890015
families O 0 0.05355997011065483
. O 0 0.04815646633505821

We O 0 0.028532862663269043
show O 0 0.022702347487211227
that O 0 0.011227375827729702
sodium O 0 0.020661799237132072
channels O 0 0.011474328115582466
with O 0 0.008694842457771301
the O 0 0.015556217171251774
missense O 1 0.8636172413825989
mutation O 0 0.14998818933963776
recover O 0 0.2648009657859802
from O 0 0.014020610600709915
inactivation O 1 0.9966591596603394
more O 0 0.008126119151711464
rapidly O 0 0.014205715619027615
than O 0 0.0067534795962274075
normal O 0 0.00941604096442461
and O 0 0.007232312113046646
that O 0 0.007112290244549513
the O 0 0.015489339828491211
frameshift O 1 0.9996366500854492
mutation O 1 0.5340758562088013
causes O 0 0.31631556153297424
the O 0 0.016995519399642944
sodium O 0 0.04666509851813316
channel O 0 0.013828099705278873
to O 0 0.00863349437713623
be O 0 0.009460749104619026
non O 0 0.15473654866218567
- O 1 0.9966102242469788
functional O 0 0.047353047877550125
. O 0 0.03275734931230545

Our O 0 0.032200757414102554
results O 0 0.014907434582710266
indicate O 0 0.012909166514873505
that O 0 0.007289981469511986
mutations O 0 0.014793857000768185
in O 0 0.012851164676249027
cardiac O 1 0.9999984502792358
ion O 1 0.9999486207962036
- O 1 0.9999287128448486
channel O 0 0.020938068628311157
genes O 0 0.009991439990699291
contribute O 0 0.009782535955309868
to O 0 0.007375300861895084
the O 0 0.01043302845209837
risk O 0 0.04409636929631233
of O 0 0.042323194444179535
developing O 1 0.9697616696357727
IVF B-Disease 1 0.9999616146087646
. O 0 0.03033551760017872
. O 0 0.03693684563040733

Molecular O 0 0.06109531223773956
heterogeneity O 0 0.08824367076158524
in O 0 0.028173131868243217
mucopolysaccharidosis B-Disease 1 0.9995201826095581
IVA I-Disease 1 0.9999439716339111
in O 0 0.01843896508216858
Australia O 0 0.018907960504293442
and O 0 0.012307878583669662
Northern O 0 0.016861671581864357
Ireland O 0 0.02007603645324707
: O 0 0.012755236588418484
nine O 0 0.014079861342906952
novel O 0 0.023375175893306732
mutations O 0 0.018574925139546394
including O 0 0.012768273241817951
T312S O 1 0.807985782623291
, O 0 0.013425728306174278
a O 0 0.015769019722938538
common O 0 0.022385545074939728
allele O 0 0.1495675891637802
that O 0 0.013334516435861588
confers O 1 0.9432169198989868
a O 1 0.526703953742981
mild O 1 0.999881386756897
phenotype O 1 0.9990266561508179
. O 0 0.05370357260107994

Mucopolysaccharidosis B-Disease 1 0.9979473948478699
IVA I-Disease 1 0.9999481439590454
( O 1 0.6842966675758362
MPS B-Disease 1 0.9962628483772278
IVA I-Disease 1 0.9999948740005493
) O 0 0.02721984125673771
is O 0 0.019232602789998055
an O 0 0.258097380399704
autosomal B-Disease 1 0.9999986886978149
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
caused O 1 0.999794065952301
by O 0 0.20614098012447357
a O 1 0.9211724400520325
genetic B-Disease 1 0.9893581867218018
defect I-Disease 1 0.9999152421951294
in O 0 0.018899252638220787
N O 1 0.9700389504432678
- O 1 0.9982878565788269
acetylgalactosamine O 1 0.9979567527770996
- O 1 0.9993587136268616
6 O 1 0.6493075489997864
- O 1 0.9999524354934692
sulfate O 1 0.9999221563339233
sulfatase O 1 0.9999855756759644
( O 1 0.8489505052566528
GALNS O 1 0.9996170997619629
) O 0 0.039944205433130264
. O 0 0.036831896752119064

Previous O 0 0.031831465661525726
studies O 0 0.019296452403068542
of O 0 0.016282470896840096
patients O 0 0.33879145979881287
from O 0 0.010981326922774315
a O 0 0.017270077019929886
British O 0 0.46069058775901794
- O 1 0.9982200264930725
Irish O 0 0.10569475591182709
population O 0 0.007363126613199711
showed O 0 0.007976606488227844
that O 0 0.004675587173551321
the O 0 0.010134562849998474
I113F O 1 0.9776986837387085
mutation O 0 0.01765509694814682
is O 0 0.006762717384845018
the O 0 0.006383582949638367
most O 0 0.005732004065066576
common O 0 0.009020356461405754
single O 0 0.01771019957959652
mutation O 0 0.041923683136701584
among O 0 0.06564220041036606
MPS B-Disease 1 0.9999150037765503
IVA I-Disease 1 0.9999998807907104
patients O 1 0.9998944997787476
and O 0 0.262655109167099
produces O 1 0.6682130098342896
a O 1 0.8583560585975647
severe O 1 0.9999904632568359
clinical O 1 0.9999802112579346
phenotype O 1 0.9999480247497559
. O 0 0.10040877014398575

We O 0 0.02846745401620865
studied O 0 0.02751556970179081
mutations O 0 0.017518196254968643
in O 0 0.010333388112485409
the O 0 0.01666596159338951
GALNS O 1 0.9984777569770813
gene O 0 0.015321074053645134
from O 0 0.010003299452364445
23 O 0 0.01671144925057888
additional O 0 0.017179589718580246
MPS B-Disease 1 0.9993315935134888
IVA I-Disease 1 0.9999997615814209
patients O 1 0.9996429681777954
( O 0 0.023222167044878006
15 O 0 0.012646405957639217
from O 0 0.008034300990402699
Australia O 0 0.011474663391709328
, O 0 0.008469903841614723
8 O 0 0.010427819564938545
from O 0 0.006166679784655571
Northern O 0 0.010125115513801575
Ireland O 0 0.014419158920645714
) O 0 0.008507823571562767
, O 0 0.006018056999891996
with O 0 0.006601058878004551
various O 0 0.008508116938173771
clinical O 1 0.9964337348937988
phenotypes O 1 0.9997321963310242
( O 1 0.9835768342018127
severe O 1 0.9998993873596191
, O 0 0.09021200984716415
16 O 0 0.02317052148282528
cases O 0 0.013809720985591412
; O 0 0.010938332416117191
intermediate O 0 0.045792121440172195
, O 0 0.011028274893760681
4 O 0 0.017271487042307854
cases O 0 0.0171340499073267
; O 0 0.018248198553919792
mild O 1 0.95847088098526
, O 0 0.020128170028328896
3 O 0 0.027989430353045464
cases O 0 0.0273347906768322
) O 0 0.030036503449082375
. O 0 0.03123268112540245

We O 0 0.021706612780690193
found O 0 0.013315295800566673
two O 0 0.010242654010653496
common O 0 0.01357604842633009
mutations O 0 0.014451028779149055
that O 0 0.0057530635967850685
together O 0 0.00765626085922122
accounted O 0 0.011700031347572803
for O 0 0.006626588758081198
32 O 0 0.012231109663844109
% O 0 0.00835904199630022
of O 0 0.007871454581618309
the O 0 0.01266513392329216
44 O 0 0.032853398472070694
unrelated O 0 0.07763776928186417
alleles O 0 0.04213467985391617
in O 0 0.01552974060177803
these O 0 0.018490754067897797
patients O 1 0.9323753714561462
. O 0 0.04273839667439461

One O 0 0.029928145930171013
is O 0 0.018993055447936058
the O 0 0.02170470915734768
T312S O 1 0.9924030303955078
mutation O 0 0.06644636392593384
, O 0 0.014818408526480198
a O 0 0.016403300687670708
novel O 0 0.03311073035001755
mutation O 0 0.027195395901799202
found O 0 0.013646523468196392
exclusively O 0 0.02245180495083332
in O 0 0.021533077582716942
milder O 1 0.9894184470176697
patients O 1 0.9919775724411011
. O 0 0.04733391851186752

The O 0 0.027201425284147263
other O 0 0.012069149874150753
is O 0 0.010525952093303204
the O 0 0.012500095181167126
previously O 0 0.01733340322971344
described O 0 0.024803798645734787
I113F O 1 0.9857327938079834
that O 0 0.013009893707931042
produces O 0 0.03252976015210152
a O 0 0.08943285793066025
severe O 1 0.999727189540863
phenotype O 1 0.9984790682792664
. O 0 0.056568246334791183

The O 0 0.05360299348831177
I113F O 1 0.849114716053009
and O 0 0.03190997987985611
T312S O 1 0.8165983557701111
mutations O 0 0.027643106877803802
accounted O 0 0.020482774823904037
for O 0 0.011327716521918774
8 O 0 0.01725594513118267
( O 0 0.011738857254385948
18 O 0 0.012745415791869164
% O 0 0.01002541370689869
) O 0 0.00809138361364603
and O 0 0.007044196594506502
6 O 0 0.013531772419810295
( O 0 0.0122066093608737
14 O 0 0.011483310721814632
% O 0 0.008895798586308956
) O 0 0.009168682619929314
of O 0 0.01166148204356432
44 O 0 0.029867853969335556
unrelated O 0 0.051830094307661057
alleles O 0 0.07211343199014664
, O 0 0.026110108941793442
respectively O 0 0.03738198056817055
. O 0 0.03712210804224014

The O 0 0.04047703742980957
relatively O 0 0.03247919678688049
high O 0 0.36783865094184875
residual O 1 0.9966188669204712
GALNS O 1 0.999661922454834
activity O 0 0.01979430578649044
seen O 0 0.013079016469419003
when O 0 0.01050560362637043
the O 0 0.014036484993994236
T312S O 0 0.447670042514801
mutant O 0 0.05252060294151306
cDNA O 0 0.042896851897239685
is O 0 0.015401939861476421
overexpressed O 0 0.07933679968118668
in O 0 0.012629841454327106
mutant O 1 0.5059241056442261
cells O 0 0.01843041181564331
provides O 0 0.01279411930590868
an O 0 0.008099229075014591
explanation O 0 0.011903923936188221
for O 0 0.00962701253592968
the O 0 0.06287480890750885
mild O 1 0.9999361038208008
phenotype O 1 0.9995952248573303
in O 0 0.036719322204589844
patients O 1 0.9829067587852478
with O 0 0.02135016955435276
this O 0 0.020333578810095787
mutation O 1 0.5625674724578857
. O 0 0.03096257895231247

The O 0 0.03388796001672745
distribution O 0 0.023911623284220695
and O 0 0.013801023364067078
relative O 0 0.01613859459757805
frequencies O 0 0.012026089243590832
of O 0 0.011562683619558811
the O 0 0.01647176779806614
I113F O 1 0.992419421672821
and O 0 0.020488008856773376
T312S O 1 0.9862719774246216
mutations O 0 0.01836327649652958
in O 0 0.008643724024295807
Australia O 0 0.013166594319045544
corresponded O 0 0.014740075916051865
to O 0 0.006215387023985386
those O 0 0.0048871212638914585
observed O 0 0.0061623770743608475
in O 0 0.0050676544196903706
Northern O 0 0.00972355343401432
Ireland O 0 0.011703798547387123
and O 0 0.006578793283551931
are O 0 0.0037455325946211815
unique O 0 0.0061832452192902565
to O 0 0.005053086671978235
these O 0 0.003915656823664904
two O 0 0.0051567209884524345
populations O 0 0.008026624098420143
, O 0 0.007570338435471058
suggesting O 0 0.009842470288276672
that O 0 0.005375965964049101
both O 0 0.007115032058209181
mutations O 0 0.0109477574005723
were O 0 0.006779989693313837
probably O 0 0.008889065124094486
introduced O 0 0.008624798618257046
to O 0 0.006978587247431278
Australia O 0 0.010609718970954418
by O 0 0.009443244896829128
Irish O 0 0.023755498230457306
migrants O 0 0.018118958920240402
during O 0 0.01566380262374878
the O 0 0.017741506919264793
19th O 0 0.04531726613640785
century O 0 0.06170639395713806
. O 0 0.0441117063164711

Haplotype O 0 0.12326569110155106
analysis O 0 0.025405539199709892
using O 0 0.017532357946038246
6 O 0 0.02823415771126747
RFLPs O 0 0.25558406114578247
provides O 0 0.01614433526992798
additional O 0 0.009553992189466953
data O 0 0.00661431485787034
that O 0 0.0058675180189311504
the O 0 0.012528090737760067
I113F O 1 0.9873644709587097
mutation O 0 0.06925787031650543
originated O 0 0.019798696041107178
from O 0 0.013054555281996727
a O 0 0.020953526720404625
common O 0 0.029834559187293053
ancestor O 0 0.1841362565755844
. O 0 0.04184587672352791

The O 0 0.03071856126189232
other O 0 0.0149118946865201
9 O 0 0.025553306564688683
novel O 0 0.030477145686745644
mutations O 0 0.018553204834461212
identified O 0 0.012241771444678307
in O 0 0.00796562246978283
these O 0 0.0073101413436234
23 O 0 0.020305130630731583
patients O 0 0.2838788330554962
were O 0 0.007155467756092548
each O 0 0.005989754572510719
limited O 0 0.009356336668133736
to O 0 0.008833492174744606
a O 0 0.017123356461524963
single O 0 0.03266509994864464
family O 0 0.042543187737464905
. O 0 0.036842942237854004

These O 0 0.021874235942959785
data O 0 0.014903745613992214
provide O 0 0.013197746127843857
further O 0 0.009845582768321037
evidence O 0 0.009772531688213348
for O 0 0.00974238570779562
extensive O 0 0.022500956431031227
allelic O 1 0.9105551838874817
heterogeneity O 1 0.7121557593345642
in O 0 0.017481835559010506
MPS B-Disease 1 0.9866814613342285
IVA I-Disease 1 0.9999936819076538
in O 0 0.0225173681974411
British O 1 0.9886730313301086
- O 1 0.999990701675415
Irish O 1 0.9986377358436584
patients O 1 0.9980584979057312
and O 0 0.01151282712817192
provide O 0 0.009220444597303867
evidence O 0 0.007075500208884478
for O 0 0.006351223681122065
their O 0 0.007713159546256065
transmission O 0 0.014216571114957333
to O 0 0.007748126983642578
Australia O 0 0.0115694310516119
by O 0 0.010288388468325138
British O 0 0.037110403180122375
- O 1 0.9927813410758972
Irish O 0 0.23019059002399445
migrants O 0 0.035810768604278564
. O 0 0.021502606570720673
. O 0 0.02961754985153675

Identification O 0 0.03938181325793266
of O 0 0.028660831972956657
constitutional O 0 0.33339017629623413
WT1 O 1 0.9999783039093018
mutations O 0 0.04301642253994942
, O 0 0.013421396724879742
in O 0 0.01106493640691042
patients O 1 0.5480179786682129
with O 0 0.0777779221534729
isolated O 1 0.999954342842102
diffuse B-Disease 1 0.9999996423721313
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.06663920730352402
and O 0 0.015675431117415428
analysis O 0 0.0128496577963233
of O 0 0.34587159752845764
genotype O 1 0.9999613761901855
/ O 1 0.9999207258224487
phenotype O 1 0.5414003729820251
correlations O 0 0.020923728123307228
by O 0 0.010132869705557823
use O 0 0.0083651477470994
of O 0 0.013976854272186756
a O 0 0.029198573902249336
computerized O 1 0.9417436718940735
mutation O 0 0.17977078258991241
database O 0 0.043009620159864426
. O 0 0.036508526653051376

Constitutional O 0 0.053406380116939545
mutations O 0 0.03155602887272835
of O 0 0.019248448312282562
the O 0 0.06640539318323135
WT1 O 1 0.9999724626541138
gene O 0 0.020112738013267517
, O 0 0.010939840227365494
encoding O 0 0.014270881190896034
a O 0 0.016591496765613556
zinc O 1 0.9987523555755615
- O 1 0.998835027217865
finger O 1 0.925963819026947
transcription O 0 0.06795944273471832
factor O 0 0.01605086587369442
involved O 0 0.0106117008253932
in O 0 0.021803805604577065
renal O 1 1.0
and O 1 0.9956974983215332
gonadal O 1 0.9999996423721313
development O 1 0.90626460313797
, O 0 0.009655969217419624
are O 0 0.0037435637786984444
found O 0 0.004607113543897867
in O 0 0.004211191087961197
most O 0 0.005589363165199757
patients O 0 0.030842185020446777
with O 0 0.03243663161993027
Denys B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999998807907104
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.9999233484268188
DDS B-Disease 1 0.9999996423721313
) O 0 0.025743678212165833
, O 0 0.01764576882123947
or O 0 0.23223409056663513
diffuse B-Disease 1 0.9999939203262329
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9997993111610413
DMS B-Disease 1 0.9999945163726807
) O 0 0.01786983385682106
associated O 0 0.013226442039012909
with O 0 0.013530315831303596
pseudohermaphroditism B-Disease 1 0.9996953010559082
and O 0 0.27267196774482727
/ O 1 0.9999740123748779
or O 1 0.9881377816200256
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999996423721313
( O 1 0.9984756112098694
WT B-Disease 1 0.9999617338180542
) O 0 0.043676458299160004
. O 0 0.040242280811071396

Most O 0 0.03754561394453049
mutations O 0 0.05319378897547722
in O 0 0.03720421344041824
DDS B-Disease 1 0.9999964237213135
patients O 1 0.984710156917572
lie O 0 0.12606096267700195
in O 0 0.014904893934726715
exon O 0 0.1316971778869629
8 O 0 0.02053210511803627
or O 0 0.012974867597222328
exon O 0 0.03634969890117645
9 O 0 0.019366087391972542
, O 0 0.01346042100340128
encoding O 0 0.02161455899477005
zinc O 1 0.7741954326629639
finger O 0 0.263995885848999
2 O 0 0.026084527373313904
or O 0 0.021943245083093643
zinc O 1 0.997521698474884
finger O 1 0.6917921304702759
3 O 0 0.014522047713398933
, O 0 0.00963589083403349
respectively O 0 0.010245961137115955
, O 0 0.007770236115902662
with O 0 0.007585227023810148
a O 0 0.015788717195391655
hot O 1 0.8524374961853027
spot O 0 0.2870853841304779
( O 0 0.027434801682829857
R394W O 1 0.7832664251327515
) O 0 0.019598502665758133
in O 0 0.017766978591680527
exon O 0 0.07160419225692749
9 O 0 0.0477023720741272
. O 0 0.03877216577529907

We O 0 0.023236330598592758
analyzed O 0 0.018644364550709724
a O 0 0.01280189212411642
series O 0 0.012354821898043156
of O 0 0.01175257284194231
24 O 0 0.021399740129709244
patients O 0 0.34583115577697754
, O 0 0.010187452659010887
10 O 0 0.011087317019701004
with O 0 0.014056448824703693
isolated B-Disease 1 0.9976024031639099
DMS I-Disease 1 0.9999985694885254
( O 1 0.9710894823074341
IDMS B-Disease 1 0.9999545812606812
) O 0 0.014526081271469593
, O 0 0.008965732529759407
10 O 0 0.010345958173274994
with O 0 0.013073270209133625
DDS B-Disease 1 0.9998743534088135
, O 0 0.011877714656293392
and O 0 0.010723349638283253
4 O 0 0.0202739629894495
with O 0 0.055487580597400665
urogenital B-Disease 1 0.9999991655349731
abnormalities I-Disease 1 0.9999959468841553
and O 1 0.9967519044876099
/ O 1 0.9999958276748657
or O 1 0.8937111496925354
WT B-Disease 1 0.9998388290405273
. O 0 0.0501667857170105

We O 0 0.030506528913974762
report O 0 0.03732544556260109
WT1 O 1 0.9973719120025635
heterozygous O 0 0.056358933448791504
mutations O 0 0.02565617859363556
in O 0 0.013362362049520016
16 O 0 0.024276260286569595
patients O 1 0.6282116174697876
, O 0 0.013147563673555851
4 O 0 0.01739003136754036
of O 0 0.015211132355034351
whom O 0 0.03236641734838486
presented O 0 0.04197784140706062
with O 0 0.04485196992754936
IDMS B-Disease 1 0.9997164607048035
. O 0 0.05581929162144661

One O 0 0.028871173039078712
male O 0 0.029895832762122154
and O 0 0.01399051770567894
two O 0 0.016221191734075546
female O 1 0.9971213936805725
IDMS B-Disease 1 0.9999991655349731
patients O 1 0.9998868703842163
with O 1 0.9952073693275452
WT1 O 1 0.9999992847442627
mutations O 1 0.9977166652679443
underwent O 1 0.9998712539672852
normal O 1 0.9372162222862244
puberty O 1 0.9988221526145935
. O 0 0.059341952204704285

Two O 0 0.031075937673449516
mutations O 0 0.035778068006038666
associated O 0 0.023611504584550858
with O 0 0.02157234027981758
IDMS B-Disease 1 0.999934196472168
are O 0 0.007827420718967915
different O 0 0.00566041050478816
from O 0 0.008364918641746044
those O 0 0.00888421107083559
described O 0 0.03933003544807434
in O 0 0.15468548238277435
DDS B-Disease 1 0.9999992847442627
patients O 1 0.9992120265960693
. O 0 0.05173410102725029

No O 0 0.06494928151369095
WT1 O 1 0.9987201690673828
mutations O 0 0.029617469757795334
were O 0 0.012713821604847908
detected O 0 0.014728875830769539
in O 0 0.006678973790258169
the O 0 0.009054014459252357
six O 0 0.01463306788355112
other O 0 0.032676223665475845
IDMS B-Disease 1 0.9999992847442627
patients O 1 0.9985235333442688
, O 0 0.02282315120100975
suggesting O 0 0.025005843490362167
genetic O 0 0.02372741885483265
heterogeneity O 1 0.8183902502059937
of O 0 0.119329534471035
this O 0 0.23220288753509521
disease O 1 0.9999725818634033
. O 0 0.08344908803701401

We O 0 0.042128391563892365
analyzed O 0 0.06410609930753708
genotype O 1 0.9969252943992615
/ O 1 0.9996808767318726
phenotype O 1 0.8126609921455383
correlations O 0 0.03291700780391693
, O 0 0.010471684858202934
on O 0 0.007185976020991802
the O 0 0.007284766063094139
basis O 0 0.005868169944733381
of O 0 0.007438121363520622
the O 0 0.00832044705748558
constitution O 0 0.0119038550183177
of O 0 0.011561974883079529
a O 0 0.09114160388708115
WT1 O 1 0.9998637437820435
mutation O 0 0.02261374332010746
database O 0 0.013115922920405865
of O 0 0.013066885992884636
84 O 1 0.7136474251747131
germ O 1 0.9999669790267944
- O 1 0.9997228980064392
line O 0 0.048358138650655746
mutations O 0 0.012660937383770943
, O 0 0.007306975312530994
to O 0 0.006674960721284151
compare O 0 0.009878996759653091
the O 0 0.007773375138640404
distribution O 0 0.008539428003132343
and O 0 0.008105755783617496
type O 0 0.03387651592493057
of O 0 0.017148001119494438
mutations O 0 0.026726145297288895
, O 0 0.008361391723155975
according O 0 0.008298988454043865
to O 0 0.009136057458817959
the O 0 0.015228327363729477
different O 0 0.015246201306581497
symptoms O 1 0.9975492358207703
. O 0 0.04167073965072632

This O 0 0.02346440590918064
demonstrated O 0 0.032133348286151886
( O 0 0.021396322175860405
1 O 0 0.0163416787981987
) O 0 0.010650621727108955
the O 0 0.009560473263263702
association O 0 0.011735317297279835
between O 0 0.008950483053922653
mutations O 0 0.009858057834208012
in O 0 0.00652982946485281
exons O 0 0.018127622082829475
8 O 0 0.011120570823550224
and O 0 0.007912207394838333
9 O 0 0.01621854677796364
and O 0 0.01469624973833561
DMS B-Disease 1 0.9999198913574219
; O 0 0.013158406130969524
( O 0 0.01303552370518446
2 O 0 0.013698776252567768
) O 0 0.011227206327021122
among O 0 0.013552787713706493
patients O 0 0.48897087574005127
with O 0 0.02067854255437851
DMS B-Disease 1 0.9999477863311768
, O 0 0.010918520390987396
a O 0 0.009713063016533852
higher O 0 0.008523826487362385
frequency O 0 0.008438167162239552
of O 0 0.00913911685347557
exon O 0 0.030200060456991196
8 O 0 0.015233349055051804
mutations O 0 0.011810577474534512
among O 0 0.009552918374538422
46 O 0 0.02134181186556816
, O 0 0.042188115417957306
XY O 1 0.9999617338180542
patients O 1 0.9283836483955383
with O 0 0.01623501628637314
female O 1 0.8533977270126343
phenotype O 0 0.20278608798980713
than O 0 0.007850413210690022
among O 0 0.012098032981157303
46 O 0 0.0242116991430521
, O 0 0.02412826009094715
XY O 1 0.999923825263977
patients O 1 0.5845396518707275
with O 0 0.012832021340727806
sexual O 1 0.6510222554206848
ambiguity O 1 0.8710092902183533
or O 0 0.10738513618707657
male O 1 0.98466557264328
phenotype O 1 0.9977684020996094
; O 0 0.012449261732399464
and O 0 0.010036073625087738
( O 0 0.014033970423042774
3 O 0 0.011604556813836098
) O 0 0.008412436582148075
statistically O 0 0.008171879686415195
significant O 0 0.006749175488948822
evidence O 0 0.006874612998217344
that O 0 0.005200990010052919
mutations O 0 0.009291695430874825
in O 0 0.0074455393478274345
exons O 0 0.018817491829395294
8 O 0 0.013912691734731197
and O 0 0.01153805386275053
9 O 0 0.019041070714592934
preferentially O 0 0.027852928265929222
affect O 0 0.016040733084082603
amino O 0 0.015136136673390865
acids O 0 0.011915010400116444
with O 0 0.009066891856491566
different O 0 0.0075182621367275715
functions O 0 0.016323374584317207
. O 0 0.018065258860588074
. O 0 0.03140513598918915

The O 0 0.06687528640031815
185delAG O 1 0.9968780279159546
BRCA1 O 1 0.9981716871261597
mutation O 0 0.04924807325005531
originated O 0 0.027181100100278854
before O 0 0.013161019422113895
the O 0 0.012139974161982536
dispersion O 0 0.02538125216960907
of O 0 0.010383471846580505
Jews O 0 0.015534961596131325
in O 0 0.00801300909370184
the O 0 0.012291386723518372
diaspora O 0 0.10248203575611115
and O 0 0.011411597020924091
is O 0 0.010363881476223469
not O 0 0.008620472624897957
limited O 0 0.015735305845737457
to O 0 0.021625453606247902
Ashkenazim O 1 0.8531354665756226
. O 0 0.040901169180870056

The O 0 0.047658395022153854
185delAG O 1 0.9405540823936462
mutation O 0 0.10865391045808792
in O 0 0.022386524826288223
BRCA1 O 1 0.9960499405860901
is O 0 0.014512469992041588
detected O 0 0.016050031408667564
in O 0 0.009395603090524673
Ashkenazi O 0 0.0319160595536232
Jews O 0 0.015374578535556793
both O 0 0.010678493417799473
in O 0 0.01935647614300251
familial B-Disease 1 0.9999996423721313
breast I-Disease 1 1.0
and I-Disease 1 0.999998927116394
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9314767718315125
in O 0 0.03000473603606224
the O 0 0.07361678779125214
general O 0 0.18645969033241272
population O 0 0.0256380382925272
. O 0 0.029928965494036674

All O 0 0.042357515543699265
tested O 0 0.10222480446100235
Ashkenazi O 1 0.9746179580688477
mutation O 0 0.0770910382270813
carriers O 0 0.02922338806092739
share O 0 0.014600912109017372
the O 0 0.013095006346702576
same O 0 0.014862525276839733
allelic O 1 0.6645585894584656
pattern O 0 0.03854871168732643
at O 0 0.029821546748280525
the O 0 0.1352040022611618
BRCA1 O 1 0.9996638298034668
locus O 1 0.9636346101760864
. O 0 0.04598338156938553

Our O 0 0.03267059475183487
previous O 0 0.02206038311123848
study O 0 0.01452283188700676
showed O 0 0.012020181864500046
that O 0 0.006582146510481834
this O 0 0.009409197606146336
Ashkenazi O 1 0.9817869067192078
mutation O 0 0.1588401347398758
also O 0 0.00901052076369524
occurs O 0 0.00809885747730732
in O 0 0.0073276711627841
Iraqi O 0 0.014787005260586739
Jews O 0 0.015220650471746922
with O 0 0.010841925628483295
a O 0 0.019514087587594986
similar O 0 0.025548990815877914
allelic O 1 0.9896016716957092
pattern O 1 0.611894428730011
. O 0 0.04475860297679901

We O 0 0.028412500396370888
extended O 0 0.0289128627628088
our O 0 0.01663835346698761
analysis O 0 0.010060789994895458
to O 0 0.008684524334967136
other O 0 0.008927097544074059
non O 0 0.02857702597975731
- O 1 0.9037488698959351
Ashkenazi O 1 0.5380878448486328
subsets O 0 0.044531650841236115
354 O 0 0.039759907871484756
of O 0 0.018776029348373413
Moroccan O 0 0.04378785192966461
origin O 0 0.014142430387437344
, O 0 0.015672532841563225
200 O 0 0.025787102058529854
Yemenites O 0 0.45210906863212585
and O 0 0.024017449468374252
150 O 0 0.033269353210926056
Iranian O 0 0.040543150156736374
Jews O 0 0.05653076618909836
. O 0 0.04464937001466751

Heteroduplex O 1 0.5002133846282959
analysis O 0 0.02863750420510769
complemented O 0 0.03904011845588684
by O 0 0.014146419242024422
direct O 0 0.017259947955608368
DNA O 0 0.017994744703173637
sequencing O 0 0.020491894334554672
of O 0 0.019288746640086174
abnormally O 1 0.9821891188621521
migrating O 0 0.05294377729296684
bands O 0 0.0356922522187233
were O 0 0.018758827820420265
employed O 0 0.03996456414461136
. O 0 0.03580852970480919

Four O 0 0.02431466430425644
of O 0 0.022103866562247276
Moroccan O 0 0.07167336344718933
origin O 0 0.014640646986663342
( O 0 0.014949969947338104
1 O 0 0.012914003804326057
. O 0 0.008202475495636463
1 O 0 0.011601068079471588
% O 0 0.009781557135283947
) O 0 0.007797636557370424
and O 0 0.006478023249655962
none O 0 0.008393043652176857
of O 0 0.009675195440649986
the O 0 0.019017476588487625
Yemenites O 1 0.9986960291862488
or O 0 0.012818354181945324
Iranians O 0 0.017437288537621498
was O 0 0.013388563878834248
a O 0 0.013210657052695751
carrier O 0 0.033452387899160385
of O 0 0.015364043414592743
the O 0 0.030418025329709053
185delAG O 1 0.998760461807251
mutation O 0 0.24306800961494446
. O 0 0.037890296429395676

BRCA1 O 1 0.9994432330131531
allelic O 1 0.9552834033966064
patterns O 0 0.030061839148402214
were O 0 0.01213542278856039
determined O 0 0.01273898035287857
for O 0 0.007098416797816753
four O 0 0.007418994791805744
of O 0 0.008314819075167179
these O 0 0.005707974079996347
individuals O 0 0.006372096948325634
and O 0 0.006581841502338648
for O 0 0.0062346081249415874
12 O 0 0.010457508265972137
additional O 0 0.01087325718253851
non O 0 0.05607757344841957
- O 1 0.9892768859863281
Ashkenazi O 1 0.8853959441184998
185delAG O 1 0.9267368912696838
mutation O 0 0.03639114275574684
carriers O 0 0.027709992602467537
who O 0 0.02951851114630699
had O 1 0.9854771494865417
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 1 0.8593835830688477

Six O 0 0.04981263726949692
non O 1 0.7184162139892578
- O 1 0.9979833364486694
Ashkenazi O 1 0.8247990608215332
individuals O 0 0.015776844695210457
shared O 0 0.01803051307797432
the O 0 0.015779005363583565
common O 0 0.2543657422065735
Ashkenazi O 1 0.999750554561615
haplotype O 1 0.977253258228302
, O 0 0.009486241266131401
four O 0 0.007354440167546272
had O 0 0.008139008656144142
a O 0 0.00989769957959652
closely O 0 0.009492911398410797
related O 0 0.009676470421254635
pattern O 0 0.014231433160603046
, O 0 0.0075567662715911865
and O 0 0.006796758621931076
the O 0 0.009456653147935867
rest O 0 0.04068906977772713
( O 0 0.054640982300043106
n O 0 0.05846961587667465
= O 0 0.025391751900315285
6 O 0 0.016311082988977432
) O 0 0.010948252864181995
displayed O 0 0.016854943707585335
a O 0 0.01899314671754837
distinct O 0 0.034450024366378784
BRCA1 O 1 0.9976295232772827
allelic O 1 0.9948899745941162
pattern O 1 0.5060149431228638
. O 0 0.05173797905445099

We O 0 0.02862432226538658
conclude O 0 0.03161211311817169
that O 0 0.01235264539718628
the O 0 0.020526105538010597
185delAG O 1 0.998815655708313
BRCA1 O 1 0.9985290765762329
mutation O 0 0.03478444367647171
occurs O 0 0.011774091981351376
in O 0 0.007451739627867937
some O 0 0.007930679246783257
non O 0 0.4008016884326935
- O 1 0.999077558517456
Ashkenazi O 1 0.9393500089645386
populations O 0 0.013474720530211926
at O 0 0.012586109340190887
rates O 0 0.012598405592143536
comparable O 0 0.013013016432523727
with O 0 0.010592009872198105
that O 0 0.009935973212122917
of O 0 0.023409053683280945
Ashkenazim O 1 0.9971229434013367
. O 0 0.04277340695261955

The O 0 0.027544891461730003
majority O 0 0.024251142516732216
of O 0 0.023566268384456635
Jewish O 1 0.6736846566200256
185delAG O 1 0.9997419714927673
mutation O 0 0.4646693766117096
carriers O 0 0.02603573352098465
have O 0 0.008131067268550396
a O 0 0.013211055658757687
common O 0 0.01859305612742901
allelic O 1 0.9760655760765076
pattern O 0 0.1003604605793953
, O 0 0.011494942009449005
supporting O 0 0.01835618168115616
the O 0 0.01660035364329815
founder O 1 0.9915385842323303
effect O 0 0.013339423574507236
notion O 0 0.015265808440744877
, O 0 0.008273111656308174
but O 0 0.006191223859786987
dating O 0 0.012024173513054848
the O 0 0.009246714413166046
mutations O 0 0.009496817365288734
origin O 0 0.005390395876020193
to O 0 0.005256337579339743
an O 0 0.006383044645190239
earlier O 0 0.008622164838016033
date O 0 0.01042062509804964
than O 0 0.00871289148926735
currently O 0 0.016456516459584236
estimated O 0 0.022874489426612854
. O 0 0.029759006574749947

However O 0 0.024302316829562187
, O 0 0.01588030345737934
the O 0 0.012728698551654816
different O 0 0.008214983157813549
allelic O 0 0.18132565915584564
pattern O 0 0.026356881484389305
at O 0 0.019596125930547714
the O 0 0.124827541410923
BRCA1 O 1 0.9997180104255676
locus O 0 0.12045429646968842
even O 0 0.007166329771280289
in O 0 0.005964963231235743
some O 0 0.006109670735895634
Jewish O 0 0.04053093492984772
mutation O 0 0.23829351365566254
carriers O 0 0.03206576406955719
, O 0 0.011107412166893482
might O 0 0.008151523768901825
suggest O 0 0.008199434727430344
that O 0 0.005733643192797899
the O 0 0.01269160769879818
mutation O 0 0.027468066662549973
arose O 0 0.024719441309571266
independently O 0 0.019791463389992714
. O 0 0.018365683034062386
. O 0 0.02698083035647869

Crystal O 0 0.08568090200424194
structure O 0 0.03191937506198883
of O 0 0.026131130754947662
the O 1 0.9351195693016052
hemochromatosis B-Disease 1 1.0
protein O 1 0.9822484254837036
HFE O 1 0.9998794794082642
and O 0 0.019467301666736603
characterization O 0 0.027990441769361496
of O 0 0.014483356848359108
its O 0 0.016312306746840477
interaction O 0 0.028411537408828735
with O 0 0.03624583035707474
transferrin O 1 0.999626636505127
receptor O 0 0.32223808765411377
. O 0 0.038199834525585175

HFE O 1 0.9975554347038269
is O 0 0.03440163657069206
an O 0 0.060261864215135574
MHC O 1 0.9999678134918213
- O 1 0.9990648627281189
related O 0 0.017199529334902763
protein O 0 0.009838705882430077
that O 0 0.0050300247967243195
is O 0 0.006502554286271334
mutated O 0 0.01453715842217207
in O 0 0.009169506840407848
the O 0 0.024375637993216515
iron B-Disease 1 0.9999957084655762
- I-Disease 1 0.9999997615814209
overload I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999998807907104
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9988738894462585

HFE O 1 0.9948062300682068
binds O 0 0.09952113777399063
to O 0 0.04036712273955345
transferrin O 1 0.9992425441741943
receptor O 1 0.9933340549468994
( O 1 0.5949001312255859
TfR O 1 0.9995998740196228
) O 0 0.017294274643063545
and O 0 0.012136217206716537
reduces O 0 0.01809079200029373
its O 0 0.009962053969502449
affinity O 0 0.02074330300092697
for O 0 0.01409853994846344
iron O 1 0.9985851049423218
- O 1 0.998799204826355
loaded O 0 0.10534225404262543
transferrin O 1 0.9904622435569763
, O 0 0.03311345353722572
implicating O 1 0.9961848855018616
HFE O 1 0.9997785687446594
in O 0 0.08257169276475906
iron O 1 0.999884843826294
metabolism O 1 0.9956009387969971
. O 0 0.05351576581597328

The O 0 0.07386960089206696
2 O 0 0.07993102073669434
. O 0 0.06209079176187515

6 O 0 0.0511060394346714
A O 0 0.04674530774354935
crystal O 1 0.6599918603897095
structure O 0 0.027425551787018776
of O 0 0.029886318370699883
HFE O 1 0.9998244643211365
reveals O 0 0.07385820150375366
the O 0 0.013927089981734753
locations O 0 0.014613128267228603
of O 0 0.16361482441425323
hemochromatosis B-Disease 1 0.9999998807907104
mutations O 1 0.5311627388000488
and O 0 0.017456620931625366
a O 0 0.4395367205142975
patch O 1 0.9999188184738159
of O 0 0.3034690022468567
histidines O 1 0.9997110962867737
that O 0 0.007435228675603867
could O 0 0.00681248540058732
be O 0 0.006510426290333271
involved O 0 0.010763329453766346
in O 0 0.01565479300916195
pH O 1 0.9996129870414734
- O 1 0.999089241027832
dependent O 0 0.04772816225886345
interactions O 0 0.03514352813363075
. O 0 0.03021063283085823

We O 0 0.02713414654135704
also O 0 0.01954265497624874
demonstrate O 0 0.025943832471966743
that O 0 0.0165507011115551
soluble O 1 0.9619286060333252
TfR O 1 0.9997743964195251
and O 0 0.0596713088452816
HFE O 1 0.9999560117721558
bind O 0 0.05145229026675224
tightly O 0 0.028658907860517502
at O 0 0.013550736010074615
the O 0 0.013325154781341553
basic O 0 0.023651760071516037
pH O 1 0.8506982922554016
of O 0 0.011992334388196468
the O 0 0.026005515828728676
cell O 0 0.11785753816366196
surface O 0 0.01282220333814621
, O 0 0.007745195180177689
but O 0 0.0055770049802958965
not O 0 0.005729548167437315
at O 0 0.010658945888280869
the O 0 0.01826433651149273
acidic O 1 0.9765575528144836
pH O 1 0.994962215423584
of O 0 0.1877308189868927
intracellular O 1 0.9994945526123047
vesicles O 1 0.9925602674484253
. O 0 0.04523232951760292

TfR O 1 0.9992848038673401
HFE O 1 0.9995868802070618
stoichiometry O 1 0.9058961272239685
( O 0 0.040706004947423935
2 O 0 0.02623974345624447
1 O 0 0.01956222392618656
) O 0 0.014690287411212921
differs O 0 0.018703892827033997
from O 0 0.01737239956855774
TfR O 1 0.9986274242401123
transferrin O 1 0.9981710910797119
stoichiometry O 1 0.9093269109725952
( O 0 0.024859480559825897
2 O 0 0.020088765770196915
2 O 0 0.017347443848848343
) O 0 0.011672704480588436
, O 0 0.008391893468797207
implying O 0 0.014365372247993946
a O 0 0.008857227861881256
different O 0 0.005261656362563372
mode O 0 0.012488894164562225
of O 0 0.00926986988633871
binding O 0 0.01385465357452631
for O 0 0.014179214835166931
HFE O 1 0.9999189376831055
and O 0 0.03217385709285736
transferrin O 1 0.9989509582519531
to O 0 0.02588675171136856
TfR O 1 0.9995027780532837
, O 0 0.011808517388999462
consistent O 0 0.013288671150803566
with O 0 0.008060668595135212
our O 0 0.012082339264452457
demonstration O 0 0.0281977578997612
that O 0 0.012315086089074612
HFE O 1 0.9997313618659973
, O 0 0.027358833700418472
transferrin O 1 0.9971283078193665
, O 0 0.019435934722423553
and O 0 0.021844130009412766
TfR O 1 0.9986650943756104
form O 0 0.027624549344182014
a O 0 0.0380045548081398
ternary O 1 0.9274327754974365
complex O 0 0.05659015104174614
. O 0 0.04231645166873932

Identification O 0 0.03643832355737686
of O 0 0.018215063959360123
three O 0 0.01582578755915165
novel O 0 0.0386027991771698
mutations O 0 0.01619970239698887
and O 0 0.009075971320271492
a O 0 0.011677590198814869
high O 0 0.015040507540106773
frequency O 0 0.009049351327121258
of O 0 0.008423270657658577
the O 0 0.013431237079203129
Arg778Leu O 1 0.9981980919837952
mutation O 0 0.07499152421951294
in O 0 0.014525924809277058
Korean O 1 0.997698962688446
patients O 1 0.9987433552742004
with O 1 0.7303909063339233
Wilson B-Disease 1 0.9999110698699951
disease I-Disease 1 0.9999785423278809
. O 0 0.08817224949598312

Four O 0 0.04233425483107567
mutations O 0 0.07151861488819122
- O 1 0.9984855055809021
- O 1 0.998199462890625
R778L O 1 0.9645601511001587
, O 0 0.0209293644875288
A874V O 1 0.6995173096656799
, O 0 0.01597890444099903
L1083F O 0 0.3862326443195343
, O 0 0.012227803468704224
and O 0 0.014278496615588665
2304delC O 1 0.9990334510803223
- O 1 0.9991641044616699
- O 1 0.5685439705848694
in O 0 0.00782758928835392
the O 0 0.01127815805375576
copper O 0 0.34902092814445496
- O 1 0.7608535885810852
transporting O 0 0.028042901307344437
enzyme O 0 0.022594274953007698
, O 0 0.014537997543811798
P O 1 0.9946084022521973
- O 1 0.999629020690918
type O 1 0.939570963382721
ATPase O 1 0.9991899132728577
( O 0 0.0387924499809742
ATP7B O 1 0.9919865131378174
) O 0 0.012028457596898079
, O 0 0.00749687384814024
were O 0 0.0066009750589728355
identified O 0 0.009907994419336319
in O 0 0.010467060841619968
Korean O 1 0.9381847381591797
Patients O 1 0.9964140057563782
with O 1 0.5256627202033997
Wilson B-Disease 1 0.99993896484375
disease I-Disease 1 0.9999903440475464
. O 0 0.15716391801834106

Arg778Leu O 1 0.8521112203598022
, O 0 0.02400585636496544
the O 0 0.016039574518799782
most O 0 0.009763284586369991
frequently O 0 0.01093679666519165
reported O 0 0.011056747287511826
mutation O 0 0.013104424811899662
of O 0 0.008512243628501892
this O 0 0.007845522835850716
enzyme O 0 0.0509335920214653
, O 0 0.006768971681594849
was O 0 0.007340536452829838
found O 0 0.0043328613974153996
in O 0 0.003911688458174467
six O 0 0.0060101039707660675
of O 0 0.00872714538127184
eight O 0 0.015413707122206688
unrelated O 1 0.5931070446968079
patients O 1 0.9880315065383911
studied O 0 0.02332846261560917
, O 0 0.012900624424219131
an O 0 0.013770980760455132
allele O 0 0.044170789420604706
frequency O 0 0.01728469878435135
of O 0 0.01878623105585575
37 O 0 0.04559757560491562
. O 0 0.035442907363176346

5 O 0 0.04290938004851341
% O 0 0.022622358053922653
, O 0 0.012920156121253967
which O 0 0.00938954297453165
is O 0 0.00835920125246048
considerably O 0 0.010018318891525269
higher O 0 0.007575416471809149
than O 0 0.005234673153609037
those O 0 0.006124595645815134
in O 0 0.007401198614388704
other O 0 0.009417031891644001
Asian O 0 0.03432946652173996
populations O 0 0.024303672835230827
. O 0 0.030819399282336235

The O 0 0.03931083902716637
novel O 0 0.045773983001708984
single O 0 0.035215411335229874
nucleotide O 0 0.04026854410767555
deletion O 0 0.046402402222156525
, O 0 0.020158322528004646
2304delC O 1 0.911198079586029
, O 0 0.013951188884675503
was O 0 0.0167129747569561
found O 0 0.01134143304079771
in O 0 0.010781046003103256
one O 0 0.019145356491208076
patient O 1 0.9811439514160156
. O 0 0.03519780561327934

Since O 0 0.032327014952898026
a O 0 0.026286257430911064
mutation O 0 0.03141172230243683
at O 0 0.02500452846288681
cDNA O 0 0.06649477034807205
nucleotide O 0 0.06175265461206436
2302 O 1 0.9984717965126038
( O 0 0.035487718880176544
2302insC O 1 0.7847467064857483
) O 0 0.013051447458565235
had O 0 0.00978864450007677
been O 0 0.007188677787780762
previously O 0 0.009909996762871742
described O 0 0.009639901109039783
, O 0 0.006321393419057131
this O 0 0.004451918415725231
region O 0 0.0077471015974879265
of O 0 0.007942854426801205
the O 0 0.058894261717796326
ATP7B O 1 0.9999958276748657
gene O 0 0.10014116764068604
may O 0 0.010688815265893936
be O 0 0.00772874103859067
susceptible O 0 0.05032464116811752
to O 0 0.015607520937919617
gene O 0 0.10021886229515076
rearrangements O 1 0.9939739108085632
causing O 1 0.9965388774871826
Wilson B-Disease 1 0.9997960925102234
disease I-Disease 1 0.999969482421875
. O 0 0.08970718830823898

Disruption O 0 0.08723771572113037
of O 0 0.030716149136424065
splicing O 0 0.03618861362338066
regulated O 0 0.019653111696243286
by O 0 0.012942152097821236
a O 0 0.023173650726675987
CUG O 1 0.999671459197998
- O 1 0.996759831905365
binding O 0 0.03173557296395302
protein O 0 0.03003864362835884
in O 0 0.03519180044531822
myotonic B-Disease 1 0.9999978542327881
dystrophy I-Disease 1 0.999998927116394
. O 0 0.2490321546792984

Myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.9999980926513672
DM B-Disease 1 1.0
) O 0 0.49671635031700134
is O 0 0.015040729194879532
caused O 0 0.022450873628258705
by O 0 0.011278094723820686
a O 0 0.02877168543636799
CTG O 1 0.9995589852333069
expansion O 0 0.020241815596818924
in O 0 0.00877956859767437
the O 0 0.011009316891431808
3 O 0 0.01692243292927742
untranslated O 0 0.054393649101257324
region O 0 0.018102377653121948
of O 0 0.021057497709989548
the O 1 0.7853260040283203
DM B-Disease 1 0.9999994039535522
gene O 0 0.13559089601039886
. O 0 0.04696962609887123

One O 0 0.036560215055942535
model O 0 0.043989624828100204
of O 1 0.6906006336212158
DM B-Disease 1 0.9999998807907104
pathogenesis O 1 0.9999769926071167
suggests O 0 0.03387885540723801
that O 0 0.012341923080384731
RNAs O 0 0.026735680177807808
from O 0 0.008017695508897305
the O 0 0.009074280969798565
expanded O 0 0.014017557725310326
allele O 0 0.019405659288167953
create O 0 0.011009734123945236
a O 0 0.010507240891456604
gain O 0 0.014403845183551311
- O 1 0.8075599670410156
of O 0 0.020749181509017944
- O 1 0.9984629154205322
function O 0 0.013475270941853523
mutation O 0 0.012567562982439995
by O 0 0.007644256576895714
the O 0 0.011355203576385975
inappropriate O 0 0.019160062074661255
binding O 0 0.012806315906345844
of O 0 0.011955070309340954
proteins O 0 0.012925447896122932
to O 0 0.013145583681762218
the O 0 0.025230426341295242
CUG O 1 0.9979400038719177
repeats O 0 0.07504796981811523
. O 0 0.04635661467909813

Data O 0 0.028119979426264763
presented O 0 0.023420162498950958
here O 0 0.013758253306150436
indicate O 0 0.010144186206161976
that O 0 0.005972341168671846
the O 0 0.009737612679600716
conserved O 0 0.018686290830373764
heterogeneous O 0 0.04485119506716728
nuclear O 0 0.028419792652130127
ribonucleoprotein O 1 0.8939020037651062
, O 0 0.017468679696321487
CUG O 1 0.9949266910552979
- O 1 0.8289290070533752
binding O 0 0.017436813563108444
protein O 0 0.015126222744584084
( O 0 0.018850430846214294
CUG O 1 0.9983530044555664
- O 1 0.9983870983123779
BP O 0 0.4740074872970581
) O 0 0.011933467350900173
, O 0 0.008360402658581734
may O 0 0.008544771932065487
mediate O 0 0.021009182557463646
the O 0 0.016151031479239464
trans O 1 0.9892220497131348
- O 1 0.9921985268592834
dominant O 0 0.037405647337436676
effect O 0 0.013867833651602268
of O 0 0.01430938858538866
the O 0 0.02595132775604725
RNA O 0 0.0505930557847023
. O 0 0.030101893469691277

CUG O 1 0.9996846914291382
- O 1 0.9991745352745056
BP O 0 0.18378329277038574
was O 0 0.02080037072300911
found O 0 0.010182404890656471
to O 0 0.008981956169009209
bind O 0 0.013556261546909809
to O 0 0.007838117890059948
the O 0 0.013203447684645653
human O 1 0.7320180535316467
cardiac O 1 0.9999996423721313
troponin O 1 0.9999997615814209
T O 1 0.9999840259552002
( O 0 0.0954827293753624
cTNT O 1 0.9570332765579224
) O 0 0.020883413031697273
pre O 0 0.25712281465530396
- O 1 0.9941912293434143
messenger O 0 0.14099612832069397
RNA O 0 0.024669978767633438
and O 0 0.01252361573278904
regulate O 0 0.02166569046676159
its O 0 0.017694611102342606
alternative O 0 0.035556450486183167
splicing O 0 0.04506542906165123
. O 0 0.03255907818675041

Splicing O 0 0.059598952531814575
of O 0 0.030443264171481133
cTNT O 1 0.7022223472595215
was O 0 0.06339754164218903
disrupted O 1 0.9495089650154114
in O 1 0.9402608871459961
DM B-Disease 1 1.0
striated O 1 0.9999988079071045
muscle O 1 0.9998379945755005
and O 0 0.02249070070683956
in O 0 0.015723638236522675
normal O 0 0.032193683087825775
cells O 0 0.024109862744808197
expressing O 0 0.03196465224027634
transcripts O 0 0.029560796916484833
that O 0 0.014673522673547268
contain O 0 0.033270400017499924
CUG O 1 0.991637647151947
repeats O 0 0.07641347497701645
. O 0 0.04795984551310539

Altered O 0 0.051554787904024124
expression O 0 0.027993543073534966
of O 0 0.02049064077436924
genes O 0 0.02183258906006813
regulated O 0 0.028069520369172096
posttranscriptionally O 0 0.46830323338508606
by O 0 0.025796817615628242
CUG O 1 0.9999440908432007
- O 1 0.9996218681335449
BP O 1 0.5829198956489563
therefore O 0 0.019503923133015633
may O 0 0.016891522333025932
contribute O 0 0.0315454825758934
to O 0 0.0590917132794857
DM B-Disease 1 0.9999996423721313
pathogenesis O 1 0.9999330043792725
. O 0 0.03992592543363571
. O 0 0.043743036687374115

Identification O 0 0.03995218127965927
of O 0 0.02460567094385624
a O 0 0.027330758050084114
novel O 0 0.10537764430046082
nonsense O 1 0.9574291110038757
mutation O 0 0.0495951771736145
and O 0 0.012283754535019398
a O 0 0.015920398756861687
missense O 0 0.05498337745666504
substitution O 0 0.019005222246050835
in O 0 0.00839484203606844
the O 0 0.016214072704315186
vasopressin O 1 0.9987499713897705
- O 1 0.9998968839645386
neurophysin O 1 0.9997125267982483
II O 1 0.9995442032814026
gene O 0 0.014652743935585022
in O 0 0.007852399721741676
two O 0 0.008913827128708363
Spanish O 0 0.024684347212314606
kindreds O 1 0.97735595703125
with O 1 0.5406848192214966
familial B-Disease 1 0.9999996423721313
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999978542327881
. O 1 0.6769273281097412

Familial B-Disease 1 0.9999712705612183
neurohypophyseal I-Disease 1 0.9999953508377075
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
( O 1 0.9997231364250183
FNDI B-Disease 1 0.9999972581863403
) O 0 0.02967560477554798
is O 0 0.014148415066301823
an O 0 0.05803810805082321
autosomal B-Disease 1 0.9999933242797852
dominant I-Disease 1 0.9999979734420776
disease I-Disease 1 0.9999998807907104
caused O 1 0.9999840259552002
by O 1 0.9994099140167236
deficiency O 1 1.0
in O 0 0.451477974653244
the O 1 0.9988455772399902
antidiuretic O 1 0.9999996423721313
hormone O 1 0.9999889135360718
arginine O 1 0.9997276663780212
vasopressin O 1 0.9994423985481262
( O 0 0.15252554416656494
AVP O 1 0.9931825995445251
) O 0 0.013598129153251648
encoded O 0 0.009351418353617191
by O 0 0.009549534879624844
the O 0 0.016296712681651115
AVP O 1 0.9995649456977844
- O 1 0.9988705515861511
neurophysin O 1 0.9990673661231995
II O 1 0.9998910427093506
( O 1 0.8919042944908142
AVP O 1 0.9999862909317017
- O 1 0.9998493194580078
NPII O 1 0.9995381832122803
) O 0 0.024434419348835945
gene O 0 0.0228356271982193
on O 0 0.022688541561365128
chromosome O 0 0.05890660732984543
20p13 O 0 0.48219138383865356
. O 0 0.04492511600255966

In O 0 0.02436957135796547
this O 0 0.013528113253414631
study O 0 0.012939047068357468
, O 0 0.009128836914896965
we O 0 0.007757067214697599
analyzed O 0 0.008473528549075127
two O 0 0.006285603158175945
families O 0 0.010633912868797779
with O 0 0.012177901342511177
FNDI B-Disease 1 0.9980295300483704
using O 0 0.010841925628483295
direct O 0 0.015665436163544655
automated O 0 0.02795637957751751
fluorescent O 0 0.04250122979283333
, O 0 0.011947388760745525
solid O 0 0.017560256645083427
phase O 0 0.02249792404472828
, O 0 0.01186066772788763
single O 0 0.01979929953813553
- O 0 0.32589849829673767
stranded O 0 0.032109469175338745
DNA O 0 0.014672945253551006
sequencing O 0 0.01587086357176304
of O 0 0.01656286045908928
PCR O 0 0.16116215288639069
- O 1 0.9933280944824219
amplified O 1 0.8775079846382141
AVP O 1 0.9998588562011719
- O 1 0.9977414608001709
NPII O 1 0.990894079208374
DNA O 0 0.05579807609319687
. O 0 0.04590294137597084

In O 0 0.02032865770161152
one O 0 0.013718067668378353
of O 0 0.01244854461401701
the O 0 0.01682625524699688
families O 0 0.020095689222216606
, O 0 0.012272494845092297
affected O 0 0.012873559258878231
individuals O 0 0.009178338572382927
presented O 0 0.014339901506900787
a O 0 0.014071021229028702
novel O 0 0.041427794843912125
nonsense O 1 0.8055375814437866
mutation O 0 0.018325913697481155
in O 0 0.008786979131400585
exon O 0 0.025850441306829453
3 O 0 0.010648621246218681
of O 0 0.008632278069853783
the O 0 0.010188750922679901
gene O 0 0.010722084902226925
, O 0 0.007422524970024824
consisting O 0 0.010399664752185345
in O 0 0.0067452131770551205
a O 0 0.013192500919103622
G O 0 0.4879804849624634
to O 0 0.013459434732794762
T O 1 0.6697685718536377
transition O 0 0.021434668451547623
at O 0 0.016531463712453842
nucleotide O 0 0.030985761433839798
2101 O 1 0.8080345392227173
, O 0 0.010731385089457035
which O 0 0.007505776826292276
produces O 0 0.009744447655975819
a O 0 0.009984645061194897
stop O 0 0.01744978316128254
signal O 0 0.015705375000834465
in O 0 0.011344967409968376
codon O 0 0.03945870324969292
82 O 0 0.057887185364961624
( O 0 0.04924361780285835
Glu O 1 0.9996389150619507
) O 0 0.026719955727458
of O 0 0.03459824249148369
NPII O 1 0.992833137512207
. O 0 0.05151302367448807

The O 0 0.053281933069229126
premature O 1 0.9820249080657959
termination O 1 0.9862261414527893
eliminates O 0 0.290662556886673
part O 0 0.017108073458075523
of O 0 0.013935553841292858
the O 0 0.23405012488365173
C O 1 0.9998098015785217
- O 1 0.9998633861541748
terminal O 1 0.8846078515052795
domain O 0 0.01638341136276722
of O 0 0.013647492974996567
NPII O 1 0.998325526714325
, O 0 0.01000449899584055
including O 0 0.008153039030730724
a O 0 0.013416420668363571
cysteine O 0 0.03464279696345329
residue O 0 0.024586819112300873
in O 0 0.008180645294487476
position O 0 0.01247361209243536
85 O 0 0.018690694123506546
, O 0 0.009057271294295788
which O 0 0.005663482006639242
could O 0 0.00563045172020793
be O 0 0.004721370525658131
involved O 0 0.006753434427082539
in O 0 0.0070243896916508675
the O 0 0.012740586884319782
correct O 0 0.030373182147741318
folding O 0 0.3237425684928894
of O 0 0.02453315071761608
the O 0 0.09767340123653412
prohormone O 1 0.9997544884681702
. O 0 0.0521998256444931

In O 0 0.022965993732213974
the O 0 0.019697993993759155
second O 0 0.027144035324454308
family O 0 0.028293143957853317
, O 0 0.0140673303976655
a O 0 0.01876261457800865
G279A O 1 0.9426057934761047
substitution O 0 0.02006297931075096
at O 0 0.011381682939827442
position O 0 0.015221349895000458
- O 0 0.12800860404968262
1 O 0 0.010516613721847534
of O 0 0.008113895542919636
the O 0 0.011266488581895828
signal O 0 0.025409642606973648
peptide O 0 0.023053651675581932
was O 0 0.014064447954297066
observed O 0 0.011674375273287296
in O 0 0.01024310290813446
all O 0 0.013943333178758621
affected O 0 0.027356332167983055
individuals O 0 0.02571205236017704
. O 0 0.03626134246587753

This O 0 0.03287310153245926
missense O 0 0.09503703564405441
mutation O 0 0.037139974534511566
, O 0 0.017387382686138153
which O 0 0.014186469838023186
replaces O 1 0.9737981557846069
Ala O 1 0.9998652935028076
with O 0 0.028893228620290756
Thr O 1 0.9999607801437378
, O 0 0.015821034088730812
is O 0 0.011397452093660831
frequent O 0 0.18238550424575806
among O 1 0.9782733917236328
FNDI B-Disease 1 1.0
patients O 1 0.9999675750732422
and O 0 0.10561955720186234
is O 0 0.012581245973706245
thought O 0 0.01045149564743042
to O 0 0.008140632882714272
reduce O 0 0.012823724187910557
the O 0 0.0110856294631958
efficiency O 0 0.021540910005569458
of O 0 0.020451508462429047
cleavage O 1 0.993923008441925
by O 0 0.02484878897666931
signal O 0 0.07389971613883972
peptidases O 1 0.6244392991065979
. O 0 0.02764405682682991
. O 0 0.03765503689646721

Genetic O 0 0.056750424206256866
heterogeneity O 0 0.08781030029058456
of O 0 0.15909422934055328
Saethre B-Disease 1 0.9999936819076538
- I-Disease 1 0.9999997615814209
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
, O 0 0.08701463043689728
due O 0 0.04505205154418945
to O 0 0.02622821368277073
TWIST O 1 0.9935023188591003
and O 0 0.35905489325523376
FGFR O 1 0.999891996383667
mutations O 0 0.11559431999921799
. O 0 0.04153607785701752

Thirty O 0 0.08355904370546341
- O 1 0.7365360260009766
two O 0 0.018355023115873337
unrelated O 0 0.03547263890504837
patients O 0 0.08966074883937836
with O 0 0.010108133777976036
features O 0 0.015170015394687653
of O 0 0.18472358584403992
Saethre B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
, O 0 0.031485360115766525
a O 0 0.08332659304141998
common O 1 0.8984801769256592
autosomal B-Disease 1 0.9999696016311646
dominant I-Disease 1 0.9997472167015076
condition I-Disease 1 0.9996631145477295
of O 1 0.99981290102005
craniosynostosis B-Disease 1 1.0
and O 1 0.9998890161514282
limb B-Disease 1 0.9999997615814209
anomalies I-Disease 1 0.9998613595962524
, O 0 0.015912512317299843
were O 0 0.008904960937798023
screened O 0 0.020835215225815773
for O 0 0.009044547565281391
mutations O 0 0.013897915370762348
in O 0 0.010389333590865135
TWIST O 1 0.9404356479644775
, O 0 0.047266896814107895
FGFR2 O 1 0.9995255470275879
, O 0 0.02798709087073803
and O 0 0.02988157607614994
FGFR3 O 1 0.9984660148620605
. O 0 0.04654191806912422

Nine O 0 0.048208728432655334
novel O 0 0.046941693872213364
and O 0 0.023824788630008698
three O 0 0.02763838693499565
recurrent O 1 0.9999741315841675
TWIST O 1 0.9997733235359192
mutations O 0 0.23525696992874146
were O 0 0.012067005038261414
found O 0 0.012658935971558094
in O 0 0.011896396987140179
12 O 0 0.024717865511775017
families O 0 0.031318988651037216
. O 0 0.033793676644563675

Seven O 0 0.03591548278927803
families O 0 0.021546533331274986
were O 0 0.010976050049066544
found O 0 0.008512606844305992
to O 0 0.007317213341593742
have O 0 0.006756211631000042
the O 0 0.014646411873400211
FGFR3 O 1 0.9998884201049805
P250R O 1 0.9997722506523132
mutation O 0 0.29168352484703064
, O 0 0.010453486815094948
and O 0 0.008035250939428806
one O 0 0.007188803516328335
individual O 0 0.007471287157386541
was O 0 0.009861218743026257
found O 0 0.006512566935271025
to O 0 0.006272675469517708
have O 0 0.006313682068139315
an O 0 0.014806537888944149
FGFR2 O 1 0.9996834993362427
VV269 O 1 0.9991241097450256
- O 1 0.9934966564178467
270 O 0 0.07473225146532059
deletion O 0 0.08625069260597229
. O 0 0.046755995601415634

To O 0 0.02784264087677002
date O 0 0.022800903767347336
, O 0 0.014444396831095219
our O 0 0.014847799204289913
detection O 0 0.023587265983223915
rate O 0 0.01381609495729208
for O 0 0.012209063395857811
TWIST O 1 0.743442952632904
or O 0 0.02130679227411747
FGFR O 1 0.9992282390594482
mutations O 0 0.017322354018688202
is O 0 0.008229720406234264
68 O 0 0.01457583624869585
% O 0 0.008165843784809113
in O 0 0.00725222984328866
our O 0 0.017141172662377357
Saethre B-Disease 1 0.9999485015869141
- I-Disease 1 0.9999990463256836
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
patients O 1 0.9998805522918701
, O 0 0.01956423930823803
including O 0 0.011378271505236626
our O 0 0.018212541937828064
five O 0 0.016988901421427727
patients O 1 0.9350084662437439
elsewhere O 0 0.017663467675447464
reported O 0 0.020060284063220024
with O 0 0.022283224388957024
TWIST O 1 0.9934521913528442
mutations O 0 0.06235627830028534
. O 0 0.038549184799194336

More O 0 0.017640389502048492
than O 0 0.012220766395330429
35 O 0 0.020333174616098404
different O 0 0.0117765162140131
TWIST O 0 0.09197474271059036
mutations O 0 0.01997920498251915
are O 0 0.007828460074961185
now O 0 0.011879269033670425
known O 0 0.01245681382715702
in O 0 0.011424211785197258
the O 0 0.0179356187582016
literature O 0 0.029282221570611
. O 0 0.033653873950242996

The O 0 0.03288126364350319
most O 0 0.01852962002158165
common O 0 0.02380327507853508
phenotypic O 0 0.0991128459572792
features O 0 0.021278858184814453
, O 0 0.0103119146078825
present O 0 0.00819015596061945
in O 0 0.004932185634970665
more O 0 0.003731920849531889
than O 0 0.0038717847783118486
a O 0 0.006328567862510681
third O 0 0.012493434362113476
of O 0 0.010567436926066875
our O 0 0.1263805776834488
patients O 1 0.9950540065765381
with O 0 0.09388626366853714
TWIST O 1 0.9996541738510132
mutations O 0 0.05161089077591896
, O 0 0.010307633318006992
are O 0 0.008524141274392605
coronal B-Disease 1 0.9868828654289246
synostosis I-Disease 1 0.9937553405761719
, O 0 0.018940450623631477
brachycephaly B-Disease 1 0.9723404049873352
, O 0 0.023741841316223145
low B-Disease 1 0.9450540542602539
frontal I-Disease 1 0.9999892711639404
hairline I-Disease 1 0.9999996423721313
, O 1 0.9928359389305115
facial B-Disease 1 0.9999942779541016
asymmetry I-Disease 1 0.9999732971191406
, O 1 0.997564435005188
ptosis B-Disease 1 0.9999997615814209
, O 1 0.9376761317253113
hypertelorism B-Disease 1 0.9999881982803345
, O 0 0.03603534400463104
broad B-Disease 1 0.6723304390907288
great I-Disease 1 0.9457609057426453
toes I-Disease 1 0.9994294047355652
, O 0 0.034898534417152405
and O 0 0.03205857425928116
clinodactyly B-Disease 1 0.9917140007019043
. O 0 0.0463399738073349

Significant O 0 0.05455225706100464
intra O 1 0.9982210993766785
- O 1 0.9990744590759277
and O 0 0.04292415827512741
interfamilial O 1 0.9992115497589111
phenotypic O 0 0.431657075881958
variability O 0 0.10331566631793976
is O 0 0.012379616498947144
present O 0 0.013277185149490833
for O 0 0.010259616188704967
either O 0 0.01727176271378994
TWIST O 1 0.9634555578231812
mutations O 0 0.07133293151855469
or O 0 0.03740961477160454
FGFR O 1 0.9996798038482666
mutations O 0 0.10836920142173767
. O 0 0.037605784833431244

The O 0 0.03598190099000931
overlap O 0 0.029865369200706482
in O 0 0.017017073929309845
clinical O 1 0.8070449233055115
features O 0 0.016710760071873665
and O 0 0.009311530739068985
the O 0 0.011324596591293812
presence O 0 0.016572928056120872
, O 0 0.006462831050157547
in O 0 0.004579299595206976
the O 0 0.006377077661454678
same O 0 0.006345211062580347
genes O 0 0.006565835326910019
, O 0 0.005293356720358133
of O 0 0.006469533778727055
mutations O 0 0.008106322959065437
for O 0 0.004370464477688074
more O 0 0.00394548149779439
than O 0 0.00532623752951622
one O 0 0.00972981657832861
craniosynostotic B-Disease 1 0.9945348501205444
condition I-Disease 1 0.6482930183410645
- O 1 0.6405377388000488
such O 0 0.007949448190629482
as O 0 0.012139733880758286
Saethre B-Disease 1 0.9850947856903076
- I-Disease 1 0.9958575367927551
Chotzen I-Disease 1 0.9635422825813293
, I-Disease 0 0.016074245795607567
Crouzon I-Disease 1 0.9821701049804688
, I-Disease 0 0.018372269347310066
and I-Disease 0 0.20830905437469482
Pfeiffer I-Disease 1 0.9999984502792358
syndromes I-Disease 1 0.9999988079071045
- O 1 0.9997338652610779
support O 0 0.025975748896598816
the O 0 0.01569169946014881
hypothesis O 0 0.018391262739896774
that O 0 0.00781865231692791
TWIST O 1 0.58645099401474
and O 0 0.012477808631956577
FGFRs O 1 0.9190110564231873
are O 0 0.005171796772629023
components O 0 0.008816678076982498
of O 0 0.007585708051919937
the O 0 0.010125864297151566
same O 0 0.010649033822119236
molecular O 0 0.014920681715011597
pathway O 0 0.016943123191595078
involved O 0 0.007388116326183081
in O 0 0.006964556872844696
the O 0 0.011186407878994942
modulation O 0 0.38296040892601013
of O 1 0.9206515550613403
craniofacial O 1 1.0
and O 1 0.9996873140335083
limb O 1 0.9999996423721313
development O 1 0.9907897710800171
in O 0 0.032685257494449615
humans O 0 0.024735184386372566
. O 0 0.021071244031190872
. O 0 0.03128982335329056

Mutation O 0 0.06987883150577545
analysis O 0 0.032503336668014526
of O 0 0.04533134028315544
UBE3A O 1 0.9999828338623047
in O 1 0.9996730089187622
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999977350234985
. O 1 0.9750154614448547

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9980518817901611
AS B-Disease 1 0.9950754046440125
) O 0 0.02374112978577614
is O 0 0.012482726946473122
caused O 0 0.018956298008561134
by O 0 0.01648685336112976
chromosome O 0 0.3908933401107788
15q11 O 1 0.9978430271148682
- O 1 0.9983491897583008
q13 O 1 0.9659448266029358
deletions O 0 0.035943806171417236
of O 0 0.016226230189204216
maternal O 1 0.7503218650817871
origin O 0 0.012841121293604374
, O 0 0.011274182237684727
by O 0 0.016013797372579575
paternal O 1 0.9975222945213318
uniparental B-Disease 1 0.9999966621398926
disomy I-Disease 1 0.9999862909317017
( O 1 0.9820166230201721
UPD B-Disease 1 0.999984860420227
) O 0 0.016319936141371727
15 O 0 0.013494396582245827
, O 0 0.011410876177251339
by O 0 0.016278225928544998
imprinting O 1 0.999725878238678
defects O 1 0.998955488204956
, O 0 0.01168801635503769
and O 0 0.010050327517092228
by O 0 0.010960083454847336
mutations O 0 0.01717880181968212
in O 0 0.012257511727511883
the O 0 0.034130122512578964
UBE3A O 1 0.9999047517776489
gene O 0 0.05520425736904144
. O 0 0.041685137897729874

UBE3A O 1 0.9889630675315857
encodes O 0 0.08093703538179398
a O 0 0.052991632372140884
ubiquitin O 1 0.9793429374694824
- O 1 0.9965580105781555
protein O 0 0.03410067781805992
ligase O 0 0.04544880986213684
and O 0 0.019129600375890732
shows O 0 0.03233873471617699
brain O 1 0.9817847013473511
- O 1 0.9936710596084595
specific O 0 0.030449964106082916
imprinting O 1 0.8785049319267273
. O 0 0.0434349849820137

Here O 0 0.031933389604091644
we O 0 0.02135300822556019
describe O 0 0.03958509862422943
UBE3A O 1 0.9988415837287903
coding O 1 0.7240462899208069
- O 1 0.9866135716438293
region O 0 0.02651289291679859
mutations O 0 0.019996969029307365
detected O 0 0.016692113131284714
by O 0 0.012048975564539433
SSCP O 1 0.9797652363777161
analysis O 0 0.00973336398601532
in O 0 0.009979311376810074
13 O 0 0.01927541010081768
AS B-Disease 0 0.03331368789076805
individuals O 0 0.017451444640755653
or O 0 0.018244855105876923
families O 0 0.032729923725128174
. O 0 0.03439810499548912

Two O 0 0.025026777759194374
identical O 0 0.03249651938676834
de O 0 0.06258291751146317
novo O 0 0.2647946774959564
5 O 0 0.03957109525799751
- O 1 0.8069372177124023
bp O 0 0.05048675462603569
duplications O 0 0.045264773070812225
in O 0 0.01918056420981884
exon O 0 0.055252306163311005
16 O 0 0.025510771200060844
were O 0 0.016696341335773468
found O 0 0.02350994572043419
. O 0 0.029943538829684258

Among O 0 0.029727865010499954
the O 0 0.017014410346746445
other O 0 0.009337086230516434
11 O 0 0.015138013288378716
unique O 0 0.01390607189387083
mutations O 0 0.014742031693458557
, O 0 0.008578757755458355
8 O 0 0.011482574045658112
were O 0 0.007361109834164381
small O 0 0.010494035668671131
deletions O 0 0.02469974383711815
or O 0 0.012591646052896976
insertions O 0 0.06358722597360611
predicted O 0 0.01673584058880806
to O 0 0.011432718485593796
cause O 0 0.062493350356817245
frameshifts O 1 0.972021758556366
, O 0 0.012208132073283195
1 O 0 0.012389103882014751
was O 0 0.012255950830876827
a O 0 0.01090762484818697
mutation O 0 0.012018194422125816
to O 0 0.006856289226561785
a O 0 0.009640141390264034
stop O 0 0.015819549560546875
codon O 0 0.022701838985085487
, O 0 0.00864772591739893
1 O 0 0.010587487369775772
was O 0 0.01169124711304903
a O 0 0.012470047920942307
missense O 0 0.260635644197464
mutation O 0 0.02110726200044155
, O 0 0.008883568458259106
and O 0 0.007405070587992668
1 O 0 0.01208607479929924
was O 0 0.011765971779823303
predicted O 0 0.011522206477820873
to O 0 0.008497430942952633
cause O 0 0.018233194947242737
insertion O 0 0.02830682136118412
of O 0 0.0119323143735528
an O 0 0.015358618460595608
isoleucine O 1 0.9726507663726807
in O 0 0.009987068362534046
the O 0 0.013196851126849651
hect O 1 0.5074455142021179
domain O 0 0.014998761005699635
of O 0 0.011066940613090992
the O 0 0.04433613270521164
UBE3A O 1 0.9999880790710449
protein O 0 0.015933971852064133
, O 0 0.008456015959382057
which O 0 0.006273789796978235
functions O 0 0.009357326664030552
in O 0 0.011400692164897919
E2 O 1 0.9788901805877686
binding O 0 0.023022186011075974
and O 0 0.02058645337820053
ubiquitin O 0 0.09127458184957504
transfer O 0 0.03868047520518303
. O 0 0.038468342274427414

Eight O 0 0.02838016301393509
of O 0 0.019823115319013596
the O 0 0.01985878124833107
cases O 0 0.03403289243578911
were O 0 0.02299661375582218
familial O 1 0.9999691247940063
, O 0 0.040172334760427475
and O 0 0.014179808087646961
five O 0 0.01546329166740179
were O 0 0.016423862427473068
sporadic O 0 0.06573603302240372
. O 0 0.03594481199979782

In O 0 0.027634363621473312
two O 0 0.023576922714710236
familial O 1 0.9973388314247131
cases O 0 0.026030588895082474
and O 0 0.01626279205083847
one O 0 0.014384174719452858
sporadic O 0 0.174089714884758
case O 0 0.03428194671869278
, O 0 0.022561876103281975
mosaicism O 1 0.9992795586585999
for O 0 0.04803483560681343
UBE3A O 1 0.9999939203262329
mutations O 0 0.035425130277872086
was O 0 0.015949547290802002
detected O 0 0.011637456715106964
in O 0 0.005588112398982048
the O 0 0.008818183094263077
mother O 0 0.02752101980149746
of O 0 0.008813150227069855
three O 0 0.008999506942927837
AS B-Disease 0 0.32073521614074707
sons O 1 0.8037798404693604
, O 0 0.009044949896633625
in O 0 0.006487236823886633
the O 0 0.010757841169834137
maternal O 1 0.9981235861778259
grandfather O 1 0.9829034209251404
of O 0 0.011867365799844265
two O 0 0.00801266822963953
AS B-Disease 0 0.36403223872184753
first O 0 0.022701652720570564
cousins O 0 0.15806463360786438
, O 0 0.00836782157421112
and O 0 0.0062386514618992805
in O 0 0.006419401615858078
the O 0 0.010380121879279613
mother O 0 0.2837231457233429
of O 0 0.018145309761166573
an O 0 0.10206794738769531
AS B-Disease 1 0.9926538467407227
daughter O 1 0.9996457099914551
. O 0 0.04741460829973221

The O 0 0.02843634784221649
frequencies O 0 0.016714369878172874
with O 0 0.010071391239762306
which O 0 0.008116520941257477
we O 0 0.0077915801666677
detected O 0 0.012986988760530949
mutations O 0 0.008974318392574787
were O 0 0.006532508879899979
5 O 0 0.010401410982012749
( O 0 0.010211030021309853
14 O 0 0.009836805053055286
% O 0 0.00781574472784996
) O 0 0.0060129533521831036
of O 0 0.006355721037834883
35 O 0 0.010194763541221619
in O 0 0.006556336302310228
sporadic O 0 0.016465911641716957
cases O 0 0.010541612282395363
and O 0 0.010001664981245995
8 O 0 0.01752513274550438
( O 0 0.011413844302296638
80 O 0 0.0114321643486619
% O 0 0.009551466442644596
) O 0 0.008212393149733543
of O 0 0.009113426320254803
10 O 0 0.014504888094961643
in O 0 0.016096144914627075
familial O 1 0.9991432428359985
cases O 0 0.13672548532485962
. O 0 0.027689166367053986
. O 0 0.036243680864572525

The O 0 0.07260783016681671
hemochromatosis B-Disease 1 0.9999949932098389
845 O 1 0.9999583959579468
G O 1 0.9999836683273315
- O 1 0.9999797344207764
- O 1 0.9997343420982361
> O 0 0.11703445017337799
A O 0 0.015258670784533024
and O 0 0.01134844496846199
187 O 0 0.04023073986172676
C O 1 0.9769176244735718
- O 1 0.9997405409812927
- O 1 0.9998193383216858
> O 1 0.9755709767341614
G O 1 0.6217556595802307
mutations O 0 0.02355237305164337
: O 0 0.017498083412647247
prevalence O 0 0.40644773840904236
in O 0 0.016961585730314255
non O 1 0.9629217982292175
- O 1 0.9998018145561218
Caucasian O 1 0.9967118501663208
populations O 0 0.04241713508963585
. O 0 0.038226354867219925

Hemochromatosis B-Disease 1 0.999895453453064
, O 0 0.04459258168935776
the O 1 0.8860951662063599
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
of I-Disease 1 0.9999834299087524
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999991655349731
, O 1 0.9861409664154053
leads O 1 0.9982454776763916
, O 0 0.0355149544775486
if O 0 0.012867223471403122
untreated O 1 0.9989722967147827
, O 0 0.01520543359220028
to O 0 0.021478822454810143
progressive O 1 0.9999836683273315
iron B-Disease 1 0.9999990463256836
overload I-Disease 1 0.9999984502792358
and O 1 0.9449688196182251
premature B-Disease 1 0.9997445940971375
death I-Disease 1 0.9931311011314392
. O 0 0.053743693977594376

The O 0 0.4245295524597168
hemochromatosis B-Disease 1 0.9999984502792358
gene O 1 0.6470887660980225
, O 0 0.36117956042289734
HFE O 1 0.9999785423278809
, O 0 0.019921250641345978
recently O 0 0.019631486386060715
has O 0 0.008867918513715267
been O 0 0.007263025734573603
identified O 0 0.008601752109825611
, O 0 0.006578643806278706
and O 0 0.006954018492251635
characterization O 0 0.015255711041390896
of O 0 0.008823414333164692
this O 0 0.006812956649810076
gene O 0 0.009906113147735596
has O 0 0.006208098493516445
shown O 0 0.0054539879783988
that O 0 0.0035250878427177668
it O 0 0.0036355117335915565
contains O 0 0.005749993026256561
two O 0 0.004805960692465305
mutations O 0 0.007905062288045883
that O 0 0.004350334405899048
result O 0 0.0065719690173864365
in O 0 0.0076926578767597675
amino O 0 0.013734212145209312
acid O 0 0.021071618422865868
substitutions O 0 0.022361701354384422
- O 0 0.055960848927497864
cDNA O 0 0.03541867807507515
nucleotides O 0 0.025913547724485397
845 O 0 0.3228588104248047
G O 1 0.9543370008468628
- O 1 0.9983382225036621
- O 1 0.9988259673118591
> O 0 0.49633458256721497
A O 0 0.022582978010177612
( O 0 0.01758395880460739
C282Y O 0 0.061752885580062866
) O 0 0.010550359264016151
and O 0 0.010432732291519642
187 O 0 0.03266141936182976
C O 1 0.8566096425056458
- O 1 0.999455988407135
- O 1 0.9998527765274048
> O 1 0.9975579977035522
G O 1 0.9939281940460205
( O 0 0.05781025066971779
H63D O 1 0.9918184280395508
) O 0 0.038675855845212936
. O 0 0.0364537239074707

Although O 0 0.2708052396774292
hemochromatosis B-Disease 1 0.9999963045120239
is O 0 0.025492731481790543
common O 0 0.01872996985912323
in O 0 0.013780851848423481
Caucasians O 1 0.98155277967453
, O 0 0.022702163085341454
affecting O 1 0.796874463558197
> O 1 0.9974530339241028
= O 0 0.24491292238235474
1 O 0 0.021511970087885857
/ O 0 0.47973552346229553
300 O 0 0.010781402699649334
individuals O 0 0.005877428222447634
of O 0 0.007017481606453657
northern O 0 0.01048155128955841
European O 0 0.009061114862561226
origin O 0 0.0068089598789811134
, O 0 0.006205216981470585
it O 0 0.0049021621234714985
has O 0 0.00552353635430336
not O 0 0.004542041569948196
been O 0 0.006055222824215889
recognized O 0 0.01054950337857008
in O 0 0.00881208386272192
other O 0 0.010483737103641033
populations O 0 0.020983904600143433
. O 0 0.030266493558883667

The O 0 0.03243037685751915
present O 0 0.02288161776959896
study O 0 0.01607745885848999
used O 0 0.01433128397911787
PCR O 0 0.03149798512458801
and O 0 0.015513827092945576
restriction O 0 0.07144977897405624
- O 1 0.999083399772644
enzyme O 0 0.05512876436114311
digestion O 0 0.04204825684428215
to O 0 0.01109173521399498
analyze O 0 0.012002701871097088
the O 0 0.00804943311959505
frequency O 0 0.008091142401099205
of O 0 0.00874108262360096
the O 0 0.0140896737575531
845 O 1 0.9989956021308899
G O 1 0.9996628761291504
- O 1 0.9996355772018433
- O 1 0.989326000213623
> O 0 0.029663262888789177
A O 0 0.012882713228464127
and O 0 0.009732326492667198
187 O 0 0.031218865886330605
C O 1 0.9034438729286194
- O 1 0.9986839890480042
- O 1 0.9991747736930847
> O 1 0.9149836897850037
G O 0 0.2463502585887909
mutations O 0 0.01742573082447052
in O 0 0.015284290537238121
HLA O 1 0.9999383687973022
- O 1 0.5763183832168579
typed O 0 0.022547710686922073
samples O 0 0.012169825844466686
from O 0 0.01177180651575327
non O 0 0.09167855978012085
- O 1 0.9951242804527283
Caucasian O 1 0.6476312279701233
populations O 0 0.012699166312813759
, O 0 0.01046398002654314
comprising O 0 0.019617406651377678
Australian O 0 0.0259774848818779
Aboriginal O 0 0.27720022201538086
, O 0 0.014846070669591427
Chinese O 0 0.019564183428883553
, O 0 0.014526988379657269
and O 0 0.0170174241065979
Pacific O 0 0.04789356887340546
Islanders O 0 0.07809456437826157
. O 0 0.03659331798553467

Results O 0 0.02192862145602703
showed O 0 0.01669692061841488
that O 0 0.007523409556597471
the O 0 0.013634474948048592
845 O 1 0.9952074885368347
G O 1 0.9996324777603149
- O 1 0.9999432563781738
- O 1 0.9998040795326233
> O 1 0.7091778516769409
A O 0 0.022999538108706474
mutation O 0 0.017758585512638092
was O 0 0.00953393429517746
present O 0 0.006756262853741646
in O 0 0.005128353368490934
these O 0 0.004650984425097704
populations O 0 0.009271848946809769
( O 0 0.011430622078478336
allele O 0 0.017929328605532646
frequency O 0 0.010380963794887066
0 O 0 0.01147825550287962
. O 0 0.00602385587990284
32 O 0 0.011015512980520725
% O 0 0.00891477894037962
) O 0 0.007262983825057745
, O 0 0.0069230846129357815
and O 0 0.006749968510121107
, O 0 0.008202393539249897
furthermore O 0 0.00942370668053627
, O 0 0.006718344986438751
it O 0 0.004973644856363535
was O 0 0.00938007328659296
always O 0 0.009297545067965984
seen O 0 0.00837502721697092
in O 0 0.007600670680403709
conjunction O 0 0.02303830347955227
with O 0 0.05910555273294449
HLA O 1 0.9999986886978149
haplotypes O 1 0.9240055084228516
common O 0 0.016613375395536423
in O 0 0.010652078315615654
Caucasians O 0 0.12531805038452148
, O 0 0.008643515408039093
suggesting O 0 0.010097799822688103
that O 0 0.0072639742866158485
845 O 1 0.9977244734764099
G O 1 0.9998600482940674
- O 1 0.9999822378158569
- O 1 0.9999610185623169
> O 1 0.9639844298362732
A O 0 0.018932264298200607
may O 0 0.00870833732187748
have O 0 0.0050370353274047375
been O 0 0.006202529184520245
introduced O 0 0.00858251005411148
into O 0 0.008532486855983734
these O 0 0.0076452624052762985
populations O 0 0.015295390971004963
by O 0 0.020002342760562897
Caucasian O 1 0.9825974106788635
admixture O 1 0.933087944984436
. O 0 0.05289659649133682

187 O 0 0.13220493495464325
C O 1 0.9786294102668762
- O 1 0.9996121525764465
- O 1 0.9996271133422852
> O 1 0.967920184135437
G O 0 0.19722691178321838
was O 0 0.018444672226905823
present O 0 0.01420675776898861
at O 0 0.013423454016447067
an O 0 0.013953177258372307
allele O 0 0.02927430160343647
frequency O 0 0.01723017729818821
of O 0 0.018781596794724464
2 O 0 0.034217387437820435
. O 0 0.033094488084316254

68 O 0 0.05599714070558548
% O 0 0.020412757992744446
in O 0 0.009744364768266678
the O 0 0.010156925767660141
two O 0 0.008130867034196854
populations O 0 0.012877420522272587
analyzed O 0 0.0166926309466362
( O 0 0.016068188473582268
Australian O 0 0.024632716551423073
Aboriginal O 0 0.40407127141952515
and O 0 0.01987357810139656
Chinese O 0 0.03655890002846718
) O 0 0.028658071532845497
. O 0 0.02913096360862255

In O 0 0.024768125265836716
the O 0 0.020688790827989578
Australian O 0 0.026379454880952835
Aboriginal O 0 0.03103814832866192
samples O 0 0.015375790186226368
, O 0 0.011253640055656433
187 O 0 0.038763727992773056
C O 1 0.9926353096961975
- O 1 0.999891996383667
- O 1 0.999916672706604
> O 1 0.9940120577812195
G O 0 0.2694272994995117
was O 0 0.01047216821461916
found O 0 0.0054144179448485374
to O 0 0.004631388001143932
be O 0 0.004755414556711912
associated O 0 0.009073024615645409
with O 0 0.03953579440712929
HLA O 1 0.9999995231628418
haplotypes O 1 0.976916491985321
common O 0 0.017908303067088127
in O 0 0.012176088988780975
Caucasians O 1 0.9728186130523682
, O 0 0.010965247638523579
suggesting O 0 0.010359559208154678
that O 0 0.00520781846717
it O 0 0.005736603867262602
was O 0 0.010779745876789093
introduced O 0 0.013579069636762142
by O 0 0.01287445705384016
recent O 0 0.024818139150738716
admixture O 0 0.1716592013835907
. O 0 0.03868843987584114

In O 0 0.02293846756219864
the O 0 0.019559789448976517
Chinese O 0 0.0194446612149477
samples O 0 0.01248270832002163
analyzed O 0 0.010906538926064968
, O 0 0.0098726199939847
187 O 0 0.02992372028529644
C O 1 0.8864803910255432
- O 1 0.9996163845062256
- O 1 0.999847412109375
> O 1 0.9970894455909729
G O 1 0.6670961976051331
was O 0 0.012860986404120922
present O 0 0.008166763000190258
in O 0 0.00586922699585557
association O 0 0.010029210709035397
with O 0 0.00626380043104291
a O 0 0.009459521621465683
wide O 0 0.012279687449336052
variety O 0 0.011005429551005363
of O 1 0.6402093172073364
HLA O 1 0.9999998807907104
haplotypes O 1 0.9980781078338623
, O 0 0.0140458382666111
showing O 0 0.013941582292318344
this O 0 0.008273785002529621
mutation O 0 0.013784456066787243
to O 0 0.006801125127822161
be O 0 0.006340255495160818
widespread O 0 0.013369417749345303
and O 0 0.008902461268007755
likely O 0 0.009081530384719372
to O 0 0.008832177147269249
predate O 0 0.02323729731142521
the O 0 0.008810846135020256
more O 0 0.006481461692601442
genetically O 0 0.012115545570850372
restricted O 0 0.017033681273460388
845 O 1 0.9963382482528687
G O 1 0.9996209144592285
- O 1 0.9999357461929321
- O 1 0.9998098015785217
> O 1 0.8484041690826416
A O 0 0.04904819652438164
mutation O 0 0.058159273117780685
. O 0 0.035059329122304916

Genotype O 1 0.9784058332443237
- O 1 0.9947874546051025
phenotype O 1 0.5545555353164673
correlations O 0 0.10514343529939651
in O 0 0.08792978525161743
attenuated B-Disease 1 0.9999833106994629
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999963045120239
. O 1 0.6098595857620239

Germ O 1 0.9977923631668091
- O 1 0.9421053528785706
line O 0 0.03803979605436325
mutations O 0 0.02306108921766281
of O 0 0.018639294430613518
the O 1 0.7352036237716675
tumor B-Disease 1 0.9999992847442627
suppressor O 1 0.9999942779541016
APC O 1 0.9998214840888977
are O 0 0.012391087599098682
implicated O 0 0.12246193736791611
in O 0 0.026568125933408737
attenuated B-Disease 1 0.9999947547912598
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999450445175171
AAPC B-Disease 1 0.999998927116394
) O 0 0.019273782148957253
, O 0 0.012827818281948566
a O 0 0.016594592481851578
variant O 0 0.038937974721193314
of O 0 0.4991092085838318
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999979734420776
FAP B-Disease 1 0.9999997615814209
) O 0 0.28060418367385864
. O 0 0.05048387125134468

AAPC B-Disease 1 0.9996178150177002
is O 0 0.02812817320227623
recognized O 0 0.02103041298687458
by O 0 0.011760571971535683
the O 0 0.01491558738052845
occurrence O 0 0.030008705332875252
of O 0 0.0443858839571476
< O 1 0.9994155168533325
100 O 0 0.06888685375452042
colonic B-Disease 1 0.9999651908874512
adenomas I-Disease 1 0.998082160949707
and O 0 0.013710303232073784
a O 0 0.015421352349221706
later O 0 0.02055630274116993
onset O 1 0.9999809265136719
of O 1 0.9999678134918213
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9998537302017212
age O 1 0.9994553923606873
> O 1 0.9988119602203369
40 O 0 0.026710307225584984
years O 0 0.02224447764456272
) O 0 0.026452912017703056
. O 0 0.03051157109439373

The O 0 0.036382194608449936
aim O 0 0.03333166241645813
of O 0 0.015695221722126007
this O 0 0.009818408638238907
study O 0 0.01164878811687231
was O 0 0.013968615792691708
to O 0 0.013926684856414795
assess O 0 0.05764976516366005
genotype O 1 0.9937801957130432
- O 1 0.9989990592002869
phenotype O 1 0.8714682459831238
correlations O 0 0.060434967279434204
in O 0 0.035041213035583496
AAPC B-Disease 1 0.9999172687530518
families O 0 0.05872995778918266
. O 0 0.04725397750735283

By O 0 0.0401793010532856
protein O 0 0.04175427556037903
- O 1 0.7029832601547241
truncation O 0 0.29876208305358887
test O 0 0.03317663073539734
( O 0 0.02868989109992981
PTT O 0 0.4703620970249176
) O 0 0.01625204086303711
assay O 0 0.02221004106104374
, O 0 0.00898719485849142
the O 0 0.009160364046692848
entire O 0 0.01517963595688343
coding O 0 0.016334228217601776
region O 0 0.010284461081027985
of O 0 0.009754851460456848
the O 0 0.029419537633657455
APC B-Disease 1 0.9999477863311768
gene O 0 0.01823693886399269
was O 0 0.014891442842781544
screened O 0 0.021086720749735832
in O 0 0.008306331001222134
affected O 0 0.010973023250699043
individuals O 0 0.008796279318630695
from O 0 0.01317382138222456
11 O 0 0.33752262592315674
AAPC B-Disease 1 0.9999969005584717
kindreds O 1 0.9981918931007385
, O 0 0.01731160841882229
and O 0 0.012000653892755508
their O 0 0.010676690377295017
phenotypic O 0 0.02768336422741413
differences O 0 0.019890422001481056
were O 0 0.018384691327810287
examined O 0 0.04936642572283745
. O 0 0.0333852581679821

Five O 0 0.037814911454916
novel O 0 0.09060519933700562
germ O 1 0.9997262358665466
- O 1 0.9998443126678467
line O 1 0.9521623849868774
APC B-Disease 1 0.999701201915741
mutations O 0 0.02423272840678692
were O 0 0.010918458923697472
identified O 0 0.01620175689458847
in O 0 0.013848323374986649
seven O 0 0.030480174347758293
kindreds O 1 0.9161818027496338
. O 0 0.0457409992814064

Mutations O 0 0.04682173207402229
were O 0 0.014100369065999985
located O 0 0.01646839827299118
in O 0 0.007138569839298725
three O 0 0.0055962796323001385
different O 0 0.004035336431115866
regions O 0 0.006126119289547205
of O 0 0.008162383921444416
the O 0 0.04481617361307144
APC B-Disease 1 0.9999738931655884
gene O 0 0.04129374772310257
( O 0 0.011979121714830399
1 O 0 0.010467811487615108
) O 0 0.006674584001302719
at O 0 0.006876976694911718
the O 0 0.006920367479324341
5 O 0 0.009886243380606174
end O 0 0.010448832996189594
spanning O 0 0.016114044934511185
exons O 0 0.02125708758831024
4 O 0 0.011462328024208546
and O 0 0.008118439465761185
5 O 0 0.010861903429031372
, O 0 0.008347682654857635
( O 0 0.00983068160712719
2 O 0 0.010137137025594711
) O 0 0.007321842946112156
within O 0 0.0075747244991362095
exon O 0 0.028015490621328354
9 O 0 0.01409398764371872
, O 0 0.008508981205523014
and O 0 0.007936650887131691
( O 0 0.010552670806646347
3 O 0 0.009672276675701141
) O 0 0.006868661381304264
at O 0 0.0073149725794792175
the O 0 0.009872022084891796
3 O 0 0.016671033576130867
distal O 1 0.6646608710289001
end O 0 0.018650395795702934
of O 0 0.016200121492147446
the O 0 0.030153989791870117
gene O 0 0.03703754022717476
. O 0 0.03319030627608299

Variability O 0 0.048848237842321396
in O 0 0.01499132439494133
the O 0 0.015040049329400063
number O 0 0.01581834815442562
of O 1 0.9876082539558411
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
was O 1 0.8344782590866089
most O 0 0.01290959119796753
apparent O 0 0.354702353477478
in O 0 0.007815471850335598
individuals O 0 0.007620996795594692
with O 0 0.007055094465613365
mutations O 0 0.01004334818571806
in O 0 0.005399327725172043
region O 0 0.00842994824051857
1 O 0 0.009466909803450108
, O 0 0.007390529382973909
and O 0 0.012759547680616379
upper O 1 0.99996018409729
- O 1 0.9999997615814209
gastrointestinal O 1 0.9999998807907104
manifestations O 1 0.9999736547470093
were O 0 0.022681768983602524
more O 0 0.014739315025508404
severe O 1 0.9989436268806458
in O 0 0.02171584777534008
them O 0 0.0232012290507555
. O 0 0.03854408487677574

In O 0 0.022760683670639992
individuals O 0 0.016456948593258858
with O 0 0.013412280939519405
mutations O 0 0.01627228409051895
in O 0 0.008037038147449493
either O 0 0.00884295254945755
region O 0 0.014275101944804192
2 O 0 0.012614063918590546
or O 0 0.007599213160574436
region O 0 0.009736940264701843
3 O 0 0.009220453910529613
, O 0 0.0059208255261182785
the O 0 0.006155391689389944
average O 0 0.00805261917412281
number O 0 0.00685824453830719
of O 0 0.016104845330119133
adenomas B-Disease 1 0.9999480247497559
tended O 0 0.022664103657007217
to O 0 0.00881389994174242
be O 0 0.005233029834926128
lower O 0 0.00739868450909853
than O 0 0.004550943151116371
those O 0 0.004391341470181942
in O 0 0.005146979819983244
individuals O 0 0.0062138913199305534
with O 0 0.006891511380672455
mutations O 0 0.01043250598013401
in O 0 0.006493321154266596
region O 0 0.011804690584540367
1 O 0 0.012152515351772308
, O 0 0.008418899029493332
although O 0 0.00827229768037796
age O 0 0.020846400409936905
at O 0 0.17261317372322083
diagnosis O 1 0.9994402527809143
was O 0 0.08951779454946518
similar O 0 0.02443224936723709
. O 0 0.033772941678762436

In O 0 0.03801524266600609
all O 0 0.03849242255091667
AAPC B-Disease 1 0.999870777130127
kindreds O 1 0.9740988612174988
, O 0 0.021565020084381104
a O 0 0.02048821933567524
predominance O 0 0.40298429131507874
of O 0 0.027744576334953308
right O 1 0.9848301410675049
- O 1 0.999995231628418
sided O 1 0.9999984502792358
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.999937891960144
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999431371688843
was O 1 0.9471688866615295
observed O 0 0.050749171525239944
. O 0 0.043446123600006104

No O 0 0.12468170374631882
desmoid B-Disease 1 0.9997492432594299
tumors I-Disease 1 0.9998465776443481
were O 0 0.018138861283659935
found O 0 0.016164297237992287
in O 0 0.016730161383748055
these O 0 0.021323762834072113
kindreds O 1 0.9466684460639954
. O 0 0.04763057455420494

Our O 0 0.03825518116354942
data O 0 0.016582895070314407
suggest O 0 0.012980621308088303
that O 0 0.00798066332936287
, O 0 0.01150409784168005
in O 0 0.013469308614730835
AAPC B-Disease 1 0.9999427795410156
families O 0 0.01491829939186573
, O 0 0.008413698524236679
the O 0 0.008104667067527771
location O 0 0.010274220257997513
of O 0 0.011683414690196514
the O 0 0.2254147231578827
APC B-Disease 1 0.9999932050704956
mutation O 1 0.9658402800559998
may O 0 0.021792396903038025
partially O 0 0.03691361844539642
predict O 0 0.022728821262717247
specific O 0 0.014882155694067478
phenotypic O 0 0.04384618625044823
expression O 0 0.0415111742913723
. O 0 0.03859325870871544

This O 0 0.021165579557418823
should O 0 0.015152985230088234
help O 0 0.014333740808069706
in O 0 0.008568097837269306
the O 0 0.010798901319503784
design O 0 0.014513998292386532
of O 0 0.01605757139623165
tailored O 1 0.966647744178772
clinical O 1 0.9997009038925171
- O 1 0.9999668598175049
management O 1 0.7520204782485962
protocols O 0 0.06747234612703323
in O 0 0.009073915891349316
this O 0 0.00936587993055582
subset O 0 0.20882277190685272
of O 1 0.9024368524551392
FAP B-Disease 1 0.9999997615814209
patients O 1 0.9997453093528748
. O 0 0.032690875232219696
. O 0 0.03691697493195534

Wilms B-Disease 1 0.9999481439590454
' I-Disease 1 0.9884627461433411
tumor I-Disease 1 0.9976593255996704
1 O 0 0.03273069113492966
and O 0 0.02515295334160328
Dax O 1 0.99982750415802
- O 1 0.9875755310058594
1 O 0 0.02219475619494915
modulate O 0 0.03360653668642044
the O 0 0.016662757843732834
orphan O 1 0.999065101146698
nuclear O 0 0.16747896373271942
receptor O 1 0.8021524548530579
SF O 1 0.9999103546142578
- O 1 0.847786009311676
1 O 0 0.016094256192445755
in O 0 0.011439495719969273
sex O 0 0.051495201885700226
- O 1 0.9608514904975891
specific O 0 0.015826508402824402
gene O 0 0.02363690547645092
expression O 0 0.029496096074581146
. O 0 0.02832091972231865

Products O 0 0.05018414184451103
of O 0 0.03762482851743698
steroidogenic O 1 0.9994261264801025
factor O 0 0.14360328018665314
1 O 0 0.04049454256892204
( O 0 0.11218320578336716
SF O 1 0.9998995065689087
- O 1 0.924809455871582
1 O 0 0.020616304129362106
) O 0 0.013707510195672512
and O 0 0.017449773848056793
Wilms B-Disease 1 0.9999969005584717
tumor I-Disease 1 0.9999732971191406
1 O 0 0.32268524169921875
( O 0 0.49414488673210144
WT1 O 1 0.9998136162757874
) O 0 0.016823023557662964
genes O 0 0.01101746130734682
are O 0 0.006690505426377058
essential O 0 0.014722546562552452
for O 0 0.01268271915614605
mammalian O 0 0.04076959565281868
gonadogenesis O 1 0.7105630040168762
prior O 0 0.02405623346567154
to O 0 0.022460350766777992
sexual O 0 0.16405707597732544
differentiation O 1 0.9288637042045593
. O 0 0.05016680806875229

In O 0 0.02450457029044628
males O 0 0.027721885591745377
, O 0 0.04070473462343216
SF O 1 0.9999910593032837
- O 1 0.9995796084403992
1 O 0 0.02731303870677948
participates O 0 0.025070618838071823
in O 0 0.008748778142035007
sexual O 0 0.015969689935445786
development O 0 0.012997690588235855
by O 0 0.010105334222316742
regulating O 0 0.018079042434692383
expression O 0 0.012785498052835464
of O 0 0.012904440984129906
the O 0 0.10418474674224854
polypeptide O 1 0.9997890591621399
hormone O 1 0.9998291730880737
Mullerian O 1 0.9999831914901733
inhibiting O 1 0.9997199177742004
substance O 1 0.9993053674697876
( O 1 0.8424844741821289
MIS O 1 0.9996626377105713
) O 0 0.041653599590063095
. O 0 0.03820904344320297

Here O 0 0.031362924724817276
, O 0 0.016777222976088524
we O 0 0.011776099912822247
show O 0 0.016348471865057945
that O 0 0.014892667531967163
WT1 O 1 0.9997192025184631
- O 1 0.9986569881439209
KTS O 1 0.9984002709388733
isoforms O 0 0.03307174891233444
associate O 0 0.031873445957899094
and O 0 0.01910148747265339
synergize O 1 0.9846935272216797
with O 0 0.08131378889083862
SF O 1 0.9999955892562866
- O 1 0.9990893602371216
1 O 0 0.0256638266146183
to O 0 0.021942421793937683
promote O 0 0.13882885873317719
MIS O 1 0.9996520280838013
expression O 0 0.050063591450452805
. O 0 0.03670655936002731

In O 0 0.0342719703912735
contrast O 0 0.04334321618080139
, O 0 0.03990140184760094
WT1 O 1 0.9997652173042297
missense O 1 0.8871530890464783
mutations O 0 0.02750510908663273
, O 0 0.011613967828452587
associated O 0 0.010877571068704128
with O 0 0.010385725647211075
male B-Disease 0 0.1320073902606964
pseudohermaphroditism I-Disease 1 0.9993783235549927
in O 0 0.042219553142786026
Denys B-Disease 1 0.9999972581863403
- I-Disease 1 0.9999995231628418
Drash I-Disease 1 0.9999991655349731
syndrome I-Disease 1 0.9999997615814209
, O 0 0.08634555339813232
fail O 0 0.09733810275793076
to O 0 0.019434254616498947
synergize O 1 0.9988588094711304
with O 0 0.45547059178352356
SF O 1 0.9999979734420776
- O 1 0.9997535347938538
1 O 0 0.04896947368979454
. O 0 0.034517548978328705

Additionally O 0 0.03804144635796547
, O 0 0.020527655258774757
the O 0 0.02183973789215088
X O 1 0.965120255947113
- O 1 0.9804505109786987
linked O 0 0.027218464761972427
, O 0 0.013174175284802914
candidate O 0 0.021921880543231964
dosage O 1 0.9210524559020996
- O 1 0.9912601113319397
sensitive O 0 0.05184092000126839
sex O 0 0.06785832345485687
- O 1 0.9901294112205505
reversal O 0 0.3884548544883728
gene O 0 0.017231566831469536
, O 0 0.016260802745819092
Dax O 1 0.9997069239616394
- O 1 0.8637140989303589
1 O 0 0.015812527388334274
, O 0 0.013488913886249065
antagonizes O 0 0.24279078841209412
synergy O 0 0.09011027216911316
between O 0 0.023326488211750984
SF O 1 0.9999821186065674
- O 1 0.9990435242652893
1 O 0 0.025798989459872246
and O 0 0.018429189920425415
WT1 O 1 0.9992682337760925
, O 0 0.01137123629450798
most O 0 0.006998859345912933
likely O 0 0.008730122819542885
through O 0 0.008380413986742496
a O 0 0.010631965473294258
direct O 0 0.015705976635217667
interaction O 0 0.02092837169766426
with O 0 0.038646284490823746
SF O 1 0.9999969005584717
- O 1 0.9987581968307495
1 O 0 0.048161182552576065
. O 0 0.03782326355576515

We O 0 0.02977786213159561
propose O 0 0.039032045751810074
that O 0 0.018884453922510147
WT1 O 1 0.9946290850639343
and O 0 0.029569115489721298
Dax O 1 0.9999516010284424
- O 1 0.9990580677986145
1 O 0 0.025547947734594345
functionally O 0 0.028183164075016975
oppose O 0 0.016475245356559753
each O 0 0.006540503818541765
other O 0 0.006312638055533171
in O 0 0.009575403295457363
testis O 1 0.5168362855911255
development O 0 0.018589235842227936
by O 0 0.019744394347071648
modulating O 1 0.9995501637458801
SF O 1 0.9999957084655762
- O 1 0.999674916267395
1 O 0 0.29763728380203247
- O 1 0.9980633854866028
mediated O 1 0.825265645980835
transactivation O 1 0.9426162838935852
. O 0 0.02947726473212242
. O 0 0.03404290974140167

A O 0 0.052875082939863205
mouse O 0 0.057224150747060776
model O 0 0.036902930587530136
for O 0 0.04550476744771004
Prader B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999998807907104
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999996423721313
- O 1 0.9999983310699463
centre O 1 0.9995177984237671
mutations O 0 0.4477791488170624
. O 0 0.03967022895812988

Imprinting O 0 0.0957760214805603
in O 0 0.02345849573612213
the O 0 0.030972326174378395
15q11 O 1 0.9987325072288513
- O 1 0.9987253546714783
q13 O 1 0.8386515378952026
region O 0 0.02322487160563469
involves O 0 0.019029401242733
an O 0 0.014983187429606915
imprinting O 1 0.9989547729492188
centre O 1 0.9972966313362122
( O 1 0.9428111910820007
IC O 1 0.9999241828918457
) O 0 0.013687108643352985
, O 0 0.009377730078995228
mapping O 0 0.011989793740212917
in O 0 0.0065614450722932816
part O 0 0.00907055102288723
to O 0 0.007698269095271826
the O 0 0.012426541186869144
promoter O 1 0.5465297698974609
and O 0 0.012211513705551624
first O 0 0.020093511790037155
exon O 0 0.15782976150512695
of O 0 0.03576477989554405
SNRPN O 1 0.9991587400436401
. O 0 0.04807740077376366

Deletion O 0 0.07930542528629303
of O 0 0.03196895122528076
this O 0 0.027261005714535713
IC O 1 0.9989094734191895
abolishes O 1 0.9777933955192566
local O 0 0.026059994474053383
paternally O 0 0.09493186324834824
derived O 0 0.017353670671582222
gene O 0 0.013653424568474293
expression O 0 0.010240198113024235
and O 0 0.007823532447218895
results O 0 0.010251765139400959
in O 0 0.04088851809501648
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999938011169434
PWS B-Disease 1 0.9999998807907104
) O 0 0.35367366671562195
. O 0 0.04337291792035103

We O 0 0.020344838500022888
have O 0 0.010978085920214653
created O 0 0.0160063449293375
two O 0 0.012957645580172539
deletion O 0 0.1305209994316101
mutations O 0 0.022306090220808983
in O 0 0.012421713210642338
mice O 0 0.028516732156276703
to O 0 0.01482124999165535
understand O 0 0.19466692209243774
PWS B-Disease 1 0.9999954700469971
and O 0 0.018811235204339027
the O 0 0.022659296169877052
mechanism O 0 0.09913134574890137
of O 0 0.025997230783104897
this O 0 0.028957556933164597
IC O 1 0.9988231062889099
. O 0 0.04628985747694969

Mice O 0 0.29222047328948975
harbouring O 1 0.9896573424339294
an O 0 0.038972266018390656
intragenic O 1 0.9987918734550476
deletion O 1 0.8931939601898193
in O 0 0.021520467475056648
Snrpn O 1 0.9993066787719727
are O 0 0.011918401345610619
phenotypically O 1 0.6303529143333435
normal O 0 0.017449988052248955
, O 0 0.012408699840307236
suggesting O 0 0.012847758829593658
that O 0 0.008182898163795471
mutations O 0 0.013677905313670635
of O 0 0.014938507229089737
SNRPN O 1 0.9995741248130798
are O 0 0.009459950029850006
not O 0 0.010393296368420124
sufficient O 0 0.023486671969294548
to O 0 0.025998463854193687
induce O 1 0.9696247577667236
PWS B-Disease 1 0.9999731779098511
. O 0 0.06719594448804855

Mice O 0 0.05791023001074791
with O 0 0.019209422171115875
a O 0 0.02014206349849701
larger O 0 0.01854124665260315
deletion O 0 0.031298208981752396
involving O 0 0.016241073608398438
both O 0 0.01278726663440466
Snrpn O 1 0.9296407699584961
and O 0 0.015042191371321678
the O 0 0.05670017749071121
putative O 1 0.9999843835830688
PWS O 1 1.0
- O 1 0.9999979734420776
IC O 1 0.999800980091095
lack O 0 0.028024086728692055
expression O 0 0.014260200783610344
of O 0 0.011779919266700745
the O 0 0.021633664146065712
imprinted O 1 0.9910353422164917
genes O 0 0.019907234236598015
Zfp127 O 1 0.9445601105690002
( O 0 0.021115601062774658
mouse O 0 0.02836131490767002
homologue O 0 0.05769890174269676
of O 0 0.021761419251561165
ZNF127 O 1 0.9993670582771301
) O 0 0.022151783108711243
, O 0 0.02157129906117916
Ndn O 1 0.9989062547683716
and O 0 0.02036410942673683
Ipw O 1 0.9171558022499084
, O 0 0.015323410741984844
and O 0 0.012976199388504028
manifest O 0 0.0626157745718956
several O 0 0.015527880750596523
phenotypes O 1 0.6788986921310425
common O 0 0.11689146608114243
to O 1 0.5023765563964844
PWS B-Disease 1 0.999998927116394
infants O 1 0.9995715022087097
. O 0 0.06608764082193375

These O 0 0.021272791549563408
data O 0 0.0156303271651268
demonstrate O 0 0.015058031305670738
that O 0 0.006001819856464863
both O 0 0.005730537697672844
the O 0 0.0078113386407494545
position O 0 0.010135237127542496
of O 0 0.010318701155483723
the O 0 0.24162866175174713
IC O 1 0.9996685981750488
and O 0 0.00800219178199768
its O 0 0.007289684843271971
role O 0 0.009588069282472134
in O 0 0.005329120438545942
the O 0 0.008049075491726398
coordinate O 0 0.019105985760688782
expression O 0 0.00984768383204937
of O 0 0.008158169686794281
genes O 0 0.007911055348813534
is O 0 0.0063835131004452705
conserved O 0 0.010933887213468552
between O 0 0.009740573354065418
mouse O 0 0.04831225425004959
and O 0 0.007593889255076647
human O 0 0.008365352638065815
, O 0 0.00736797321587801
and O 0 0.005870907101780176
indicate O 0 0.006506531964987516
that O 0 0.004217119421809912
the O 0 0.008318901993334293
mouse O 0 0.026128074154257774
is O 0 0.00684233196079731
a O 0 0.009497367776930332
suitable O 0 0.01579798199236393
model O 0 0.012293807230889797
system O 0 0.008631539531052113
in O 0 0.005902417469769716
which O 0 0.005500726867467165
to O 0 0.006504556629806757
investigate O 0 0.013321548700332642
the O 0 0.01053218636661768
molecular O 0 0.012637557461857796
mechanisms O 0 0.011112436652183533
of O 0 0.011146936565637589
imprinting O 1 0.6018584966659546
in O 0 0.008060947060585022
this O 0 0.007149061653763056
region O 0 0.011404250748455524
of O 0 0.011810444295406342
the O 0 0.022038839757442474
genome O 0 0.03484482318162918
. O 0 0.01911463588476181
. O 0 0.028429746627807617

Mutations O 0 0.04021101072430611
of O 0 0.019462523981928825
the O 0 0.021838372573256493
ATM O 0 0.3256950080394745
gene O 0 0.017791209742426872
detected O 0 0.01581166684627533
in O 0 0.011604361236095428
Japanese O 1 0.9168694019317627
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.9998443126678467
: O 0 0.018946439027786255
possible O 0 0.012422882951796055
preponderance O 0 0.30487173795700073
of O 0 0.011105730198323727
the O 0 0.012951865792274475
two O 0 0.014376030303537846
founder O 1 0.9980119466781616
mutations O 0 0.4311779737472534
4612del165 O 1 0.989285409450531
and O 0 0.04170174524188042
7883del5 O 1 0.9783568978309631
. O 0 0.04921342805027962

The O 0 0.04375753179192543
ATM O 0 0.25238296389579773
( O 0 0.0384504608809948
A O 1 0.9638610482215881
- O 1 0.9999796152114868
T O 1 0.9999244213104248
, O 0 0.02095860429108143
mutated O 0 0.05473855882883072
) O 0 0.014560680836439133
gene O 0 0.014467759989202023
on O 0 0.013291061855852604
human O 0 0.024858050048351288
chromosome O 0 0.07230766862630844
11q22 O 1 0.6795357465744019
. O 0 0.04571234807372093

3 O 0 0.03564270958304405
has O 0 0.01766173727810383
recently O 0 0.016053983941674232
been O 0 0.008458863012492657
identified O 0 0.008696293458342552
as O 0 0.0064454758539795876
the O 0 0.007715882733464241
gene O 0 0.008616012521088123
responsible O 0 0.008377675898373127
for O 0 0.006852705962955952
the O 0 0.013508878648281097
human O 1 0.8889667987823486
recessive B-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999998807907104
( O 1 0.99982750415802
A B-Disease 1 0.9999895095825195
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.9999865293502808
) O 0 0.03382466733455658
. O 0 0.02992013841867447

In O 0 0.022831447422504425
order O 0 0.019513461738824844
to O 0 0.011541372165083885
define O 0 0.015555181540548801
the O 0 0.010766339488327503
types O 0 0.012663142755627632
of O 1 0.6699544787406921
disease O 1 0.9999997615814209
- O 1 0.9999954700469971
causing O 1 0.9972911477088928
ATM O 1 0.9341731071472168
mutations O 0 0.011452432721853256
in O 0 0.007434637285768986
Japanese O 0 0.0846056118607521
A B-Disease 1 0.9999265670776367
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999988079071045
patients O 1 0.9908692836761475
as O 0 0.009038045071065426
well O 0 0.007657370064407587
as O 0 0.006572699639946222
to O 0 0.007113934028893709
look O 0 0.010903587564826012
for O 0 0.008659984916448593
possible O 0 0.015303305350244045
mutational O 1 0.9876598715782166
hotspots O 0 0.4577498733997345
, O 0 0.015432202257215977
reverse O 0 0.032668691128492355
- O 1 0.9711054563522339
transcribed O 0 0.02418731153011322
RNA O 0 0.016292355954647064
derived O 0 0.008305096998810768
from O 0 0.006659603677690029
ten O 0 0.012010587379336357
patients O 0 0.03609912097454071
belonging O 0 0.01443398091942072
to O 0 0.007326137740164995
eight O 0 0.01147689763456583
unrelated O 0 0.01758875884115696
Japanese O 0 0.047014277428388596
A B-Disease 1 0.9990248680114746
- I-Disease 1 0.9999959468841553
T I-Disease 1 0.9999290704727173
families O 0 0.016443641856312752
was O 0 0.014026807621121407
analyzed O 0 0.012056847102940083
for O 0 0.008731345646083355
mutations O 0 0.0121091203764081
by O 0 0.010171971283853054
the O 0 0.018228864297270775
restriction O 0 0.07959627360105515
endonuclease O 1 0.9719215035438538
fingerprinting O 0 0.08150354772806168
method O 0 0.03354685381054878
. O 0 0.03405831381678581

As O 0 0.026173865422606468
has O 0 0.014659390784800053
been O 0 0.010328263975679874
reported O 0 0.011444458737969398
by O 0 0.009523577988147736
others O 0 0.010309696197509766
, O 0 0.009160495363175869
mutations O 0 0.010742537677288055
that O 0 0.005791292060166597
lead O 0 0.011428036727011204
to O 0 0.00971241481602192
exon O 0 0.31856784224510193
skipping O 0 0.07233036309480667
or O 0 0.016271688044071198
premature O 1 0.8984917402267456
protein O 0 0.018324358388781548
truncation O 0 0.06709427386522293
were O 0 0.009684959426522255
also O 0 0.011012780480086803
predominant O 0 0.029437009245157242
in O 0 0.014362402260303497
our O 0 0.028969934210181236
mutants O 1 0.7387956380844116
. O 0 0.0368710495531559

Six O 0 0.030157756060361862
different O 0 0.014850053936243057
mutations O 0 0.018046138808131218
were O 0 0.009502914734184742
identified O 0 0.011335333809256554
on O 0 0.008738916367292404
12 O 0 0.011568929068744183
of O 0 0.011563936248421669
the O 0 0.020156212151050568
16 O 0 0.03937820345163345
alleles O 0 0.060948263853788376
examined O 0 0.05229412764310837
. O 0 0.04235045611858368

Four O 0 0.028067125007510185
were O 0 0.01779942959547043
deletions O 0 0.038144178688526154
involving O 0 0.018512286245822906
a O 0 0.015474309213459492
loss O 0 0.019539708271622658
of O 0 0.013333375565707684
a O 0 0.03182312101125717
single O 0 0.23915863037109375
exon O 1 0.8530467748641968
exon O 0 0.12028556317090988
7 O 0 0.020796429365873337
, O 0 0.013756482861936092
exon O 0 0.037332069128751755
16 O 0 0.018278026953339577
, O 0 0.0179055854678154
exon O 0 0.052344199270009995
33 O 0 0.03505590930581093
or O 0 0.025106633082032204
exon O 0 0.07285912334918976
35 O 0 0.04980488494038582
. O 0 0.044327303767204285

The O 0 0.03326794505119324
others O 0 0.020140282809734344
were O 0 0.015129199251532555
minute O 0 0.02874542400240898
deletions O 0 0.038641538470983505
, O 0 0.020210707560181618
4649delA O 0 0.08449013531208038
in O 0 0.017460422590374947
exon O 0 0.057132039219141006
33 O 0 0.03218487277626991
and O 0 0.02177175134420395
7883del5 O 0 0.1112220361828804
in O 0 0.02472621202468872
exon O 0 0.08926014602184296
55 O 0 0.06006520241498947
. O 0 0.04707028344273567

The O 0 0.05274524912238121
mutations O 0 0.06247704103589058
4612del165 O 1 0.8775141835212708
and O 0 0.022244330495595932
7883del5 O 1 0.8061550855636597
were O 0 0.008996726013720036
found O 0 0.005974810570478439
in O 0 0.00464199623093009
more O 0 0.0035710635129362345
than O 0 0.004111816640943289
two O 0 0.005137256346642971
unrelated O 0 0.012101228348910809
families O 0 0.01018366776406765
; O 0 0.008981353603303432
44 O 0 0.01404086034744978
% O 0 0.009222445078194141
( O 0 0.008581914938986301
7 O 0 0.009518448263406754
of O 0 0.006461340468376875
16 O 0 0.009827164933085442
) O 0 0.007132407743483782
of O 0 0.007839423604309559
the O 0 0.012020436115562916
mutant O 1 0.9429011940956116
alleles O 0 0.023447029292583466
had O 0 0.010829323902726173
one O 0 0.008734540082514286
of O 0 0.010701075196266174
the O 0 0.014982341788709164
two O 0 0.017284587025642395
mutations O 0 0.038995902985334396
. O 0 0.032857876271009445

The O 0 0.0535951629281044
4612del165 O 1 0.9765962362289429
mutations O 0 0.02708967961370945
in O 0 0.010667044669389725
three O 0 0.008472362533211708
different O 0 0.005966241471469402
families O 0 0.008521933108568192
were O 0 0.005761497654020786
all O 0 0.006338609382510185
ascribed O 0 0.014515087939798832
to O 0 0.006988890469074249
the O 0 0.008823256008327007
same O 0 0.014349136501550674
T O 1 0.999919056892395
- O 1 0.9998716115951538
- O 1 0.9994237422943115
> O 0 0.15526676177978516
A O 0 0.014418557286262512
substitution O 0 0.01536551397293806
at O 0 0.011073957197368145
the O 0 0.015631185844540596
splice O 0 0.08035717904567719
donor O 0 0.03389247879385948
site O 0 0.023539617657661438
in O 0 0.020947858691215515
intron O 1 0.9273965954780579
33 O 0 0.061935991048812866
. O 0 0.04225979372859001

Microsatellite O 1 0.7539672255516052
genotyping O 0 0.2060548961162567
around O 0 0.027958806604146957
the O 0 0.029629696160554886
ATM O 1 0.9728403687477112
locus O 0 0.4033227860927582
also O 0 0.011595165356993675
indicated O 0 0.011525693349540234
that O 0 0.006049572490155697
a O 0 0.01082011591643095
common O 0 0.016091305762529373
haplotype O 1 0.8394781351089478
was O 0 0.014536337926983833
shared O 0 0.012416358105838299
by O 0 0.00897399801760912
the O 0 0.015783872455358505
mutant O 1 0.7433030009269714
alleles O 0 0.03721092641353607
in O 0 0.015693319961428642
both O 0 0.02145753614604473
mutations O 0 0.04453584924340248
. O 0 0.034421924501657486

This O 0 0.02270529791712761
suggests O 0 0.02053895778954029
that O 0 0.006769221741706133
these O 0 0.005847254768013954
two O 0 0.009698382578790188
founder O 1 0.9769466519355774
mutations O 0 0.029501991346478462
may O 0 0.011908410117030144
be O 0 0.008651037700474262
predominant O 0 0.026524238288402557
among O 0 0.01793537475168705
Japanese O 0 0.17724360525608063
ATM O 1 0.9728187322616577
mutant O 1 0.6369631886482239
alleles O 0 0.07747865468263626
. O 0 0.04860547557473183

W474C O 1 0.9653170704841614
amino O 0 0.06781689822673798
acid O 0 0.13429439067840576
substitution O 0 0.037906333804130554
affects O 0 0.023250317201018333
early O 0 0.010197651572525501
processing O 0 0.008472904562950134
of O 0 0.007896317169070244
the O 0 0.010059402324259281
alpha O 0 0.0318412259221077
- O 0 0.05018186569213867
subunit O 0 0.01949281431734562
of O 0 0.011922714300453663
beta O 0 0.19794778525829315
- O 1 0.985571026802063
hexosaminidase O 1 0.8396268486976624
A O 0 0.017477186396718025
and O 0 0.00991812627762556
is O 0 0.009778942912817001
associated O 0 0.014147165231406689
with O 0 0.049963030964136124
subacute O 1 0.9999997615814209
G B-Disease 1 0.9999874830245972
( I-Disease 1 0.9687132239341736
M2 I-Disease 1 0.9994922876358032
) I-Disease 0 0.04379839822649956
gangliosidosis I-Disease 1 0.5536006093025208
. O 0 0.044106703251600266

Mutations O 0 0.04459645599126816
in O 0 0.02000376023352146
the O 0 0.03136738762259483
HEXA O 1 0.9999593496322632
gene O 0 0.021899916231632233
, O 0 0.01099246833473444
encoding O 0 0.01091957651078701
the O 0 0.010564634576439857
alpha O 0 0.024955449625849724
- O 0 0.033965032547712326
subunit O 0 0.02134668081998825
of O 0 0.012531673535704613
beta O 0 0.125588521361351
- O 1 0.9624678492546082
hexosaminidase O 1 0.8900145888328552
A O 0 0.04071160778403282
( O 0 0.022777950391173363
Hex O 0 0.12072285264730453
A O 0 0.019392933696508408
) O 0 0.010330619290471077
, O 0 0.007248523645102978
that O 0 0.0061071524396538734
abolish O 0 0.023643260821700096
Hex O 0 0.04337548092007637
A O 0 0.020088715478777885
enzyme O 0 0.023257680237293243
activity O 0 0.02054538019001484
cause O 1 0.9982226490974426
Tay B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Sachs I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999996423721313
( O 1 0.9991457462310791
TSD B-Disease 1 0.999996542930603
) O 0 0.01592775247991085
, O 0 0.01011507399380207
the O 0 0.01343507319688797
fatal O 1 0.9987322688102722
infantile B-Disease 1 0.9999915361404419
form I-Disease 0 0.40178051590919495
of I-Disease 1 0.9894528388977051
G I-Disease 1 0.9999924898147583
( I-Disease 1 0.9790623188018799
M2 I-Disease 1 0.9997846484184265
) I-Disease 0 0.027163522318005562
gangliosidosis I-Disease 1 0.9380478262901306
, I-Disease 0 0.022606242448091507
Type I-Disease 0 0.03760567307472229
1 I-Disease 0 0.03427307307720184
. O 0 0.03495650738477707

Less O 0 0.03991299867630005
severe O 1 0.9904317259788513
, O 0 0.3959648609161377
subacute O 1 0.9999994039535522
( O 1 0.999509334564209
juvenile O 1 0.9999991655349731
- O 1 0.9999996423721313
onset O 1 0.9999995231628418
) O 1 0.7466894388198853
and O 1 0.6788394451141357
chronic O 1 0.9999998807907104
( O 1 0.9992315769195557
adult O 1 0.9999305009841919
- O 1 0.9999996423721313
onset O 1 0.9999992847442627
) O 0 0.07644655555486679
variants O 0 0.010537912137806416
are O 0 0.004855246748775244
characterized O 0 0.009647205471992493
by O 0 0.006386441178619862
a O 0 0.011884812265634537
broad O 0 0.3831946551799774
spectrum O 1 0.5950929522514343
of O 1 0.8021589517593384
clinical O 1 0.9999817609786987
manifestations O 1 0.9999953508377075
and O 1 0.6029468774795532
are O 0 0.006731349974870682
associated O 0 0.008890477009117603
with O 0 0.009667715057730675
residual O 1 0.8186705708503723
levels O 0 0.014540429227054119
of O 0 0.019536428153514862
Hex O 1 0.9912875294685364
A O 1 0.7144734859466553
enzyme O 0 0.07323171198368073
activity O 0 0.03107084333896637
. O 0 0.03134305775165558

We O 0 0.02286810427904129
identified O 0 0.020706769078969955
a O 0 0.02457364648580551
1422 O 1 0.9970988035202026
G O 1 0.9989062547683716
- O 1 0.9998608827590942
- O 1 0.9998006224632263
> O 1 0.9908265471458435
C O 1 0.7088439464569092
( O 0 0.021274687722325325
amino O 0 0.021376686170697212
acid O 0 0.03553985431790352
W474C O 1 0.5442814826965332
) O 0 0.01294860988855362
substitution O 0 0.014603574760258198
in O 0 0.006455979309976101
the O 0 0.007502996362745762
first O 0 0.009369541890919209
position O 0 0.011462241411209106
of O 0 0.01155149471014738
exon O 0 0.03279343619942665
13 O 0 0.015468381345272064
of O 0 0.017377372831106186
HEXA O 1 0.9986932873725891
of O 0 0.016092989593744278
a O 0 0.020556479692459106
non O 1 0.6295689940452576
- O 1 0.9936991930007935
Jewish O 0 0.14169421792030334
proband O 1 0.9854275584220886
who O 0 0.024624504148960114
manifested O 1 0.9517091512680054
a O 0 0.3282005488872528
subacute O 1 0.9999972581863403
variant O 1 0.9907166361808777
of O 1 0.9785551428794861
G B-Disease 1 0.9999843835830688
( I-Disease 1 0.9089323282241821
M2 I-Disease 1 0.99864262342453
) I-Disease 0 0.04390531778335571
gangliosidosis I-Disease 0 0.4172894060611725
. O 0 0.044316407293081284

On O 0 0.0259405504912138
the O 0 0.021610982716083527
second O 0 0.05574389919638634
maternally O 1 0.984821617603302
inherited O 1 0.9986531734466553
allele O 0 0.2752310633659363
, O 0 0.01195451244711876
we O 0 0.007706935983151197
identified O 0 0.01084140408784151
the O 0 0.013005810789763927
common O 1 0.844311535358429
infantile O 1 0.9999998807907104
disease O 1 0.9999996423721313
- O 1 0.9999934434890747
causing O 1 0.9955610036849976
4 O 1 0.5721634030342102
- O 1 0.9982187151908875
bp O 0 0.06667538732290268
insertion O 0 0.05106569454073906
, O 0 0.020657533779740334
+ O 0 0.279741495847702
TATC O 1 0.9748061895370483
1278 O 1 0.9733826518058777
, O 0 0.021415134891867638
in O 0 0.018499428406357765
exon O 0 0.07235950976610184
11 O 0 0.04160185903310776
. O 0 0.0352044440805912

Pulse O 1 0.9857677817344666
- O 1 0.9647604823112488
chase O 0 0.0629941076040268
analysis O 0 0.01903715915977955
using O 0 0.01685038022696972
proband O 1 0.7143250107765198
fibroblasts O 0 0.06717227399349213
revealed O 0 0.01809145323932171
that O 0 0.0074343555606901646
the O 0 0.01119703147560358
W474C O 1 0.8409237265586853
- O 1 0.7267663478851318
containing O 0 0.015147564932703972
alpha O 0 0.05170309171080589
- O 1 0.8361045122146606
subunit O 0 0.031011680141091347
precursor O 0 0.024014903232455254
was O 0 0.013891459442675114
normally O 0 0.010899350978434086
synthesized O 0 0.014317810535430908
, O 0 0.007250837050378323
but O 0 0.004892852157354355
not O 0 0.006090056151151657
phosphorylated O 0 0.03339467942714691
or O 0 0.009131562896072865
secreted O 0 0.017595823854207993
, O 0 0.007221746724098921
and O 0 0.007103964686393738
the O 0 0.012153533287346363
mature O 0 0.30014222860336304
lysosomal O 1 0.9999252557754517
alpha O 1 0.9876716136932373
- O 1 0.9978196620941162
subunit O 0 0.05819953605532646
was O 0 0.024506837129592896
not O 0 0.01667473092675209
detected O 0 0.036351703107357025
. O 0 0.03126305341720581

When O 0 0.030543198809027672
the O 0 0.024876127019524574
W474C O 1 0.7947198152542114
- O 0 0.4650983512401581
containing O 0 0.021183906123042107
alpha O 0 0.0482294037938118
- O 1 0.575282871723175
subunit O 0 0.032156962901353836
was O 0 0.020554708316922188
transiently O 1 0.7141615152359009
co O 0 0.4730990529060364
- O 0 0.17167367041110992
expressed O 0 0.009931896813213825
with O 0 0.006701473146677017
the O 0 0.010646049864590168
beta O 1 0.5001967549324036
- O 0 0.4557715058326721
subunit O 0 0.01962210424244404
to O 0 0.008623461239039898
produce O 0 0.010843389667570591
Hex O 0 0.03724074736237526
A O 0 0.019644659012556076
( O 0 0.018146848306059837
alphabeta O 0 0.4277932941913605
) O 0 0.01235894113779068
in O 0 0.01156266126781702
COS O 1 0.9999135732650757
- O 1 0.9799709320068359
7 O 0 0.015931984409689903
cells O 0 0.008959027007222176
, O 0 0.005735095124691725
the O 0 0.008149215951561928
mature O 0 0.02072666585445404
alpha O 0 0.2707761526107788
- O 1 0.9818204045295715
subunit O 0 0.03256787732243538
was O 0 0.011079322546720505
present O 0 0.008577792905271053
, O 0 0.0064023868180811405
but O 0 0.004585376475006342
its O 0 0.00582461291924119
level O 0 0.008856282569468021
was O 0 0.009526687674224377
much O 0 0.0057029020972549915
lower O 0 0.006938457023352385
than O 0 0.003517341334372759
that O 0 0.0034837655257433653
from O 0 0.005445738323032856
normal O 0 0.010739278979599476
alpha O 0 0.17806218564510345
- O 1 0.9927994012832642
subunit O 0 0.11344414204359055
transfections O 0 0.48738566040992737
, O 0 0.008938520215451717
although O 0 0.006575721316039562
higher O 0 0.006284995004534721
than O 0 0.004495393950492144
in O 0 0.0053618592210114
those O 0 0.007668407168239355
cells O 0 0.01360086165368557
transfected O 0 0.041683685034513474
with O 0 0.009461890906095505
an O 0 0.012493493035435677
alpha O 0 0.2617085874080658
- O 1 0.9601926803588867
subunit O 0 0.0501333512365818
associated O 0 0.024416601285338402
with O 0 0.03552781045436859
infantile O 1 0.9999833106994629
TSD B-Disease 1 0.999941349029541
. O 0 0.07416170090436935

Furthermore O 0 0.04707665741443634
, O 0 0.019425898790359497
the O 0 0.014353432692587376
precursor O 0 0.021848032251000404
level O 0 0.011874389834702015
of O 0 0.010626601055264473
the O 0 0.016301317140460014
W474C O 1 0.9985266923904419
alpha O 1 0.9138715863227844
- O 1 0.9883309006690979
subunit O 0 0.02917841263115406
was O 0 0.013369028456509113
found O 0 0.0073109581135213375
to O 0 0.007890632376074791
accumulate O 0 0.014726772904396057
in O 0 0.005797098390758038
comparison O 0 0.00861753523349762
to O 0 0.006841025780886412
the O 0 0.009833745658397675
normal O 0 0.016700146719813347
alpha O 0 0.34674373269081116
- O 1 0.9932050704956055
subunit O 0 0.10112471878528595
precursor O 0 0.06495139002799988
levels O 0 0.032712172716856
. O 0 0.03318789228796959

We O 0 0.022532502189278603
conclude O 0 0.02307308278977871
that O 0 0.009655731730163097
the O 0 0.01721459999680519
1422 O 1 0.9995046854019165
G O 1 0.9997228980064392
- O 1 0.9999576807022095
- O 1 0.9999250173568726
> O 1 0.9966896772384644
C O 1 0.8257670998573303
mutation O 0 0.01873287372291088
is O 0 0.007764800451695919
the O 0 0.008799036033451557
cause O 0 0.01815054565668106
of O 0 0.03451009839773178
Hex B-Disease 1 0.9998855590820312
A I-Disease 1 0.9998588562011719
enzyme I-Disease 1 0.9999809265136719
deficiency I-Disease 1 0.9999992847442627
in O 0 0.028048725798726082
the O 0 0.28161001205444336
proband O 1 0.9990087151527405
. O 0 0.049513135105371475

The O 0 0.0435042604804039
resulting O 0 0.04543234780430794
W474C O 1 0.7785051465034485
substitution O 0 0.04377848654985428
clearly O 0 0.02293051965534687
interferes O 0 0.03699437156319618
with O 0 0.01366625539958477
alpha O 1 0.6477429270744324
- O 1 0.9902386665344238
subunit O 0 0.04070436581969261
processing O 0 0.012173667550086975
, O 0 0.007559827528893948
but O 0 0.005211365409195423
because O 0 0.00573280593380332
the O 0 0.008445910178124905
base O 0 0.016668641939759254
substitution O 0 0.018632996827363968
falls O 0 0.03977960720658302
at O 0 0.008973183110356331
the O 0 0.007820919156074524
first O 0 0.007905414327979088
position O 0 0.011209786869585514
of O 0 0.011125647462904453
exon O 0 0.04396224021911621
13 O 0 0.016979675740003586
, O 0 0.013613763265311718
aberrant O 1 0.7552385330200195
splicing O 0 0.021368054673075676
may O 0 0.00883127935230732
also O 0 0.007525360677391291
contribute O 0 0.012959035113453865
to O 0 0.01360382977873087
Hex B-Disease 1 0.9872322082519531
A I-Disease 1 0.9827390909194946
deficiency I-Disease 1 0.9999947547912598
in O 0 0.019626228138804436
this O 0 0.019827743992209435
proband O 1 0.9958876967430115
. O 0 0.027094630524516106
. O 0 0.031245946884155273

Two O 0 0.04357998073101044
frequent O 0 0.07837409526109695
missense O 1 0.7533336281776428
mutations O 1 0.5323570370674133
in O 1 0.660410463809967
Pendred B-Disease 1 0.9999967813491821
syndrome I-Disease 1 0.9999998807907104
. O 1 0.8103504180908203

Pendred B-Disease 1 0.9999932050704956
syndrome I-Disease 1 0.9999997615814209
is O 1 0.907607913017273
an O 1 0.9998449087142944
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999984502792358
by O 1 0.9998331069946289
early O 1 0.9999877214431763
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999908208847046
goiter B-Disease 1 1.0
. O 1 0.9891374707221985

A O 0 0.037306156009435654
century O 0 0.0297442227602005
after O 0 0.016835952177643776
its O 0 0.012753566727042198
recognition O 0 0.01664949767291546
as O 0 0.015206033363938332
a O 1 0.7966488003730774
syndrome O 1 0.9999994039535522
by O 0 0.4238048791885376
Vaughan O 1 0.999954342842102
Pendred O 1 0.9998420476913452
, O 0 0.030929433181881905
the O 1 0.6777804493904114
disease O 1 0.9999972581863403
gene O 1 0.9580512642860413
( O 1 0.8255033493041992
PDS O 1 0.9998798370361328
) O 0 0.015001199208199978
was O 0 0.017108144238591194
mapped O 0 0.025968512520194054
to O 0 0.019419429823756218
chromosome O 0 0.08953651040792465
7q22 O 1 0.9796177744865417
- O 1 0.995895266532898
q31 O 1 0.8830599188804626
. O 0 0.04925478994846344

1 O 0 0.04141382500529289
and O 0 0.02121560461819172
, O 0 0.01687522605061531
recently O 0 0.019263194873929024
, O 0 0.01117265596985817
found O 0 0.009268845431506634
to O 0 0.010591504164040089
encode O 0 0.022137923166155815
a O 0 0.030009135603904724
putative O 1 0.9942155480384827
sulfate O 1 0.9996492862701416
transporter O 1 0.9934396147727966
. O 0 0.05127044394612312

We O 0 0.028724007308483124
performed O 0 0.028358610346913338
mutation O 0 0.02369028702378273
analysis O 0 0.008850298821926117
of O 0 0.010861795395612717
the O 0 0.05226391181349754
PDS B-Disease 1 0.9999903440475464
gene O 0 0.02525445446372032
in O 0 0.010747550055384636
patients O 0 0.15407340228557587
from O 0 0.011882578954100609
14 O 0 0.02534339390695095
Pendred B-Disease 1 0.9875275492668152
families O 0 0.01688695326447487
originating O 0 0.019186628982424736
from O 0 0.010213140398263931
seven O 0 0.012224831618368626
countries O 0 0.008984724059700966
and O 0 0.013166837394237518
identified O 0 0.019693685695528984
all O 0 0.01902357116341591
mutations O 0 0.039168693125247955
. O 0 0.03239918872714043

The O 0 0.03831858187913895
mutations O 0 0.03052731789648533
include O 0 0.014192740432918072
three O 0 0.011640544980764389
single O 0 0.02114860527217388
base O 0 0.02507794089615345
deletions O 0 0.02878580614924431
, O 0 0.011916565708816051
one O 0 0.013045698404312134
splice O 0 0.050016630440950394
site O 0 0.023058447986841202
mutation O 0 0.020554961636662483
and O 0 0.01336573250591755
10 O 0 0.02572149597108364
missense O 0 0.2772444486618042
mutations O 0 0.04919342324137688
. O 0 0.040678564459085464

One O 0 0.04286356270313263
missense O 0 0.479927659034729
mutation O 0 0.43018245697021484
( O 0 0.12204832583665848
L236P O 1 0.9777225255966187
) O 0 0.014690590091049671
was O 0 0.012540243566036224
found O 0 0.007050179410725832
in O 0 0.005412918981164694
a O 0 0.008303243666887283
homozygous O 0 0.013631974346935749
state O 0 0.006105616223067045
in O 0 0.006919082719832659
two O 0 0.00883188471198082
consanguineous O 1 0.9720507860183716
families O 0 0.01383314561098814
and O 0 0.008512405678629875
in O 0 0.007635673973709345
a O 0 0.010431591421365738
heterozygous O 0 0.01572546735405922
state O 0 0.0067789494059979916
in O 0 0.0066166711039841175
five O 0 0.01077192835509777
additional O 0 0.017308933660387993
non O 1 0.8043203353881836
- O 1 0.9996055960655212
consanguineous O 1 0.99565190076828
families O 0 0.05354703590273857
. O 0 0.04284442216157913

Another O 0 0.054129790514707565
missense O 1 0.8020983934402466
mutation O 1 0.8747379779815674
( O 0 0.2166958600282669
T416P O 1 0.9967946410179138
) O 0 0.014535633847117424
was O 0 0.011247190646827221
found O 0 0.005563452374190092
in O 0 0.005492703057825565
a O 0 0.007965664379298687
homozygous O 0 0.013187547214329243
state O 0 0.005667502526193857
in O 0 0.005737271159887314
one O 0 0.00730707636103034
family O 0 0.012422234751284122
and O 0 0.007055275607854128
in O 0 0.007062266580760479
a O 0 0.012553215958178043
heterozygous O 0 0.019207121804356575
state O 0 0.010148395784199238
in O 0 0.011458784341812134
four O 0 0.018144268542528152
families O 0 0.032999031245708466
. O 0 0.03753752261400223

Pendred B-Disease 1 0.9928834438323975
patients O 0 0.17912110686302185
in O 0 0.016623161733150482
three O 0 0.01901789754629135
non O 1 0.9803646802902222
- O 1 0.9999423027038574
consanguineous O 1 0.99921715259552
families O 0 0.020404281094670296
were O 0 0.010226317681372166
shown O 0 0.009964806027710438
to O 0 0.009923039004206657
be O 0 0.010134237818419933
compound O 0 0.03819067403674126
heterozygotes O 0 0.4077354669570923
for O 0 0.02297406643629074
L236P O 1 0.9786877632141113
and O 0 0.038565028458833694
T416P O 1 0.9788829684257507
. O 0 0.04587836191058159

In O 0 0.02481759712100029
total O 0 0.016739334911108017
, O 0 0.012880299240350723
one O 0 0.009257188066840172
or O 0 0.0067216260358691216
both O 0 0.005891288630664349
of O 0 0.007232017815113068
these O 0 0.005536023061722517
mutations O 0 0.009154142811894417
were O 0 0.005325287580490112
found O 0 0.00523742800578475
in O 0 0.005186202935874462
nine O 0 0.008309486322104931
of O 0 0.01033940352499485
the O 0 0.01453594770282507
14 O 0 0.023826519027352333
families O 0 0.02594027854502201
analyzed O 0 0.03633740544319153
. O 0 0.03284106031060219

The O 0 0.03153951093554497
identification O 0 0.025158707052469254
of O 0 0.016234515234827995
two O 0 0.015353700146079063
frequent O 1 0.9612072110176086
PDS B-Disease 1 0.9999947547912598
mutations O 0 0.06309939920902252
will O 0 0.012079188600182533
facilitate O 0 0.020224489271640778
the O 0 0.01898050308227539
molecular O 0 0.42283275723457336
diagnosis O 1 0.9999781847000122
of O 1 0.9996515512466431
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8984640836715698

Insertional O 1 0.9507657289505005
mutation O 0 0.06650102138519287
by O 0 0.029708823189139366
transposable O 1 0.9908671379089355
element O 0 0.1349058449268341
, O 0 0.02376585267484188
L1 O 1 0.9895573258399963
, O 0 0.01083227526396513
in O 0 0.009371507912874222
the O 0 0.019316429272294044
DMD B-Disease 1 0.9999934434890747
gene O 0 0.01793288066983223
results O 0 0.010621568188071251
in O 0 0.016071973368525505
X B-Disease 1 0.9989534616470337
- I-Disease 1 0.9999686479568481
linked I-Disease 1 0.9991182684898376
dilated I-Disease 1 0.9999932050704956
cardiomyopathy I-Disease 1 0.9999992847442627
. O 0 0.2781756818294525

X B-Disease 1 0.9944906234741211
- I-Disease 1 0.9999057054519653
linked I-Disease 1 0.9995902180671692
dilated I-Disease 1 0.9999994039535522
cardiomyopathy I-Disease 1 1.0
( O 1 0.9996657371520996
XLDCM B-Disease 1 0.9999767541885376
) O 0 0.02167632058262825
is O 0 0.011080872267484665
a O 0 0.01466219313442707
clinical O 1 0.7937553524971008
phenotype O 1 0.9215226769447327
of O 0 0.06840745359659195
dystrophinopathy B-Disease 1 0.9998772144317627
which O 0 0.012309729121625423
is O 0 0.011458016000688076
characterized O 0 0.036640167236328125
by O 0 0.02452266588807106
preferential O 1 0.9996410608291626
myocardial B-Disease 1 0.9999996423721313
involvement I-Disease 1 0.9813536405563354
without O 0 0.019689112901687622
any O 0 0.016804276034235954
overt O 1 0.9897063970565796
clinical O 1 0.9991902709007263
signs O 1 0.9983727931976318
of O 1 0.9998290538787842
skeletal B-Disease 1 0.9999998807907104
myopathy I-Disease 1 0.9999998807907104
. O 1 0.8220534920692444

To O 0 0.025452589616179466
date O 0 0.018392181023955345
, O 0 0.010471556335687637
several O 0 0.008036346174776554
mutations O 0 0.0123103903606534
in O 0 0.009397040121257305
the O 1 0.5823488235473633
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999512434005737
, O 1 0.9988546371459961
DMD O 1 0.9999997615814209
, O 0 0.017589371651411057
have O 0 0.005897864233702421
been O 0 0.006301757413893938
identified O 0 0.00867049116641283
in O 0 0.007021177560091019
patients O 1 0.508917510509491
with O 0 0.01868666708469391
XLDCM B-Disease 1 0.9999502897262573
, O 0 0.011417213827371597
but O 0 0.007457353174686432
a O 0 0.010434391908347607
pathogenic O 0 0.02034762315452099
correlation O 0 0.01212220173329115
of O 0 0.008423223160207272
these O 0 0.007807222660630941
cardiospecific O 1 0.9690513014793396
mutations O 0 0.018614638596773148
in O 0 0.0132149588316679
DMD O 1 0.9999897480010986
with O 0 0.01648171804845333
the O 1 0.8014430999755859
XLDCM B-Disease 1 0.999997615814209
phenotype O 1 0.9988921284675598
has O 0 0.01567958854138851
remained O 0 0.022926464676856995
to O 0 0.015218277461826801
be O 0 0.019474966451525688
elucidated O 0 0.13630981743335724
. O 0 0.03587905317544937

We O 0 0.02548079937696457
report O 0 0.018119748681783676
here O 0 0.011045617051422596
the O 0 0.010342023335397243
identification O 0 0.011513130739331245
of O 0 0.009525040164589882
a O 0 0.013575040735304356
unique O 0 0.017771614715456963
de O 0 0.2596772015094757
novo O 1 0.9858489036560059
L1 O 1 0.9957528114318848
insertion O 0 0.038527075201272964
in O 0 0.011574951000511646
the O 0 0.015038884244859219
muscle O 1 0.5636489987373352
exon O 0 0.2634599804878235
1 O 0 0.021327892318367958
in O 0 0.01616695150732994
DMD O 1 0.999826967716217
in O 0 0.015321901068091393
three O 0 0.024075251072645187
XLDCM B-Disease 1 0.9999749660491943
patients O 1 0.9288095831871033
from O 0 0.016296692192554474
two O 0 0.015951447188854218
unrelated O 0 0.04141724854707718
Japanese O 0 0.05455069988965988
families O 0 0.04207087680697441
. O 0 0.042681965976953506

The O 0 0.036802735179662704
insertion O 0 0.048491619527339935
was O 0 0.02146659977734089
a O 0 0.017819982022047043
5 O 0 0.022918889299035072
- O 1 0.9185556769371033
truncated O 0 0.027190465480089188
form O 0 0.01088232733309269
of O 0 0.013021291233599186
human O 0 0.03227873891592026
L1 O 1 0.999007523059845
inversely O 0 0.03142392262816429
integrated O 0 0.021039461717009544
in O 0 0.007752866018563509
the O 0 0.010642112232744694
5 O 0 0.018242573365569115
- O 1 0.9356708526611328
untranslated O 0 0.05501357093453407
region O 0 0.01157570444047451
in O 0 0.00785707775503397
the O 0 0.01271031517535448
muscle O 1 0.9802095890045166
exon O 1 0.9623481631278992
1 O 0 0.014805911108851433
, O 0 0.008763023652136326
which O 0 0.005976266693323851
affected O 0 0.009671613574028015
the O 0 0.009520677849650383
transcription O 0 0.017921706661581993
or O 0 0.007099043112248182
the O 0 0.007487024646252394
stability O 0 0.01795804873108864
of O 0 0.01190584059804678
the O 0 0.12473943829536438
muscle O 1 0.9924992918968201
form O 0 0.0199737548828125
of O 0 0.14335909485816956
dystrophin O 1 0.9996098875999451
transcripts O 0 0.017450781539082527
but O 0 0.005200723651796579
not O 0 0.0035401578061282635
that O 0 0.0034066135995090008
of O 0 0.005912497639656067
the O 0 0.015891902148723602
brain O 1 0.9955917000770569
or O 1 0.5734469294548035
Purkinje O 1 0.9999901056289673
cell O 1 0.9125439524650574
form O 0 0.016326110810041428
, O 0 0.01063569262623787
probably O 0 0.00962822139263153
due O 0 0.00828060694038868
to O 0 0.0074651506729424
its O 0 0.00990727823227644
unique O 0 0.014708698727190495
site O 0 0.020072538405656815
of O 0 0.021502135321497917
integration O 0 0.05414126440882683
. O 0 0.040275938808918

We O 0 0.030008915811777115
speculate O 0 0.024385228753089905
that O 0 0.007375992368906736
this O 0 0.007400344591587782
insertion O 0 0.019554121419787407
of O 0 0.010473176836967468
an O 0 0.013972215354442596
L1 O 1 0.996494472026825
sequence O 0 0.01641220413148403
in O 0 0.017125137150287628
DMD O 1 0.999995231628418
is O 0 0.013678137212991714
responsible O 0 0.01330486312508583
for O 0 0.005665732081979513
some O 0 0.004069221671670675
of O 0 0.006255903746932745
the O 0 0.007934292778372765
population O 0 0.007846053689718246
of O 0 0.012786377221345901
Japanese O 1 0.9090632200241089
patients O 1 0.9982914328575134
with O 0 0.34276679158210754
XLDCM B-Disease 1 0.9999494552612305
. O 0 0.028568916022777557
. O 0 0.03358500823378563

Severe O 1 0.9945048689842224
early O 1 0.9625824689865112
- O 1 0.9999996423721313
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999988079071045
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9998262524604797
red O 1 0.9999988079071045
hair O 1 0.9999977350234985
pigmentation O 1 0.9999994039535522
caused O 1 0.9999406337738037
by O 1 0.9983019828796387
POMC O 1 0.9999996423721313
mutations O 1 0.5580280423164368
in O 0 0.024830346927046776
humans O 0 0.03402027487754822
. O 0 0.03481544926762581

Sequential O 0 0.0831615999341011
cleavage O 0 0.08293508738279343
of O 0 0.022072935476899147
the O 0 0.01961582340300083
precursor O 0 0.05719480663537979
protein O 0 0.017839012667536736
pre O 0 0.05708407238125801
- O 1 0.9912399649620056
pro O 1 0.8951277136802673
- O 1 0.9997366070747375
opiomelanocortin O 1 0.9996833801269531
( O 0 0.33668968081474304
POMC O 1 0.999685525894165
) O 0 0.017762336879968643
generates O 0 0.021593274548649788
the O 0 0.020362060517072678
melanocortin O 1 0.9952402114868164
peptides O 0 0.06361124664545059
adrenocorticotrophin O 1 0.9736064672470093
( O 0 0.053356464952230453
ACTH O 1 0.9983181953430176
) O 0 0.0215544942766428
, O 0 0.022021068260073662
melanocyte O 1 0.9998250603675842
- O 1 0.9998331069946289
stimulating O 1 0.9987860321998596
hormones O 1 0.98338782787323
( O 0 0.43029022216796875
MSH O 1 0.9999605417251587
) O 0 0.016457775607705116
alpha O 0 0.02325735054910183
, O 0 0.01135118305683136
beta O 0 0.019183091819286346
and O 0 0.008948851376771927
gamma O 0 0.020379450172185898
as O 0 0.007145917043089867
well O 0 0.006318363361060619
as O 0 0.0069265831261873245
the O 0 0.012952988035976887
opioid O 1 0.9998624324798584
- O 1 0.9999411106109619
receptor O 1 0.8959757685661316
ligand O 1 0.8706653118133545
beta O 1 0.8647492527961731
- O 1 0.9973903298377991
endorphin O 1 0.9949657320976257
. O 0 0.05626647174358368

While O 0 0.02489117905497551
a O 0 0.018243497237563133
few O 0 0.012611581943929195
cases O 0 0.01449408195912838
of O 0 0.15685904026031494
isolated O 1 0.9999933242797852
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
have O 0 0.011716955341398716
been O 0 0.011065290309488773
reported O 0 0.019919494166970253
( O 0 0.08681800216436386
OMIM O 1 0.999953031539917
201400 O 1 0.9357693791389465
) O 0 0.01386316493153572
, O 0 0.011890986002981663
an O 0 0.02146216481924057
inherited O 1 0.9999932050704956
POMC O 1 0.9999997615814209
defect O 1 0.9999741315841675
has O 0 0.02062029205262661
not O 0 0.010548318736255169
been O 0 0.011293502524495125
described O 0 0.01876765862107277
so O 0 0.014629939571022987
far O 0 0.020605938509106636
. O 0 0.029827123507857323

Recent O 0 0.03683364763855934
studies O 0 0.01992432214319706
in O 0 0.014911545440554619
animal O 0 0.019896259531378746
models O 0 0.016813432797789574
elucidated O 0 0.03410949185490608
a O 0 0.012175974436104298
central O 0 0.011773142963647842
role O 0 0.011974247172474861
of O 0 0.017583537846803665
alpha O 1 0.9989836812019348
- O 1 0.9999434947967529
MSH O 1 0.9998750686645508
in O 0 0.008652803488075733
the O 0 0.008395993150770664
regulation O 0 0.011063036508858204
of O 0 0.01041462179273367
food O 0 0.023677729070186615
intake O 0 0.10856212675571442
by O 0 0.00811869278550148
activation O 0 0.013971414417028427
of O 0 0.009148440323770046
the O 0 0.014156218618154526
brain O 1 0.9808576107025146
melanocortin O 1 0.9999797344207764
- O 1 0.9985644221305847
4 O 0 0.028563659638166428
- O 1 0.9870914220809937
receptor O 0 0.04779564589262009
( O 0 0.026993216946721077
MC4 O 1 0.9998937845230103
- O 1 0.9979689717292786
R O 1 0.7714274525642395
; O 0 0.014910019934177399
refs O 0 0.03806404769420624
3 O 0 0.018725907430052757
- O 0 0.07995371520519257
5 O 0 0.012403431348502636
) O 0 0.008170850574970245
and O 0 0.006399074569344521
the O 0 0.009259479120373726
linkage O 0 0.028081011027097702
of O 0 0.015143266879022121
human O 1 0.5246556997299194
obesity B-Disease 1 0.9999939203262329
to O 0 0.02210785634815693
chromosome O 0 0.09572845697402954
2 O 0 0.011443296447396278
in O 0 0.006848176941275597
close O 0 0.010116863995790482
proximity O 0 0.014537191018462181
to O 0 0.008863333612680435
the O 0 0.020566705614328384
POMC O 1 0.9999843835830688
locus O 1 0.6257193684577942
, O 0 0.010703013278543949
led O 0 0.013062899932265282
to O 0 0.006831505335867405
the O 0 0.007279849611222744
proposal O 0 0.009194801561534405
of O 0 0.007331383414566517
an O 0 0.010083001106977463
association O 0 0.13780109584331512
of O 1 0.7752040028572083
POMC O 1 0.9999990463256836
with O 1 0.7809233665466309
human O 1 0.9899128675460815
obesity B-Disease 1 0.9999961853027344
. O 0 0.09708604216575623

The O 0 0.034627847373485565
dual O 0 0.039168257266283035
role O 0 0.027791570872068405
of O 0 0.029535939916968346
alpha O 1 0.9971535205841064
- O 1 0.999927282333374
MSH O 1 0.9999004602432251
in O 0 0.014974224381148815
regulating O 0 0.032010409981012344
food O 0 0.027727950364351273
intake O 0 0.37929168343544006
and O 0 0.016479918733239174
influencing O 1 0.8364589810371399
hair O 1 0.997410237789154
pigmentation O 1 0.9999183416366577
predicts O 0 0.16477756202220917
that O 0 0.008150827139616013
the O 0 0.013261651620268822
phenotype O 0 0.47159749269485474
associated O 0 0.009723598137497902
with O 0 0.009915837086737156
a O 0 0.06159020587801933
defect O 1 0.9993152618408203
in O 0 0.023549919947981834
POMC O 1 0.9999626874923706
function O 0 0.014767116867005825
would O 0 0.010970213450491428
include O 0 0.021217262372374535
obesity B-Disease 1 0.9999867677688599
, O 0 0.09048748016357422
alteration O 1 0.9975626468658447
in O 1 0.5522829294204712
pigmentation O 1 0.9999980926513672
and O 1 0.9998750686645508
ACTH B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
. O 1 0.5906255841255188

The O 0 0.03437361121177673
observation O 0 0.06452352553606033
of O 0 0.02217361330986023
these O 0 0.013652006164193153
symptoms O 1 0.999396800994873
in O 0 0.013444904237985611
two O 0 0.015121998265385628
probands O 1 0.9992608428001404
prompted O 0 0.12040658295154572
us O 0 0.014454086311161518
to O 0 0.010001249611377716
search O 0 0.015965959057211876
for O 0 0.010892782360315323
mutations O 0 0.016132600605487823
within O 0 0.014657330699265003
their O 0 0.024097179993987083
POMC O 1 0.9998661279678345
genes O 0 0.042830128222703934
. O 0 0.03766734153032303

Patient O 1 0.9750273823738098
1 O 0 0.03225504234433174
was O 0 0.02179311215877533
found O 0 0.00950821302831173
to O 0 0.007673240732401609
be O 0 0.006376569624990225
a O 0 0.010450123809278011
compound O 0 0.02540244720876217
heterozygote O 0 0.053561244159936905
for O 0 0.008568189106881618
two O 0 0.007734070532023907
mutations O 0 0.012078152038156986
in O 0 0.009459808468818665
exon O 0 0.04366671293973923
3 O 0 0.0204510185867548
( O 0 0.021721480414271355
G7013T O 1 0.9139004349708557
, O 0 0.01852327771484852
C7133delta O 1 0.9266567826271057
) O 0 0.012146802619099617
which O 0 0.007811164949089289
interfere O 0 0.014085429720580578
with O 0 0.007956369780004025
appropriate O 0 0.012589143589138985
synthesis O 0 0.017428318038582802
of O 0 0.023813748732209206
ACTH O 1 0.9999586343765259
and O 0 0.05285855010151863
alpha O 1 0.9882349967956543
- O 1 0.9995173215866089
MSH O 1 0.9996230602264404
. O 0 0.05063845217227936

Patient O 1 0.9084376096725464
2 O 0 0.033353280276060104
was O 0 0.025312423706054688
homozygous O 0 0.028557628393173218
for O 0 0.011350477114319801
a O 0 0.0161020215600729
mutation O 0 0.022222530096769333
in O 0 0.012600798159837723
exon O 0 0.15415261685848236
2 O 0 0.025940505787730217
( O 0 0.027250196784734726
C3804A O 1 0.5815718173980713
) O 0 0.024757418781518936
which O 0 0.024305231869220734
abolishes O 1 0.9797894954681396
POMC O 1 0.998814582824707
translation O 0 0.07108138501644135
. O 0 0.05000188201665878

These O 0 0.01883888989686966
findings O 0 0.01703661121428013
represent O 0 0.011892911978065968
the O 0 0.010428667068481445
first O 0 0.010426739230751991
examples O 0 0.010513905435800552
of O 0 0.011389326304197311
a O 0 0.43851661682128906
genetic B-Disease 1 0.980511486530304
defect I-Disease 1 0.9998881816864014
within O 0 0.018207084387540817
the O 0 0.46341535449028015
POMC O 1 0.9999855756759644
gene O 0 0.013757431879639626
and O 0 0.008791557513177395
define O 0 0.01405943464487791
a O 0 0.014655609615147114
new O 1 0.5072935223579407
monogenic B-Disease 1 0.9999994039535522
endocrine I-Disease 1 0.9999994039535522
disorder I-Disease 1 0.9999881982803345
resulting O 0 0.21684657037258148
in O 0 0.01905905455350876
early O 1 0.9700185656547546
- O 1 0.9999990463256836
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 1 0.9999940395355225
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9997820258140564
red O 1 0.9999974966049194
hair O 1 0.9999872446060181
pigmentation O 1 0.9999895095825195
. O 0 0.05087879300117493
. O 0 0.04181627184152603

A O 0 0.049015965312719345
European O 0 0.03604663535952568
multicenter O 1 0.9738993644714355
study O 0 0.03209925442934036
of O 1 0.9362071752548218
phenylalanine B-Disease 1 0.9999995231628418
hydroxylase I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
: O 1 0.5317758917808533
classification O 0 0.31383228302001953
of O 0 0.020043643191456795
105 O 1 0.5609035491943359
mutations O 0 0.014713785611093044
and O 0 0.007941904477775097
a O 0 0.00934589747339487
general O 0 0.014197670854628086
system O 0 0.011860126629471779
for O 0 0.010926923714578152
genotype O 1 0.9592486023902893
- O 1 0.92212975025177
based O 0 0.016947580501437187
prediction O 0 0.031894221901893616
of O 0 0.03831919655203819
metabolic O 1 0.9994192123413086
phenotype O 1 0.9891061186790466
. O 0 0.04835586994886398

Phenylketonuria B-Disease 1 0.9999769926071167
( O 1 0.9955741167068481
PKU B-Disease 1 0.9999945163726807
) O 0 0.04174268618226051
and O 0 0.03420151025056839
mild B-Disease 1 0.9999163150787354
hyperphenylalaninemia I-Disease 1 0.9999990463256836
( O 1 0.9997308850288391
MHP B-Disease 1 0.9999998807907104
) O 0 0.04526551440358162
are O 0 0.015047362074255943
allelic B-Disease 1 0.9998658895492554
disorders I-Disease 1 0.9999963045120239
caused O 1 0.9581239223480225
by O 0 0.01870732754468918
mutations O 0 0.017006132751703262
in O 0 0.008543195202946663
the O 0 0.017480207607150078
gene O 0 0.029855849221348763
encoding O 0 0.034874748438596725
phenylalanine O 1 0.9989907145500183
hydroxylase O 1 0.9999337196350098
( O 1 0.9904919266700745
PAH O 1 0.9999966621398926
) O 0 0.05016419291496277
. O 0 0.041745562106370926

Previous O 0 0.034329477697610855
studies O 0 0.01828433759510517
have O 0 0.008024106733500957
suggested O 0 0.009805917739868164
that O 0 0.00587928481400013
the O 0 0.010916476137936115
highly O 0 0.021005356684327126
variable O 0 0.037318091839551926
metabolic O 1 0.9970160722732544
phenotypes O 1 0.9964463114738464
of O 1 0.9998832941055298
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999433755874634
with O 1 0.9997567534446716
PAH O 1 0.9999998807907104
genotypes O 1 0.999735414981842
. O 0 0.062237776815891266

We O 0 0.028337761759757996
identified O 0 0.027683507651090622
both O 0 0.020625991746783257
causative O 1 0.9064072370529175
mutations O 0 0.03122944012284279
in O 0 0.02158650942146778
686 O 1 0.9997169375419617
patients O 1 0.9733452796936035
from O 0 0.01766725815832615
seven O 0 0.02335124835371971
European O 0 0.02978544309735298
centers O 0 0.05203425511717796
. O 0 0.03745584934949875

On O 0 0.023434650152921677
the O 0 0.014998987317085266
basis O 0 0.011051440611481667
of O 0 0.010563129559159279
the O 0 0.013258207589387894
phenotypic O 0 0.02470727078616619
characteristics O 0 0.01685146987438202
of O 0 0.02305271290242672
297 O 1 0.9988663196563721
functionally O 1 0.9992080330848694
hemizygous O 1 0.9998050332069397
patients O 1 0.9049878120422363
, O 0 0.012241552583873272
105 O 0 0.021542754024267197
of O 0 0.01092561986297369
the O 0 0.013610268011689186
mutations O 0 0.012549658305943012
were O 0 0.0076785157434642315
assigned O 0 0.014673056080937386
to O 0 0.007288787513971329
one O 0 0.00851407554000616
of O 0 0.011108998209238052
four O 0 0.01714329980313778
arbitrary O 0 0.03458289057016373
phenotype O 1 0.7681752443313599
categories O 0 0.045250147581100464
. O 0 0.0386059395968914

We O 0 0.025707099586725235
proposed O 0 0.02300712652504444
and O 0 0.014497487805783749
tested O 0 0.02207084558904171
a O 0 0.015826499089598656
simple O 0 0.01785304956138134
model O 0 0.01696619763970375
for O 0 0.011732397601008415
correlation O 0 0.02312016300857067
between O 0 0.020860761404037476
genotype O 1 0.5159075260162354
and O 0 0.023955896496772766
phenotypic O 0 0.04705052077770233
outcome O 0 0.03949211165308952
. O 0 0.038121163845062256

The O 0 0.04360143095254898
observed O 0 0.033954255282878876
phenotype O 0 0.05210728198289871
matched O 0 0.02573191188275814
the O 0 0.016683993861079216
predicted O 0 0.02222093567252159
phenotype O 0 0.039187464863061905
in O 0 0.008481103926897049
79 O 0 0.02065996639430523
% O 0 0.009854260832071304
of O 0 0.008776968345046043
the O 0 0.010957376100122929
cases O 0 0.013744671829044819
, O 0 0.00801598560065031
and O 0 0.00556434178724885
in O 0 0.004465151112526655
only O 0 0.00509760482236743
5 O 0 0.009046744555234909
of O 0 0.010730251669883728
184 O 1 0.8732412457466125
patients O 1 0.7615885138511658
was O 0 0.017688950523734093
the O 0 0.01283680647611618
observed O 0 0.01400519348680973
phenotype O 0 0.031002962961792946
more O 0 0.005274063907563686
than O 0 0.006152248941361904
one O 0 0.00855152029544115
category O 0 0.01371126901358366
away O 0 0.011546071618795395
from O 0 0.009795690886676311
that O 0 0.010573845356702805
expected O 0 0.020776988938450813
. O 0 0.029322504997253418

Among O 0 0.02540097013115883
the O 0 0.016788771376013756
seven O 0 0.017658211290836334
contributing O 0 0.031094789505004883
centers O 0 0.020043473690748215
, O 0 0.009282858110964298
the O 0 0.009271666407585144
proportion O 0 0.01808195747435093
of O 0 0.10663466900587082
patients O 1 0.9905710220336914
for O 0 0.009941833093762398
whom O 0 0.051053669303655624
the O 0 0.01962474174797535
observed O 0 0.019060080870985985
phenotype O 0 0.14189188182353973
did O 0 0.007572567090392113
not O 0 0.005377822555601597
match O 0 0.008594849146902561
the O 0 0.009097597561776638
predicted O 0 0.014949276112020016
phenotype O 0 0.02197311259806156
was O 0 0.01285890955477953
4 O 0 0.013804593123495579
% O 0 0.012195603922009468
- O 0 0.047826800495386124
23 O 0 0.01738729327917099
% O 0 0.01447752770036459
( O 0 0.024026887491345406
P O 1 0.9597511291503906
< O 1 0.7399272322654724
. O 0 0.016665056347846985
0001 O 1 0.8243485689163208
) O 0 0.013627909123897552
, O 0 0.01018668245524168
suggesting O 0 0.010647904127836227
that O 0 0.005804273299872875
differences O 0 0.007547037210315466
in O 0 0.005359975155442953
methods O 0 0.006120521109551191
used O 0 0.005613272078335285
for O 0 0.00887515489012003
mutation O 0 0.062930166721344
detection O 1 0.7731643319129944
or O 0 0.15346436202526093
phenotype O 1 0.996300458908081
classification O 0 0.32728850841522217
may O 0 0.009131383150815964
account O 0 0.007849016226828098
for O 0 0.005990236531943083
a O 0 0.009235861711204052
considerable O 0 0.014132356271147728
proportion O 0 0.022016797214746475
of O 0 0.18964526057243347
genotype O 1 0.9999009370803833
- O 1 0.9998887777328491
phenotype O 1 0.9373511075973511
inconsistencies O 0 0.07784444838762283
. O 0 0.042456965893507004

Our O 0 0.03088793344795704
data O 0 0.013688062317669392
indicate O 0 0.012632131576538086
that O 0 0.010686496272683144
the O 0 0.054132964462041855
PAH O 1 1.0
- O 1 0.9999831914901733
mutation O 1 0.8415499925613403
genotype O 0 0.1741434931755066
is O 0 0.009351013228297234
the O 0 0.010216254740953445
main O 0 0.021903464570641518
determinant O 1 0.9584183096885681
of O 0 0.10525289177894592
metabolic O 1 0.9998739957809448
phenotype O 1 0.9798706769943237
in O 0 0.01590123400092125
most O 0 0.04521186277270317
patients O 1 0.999962568283081
with O 1 0.9999405145645142
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
. O 1 0.8421066403388977

In O 0 0.022830555215477943
the O 0 0.018542762845754623
present O 0 0.01590428687632084
study O 0 0.010785553604364395
, O 0 0.009707862511277199
the O 0 0.010821940377354622
classification O 0 0.029970433562994003
of O 0 0.14261680841445923
105 O 1 0.9999113082885742
PAH O 1 1.0
mutations O 0 0.07150019705295563
may O 0 0.009304609149694443
allow O 0 0.008007227443158627
the O 0 0.008128021843731403
prediction O 0 0.01360908430069685
of O 0 0.00943788606673479
the O 0 0.014667072333395481
biochemical O 0 0.22773832082748413
phenotype O 1 0.7212216854095459
in O 0 0.0118489945307374
> O 0 0.3689197301864624
10 O 0 0.011435096152126789
, O 0 0.011637989431619644
000 O 0 0.026634791865944862
genotypes O 0 0.4148736596107483
, O 0 0.011461690068244934
which O 0 0.0076374090276658535
may O 0 0.00776287168264389
be O 0 0.0052933767437934875
useful O 0 0.006432645488530397
for O 0 0.005688080098479986
the O 0 0.010320322588086128
management O 0 0.026710039004683495
of O 0 0.06646209210157394
hyperphenylalaninemia B-Disease 1 0.9999866485595703
in O 0 0.18371880054473877
newborns O 1 0.9997729659080505
. O 0 0.0483115017414093

Somatic O 0 0.47449877858161926
instability O 0 0.10053455084562302
of O 0 0.027533141896128654
the O 0 0.27271968126296997
CTG O 1 0.9999597072601318
repeat O 0 0.32509785890579224
in O 0 0.012976137921214104
mice O 0 0.02152305282652378
transgenic O 0 0.027026984840631485
for O 0 0.014024103991687298
the O 1 0.9861330389976501
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9982526898384094
is O 0 0.4986421465873718
age O 0 0.27682048082351685
dependent O 0 0.01857566460967064
but O 0 0.007586703170090914
not O 0 0.007302158512175083
correlated O 0 0.013311450369656086
to O 0 0.008176819421350956
the O 0 0.01300593838095665
relative O 0 0.031531427055597305
intertissue O 1 0.9948216676712036
transcription O 0 0.46911418437957764
levels O 0 0.032038185745477676
and O 0 0.03984743729233742
proliferative O 1 0.9999672174453735
capacities O 1 0.7081514596939087
. O 0 0.05064813047647476

A O 0 0.14682795107364655
( O 0 0.1696077585220337
CTG O 1 0.9977692365646362
) O 0 0.026122992858290672
nexpansion O 0 0.046982668340206146
in O 0 0.010655058547854424
the O 0 0.01381938811391592
3 O 0 0.023458577692508698
- O 1 0.9739461541175842
untranslated O 1 0.5766162276268005
region O 0 0.021269645541906357
( O 0 0.018984492868185043
UTR O 0 0.06150422245264053
) O 0 0.009626039303839207
of O 0 0.011789004318416119
the O 0 0.029633328318595886
DM O 1 0.9999992847442627
protein O 0 0.04376718029379845
kinase O 1 0.7809133529663086
gene O 0 0.02210064046084881
( O 0 0.02208389900624752
DMPK O 1 0.9609667062759399
) O 0 0.01233095396310091
is O 0 0.00926197785884142
responsible O 0 0.017076821997761726
for O 0 0.0224260576069355
causing O 1 0.9999271631240845
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999983310699463
DM B-Disease 1 1.0
) O 1 0.5312256813049316
. O 0 0.04534057900309563

Major O 0 0.25903400778770447
instability O 1 0.8829541802406311
, O 0 0.0199210774153471
with O 0 0.012969776056706905
very O 0 0.011371063068509102
large O 0 0.011667216196656227
expansions O 0 0.024608250707387924
between O 0 0.013746612705290318
generations O 0 0.019410638138651848
and O 0 0.011356686241924763
high O 0 0.02092379331588745
levels O 0 0.01554703339934349
of O 0 0.027819935232400894
somatic O 1 0.9992693066596985
mosaicism O 1 0.9998794794082642
, O 0 0.02207387052476406
is O 0 0.01641908846795559
observed O 0 0.0211531613022089
in O 0 0.02126815728843212
patients O 1 0.817487895488739
. O 0 0.04010242223739624

There O 0 0.02659332938492298
is O 0 0.01649891957640648
a O 0 0.016079450026154518
good O 0 0.017476774752140045
correlation O 0 0.01668543741106987
between O 0 0.012144251726567745
repeat O 0 0.030954822897911072
size O 0 0.011879807338118553
( O 0 0.010168295353651047
at O 0 0.007734216749668121
least O 0 0.006110586225986481
in O 0 0.008790742605924606
leucocytes O 1 0.9909242987632751
) O 0 0.016155706718564034
, O 0 0.01554675679653883
clinical O 1 0.9640284180641174
severity O 1 0.9937007427215576
and O 0 0.04500507935881615
age O 1 0.7795199155807495
of O 1 0.9717460870742798
onset O 1 0.9999971389770508
. O 1 0.7174711227416992

The O 0 0.07309222221374512
trinucleotide O 1 0.997634768486023
repeat O 1 0.8348656296730042
instability O 1 0.7539729475975037
mechanisms O 0 0.03397362679243088
involved O 0 0.021925732493400574
in O 0 0.05295075103640556
DM B-Disease 1 0.9999998807907104
and O 0 0.03508135303854942
other O 0 0.01652122475206852
human O 1 0.9935340881347656
genetic B-Disease 1 0.9999765157699585
diseases I-Disease 1 0.9999996423721313
are O 0 0.0203864686191082
unknown O 0 0.046121153980493546
. O 0 0.0327976755797863

We O 0 0.03573031723499298
studied O 0 0.04387103021144867
somatic O 0 0.11298719048500061
instability O 0 0.07826951146125793
by O 0 0.018506092950701714
measuring O 0 0.1267649084329605
the O 0 0.0642261803150177
CTG O 1 0.9999017715454102
repeat O 0 0.08209746330976486
length O 0 0.0150712626054883
at O 0 0.010457444004714489
several O 0 0.007412603124976158
ages O 0 0.01209315937012434
in O 0 0.006986006163060665
various O 0 0.006880429573357105
tissues O 0 0.01612778753042221
of O 0 0.012275229208171368
transgenic O 0 0.39476871490478516
mice O 0 0.021487904712557793
carrying O 0 0.018058909103274345
a O 0 0.020285040140151978
( O 0 0.12481822818517685
CTG O 1 0.9994959831237793
) O 0 0.01874653436243534
55expansion O 0 0.09088508784770966
surrounded O 0 0.02449529431760311
by O 0 0.010012160986661911
45 O 0 0.015251271426677704
kb O 0 0.033103037625551224
of O 0 0.014554565772414207
the O 0 0.02452820912003517
human O 1 0.9298135042190552
DM B-Disease 1 0.9999997615814209
region O 0 0.03505966067314148
, O 0 0.014039117842912674
using O 0 0.011604475788772106
small O 0 0.019381580874323845
- O 1 0.9897472858428955
pool O 0 0.2723817229270935
PCR O 0 0.08838508278131485
. O 0 0.041141919791698456

These O 0 0.026893120259046555
mice O 0 0.030610037967562675
have O 0 0.008865018375217915
been O 0 0.00845105480402708
shown O 0 0.008066554553806782
to O 0 0.00800237338989973
reproduce O 0 0.014116890728473663
the O 0 0.014627169817686081
intergenerational O 1 0.9936079978942871
and O 0 0.018847281113266945
somatic O 1 0.9185477495193481
instability O 0 0.16493859887123108
of O 0 0.015132519416511059
the O 0 0.02089688554406166
55 O 0 0.4074249267578125
CTG O 1 0.9998973608016968
repeat O 0 0.10591211169958115
suggesting O 0 0.0148033257573843
that O 0 0.006179009564220905
surrounding O 0 0.011748497374355793
sequences O 0 0.009280114434659481
and O 0 0.008696228265762329
the O 0 0.014044015668332577
chromatin O 0 0.26272082328796387
environment O 0 0.016274040564894676
are O 0 0.00693196477368474
involved O 0 0.013173028826713562
in O 0 0.017304327338933945
instability O 1 0.9860910773277283
mechanisms O 0 0.4342828094959259
. O 0 0.04335395246744156

As O 0 0.024648427963256836
observed O 0 0.015515741892158985
in O 0 0.0072700148448348045
some O 0 0.0062217409722507
of O 0 0.009304873645305634
the O 0 0.01562522165477276
tissues O 1 0.9858421683311462
of O 1 0.9993144273757935
DM B-Disease 1 1.0
patients O 1 0.999969482421875
, O 0 0.031453441828489304
there O 0 0.007703092880547047
is O 0 0.007667812053114176
a O 0 0.010353625752031803
tendency O 0 0.027595030143857002
for O 0 0.009634584188461304
repeat O 0 0.0959269106388092
length O 0 0.016731487587094307
and O 0 0.016969600692391396
somatic O 1 0.9273079633712769
mosaicism O 1 0.9571560025215149
to O 0 0.011982955038547516
increase O 0 0.01026651356369257
with O 0 0.008740573190152645
the O 0 0.011802131310105324
age O 0 0.017766423523426056
of O 0 0.019085142761468887
the O 0 0.12130104750394821
mouse O 1 0.7848192453384399
. O 0 0.03837807476520538

Furthermore O 0 0.047077685594558716
, O 0 0.018428944051265717
we O 0 0.011465785093605518
observed O 0 0.011143877170979977
no O 0 0.009142132475972176
correlation O 0 0.014037045650184155
between O 0 0.010030469857156277
the O 0 0.01661532185971737
somatic O 1 0.9465698599815369
mutation O 0 0.13100312650203705
rate O 0 0.027243247255682945
and O 0 0.03972753509879112
tissue O 1 0.9971279501914978
proliferation O 1 0.994247555732727
capacity O 0 0.05805879458785057
. O 0 0.041151292622089386

The O 0 0.05682716518640518
somatic O 1 0.8693555593490601
mutation O 0 0.06907900422811508
rates O 0 0.019599860534071922
in O 0 0.010143937543034554
different O 0 0.007873755879700184
tissues O 0 0.02361673302948475
were O 0 0.007015494629740715
also O 0 0.006632631178945303
not O 0 0.005234125070273876
correlated O 0 0.010069788433611393
to O 0 0.006058495491743088
the O 0 0.008805334568023682
relative O 0 0.02449548803269863
inter O 1 0.9995796084403992
- O 1 0.9998787641525269
tissue O 0 0.4528905153274536
difference O 0 0.011266743764281273
in O 0 0.006742785219103098
transcriptional O 0 0.016200613230466843
levels O 0 0.006932529620826244
of O 0 0.006417892873287201
the O 0 0.008212381042540073
three O 0 0.009160065092146397
genes O 0 0.013582508079707623
( O 0 0.023224307224154472
DMAHP O 1 0.9991729855537415
, O 0 0.019032681360840797
DMPK O 1 0.9926344752311707
and O 0 0.013850433751940727
59 O 0 0.0301064345985651
) O 0 0.01437552459537983
surrounding O 0 0.021048346534371376
the O 0 0.018628058955073357
repeat O 0 0.13668707013130188
. O 0 0.02305120788514614
. O 0 0.031270336359739304

A O 0 0.05553324520587921
novel O 0 0.08022277802228928
missense O 1 0.9208360910415649
mutation O 0 0.1422075778245926
in O 0 0.01628638058900833
patients O 0 0.41532260179519653
from O 0 0.014813775196671486
a O 1 0.7749667763710022
retinoblastoma B-Disease 1 0.9999940395355225
pedigree O 1 0.9900122880935669
showing O 0 0.04858076199889183
only O 0 0.01429457776248455
mild O 1 0.854591429233551
expression O 0 0.024310071021318436
of O 0 0.036122921854257584
the O 1 0.9837687611579895
tumor B-Disease 1 0.9999967813491821
phenotype O 1 0.9981643557548523
. O 0 0.046035513281822205

We O 0 0.028278937563300133
have O 0 0.014254129491746426
used O 0 0.013752819038927555
single O 0 0.02626049518585205
strand O 0 0.04424617066979408
conformation O 0 0.038318462669849396
polymorphism O 0 0.026322323828935623
analysis O 0 0.008944284170866013
to O 0 0.00729879317805171
study O 0 0.007219613529741764
the O 0 0.008511656895279884
27 O 0 0.013920157216489315
exons O 0 0.020454958081245422
of O 0 0.011301151476800442
the O 0 0.03824629634618759
RB1 O 1 0.9999632835388184
gene O 0 0.01650647260248661
in O 0 0.007917315699160099
individuals O 0 0.007674660999327898
from O 0 0.008928102441132069
a O 0 0.015007668174803257
family O 0 0.04905376955866814
showing O 0 0.07337245345115662
mild O 1 0.976047158241272
expression O 0 0.04182332381606102
of O 0 0.0662524402141571
the O 1 0.9714348316192627
retinoblastoma B-Disease 1 0.9999958276748657
phenotype O 1 0.9989387392997742
. O 0 0.0548739992082119

In O 0 0.021037934347987175
this O 0 0.013610204681754112
family O 0 0.027280429378151894
affected O 0 0.021654311567544937
individuals O 0 0.01621777005493641
developed O 1 0.8345701694488525
unilateral B-Disease 1 0.999891996383667
tumors I-Disease 1 0.999998927116394
and O 0 0.08503016084432602
, O 0 0.010621539317071438
as O 0 0.0072050695307552814
a O 0 0.008472250774502754
result O 0 0.007593933027237654
of O 0 0.011849707923829556
linkage O 1 0.8754660487174988
analysis O 0 0.010073991492390633
, O 0 0.013950331136584282
unaffected O 1 0.7618764638900757
mutation O 0 0.027631495147943497
carriers O 0 0.016705753281712532
were O 0 0.007334569469094276
also O 0 0.00878521054983139
identified O 0 0.011428683064877987
within O 0 0.011753923259675503
the O 0 0.02217051573097706
pedigree O 0 0.4371761977672577
. O 0 0.03573731333017349

A O 0 0.04970704764127731
single O 0 0.03935212641954422
band O 0 0.0412561409175396
shift O 0 0.02332136034965515
using O 0 0.012354506179690361
SSCP O 1 0.9634965062141418
was O 0 0.016184940934181213
identified O 0 0.012245126999914646
in O 0 0.008868400007486343
exon O 0 0.03132554143667221
21 O 0 0.013942567631602287
which O 0 0.007360980845987797
resulted O 0 0.010391069576144218
in O 0 0.008285867050290108
a O 0 0.013242109678685665
missense O 0 0.037720561027526855
mutation O 0 0.020377641543745995
converting O 0 0.022777818143367767
a O 0 0.03249137103557587
cys O 1 0.9999799728393555
- O 1 0.9999473094940186
- O 1 0.9999328851699829
> O 1 0.9916103482246399
arg O 1 0.9962634444236755
at O 0 0.016272971406579018
nucleotide O 0 0.021185563877224922
position O 0 0.014498291537165642
28 O 0 0.018211401998996735
in O 0 0.014334605075418949
the O 0 0.02461463212966919
exon O 0 0.10215761512517929
. O 0 0.04564373195171356

The O 0 0.04442954808473587
mutation O 0 0.055492665618658066
destroyed O 0 0.05631600692868233
an O 0 0.036336757242679596
NdeI O 1 0.9988604784011841
restriction O 0 0.2643260657787323
enzyme O 0 0.07149804383516312
site O 0 0.04291579872369766
. O 0 0.03679129108786583

Analysis O 0 0.021787362173199654
of O 0 0.015636930242180824
all O 0 0.01201946847140789
family O 0 0.017063846811652184
members O 0 0.011551842093467712
demonstrated O 0 0.012134760618209839
that O 0 0.005923825781792402
the O 0 0.0100865438580513
missense O 0 0.05884966626763344
mutation O 0 0.1223277822136879
co O 1 0.988376796245575
- O 1 0.9997959733009338
segregated O 1 0.9935598373413086
with O 0 0.3543780446052551
patients O 1 0.9997791647911072
with O 1 0.9768562912940979
tumors B-Disease 1 0.9999990463256836
or O 0 0.07628609240055084
who O 0 0.020759357139468193
, O 0 0.007877104915678501
as O 0 0.006755898240953684
a O 0 0.008706720545887947
result O 0 0.0086943618953228
of O 0 0.01343458704650402
linkage O 1 0.6971942186355591
analysis O 0 0.009532736614346504
had O 0 0.010453123599290848
been O 0 0.009336530230939388
predicted O 0 0.015424681827425957
to O 0 0.011189241893589497
carry O 0 0.017857758328318596
the O 0 0.03026610054075718
predisposing O 1 0.9707480072975159
mutation O 0 0.10235008597373962
. O 0 0.04295917600393295

These O 0 0.018290618434548378
observations O 0 0.01810765452682972
point O 0 0.012902794405817986
to O 0 0.008293339051306248
another O 0 0.01001772191375494
region O 0 0.01138872466981411
of O 0 0.010370382107794285
the O 0 0.1155780777335167
RB1 O 1 0.9999927282333374
gene O 0 0.021283486858010292
where O 0 0.012089844793081284
mutations O 0 0.010231309570372105
only O 0 0.006313312333077192
modify O 0 0.012408560141921043
the O 0 0.008244059048593044
function O 0 0.008121981285512447
of O 0 0.007660022471100092
the O 0 0.010857339948415756
gene O 0 0.011465623043477535
and O 0 0.007404058240354061
raise O 0 0.010235019959509373
important O 0 0.007187933195382357
questions O 0 0.009749040938913822
for O 0 0.008910481818020344
genetic O 0 0.04420093446969986
counseling O 1 0.9896175265312195
in O 0 0.010790246538817883
families O 0 0.014679193496704102
with O 0 0.01207566075026989
these O 0 0.01185673475265503
distinctive O 1 0.9405766129493713
phenotypes O 1 0.9199528098106384
. O 0 0.024811943992972374
. O 0 0.03225769102573395

Maternal B-Disease 1 0.9896402955055237
disomy I-Disease 1 0.9993793964385986
and O 1 0.9959307312965393
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9979426264762878
with O 1 0.9741173982620239
gamete O 1 0.9999877214431763
complementation O 1 0.9999867677688599
in O 0 0.01392263825982809
a O 0 0.01609598472714424
case O 0 0.016842229291796684
of O 0 0.027566837146878242
familial O 1 0.9999909400939941
translocation O 1 0.9998244643211365
( O 0 0.023942450061440468
3 O 0 0.014442449435591698
; O 0 0.009724915958940983
15 O 0 0.013896332122385502
) O 0 0.0156476441770792
( O 0 0.022288968786597252
p25 O 1 0.8966037631034851
; O 0 0.022176027297973633
q11 O 1 0.6590665578842163
. O 0 0.01774017885327339
2 O 0 0.03131597116589546
) O 0 0.02632385492324829
. O 0 0.03369738906621933

Maternal B-Disease 1 0.9977662563323975
uniparental I-Disease 1 0.9999610185623169
disomy I-Disease 1 0.9999690055847168
( I-Disease 1 0.995278000831604
UPD I-Disease 1 0.9999945163726807
) I-Disease 0 0.02385103516280651
for I-Disease 0 0.01339367963373661
chromosome I-Disease 0 0.051247116178274155
15 I-Disease 0 0.013524243608117104
is O 0 0.008013933897018433
responsible O 0 0.009439642541110516
for O 0 0.00565331568941474
an O 0 0.0066127353347837925
estimated O 0 0.007563040126115084
30 O 0 0.007025470025837421
% O 0 0.0064881956204771996
of O 0 0.008759528398513794
cases O 0 0.014646130613982677
of O 1 0.9843473434448242
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999958276748657
PWS B-Disease 1 0.9999998807907104
) O 0 0.2629304528236389
. O 0 0.04507898911833763

We O 0 0.024658288806676865
report O 0 0.018583903089165688
on O 0 0.010237565264105797
an O 0 0.00867511611431837
unusual O 0 0.011064060963690281
case O 0 0.011629188433289528
of O 0 0.015546698123216629
maternal B-Disease 1 0.9997077584266663
disomy I-Disease 1 0.9998898506164551
15 I-Disease 0 0.11138412356376648
in O 0 0.12640580534934998
PWS B-Disease 1 0.9999996423721313
that O 0 0.008875750005245209
is O 0 0.007588034961372614
most O 0 0.005542968399822712
consistent O 0 0.01007955614477396
with O 0 0.007572971750050783
adjacent O 0 0.02148662507534027
- O 1 0.8200575113296509
1 O 0 0.01349636446684599
segregation O 0 0.025124870240688324
of O 0 0.011098474264144897
a O 0 0.04042888805270195
paternal O 1 0.9993057250976562
t O 1 0.9968138337135315
( O 0 0.014277303591370583
3 O 0 0.01237373985350132
; O 0 0.00878029502928257
15 O 0 0.01102377101778984
) O 0 0.012421959079802036
( O 0 0.017937880009412766
p25 O 1 0.8599786758422852
; O 0 0.01602128893136978
q11 O 0 0.050066567957401276
. O 0 0.009875397197902203
2 O 0 0.012670585885643959
) O 0 0.009783562272787094
with O 0 0.008935767225921154
simultaneous O 0 0.025101060047745705
maternal O 1 0.9868083596229553
meiotic O 1 0.9998999834060669
nondisjunction O 1 0.9991050362586975
for O 0 0.04039086401462555
chromosome O 0 0.11502702534198761
15 O 0 0.04634624347090721
. O 0 0.04061650112271309

The O 0 0.05366876348853111
patient O 1 0.99955815076828
( O 1 0.9047982692718506
J O 1 0.9998637437820435
. O 0 0.019303085282444954
B O 1 0.9422386288642883
. O 0 0.008194209076464176
) O 0 0.006967518944293261
, O 0 0.005875537171959877
a O 0 0.008297230117022991
17 O 0 0.014457008801400661
- O 0 0.3919234871864319
year O 0 0.012675536796450615
- O 1 0.973345160484314
old O 0 0.3625127971172333
white O 1 0.5506872534751892
male O 1 0.7800531983375549
with O 1 0.6618204116821289
PWS B-Disease 1 0.9999997615814209
, O 0 0.018606675788760185
was O 0 0.01397798489779234
found O 0 0.0068044825457036495
to O 0 0.005231652408838272
have O 0 0.004797189962118864
47 O 0 0.012243038974702358
chromosomes O 0 0.011011369526386261
with O 0 0.00789832603186369
a O 0 0.015077725984156132
supernumerary O 1 0.9987794756889343
, O 0 0.022274531424045563
paternal O 1 0.9978137016296387
der O 1 0.9964763522148132
( O 0 0.01419084519147873
15 O 0 0.010338773019611835
) O 0 0.007214011158794165
consisting O 0 0.009105927310883999
of O 0 0.006735878065228462
the O 0 0.010320269502699375
short O 0 0.01501645427197218
arm O 1 0.7457091808319092
and O 0 0.009958937764167786
the O 0 0.0328967347741127
proximal O 1 0.9997908473014832
long O 0 0.40100210905075073
arm O 1 0.9113427996635437
of O 0 0.024116497486829758
chromosome O 0 0.25665098428726196
15 O 0 0.020125584676861763
, O 0 0.016595613211393356
and O 0 0.025868037715554237
distal O 1 0.9996634721755981
chromosome O 1 0.9895182251930237
arm O 1 0.9976181387901306
3p O 1 0.9985696077346802
. O 0 0.059624314308166504

The O 0 0.05369452387094498
t O 1 0.9302220940589905
( O 0 0.024817246943712234
3 O 0 0.018416615203022957
; O 0 0.011788468807935715
15 O 0 0.011843155138194561
) O 0 0.009703838266432285
was O 0 0.009881973266601562
present O 0 0.007816554978489876
in O 0 0.0057608745992183685
the O 0 0.007949032820761204
balanced O 0 0.012612342834472656
state O 0 0.006783291697502136
in O 0 0.008194692432880402
the O 0 0.019640818238258362
patients O 1 0.9881075024604797
father O 1 0.8802086114883423
and O 0 0.0251585952937603
a O 0 0.304935485124588
sister O 1 0.9910882711410522
. O 0 0.04229346290230751

Fluorescent O 0 0.14505527913570404
in O 0 0.033538199961185455
situ O 0 0.3989820182323456
hybridization O 0 0.0335424579679966
analysis O 0 0.013006114400923252
demonstrated O 0 0.016782246530056
that O 0 0.010071082040667534
the O 0 0.02258697897195816
PWS B-Disease 1 0.9999963045120239
critical O 0 0.03393203765153885
region O 0 0.01919078454375267
resided O 0 0.030697230249643326
on O 0 0.011326326988637447
the O 0 0.014830652624368668
derivative O 0 0.2923871874809265
chromosome O 0 0.0258767269551754
3 O 0 0.011195468716323376
and O 0 0.0068929861299693584
that O 0 0.004696597345173359
there O 0 0.0054518054239451885
was O 0 0.008728943765163422
no O 0 0.007427912671118975
deletion O 0 0.018492311239242554
of O 0 0.013015380129218102
the O 0 0.4882246255874634
PWS B-Disease 1 0.9999991655349731
region O 0 0.021036993712186813
on O 0 0.0104212099686265
the O 0 0.010841721668839455
normal O 0 0.014284276403486729
pair O 0 0.017551302909851074
of O 0 0.01742454618215561
15s O 1 0.998927652835846
present O 0 0.03717740252614021
in O 0 0.032453469932079315
J O 1 0.9997768998146057
. O 0 0.04337621480226517

B O 1 0.9660311937332153
. O 0 0.09990857541561127

Methylation O 0 0.06635333597660065
analysis O 0 0.019919125363230705
at O 0 0.018807996064424515
exon O 0 0.04146089032292366
alpha O 0 0.02591441012918949
of O 0 0.011002124287188053
the O 0 0.013128879480063915
small O 0 0.014962103217840195
nuclear O 0 0.03210386261343956
ribonucleoprotein O 1 0.9972078204154968
- O 1 0.9736565351486206
associated O 0 0.02311239391565323
polypeptide O 1 0.9203349351882935
N O 1 0.604422390460968
( O 0 0.03113306500017643
SNRPN O 1 0.993874728679657
) O 0 0.017641685903072357
gene O 0 0.01395245548337698
showed O 0 0.012421316467225552
a O 0 0.011967591941356659
pattern O 0 0.017901241779327393
characteristic O 0 0.016298172995448112
of O 0 0.011015803553164005
only O 0 0.009362947195768356
the O 0 0.018509140238165855
maternal O 1 0.999632716178894
chromosome O 1 0.772801399230957
15 O 0 0.026586074382066727
in O 0 0.024877816438674927
J O 1 0.997564435005188
. O 0 0.042986318469047546

B O 1 0.934683620929718
. O 0 0.10135671496391296

Maternal B-Disease 1 0.9965597987174988
disomy I-Disease 1 0.9941522479057312
was O 0 0.04132543504238129
confirmed O 0 0.02265494503080845
by O 0 0.017666859552264214
polymerase O 0 0.3477352559566498
chain O 0 0.03025216795504093
reaction O 0 0.018359065055847168
analysis O 0 0.010464719496667385
of O 0 0.013404863886535168
microsatellite O 0 0.07351230829954147
repeats O 0 0.020617075264453888
at O 0 0.012803440913558006
the O 0 0.01680922321975231
gamma O 1 0.780868411064148
- O 1 0.9975810050964355
aminobutyric O 1 0.99592125415802
acid O 0 0.4612520933151245
receptor O 0 0.07239682972431183
beta3 O 1 0.7894952297210693
subunit O 0 0.10006150603294373
( O 0 0.055719222873449326
GABRB3 O 1 0.9905924201011658
) O 0 0.04627333953976631
locus O 0 0.09024609625339508
. O 0 0.046138446778059006

A O 0 0.23132027685642242
niece O 1 0.9997163414955139
( O 1 0.7392476201057434
B O 1 0.996777355670929
. O 0 0.018043503165245056
B O 1 0.7685812711715698
. O 0 0.009057472459971905
) O 0 0.007708737626671791
with O 0 0.005675489082932472
45 O 0 0.010011126287281513
chromosomes O 0 0.010821337811648846
and O 0 0.006951457355171442
the O 0 0.008953740820288658
derivative O 0 0.016788259148597717
3 O 0 0.009276150725781918
but O 0 0.0051609524525702
without O 0 0.006354173179715872
the O 0 0.010556863620877266
der O 1 0.9083069562911987
( O 0 0.013633140362799168
15 O 0 0.012557602487504482
) O 0 0.010735257528722286
demonstrated O 0 0.014700283296406269
a O 0 0.015263479202985764
phenotype O 0 0.06153025105595589
consistent O 0 0.013982743956148624
with O 0 0.00807841308414936
that O 0 0.005945531651377678
reported O 0 0.010885140858590603
for O 0 0.01132881548255682
haploinsufficiency O 1 0.9295436143875122
of O 0 0.06402258574962616
distal O 1 0.9998747110366821
3 O 0 0.2357681691646576
p O 0 0.48785290122032166
. O 0 0.043697793036699295

Uniparental B-Disease 1 0.9999535083770752
disomy I-Disease 1 0.9982274174690247
associated O 0 0.03185262158513069
with O 0 0.018697815015912056
unbalanced O 1 0.8271418809890747
segregation O 1 0.8812957406044006
of O 0 0.1631288230419159
non O 1 0.9995393753051758
- O 1 0.9999942779541016
Robertsonian O 1 0.9999632835388184
translocations O 1 0.9450865387916565
has O 0 0.010933958925306797
been O 0 0.0077470652759075165
reported O 0 0.009181739762425423
previously O 0 0.008585185743868351
but O 0 0.0054412358440458775
has O 0 0.005482450593262911
not O 0 0.004361508414149284
, O 0 0.005739360116422176
to O 0 0.005853611044585705
our O 0 0.008740974590182304
knowledge O 0 0.010129282251000404
, O 0 0.007395546417683363
been O 0 0.006809421349316835
observed O 0 0.008880466222763062
in O 0 0.008097954094409943
a O 0 0.0163416787981987
case O 0 0.024108868092298508
of O 0 0.22822824120521545
PWS B-Disease 1 0.9999971389770508
. O 0 0.07713695615530014

Furthermore O 0 0.05666811019182205
, O 0 0.02048265002667904
our O 0 0.01591157168149948
findings O 0 0.013501781038939953
are O 0 0.006663919892162085
best O 0 0.012918234802782536
interpreted O 0 0.011911256238818169
as O 0 0.013238821178674698
true O 0 0.030399460345506668
gamete O 1 0.9934547543525696
complementation O 1 0.9996966123580933
resulting O 0 0.05569623038172722
in O 0 0.037369005382061005
maternal B-Disease 1 0.9999560117721558
UPD I-Disease 1 0.9999982118606567
15 I-Disease 1 0.5484216213226318
and O 0 0.25225645303726196
PWS B-Disease 1 0.9999619722366333

Schwartz B-Disease 1 0.9958063364028931
- I-Disease 1 0.9999384880065918
Jampel I-Disease 1 0.9999759197235107
syndrome I-Disease 1 0.9999992847442627
type I-Disease 1 0.9137241244316101
2 I-Disease 0 0.033762771636247635
and O 0 0.03486908972263336
Stuve B-Disease 1 0.9999749660491943
- I-Disease 1 0.9999984502792358
Wiedemann I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999998807907104
: O 0 0.04934559762477875
a O 0 0.020247887820005417
case O 0 0.018744217231869698
for O 0 0.016175486147403717
" O 0 0.038291119039058685
lumping O 1 0.7590168118476868
" O 0 0.04309133067727089
. O 0 0.03685452416539192

Recent O 0 0.029805438593029976
studies O 0 0.016536161303520203
demonstrated O 0 0.016624828800559044
the O 0 0.010690676048398018
existence O 0 0.012372720055282116
of O 0 0.01032943930476904
a O 0 0.03434186428785324
genetically O 0 0.01715598627924919
distinct O 0 0.00944651011377573
, O 0 0.008021230809390545
usually O 0 0.006969023030251265
lethal O 0 0.009531961753964424
form O 0 0.006188120227307081
of O 0 0.007692501414567232
the O 0 0.02569846250116825
Schwartz B-Disease 1 0.9999364614486694
- I-Disease 1 0.9999994039535522
Jampel I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 1 0.9996949434280396
SJS B-Disease 1 0.9999994039535522
) O 0 0.018936751410365105
of O 0 0.05061298981308937
myotonia B-Disease 1 0.9999948740005493
and O 1 0.9797849059104919
skeletal B-Disease 1 0.9999994039535522
dysplasia I-Disease 1 0.9999998807907104
, O 0 0.05547347664833069
which O 0 0.012891684658825397
we O 0 0.01525235828012228
called O 1 0.7766048908233643
SJS B-Disease 1 0.9999943971633911
type I-Disease 0 0.1788204461336136
2 I-Disease 0 0.03740554302930832
. O 0 0.03262156993150711

This O 0 0.05841474607586861
disorder O 1 0.9999396800994873
is O 0 0.02443249337375164
reminiscent O 1 0.5465498566627502
of O 0 0.018341708928346634
another O 0 0.20535112917423248
rare O 0 0.19991986453533173
condition O 1 0.620199978351593
, O 0 0.011339764110744
the O 0 0.17392532527446747
Stuve B-Disease 1 0.9999984502792358
- I-Disease 1 0.9999997615814209
Wiedemann I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.9994072914123535
SWS B-Disease 1 0.9999890327453613
) O 0 0.01348572876304388
, O 0 0.00804354902356863
which O 0 0.006514932960271835
comprises O 0 0.01663970947265625
campomelia B-Disease 0 0.42191988229751587
at O 0 0.015097027644515038
birth O 1 0.8697710633277893
with O 1 0.9138916730880737
skeletal B-Disease 1 0.9999995231628418
dysplasia I-Disease 1 1.0
, O 1 0.9989921450614929
contractures B-Disease 1 0.999998927116394
, O 0 0.21625109016895294
and O 0 0.022047024220228195
early B-Disease 0 0.03524459898471832
death I-Disease 1 0.8907611966133118
. O 0 0.04025905206799507

To O 0 0.02574145421385765
test O 0 0.0225648432970047
for O 0 0.012454983778297901
possible O 0 0.01703246682882309
nosologic O 1 0.9617646932601929
identity O 0 0.02203204855322838
between O 0 0.01537574827671051
these O 0 0.014812897890806198
disorders O 1 0.9999815225601196
, O 0 0.01549217477440834
we O 0 0.00750697823241353
reviewed O 0 0.010252456180751324
the O 0 0.007620880845934153
literature O 0 0.007071920204907656
and O 0 0.0058253975585103035
obtained O 0 0.006925979629158974
a O 0 0.008773856796324253
follow O 0 0.011614295653998852
- O 0 0.26218071579933167
up O 0 0.006881994195282459
of O 0 0.006128932815045118
the O 0 0.006620351225137711
only O 0 0.005349382292479277
two O 0 0.0064098709262907505
surviving O 1 0.7298005223274231
patients O 1 0.6407862305641174
, O 0 0.009511508047580719
one O 0 0.011004495434463024
with O 0 0.14605630934238434
SJS B-Disease 1 0.999998927116394
type I-Disease 0 0.18991343677043915
2 I-Disease 0 0.014286861754953861
at O 0 0.009720688685774803
age O 0 0.010605781339108944
10 O 0 0.008426297456026077
years O 0 0.007287435233592987
and O 0 0.007831776514649391
another O 0 0.01294817216694355
with O 0 0.01671764999628067
SWS B-Disease 1 0.9998681545257568
at O 0 0.026103900745511055
age O 0 0.030012348666787148
7 O 0 0.03070802614092827
years O 0 0.026481540873646736
. O 0 0.03451964631676674

Patients O 0 0.32699865102767944
reported O 0 0.023209456354379654
as O 0 0.014920639805495739
having O 0 0.025163793936371803
either O 1 0.7480972409248352
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 0.9348075985908508
SWS B-Disease 1 0.9999514818191528
presented O 0 0.020383650436997414
a O 0 0.012840897776186466
combination O 0 0.013261738233268261
of O 0 0.010306787677109241
a O 0 0.021929878741502762
severe O 1 0.9998506307601929
, O 1 0.9831941723823547
prenatal O 1 0.9999998807907104
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999887943267822
with O 1 0.9999910593032837
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999990463256836
respiratory O 1 1.0
and O 1 0.9994832277297974
feeding O 1 0.9998724460601807
difficulties O 1 0.9997466206550598
, O 0 0.44389018416404724
tendency O 1 0.9506261944770813
to O 0 0.057258326560258865
hyperthermia B-Disease 1 0.9999935626983643
, O 0 0.015551989898085594
and O 0 0.010676780715584755
frequent O 0 0.03943413496017456
death O 1 0.6545926928520203
in O 0 0.011929109692573547
infancy O 1 0.9669974446296692
) O 0 0.009329212829470634
with O 0 0.007951384410262108
a O 0 0.014191245660185814
distinct O 0 0.02392672374844551
campomelic B-Disease 1 0.9999423027038574
- I-Disease 1 0.9999959468841553
metaphyseal I-Disease 1 0.999992847442627
skeletal I-Disease 1 0.9999946355819702
dysplasia I-Disease 1 0.9999977350234985
. O 0 0.12437750399112701

The O 0 0.030900875106453896
similarity O 0 0.023825224488973618
of O 0 0.016573775559663773
the O 0 0.036941319704055786
clinical O 1 0.9926153421401978
and O 0 0.17573736608028412
radiographic O 1 0.9998949766159058
findings O 0 0.03417718783020973
is O 0 0.01058964617550373
so O 0 0.007122204639017582
extensive O 0 0.013423616997897625
that O 0 0.007526949979364872
these O 0 0.009802376851439476
disorders O 1 0.9999163150787354
appear O 0 0.012486358173191547
to O 0 0.009295129217207432
be O 0 0.008153154514729977
a O 0 0.016749689355492592
single O 0 0.032650865614414215
entity O 0 0.05707229673862457
. O 0 0.03833877295255661

The O 0 0.03682691603899002
follow O 0 0.032472364604473114
- O 1 0.7294477224349976
up O 0 0.016776718199253082
observation O 0 0.022103730589151382
of O 0 0.008894914761185646
an O 0 0.007760301697999239
identical O 0 0.008501148782670498
and O 0 0.006314717698842287
unique O 0 0.008426684886217117
pattern O 0 0.07363525778055191
of O 1 0.9539330005645752
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.11651472747325897
the O 0 0.24519549310207367
two O 0 0.013317476026713848
patients O 1 0.9849640727043152
( O 0 0.016701022163033485
one O 0 0.009086676873266697
with O 0 0.20916686952114105
SJS B-Disease 1 0.9999994039535522
type I-Disease 0 0.10310389846563339
2 I-Disease 0 0.011309647932648659
, O 0 0.0078471340239048
one O 0 0.008134144358336926
with O 0 0.011460869573056698
SWS B-Disease 1 0.999600350856781
) O 0 0.01714048907160759
surviving O 0 0.04678218811750412
beyond O 0 0.022579828277230263
infancy O 0 0.44113248586654663
adds O 0 0.021563712507486343
to O 0 0.008581302128732204
the O 0 0.009218407794833183
evidence O 0 0.00942989531904459
in O 0 0.008871610276401043
favor O 0 0.014113115146756172
of O 0 0.020679229870438576
identity O 0 0.03886689990758896
. O 0 0.03362695127725601

The O 0 0.034066393971443176
hypothesis O 0 0.03507848083972931
that O 0 0.017019197344779968
SWS B-Disease 1 0.9998748302459717
and O 1 0.7667869925498962
SJS B-Disease 1 0.9999995231628418
type I-Disease 1 0.5618771314620972
2 I-Disease 0 0.013490989804267883
are O 0 0.005780356004834175
the O 0 0.010911086574196815
same O 0 0.018895747140049934
disorder O 1 0.9999508857727051
should O 0 0.013042917475104332
be O 0 0.009329008869826794
testable O 0 0.0265438761562109
by O 0 0.014008866623044014
molecular O 0 0.020971154794096947
methods O 0 0.018946439027786255
. O 0 0.01854831725358963
. O 0 0.031571418046951294

A O 0 0.06253045052289963
mouse O 0 0.0611693449318409
model O 0 0.035554323345422745
of O 0 0.040932875126600266
severe O 1 0.9999916553497314
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999886751174927
defects O 1 0.9999994039535522
in O 1 0.9976892471313477
hemostasis O 1 0.9999994039535522
and O 1 0.9992836117744446
thrombosis B-Disease 1 0.9999994039535522
. O 1 0.8864119052886963

von B-Disease 1 0.9954684972763062
Willebrand I-Disease 1 0.9999752044677734
factor I-Disease 1 0.9950892329216003
( I-Disease 1 0.9898681640625
vWf I-Disease 1 0.9999682903289795
) I-Disease 1 0.9978981018066406
deficiency I-Disease 1 0.9999998807907104
causes O 1 0.9999949932098389
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9983211159706116
humans O 1 0.9560588002204895
. O 0 0.06906740367412567

We O 0 0.02554970234632492
generated O 0 0.023808542639017105
a O 0 0.023463213816285133
mouse O 0 0.04350188001990318
model O 0 0.02089652605354786
for O 0 0.01260199025273323
this O 0 0.012890453450381756
disease O 1 0.9858424067497253
by O 0 0.01577918417751789
using O 0 0.01723448932170868
gene O 0 0.027730640023946762
targeting O 0 0.04096544533967972
. O 0 0.03624585643410683

vWf B-Disease 1 0.9997358918190002
- I-Disease 1 0.9999667406082153
deficient I-Disease 1 0.9997215867042542
mice O 0 0.06929969042539597
appeared O 0 0.02091723121702671
normal O 0 0.017249274998903275
at O 0 0.01746983453631401
birth O 0 0.4992488920688629
; O 0 0.010317523032426834
they O 0 0.007061226759105921
were O 0 0.010769438929855824
viable O 0 0.02755928970873356
and O 0 0.021743733435869217
fertile O 0 0.3608497381210327
. O 0 0.042447011917829514

Neither O 0 0.1144576221704483
vWf O 1 0.9708824753761292
nor O 0 0.1011657789349556
vWf O 1 0.9890845417976379
propolypeptide O 1 0.9929972290992737
( O 0 0.21937502920627594
von B-Disease 1 0.9990311861038208
Willebrand I-Disease 1 0.9999982118606567
antigen O 1 0.9999725818634033
II O 1 0.9998058676719666
) O 0 0.017120996490120888
were O 0 0.012158778496086597
detectable O 0 0.027898671105504036
in O 0 0.011632713489234447
plasma O 0 0.12099011242389679
, O 0 0.01914040558040142
platelets O 1 0.9960851669311523
, O 0 0.018332280218601227
or O 0 0.0204787515103817
endothelial O 1 0.9952794313430786
cells O 0 0.01592421717941761
of O 0 0.014811720699071884
the O 0 0.02643558755517006
homozygous O 1 0.9289028644561768
mutant O 1 0.987062394618988
mice O 0 0.2199079990386963
. O 0 0.046181388199329376

The O 0 0.05324612185359001
mutant O 1 0.9894389510154724
mice O 1 0.905015230178833
exhibited O 1 0.9611651301383972
defects O 1 0.9995273351669312
in O 0 0.03223225474357605
hemostasis O 1 0.9999854564666748
with O 0 0.05639621987938881
a O 1 0.9692297577857971
highly O 1 0.9988848567008972
prolonged O 1 0.9999955892562866
bleeding O 1 0.9999992847442627
time O 0 0.4451501965522766
and O 1 0.8333171010017395
spontaneous O 1 0.9998557567596436
bleeding O 1 0.9999816417694092
events O 0 0.014878158457577229
in O 0 0.009391787461936474
approximately O 0 0.01288914866745472
10 O 0 0.0145693589001894
% O 0 0.018218621611595154
of O 0 0.0291760116815567
neonates O 1 0.9947831034660339
. O 0 0.04573261737823486

As O 0 0.023748314008116722
in O 0 0.014085767790675163
the O 0 0.018329834565520287
human O 0 0.30549103021621704
disease O 1 0.9999321699142456
, O 0 0.019942011684179306
the O 0 0.23898081481456757
factor O 1 0.9817885756492615
VIII O 1 0.9999892711639404
level O 0 0.02127302810549736
in O 0 0.007549416273832321
these O 0 0.005870678927749395
mice O 0 0.019085116684436798
was O 0 0.010919056832790375
reduced O 0 0.008819100446999073
strongly O 0 0.008126700296998024
as O 0 0.006429689936339855
a O 0 0.007624518126249313
result O 0 0.006386377848684788
of O 0 0.007766961120069027
the O 0 0.01267821155488491
lack O 0 0.04726190119981766
of O 0 0.03853132203221321
protection O 1 0.9894891381263733
provided O 0 0.18985237181186676
by O 0 0.06352946162223816
vWf O 1 0.9949020147323608
. O 0 0.04391138255596161

Defective O 1 0.9998897314071655
thrombosis B-Disease 1 0.9999954700469971
in O 0 0.22220240533351898
mutant O 1 0.9998058676719666
mice O 1 0.9147914052009583
was O 0 0.03631328418850899
also O 0 0.010671301744878292
evident O 0 0.014059117995202541
in O 0 0.006947461981326342
an O 0 0.008913405239582062
in O 0 0.011631825938820839
vivo O 1 0.8873842358589172
model O 0 0.04616222158074379
of O 1 0.7974550724029541
vascular B-Disease 1 0.9999996423721313
injury I-Disease 1 0.9999769926071167
. O 1 0.6045013070106506

In O 0 0.02655528113245964
this O 0 0.016605649143457413
model O 0 0.02114635705947876
, O 0 0.01560688205063343
the O 0 0.01915479451417923
exteriorized O 1 0.9959749579429626
mesentery O 1 0.9983453750610352
was O 0 0.2574463486671448
superfused O 1 0.9976400136947632
with O 0 0.3550143837928772
ferric O 1 0.9999974966049194
chloride O 1 0.9970017075538635
and O 0 0.0158087145537138
the O 0 0.017360258847475052
accumulation O 1 0.7696789503097534
of O 0 0.3251323699951172
fluorescently O 1 0.9999864101409912
labeled O 1 0.999476969242096
platelets O 1 0.9997096657752991
was O 0 0.03642682731151581
observed O 0 0.021907828748226166
by O 0 0.02503388561308384
intravital O 1 0.9710872173309326
microscopy O 0 0.07352478057146072
. O 0 0.043625518679618835

We O 0 0.028562795370817184
conclude O 0 0.028927499428391457
that O 0 0.010621408931910992
these O 0 0.008499883115291595
mice O 0 0.017353128641843796
very O 0 0.011114238761365414
closely O 0 0.018195530399680138
mimic O 1 0.947775661945343
severe O 1 0.9999058246612549
human O 1 0.9999197721481323
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9950333833694458
will O 0 0.03526798635721207
be O 0 0.006723055616021156
very O 0 0.005901158321648836
useful O 0 0.006391929928213358
for O 0 0.005442201159894466
investigating O 0 0.009593700990080833
the O 0 0.008530108258128166
role O 0 0.016039477661252022
of O 0 0.02746153250336647
vWf O 1 0.9974818825721741
in O 0 0.012707862071692944
normal O 0 0.030616987496614456
physiology O 1 0.8851566910743713
and O 0 0.033403608947992325
in O 1 0.5842140316963196
disease O 1 0.9999918937683105
models O 0 0.08119243383407593
. O 0 0.023835835978388786
. O 0 0.03265262767672539

Oral O 1 0.8430343270301819
contraceptives O 1 0.9584572911262512
and O 0 0.020829293876886368
the O 0 0.02725573442876339
risk O 1 0.9936561584472656
of O 1 0.9999181032180786
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9991716146469116

Hereditary B-Disease 1 0.9999985694885254
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Clinical O 1 0.9999858140945435
Study O 1 0.9587172269821167
Group O 1 0.8561238646507263
. O 0 0.048404935747385025

BACKGROUND O 0 0.10714120417833328
Women O 0 0.030061468482017517
with O 0 0.014487722888588905
mutations O 0 0.01530822366476059
in O 0 0.0080714775249362
either O 0 0.008884713985025883
the O 0 0.016448330134153366
BRCA1 O 1 0.999299168586731
or O 0 0.013197422958910465
the O 0 0.08470718562602997
BRCA2 O 1 0.9994232654571533
gene O 0 0.01145084761083126
have O 0 0.005537136923521757
a O 0 0.01115246582776308
high O 0 0.03761067986488342
lifetime O 1 0.9736116528511047
risk O 1 0.9994692206382751
of O 1 0.9999498128890991
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.9566382765769958

Oral O 1 0.7377241253852844
contraceptives O 1 0.991807758808136
protect O 1 0.9901761412620544
against O 1 0.9999655485153198
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.892665684223175
general O 1 0.9816612005233765
, O 0 0.039338234812021255
but O 0 0.005981665104627609
it O 0 0.004457833245396614
is O 0 0.0046965377405285835
not O 0 0.004464472644031048
known O 0 0.006334706209599972
whether O 0 0.004968865774571896
they O 0 0.0042016590014100075
also O 0 0.005706026218831539
protect O 0 0.011815167963504791
against O 0 0.022091876715421677
hereditary B-Disease 1 0.9999899864196777
forms I-Disease 1 0.9984455704689026
of I-Disease 1 0.9999920129776001
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9791289567947388

METHODS O 0 0.035601869225502014
We O 0 0.019404852762818336
enrolled O 0 0.03670412302017212
207 O 0 0.07283078879117966
women O 0 0.05230710655450821
with O 1 0.9593451619148254
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9920084476470947
161 O 1 0.9954726099967957
of O 0 0.06669475138187408
their O 0 0.01332731544971466
sisters O 1 0.9681456089019775
as O 0 0.010398024693131447
controls O 0 0.015379877761006355
in O 0 0.008939999155700207
a O 0 0.01711653545498848
case O 0 0.18542219698429108
- O 1 0.9986456036567688
control O 0 0.044005125761032104
study O 0 0.027238629758358
. O 0 0.031526535749435425

All O 0 0.025145553052425385
the O 0 0.021657884120941162
patients O 0 0.3927936851978302
carried O 0 0.01900087669491768
a O 0 0.021197710186243057
pathogenic O 1 0.5756295323371887
mutation O 0 0.021734585985541344
in O 0 0.009675533510744572
either O 0 0.0163556020706892
BRCA1 O 1 0.9956820011138916
( O 0 0.019742244854569435
179 O 0 0.0816812738776207
women O 0 0.03373488783836365
) O 0 0.018579820170998573
or O 0 0.020515309646725655
BRCA2 O 1 0.9974890947341919
( O 0 0.03286971524357796
28 O 0 0.03685927391052246
women O 0 0.04295394569635391
) O 0 0.03179138898849487
. O 0 0.03466751053929329

The O 0 0.03773575276136398
control O 0 0.034235041588544846
women O 0 0.023342277854681015
were O 0 0.011896862648427486
enrolled O 0 0.038609039038419724
regardless O 0 0.01573825627565384
of O 0 0.011741910129785538
whether O 0 0.010772507637739182
or O 0 0.008616517297923565
not O 0 0.006311391480267048
they O 0 0.006656443700194359
had O 0 0.013955795206129551
either O 0 0.01866164617240429
mutation O 0 0.04029381275177002
. O 0 0.03157690912485123

Lifetime O 0 0.0692400112748146
histories O 0 0.05057710036635399
of O 0 0.08033738285303116
oral O 1 0.9999669790267944
- O 1 0.9999969005584717
contraceptive O 1 0.9999467134475708
use O 0 0.008929114788770676
were O 0 0.00582327414304018
obtained O 0 0.006222456693649292
by O 0 0.006379567552357912
interview O 0 0.011253544129431248
or O 0 0.005587450228631496
by O 0 0.006282113026827574
written O 0 0.009469718672335148
questionnaire O 0 0.014240575022995472
and O 0 0.006290468852967024
were O 0 0.005691290833055973
compared O 0 0.009049899876117706
between O 0 0.01173801627010107
patients O 1 0.9667530655860901
and O 0 0.01573873683810234
control O 0 0.311141699552536
women O 0 0.13976798951625824
, O 0 0.010385119356215
after O 0 0.013597073964774609
adjustment O 0 0.43895959854125977
for O 0 0.008810888044536114
year O 0 0.011315749026834965
of O 0 0.01963694393634796
birth O 1 0.9861029386520386
and O 0 0.04420015960931778
parity O 1 0.9004406929016113
. O 0 0.03635728731751442

RESULTS O 0 0.029533356428146362
The O 0 0.021047227084636688
adjusted O 0 0.03176666423678398
odds O 0 0.06311159580945969
ratio O 1 0.8159413933753967
for O 1 0.9957608580589294
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 0.16084878146648407
with O 0 0.012087224051356316
any O 0 0.008526848629117012
past O 0 0.012990985997021198
use O 0 0.010438217781484127
of O 0 0.018001021817326546
oral O 1 0.990934431552887
contraceptives O 1 0.9996503591537476
was O 0 0.2985067069530487
0 O 0 0.054159149527549744
. O 0 0.037506088614463806

5 O 0 0.04721071198582649
( O 0 0.02960570529103279
95 O 0 0.026013948023319244
percent O 0 0.017594875767827034
confidence O 0 0.029713887721300125
interval O 0 0.026476673781871796
, O 0 0.011963306926190853
0 O 0 0.01485343836247921
. O 0 0.00746315810829401
3 O 0 0.010895033366978168
to O 0 0.00924006849527359
0 O 0 0.01941753178834915
. O 0 0.013392811641097069
8 O 0 0.025073358789086342
) O 0 0.0255107581615448
. O 0 0.02893521450459957

The O 0 0.06321422755718231
risk O 1 0.8049368262290955
decreased O 0 0.06793364137411118
with O 0 0.013075742870569229
increasing O 0 0.016440793871879578
duration O 0 0.02309867925941944
of O 0 0.012437857687473297
use O 0 0.010578635148704052
( O 0 0.024931197986006737
P O 0 0.15941721200942993
for O 0 0.008566301316022873
trend O 0 0.018612394109368324
, O 0 0.013499151915311813
< O 0 0.2413867712020874
0 O 0 0.019310109317302704
. O 0 0.011381285265088081
001 O 1 0.7794198989868164
) O 0 0.010238290764391422
; O 0 0.006457561161369085
use O 0 0.004824160598218441
for O 0 0.004822137299925089
six O 0 0.0063962796702980995
or O 0 0.005707584321498871
more O 0 0.003901697928085923
years O 0 0.007319739554077387
was O 0 0.011779074557125568
associated O 0 0.008098835125565529
with O 0 0.0069931247271597385
a O 0 0.011816378682851791
60 O 0 0.015681643038988113
percent O 0 0.018323026597499847
reduction O 0 0.038744162768125534
in O 0 0.01913750357925892
risk O 0 0.10519727319478989
. O 0 0.03290087729692459

Oral O 1 0.94254469871521
- O 1 0.9978922009468079
contraceptive O 1 0.9956167936325073
use O 0 0.01951448991894722
protected O 1 0.7301526665687561
against O 1 0.9995166063308716
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
both O 0 0.015739068388938904
for O 0 0.011444981209933758
carriers O 0 0.019064806401729584
of O 0 0.011915190145373344
the O 0 0.29472190141677856
BRCA1 O 1 0.9999327659606934
mutation O 1 0.6940874457359314
( O 0 0.017370419576764107
odds O 0 0.0254195686429739
ratio O 0 0.01664659194648266
, O 0 0.008669089525938034
0 O 0 0.012123474851250648
. O 0 0.006446254439651966
5 O 0 0.009481905959546566
; O 0 0.007389965932816267
95 O 0 0.012180344201624393
percent O 0 0.011401766911149025
confidence O 0 0.020179642364382744
interval O 0 0.021190818399190903
, O 0 0.009838729165494442
0 O 0 0.011763487942516804
. O 0 0.005982728209346533
3 O 0 0.007616865914314985
to O 0 0.006677556782960892
0 O 0 0.01177926454693079
. O 0 0.006261161994189024
9 O 0 0.010644000954926014
) O 0 0.006894399411976337
and O 0 0.005101003684103489
for O 0 0.005320682656019926
carriers O 0 0.011371579021215439
of O 0 0.009357388131320477
the O 0 0.05620121583342552
BRCA2 O 1 0.9999302625656128
mutation O 1 0.5146250128746033
( O 0 0.018613481894135475
odds O 0 0.02890472114086151
ratio O 0 0.01796705089509487
, O 0 0.008592965081334114
0 O 0 0.01323299203068018
. O 0 0.006823554169386625
4 O 0 0.01095369178801775
; O 0 0.008943355642259121
95 O 0 0.013067838735878468
percent O 0 0.011869573965668678
confidence O 0 0.02021629363298416
interval O 0 0.022666994482278824
, O 0 0.01135404221713543
0 O 0 0.014585908502340317
. O 0 0.008135221898555756
2 O 0 0.011290324851870537
to O 0 0.00930023193359375
1 O 0 0.015834493562579155
. O 0 0.011860103346407413
1 O 0 0.025527875870466232
) O 0 0.02388010174036026
. O 0 0.02946198731660843

CONCLUSIONS O 0 0.08127548545598984
Oral O 1 0.9963794350624084
- O 1 0.9999620914459229
contraceptive O 1 0.9998862743377686
use O 0 0.012494311667978764
may O 0 0.009288148954510689
reduce O 0 0.012153614312410355
the O 0 0.011984789744019508
risk O 1 0.9519455432891846
of O 1 0.9997735619544983
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.6083095669746399
women O 1 0.8297809362411499
with O 0 0.1635301262140274
pathogenic O 1 0.998374342918396
mutations O 0 0.031206976622343063
in O 0 0.012998087331652641
the O 0 0.2709581255912781
BRCA1 O 1 0.9998756647109985
or O 0 0.32430097460746765
BRCA2 O 1 0.9989614486694336
gene O 0 0.09262780100107193

A O 0 0.04944639652967453
Japanese O 0 0.05184701085090637
family O 0 0.04245932027697563
with O 0 0.027961721643805504
adrenoleukodystrophy B-Disease 1 0.9999908208847046
with O 0 0.021776845678687096
a O 0 0.03162343055009842
codon O 0 0.3646240532398224
291 O 0 0.36519360542297363
deletion O 0 0.18938788771629333
: O 0 0.015429557301104069
a O 0 0.015910424292087555
clinical O 1 0.8461624979972839
, O 0 0.03683920577168465
biochemical O 1 0.7883079648017883
, O 0 0.0713784247636795
pathological O 1 0.9988529682159424
, O 0 0.024626869708299637
and O 0 0.01910095289349556
genetic O 0 0.04859202727675438
report O 0 0.024344567209482193
. O 0 0.02881063148379326

We O 0 0.022993024438619614
report O 0 0.017495011910796165
a O 0 0.0146690858528018
Japanese O 0 0.02285139262676239
family O 0 0.0705898106098175
with O 1 0.9302239418029785
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999748468399048
ALD B-Disease 1 1.0
) O 0 0.016529470682144165
with O 0 0.00832407921552658
a O 0 0.00969943031668663
three O 0 0.008638116531074047
base O 0 0.016425911337137222
pair O 0 0.02218307927250862
deletion O 0 0.07549871504306793
( O 0 0.02654849737882614
delGAG O 1 0.9484608769416809
291 O 0 0.09553173929452896
) O 0 0.016558773815631866
in O 0 0.015611959621310234
the O 0 0.04400835931301117
ALD B-Disease 1 0.9999980926513672
gene O 0 0.19669131934642792
. O 0 0.04695358872413635

A O 0 0.04911404103040695
variety O 0 0.024687327444553375
of O 0 0.0227693859487772
phenotypes O 0 0.1506723016500473
were O 0 0.012602772563695908
observed O 0 0.015393299981951714
within O 0 0.01437824685126543
this O 0 0.015349910594522953
family O 0 0.04300127178430557
. O 0 0.03743259236216545

While O 0 0.029721153900027275
the O 0 0.03155601769685745
proband O 1 0.998846173286438
( O 0 0.20869405567646027
patient O 1 0.9812198281288147
1 O 0 0.024018066003918648
) O 0 0.012396476231515408
was O 0 0.013413229025900364
classified O 0 0.012170377187430859
as O 0 0.006701548583805561
having O 0 0.009248332120478153
a O 0 0.009978660382330418
rare O 0 0.01745089516043663
intermediate O 0 0.37269648909568787
type O 0 0.025078754872083664
of O 0 0.017843924462795258
adult O 1 0.9565685987472534
cerebral O 1 0.9999806880950928
and O 1 0.9754503965377808
cerebello O 1 0.9999994039535522
- O 1 0.9999991655349731
brain O 1 0.9977924823760986
stem O 0 0.05631210282444954
forms O 0 0.009456475265324116
, O 0 0.009170233272016048
his O 0 0.026322433724999428
younger O 1 0.9788441061973572
brother O 1 0.9989839196205139
( O 0 0.30159664154052734
patient O 1 0.9928808212280273
2 O 0 0.015822414308786392
) O 0 0.010194666683673859
and O 0 0.010038238018751144
nephew O 1 0.999408483505249
( O 0 0.17991669476032257
patient O 1 0.9769864678382874
3 O 0 0.016288483515381813
) O 0 0.01098571065813303
had O 0 0.015334293246269226
a O 0 0.1394527703523636
childhood O 1 0.9999898672103882
ALD B-Disease 1 0.9999998807907104
type O 1 0.9996695518493652
. O 0 0.06701179593801498

Another O 0 0.07954148948192596
nephew O 1 0.9986507296562195
( O 0 0.20858435332775116
patient O 1 0.9667428135871887
4 O 0 0.023279529064893723
) O 0 0.012474728748202324
of O 0 0.013046669773757458
patient O 1 0.978816568851471
1 O 0 0.019379479810595512
was O 0 0.019127080217003822
classified O 0 0.015117869712412357
as O 0 0.01015977468341589
having O 0 0.016400231048464775
an O 0 0.0229708943516016
adolescent O 1 0.9996894598007202
form O 0 0.10781241208314896
. O 0 0.04362187907099724

The O 0 0.040360838174819946
tau O 0 0.1427091509103775
level O 0 0.023297615349292755
in O 0 0.015277775004506111
the O 0 0.035529013723134995
cerebrospinal O 1 0.9999948740005493
fluid O 1 0.9999570846557617
( O 1 0.994860053062439
CSF O 1 0.9999819993972778
) O 0 0.015134282410144806
in O 0 0.008958285674452782
patient O 1 0.7468457818031311
1 O 0 0.012538802810013294
was O 0 0.010824236087501049
as O 0 0.006407526321709156
high O 0 0.008533834479749203
as O 0 0.005427272524684668
that O 0 0.00494431983679533
of O 0 0.013539006002247334
patients O 1 0.9998679161071777
with O 1 0.9998868703842163
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997941851615906
AD B-Disease 1 0.9983012676239014
) O 0 0.03502790629863739
. O 0 0.0312904454767704

His O 0 0.09392841905355453
brain O 1 0.9552321434020996
magnetic O 0 0.04885215312242508
resonance O 1 0.5892307758331299
image O 1 0.9029768705368042
( O 0 0.37469345331192017
MRI O 1 0.9834186434745789
) O 0 0.013644366525113583
showed O 0 0.013703055679798126
abnormalities B-Disease 0 0.03516901656985283
in I-Disease 0 0.008042377419769764
the I-Disease 0 0.014813301153481007
bilateral I-Disease 1 0.995512068271637
cerebellar I-Disease 1 0.999998927116394
hemispheres I-Disease 1 0.9993366599082947
and O 1 0.9385493993759155
brain O 1 0.9997082352638245
stem O 1 0.6037183403968811
, O 0 0.009630268439650536
but O 0 0.0061962539330124855
not O 0 0.005176718812435865
in O 0 0.006986760068684816
the O 0 0.035171955823898315
cerebral O 1 0.9999632835388184
white O 1 0.9505322575569153
matter O 0 0.013243095017969608
, O 0 0.009501800872385502
where O 0 0.008638761006295681
marked O 0 0.013579972088336945
reductions O 0 0.016206420958042145
of O 0 0.014142550528049469
the O 1 0.9370021224021912
cerebral O 1 0.9999984502792358
blood O 1 0.9998377561569214
flow O 1 0.5874062180519104
and O 0 0.1269470453262329
oxygen O 1 0.953010618686676
metabolism O 0 0.13586154580116272
were O 0 0.009186668321490288
clearly O 0 0.013141488656401634
demonstrated O 0 0.015964850783348083
by O 0 0.01568303443491459
positron O 1 0.8779960870742798
emission O 0 0.2969036102294922
tomography O 1 0.7974007725715637
( O 0 0.0606909841299057
PET O 1 0.7668079733848572
) O 0 0.03581617400050163
. O 0 0.03472054377198219

In O 0 0.03738453611731529
patients O 0 0.4638345539569855
2 O 0 0.021898433566093445
and O 0 0.011733110062777996
3 O 0 0.014707149937748909
, O 0 0.009344304911792278
the O 0 0.009316651150584221
autopsy O 0 0.06208489090204239
findings O 0 0.013410980813205242
showed O 0 0.017348622903227806
massive O 1 0.9500238299369812
demyelination B-Disease 1 0.9999948740005493
of I-Disease 1 0.8958437442779541
the I-Disease 1 0.9965683221817017
cerebral I-Disease 1 0.999997615814209
white I-Disease 1 0.9855519533157349
matter I-Disease 0 0.012800909578800201
with O 0 0.008096452802419662
sparing O 0 0.09631486237049103
of O 0 0.018328411504626274
the O 1 0.9763201475143433
U O 1 0.9999990463256836
- O 1 0.9999912977218628
fibers O 1 0.8994718790054321
, O 0 0.011457557789981365
compatible O 0 0.016934111714363098
with O 0 0.00902814231812954
the O 0 0.01358482614159584
findings O 0 0.0207392405718565
of O 0 0.11241865158081055
childhood O 1 0.9999868869781494
ALD B-Disease 1 0.9999997615814209
. O 1 0.5919598937034607

Oleic O 1 0.9531979560852051
and O 0 0.056143056601285934
erucic O 1 0.999228835105896
acids O 0 0.049029793590307236
( O 0 0.03687625005841255
Lorenzos O 1 0.9109358787536621
Oil O 0 0.020015129819512367
) O 0 0.01046370342373848
were O 0 0.007407830562442541
administered O 0 0.019811108708381653
to O 0 0.010561221279203892
patients O 1 0.7288848757743835
1 O 0 0.013968575745821
and O 0 0.009179232642054558
4 O 0 0.012573670595884323
, O 0 0.009296770207583904
but O 0 0.0072235651314258575
sufficient O 0 0.014296536333858967
effectiveness O 0 0.026255208998918533
was O 0 0.02052474580705166
not O 0 0.013678129762411118
obtained O 0 0.02302534319460392
. O 0 0.02967117540538311

The O 0 0.028584878891706467
findings O 0 0.019767392426729202
in O 0 0.010404082015156746
this O 0 0.008635959587991238
family O 0 0.015929104760289192
suggest O 0 0.010386976413428783
that O 0 0.007196703460067511
delGAG291 O 1 0.7586266398429871
is O 0 0.008451947011053562
part O 0 0.009223434142768383
of O 0 0.00939152017235756
the O 0 0.014796197414398193
cause O 1 0.5702335834503174
of O 0 0.2800937592983246
Japanese O 1 0.9984912872314453
ALD B-Disease 1 0.9999997615814209
with O 0 0.0532827153801918
phenotypic O 0 0.13325448334217072
variations O 0 0.04241302236914635
. O 0 0.03951267525553703

Moreover O 0 0.04640752822160721
, O 0 0.0177841205149889
although O 0 0.009525527246296406
the O 0 0.01066657155752182
scale O 0 0.012423843145370483
of O 0 0.009399078786373138
the O 0 0.01183263584971428
study O 0 0.010633019730448723
is O 0 0.008054040372371674
limited O 0 0.007782584056258202
, O 0 0.005862663500010967
there O 0 0.0052413842640817165
is O 0 0.005708846263587475
a O 0 0.007514299359172583
possibility O 0 0.011913202702999115
that O 0 0.007736193016171455
PET O 1 0.8105234503746033
can O 0 0.009928137995302677
detect O 0 0.02414996176958084
an O 0 0.022654535248875618
insidious B-Disease 1 0.9999531507492065
lesion I-Disease 1 0.9998562335968018
which O 0 0.011692700907588005
is O 0 0.011653385125100613
undetectable O 1 0.6198025345802307
by O 0 0.012444634921848774
computed O 0 0.024668866768479347
tomogram O 1 0.9969346523284912
( O 0 0.4272262156009674
CT O 1 0.9995124340057373
) O 0 0.017725976184010506
or O 0 0.013113209046423435
MRI O 0 0.27554556727409363
analysis O 0 0.008203034289181232
, O 0 0.006880593486130238
and O 0 0.005356414709240198
that O 0 0.004347505513578653
the O 0 0.006380855571478605
higher O 0 0.007323794066905975
level O 0 0.010047481395304203
of O 0 0.011216909624636173
tau O 1 0.8586148023605347
reflects O 0 0.01934788003563881
the O 0 0.011972175911068916
process O 0 0.014523984864354134
of O 0 0.14616426825523376
neuronal B-Disease 1 0.9996918439865112
degeneration I-Disease 1 0.9999996423721313
in O 1 0.9875965118408203
ALD B-Disease 1 0.9999995231628418
. O 0 0.2109108865261078

Lorenzos O 1 0.9710065126419067
Oil O 0 0.04299844801425934
should O 0 0.014653936959803104
be O 0 0.008726963773369789
given O 0 0.009316404350101948
in O 0 0.008470837026834488
the O 0 0.013841486535966396
early O 0 0.02343834936618805
stage O 0 0.19164198637008667
. O 0 0.024143552407622337
. O 0 0.03272353485226631

Nonsense O 0 0.1609845906496048
mutation O 0 0.04137110337615013
in O 0 0.01619541086256504
exon O 0 0.04057416319847107
4 O 0 0.017686283215880394
of O 0 0.01297295093536377
human O 0 0.01997106522321701
complement O 1 0.9587373733520508
C9 O 1 0.999984622001648
gene O 0 0.02103690803050995
is O 0 0.010643960908055305
the O 0 0.011004043743014336
major O 0 0.019711123779416084
cause O 0 0.20114724338054657
of O 0 0.10261139273643494
Japanese O 1 0.9977635145187378
complement B-Disease 1 0.9999079704284668
C9 I-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999984502792358
. O 0 0.11084526032209396

Deficiency B-Disease 1 0.9999454021453857
of I-Disease 0 0.03164609521627426
the I-Disease 0 0.05316624045372009
ninth I-Disease 1 0.9994540810585022
component I-Disease 1 0.8430703282356262
of I-Disease 0 0.024866992607712746
human I-Disease 1 0.631976306438446
complement I-Disease 1 0.9981979727745056
( O 1 0.9722856283187866
C9 O 1 0.9999667406082153
) O 0 0.012097164988517761
is O 0 0.007043993100523949
the O 0 0.007909206673502922
most O 0 0.008427808992564678
common O 1 0.8649739027023315
complement B-Disease 1 0.9999886751174927
deficiency I-Disease 1 1.0
in O 0 0.07909715920686722
Japan O 0 0.4845990836620331
but O 0 0.010349814780056477
is O 0 0.00975860096514225
rare O 0 0.013517090119421482
in O 0 0.01003280933946371
other O 0 0.009563214145600796
countries O 0 0.015320475213229656
. O 0 0.028597697615623474

We O 0 0.026675859466195107
studied O 0 0.022555798292160034
the O 0 0.015009014867246151
molecular O 0 0.014540320262312889
basis O 0 0.01332089863717556
of O 0 0.05913390964269638
C9 B-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.999992847442627
in O 0 0.014862707816064358
four O 0 0.017930522561073303
Japanese O 1 0.9916781187057495
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
deficient I-Disease 1 0.9999936819076538
patients O 1 0.9987723231315613
who O 0 0.2408822476863861
had O 1 0.5335310697555542
suffered O 1 0.999993085861206
from O 1 0.9997275471687317
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9822137355804443

Direct O 0 0.04758841171860695
sequencing O 0 0.04381505027413368
of O 0 0.03477209433913231
amplified O 0 0.33328381180763245
C9 O 1 0.9990353584289551
cDNA O 0 0.07291479408740997
and O 0 0.020028190687298775
DNA O 0 0.020522644743323326
revealed O 0 0.02049735188484192
a O 0 0.017895013093948364
nonsense O 0 0.04110465198755264
substitution O 0 0.03035832941532135
( O 0 0.02550201117992401
CGA O 1 0.8995194435119629
- O 1 0.9995802044868469
- O 1 0.9998250603675842
> O 1 0.9930471777915955
TGA O 1 0.9969038367271423
) O 0 0.013724378310143948
at O 0 0.012759764678776264
codon O 0 0.02551301009953022
95 O 0 0.015753448009490967
in O 0 0.009189269505441189
exon O 0 0.02471286430954933
4 O 0 0.011487046256661415
in O 0 0.007440375164151192
the O 0 0.011765495873987675
four O 0 0.03081406094133854
C9 B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999904632568359
deficient I-Disease 1 0.9994351267814636
individuals O 0 0.03815548121929169
. O 0 0.03888032212853432

An O 0 0.04117559641599655
allele O 0 0.46926814317703247
- O 1 0.9472857117652893
specific O 0 0.01800655946135521
polymerase O 0 0.39706170558929443
chain O 0 0.3091632127761841
reaction O 0 0.032459042966365814
system O 0 0.016967426985502243
designed O 0 0.01736091636121273
to O 0 0.009779524989426136
detect O 0 0.015053167007863522
exclusively O 0 0.009251582436263561
only O 0 0.005254433024674654
one O 0 0.005792005453258753
of O 0 0.006267048418521881
the O 0 0.009280039928853512
normal O 0 0.013318235985934734
and O 0 0.012315748259425163
mutant O 1 0.8853211998939514
alleles O 0 0.022894905880093575
indicated O 0 0.009111384861171246
that O 0 0.004000299144536257
all O 0 0.004549591802060604
the O 0 0.006860869005322456
four O 0 0.008278192020952702
patients O 0 0.05436292663216591
were O 0 0.00676143541932106
homozygous O 0 0.014881052076816559
for O 0 0.00712981540709734
the O 0 0.010883724316954613
mutation O 0 0.01760454662144184
in O 0 0.00839316751807928
exon O 0 0.07857689261436462
4 O 0 0.011136060580611229
and O 0 0.00644270982593298
that O 0 0.005215912591665983
the O 0 0.007637574337422848
parents O 0 0.014158607460558414
of O 0 0.016032405197620392
patient O 1 0.9968959093093872
2 O 0 0.027629010379314423
were O 0 0.021600594744086266
heterozygous O 0 0.05080311372876167
. O 0 0.03426876664161682

The O 0 0.042616330087184906
common O 0 0.034697700291872025
mutation O 0 0.03327658027410507
at O 0 0.01971847005188465
codon O 0 0.038123611360788345
95 O 0 0.022076686844229698
in O 0 0.014319277368485928
exon O 0 0.0402507409453392
4 O 0 0.018119173124432564
might O 0 0.010833808220922947
be O 0 0.006716604810208082
responsible O 0 0.01232528779655695
for O 0 0.010305396281182766
most O 0 0.017299769446253777
Japanese O 1 0.9958101511001587
C9 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999997615814209
. O 0 0.0774867832660675
. O 0 0.04720854386687279

BRCA1 O 1 0.7477262616157532
required O 0 0.027418965473771095
for O 0 0.024422919377684593
transcription O 1 0.9203020930290222
- O 1 0.9996386766433716
coupled O 1 0.9490299820899963
repair O 1 0.9977877140045166
of O 0 0.36043110489845276
oxidative O 1 0.9994694590568542
DNA O 0 0.2680053412914276
damage O 1 0.5167277455329895
. O 0 0.046570248901844025

The O 0 0.13112089037895203
breast B-Disease 1 0.9999939203262329
and I-Disease 1 0.9996370077133179
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999997615814209
gene O 1 0.9997507929801941
BRCA1 O 1 0.9999686479568481
encodes O 0 0.4072660207748413
a O 0 0.24280673265457153
zinc O 1 0.9997982382774353
finger O 1 0.9749061465263367
protein O 0 0.021681442856788635
of O 0 0.02041991986334324
unknown O 0 0.031888630241155624
function O 0 0.029919017106294632
. O 0 0.03153282776474953

Association O 0 0.042134836316108704
of O 0 0.022989416494965553
the O 0 0.030333157628774643
BRCA1 O 1 0.9944684505462646
protein O 0 0.013809527270495892
with O 0 0.009710218757390976
the O 0 0.014066088013350964
DNA O 0 0.04850579425692558
repair O 1 0.998072624206543
protein O 0 0.021266818046569824
Rad51 O 1 0.8771315217018127
and O 0 0.008493269793689251
changes O 0 0.006762704346328974
in O 0 0.005812641698867083
the O 0 0.008884159848093987
phosphorylation O 0 0.01593395695090294
and O 0 0.008892040699720383
cellular O 0 0.014129306189715862
localization O 0 0.017888883128762245
of O 0 0.00867507979273796
the O 0 0.010029464960098267
protein O 0 0.009868993423879147
after O 0 0.009820795617997646
exposure O 0 0.016421036794781685
to O 0 0.009168804623186588
DNA O 0 0.0510769858956337
- O 1 0.9974082112312317
damaging O 0 0.2797306180000305
agents O 0 0.011607997119426727
are O 0 0.004811238497495651
consistent O 0 0.009096152149140835
with O 0 0.00686084246262908
a O 0 0.011144381947815418
role O 0 0.020268794149160385
for O 0 0.01826675422489643
BRCA1 O 1 0.9977154731750488
in O 0 0.021724337711930275
DNA O 0 0.05671313405036926
repair O 1 0.8728123903274536
. O 0 0.04344455152750015

Here O 0 0.027764197438955307
, O 0 0.014506258070468903
it O 0 0.008264876902103424
is O 0 0.007996107451617718
shown O 0 0.008317367173731327
that O 0 0.0065842182375490665
mouse O 0 0.026527702808380127
embryonic O 0 0.05916175618767738
stem O 0 0.14161980152130127
cells O 0 0.07806889712810516
deficient B-Disease 1 0.9855519533157349
in I-Disease 0 0.019610170274972916
BRCA1 I-Disease 1 0.9990434050559998
are O 0 0.009984918870031834
defective O 0 0.49494507908821106
in O 0 0.008612885139882565
the O 0 0.010420777834951878
ability O 0 0.009306675754487514
to O 0 0.0073373327031731606
carry O 0 0.009538662619888783
out O 0 0.011416186578571796
transcription O 0 0.058365173637866974
- O 1 0.9971957206726074
coupled O 1 0.6575855612754822
repair O 1 0.9490435123443604
of O 0 0.12469590455293655
oxidative O 1 0.9998223185539246
DNA O 1 0.5393845438957214
damage O 1 0.6060214042663574
, O 0 0.011951003223657608
and O 0 0.010625968687236309
are O 0 0.009375423192977905
hypersensitive O 1 0.9974894523620605
to O 0 0.023910511285066605
ionizing O 1 0.9987404942512512
radiation O 1 0.9817373752593994
and O 0 0.03870926797389984
hydrogen O 0 0.2914513647556305
peroxide O 1 0.6755004525184631
. O 0 0.03804275393486023

These O 0 0.018768973648548126
results O 0 0.015093320049345493
suggest O 0 0.01708141900599003
that O 0 0.013321975246071815
BRCA1 O 1 0.9976797699928284
participates O 0 0.08435644954442978
, O 0 0.011844963766634464
directly O 0 0.00989769957959652
or O 0 0.008374245837330818
indirectly O 0 0.011888689361512661
, O 0 0.00783365499228239
in O 0 0.009268626570701599
transcription O 0 0.2901687026023865
- O 1 0.9983820915222168
coupled O 1 0.5465822815895081
repair O 1 0.9734992384910583
of O 0 0.381710410118103
oxidative O 1 0.9998362064361572
DNA O 0 0.30803388357162476
damage O 0 0.3895915150642395
. O 0 0.02279621921479702
. O 0 0.033832017332315445

Truncation O 1 0.7140430808067322
mutations O 0 0.0431615449488163
in O 0 0.01873753033578396
the O 0 0.023376332595944405
transactivation O 1 0.9692803621292114
region O 0 0.03203659877181053
of O 0 0.05552659556269646
PAX6 O 1 0.9999724626541138
result O 0 0.028516385704278946
in O 0 0.022817155346274376
dominant O 1 0.9962090253829956
- O 1 0.9997257590293884
negative O 0 0.07107570767402649
mutants O 1 0.5715430974960327
. O 0 0.04174641892313957

PAX6 O 1 0.999402642250061
is O 0 0.028255529701709747
a O 0 0.023538939654827118
transcription O 0 0.026701906695961952
factor O 0 0.014391401782631874
with O 0 0.007493425626307726
two O 0 0.007944916374981403
DNA O 0 0.019468441605567932
- O 1 0.9665946364402771
binding O 0 0.016736580058932304
domains O 0 0.02083471231162548
( O 0 0.015950849279761314
paired O 0 0.027189776301383972
box O 0 0.027392392978072166
and O 0 0.014623802155256271
homeobox O 1 0.8934922218322754
) O 0 0.01111218985170126
and O 0 0.0085111353546381
a O 0 0.016298111528158188
proline O 1 0.9680221676826477
- O 1 0.998379111289978
serine O 1 0.9957642555236816
- O 1 0.9986090064048767
threonine O 1 0.9525548815727234
( O 0 0.056353505700826645
PST O 1 0.9974583983421326
) O 0 0.029800407588481903
- O 1 0.8411369323730469
rich O 0 0.04755965247750282
transactivation O 1 0.9356576800346375
domain O 0 0.059134453535079956
. O 0 0.04383295401930809

PAX6 O 1 0.9999202489852905
regulates O 1 0.9818758368492126
eye O 1 0.9906541705131531
development O 0 0.03381922468543053
in O 0 0.01728946343064308
animals O 0 0.01605120487511158
ranging O 0 0.020928410813212395
from O 0 0.017469383776187897
jellyfish O 0 0.06501418352127075
to O 0 0.018979094922542572
Drosophila O 0 0.04145664721727371
to O 0 0.022345643490552902
humans O 0 0.02902296744287014
. O 0 0.035188425332307816

Heterozygous O 0 0.08091164380311966
mutations O 0 0.033709097653627396
in O 0 0.014620518311858177
the O 0 0.018368544057011604
human O 0 0.1611981987953186
PAX6 O 1 0.9999833106994629
gene O 0 0.021651677787303925
result O 0 0.010475671850144863
in O 0 0.007884415797889233
various O 0 0.009794313460588455
phenotypes O 0 0.039562251418828964
, O 0 0.01260576955974102
including O 0 0.01542400848120451
aniridia B-Disease 1 0.9998263716697693
, O 0 0.053265951573848724
Peters B-Disease 1 0.9998348951339722
anomaly I-Disease 1 0.9998247027397156
, O 1 0.567518949508667
autosomal B-Disease 1 0.9999551773071289
dominant I-Disease 1 0.9999548196792603
keratitis I-Disease 1 0.9999997615814209
, O 1 0.9863541722297668
and O 1 0.9971879124641418
familial B-Disease 1 0.9999998807907104
foveal I-Disease 1 0.9999995231628418
dysplasia I-Disease 1 0.9999998807907104
. O 1 0.9266504645347595

It O 0 0.020939595997333527
is O 0 0.015298673883080482
believed O 0 0.013671904802322388
that O 0 0.007081391755491495
the O 0 0.012769930996000767
mutated O 0 0.031173786148428917
allele O 0 0.028634166345000267
of O 0 0.01976466178894043
PAX6 O 1 0.9998165965080261
produces O 0 0.02260424941778183
an O 0 0.015342187136411667
inactive O 1 0.9729117751121521
protein O 0 0.017268700525164604
and O 0 0.015399646945297718
aniridia B-Disease 1 0.9999021291732788
is O 0 0.01842481642961502
caused O 0 0.07616213709115982
due O 0 0.022793106734752655
to O 0 0.02492396906018257
genetic O 0 0.1820400208234787
haploinsufficiency O 1 0.9966837763786316
. O 0 0.041697997599840164

However O 0 0.02606409229338169
, O 0 0.017228588461875916
several O 0 0.014328326098620892
truncation O 1 0.927358865737915
mutations O 0 0.021298028528690338
have O 0 0.006450076587498188
been O 0 0.006557626184076071
found O 0 0.004994847346097231
to O 0 0.004665226675570011
occur O 0 0.00491389911621809
in O 0 0.005405581556260586
the O 0 0.011241602711379528
C O 1 0.9946271777153015
- O 1 0.9958670139312744
terminal O 0 0.04621613025665283
half O 0 0.010978029109537601
of O 0 0.015670252963900566
PAX6 O 1 0.9999635219573975
in O 0 0.016368962824344635
patients O 1 0.970109224319458
with O 0 0.026150086894631386
Aniridia B-Disease 1 0.9999212026596069
resulting O 0 0.0373646579682827
in O 0 0.01195940189063549
mutant O 0 0.4379143714904785
proteins O 0 0.009260948747396469
that O 0 0.004378306679427624
retain O 0 0.01080921571701765
the O 0 0.00984970759600401
DNA O 0 0.022850198671221733
- O 1 0.9743409752845764
binding O 0 0.013625320978462696
domains O 0 0.012535342946648598
but O 0 0.005616714246571064
have O 0 0.00453159911558032
lost O 0 0.010765010491013527
most O 0 0.007380475755780935
of O 0 0.012554540298879147
the O 0 0.043625716120004654
transactivation O 1 0.9994882345199585
domain O 0 0.06317596137523651
. O 0 0.036683324724435806

It O 0 0.02154413051903248
is O 0 0.01476688776165247
not O 0 0.008049044758081436
clear O 0 0.010406379587948322
whether O 0 0.00895614456385374
such O 0 0.007952412590384483
mutants O 0 0.32682308554649353
really O 0 0.01606651023030281
behave O 0 0.013256131671369076
as O 0 0.008665869943797588
loss O 0 0.06710377335548401
- O 1 0.9976282715797424
of O 0 0.16398927569389343
- O 1 0.9998881816864014
function O 0 0.022139959037303925
mutants O 0 0.0553349032998085
as O 0 0.014847055077552795
predicted O 0 0.022390803322196007
by O 0 0.022902198135852814
haploinsufficiency O 1 0.867040753364563
. O 0 0.04092773050069809

Contrary O 0 0.04367498680949211
to O 0 0.015670200809836388
this O 0 0.00997188314795494
theory O 0 0.012352906167507172
, O 0 0.008385741151869297
our O 0 0.009260131046175957
data O 0 0.006382705643773079
showed O 0 0.0075659300200641155
that O 0 0.004131648223847151
these O 0 0.005257776007056236
mutants O 0 0.023526446893811226
are O 0 0.006655292585492134
dominant O 0 0.1050671711564064
- O 1 0.9490926861763
negative O 0 0.01776277646422386
in O 0 0.014351855032145977
transient O 1 0.9916713237762451
transfection O 1 0.996677041053772
assays O 0 0.022057194262742996
when O 0 0.009961828589439392
they O 0 0.005581975914537907
are O 0 0.0057584987953305244
coexpressed O 0 0.04252595454454422
with O 0 0.01568365842103958
wild O 0 0.28193506598472595
- O 1 0.9997633099555969
type O 1 0.9708589911460876
PAX6 O 1 0.9997521042823792
. O 0 0.05282606929540634

We O 0 0.018445337191224098
found O 0 0.010507369413971901
that O 0 0.006544012110680342
the O 0 0.011586255393922329
dominant O 1 0.9684273600578308
- O 1 0.9995396137237549
negative O 0 0.025674866512417793
effects O 0 0.017526013776659966
result O 0 0.0079362066462636
from O 0 0.007906356826424599
the O 0 0.011410440318286419
enhanced O 0 0.050505753606557846
DNA O 0 0.014186803251504898
binding O 0 0.012420227751135826
ability O 0 0.01142304390668869
of O 0 0.013492842204868793
these O 0 0.015521910972893238
mutants O 0 0.2566899359226227
. O 0 0.039860811084508896

Kinetic O 0 0.06661320477724075
studies O 0 0.02211017534136772
of O 0 0.01970810629427433
binding O 0 0.024195831269025803
and O 0 0.016927078366279602
dissociation O 0 0.22994711995124817
revealed O 0 0.01653929613530636
that O 0 0.0077250441536307335
various O 0 0.008696408942341805
truncation O 0 0.07141212373971939
mutants O 0 0.03788585960865021
have O 0 0.008441486395895481
3 O 0 0.017520273104310036
- O 1 0.8472627401351929
5 O 0 0.018136994913220406
- O 1 0.5754377841949463
fold O 0 0.020403815433382988
higher O 0 0.010457311756908894
affinity O 0 0.01196326781064272
to O 0 0.007037859410047531
various O 0 0.007475382182747126
DNA O 0 0.014739383943378925
- O 0 0.26804009079933167
binding O 0 0.010611020028591156
sites O 0 0.008214105851948261
when O 0 0.006631433963775635
compared O 0 0.006811665371060371
with O 0 0.0070050484500825405
the O 0 0.013974685221910477
wild O 0 0.3130655884742737
- O 1 0.99983811378479
type O 1 0.9886648654937744
PAX6 O 1 0.9998797178268433
. O 0 0.04994222894310951

These O 0 0.022643310949206352
results O 0 0.015425629913806915
provide O 0 0.014346236363053322
a O 0 0.013286284171044827
new O 0 0.01365269348025322
insight O 0 0.019653063267469406
into O 0 0.008753564208745956
the O 0 0.009695240296423435
role O 0 0.01608549989759922
of O 0 0.04101935029029846
mutant O 1 0.9996987581253052
PAX6 O 1 0.999993085861206
in O 0 0.08989129960536957
causing O 1 0.9909638166427612
aniridia B-Disease 1 0.9998226761817932
. O 0 0.0366237610578537
. O 0 0.04193033277988434

Reversal O 1 0.8289403915405273
of O 1 0.9929384589195251
severe O 1 0.9999998807907104
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9997617602348328
excellent O 1 0.999794065952301
neuropsychologic O 1 0.9999699592590332
outcome O 0 0.02001660130918026
in O 0 0.010167873464524746
very B-Disease 0 0.012169459834694862
- I-Disease 1 0.9770213961601257
long I-Disease 0 0.05963842198252678
- I-Disease 1 0.9990456700325012
chain I-Disease 1 0.9558125138282776
acyl I-Disease 1 0.9998216032981873
- I-Disease 1 0.9999691247940063
coenzyme I-Disease 1 0.9998249411582947
A I-Disease 1 0.9996672868728638
dehydrogenase I-Disease 1 0.9999876022338867
deficiency I-Disease 1 0.9999966621398926
. O 0 0.07720047980546951

Very B-Disease 0 0.042657263576984406
- I-Disease 1 0.8595015406608582
long I-Disease 0 0.05832967534661293
- I-Disease 1 0.9979409575462341
chain I-Disease 1 0.8768035769462585
acyl I-Disease 1 0.9996094107627869
- I-Disease 1 0.9997724890708923
coenzyme I-Disease 1 0.9931138157844543
A I-Disease 1 0.9667420387268066
dehydrogenase I-Disease 1 0.9997599720954895
( I-Disease 1 0.6269798278808594
VLCAD I-Disease 1 0.9999791383743286
) I-Disease 1 0.7030935883522034
deficiency I-Disease 1 0.9999953508377075
is O 0 0.0189936775714159
a O 1 0.6482623815536499
disorder O 1 0.999998927116394
of O 1 0.9996939897537231
fatty O 1 0.9999982118606567
acid O 1 0.9999178647994995
beta O 1 0.9899342656135559
oxidation O 0 0.44692057371139526
that O 0 0.008861273527145386
reportedly O 0 0.01969335786998272
has O 0 0.010023488663136959
high O 0 0.0184378232806921
rates O 0 0.019210441038012505
of O 0 0.03951328620314598
morbidity O 1 0.9999730587005615
and O 0 0.47890952229499817
mortality O 1 0.9988313317298889
. O 0 0.05771113559603691

We O 0 0.026717765256762505
describe O 0 0.02109925076365471
the O 0 0.012594053521752357
outcome O 0 0.01087655033916235
of O 0 0.009301858022809029
a O 0 0.012048782780766487
5 O 0 0.016784420236945152
- O 1 0.850624680519104
year O 0 0.013189787976443768
- O 1 0.9524438381195068
old O 1 0.601498544216156
girl O 1 0.999047577381134
with O 1 0.9809515476226807
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.8434217572212219
was O 0 0.22975121438503265
first O 0 0.010917387902736664
seen O 0 0.009582343511283398
at O 0 0.008423477411270142
5 O 0 0.008196557871997356
months O 0 0.0072150700725615025
of O 0 0.008644855581223965
age O 0 0.08433085680007935
with O 1 0.9164695739746094
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999998807907104
hepatomegaly B-Disease 1 1.0
, O 1 0.9999966621398926
encephalopathy B-Disease 1 1.0
, O 1 0.9945479035377502
and O 1 0.9790236949920654
hypotonia B-Disease 1 0.9999723434448242
. O 0 0.08246280252933502

Biochemical O 0 0.11272270977497101
studies O 0 0.05103922635316849
indicated O 1 0.9778318405151367
VLCAD B-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
caused O 1 0.9987547397613525
by O 0 0.19043591618537903
a O 1 0.9167550802230835
stable O 1 0.9993255138397217
yet O 0 0.36266541481018066
inactive O 1 0.9975907802581787
enzyme O 0 0.2010756880044937
. O 0 0.03918146342039108

Molecular O 0 0.05128125473856926
genetic O 0 0.024959677830338478
analysis O 0 0.01385223213583231
of O 0 0.015301432460546494
her O 0 0.14124657213687897
VLCAD O 1 0.9997501969337463
gene O 0 0.023670872673392296
revealed O 0 0.020171597599983215
a O 0 0.02155749313533306
T1372C O 1 0.989747166633606
( O 0 0.0429903008043766
F458L O 1 0.9514986276626587
) O 0 0.022696301341056824
missense O 0 0.053759921342134476
mutation O 0 0.025990596041083336
and O 0 0.015495563857257366
a O 0 0.03255549073219299
1668 O 1 0.9995524287223816
ACAG O 1 0.9999117851257324
1669 O 1 0.9995655417442322
splice O 1 0.9045496582984924
site O 0 0.06136900186538696
mutation O 0 0.06369681656360626
. O 0 0.040358297526836395

After O 0 0.04456959664821625
initial O 0 0.04981796443462372
treatment O 1 0.993841290473938
with O 0 0.3302448093891144
intravenous O 1 0.999996542930603
glucose O 1 0.9998243451118469
and O 1 0.8980692625045776
carnitine O 1 0.9999891519546509
, O 0 0.021693533286452293
the O 0 0.024150636047124863
patient O 1 0.9914363026618958
has O 0 0.010500520467758179
thrived O 0 0.02324623055756092
on O 0 0.009455965831875801
a O 0 0.013290786184370518
low O 0 0.34479472041130066
- O 1 0.9987466335296631
fat O 0 0.14416442811489105
diet O 0 0.02519906312227249
supplemented O 0 0.01917458511888981
with O 0 0.011578748933970928
medium O 0 0.11629357188940048
- O 1 0.9974873065948486
chain O 1 0.541918158531189
triglyceride O 1 0.8989045023918152
oil O 0 0.027406301349401474
and O 0 0.023976974189281464
carnitine O 1 0.9991269707679749
and O 0 0.031061749905347824
avoidance O 1 0.9987109899520874
of O 0 0.3894783854484558
fasting O 1 0.997832715511322
. O 0 0.06129595264792442

Her O 1 0.9991400241851807
ventricular O 1 0.999998927116394
hypertrophy O 1 0.999985933303833
resolved O 0 0.42352673411369324
significantly O 0 0.02145552635192871
over O 0 0.01370800007134676
1 O 0 0.01574215479195118
year O 0 0.010409296490252018
, O 0 0.010685053654015064
and O 0 0.017834583297371864
cognitively O 1 0.9997143149375916
, O 0 0.012314273975789547
she O 0 0.011687763035297394
is O 0 0.007242144085466862
in O 0 0.006892663426697254
the O 0 0.011775663122534752
superior O 0 0.060313206166028976
range O 0 0.019392864778637886
for O 0 0.01853581704199314
age O 0 0.04185700789093971
. O 0 0.03488742187619209

Clinical O 0 0.3282310366630554
recognition O 0 0.4612041413784027
of O 1 0.9998792409896851
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.9735739231109619
important O 0 0.034853361546993256
because O 0 0.008903415873646736
it O 0 0.0044051893055438995
is O 0 0.004801011644303799
one O 0 0.004671576898545027
of O 0 0.005589079577475786
the O 0 0.007992031052708626
few O 0 0.009337138384580612
directly O 0 0.053494058549404144
treatable O 1 0.9999984502792358
causes O 1 0.999876856803894
of O 1 0.9998437166213989
cardiomyopathy B-Disease 1 1.0
in O 1 0.9933217167854309
children O 1 0.9979606866836548
. O 0 0.03496875241398811
. O 0 0.034421488642692566

Cloning O 0 0.04303458705544472
of O 0 0.02016325853765011
a O 0 0.018517665565013885
novel O 0 0.024652909487485886
member O 0 0.017235491424798965
of O 0 0.012116687372326851
the O 0 0.024044856429100037
low O 1 0.9952523708343506
- O 1 0.9999797344207764
density O 1 0.9967942833900452
lipoprotein O 1 0.9999920129776001
receptor O 1 0.8909191489219666
family O 0 0.046487100422382355
. O 0 0.03650224953889847

A O 0 0.046144627034664154
gene O 0 0.027624476701021194
encoding O 0 0.0205830205231905
a O 0 0.018426574766635895
novel O 0 0.058712247759103775
transmembrane O 1 0.96709144115448
protein O 0 0.014910425059497356
was O 0 0.012308221310377121
identified O 0 0.01002811174839735
by O 0 0.007503408007323742
DNA O 0 0.008079337887465954
sequence O 0 0.006432260852307081
analysis O 0 0.004756059963256121
within O 0 0.006270173005759716
the O 0 0.013241760432720184
insulin B-Disease 1 0.999650239944458
- I-Disease 1 0.9999912977218628
dependent I-Disease 1 0.9996370077133179
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9989827275276184
IDDM B-Disease 1 0.999980092048645
) O 0 0.04399409890174866
locus O 0 0.36996644735336304
IDDM4 O 1 0.9920660853385925
on O 0 0.04188928008079529
chromosome O 0 0.23830199241638184
11q13 O 1 0.7545428276062012
. O 0 0.053071800619363785

Based O 0 0.027743753045797348
on O 0 0.0163432564586401
its O 0 0.016431907191872597
chromosomal O 0 0.2733525037765503
position O 0 0.017194155603647232
, O 0 0.010073221288621426
this O 0 0.007171868346631527
gene O 0 0.010223761200904846
is O 0 0.0071866936050355434
a O 0 0.010812714695930481
candidate O 0 0.016377072781324387
for O 0 0.017263362184166908
conferring O 1 0.9626743793487549
susceptibility O 1 0.9997853636741638
to O 1 0.579903781414032
diabetes B-Disease 1 0.9999955892562866
. O 0 0.09253328293561935

The O 0 0.03364872932434082
gene O 0 0.027078777551651
, O 0 0.01757591962814331
termed O 0 0.037057697772979736
low O 0 0.08863266557455063
- O 1 0.9989144802093506
density O 1 0.8664726614952087
lipoprotein O 1 0.9999806880950928
receptor O 0 0.18897882103919983
related O 0 0.013590961694717407
protein O 0 0.013060072436928749
5 O 0 0.014470302499830723
( O 0 0.017540961503982544
LRP5 O 1 0.9181442856788635
) O 0 0.011116943322122097
, O 0 0.008564992807805538
encodes O 0 0.013544376008212566
a O 0 0.009467460215091705
protein O 0 0.008807952515780926
of O 0 0.010169661603868008
1615 O 0 0.10765930265188217
amino O 0 0.015319878235459328
acids O 0 0.010021724738180637
that O 0 0.005707846954464912
contains O 0 0.009608149528503418
conserved O 0 0.014460010454058647
modules O 0 0.014984284527599812
which O 0 0.005283167585730553
are O 0 0.0036306544207036495
characteristic O 0 0.00842369720339775
of O 0 0.007729833945631981
the O 0 0.013089324347674847
low O 1 0.9667079448699951
- O 1 0.9999613761901855
density O 1 0.9966742992401123
lipoprotein O 1 0.9999982118606567
( O 1 0.9986031651496887
LDL O 1 0.9999974966049194
) O 0 0.10073654353618622
receptor O 0 0.09718161076307297
family O 0 0.041219670325517654
. O 0 0.03653330355882645

These O 0 0.025046424940228462
modules O 0 0.03762209787964821
include O 0 0.018779413774609566
a O 0 0.021410800516605377
putative O 1 0.9124307036399841
signal O 0 0.04486650601029396
peptide O 0 0.02824813313782215
for O 0 0.009608210064470768
protein O 0 0.009929182939231396
export O 0 0.01214073970913887
, O 0 0.009077347815036774
four O 0 0.013769659213721752
epidermal O 1 0.9989421963691711
growth O 0 0.1476728618144989
factor O 1 0.8482531905174255
( O 1 0.7682530879974365
EGF O 1 0.9999185800552368
) O 0 0.016299596056342125
repeats O 0 0.019059954211115837
with O 0 0.009624829515814781
associated O 0 0.013145237229764462
spacer O 0 0.04417544975876808
domains O 0 0.01645032875239849
, O 0 0.011211147531867027
three O 0 0.015486713498830795
LDL O 1 0.9999927282333374
- O 1 0.9999085664749146
receptor O 1 0.838123083114624
( O 0 0.024345217272639275
LDLR O 1 0.9791265726089478
) O 0 0.013173959217965603
repeats O 0 0.015618733130395412
, O 0 0.008876051753759384
a O 0 0.012079023756086826
single O 0 0.0284336619079113
transmembrane O 1 0.9169834852218628
spanning O 0 0.0362304262816906
domain O 0 0.026584172621369362
, O 0 0.014329619705677032
and O 0 0.015863575041294098
a O 0 0.029125094413757324
cytoplasmic O 0 0.26075103878974915
domain O 0 0.05273481085896492
. O 0 0.038742054253816605

The O 0 0.03310804069042206
encoded O 0 0.022683586925268173
protein O 0 0.013495241291821003
has O 0 0.0074957311153411865
a O 0 0.008729125373065472
unique O 0 0.009919573552906513
organization O 0 0.015620271675288677
of O 0 0.02921242080628872
EGF O 1 0.9999837875366211
and O 0 0.20005027949810028
LDLR O 1 0.9999532699584961
repeats O 0 0.2264213263988495
; O 0 0.011800074018537998
therefore O 0 0.009991731494665146
, O 0 0.012148651294410229
LRP5 O 1 0.954785168170929
likely O 0 0.012012170627713203
represents O 0 0.013691344298422337
a O 0 0.011406056582927704
new O 0 0.012708161026239395
category O 0 0.017893731594085693
of O 0 0.015776947140693665
the O 0 0.032422393560409546
LDLR O 1 0.999559223651886
family O 0 0.21468712389469147
. O 0 0.04695552587509155

Both O 0 0.026928802952170372
human O 0 0.026428671553730965
and O 0 0.02488761395215988
mouse O 1 0.9441722631454468
LRP5 O 1 0.999932050704956
cDNAs O 1 0.9937534928321838
have O 0 0.008698752149939537
been O 0 0.008695635944604874
isolated O 0 0.012278786860406399
and O 0 0.007176046259701252
the O 0 0.010477734729647636
encoded O 0 0.012541057541966438
mature O 0 0.016517391428351402
proteins O 0 0.007491121534258127
are O 0 0.004249160643666983
95 O 0 0.011511090211570263
% O 0 0.009422295726835728
identical O 0 0.010707761161029339
, O 0 0.008711615577340126
indicating O 0 0.011666247621178627
a O 0 0.010795378126204014
high O 0 0.017538486048579216
degree O 0 0.015902571380138397
of O 0 0.018528761342167854
evolutionary O 0 0.034299030900001526
conservation O 0 0.0424223430454731
. O 0 0.02350323460996151
. O 0 0.029148995876312256

The O 0 0.05736551061272621
APC B-Disease 1 0.9844337701797485
variants O 0 0.04627765342593193
I1307K O 0 0.1740906834602356
and O 0 0.021807342767715454
E1317Q O 0 0.18890152871608734
are O 0 0.010586678050458431
associated O 0 0.027465328574180603
with O 1 0.9985783100128174
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.8722347617149353
but O 0 0.01250683143734932
not O 0 0.00756365992128849
always O 0 0.011602664366364479
with O 0 0.01017824374139309
a O 0 0.01781156286597252
family O 0 0.028753500431776047
history O 0 0.033554647117853165
. O 0 0.036952804774045944

Classical O 1 0.7533436417579651
familial B-Disease 1 0.9999977350234985
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999784231185913
FAP B-Disease 1 0.9999996423721313
) O 0 0.0255503561347723
is O 0 0.011408250778913498
a O 0 0.016251681372523308
high O 1 0.9697601795196533
- O 1 0.9999953508377075
penetrance O 1 0.9999985694885254
autosomal B-Disease 1 0.9999991655349731
dominant I-Disease 1 0.9999973773956299
disease I-Disease 1 0.9999990463256836
that O 0 0.07712829858064651
predisposes O 1 0.9990721940994263
to O 0 0.009329564869403839
hundreds O 0 0.010247779078781605
or O 0 0.007624633610248566
thousands O 0 0.017155084758996964
of O 1 0.99605393409729
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999860525131226
carcinoma I-Disease 1 1.0
and O 0 0.08291905373334885
that O 0 0.008739056997001171
results O 0 0.007966146804392338
from O 0 0.009474317543208599
truncating O 1 0.8047270178794861
mutations O 0 0.01981492154300213
in O 0 0.012822084128856659
the O 0 0.033946409821510315
APC B-Disease 1 0.9998701810836792
gene O 0 0.05037852004170418
. O 0 0.03446786105632782

A O 0 0.057359009981155396
variant O 0 0.056899331510066986
of O 0 0.053505223244428635
FAP B-Disease 1 0.9999982118606567
is O 1 0.9939360022544861
attenuated B-Disease 1 0.9999978542327881
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999958276748657
, O 0 0.032750654965639114
which O 0 0.009027994237840176
results O 0 0.009040329605340958
from O 0 0.012885727919638157
germ O 1 0.9999368190765381
- O 1 0.9994353652000427
line O 0 0.022902827709913254
mutations O 0 0.010179983451962471
in O 0 0.0056059998460114
the O 0 0.007743459194898605
5 O 0 0.009512807242572308
and O 0 0.006912906654179096
3 O 0 0.010547014884650707
regions O 0 0.008956381119787693
of O 0 0.011961785145103931
the O 0 0.040399715304374695
APC B-Disease 1 0.999879002571106
gene O 0 0.048183001577854156
. O 0 0.03410136699676514

Attenuated B-Disease 1 0.9999091625213623
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999990463256836
patients O 1 0.999751627445221
have O 0 0.018293578177690506
" O 0 0.3407324254512787
multiple O 1 0.752413809299469
" O 1 0.9998944997787476
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 1 0.5349116325378418
typically O 0 0.011665082536637783
fewer O 0 0.00894139800220728
than O 0 0.00653566000983119
100 O 0 0.011569583788514137
) O 0 0.009291889145970345
without O 0 0.009059675969183445
the O 0 0.01800890639424324
florid O 1 0.9953870177268982
phenotype O 1 0.6586589813232422
of O 0 0.04859317094087601
classical O 1 0.8082093000411987
FAP B-Disease 1 0.9999749660491943
. O 0 0.06468573212623596

Another O 0 0.0368705578148365
group O 0 0.027752971276640892
of O 0 0.026139408349990845
patients O 1 0.9936995506286621
with O 0 0.26153215765953064
multiple O 1 0.9814403057098389
adenomas B-Disease 1 0.9999978542327881
has O 0 0.01680087484419346
no O 0 0.009847089648246765
mutations O 0 0.01054670661687851
in O 0 0.007342103403061628
the O 0 0.016596438363194466
APC B-Disease 1 0.9999263286590576
gene O 0 0.01656302995979786
, O 0 0.009431201033294201
and O 0 0.007740961387753487
their O 0 0.008535540662705898
phenotype O 0 0.08549343794584274
probably O 0 0.009803232736885548
results O 0 0.005331540014594793
from O 0 0.006000910419970751
variation O 0 0.008978637866675854
at O 0 0.010103545151650906
a O 0 0.01574249379336834
locus O 1 0.8143672347068787
, O 0 0.015480286441743374
or O 0 0.014266569167375565
loci O 0 0.03305605798959732
, O 0 0.012068950571119785
elsewhere O 0 0.013870194554328918
in O 0 0.012578871101140976
the O 0 0.023539232090115547
genome O 0 0.04081510379910469
. O 0 0.03608493506908417

Recently O 0 0.046124931424856186
, O 0 0.018399516120553017
however O 0 0.01031077653169632
, O 0 0.010428480803966522
a O 0 0.013451547361910343
missense O 0 0.10074375569820404
variant O 0 0.030441012233495712
of O 0 0.03234618157148361
APC B-Disease 1 0.9999736547470093
( O 0 0.24231043457984924
I1307K O 1 0.9841064214706421
) O 0 0.013046307489275932
was O 0 0.01163056492805481
described O 0 0.01081897784024477
that O 0 0.005973043851554394
confers O 0 0.0205735694617033
an O 0 0.008688729256391525
increased O 0 0.014162103645503521
risk O 1 0.8992945551872253
of O 1 0.999799907207489
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9101982116699219
including O 0 0.30813243985176086
multiple O 1 0.9345570206642151
adenomas B-Disease 1 0.9999799728393555
, O 0 0.04227203130722046
in O 0 0.03402305021882057
Ashkenazim O 1 0.9769223928451538
. O 0 0.052233580499887466

We O 0 0.022949714213609695
have O 0 0.01128418929874897
studied O 0 0.01451769471168518
a O 0 0.010662375949323177
set O 0 0.010274549946188927
of O 0 0.01184497494250536
164 O 0 0.1859457641839981
patients O 1 0.824633777141571
with O 0 0.19813601672649384
multiple O 1 0.9998112320899963
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999631643295288
/ I-Disease 1 0.9999996423721313
or I-Disease 1 0.9918199777603149
carcinoma I-Disease 1 0.9999997615814209
and O 0 0.023622438311576843
analyzed O 0 0.024148961529135704
codons O 0 0.051106687635183334
1263 O 1 0.9790523648262024
- O 1 0.9971708655357361
1377 O 1 0.9812978506088257
( O 0 0.032005004584789276
exon O 0 0.0841100662946701
15G O 0 0.09564854204654694
) O 0 0.013422847725450993
of O 0 0.011367709375917912
the O 0 0.01739412359893322
APC B-Disease 1 0.9991862177848816
gene O 0 0.026077017188072205
for O 0 0.022598877549171448
germ O 1 0.9998235106468201
- O 1 0.9989802241325378
line O 0 0.06162966042757034
variants O 0 0.043290551751852036
. O 0 0.03689149394631386

Three O 0 0.03215319290757179
patients O 0 0.05642541125416756
with O 0 0.016898246482014656
the O 0 0.052662067115306854
I1307K O 1 0.999817430973053
allele O 1 0.5198485851287842
were O 0 0.011497181840240955
detected O 0 0.016027800738811493
, O 0 0.010085592046380043
each O 0 0.008684184402227402
of O 0 0.019322944805026054
Ashkenazi O 1 0.9324925541877747
descent O 0 0.18140482902526855
. O 0 0.04019826278090477

Four O 0 0.04183627665042877
patients O 0 0.26921626925468445
had O 0 0.022307032719254494
a O 0 0.037987612187862396
germ O 1 0.9997554421424866
- O 1 0.9987321496009827
line O 0 0.10649355500936508
E1317Q O 1 0.9655874967575073
missense O 0 0.20890913903713226
variant O 0 0.03038068301975727
of O 0 0.018120966851711273
APC O 1 0.9987201690673828
that O 0 0.008018841035664082
was O 0 0.010541382245719433
not O 0 0.0047638374380767345
present O 0 0.006335894577205181
in O 0 0.0057329097762703896
controls O 0 0.011706479825079441
; O 0 0.006343801040202379
one O 0 0.005127578508108854
of O 0 0.005984114948660135
these O 0 0.004761515650898218
individuals O 0 0.005782485939562321
had O 0 0.007509202230721712
an O 0 0.007533377967774868
unusually O 0 0.016331976279616356
large O 0 0.00926415715366602
number O 0 0.009411025792360306
of O 0 0.018545258790254593
metaplastic B-Disease 1 0.9997952580451965
polyps I-Disease 1 0.9994732737541199
of I-Disease 0 0.04794987663626671
the I-Disease 1 0.5632870197296143
colorectum I-Disease 1 0.9993417859077454
. O 0 0.05085393041372299

There O 0 0.027414513751864433
is O 0 0.015570887364447117
increasing O 0 0.013026238419115543
evidence O 0 0.00902566034346819
that O 0 0.0058940742164850235
there O 0 0.007615820504724979
exist O 0 0.012193880043923855
germ O 1 0.9961280822753906
- O 1 0.9744722843170166
line O 0 0.01899825409054756
variants O 0 0.011103624477982521
of O 0 0.010250885039567947
the O 0 0.020222846418619156
APC B-Disease 1 0.9998672008514404
gene O 0 0.01616426557302475
that O 0 0.007817472331225872
predispose O 0 0.021992353722453117
to O 0 0.007372627500444651
the O 0 0.008504592813551426
development O 0 0.012211030349135399
of O 0 0.04507678747177124
multiple O 1 0.9997045397758484
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999993085861206
carcinoma I-Disease 1 1.0
, O 0 0.21632134914398193
but O 0 0.008338246494531631
without O 0 0.0074711632914841175
the O 0 0.012791349552571774
florid O 1 0.9992865920066833
phenotype O 1 0.9077386260032654
of O 0 0.023291459307074547
classical O 1 0.8861904740333557
FAP B-Disease 1 0.9999984502792358
, O 0 0.012629776261746883
and O 0 0.008193670772016048
possibly O 0 0.00828664842993021
with O 0 0.007549898698925972
importance O 0 0.44966357946395874
for O 1 0.9999109506607056
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999724626541138
in O 0 0.057020097970962524
the O 0 0.22187824547290802
general O 0 0.30467575788497925
population O 0 0.019350267946720123
. O 0 0.018085455521941185
. O 0 0.027122007682919502

Genomic O 0 0.05277854949235916
structure O 0 0.026541007682681084
of O 0 0.01993880607187748
the O 1 0.6024314761161804
human O 1 0.999985933303833
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999996423721313
CLD B-Disease 1 0.9999998807907104
) O 1 0.8712196350097656
gene O 0 0.055044736713171005
. O 0 0.03968818858265877

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999998807907104
diarrhea I-Disease 1 1.0
( O 1 0.9999994039535522
CLD B-Disease 1 1.0
) O 1 0.9284108281135559
is O 0 0.019533347338438034
caused O 0 0.05152040719985962
by O 0 0.011569463647902012
mutations O 0 0.013813318684697151
in O 0 0.007307359483093023
a O 0 0.012453658506274223
gene O 0 0.01584533043205738
which O 0 0.012445311062037945
encodes O 0 0.03863593190908432
an O 0 0.08469748497009277
intestinal O 1 0.9999992847442627
anion O 1 0.9999790191650391
transporter O 1 0.9983246922492981
. O 0 0.05610857903957367

We O 0 0.024409880861639977
report O 0 0.015074384398758411
here O 0 0.01186486054211855
the O 0 0.012060106731951237
complete O 0 0.017659686505794525
genomic O 0 0.02047809772193432
organization O 0 0.01507202722132206
of O 0 0.012259196490049362
the O 0 0.01836349628865719
human O 0 0.4532550275325775
CLD B-Disease 1 0.9999967813491821
gene O 0 0.025021415203809738
which O 0 0.010275563225150108
spans O 0 0.025281675159931183
approximately O 0 0.018691258504986763
39kb O 1 0.7288234829902649
, O 0 0.016127604991197586
and O 0 0.015979330986738205
comprises O 0 0.037241701036691666
21 O 0 0.0435841865837574
exons O 0 0.07203612476587296
. O 0 0.041365958750247955

All O 0 0.05339277535676956
exon O 1 0.6732401251792908
/ O 1 0.9336669445037842
intron O 0 0.35887935757637024
boundaries O 0 0.028224101290106773
conform O 0 0.033968839794397354
to O 0 0.01695961318910122
the O 0 0.03283355012536049
GT O 1 0.9997904896736145
/ O 1 0.9998145699501038
AG O 1 0.9991156458854675
rule O 0 0.06340274959802628
. O 0 0.04616948962211609

An O 0 0.022688843309879303
analysis O 0 0.014033390209078789
of O 0 0.01393674686551094
the O 0 0.020508181303739548
putative O 1 0.9702461957931519
promoter O 1 0.8673596382141113
region O 0 0.017632102593779564
sequence O 0 0.012601206079125404
shows O 0 0.012530244886875153
a O 0 0.019110847264528275
putative O 1 0.9778589606285095
TATA O 1 0.9998513460159302
box O 0 0.2386208474636078
and O 0 0.020735003054142
predicts O 0 0.05906936526298523
multiple O 0 0.024919714778661728
transcription O 0 0.05942895635962486
factor O 0 0.0391826368868351
binding O 0 0.029523856937885284
sites O 0 0.03201339766383171
. O 0 0.03004816360771656

The O 0 0.04318641498684883
genomic O 0 0.058896709233522415
structure O 0 0.02868552692234516
was O 0 0.01805933564901352
determined O 0 0.01283576712012291
using O 0 0.00700877420604229
DNA O 0 0.007737193256616592
from O 0 0.004892620258033276
several O 0 0.004376024939119816
sources O 0 0.004882606212049723
including O 0 0.005801387596875429
multiple O 0 0.008297434076666832
large O 0 0.016378309577703476
- O 1 0.9996534585952759
insert O 1 0.8612350225448608
libaries O 1 0.6714835166931152
and O 0 0.01255782786756754
genomic O 0 0.022426649928092957
DNA O 0 0.017801186069846153
from O 0 0.02002178691327572
Finnish O 1 0.9995501637458801
CLD B-Disease 1 0.9999991655349731
patients O 1 0.9994058609008789
and O 0 0.05211206153035164
controls O 0 0.22120817005634308
. O 0 0.044986411929130554

Exon O 1 0.9528495073318481
- O 1 0.9711970686912537
specific O 0 0.023882746696472168
primers O 0 0.06051504984498024
developed O 0 0.018510660156607628
in O 0 0.0094443429261446
this O 0 0.006724479608237743
study O 0 0.009021651931107044
will O 0 0.00837536621838808
facilitate O 0 0.018367638811469078
mutation O 0 0.02524370141327381
screening O 0 0.03060253895819187
studies O 0 0.010834903456270695
of O 0 0.01648380421102047
patients O 1 0.9963605999946594
with O 0 0.29692983627319336
the O 1 0.9965356588363647
disease O 1 0.9999972581863403
. O 1 0.5012705326080322

Genomic O 0 0.07227592170238495
sequencing O 0 0.03764722868800163
of O 0 0.025513360276818275
a O 0 0.039310481399297714
BAC O 1 0.9998983144760132
clone O 1 0.9995085000991821
H O 1 0.9999606609344482
_ O 0 0.03957417979836464
RG364P16 O 1 0.8053004145622253
revealed O 0 0.017131680622696877
the O 0 0.009432497434318066
presence O 0 0.01018225122243166
of O 0 0.008403213694691658
another O 0 0.012756844982504845
, O 0 0.009290439076721668
highly O 0 0.012483013793826103
homologous O 0 0.020188145339488983
gene O 0 0.010157673619687557
3 O 0 0.009991627186536789
of O 0 0.010125592350959778
the O 0 0.025740843266248703
CLD B-Disease 1 0.9999905824661255
gene O 0 0.018076181411743164
, O 0 0.008591542951762676
with O 0 0.006378605961799622
a O 0 0.009164135903120041
similar O 0 0.007734107319265604
genomic O 0 0.015557246282696724
structure O 0 0.011351654306054115
, O 0 0.007314626593142748
recently O 0 0.009852027520537376
identified O 0 0.008231238462030888
as O 0 0.008628901094198227
the O 0 0.3319910168647766
Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
gene O 1 0.9998034834861755
( O 1 0.9969835877418518
PDS B-Disease 1 0.999974250793457
) O 0 0.03298552334308624
. O 0 0.02370702289044857
. O 0 0.03096531331539154

The O 0 0.06308566778898239
APCI1307K O 1 0.9998712539672852
allele O 1 0.98111891746521
and O 1 0.5983952879905701
cancer B-Disease 1 0.9999839067459106
risk O 1 0.7087247967720032
in O 0 0.01093889120966196
a O 0 0.0434609018266201
community O 0 0.08874841779470444
- O 1 0.9756845831871033
based O 0 0.013253193348646164
study O 0 0.012603300623595715
of O 0 0.017599014565348625
Ashkenazi O 1 0.9689548015594482
Jews O 0 0.0721634030342102
. O 0 0.03981151431798935

Mutations O 0 0.06054634228348732
in O 0 0.028915058821439743
APC O 1 0.9858300089836121
are O 0 0.015293975360691547
classically O 1 0.8590472340583801
associated O 0 0.024136008694767952
with O 0 0.39144307374954224
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999970197677612
FAP B-Disease 1 0.9999998807907104
) O 0 0.02511841244995594
, O 0 0.012638972140848637
a O 0 0.017911287024617195
highly O 1 0.7033166885375977
penetrant O 1 0.9999958276748657
autosomal B-Disease 1 0.9999991655349731
dominant I-Disease 1 0.9999988079071045
disorder I-Disease 1 1.0
characterized O 1 0.9999955892562866
by O 1 0.9998080134391785
multiple O 1 0.9999918937683105
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9892946481704712
, O 0 0.46787434816360474
without O 0 0.03719198331236839
surgical O 1 0.9999681711196899
intervention O 1 0.9652356505393982
, O 0 0.010845563374459743
the O 0 0.012357976287603378
development O 0 0.30003997683525085
of O 1 0.9998915195465088
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999897480010986
CRC B-Disease 1 0.9999960660934448
) O 0 0.05268825963139534
. O 0 0.03982234001159668

APC B-Disease 1 0.9692907929420471
is O 0 0.03273996338248253
a O 0 0.22913478314876556
tumour O 1 0.9999997615814209
- O 1 0.9999982118606567
suppressor O 1 0.9999911785125732
gene O 0 0.035576026886701584
, O 0 0.01404421404004097
and O 0 0.01566663198173046
somatic O 1 0.8167549967765808
loss O 1 0.8061036467552185
occurs O 0 0.05901291221380234
in O 0 0.0383872389793396
tumours B-Disease 1 0.9999802112579346
. O 0 0.060203924775123596

The O 0 0.05559319257736206
germline O 1 0.9959346055984497
T O 1 0.9984744191169739
- O 1 0.9646016359329224
to O 0 0.01969250850379467
- O 1 0.8477361798286438
A O 0 0.027909215539693832
transversion O 1 0.7473908066749573
responsible O 0 0.016232632100582123
for O 0 0.010542836971580982
the O 0 0.018323151394724846
APC O 1 0.9993185997009277
I1307K O 1 0.9756186008453369
allele O 0 0.032772716134786606
converts O 0 0.019279642030596733
the O 0 0.01121753454208374
wild O 0 0.01902535930275917
- O 1 0.5254607200622559
type O 0 0.013424642384052277
sequence O 0 0.007512209005653858
to O 0 0.007025111000984907
a O 0 0.018109558150172234
homopolymer O 1 0.9999434947967529
tract O 1 0.9999982118606567
( O 1 0.9954902529716492
A8 O 1 0.9999758005142212
) O 0 0.014693143777549267
that O 0 0.007725987583398819
is O 0 0.013082994148135185
genetically O 0 0.024406690150499344
unstable O 1 0.9518576264381409
and O 0 0.02351849526166916
prone O 1 0.9965320825576782
to O 0 0.04618603363633156
somatic O 1 0.9875175356864929
mutation O 0 0.16712377965450287
. O 0 0.040217600762844086

The O 0 0.0574730820953846
I1307K O 1 0.989190936088562
allele O 0 0.10985513031482697
was O 0 0.03133586049079895
found O 0 0.017838692292571068
in O 0 0.018727730959653854
6 O 0 0.03855116292834282
. O 0 0.03719542175531387

1 O 0 0.04491971433162689
% O 0 0.028872601687908173
of O 0 0.02699672430753708
unselected O 1 0.9408002495765686
Ashkenazi O 1 0.7746114730834961
Jews O 0 0.03341927006840706
and O 0 0.015110595151782036
higher O 0 0.01509448979049921
proportions O 0 0.039153315126895905
of O 0 0.02171916887164116
Ashkenazim O 1 0.998581051826477
with O 0 0.019079729914665222
family O 0 0.06740136444568634
or O 0 0.011792213656008244
personal O 0 0.022748317569494247
histories O 0 0.10229813307523727
of O 1 0.8892654180526733
CRC B-Disease 1 0.9999982118606567
( O 1 0.9044862389564514
ref O 1 0.9950675964355469
. O 0 0.018557915464043617
2 O 0 0.02810659073293209
) O 0 0.02609563060104847
. O 0 0.03146344795823097

To O 0 0.02459985576570034
evaluate O 0 0.027766773477196693
the O 0 0.01526610180735588
role O 0 0.02093273401260376
of O 0 0.02322029136121273
I1307K O 1 0.9993946552276611
in O 0 0.06055831536650658
cancer B-Disease 1 0.9999186992645264
, O 0 0.0164091344922781
we O 0 0.011891096830368042
genotyped O 1 0.5461201071739197
5 O 0 0.020482243970036507
, O 0 0.020423775538802147
081 O 1 0.9786058068275452
Ashkenazi O 0 0.3372977077960968
volunteers O 0 0.03573428839445114
in O 0 0.014824132435023785
a O 0 0.021724728867411613
community O 0 0.030446825549006462
survey O 0 0.03731347620487213
. O 0 0.03499434515833855

Risk O 0 0.06370751559734344
of O 0 0.059548381716012955
developing O 1 0.9995334148406982
colorectal B-Disease 1 1.0
, I-Disease 1 0.9989731311798096
breast I-Disease 1 0.9999995231628418
and I-Disease 1 0.6617250442504883
other I-Disease 0 0.019000621512532234
cancers I-Disease 1 0.9967648983001709
were O 0 0.008530154824256897
compared O 0 0.010273436084389687
between O 0 0.014227387495338917
genotyped O 1 0.9967183470726013
I1307K O 1 0.9863312244415283
carriers O 0 0.02839864417910576
and O 0 0.013741583563387394
non O 1 0.5416910648345947
- O 1 0.9933633804321289
carriers O 0 0.02246934548020363
and O 0 0.008421343751251698
their O 0 0.009061507880687714
first O 0 0.021154724061489105
- O 1 0.966988205909729
degree O 0 0.03763961046934128
relatives O 0 0.06349152326583862
. O 0 0.0382264070212841

Sperm O 0 0.06051437184214592
DNA O 0 0.027250932529568672
analysis O 0 0.01498587615787983
in O 0 0.015902899205684662
a O 0 0.036797378212213516
Friedreich B-Disease 1 0.9999853372573853
ataxia I-Disease 1 0.9999970197677612
premutation O 1 0.9999305009841919
carrier O 1 0.9937818646430969
suggests O 0 0.030425986275076866
both O 0 0.018210116773843765
meiotic O 1 0.9917086958885193
and O 0 0.025402268394827843
mitotic O 1 0.9153019785881042
expansion O 0 0.03284616768360138
in O 0 0.016623908653855324
the O 0 0.03229875490069389
FRDA B-Disease 1 0.9997096657752991
gene O 0 0.0539964959025383
. O 0 0.04007311910390854

Friedreich B-Disease 1 0.999985933303833
ataxia I-Disease 1 0.9999908208847046
is O 0 0.22973905503749847
usually O 0 0.019607365131378174
caused O 0 0.02559593692421913
by O 0 0.00954305287450552
an O 0 0.010253546759486198
expansion O 0 0.0166411604732275
of O 0 0.012932322919368744
a O 0 0.057949695736169815
GAA O 1 0.976776123046875
trinucleotide O 1 0.9988272786140442
repeat O 0 0.12845709919929504
in O 0 0.015456143766641617
intron O 1 0.9631050229072571
1 O 0 0.01797390915453434
of O 0 0.016288062557578087
the O 0 0.03296232223510742
FRDA B-Disease 1 0.999846339225769
gene O 0 0.048625148832798004
. O 0 0.03555026650428772

Occasionally O 0 0.03523430973291397
, O 0 0.018237421289086342
a O 0 0.016770394518971443
fully O 0 0.019950950518250465
expanded O 0 0.022344881668686867
allele O 0 0.03438190370798111
has O 0 0.010143464431166649
been O 0 0.00764208659529686
found O 0 0.0073156654834747314
to O 0 0.007312868256121874
arise O 0 0.011360229924321175
from O 0 0.007694495841860771
a O 0 0.012694049626588821
premutation O 1 0.9000762701034546
of O 0 0.014708340167999268
100 O 0 0.020860645920038223
or O 0 0.017274949699640274
less O 0 0.021997669711709023
triplet O 1 0.9887796640396118
repeats O 0 0.07189688086509705
. O 0 0.04267510399222374

We O 0 0.025606494396924973
have O 0 0.01344013586640358
examined O 0 0.022215351462364197
the O 0 0.01592988334596157
sperm O 0 0.021539751440286636
DNA O 0 0.016206568107008934
of O 0 0.016770001500844955
a O 0 0.0378151573240757
premutation O 1 0.9984209537506104
carrier O 1 0.962601363658905
. O 0 0.04557972028851509

This O 0 0.038271572440862656
mans O 0 0.15259283781051636
leucocyte O 1 0.7691750526428223
DNA O 0 0.028044840320944786
showed O 0 0.018679803237318993
one O 0 0.013364714570343494
normal O 0 0.017804889008402824
allele O 0 0.028067821636795998
and O 0 0.010621728375554085
one O 0 0.011223088018596172
allele O 0 0.023102963343262672
of O 0 0.013566150330007076
approximately O 0 0.01756294071674347
100 O 0 0.02749299257993698
repeats O 0 0.051016807556152344
. O 0 0.03529103472828865

His O 0 0.043086905032396317
sperm O 0 0.032031916081905365
showed O 0 0.01892792619764805
an O 0 0.013818368315696716
expanded O 0 0.021932382136583328
allele O 0 0.031116582453250885
in O 0 0.010132046416401863
a O 0 0.014569427818059921
tight O 0 0.029131270945072174
range O 0 0.014926500618457794
centering O 0 0.032658737152814865
on O 0 0.00991521030664444
a O 0 0.011757956817746162
size O 0 0.011268229223787785
of O 0 0.014613484963774681
approximately O 0 0.025506773963570595
320 O 0 0.07152337580919266
trinucleotide O 1 0.9523305296897888
repeats O 0 0.08719363063573837
. O 0 0.050358764827251434

His O 0 0.06885143369436264
affected O 0 0.18007716536521912
son O 1 0.9955617189407349
has O 0 0.03077736869454384
repeat O 0 0.07699792832136154
sizes O 0 0.026977727189660072
of O 0 0.02750198170542717
1040 O 1 0.9211145043373108
and O 0 0.03562634810805321
540 O 0 0.27282699942588806
. O 0 0.04357718676328659

These O 0 0.020031526684761047
data O 0 0.013075841590762138
suggest O 0 0.011654851026833057
that O 0 0.006808460224419832
expansion O 0 0.014403284527361393
occurs O 0 0.008512896485626698
in O 0 0.00644800765439868
two O 0 0.006943801883608103
stages O 0 0.014602970331907272
, O 0 0.008979647420346737
the O 0 0.009345363825559616
first O 0 0.012641078792512417
during O 0 0.018507838249206543
meiosis O 1 0.5399438738822937
followed O 0 0.019067900255322456
by O 0 0.012695633806288242
a O 0 0.019972145557403564
second O 0 0.10708438605070114
mitotic O 1 0.9918724894523621
expansion O 0 0.10019490122795105
. O 0 0.04503505304455757

We O 0 0.02591550536453724
also O 0 0.014919595792889595
show O 0 0.013584800064563751
that O 0 0.006519777234643698
in O 0 0.00676060700789094
all O 0 0.008275381289422512
informative O 0 0.025410937145352364
carrier O 0 0.16555127501487732
father O 0 0.02773074060678482
to O 0 0.011156463995575905
affected O 0 0.023598195984959602
child O 1 0.9367625117301941
transmissions O 0 0.03040776215493679
, O 0 0.007859112694859505
with O 0 0.006579522043466568
the O 0 0.008386978879570961
notable O 0 0.010393491946160793
exception O 0 0.012259820476174355
of O 0 0.011272958479821682
the O 0 0.0500577911734581
premutation O 1 0.9997085928916931
carrier O 1 0.8523488640785217
, O 0 0.011082226410508156
the O 0 0.012080930173397064
expansion O 0 0.024515878409147263
size O 0 0.018948180601000786
decreases O 0 0.03222528472542763
. O 0 0.018972551450133324
. O 0 0.028113750740885735

The O 0 0.05511052533984184
R496H O 1 0.6495745182037354
mutation O 0 0.05269504711031914
of O 0 0.030949102714657784
arylsulfatase O 1 0.998540997505188
A O 1 0.8213821053504944
does O 0 0.02416640892624855
not O 0 0.019940819591283798
cause O 1 0.9586201906204224
metachromatic B-Disease 1 0.9999531507492065
leukodystrophy I-Disease 1 0.9999827146530151
. O 0 0.07861514389514923

Deficiency B-Disease 1 0.9999293088912964
of I-Disease 0 0.1183161810040474
arylsulfatase I-Disease 1 0.9996746778488159
A I-Disease 1 0.9958223104476929
( O 1 0.9926677346229553
ARSA O 1 0.9999921321868896
) O 0 0.05941120535135269
enzyme O 0 0.2615165710449219
activity O 0 0.04132632166147232
causes O 1 0.9981492757797241
metachromatic B-Disease 1 0.9999949932098389
leukodystrophy I-Disease 1 0.9999996423721313
( O 1 0.9988916516304016
MLD B-Disease 1 0.9999920129776001
) O 0 0.058482665568590164
. O 0 0.04687707498669624

A O 0 0.03810128569602966
number O 0 0.021608494222164154
of O 0 0.031504254788160324
ARSA O 1 0.9999476671218872
gene O 0 0.05846337974071503
mutations O 0 0.032265376299619675
responsible O 0 0.03713681548833847
for O 0 0.07717913389205933
MLD B-Disease 1 0.9999946355819702
have O 0 0.017212800681591034
been O 0 0.019954737275838852
identified O 0 0.033644579350948334
. O 0 0.03301507234573364

Recently O 0 0.04277513921260834
, O 0 0.02116360142827034
the O 0 0.019945655018091202
R496H O 1 0.9819648861885071
mutation O 0 0.13738535344600677
of O 0 0.04252029210329056
ARSA O 1 0.9999762773513794
was O 0 0.02288714237511158
proposed O 0 0.011147734709084034
to O 0 0.006843092851340771
be O 0 0.005754814948886633
a O 0 0.00908853579312563
cause O 0 0.032354578375816345
of O 1 0.5641672015190125
MLD B-Disease 1 0.9999998807907104
( O 1 0.976515531539917
Draghia O 1 0.9994214773178101
et O 1 0.6917828321456909
al O 0 0.31841200590133667
. O 0 0.014919202774763107
, O 0 0.01750849187374115
1997 O 0 0.03398605436086655
) O 0 0.028559532016515732
. O 0 0.033423569053411484

We O 0 0.02326180972158909
have O 0 0.01200497429817915
investigated O 0 0.02295989915728569
the O 0 0.019505249336361885
R496H O 1 0.9942571520805359
mutation O 0 0.03254535049200058
and O 0 0.010063174180686474
found O 0 0.007882649078965187
this O 0 0.006518177688121796
mutation O 0 0.013244104571640491
at O 0 0.008567624725401402
a O 0 0.008481415919959545
relatively O 0 0.007966169156134129
high O 0 0.010826769284904003
frequency O 0 0.007855435833334923
in O 0 0.005428209435194731
an O 0 0.006637508049607277
African O 0 0.01340868603438139
American O 0 0.013431250117719173
population O 0 0.010719708167016506
( O 0 0.01617821864783764
f O 0 0.0322430320084095
= O 0 0.023852912709116936
0 O 0 0.016991043463349342
. O 0 0.010338968597352505
09 O 0 0.04051993414759636
, O 0 0.018800275400280952
n O 0 0.03902494162321091
= O 0 0.04015767201781273
61 O 0 0.039589930325746536
subjects O 0 0.034283097833395004
) O 0 0.031062934547662735
. O 0 0.032439202070236206

The O 0 0.16172394156455994
ARSA O 1 0.9999521970748901
enzyme O 0 0.39424434304237366
activity O 0 0.01991599053144455
in O 0 0.010568782687187195
subjects O 0 0.012607662938535213
with O 0 0.00733913341537118
and O 0 0.008124331943690777
without O 0 0.008516772650182247
the O 0 0.028420571237802505
R496H O 1 0.9998416900634766
mutation O 0 0.4958881437778473
was O 0 0.019014006480574608
determined O 0 0.012745331972837448
and O 0 0.009295129217207432
found O 0 0.008486872538924217
to O 0 0.010194821283221245
be O 0 0.01089203916490078
normal O 0 0.023500598967075348
. O 0 0.027916330844163895

It O 0 0.022868609055876732
is O 0 0.015894930809736252
therefore O 0 0.01295898761600256
concluded O 0 0.014428636059165001
that O 0 0.007600742392241955
the O 0 0.013059630058705807
R496H O 1 0.9308706521987915
mutation O 0 0.049538567662239075
of O 0 0.04104290157556534
ARSA O 1 0.999977707862854
does O 0 0.013628923334181309
not O 0 0.00685219606384635
negatively O 0 0.009761928580701351
influence O 0 0.00847887434065342
the O 0 0.008701886050403118
activity O 0 0.011417224071919918
of O 0 0.03816831856966019
ARSA O 1 0.9999947547912598
and O 0 0.017891597002744675
is O 0 0.011580015532672405
not O 0 0.00866819266229868
a O 0 0.020543143153190613
cause O 0 0.30132433772087097
of O 1 0.5893043279647827
MLD B-Disease 1 0.9999921321868896

Down O 0 0.06303092837333679
- O 0 0.07381804287433624
regulation O 0 0.023676075041294098
of O 0 0.02188429795205593
transmembrane O 1 0.9583690166473389
carbonic O 1 0.9984365105628967
anhydrases O 1 0.9997124075889587
in O 1 0.9652529358863831
renal B-Disease 1 1.0
cell I-Disease 1 0.9999982118606567
carcinoma I-Disease 1 1.0
cell O 1 0.9787641763687134
lines O 0 0.019064700230956078
by O 0 0.01433651801198721
wild O 0 0.047222137451171875
- O 1 0.9991366267204285
type O 1 0.8385990858078003
von B-Disease 1 0.9978309273719788
Hippel I-Disease 1 0.9998937845230103
- I-Disease 1 0.9997434020042419
Lindau I-Disease 1 0.9988676309585571
transgenes O 1 0.8460846543312073
. O 0 0.06287629902362823

To O 0 0.03671535849571228
discover O 0 0.04576851427555084
genes O 0 0.018169580027461052
involved O 0 0.016124874353408813
in O 0 0.01716606318950653
von B-Disease 1 0.9116207957267761
Hippel I-Disease 1 0.9999268054962158
- I-Disease 1 0.9999693632125854
Lindau I-Disease 1 0.9999561309814453
( O 1 0.5606498122215271
VHL B-Disease 1 0.9995498061180115
) O 0 0.03629135712981224
- O 1 0.9969099164009094
mediated O 1 0.7914429306983948
carcinogenesis O 1 0.9963646531105042
, O 0 0.015179479494690895
we O 0 0.012615293264389038
used O 0 0.025290196761488914
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9999572038650513
carcinoma I-Disease 1 0.9999998807907104
cell O 1 0.8408982753753662
lines O 0 0.03401161730289459
stably O 1 0.5544896125793457
transfected O 1 0.5236589312553406
with O 0 0.020166009664535522
wild O 1 0.535632312297821
- O 1 0.9999730587005615
type O 1 0.9988844990730286
VHL O 1 0.9999798536300659
- O 1 0.9994683861732483
expressing O 1 0.6110364198684692
transgenes O 1 0.8752282857894897
. O 0 0.04643535614013672

Large O 0 0.05231725797057152
- O 1 0.8711144924163818
scale O 0 0.04165071249008179
RNA O 0 0.04485812783241272
differential O 0 0.03665860742330551
display O 0 0.02384168840944767
technology O 0 0.015067970380187035
applied O 0 0.009628848172724247
to O 0 0.007205825764685869
these O 0 0.006615480873733759
cell O 0 0.012937390245497227
lines O 0 0.010497934184968472
identified O 0 0.009693588130176067
several O 0 0.007261127233505249
differentially O 0 0.027625974267721176
expressed O 0 0.01285273302346468
genes O 0 0.00991443358361721
, O 0 0.007430514320731163
including O 0 0.007722910027951002
an O 0 0.012931814417243004
alpha O 1 0.7411633729934692
carbonic O 1 0.9978011250495911
anhydrase O 1 0.9996125102043152
gene O 0 0.039873044937849045
, O 0 0.02767506055533886
termed O 0 0.13322332501411438
CA12 O 1 0.9921168684959412
. O 0 0.05298994109034538

The O 0 0.040198277682065964
deduced O 0 0.05355056747794151
protein O 0 0.02075294964015484
sequence O 0 0.013665521517395973
was O 0 0.014391104690730572
classified O 0 0.013520948588848114
as O 0 0.007932611741125584
a O 0 0.011660581454634666
one O 0 0.014784581027925014
- O 1 0.9963672161102295
pass O 0 0.1343272179365158
transmembrane O 1 0.9799714088439941
CA O 0 0.041447874158620834
possessing O 0 0.019479282200336456
an O 0 0.01230977475643158
apparently O 0 0.017956485971808434
intact O 0 0.06304464489221573
catalytic O 0 0.08160974085330963
domain O 0 0.02002881094813347
in O 0 0.013157812878489494
the O 0 0.025111770257353783
extracellular O 1 0.9885963797569275
CA O 1 0.8348631262779236
module O 1 0.6163457632064819
. O 0 0.04339006543159485

Reintroduced O 0 0.11012911051511765
wild O 0 0.4034084975719452
- O 1 0.9998773336410522
type O 1 0.9866154193878174
VHL B-Disease 1 0.9995763897895813
strongly O 0 0.0272306427359581
inhibited O 0 0.05606739968061447
the O 0 0.017875291407108307
overexpression O 0 0.05133308470249176
of O 0 0.014221643097698689
the O 0 0.01939440332353115
CA12 O 1 0.9953183531761169
gene O 0 0.016846241429448128
in O 0 0.01072701346129179
the O 0 0.07276401668787003
parental O 1 0.9999955892562866
renal B-Disease 1 1.0
cell I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
cell O 1 0.9993616938591003
lines O 0 0.08390934765338898
. O 0 0.04492538422346115

Similar O 0 0.025137290358543396
results O 0 0.013165269047021866
were O 0 0.010455559939146042
obtained O 0 0.014583961106836796
with O 0 0.015717025846242905
CA9 O 1 0.9988862872123718
, O 0 0.01988411881029606
encoding O 0 0.02279956452548504
another O 0 0.02547360397875309
transmembrane O 1 0.8468506932258606
CA O 0 0.03562098369002342
with O 0 0.012962768785655499
an O 0 0.018769044429063797
intact O 0 0.4752608835697174
catalytic O 1 0.7647282481193542
domain O 0 0.04599136859178543
. O 0 0.03612784668803215

Although O 0 0.024197958409786224
both O 0 0.014895514585077763
domains O 0 0.02273193746805191
of O 0 0.01644502952694893
the O 0 0.3015952706336975
VHL B-Disease 1 0.9999747276306152
protein O 0 0.01737312413752079
contribute O 0 0.014029234647750854
to O 0 0.008717283606529236
regulation O 0 0.014224979095160961
of O 0 0.015153227373957634
CA12 O 1 0.9998277425765991
expression O 0 0.018784496933221817
, O 0 0.011433091014623642
the O 0 0.015239858999848366
elongin O 1 0.9807268381118774
binding O 0 0.023196231573820114
domain O 0 0.022845005616545677
alone O 0 0.018246877938508987
could O 0 0.014666836708784103
effectively O 0 0.03283294290304184
regulate O 0 0.06094013527035713
CA9 O 1 0.9979314804077148
expression O 0 0.06904546916484833
. O 0 0.04719387739896774

We O 0 0.04834313318133354
mapped O 0 0.07819666713476181
CA12 O 1 0.9933577179908752
and O 0 0.04764517396688461
CA9 O 1 0.9996351003646851
loci O 0 0.09721725434064865
to O 0 0.0305058304220438
chromosome O 0 0.11530067771673203
bands O 0 0.0784192681312561
15q22 O 1 0.9813847541809082
and O 0 0.044236645102500916
17q21 O 1 0.9280635714530945
. O 0 0.054915688931941986

2 O 0 0.04650913178920746
respectively O 0 0.031269609928131104
, O 0 0.022703057155013084
regions O 0 0.022147051990032196
prone O 1 0.6109718680381775
to O 0 0.017190728336572647
amplification O 0 0.10762761533260345
in O 0 0.013599274680018425
some O 0 0.015497717075049877
human O 0 0.19872954487800598
cancers B-Disease 1 0.9998379945755005
. O 0 0.05127217620611191

Additional O 0 0.03307434916496277
experiments O 0 0.023423653095960617
are O 0 0.008517461828887463
needed O 0 0.01181052066385746
to O 0 0.008231309242546558
define O 0 0.01303628459572792
the O 0 0.00988932978361845
role O 0 0.017012599855661392
of O 0 0.027408458292484283
CA O 1 0.9948304295539856
IX O 1 0.9999881982803345
and O 1 0.5752562284469604
CA O 1 0.9945904016494751
XII O 1 0.9999701976776123
enzymes O 0 0.0224958173930645
in O 0 0.008107856847345829
the O 0 0.009712218306958675
regulation O 0 0.014360417611896992
of O 0 0.01327708549797535
pH O 1 0.9412302374839783
in O 0 0.010118616744875908
the O 0 0.01912374049425125
extracellular O 1 0.9918585419654846
microenvironment O 1 0.992616593837738
and O 0 0.010657920502126217
its O 0 0.010437065735459328
potential O 0 0.015944818034768105
impact O 0 0.0204111710190773
on O 0 0.07942314445972443
cancer B-Disease 1 0.999994158744812
cell O 1 0.9721664786338806
growth O 0 0.07967040687799454
. O 0 0.03699570894241333

A O 0 0.04685685783624649
gene O 0 0.030281145125627518
encoding O 0 0.024563290178775787
a O 0 0.02059280127286911
transmembrane O 0 0.24877439439296722
protein O 0 0.015303235501050949
is O 0 0.009817926213145256
mutated O 0 0.021336762234568596
in O 0 0.01084406953305006
patients O 1 0.9455998539924622
with O 1 0.9914911389350891
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999985694885254
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999986886978149
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.9008194208145142
. O 0 0.051846131682395935

Wolfram B-Disease 1 0.9999953508377075
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9986594915390015
WFS B-Disease 1 0.9999945163726807
; O 1 0.6756815314292908
OMIM O 1 0.9999771118164062
222300 O 1 0.9969184398651123
) O 0 0.02146988920867443
is O 0 0.015771491453051567
an O 0 0.2329951822757721
autosomal B-Disease 1 0.9999974966049194
recessive I-Disease 1 0.9999998807907104
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 1 0.9553369283676147
by O 1 0.6272211670875549
young O 1 0.999908447265625
- O 1 0.9999955892562866
onset O 1 0.9999985694885254
non O 1 0.9999803304672241
- O 1 0.9999995231628418
immune O 1 0.9999995231628418
insulin B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999995231628418
dependent I-Disease 1 0.9999277591705322
diabetes I-Disease 1 1.0
mellitus I-Disease 1 0.9999998807907104
and O 1 0.9995385408401489
progressive O 1 0.9999990463256836
optic B-Disease 1 0.9999997615814209
atrophy I-Disease 1 0.9999929666519165
. O 0 0.3001648485660553

Linkage O 0 0.10562748461961746
to O 0 0.0317671000957489
markers O 0 0.04824085533618927
on O 0 0.026783006265759468
chromosome O 1 0.5312862992286682
4p O 1 0.9985450506210327
was O 0 0.029021235182881355
confirmed O 0 0.017575053498148918
in O 0 0.014062371104955673
five O 0 0.019429251551628113
families O 0 0.03007533960044384
. O 0 0.03452688828110695

On O 0 0.023791709914803505
the O 0 0.017077255994081497
basis O 0 0.013727637939155102
of O 0 0.020336613059043884
meiotic O 1 0.999937891960144
recombinants O 1 0.999955415725708
and O 1 0.9698533415794373
disease O 1 0.9999994039535522
- O 1 0.9999861717224121
associated O 0 0.21905675530433655
haplotypes O 1 0.808240532875061
, O 0 0.012982460670173168
the O 0 0.02426447719335556
WFS B-Disease 1 0.9999674558639526
gene O 0 0.01855740323662758
was O 0 0.014196970500051975
localized O 0 0.02230580896139145
to O 0 0.012816821224987507
a O 0 0.0996415838599205
BAC O 1 0.9999886751174927
/ O 1 0.9999102354049683
P1 O 1 0.9978808164596558
contig O 1 0.6323375105857849
of O 0 0.015495387837290764
less O 0 0.01262484211474657
than O 0 0.01453855074942112
250 O 0 0.040678638964891434
kb O 0 0.20407143235206604
. O 0 0.04595338925719261

Mutations O 0 0.04739561676979065
in O 0 0.017419876530766487
a O 0 0.02070312388241291
novel O 0 0.03745624050498009
gene O 0 0.027256792411208153
( O 0 0.024766596034169197
WFS1 O 1 0.9811543822288513
) O 0 0.013506812043488026
encoding O 0 0.012531047686934471
a O 0 0.014636257663369179
putative O 1 0.5896943807601929
transmembrane O 0 0.37767666578292847
protein O 0 0.011618074029684067
were O 0 0.0058419955894351006
found O 0 0.005393157713115215
in O 0 0.004780841525644064
all O 0 0.005896829534322023
affected O 0 0.010093477554619312
individuals O 0 0.007032469380646944
in O 0 0.008166803047060966
six O 0 0.05146569758653641
WFS B-Disease 1 0.9999922513961792
families O 0 0.022944828495383263
, O 0 0.01040453277528286
and O 0 0.00795977283269167
these O 0 0.006155164912343025
mutations O 0 0.01079852506518364
were O 0 0.006891898810863495
associated O 0 0.011960061267018318
with O 0 0.018039781600236893
the O 1 0.9601966142654419
disease O 1 0.9999966621398926
phenotype O 1 0.9998120665550232
. O 0 0.06710799038410187

WFS1 O 1 0.9932072758674622
appears O 0 0.03804188221693039
to O 0 0.016609853133559227
function O 0 0.01335642859339714
in O 0 0.008689283393323421
survival O 0 0.023811137303709984
of O 0 0.01931046135723591
islet O 1 0.9999178647994995
beta O 1 0.9998633861541748
- O 1 0.9999839067459106
cells O 0 0.18158526718616486
and O 0 0.018570492044091225
neurons O 0 0.034656066447496414
. O 0 0.020146118476986885
. O 0 0.0321655347943306

Stable O 0 0.1049562394618988
interaction O 0 0.027068423107266426
between O 0 0.014090615324676037
the O 0 0.011839562095701694
products O 0 0.0120159350335598
of O 0 0.012418211437761784
the O 0 0.13055790960788727
BRCA1 O 1 0.9999076128005981
and O 1 0.8615370392799377
BRCA2 O 1 0.9999982118606567
tumor B-Disease 1 0.9999980926513672
suppressor O 1 0.9998323917388916
genes O 0 0.020285164937376976
in O 0 0.01767808571457863
mitotic O 1 0.9917771816253662
and O 0 0.08383572846651077
meiotic O 1 0.9999154806137085
cells O 1 0.633057177066803
. O 0 0.04731355980038643

BRCA1 O 1 0.999230146408081
and O 0 0.045326411724090576
BRCA2 O 1 0.9905698299407959
account O 0 0.01628468558192253
for O 0 0.009722442366182804
most O 0 0.007522341329604387
cases O 0 0.009532717987895012
of O 0 0.017342720180749893
familial O 1 0.9999334812164307
, O 0 0.09803003072738647
early O 1 0.7338449358940125
onset O 1 0.9999995231628418
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999569654464722
/ I-Disease 1 1.0
or I-Disease 1 0.9999964237213135
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9309377074241638
encode O 0 0.04207892715930939
products O 0 0.016037970781326294
that O 0 0.008247370831668377
each O 0 0.010337651707231998
interact O 0 0.02031984180212021
with O 0 0.02215328998863697
hRAD51 O 1 0.7775899767875671
. O 0 0.045767948031425476

Results O 0 0.023418091237545013
presented O 0 0.02047550491988659
here O 0 0.013780140317976475
show O 0 0.015760326758027077
that O 0 0.011590410023927689
BRCA1 O 1 0.9926245808601379
and O 0 0.024453260004520416
BRCA2 O 1 0.9949007034301758
coexist O 0 0.02921627089381218
in O 0 0.011127641424536705
a O 0 0.01571568287909031
biochemical O 0 0.03172057867050171
complex O 0 0.017355525866150856
and O 0 0.012826385907828808
colocalize O 1 0.929597795009613
in O 0 0.01509192306548357
subnuclear O 1 0.9994661211967468
foci O 1 0.9959033131599426
in O 0 0.018850071355700493
somatic O 1 0.9706640839576721
cells O 0 0.016460122540593147
and O 0 0.008839030750095844
on O 0 0.009852186776697636
the O 0 0.012681961059570312
axial O 0 0.03664085268974304
elements O 0 0.017704466357827187
of O 0 0.0217546708881855
developing O 0 0.4305078089237213
synaptonemal O 1 0.999468982219696
complexes O 1 0.9079084992408752
. O 0 0.0448325015604496

Like O 0 0.07399813085794449
BRCA1 O 1 0.9954627156257629
and O 0 0.053386278450489044
RAD51 O 1 0.9998683929443359
, O 0 0.053210724145174026
BRCA2 O 1 0.9970721006393433
relocates O 1 0.940188467502594
to O 0 0.03433779627084732
PCNA O 1 0.9997418522834778
+ O 0 0.488081693649292
replication O 0 0.03350883722305298
sites O 0 0.013488944619894028
following O 0 0.013126897625625134
exposure O 0 0.0277523472905159
of O 0 0.02472977712750435
S O 1 0.9998725652694702
phase O 1 0.9800293445587158
cells O 0 0.040857430547475815
to O 0 0.026377789676189423
hydroxyurea O 1 0.9995068311691284
or O 0 0.14170795679092407
UV O 1 0.9998884201049805
irradiation O 1 0.8641840815544128
. O 0 0.05476817116141319

Thus O 0 0.040976814925670624
, O 0 0.03928104043006897
BRCA1 O 1 0.9966296553611755
and O 0 0.02967657893896103
BRCA2 O 1 0.9926879405975342
participate O 0 0.017994893714785576
, O 0 0.01024549175053835
together O 0 0.009244932793080807
, O 0 0.00763738015666604
in O 0 0.007352087646722794
a O 0 0.018730618059635162
pathway O 1 0.9878906011581421
( O 0 0.2337784767150879
s O 1 0.8786406517028809
) O 0 0.009176292456686497
associated O 0 0.006231625564396381
with O 0 0.005815902724862099
the O 0 0.008950169198215008
activation O 0 0.016467779874801636
of O 0 0.011889740824699402
double O 0 0.4482903480529785
- O 1 0.9990410208702087
strand O 0 0.38179150223731995
break O 0 0.19311058521270752
repair O 1 0.9965032339096069
and O 0 0.05552081763744354
/ O 1 0.9985100626945496
or O 0 0.02982242964208126
homologous O 0 0.0893535166978836
recombination O 0 0.0861736536026001
. O 0 0.0453050471842289

Dysfunction O 1 0.9994947910308838
of O 0 0.04476318880915642
this O 0 0.029698580503463745
pathway O 1 0.9892143607139587
may O 0 0.013011871837079525
be O 0 0.0066194734536111355
a O 0 0.009730372577905655
general O 0 0.013097681105136871
phenomenon O 0 0.013657554052770138
in O 0 0.005830157082527876
the O 0 0.0062164184637367725
majority O 0 0.0069555132649838924
of O 0 0.007729870267212391
cases O 0 0.010778103955090046
of O 1 0.8100353479385376
hereditary B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 0.999996542930603
/ I-Disease 1 1.0
or I-Disease 1 0.9999959468841553
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.5059346556663513
. O 0 0.04663281887769699

A O 0 0.06104464456439018
novel O 0 0.06529544293880463
Arg362Ser O 1 0.789964497089386
mutation O 0 0.03091486543416977
in O 0 0.01381300762295723
the O 0 0.018066193908452988
sterol O 1 0.879416286945343
27 O 0 0.067559614777565
- O 1 0.9996355772018433
hydroxylase O 1 0.9992077946662903
gene O 0 0.03371322900056839
( O 0 0.02586446888744831
CYP27 O 1 0.9878798127174377
) O 0 0.01488548330962658
: O 0 0.009887821041047573
its O 0 0.008221271447837353
effects O 0 0.012348341755568981
on O 0 0.011928265914320946
pre O 0 0.3902088403701782
- O 1 0.9930665493011475
mRNA O 0 0.030759934335947037
splicing O 0 0.027992425486445427
and O 0 0.019679803401231766
enzyme O 0 0.0348488949239254
activity O 0 0.0309563297778368
. O 0 0.03332855924963951

A O 0 0.06100229546427727
novel O 0 0.06013268604874611
C O 0 0.09704245626926422
to O 0 0.016016758978366852
A O 0 0.020299747586250305
mutation O 0 0.016770433634519577
in O 0 0.008711928501725197
the O 0 0.01446770504117012
sterol O 0 0.3244900405406952
27 O 0 0.03739096224308014
- O 1 0.9993100166320801
hydroxylase O 1 0.9975792765617371
gene O 0 0.028378518298268318
( O 0 0.024578280746936798
CYP27 O 1 0.9693426489830017
) O 0 0.01409921608865261
was O 0 0.013291286304593086
identified O 0 0.011574896983802319
by O 0 0.010878993198275566
sequencing O 0 0.025185056030750275
amplified O 0 0.04289523512125015
CYP27 O 1 0.9745258092880249
gene O 0 0.018529338762164116
products O 0 0.013331293128430843
from O 0 0.010424199514091015
a O 0 0.018196629360318184
patient O 1 0.9665162563323975
with O 0 0.18713541328907013
cerebrotendinous B-Disease 1 0.9999876022338867
xanthomatosis I-Disease 1 0.9999936819076538
( O 1 0.9941873550415039
CTX B-Disease 1 0.9999727010726929
) O 0 0.05580531433224678
. O 0 0.04736536368727684

The O 0 0.05025406926870346
mutation O 0 0.049677737057209015
changed O 0 0.028688563033938408
the O 0 0.02971670962870121
adrenodoxin O 1 0.9964820146560669
cofactor O 1 0.9897145628929138
binding O 0 0.033057063817977905
residue O 0 0.05109265446662903
362Arg O 0 0.0821366086602211
to O 0 0.02052348293364048
362Ser O 1 0.7580885887145996
( O 0 0.034110069274902344
CGT O 1 0.994886577129364
362Arg O 1 0.9368269443511963
to O 0 0.033452097326517105
AGT O 1 0.9999949932098389
362Ser O 1 0.9974061846733093
) O 0 0.016621267423033714
, O 0 0.010311534628272057
and O 0 0.008410416543483734
was O 0 0.015202449634671211
responsible O 0 0.030414920300245285
for O 0 0.020381953567266464
deficiency O 1 0.9999806880950928
in O 0 0.011690553277730942
the O 0 0.02475946769118309
sterol O 1 0.9972516894340515
27 O 1 0.7967047691345215
- O 1 0.999937891960144
hydroxylase O 1 0.9923887848854065
activity O 0 0.013153058476746082
, O 0 0.008313026279211044
as O 0 0.006720550358295441
confirmed O 0 0.008142604492604733
by O 0 0.007063788361847401
expression O 0 0.010177234187722206
of O 0 0.011828097514808178
mutant O 0 0.04574291780591011
cDNA O 0 0.050259046256542206
into O 0 0.03088722564280033
COS O 1 0.9997923970222473
- O 1 0.9981389045715332
1 O 0 0.04884698614478111
cells O 0 0.03829628974199295
. O 0 0.033881768584251404

Quantitative O 0 0.044605571776628494
analysis O 0 0.01808822527527809
showed O 0 0.014206789433956146
that O 0 0.006703110411763191
the O 0 0.010108745656907558
expression O 0 0.013505605049431324
of O 0 0.015907684341073036
CYP27 O 1 0.9995238780975342
gene O 0 0.019887901842594147
mRNA O 0 0.018488654866814613
in O 0 0.010565342381596565
the O 0 0.016749108210206032
patient O 1 0.6340084075927734
represented O 0 0.03182386979460716
52 O 0 0.05108673870563507
. O 0 0.03828810527920723

5 O 0 0.04782038927078247
% O 0 0.026234425604343414
of O 0 0.022155748680233955
the O 0 0.028451066464185715
normal O 0 0.03811757639050484
level O 0 0.04417186602950096
. O 0 0.0393933542072773

As O 0 0.029094446450471878
the O 0 0.02296409010887146
mutation O 0 0.027643976733088493
occurred O 0 0.016713587567210197
at O 0 0.012003209441900253
the O 0 0.012387162074446678
penultimate O 1 0.8224701881408691
nucleotide O 0 0.020583344623446465
of O 0 0.01331909280270338
exon O 0 0.1366502344608307
6 O 0 0.023856282234191895
( O 0 0.017975347116589546
- O 0 0.03227071464061737
2 O 0 0.011446291580796242
position O 0 0.01048775389790535
of O 0 0.01094795297831297
exon O 0 0.04133746773004532
6 O 0 0.029985370114445686
- O 1 0.9905321598052979
intron O 1 0.9873207807540894
6 O 0 0.02530757524073124
splice O 0 0.03330441936850548
site O 0 0.013563883490860462
) O 0 0.0076591093093156815
of O 0 0.007362984120845795
the O 0 0.009978165850043297
gene O 0 0.011639941483736038
, O 0 0.007848001085221767
we O 0 0.007088641636073589
hypothesized O 0 0.013170077465474606
that O 0 0.005256527103483677
the O 0 0.009901830926537514
mutation O 0 0.07458335161209106
may O 0 0.009451443329453468
partially O 0 0.016108350828289986
affect O 0 0.008971401490271091
the O 0 0.008695348165929317
normal O 0 0.01285073533654213
splicing O 0 0.017145156860351562
efficiency O 0 0.014485924504697323
in O 0 0.008587743155658245
exon O 0 0.03881809115409851
6 O 0 0.016053805127739906
and O 0 0.011393685825169086
cause O 0 0.02146637812256813
alternative O 0 0.016965782269835472
splicing O 0 0.019066426903009415
elsewhere O 0 0.011480886489152908
, O 0 0.008494543842971325
which O 0 0.007298668846487999
resulted O 0 0.012396713718771935
in O 0 0.010782674886286259
decreased O 0 0.03184450417757034
transcript O 0 0.028927993029356003
in O 0 0.01389949582517147
the O 0 0.026748977601528168
patient O 1 0.9898682832717896
. O 0 0.04408328980207443

Transfection O 1 0.6548553705215454
of O 0 0.04245978221297264
constructed O 0 0.21129703521728516
minigenes O 1 0.9854143857955933
, O 0 0.016606559976935387
with O 0 0.010633897967636585
or O 0 0.008707268163561821
without O 0 0.0064308010041713715
the O 0 0.008953284472227097
mutation O 0 0.014161969535052776
, O 0 0.00889917928725481
into O 0 0.013389605097472668
COS O 1 0.9999889135360718
- O 1 0.9985620379447937
1 O 0 0.015386110171675682
cells O 0 0.008263216353952885
confirmed O 0 0.007007281295955181
that O 0 0.004317175596952438
the O 0 0.009248003363609314
mutant O 0 0.17976650595664978
minigene O 1 0.9581459164619446
was O 0 0.015535157173871994
responsible O 0 0.01280565932393074
for O 0 0.007845362648367882
a O 0 0.010991928167641163
mRNA O 0 0.015070858411490917
species O 0 0.007289608474820852
alternatively O 0 0.014820072799921036
spliced O 0 0.018858173862099648
at O 0 0.011747644282877445
an O 0 0.014248821884393692
activated O 0 0.172834113240242
cryptic O 0 0.04816306009888649
5 O 0 0.024407515302300453
splice O 0 0.04818601906299591
site O 0 0.024515455588698387
88 O 0 0.0334659069776535
bp O 0 0.031702324748039246
upstream O 0 0.020113518461585045
from O 0 0.009665184654295444
the O 0 0.011752212420105934
3 O 0 0.017962388694286346
end O 0 0.020578855648636818
of O 0 0.02597849816083908
exon O 0 0.26225021481513977
6 O 0 0.05384137108922005
. O 0 0.04096595197916031

Our O 0 0.03600206971168518
data O 0 0.015600083395838737
suggest O 0 0.01341935619711876
that O 0 0.006960323546081781
the O 0 0.011080171912908554
C O 0 0.03136197105050087
to O 0 0.009260445833206177
A O 0 0.01733088679611683
mutation O 0 0.015391949564218521
at O 0 0.010231271386146545
the O 0 0.0110623799264431
penultimate O 1 0.882965087890625
nucleotide O 0 0.018626602366566658
of O 0 0.011528268456459045
exon O 0 0.02895413711667061
6 O 0 0.012476279400289059
of O 0 0.01017675455659628
the O 0 0.015146533027291298
CYP27 O 1 0.9992862343788147
gene O 0 0.014092615805566311
not O 0 0.0060319239273667336
only O 0 0.007530961185693741
causes O 0 0.2925804853439331
the O 0 0.14892762899398804
deficiency B-Disease 1 0.9999973773956299
in I-Disease 0 0.012010236270725727
the I-Disease 0 0.09674178808927536
sterol I-Disease 1 0.9993224143981934
27 I-Disease 1 0.8141636252403259
- I-Disease 1 0.9998695850372314
hydroxylase I-Disease 1 0.9935566782951355
activity I-Disease 0 0.013462208211421967
, O 0 0.009152434766292572
but O 0 0.006431938149034977
also O 0 0.007740016095340252
partially O 0 0.015899883583188057
leads O 0 0.014977500773966312
to O 0 0.009125810116529465
alternative O 0 0.01575162261724472
pre O 0 0.0632675513625145
- O 1 0.7272077798843384
mRNA O 0 0.02340337447822094
splicing O 0 0.018747752532362938
of O 0 0.015011277981102467
the O 0 0.02158745750784874
gene O 0 0.032855357974767685
. O 0 0.029889415949583054

To O 0 0.02965405583381653
our O 0 0.02266143076121807
knowledge O 0 0.017420785501599312
, O 0 0.010420531965792179
this O 0 0.00671981880441308
is O 0 0.006833743769675493
the O 0 0.006927875801920891
first O 0 0.008467393927276134
report O 0 0.007890397682785988
regarding O 0 0.009632056578993797
effects O 0 0.011011840775609016
on O 0 0.009076125919818878
pre O 0 0.4157724380493164
- O 1 0.8203893899917603
mRNA O 0 0.01674354076385498
splicing O 0 0.013048228807747364
of O 0 0.007652479223906994
a O 0 0.009706652723252773
mutation O 0 0.012939509935677052
at O 0 0.009512937627732754
the O 0 0.01123036164790392
- O 1 0.8663817644119263
2 O 0 0.011768621392548084
position O 0 0.011430181562900543
of O 0 0.010476182214915752
a O 0 0.01765316165983677
5 O 0 0.02843954786658287
splice O 0 0.06805786490440369
site O 0 0.04154429957270622
. O 0 0.03224898502230644

ATM O 0 0.1874956637620926
germline O 0 0.12285342812538147
mutations O 0 0.04031173884868622
in O 0 0.024117326363921165
classical O 1 0.9247685670852661
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.999514102935791
in O 0 0.020367611199617386
the O 0 0.030505353584885597
Dutch O 0 0.25058138370513916
population O 0 0.0283737201243639
. O 0 0.032248467206954956

Germline O 1 0.7230995297431946
mutations O 0 0.03631738945841789
in O 0 0.014886210672557354
the O 0 0.0193711519241333
ATM O 1 0.5253555178642273
gene O 0 0.012903662398457527
are O 0 0.004707954358309507
responsible O 0 0.011595492251217365
for O 0 0.010950318537652493
the O 1 0.6731722950935364
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999874830245972
A B-Disease 1 0.9999980926513672
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999797344207764
) O 0 0.03411458060145378
. O 0 0.03340870141983032

In O 0 0.026519086211919785
our O 0 0.023715082556009293
study O 0 0.015044932253658772
, O 0 0.009546211920678616
we O 0 0.006546378135681152
have O 0 0.004863215610384941
determined O 0 0.00915216188877821
the O 0 0.010896812193095684
ATM O 0 0.07025966793298721
mutation O 0 0.014457863755524158
spectrum O 0 0.012481297366321087
in O 0 0.006462016608566046
19 O 0 0.012256857007741928
classical O 0 0.018891451880335808
A B-Disease 1 0.9992731213569641
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999978542327881
patients O 1 0.9730755686759949
, O 0 0.008102638646960258
including O 0 0.006651665084064007
some O 0 0.0054732030257582664
immigrant O 0 0.057652052491903305
populations O 0 0.009136698208749294
, O 0 0.007498470135033131
as O 0 0.006468234118074179
well O 0 0.006822512950748205
as O 0 0.006409117951989174
12 O 0 0.010014047846198082
of O 0 0.013138892129063606
Dutch O 0 0.03475864231586456
ethnic O 0 0.02774122729897499
origin O 0 0.025688350200653076
. O 0 0.030989589169621468

Both O 0 0.0243949256837368
the O 0 0.025658661499619484
protein O 0 0.02563651092350483
truncation O 0 0.14924301207065582
test O 0 0.03286929428577423
( O 0 0.028723301365971565
PTT O 1 0.6395492553710938
) O 0 0.011834915727376938
and O 0 0.008381706662476063
the O 0 0.012692680582404137
restriction O 0 0.02607606165111065
endonuclease O 1 0.9826266169548035
fingerprinting O 1 0.8214516639709473
( O 0 0.25211572647094727
REF O 1 0.9985983967781067
) O 0 0.01249972078949213
method O 0 0.008399964310228825
were O 0 0.0055478960275650024
used O 0 0.005591587629169226
and O 0 0.005623896140605211
compared O 0 0.006782735697925091
for O 0 0.006350844632834196
their O 0 0.007761120330542326
detection O 0 0.022443201392889023
efficiency O 0 0.01714531145989895
, O 0 0.009465019218623638
identifying O 0 0.01377465296536684
76 O 0 0.021216798573732376
% O 0 0.010103898122906685
and O 0 0.007902489975094795
60 O 0 0.010726455599069595
% O 0 0.009583945386111736
of O 0 0.010689299553632736
the O 0 0.019823014736175537
mutations O 0 0.03170701488852501
, O 0 0.021074863150715828
respectively O 0 0.031221430748701096
. O 0 0.03375713899731636

Most O 0 0.04246663674712181
patients O 1 0.5218689441680908
were O 0 0.015446378849446774
found O 0 0.014086540788412094
to O 0 0.014978056773543358
be O 0 0.017991570755839348
compound O 0 0.08328764885663986
heterozygote O 1 0.8575348854064941
. O 0 0.049673475325107574

Seventeen O 0 0.08217883110046387
mutations O 0 0.03454882651567459
were O 0 0.014216363430023193
distinct O 0 0.013808644376695156
, O 0 0.010255732573568821
of O 0 0.009852776303887367
which O 0 0.009202281013131142
10 O 0 0.010911144316196442
were O 0 0.008756257593631744
not O 0 0.008887074887752533
reported O 0 0.016823163256049156
previously O 0 0.02574079856276512
. O 0 0.030819764360785484

Mutations O 0 0.05203721672296524
are O 0 0.015114258974790573
small O 0 0.02165188081562519
deletions O 0 0.0465906485915184
or O 0 0.01935366354882717
point O 0 0.02551153488457203
mutations O 0 0.02941180020570755
frequently O 0 0.022509468719363213
affecting O 0 0.04218657314777374
splice O 0 0.09913547337055206
sites O 0 0.033483799546957016
. O 0 0.03196018561720848

Moreover O 0 0.07590670138597488
, O 0 0.03750409930944443
a O 0 0.042275067418813705
16 O 0 0.05406288802623749
. O 0 0.04632101580500603

7 O 0 0.0758698582649231
- O 1 0.9913914203643799
kb O 1 0.7110049724578857
genomic O 0 0.03876993805170059
deletion O 0 0.02839878760278225
of O 0 0.011638587340712547
the O 0 0.010718797333538532
3 O 0 0.01067116018384695
end O 0 0.010626750998198986
of O 0 0.00866496842354536
the O 0 0.016518576070666313
gene O 0 0.012769149616360664
, O 0 0.0062552220188081264
most O 0 0.005253348965197802
likely O 0 0.006466319784522057
a O 0 0.007114045321941376
result O 0 0.007837142795324326
of O 0 0.010495704598724842
recombination O 0 0.024901429191231728
between O 0 0.011134580709040165
two O 0 0.010043423622846603
LINE O 0 0.045195482671260834
elements O 0 0.017936334013938904
, O 0 0.01671079732477665
was O 0 0.026133885607123375
identified O 0 0.031282760202884674
. O 0 0.03039330057799816

The O 0 0.03006327897310257
most O 0 0.01569591462612152
frequently O 0 0.017695249989628792
found O 0 0.011654901318252087
mutation O 0 0.016993926838040352
, O 0 0.00847624521702528
identified O 0 0.007804833352565765
in O 0 0.004966475535184145
three O 0 0.005939829628914595
unrelated O 0 0.014655058272182941
Turkish O 0 0.03693872317671776
A B-Disease 1 0.9995453953742981
- I-Disease 1 0.9999984502792358
T I-Disease 1 0.9999747276306152
individuals O 0 0.010906519368290901
, O 0 0.00944290217012167
was O 0 0.013083985075354576
previously O 0 0.009382485412061214
described O 0 0.00836286973208189
to O 0 0.006084934808313847
be O 0 0.0052892002277076244
a O 0 0.009746793657541275
Turkish O 0 0.023731082677841187
A B-Disease 1 0.9922775030136108
- I-Disease 1 0.999988317489624
T I-Disease 1 0.9999610185623169
founder O 1 0.997761607170105
mutation O 0 0.19714023172855377
. O 0 0.03786274418234825

The O 0 0.02751290239393711
presence O 0 0.023853546008467674
of O 0 0.01603149250149727
a O 0 0.12300184369087219
founder O 1 0.9996346235275269
mutation O 0 0.36504262685775757
among O 0 0.012775631621479988
relatively O 0 0.010434318333864212
small O 0 0.007914775982499123
ethnic O 0 0.010398476384580135
population O 0 0.00826366525143385
groups O 0 0.006958780810236931
in O 0 0.006526780314743519
Western O 0 0.010823888704180717
Europe O 0 0.011606231331825256
could O 0 0.006995668634772301
indicate O 0 0.00877849105745554
a O 0 0.010195947252213955
high O 0 0.05133485049009323
carrier O 1 0.7060917019844055
frequency O 0 0.013880821876227856
in O 0 0.010605024173855782
such O 0 0.013126272708177567
communities O 0 0.026074295863509178
. O 0 0.03221647068858147

In O 0 0.029440272599458694
patients O 0 0.08027581125497818
of O 0 0.018868105486035347
Dutch O 0 0.24763868749141693
ethnic O 0 0.022042643278837204
origin O 0 0.009966203942894936
, O 0 0.008671115152537823
however O 0 0.0062601445242762566
, O 0 0.0069135092198848724
no O 0 0.007609131745994091
significant O 0 0.010775698348879814
founder O 1 0.9856786131858826
effect O 0 0.017925838008522987
could O 0 0.011554771102964878
be O 0 0.01160214003175497
identified O 0 0.025394340977072716
. O 0 0.028879541903734207

The O 0 0.0390390045940876
observed O 0 0.031753670424222946
genetic O 0 0.0239570215344429
heterogeneity O 0 0.04107511788606644
including O 0 0.011357327923178673
the O 0 0.011606723070144653
relative O 0 0.014425489120185375
high O 0 0.015690801665186882
percentage O 0 0.012828059494495392
of O 0 0.01465055625885725
splice O 1 0.9598618745803833
- O 1 0.9976958632469177
site O 0 0.021460849791765213
mutations O 0 0.012822989374399185
had O 0 0.009910848923027515
no O 0 0.010969143360853195
reflection O 0 0.027217518538236618
on O 0 0.01554170623421669
the O 0 0.026536162942647934
phenotype O 1 0.7435268759727478
. O 0 0.033588796854019165

All O 0 0.036661215126514435
patients O 0 0.4905792772769928
manifested O 1 0.8167554140090942
classical O 1 0.5061797499656677
A B-Disease 1 0.9998552799224854
- I-Disease 1 0.9999977350234985
T I-Disease 1 0.9999263286590576
and O 0 0.019393684342503548
increased O 0 0.02818261831998825
cellular O 0 0.22831664979457855
radioresistant O 1 0.9866181015968323
DNA O 0 0.03762974590063095
synthesis O 0 0.04255371540784836
. O 0 0.03458312898874283

Determination O 0 0.05717040225863457
of O 0 0.024234408512711525
the O 0 0.022256748750805855
genomic O 0 0.03215640038251877
structure O 0 0.017290903255343437
of O 0 0.014004627242684364
the O 0 0.039674632251262665
COL4A4 O 1 0.9999006986618042
gene O 0 0.016821198165416718
and O 0 0.010900481604039669
of O 0 0.017736580222845078
novel O 1 0.7103784680366516
mutations O 1 0.964792788028717
causing O 1 0.9997443556785583
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9980529546737671

Autosomal B-Disease 1 0.999990701675415
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9951843619346619
a O 1 0.9995482563972473
progressive O 1 0.9999994039535522
hematuric B-Disease 1 0.9999997615814209
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9998871088027954
by O 1 0.9960708618164062
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999991655349731
membrane I-Disease 1 0.9999547004699707
abnormalities I-Disease 1 0.999886155128479
and O 0 0.018577029928565025
associated O 0 0.012324114330112934
with O 0 0.008880005218088627
mutations O 0 0.01061889249831438
in O 0 0.005896790884435177
either O 0 0.007750745862722397
the O 0 0.01074986346065998
COL4A3 O 1 0.9993239641189575
or O 0 0.01118704304099083
the O 0 0.018424533307552338
COL4A4 O 1 0.9999032020568848
gene O 0 0.012805634178221226
, O 0 0.00789099931716919
which O 0 0.0062011596746742725
encode O 0 0.0113113047555089
the O 0 0.012493305839598179
alpha3 O 0 0.13611666858196259
and O 0 0.022103633731603622
alpha4 O 1 0.9994422793388367
type O 1 0.9994086027145386
IV O 1 0.9999994039535522
collagen O 1 0.9999948740005493
chains O 1 0.9218406677246094
, O 0 0.037390198558568954
respectively O 0 0.041874390095472336
. O 0 0.03935587778687477

To O 0 0.026109781116247177
date O 0 0.02268924191594124
, O 0 0.016535013914108276
mutation O 0 0.023926256224513054
screening O 0 0.01990670897066593
in O 0 0.007561061531305313
the O 0 0.007980886846780777
two O 0 0.007461564615368843
genes O 0 0.009074512869119644
has O 0 0.00700946431607008
been O 0 0.0077509805560112
hampered O 0 0.06803847849369049
by O 0 0.009114176034927368
the O 0 0.012379073537886143
lack O 0 0.027243468910455704
of O 0 0.04272675886750221
genomic O 1 0.5354651212692261
structure O 0 0.04595508798956871
information O 0 0.022446034476161003
. O 0 0.028472833335399628

We O 0 0.029079660773277283
report O 0 0.019199613481760025
here O 0 0.01395826879888773
the O 0 0.01264167483896017
complete O 0 0.017245251685380936
characterization O 0 0.01833268254995346
of O 0 0.01041353214532137
the O 0 0.011265786364674568
48 O 0 0.016541598364710808
exons O 0 0.01950993575155735
of O 0 0.01013972982764244
the O 0 0.016351966187357903
COL4A4 O 1 0.9997218251228333
gene O 0 0.01426117867231369
, O 0 0.008901901543140411
a O 0 0.011142909526824951
comprehensive O 0 0.34875842928886414
gene O 0 0.014733957126736641
screen O 0 0.015065127052366734
, O 0 0.0075330850668251514
and O 0 0.006898857653141022
the O 0 0.008242901414632797
subsequent O 0 0.013062506914138794
detection O 0 0.01637444645166397
of O 0 0.00975487008690834
10 O 0 0.011447927914559841
novel O 0 0.01738809235394001
mutations O 0 0.0143373878672719
in O 0 0.010791008360683918
eight O 0 0.03176833689212799
patients O 1 0.9999207258224487
diagnosed O 1 0.9999995231628418
with O 1 0.9999388456344604
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996896982192993

Furthermore O 0 0.054531924426555634
, O 0 0.020362598821520805
we O 0 0.013643032871186733
identified O 0 0.015003404580056667
a O 0 0.016112567856907845
glycine O 0 0.03371093422174454
to O 0 0.012953683733940125
alanine O 0 0.0411016084253788
substitution O 0 0.02176455222070217
in O 0 0.010892926715314388
the O 0 0.020615611225366592
collagenous O 1 0.9999333620071411
domain O 0 0.028700044378638268
that O 0 0.008402736857533455
is O 0 0.00875026360154152
apparently O 0 0.012947197072207928
silent O 0 0.023073630407452583
in O 0 0.008572101593017578
the O 0 0.014810335822403431
heterozygous O 0 0.04582034423947334
carriers O 0 0.028582483530044556
, O 0 0.014559312723577023
in O 0 0.015068083070218563
11 O 0 0.03169139474630356
. O 0 0.03166871517896652

5 O 0 0.031618840992450714
% O 0 0.016604246571660042
of O 0 0.011860678903758526
all O 0 0.011018885299563408
control O 0 0.020967576652765274
individuals O 0 0.009863394312560558
, O 0 0.008352674543857574
and O 0 0.00712769478559494
in O 0 0.006578079424798489
one O 0 0.00881381705403328
control O 0 0.014566839672625065
individual O 0 0.012069392949342728
homozygous O 0 0.02582920715212822
for O 0 0.01310494914650917
this O 0 0.01660899631679058
glycine O 0 0.09917037934064865
substitution O 0 0.057293377816677094
. O 0 0.03991328179836273

There O 0 0.02326146326959133
has O 0 0.014739912003278732
been O 0 0.009847852401435375
no O 0 0.00766654871404171
previous O 0 0.008641228079795837
finding O 0 0.010458766482770443
of O 0 0.009458538144826889
a O 0 0.017117563635110855
glycine O 1 0.8060160279273987
substitution O 0 0.021638022735714912
that O 0 0.005699531640857458
is O 0 0.006117679178714752
not O 0 0.00439794734120369
associated O 0 0.007052589673548937
with O 0 0.007320086006075144
any O 0 0.010877104476094246
obvious O 0 0.3845798969268799
phenotype O 1 0.9652674198150635
in O 0 0.020470982417464256
homozygous O 0 0.17598487436771393
individuals O 0 0.030556444078683853
. O 0 0.04227674379944801

Founder O 1 0.9938530921936035
BRCA1 O 1 0.9972937703132629
and O 0 0.04369550198316574
BRCA2 O 1 0.9841342568397522
mutations O 0 0.028787344694137573
in O 0 0.01582052931189537
French O 0 0.46094685792922974
Canadian O 1 0.9988842606544495
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999921321868896
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9986425042152405
. O 1 0.5421581864356995

We O 0 0.020472630858421326
have O 0 0.00885014794766903
identified O 0 0.011252250522375107
four O 0 0.008226887322962284
mutations O 0 0.008877202868461609
in O 0 0.004714044742286205
each O 0 0.00446522468701005
of O 0 0.008097998797893524
the O 1 0.8388136029243469
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9999998807907104
susceptibility O 1 0.9999954700469971
genes O 0 0.21611186861991882
, O 0 0.030975427478551865
BRCA1 O 1 0.9975162744522095
and O 0 0.014249760657548904
BRCA2 O 1 0.8694989681243896
, O 0 0.008891856297850609
in O 0 0.0078004105016589165
French O 0 0.029427403584122658
Canadian O 1 0.9625424146652222
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999998807907104
and O 1 0.9999864101409912
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9917412996292114
from O 0 0.19059638679027557
Quebec O 1 0.9156820178031921
. O 0 0.04696652665734291

To O 0 0.038087520748376846
identify O 0 0.041173916310071945
founder O 1 0.9244216680526733
effects O 0 0.03279874101281166
, O 0 0.013024939224123955
we O 0 0.009995785541832447
examined O 0 0.016110165044665337
independently O 0 0.01160021498799324
ascertained O 0 0.025513170287013054
French O 0 0.03307383880019188
Canadian O 0 0.40670832991600037
cancer B-Disease 1 0.9997236132621765
families O 0 0.01423183549195528
for O 0 0.008907620795071125
the O 0 0.011985997669398785
distribution O 0 0.012412229552865028
of O 0 0.012695232406258583
these O 0 0.011168948374688625
eight O 0 0.024524157866835594
mutations O 0 0.039147935807704926
. O 0 0.03203144297003746

Mutations O 0 0.050629422068595886
were O 0 0.016300857067108154
found O 0 0.01225193403661251
in O 0 0.011894145049154758
41 O 0 0.027039486914873123
of O 0 0.024089980870485306
97 O 0 0.2207864671945572
families O 0 0.04182448983192444
. O 0 0.04063783586025238

Six O 0 0.03195575624704361
of O 0 0.02179783023893833
eight O 0 0.02423713728785515
mutations O 0 0.0224388986825943
were O 0 0.011288308538496494
observed O 0 0.0160048957914114
at O 0 0.01669967547059059
least O 0 0.019182128831744194
twice O 0 0.03283659368753433
. O 0 0.0338033027946949

The O 0 0.06539841741323471
BRCA1 O 1 0.9993928670883179
C4446T O 1 0.998394787311554
mutation O 0 0.15394902229309082
was O 0 0.019976751878857613
the O 0 0.013177765533328056
most O 0 0.010387304238975048
common O 0 0.015365601517260075
mutation O 0 0.02361484058201313
found O 0 0.008629271760582924
, O 0 0.008586800657212734
followed O 0 0.013118485920131207
by O 0 0.014693668112158775
the O 0 0.0460076630115509
BRCA2 O 1 0.9996883869171143
8765delAG O 1 0.999288022518158
mutation O 0 0.4212867021560669
. O 0 0.04756000265479088

Together O 0 0.03435400500893593
, O 0 0.018938245251774788
these O 0 0.010099602863192558
mutations O 0 0.01361849159002304
were O 0 0.006512674503028393
found O 0 0.006096308585256338
in O 0 0.006572948768734932
28 O 0 0.011213155463337898
of O 0 0.010442867875099182
41 O 0 0.023141222074627876
families O 0 0.014384194277226925
identified O 0 0.012873179279267788
to O 0 0.01047976128757
have O 0 0.010110950097441673
a O 0 0.021970165893435478
mutation O 0 0.048095446079969406
. O 0 0.03441453352570534

The O 0 0.034417953342199326
odds O 0 0.040658921003341675
of O 0 0.019400227814912796
detection O 0 0.025270352140069008
of O 0 0.010358752682805061
any O 0 0.008034096099436283
of O 0 0.00929966103285551
the O 0 0.015518087893724442
four O 0 0.04677524045109749
BRCA1 O 1 0.9998334646224976
mutations O 0 0.03730247914791107
was O 0 0.03019009344279766
18 O 0 0.03497636318206787
. O 0 0.03590787202119827

7x O 1 0.9958821535110474
greater O 0 0.032473016530275345
if O 0 0.014066880568861961
one O 0 0.009840667247772217
or O 0 0.007436786778271198
more O 0 0.006051088683307171
cases O 0 0.049054231494665146
of O 1 0.9998877048492432
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.1266610473394394
also O 0 0.013266625814139843
present O 0 0.012765772640705109
in O 0 0.011779152788221836
the O 0 0.021628214046359062
family O 0 0.05771314352750778
. O 0 0.036650992929935455

The O 0 0.03509693965315819
odds O 0 0.03977065160870552
of O 0 0.017943399026989937
detection O 0 0.023606393486261368
of O 0 0.009989925660192966
any O 0 0.00792981218546629
of O 0 0.011221569962799549
the O 0 0.01590091362595558
four O 0 0.024134548380970955
BRCA2 O 1 0.9982176423072815
mutations O 0 0.03846883773803711
was O 0 0.03700849041342735
5 O 0 0.03644926846027374
. O 0 0.03302021697163582

3x O 1 0.9492014646530151
greater O 0 0.0333285890519619
if O 0 0.013912155292928219
there O 0 0.0075905341655015945
were O 0 0.005461064167320728
at O 0 0.006135779898613691
least O 0 0.004954867530614138
five O 0 0.007522298023104668
cases O 0 0.014532574452459812
of O 1 0.9824701547622681
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
in O 0 0.36212828755378723
the O 1 0.6631331443786621
family O 1 0.8652603030204773
. O 0 0.040623437613248825

Interestingly O 0 0.05708020180463791
, O 0 0.016241027042269707
the O 0 0.012052269652485847
presence O 0 0.014287359081208706
of O 0 0.020422065630555153
a O 1 0.9966564178466797
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
case O 1 0.9990575909614563
< O 1 0.9995265007019043
36 O 0 0.01573941484093666
years O 0 0.008643356151878834
of O 0 0.00929342582821846
age O 0 0.016030246391892433
was O 0 0.014810504391789436
strongly O 0 0.011645417660474777
predictive O 0 0.013831233605742455
of O 0 0.008068873547017574
the O 0 0.008878694847226143
presence O 0 0.010567571967840195
of O 0 0.008006568998098373
any O 0 0.007556489668786526
of O 0 0.010156447067856789
the O 0 0.016576144844293594
eight O 0 0.02842322736978531
mutations O 0 0.04025157913565636
screened O 0 0.08189182728528976
. O 0 0.03598376736044884

Carriers O 0 0.04409237205982208
of O 0 0.018470387905836105
the O 0 0.014458265155553818
same O 0 0.012721377424895763
mutation O 0 0.03559839352965355
, O 0 0.008718535304069519
from O 0 0.006393353920429945
different O 0 0.00427085580304265
families O 0 0.008363756351172924
, O 0 0.007671815808862448
shared O 0 0.013148454017937183
similar O 0 0.010014316998422146
haplotypes O 0 0.2500866651535034
, O 0 0.008621235378086567
indicating O 0 0.010388324968516827
that O 0 0.00515560619533062
the O 0 0.01069490797817707
mutant O 1 0.9175476431846619
alleles O 0 0.02233319729566574
were O 0 0.007325008045881987
likely O 0 0.0070597929880023
to O 0 0.005659009795635939
be O 0 0.0049169547855854034
identical O 0 0.007052897475659847
by O 0 0.006673946511000395
descent O 0 0.01446508802473545
for O 0 0.007563341408967972
a O 0 0.01317848451435566
mutation O 0 0.019068926572799683
in O 0 0.009837404824793339
the O 0 0.020235108211636543
founder O 1 0.9934772253036499
population O 0 0.028439367190003395
. O 0 0.03278890997171402

The O 0 0.03433751314878464
identification O 0 0.028549745678901672
of O 0 0.02187306620180607
common O 1 0.6930803060531616
BRCA1 O 1 0.9999490976333618
and O 1 0.6724375486373901
BRCA2 O 1 0.9998968839645386
mutations O 0 0.03171030431985855
will O 0 0.01087793055921793
facilitate O 0 0.019626084715127945
carrier O 0 0.04685293883085251
detection O 0 0.017821114510297775
in O 0 0.007964322343468666
French O 0 0.029271772131323814
Canadian O 1 0.9080060124397278
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999997615814209
and O 1 0.9999889135360718
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9973956346511841
. O 0 0.1339811235666275

Are O 0 0.03577248752117157
Dp71 O 1 0.8139020204544067
and O 0 0.050753604620695114
Dp140 O 1 0.999575674533844
brain O 1 0.9986838698387146
dystrophin O 1 0.9988541603088379
isoforms O 0 0.038560040295124054
related O 0 0.02484440803527832
to O 0 0.02394699677824974
cognitive B-Disease 1 0.9764584302902222
impairment I-Disease 1 0.9999651908874512
in O 1 0.9988071918487549
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9995753169059753

Molecular O 0 0.05510495975613594
study O 0 0.02870338223874569
and O 0 0.020770275965332985
neuropsychological O 0 0.2689284086227417
analysis O 0 0.01127986516803503
were O 0 0.007692181039601564
performed O 0 0.013791012577712536
concurrently O 0 0.01535237580537796
on O 0 0.010204101912677288
49 O 0 0.025067521259188652
patients O 1 0.923086941242218
with O 1 0.9883861541748047
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999996423721313
DMD B-Disease 1 1.0
) O 0 0.024689754471182823
in O 0 0.008316200226545334
order O 0 0.009994312189519405
to O 0 0.008012471720576286
find O 0 0.010560408234596252
a O 0 0.01027233898639679
molecular O 0 0.010907125659286976
explanation O 0 0.01206233911216259
for O 0 0.009417391382157803
the O 0 0.019671989604830742
cognitive B-Disease 1 0.9684730768203735
impairment I-Disease 1 0.9998563528060913
observed O 0 0.03417788818478584
in O 0 0.02277953177690506
most O 0 0.34637510776519775
DMD B-Disease 1 0.9999990463256836
patients O 1 0.9994575381278992
. O 0 0.0662921816110611

Complete O 0 0.03693807125091553
analysis O 0 0.01675773225724697
of O 0 0.016319647431373596
the O 0 0.02661590464413166
dystrophin O 1 0.9993282556533813
gene O 0 0.021875625476241112
was O 0 0.017321234568953514
performed O 0 0.014191484078764915
to O 0 0.00916319154202938
define O 0 0.014046882279217243
the O 0 0.011119270697236061
localization O 0 0.02490251325070858
of O 0 0.01413907390087843
deletions O 0 0.04576925188302994
and O 0 0.014071615412831306
duplications O 0 0.0366629883646965
in O 0 0.011627440340816975
relation O 0 0.017363227903842926
to O 0 0.01266067661345005
the O 0 0.02067774347960949
different O 0 0.022845961153507233
DMD B-Disease 1 0.9999899864196777
promoters O 1 0.9802353382110596
. O 0 0.04816332086920738

Qualitative O 0 0.047994278371334076
analysis O 0 0.017630930989980698
of O 0 0.016002435237169266
the O 0 0.020045515149831772
Dp71 O 1 0.9967687129974365
transcript O 0 0.030365586280822754
and O 0 0.01031172089278698
testing O 0 0.011149048805236816
for O 0 0.006937445607036352
the O 0 0.008084321394562721
specific O 0 0.0073013161309063435
first O 0 0.011866956949234009
exon O 0 0.03805001452565193
of O 0 0.0170439425855875
Dp140 O 1 0.9682479500770569
were O 0 0.012379633262753487
also O 0 0.01333623006939888
carried O 0 0.01991528458893299
out O 0 0.022785183042287827
. O 0 0.028916407376527786

Neuropsychological O 1 0.6088751554489136
analysis O 0 0.037813447415828705
assessed O 0 0.04358525201678276
verbal O 0 0.06197412312030792
and O 0 0.0417480431497097
visuospatial O 1 0.999663233757019
intelligence O 0 0.04586421698331833
, O 0 0.023952659219503403
verbal O 1 0.5475043058395386
memory O 1 0.9584475755691528
, O 0 0.02530362270772457
and O 0 0.023884639143943787
reading O 0 0.049419697374105453
skills O 0 0.05487735942006111
. O 0 0.0378272570669651

Comparison O 0 0.04616335779428482
of O 0 0.02858729287981987
molecular O 0 0.02984842099249363
and O 0 0.020633304491639137
psychometric O 1 0.8863963484764099
findings O 0 0.019161252304911613
demonstrated O 0 0.0187153909355402
that O 0 0.008946998976171017
deletions O 0 0.024964407086372375
and O 0 0.010352911427617073
duplications O 0 0.027898751199245453
that O 0 0.006646330468356609
were O 0 0.006782276555895805
localized O 0 0.016768814995884895
in O 0 0.0076809171587228775
the O 0 0.011367741040885448
distal O 1 0.975127100944519
part O 0 0.01437452994287014
of O 0 0.01315382681787014
the O 0 0.03641768544912338
gene O 0 0.016261259093880653
seemed O 0 0.012196763418614864
to O 0 0.008304405957460403
be O 0 0.0087587283924222
preferentially O 0 0.028544971719384193
associated O 0 0.01717342622578144
with O 0 0.02201269008219242
cognitive B-Disease 1 0.9741180539131165
impairment I-Disease 1 0.9998393058776855
. O 0 0.06514199078083038

Two O 0 0.032525867223739624
altered O 0 0.04484603554010391
Dp71 O 0 0.233270063996315
transcripts O 0 0.03222631290555
and O 0 0.01457812450826168
two O 0 0.012846658937633038
deleted O 0 0.03021610900759697
Dp140 O 0 0.08329114317893982
DNA O 0 0.013524574227631092
sequences O 0 0.008241046220064163
were O 0 0.005729181692004204
found O 0 0.006030794698745012
in O 0 0.007366884965449572
four O 0 0.015283373184502125
patients O 1 0.999568521976471
with O 1 0.9983863830566406
severe O 1 0.9999998807907104
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9951000809669495

These O 0 0.020550180226564407
findings O 0 0.019328515976667404
suggest O 0 0.012331429868936539
that O 0 0.005948257632553577
some O 0 0.005018315743654966
sequences O 0 0.007438586093485355
located O 0 0.010395782999694347
in O 0 0.0063402908854186535
the O 0 0.01036351453512907
distal O 1 0.8932594060897827
part O 0 0.011577841825783253
of O 0 0.010112353600561619
the O 0 0.016717489808797836
gene O 0 0.011796100065112114
and O 0 0.006837456952780485
, O 0 0.006665406748652458
in O 0 0.005364041309803724
particular O 0 0.006740262731909752
, O 0 0.007208726834505796
some O 0 0.008362038992345333
DMD B-Disease 1 0.9999887943267822
isoforms O 0 0.015124225988984108
expressed O 0 0.010409989394247532
in O 0 0.008100650273263454
the O 0 0.048510801047086716
brain O 1 0.9915984869003296
may O 0 0.010532673448324203
be O 0 0.006371761206537485
related O 0 0.007725837174803019
to O 0 0.008117097429931164
the O 0 0.046195514500141144
cognitive B-Disease 1 0.9984259605407715
impairment I-Disease 1 0.9999892711639404
associated O 1 0.8446232676506042
with O 1 0.9373139142990112
DMD B-Disease 1 0.9999984502792358
. O 0 0.045342735946178436
. O 0 0.043808478862047195

I1307K O 1 0.9892033934593201
APC O 1 0.9918585419654846
and O 0 0.03847912326455116
hMLH1 O 1 0.8425365090370178
mutations O 0 0.024864574894309044
in O 0 0.011837231926620007
a O 0 0.015568936243653297
non O 0 0.07749602198600769
- O 1 0.9127873778343201
Jewish O 0 0.025218171998858452
family O 0 0.02127506025135517
with O 0 0.020946044474840164
hereditary B-Disease 1 0.9999852180480957
non I-Disease 1 0.999996542930603
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9957030415534973

We O 0 0.022225849330425262
describe O 0 0.020999768748879433
a O 0 0.016678063198924065
French O 0 0.024047518149018288
Canadian O 0 0.03617331013083458
hereditary B-Disease 1 0.9999550580978394
non I-Disease 1 0.9999864101409912
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999994039535522
HNPCC B-Disease 1 1.0
) O 1 0.9676814675331116
kindred O 1 0.9996170997619629
which O 0 0.013976196758449078
carries O 0 0.019547447562217712
a O 0 0.020888647064566612
novel O 0 0.04731851443648338
truncating O 1 0.985516369342804
mutation O 0 0.20763234794139862
in O 0 0.031125491484999657
hMLH1 O 1 0.9647923707962036
. O 0 0.05089007690548897

Interestingly O 0 0.06964616477489471
, O 0 0.028528423979878426
the O 0 0.031108010560274124
I1307K O 1 0.9986476302146912
APC O 1 0.9997280240058899
polymorphism O 0 0.06610444188117981
, O 0 0.011410821229219437
associated O 0 0.00789017416536808
with O 0 0.006383704487234354
an O 0 0.007896092720329762
increased O 0 0.01784169301390648
risk O 1 0.9936395287513733
of O 1 0.9999634027481079
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9942376613616943
is O 0 0.11007923632860184
also O 0 0.008293402381241322
present O 0 0.008983633480966091
in O 0 0.008166419342160225
this O 0 0.010940768755972385
family O 0 0.03171446546912193
. O 0 0.02898011915385723

The O 0 0.05763290077447891
I1307K O 1 0.9822188019752502
polymorphism O 0 0.06722990423440933
has O 0 0.014503088779747486
previously O 0 0.012335275299847126
only O 0 0.0068748085759580135
been O 0 0.006362051237374544
identified O 0 0.007815275341272354
in O 0 0.0050212787464261055
individuals O 0 0.006915378849953413
of O 0 0.013641659170389175
self O 1 0.9965651631355286
- O 1 0.9998196959495544
reported O 0 0.03147745132446289
Ashkenazi O 1 0.8882291913032532
Jewish O 0 0.04709538817405701
origins O 0 0.044567979872226715
. O 0 0.036243267357349396

In O 0 0.02238943614065647
addition O 0 0.017131710425019264
, O 0 0.012335170991718769
in O 0 0.007900198921561241
this O 0 0.007607846055179834
family O 0 0.016853854060173035
, O 0 0.008962546475231647
there O 0 0.006653490010648966
appears O 0 0.009252648800611496
to O 0 0.0053739771246910095
be O 0 0.005113651975989342
no O 0 0.005908645689487457
relationship O 0 0.010722589679062366
between O 0 0.008711796253919601
the O 0 0.01295209676027298
I1307K O 1 0.9830318689346313
polymorphism O 0 0.027016645297408104
and O 0 0.008527486585080624
the O 0 0.010918231680989265
presence O 0 0.01752285845577717
or O 0 0.013092701323330402
absence O 1 0.811320424079895
of O 1 0.9863341450691223
cancer B-Disease 1 0.9999963045120239
. O 0 0.03568076342344284
. O 0 0.03388788923621178

Identification O 0 0.039794713258743286
of O 0 0.022313609719276428
a O 0 0.022256728261709213
novel O 0 0.034244537353515625
mutation O 0 0.024725809693336487
of O 0 0.01436135545372963
the O 0 0.037066515535116196
CPO O 1 0.9975495934486389
gene O 0 0.016355793923139572
in O 0 0.01049431785941124
a O 0 0.019188787788152695
Japanese O 0 0.34995463490486145
hereditary B-Disease 1 0.9999762773513794
coproporphyria I-Disease 1 0.9999700784683228
family O 1 0.8772025108337402
. O 0 0.05029973387718201

Hereditary B-Disease 1 0.9998801946640015
coproporphyria I-Disease 1 0.9998745918273926
( O 1 0.9680171012878418
HCP B-Disease 1 0.9999133348464966
) O 0 0.02173457480967045
is O 0 0.01373884454369545
an O 0 0.056588925421237946
autosomal B-Disease 1 0.9999938011169434
dominant I-Disease 1 0.9999704360961914
disease I-Disease 1 0.9999978542327881
characterized O 1 0.9982276558876038
by O 0 0.4328713119029999
a O 1 0.9987718462944031
deficiency B-Disease 1 1.0
of I-Disease 1 0.9999539852142334
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9999995231628418
( O 1 0.9910076260566711
CPO O 1 0.9994595646858215
) O 0 0.015007873065769672
caused O 0 0.014686145819723606
by O 0 0.009633929468691349
a O 0 0.014272633008658886
mutation O 0 0.020694803446531296
in O 0 0.011829339899122715
the O 0 0.024817628785967827
CPO O 1 0.9951685667037964
gene O 0 0.04560870677232742
. O 0 0.03678039461374283

Only O 0 0.024966103956103325
11 O 0 0.025084998458623886
mutations O 0 0.019053898751735687
of O 0 0.011905469931662083
the O 0 0.01549135334789753
gene O 0 0.014609352685511112
have O 0 0.007577240467071533
been O 0 0.011020309291779995
reported O 0 0.020602019503712654
in O 0 0.02919774129986763
HCP B-Disease 1 0.999964714050293
patients O 1 0.9965152740478516
. O 0 0.050312161445617676

We O 0 0.02731850929558277
report O 0 0.020982185378670692
another O 0 0.023572996258735657
mutation O 0 0.028845060616731644
in O 0 0.013268684037029743
a O 0 0.02267659641802311
Japanese O 0 0.07105565816164017
family O 0 0.06766605377197266
. O 0 0.04376625642180443

Polymerase O 1 0.5909573435783386
chain O 0 0.09916648268699646
reaction O 0 0.07703932374715805
- O 1 0.9608555436134338
single O 0 0.03621216490864754
strand O 0 0.05837090313434601
conformational O 0 0.03957062214612961
polymorphism O 0 0.029622238129377365
and O 0 0.012029370293021202
direct O 0 0.011706318706274033
sequence O 0 0.011833918280899525
analyses O 0 0.01264286506921053
demonstrated O 0 0.01491221971809864
a O 0 0.01635011099278927
C O 0 0.1865358054637909
to O 0 0.014997027814388275
T O 0 0.4219358265399933
substitution O 0 0.018727412447333336
in O 0 0.009479103609919548
exon O 0 0.02679438516497612
1 O 0 0.011937407776713371
of O 0 0.00980136264115572
the O 0 0.013680808246135712
CPO O 1 0.8528860807418823
gene O 0 0.013850265182554722
at O 0 0.009996321983635426
nucleotide O 0 0.01483173854649067
position O 0 0.01159615907818079
85 O 0 0.01509780716150999
, O 0 0.008808444254100323
which O 0 0.007023388519883156
lies O 0 0.013718209229409695
in O 0 0.008009849116206169
the O 0 0.015381394885480404
putative O 1 0.8354040384292603
presequence O 1 0.8357635736465454
for O 0 0.016817957162857056
targeting O 0 0.02948863059282303
to O 0 0.024707959964871407
mitochondria O 0 0.06367822736501694
. O 0 0.041234713047742844

This O 0 0.03240448981523514
mutation O 0 0.036179911345243454
changes O 0 0.016480090096592903
the O 0 0.016648996621370316
codon O 0 0.03740108385682106
for O 0 0.013939643278717995
glutamine O 0 0.030217157676815987
to O 0 0.012354879640042782
a O 0 0.018134180456399918
termination O 1 0.7766056060791016
codon O 0 0.07818683236837387
at O 0 0.027072591707110405
amino O 0 0.02970978431403637
acid O 0 0.037056874483823776
position O 0 0.028581196442246437
29 O 0 0.04477538540959358
. O 0 0.03599529340863228

MaeI O 1 0.8995615839958191
restriction O 0 0.049813173711299896
analysis O 0 0.017913468182086945
showed O 0 0.015885639935731888
two O 0 0.008719850331544876
other O 0 0.009322216734290123
carriers O 0 0.02095988765358925
in O 0 0.012937846593558788
the O 0 0.020973950624465942
family O 0 0.046639584004879
. O 0 0.03748183324933052

The O 0 0.06033562123775482
C O 1 0.9995747208595276
- O 1 0.9999876022338867
T O 1 0.999874472618103
mutation O 0 0.04431896284222603
is O 0 0.01125817745923996
located O 0 0.012588598765432835
within O 0 0.00843008328229189
a O 0 0.010970374569296837
recently O 0 0.013221889734268188
proposed O 0 0.014066112227737904
putative O 0 0.032169803977012634
alternative O 0 0.01802660897374153
translation O 0 0.01823253370821476
initiation O 0 0.18624424934387207
codon O 0 0.1633927822113037
( O 0 0.06906598806381226
TIC O 1 0.9998477697372437
- O 1 0.9621164798736572
1 O 0 0.015420077368617058
) O 0 0.009319892153143883
, O 0 0.007228511851280928
supporting O 0 0.011470143683254719
that O 0 0.009641271084547043
TIC O 1 0.9999415874481201
- O 1 0.9800081253051758
1 O 0 0.012825542129576206
is O 0 0.007966696284711361
the O 0 0.009936708956956863
real O 0 0.02397722750902176
TIC O 1 0.998958945274353
rather O 0 0.01238491665571928
than O 0 0.015939857810735703
TIC O 1 0.9999513626098633
- O 1 0.9962855577468872
2 O 0 0.029835417866706848
. O 0 0.020831482484936714
. O 0 0.02827710099518299

Human B-Disease 0 0.06251293420791626
complement I-Disease 1 0.9679033160209656
factor I-Disease 1 0.9994496703147888
H I-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999997615814209
associated O 1 0.999573290348053
with O 1 0.9999942779541016
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998557567596436

This O 0 0.017633896321058273
study O 0 0.013395748101174831
reports O 0 0.010303858667612076
on O 0 0.007810174021869898
six O 0 0.010266226716339588
cases O 0 0.015189362689852715
of O 1 0.6605461239814758
deficiency B-Disease 1 0.9999996423721313
in I-Disease 0 0.015550149604678154
the I-Disease 0 0.04376532509922981
human I-Disease 0 0.02175159566104412
complement I-Disease 0 0.29093170166015625
regulatory I-Disease 0 0.21168115735054016
protein I-Disease 0 0.021566789597272873
Factor I-Disease 1 0.6697384715080261
H I-Disease 1 0.9999244213104248
( O 0 0.07622206956148148
FH O 1 0.9975873231887817
) O 0 0.010084796696901321
in O 0 0.006118430756032467
the O 0 0.008679685182869434
context O 0 0.013240041211247444
of O 0 0.03100593201816082
an O 1 0.9998457431793213
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.999948263168335

Five O 0 0.024152299389243126
of O 0 0.018043136224150658
the O 0 0.016160445287823677
cases O 0 0.012815446592867374
were O 0 0.008117648772895336
observed O 0 0.00985147524625063
in O 0 0.008154405280947685
children O 0 0.023959558457136154
presenting O 1 0.8331305384635925
with O 1 0.9998984336853027
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
HUS B-Disease 1 1.0
) O 1 0.9955310225486755
. O 0 0.06496785581111908

Two O 0 0.019918350502848625
of O 0 0.017356282100081444
the O 0 0.018809737637639046
children O 0 0.19827789068222046
exhibited O 1 0.976958692073822
a O 1 0.999528169631958
homozygous O 1 0.9999979734420776
deficiency O 1 1.0
characterized O 1 0.9990583062171936
by O 0 0.024782607331871986
the O 0 0.02215932495892048
absence O 0 0.37645024061203003
of O 0 0.013532389886677265
the O 0 0.02835768274962902
150 O 0 0.09824348986148834
- O 1 0.9996514320373535
kD O 1 0.9957008957862854
form O 0 0.010196948423981667
of O 0 0.015006358735263348
Factor O 1 0.9733702540397644
H O 1 0.999492883682251
and O 0 0.008739144541323185
the O 0 0.009761795401573181
presence O 0 0.013521216809749603
, O 0 0.007728049997240305
upon O 0 0.010146357119083405
immunoblotting O 0 0.04357094317674637
, O 0 0.007136042229831219
of O 0 0.006719385273754597
the O 0 0.010446486063301563
42 O 0 0.03310522064566612
- O 1 0.9985234141349792
kD O 1 0.9989575147628784
Factor O 0 0.23592214286327362
H O 1 0.9972694516181946
- O 0 0.19608470797538757
like O 0 0.010490377433598042
protein O 0 0.009704654105007648
1 O 0 0.012107957154512405
( O 0 0.01672613061964512
FHL O 1 0.9973376393318176
- O 1 0.5486005544662476
1 O 0 0.013070574961602688
) O 0 0.0076928650960326195
and O 0 0.006910651456564665
other O 0 0.009650910273194313
FH O 1 0.9999626874923706
- O 1 0.9983481168746948
related O 0 0.02632801979780197
protein O 0 0.02631545066833496
( O 0 0.0306071974337101
FHR O 1 0.9869595170021057
) O 0 0.029054803773760796
bands O 0 0.046792373061180115
. O 0 0.03696584701538086

Southern O 0 0.08121131360530853
blot O 0 0.38916701078414917
and O 0 0.02526196651160717
PCR O 0 0.03578571975231171
analysis O 0 0.009927804581820965
of O 0 0.008698278106749058
DNA O 0 0.009416765533387661
of O 0 0.008840124122798443
one O 0 0.012093604542315006
patient O 1 0.9951493144035339
with O 1 0.5689928531646729
homozygous O 1 0.9998817443847656
deficiency O 1 0.9999992847442627
ruled O 0 0.2632613778114319
out O 0 0.011843791231513023
the O 0 0.009728136472404003
presence O 0 0.00935728196054697
of O 0 0.007198236882686615
a O 0 0.00859580934047699
large O 0 0.008062021806836128
deletion O 0 0.016060417518019676
of O 0 0.010660805739462376
the O 0 0.2725566327571869
FH O 1 0.999996542930603
gene O 0 0.016101673245429993
as O 0 0.009946908801794052
the O 0 0.016136489808559418
underlying O 1 0.9952651262283325
defect O 1 0.999927282333374
for O 0 0.4375026524066925
the O 1 0.9973077774047852
deficiency O 1 0.9999997615814209
. O 0 0.47366848587989807

The O 0 0.02457025833427906
other O 0 0.011220918968319893
four O 0 0.013158469460904598
children O 0 0.01954721473157406
presented O 0 0.024569518864154816
with O 0 0.26001447439193726
heterozygous O 1 0.9996581077575684
deficiency O 1 0.9999997615814209
and O 0 0.10880350321531296
exhibited O 1 0.9187840819358826
a O 0 0.1878221482038498
normal O 0 0.19406449794769287
immunoblotting O 1 0.9974493384361267
pattern O 0 0.02617238461971283
of O 0 0.013688280247151852
proteins O 0 0.013489593751728535
of O 0 0.016485901549458504
the O 1 0.5872870683670044
FH O 1 0.9999951124191284
family O 0 0.45712143182754517
. O 0 0.042853944003582

Factor B-Disease 1 0.9997643828392029
H I-Disease 1 0.999997615814209
deficiency I-Disease 1 0.999998927116394
is O 0 0.026880944147706032
the O 0 0.0321197547018528
only O 0 0.19097961485385895
complement B-Disease 1 0.9999529123306274
deficiency I-Disease 1 0.9999998807907104
associated O 1 0.9389164447784424
with O 1 0.9793421626091003
HUS B-Disease 1 0.9999996423721313
. O 0 0.336360365152359

These O 0 0.02042028121650219
observations O 0 0.01813666895031929
suggest O 0 0.012846816331148148
a O 0 0.011986675672233105
role O 0 0.017881251871585846
for O 0 0.020800059661269188
FH O 1 0.9999959468841553
and O 1 0.5338095426559448
/ O 1 0.9999115467071533
or O 0 0.2045103758573532
FH O 1 0.999930739402771
receptors O 0 0.024497047066688538
in O 0 0.0124193811789155
the O 0 0.023709872737526894
pathogenesis O 1 0.9999350309371948
of O 1 0.9991450309753418
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.8285431265830994
. O 0 0.06297814100980759

Further O 0 0.029358327388763428
evidence O 0 0.01656610704958439
for O 0 0.011282178573310375
a O 0 0.01599138416349888
major O 0 0.024847399443387985
ancient O 1 0.5157356262207031
mutation O 1 0.998980700969696
underlying O 1 0.9999817609786987
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9993627667427063
linkage O 1 0.9999480247497559
disequilibrium O 1 0.9997280240058899
studies O 0 0.018270598724484444
in O 0 0.01163542177528143
the O 0 0.017788613215088844
Japanese O 0 0.03677559643983841
population O 0 0.027041476219892502
. O 0 0.0324014276266098

The O 1 0.944607138633728
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.9999862909317017
DM B-Disease 1 1.0
) O 0 0.12680916488170624
mutation O 0 0.05437077209353447
is O 0 0.01068265549838543
an O 0 0.013920490629971027
unstable O 1 0.9990257024765015
( O 1 0.696129560470581
CTG O 1 0.9999616146087646
) O 0 0.02022288367152214
n O 0 0.025463266298174858
repeat O 0 0.019522983580827713
, O 0 0.008346964605152607
present O 0 0.0072317710146307945
at O 0 0.007454543840140104
a O 0 0.008184371516108513
copy O 0 0.010968056507408619
number O 0 0.00574505003169179
of O 0 0.0077446093782782555
5 O 0 0.015277734026312828
- O 1 0.5683725476264954
37 O 0 0.017433930188417435
repeats O 0 0.017144249752163887
on O 0 0.008872353471815586
normal O 0 0.011707807891070843
chromosomes O 0 0.013398433104157448
but O 0 0.00769880460575223
amplified O 0 0.017141122370958328
to O 0 0.00990335550159216
50 O 0 0.018035197630524635
- O 0 0.409928560256958
3000 O 0 0.038166631013154984
copies O 0 0.02479339763522148
on O 0 0.03451823443174362
DM B-Disease 1 0.9999805688858032
chromosomes O 0 0.06459405273199081
. O 0 0.04397162050008774

Previous O 0 0.03320750221610069
findings O 0 0.0212935209274292
in O 0 0.012706007808446884
Caucasian O 0 0.085996612906456
populations O 0 0.012689879164099693
of O 0 0.016867544502019882
a O 1 0.9925709366798401
DM B-Disease 1 1.0
founder O 1 0.9999839067459106
chromosome O 1 0.8446431159973145
raise O 0 0.015582828782498837
a O 0 0.009496266022324562
question O 0 0.008052692748606205
about O 0 0.00644325977191329
the O 0 0.008186044171452522
molecular O 0 0.009722662158310413
events O 0 0.008561004884541035
involved O 0 0.00937812402844429
in O 0 0.009787040762603283
the O 0 0.019237974658608437
expansion O 0 0.10787493735551834
mutation O 0 0.13946053385734558
. O 0 0.0393303744494915

To O 0 0.027970120310783386
investigate O 0 0.03071632608771324
whether O 0 0.0140308178961277
a O 0 0.016461998224258423
founder O 1 0.5094304084777832
chromosome O 0 0.030372928828001022
for O 0 0.014511099085211754
the O 1 0.7442694306373596
DM B-Disease 1 0.9999998807907104
mutation O 1 0.6597194075584412
exists O 0 0.014435363933444023
in O 0 0.0075619518756866455
the O 0 0.00986388698220253
Japanese O 0 0.016694508492946625
population O 0 0.008400377817451954
, O 0 0.008441667072474957
we O 0 0.008659285493195057
genotyped O 0 0.05490622669458389
families O 0 0.012881391681730747
using O 0 0.00914616696536541
polymorphic O 0 0.03599410876631737
markers O 0 0.02115156501531601
near O 0 0.017439255490899086
the O 0 0.014794592745602131
( O 0 0.04054655134677887
CTG O 1 0.9995511174201965
) O 0 0.023136978968977928
n O 0 0.03712331876158714
repeat O 0 0.03492250293493271
region O 0 0.02592412568628788
and O 0 0.021228013560175896
constructed O 0 0.05759227275848389
haplotypes O 0 0.4104653000831604
. O 0 0.045140571892261505

Six O 0 0.031919945031404495
different O 0 0.015318842604756355
haplotypes O 0 0.04248104616999626
were O 0 0.014280262403190136
found O 0 0.017457757145166397
and O 0 0.09742408245801926
DM B-Disease 1 0.9999994039535522
alleles O 1 0.7720480561256409
were O 0 0.019806884229183197
always O 0 0.035247549414634705
haplotype O 0 0.4754261374473572
A O 0 0.05029148980975151
. O 0 0.039481885731220245

To O 0 0.024369968101382256
find O 0 0.016946563497185707
an O 0 0.008866723626852036
origin O 0 0.007464126218110323
of O 0 0.009800659492611885
the O 0 0.018835358321666718
( O 1 0.6165921688079834
CTG O 1 0.9999051094055176
) O 0 0.023887060582637787
n O 0 0.03583046793937683
repeat O 0 0.029369693249464035
mutation O 0 0.016434768214821815
and O 0 0.00807164516299963
to O 0 0.00724199041724205
investigate O 0 0.01378592848777771
the O 0 0.00899277813732624
mechanism O 0 0.012483268044888973
of O 0 0.008533232845366001
the O 0 0.010951846837997437
expansion O 0 0.03409070521593094
mutation O 0 0.014359499327838421
in O 0 0.006285409908741713
the O 0 0.008402936160564423
Japanese O 0 0.01373500656336546
population O 0 0.006736439187079668
we O 0 0.005563924554735422
have O 0 0.004756992217153311
studied O 0 0.009591218084096909
90 O 0 0.0158471018075943
Japanese O 0 0.054319754242897034
DM B-Disease 1 0.9999903440475464
families O 0 0.022054703906178474
comprising O 0 0.027766991406679153
190 O 0 0.035334471613168716
affected O 0 0.021624160930514336
and O 0 0.016989920288324356
130 O 0 0.03797324746847153
unaffected O 0 0.1552005559206009
members O 0 0.03439674898982048
. O 0 0.03605715557932854

The O 0 0.031434666365385056
results O 0 0.015383068472146988
suggest O 0 0.012109749019145966
that O 0 0.006541315466165543
a O 0 0.008761458098888397
few O 0 0.009063877165317535
common O 0 0.014160278253257275
ancestral O 1 0.6620158553123474
mutations O 0 0.01590164378285408
in O 0 0.007925577461719513
both O 0 0.010083183646202087
Caucasian O 1 0.9880708456039429
and O 0 0.011932616122066975
Japanese O 0 0.023629285395145416
populations O 0 0.009387187659740448
have O 0 0.0053870524279773235
originated O 0 0.008849140256643295
by O 0 0.00555382901802659
expansion O 0 0.010506397113204002
of O 0 0.009122839197516441
an O 0 0.012552701868116856
ancestral O 1 0.8895129561424255
n O 0 0.13459838926792145
= O 0 0.022917093709111214
5 O 0 0.013950658962130547
repeat O 0 0.01853461191058159
to O 0 0.012639401480555534
n O 0 0.03221089392900467
= O 0 0.0338485985994339
19 O 0 0.029678136110305786
- O 0 0.06591493636369705
37 O 0 0.03812318667769432
copies O 0 0.03360007703304291
. O 0 0.03519042581319809

These O 0 0.02053178660571575
data O 0 0.01478904765099287
support O 0 0.017663532868027687
multistep O 0 0.04518672451376915
models O 0 0.017233584076166153
of O 0 0.01928151398897171
triplet O 1 0.9992015957832336
repeat O 1 0.5511597394943237
expansion O 0 0.01976500079035759
that O 0 0.006524437107145786
have O 0 0.005288415588438511
been O 0 0.005847787018865347
proposed O 0 0.009416996501386166
for O 0 0.011170539073646069
both O 0 0.02442866936326027
DM B-Disease 1 0.9999996423721313
and O 1 0.8721507787704468
Friedreichs B-Disease 1 0.9999656677246094
ataxia I-Disease 1 0.9999452829360962
. O 0 0.040992651134729385
. O 0 0.04267482832074165

The O 0 0.034160565584897995
molecular O 0 0.026644330471754074
basis O 0 0.02061932161450386
of O 1 0.992547333240509
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.04871312528848648
the O 0 0.09990213066339493
western O 0 0.05368918552994728
Cape O 1 0.8925377726554871
, O 0 0.022275058552622795
South O 0 0.03868649899959564
Africa O 0 0.04520692676305771
. O 0 0.0389380045235157

Deficiency B-Disease 1 0.9999245405197144
of I-Disease 0 0.03195486590266228
the I-Disease 0 0.04757877439260483
sixth I-Disease 1 0.9978852868080139
component I-Disease 1 0.6127621531486511
of I-Disease 0 0.020192019641399384
human I-Disease 1 0.5265732407569885
complement I-Disease 1 0.9996275901794434
( O 1 0.9941761493682861
C6 O 1 0.9999949932098389
) O 0 0.011489199474453926
has O 0 0.0067453221417963505
been O 0 0.0051855831407010555
reported O 0 0.006914523895829916
in O 0 0.004775898065418005
a O 0 0.006249432452023029
number O 0 0.005436902400106192
of O 0 0.0067812297493219376
families O 0 0.008465000428259373
from O 0 0.0072036851197481155
the O 0 0.011180792935192585
western O 0 0.017224065959453583
Cape O 0 0.21057455241680145
, O 0 0.01872662641108036
South O 0 0.0331796295940876
Africa O 0 0.04364025592803955
. O 0 0.03437475115060806

Meningococcal B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999995231628418
is O 1 0.9017252922058105
endemic O 1 0.9995868802070618
in O 0 0.0194842666387558
the O 0 0.079835906624794
Cape O 1 0.8139090538024902
and O 0 0.00884758960455656
almost O 0 0.007381783332675695
all O 0 0.006680122576653957
pedigrees O 0 0.02278696931898594
of O 0 0.01825665310025215
total O 1 0.9913996458053589
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9995936751365662
C6Q0 O 1 0.9999897480010986
) O 0 0.014527138322591782
have O 0 0.006581984460353851
been O 0 0.009488428942859173
ascertained O 0 0.03028402291238308
because O 0 0.01596754975616932
of O 0 0.41560104489326477
recurrent O 1 0.9999991655349731
disease O 1 0.999998927116394
. O 1 0.9116374850273132

We O 0 0.022368518635630608
have O 0 0.01145651564002037
sequenced O 0 0.018588490784168243
the O 0 0.011314840987324715
expressed O 0 0.014351080171763897
exons O 0 0.02215881645679474
of O 0 0.013265428133308887
the O 0 0.04822845384478569
C6 O 1 0.9999829530715942
gene O 0 0.01793568767607212
from O 0 0.009457537904381752
selected O 0 0.010123586282134056
cases O 0 0.007774737197905779
and O 0 0.0063668121583759785
have O 0 0.004489808343350887
found O 0 0.005812980700284243
three O 0 0.007648816332221031
molecular O 0 0.020570963621139526
defects O 1 0.8249012231826782
leading O 0 0.028759481385350227
to O 0 0.014086985029280186
total O 1 0.9043025374412537
deficiency O 1 1.0
879delG O 1 0.9999771118164062
, O 0 0.035944677889347076
which O 0 0.007417218293994665
is O 0 0.007059057243168354
the O 0 0.009549247100949287
common O 0 0.024958685040473938
defect O 1 0.9899781942367554
in O 0 0.008317461237311363
the O 0 0.012603900395333767
Cape O 1 0.6508803367614746
and O 0 0.012868700549006462
hitherto O 0 0.3460598289966583
unreported O 0 0.05269011855125427
, O 0 0.010790047235786915
and O 0 0.012042824178934097
1195delC O 1 0.9895877838134766
and O 0 0.01695702224969864
1936delG O 1 0.9881105422973633
, O 0 0.010134590789675713
which O 0 0.006106358952820301
have O 0 0.00435043778270483
been O 0 0.005487168673425913
previously O 0 0.008819649927318096
reported O 0 0.010077258571982384
in O 0 0.010252133011817932
African O 0 0.19828937947750092
- O 1 0.9976381063461304
Americans O 0 0.03454598784446716
. O 0 0.02972300723195076

We O 0 0.02452128753066063
also O 0 0.013805177062749863
show O 0 0.011951195076107979
that O 0 0.007070504128932953
the O 0 0.012558926828205585
879delG O 1 0.9896418452262878
and O 0 0.08048127591609955
1195delC O 1 0.9998494386672974
defects O 1 0.9902787804603577
are O 0 0.007225519046187401
associated O 0 0.012224726378917694
with O 0 0.016867078840732574
characteristic O 1 0.9998635053634644
C6 O 1 1.0
/ O 1 0.9999980926513672
C7 O 1 0.9999743700027466
region O 0 0.05943365395069122
DNA O 0 0.035732027143239975
marker O 1 0.6971914172172546
haplotypes O 0 0.20371517539024353
, O 0 0.013160611502826214
although O 0 0.010440995916724205
small O 0 0.01374497078359127
variations O 0 0.016483226791024208
were O 0 0.014507369138300419
observed O 0 0.02723834291100502
. O 0 0.029409175738692284

The O 0 0.10403411835432053
1936delG O 1 0.9996277093887329
defect O 1 0.9984287619590759
was O 0 0.03044203855097294
observed O 0 0.014950975775718689
only O 0 0.008770423009991646
once O 0 0.012612906284630299
in O 0 0.007065825164318085
the O 0 0.010464197024703026
Cape O 0 0.06623050570487976
, O 0 0.009458583779633045
but O 0 0.007628956809639931
its O 0 0.010778215713799
associated O 0 0.019556598737835884
haplotype O 1 0.5307949185371399
could O 0 0.014117798767983913
be O 0 0.014443548396229744
deduced O 0 0.042611394077539444
. O 0 0.030740534886717796

The O 0 0.028303591534495354
data O 0 0.015752924606204033
from O 0 0.013162234798073769
the O 0 0.015072678215801716
haplotypes O 0 0.19626471400260925
indicate O 0 0.010546248406171799
that O 0 0.004675775766372681
these O 0 0.004316565115004778
three O 0 0.008180618286132812
molecular O 0 0.02151195891201496
defects O 1 0.9688568711280823
account O 0 0.009945635683834553
for O 0 0.008713336661458015
the O 0 0.036336369812488556
defects O 1 0.9931957721710205
in O 0 0.006740805692970753
all O 0 0.006812433712184429
the O 0 0.01180930808186531
38 O 0 0.08464235812425613
unrelated O 1 0.6823068261146545
C6Q0 O 1 0.9996389150619507
individuals O 0 0.012296244502067566
we O 0 0.008854908868670464
have O 0 0.006899249739944935
studied O 0 0.012704494409263134
from O 0 0.01205542590469122
the O 0 0.021847611293196678
Cape O 0 0.3485381305217743
. O 0 0.034662146121263504

We O 0 0.02526809647679329
have O 0 0.010997974313795567
also O 0 0.010924341157078743
observed O 0 0.013378981500864029
the O 0 0.015336827374994755
879delG O 1 0.9290176033973694
defect O 0 0.4670494496822357
in O 0 0.009804797358810902
two O 0 0.012582779861986637
Dutch O 1 0.9927389025688171
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999982118606567
deficient I-Disease 1 0.999980092048645
kindreds O 1 0.9680036306381226
, O 0 0.012762274593114853
but O 0 0.008568394929170609
the O 0 0.01381546352058649
879delG O 1 0.9989802241325378
defect O 1 0.9981362819671631
in O 0 0.010756821371614933
the O 0 0.020603733137249947
Cape O 1 0.9518232941627502
probably O 0 0.014671966433525085
did O 0 0.00799088180065155
not O 0 0.00597861222922802
come O 0 0.00788320042192936
from O 0 0.009471207857131958
The O 0 0.016065318137407303
Netherlands O 0 0.04077474772930145
. O 0 0.023772791028022766
. O 0 0.03196456655859947

Complement B-Disease 1 0.9996601343154907
C7 I-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999992847442627
: O 0 0.05185031518340111
seven O 0 0.027556106448173523
further O 0 0.028168609365820885
molecular O 1 0.6631384491920471
defects O 1 0.997887909412384
and O 0 0.017746862024068832
their O 0 0.01705648936331272
associated O 0 0.047363393008708954
marker O 1 0.9924201369285583
haplotypes O 1 0.8805039525032043
. O 0 0.0436239168047905

Seven O 0 0.03409989923238754
further O 0 0.02248297445476055
molecular O 0 0.02635713294148445
bases O 0 0.03760480135679245
of O 1 0.9978832602500916
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0658557265996933
described O 1 0.6747268438339233
. O 0 0.042181190103292465

All O 0 0.023012615740299225
these O 0 0.01211051270365715
new O 0 0.01973840594291687
molecular O 0 0.027027063071727753
defects O 1 0.9451434016227722
involve O 0 0.02247600629925728
single O 1 0.7948294878005981
- O 1 0.9994673132896423
nucleotide O 0 0.02628071792423725
events O 0 0.011718615889549255
, O 0 0.010652581229805946
deletions O 0 0.021528281271457672
and O 0 0.009475153870880604
substitutions O 0 0.01453589927405119
, O 0 0.007029346656054258
some O 0 0.005234298296272755
of O 0 0.007956810295581818
which O 0 0.009585204534232616
alter O 0 0.024349145591259003
splice O 0 0.04261528328061104
sites O 0 0.01675262488424778
, O 0 0.013395797461271286
and O 0 0.015127531252801418
others O 0 0.02252863720059395
codons O 0 0.05991659685969353
. O 0 0.03977092355489731

They O 0 0.016445167362689972
are O 0 0.008614609949290752
distributed O 0 0.013765799812972546
along O 0 0.015046097338199615
the O 0 0.02382718212902546
C7 O 1 0.9999727010726929
gene O 0 0.023159008473157883
, O 0 0.010769098065793514
but O 0 0.007961971685290337
predominantly O 0 0.014830498956143856
towards O 0 0.015789762139320374
the O 0 0.01714126020669937
3 O 0 0.02571716345846653
end O 0 0.03671063855290413
. O 0 0.03573036566376686

All O 0 0.024427441880106926
were O 0 0.017193708568811417
found O 0 0.0162663497030735
in O 0 0.018648002296686172
compound O 0 0.16053138673305511
heterozygous O 0 0.07319909334182739
individuals O 0 0.03433724120259285
. O 0 0.04249501973390579

The O 0 0.4796702563762665
C6 O 1 0.999990701675415
/ O 1 0.9999423027038574
C7 O 1 0.999936580657959
marker O 1 0.9760488867759705
haplotypes O 1 0.5184615850448608
associated O 0 0.020216016098856926
with O 0 0.019030621275305748
most O 1 0.5153171420097351
C7 B-Disease 1 0.9999996423721313
defects I-Disease 1 0.99996018409729
are O 0 0.017632542178034782
tabulated O 0 0.03588453680276871
. O 0 0.019938817247748375
. O 0 0.02880682796239853

A O 0 0.06387800723314285
genome O 0 0.05789865553379059
- O 0 0.14203770458698273
wide O 0 0.02436155453324318
search O 0 0.023569688200950623
for O 0 0.019386034458875656
chromosomal O 1 0.9934315085411072
loci O 1 0.8708663582801819
linked O 0 0.1934991329908371
to O 0 0.024910368025302887
mental O 1 0.9999909400939941
health O 1 0.9999746084213257
wellness O 1 0.9999945163726807
in O 0 0.019561976194381714
relatives O 0 0.34788715839385986
at O 0 0.03018520399928093
high O 1 0.8699764609336853
risk O 1 0.9990289211273193
for O 1 0.9994206428527832
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
among O 1 0.9895226359367371
the O 1 0.9758521914482117
Old O 1 0.9994115829467773
Order O 0 0.37039560079574585
Amish O 1 0.9651286005973816
. O 0 0.04522399604320526

Bipolar B-Disease 1 0.9999998807907104
affective I-Disease 1 0.999998927116394
disorder I-Disease 1 0.9999998807907104
( O 1 0.9999613761901855
BPAD B-Disease 1 0.9999998807907104
; O 1 0.9999566078186035
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.7755862474441528
is O 0 0.012998045422136784
characterized O 0 0.019956694915890694
by O 0 0.009643875993788242
episodes O 0 0.018986517563462257
of O 0 0.3382004201412201
mania B-Disease 1 0.9999991655349731
and O 1 0.9916813969612122
/ O 1 0.9999959468841553
or O 1 0.9135220646858215
hypomania B-Disease 1 0.9999964237213135
interspersed O 1 0.5096238255500793
with O 0 0.02149435319006443
periods O 0 0.054856907576322556
of O 1 0.624883234500885
depression B-Disease 1 0.9999845027923584
. O 0 0.24247296154499054

Compelling O 0 0.05700020119547844
evidence O 0 0.024546893313527107
supports O 0 0.028883514925837517
a O 0 0.018396198749542236
significant O 0 0.017429674044251442
genetic O 0 0.04360803961753845
component O 0 0.1654629409313202
in O 0 0.013374394737184048
the O 0 0.02991042658686638
susceptibility O 1 0.9941098690032959
to O 0 0.03170029819011688
develop O 0 0.4534966051578522
BPAD B-Disease 1 0.9996645450592041
. O 0 0.0541701577603817

To O 0 0.026883676648139954
date O 0 0.0231960266828537
, O 0 0.014272511936724186
however O 0 0.010723186656832695
, O 0 0.014188510365784168
linkage O 0 0.03950297459959984
studies O 0 0.008979265578091145
have O 0 0.005944235250353813
attempted O 0 0.013403482735157013
only O 0 0.008026931434869766
to O 0 0.011361670680344105
identify O 0 0.02289310097694397
chromosomal O 1 0.9653514623641968
loci O 0 0.09159191697835922
that O 0 0.01048352476209402
cause O 0 0.09424098581075668
or O 0 0.010808573104441166
increase O 0 0.010926252231001854
the O 0 0.01576520875096321
risk O 0 0.2167598456144333
of O 0 0.10989855229854584
developing O 1 0.9816903471946716
BPAD B-Disease 1 0.9999873638153076
. O 0 0.06522851437330246

To O 0 0.026050139218568802
determine O 0 0.01567341387271881
whether O 0 0.011129247024655342
there O 0 0.007922916673123837
could O 0 0.008048640564084053
be O 0 0.009094241075217724
protective O 1 0.9939860105514526
alleles O 0 0.0745459794998169
that O 0 0.007033561356365681
prevent O 0 0.06692003458738327
or O 0 0.008445818908512592
reduce O 0 0.013830484822392464
the O 0 0.01015576533973217
risk O 0 0.09620121121406555
of O 0 0.06870419532060623
developing O 1 0.9920489192008972
BPAD B-Disease 1 0.9999984502792358
, O 0 0.011567937210202217
similar O 0 0.0062170131132006645
to O 0 0.00559957092627883
what O 0 0.005113539751619101
is O 0 0.005216002464294434
observed O 0 0.006653361022472382
in O 0 0.006373573560267687
other O 0 0.00877539161592722
genetic B-Disease 1 0.998372495174408
disorders I-Disease 1 0.9999994039535522
, O 0 0.15712404251098633
we O 0 0.011066634207963943
used O 0 0.015096700750291348
mental O 1 0.999993085861206
health O 1 0.999990701675415
wellness O 1 0.9999991655349731
( O 1 0.6293595433235168
absence O 0 0.47064730525016785
of O 0 0.22614964842796326
any O 1 0.9532394409179688
psychiatric B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
) O 0 0.1662762463092804
as O 0 0.010504444129765034
the O 0 0.01259804517030716
phenotype O 0 0.18486833572387695
in O 0 0.008828382939100266
our O 0 0.014227728359401226
genome O 0 0.03691856190562248
- O 1 0.9369314908981323
wide O 0 0.020945096388459206
linkage O 0 0.0512150414288044
scan O 0 0.020988279953598976
of O 0 0.00913924165070057
several O 0 0.007577399257570505
large O 0 0.011916166171431541
multigeneration O 1 0.8034194111824036
Old O 0 0.08179648965597153
Order O 0 0.02475033886730671
Amish O 1 0.6149992942810059
pedigrees O 0 0.27185767889022827
exhibiting O 0 0.09865251928567886
an O 0 0.022860445082187653
extremely O 0 0.46518394351005554
high O 1 0.9156764149665833
incidence O 1 0.9998596906661987
of O 1 0.9664273858070374
BPAD B-Disease 1 0.9999939203262329
. O 0 0.09283625334501266

We O 0 0.025976242497563362
have O 0 0.012143977917730808
found O 0 0.010454789735376835
strong O 0 0.012953084893524647
evidence O 0 0.009500418789684772
for O 0 0.009220202453434467
a O 0 0.015115173533558846
locus O 0 0.04831381142139435
on O 0 0.01777437888085842
chromosome O 0 0.0745953619480133
4p O 1 0.9973878264427185
at O 0 0.025300614535808563
D4S2949 O 0 0.4421502649784088
( O 0 0.021374478936195374
maximum O 0 0.026053739711642265
GENEHUNTER O 1 0.9879606366157532
- O 1 0.9608569741249084
PLUS O 0 0.04528806731104851
nonparametric O 0 0.06171572580933571
linkage O 0 0.03917748108506203
score O 0 0.01973516307771206
= O 0 0.02458818256855011
4 O 0 0.014786018058657646
. O 0 0.01135194394737482
05 O 0 0.042587026953697205
, O 0 0.01542119961231947
P O 0 0.24016404151916504
= O 0 0.02099485881626606
5 O 0 0.01025606319308281
. O 0 0.006262761075049639
22 O 0 0.0111201461404562
x O 0 0.01684047468006611
10 O 0 0.011133456602692604
( O 0 0.014987410977482796
- O 0 0.06549878418445587
4 O 0 0.01697295717895031
) O 0 0.01307255681604147
; O 0 0.013221465051174164
SIBPAL O 0 0.471209853887558
Pempirical O 0 0.2791444659233093
value O 0 0.014634030871093273
< O 0 0.04174165427684784
3 O 0 0.013225012458860874
x O 0 0.018452314659953117
10 O 0 0.012040788307785988
( O 0 0.016791926696896553
- O 1 0.5677086710929871
5 O 0 0.015033572912216187
) O 0 0.011358763091266155
) O 0 0.008538619615137577
and O 0 0.007728199008852243
suggestive O 0 0.018351854756474495
evidence O 0 0.007878558710217476
for O 0 0.008209537714719772
a O 0 0.013775346800684929
locus O 0 0.11042563617229462
on O 0 0.016892386600375175
chromosome O 0 0.15411758422851562
4q O 1 0.9575148820877075
at O 0 0.020439499989151955
D4S397 O 0 0.4672655165195465
( O 0 0.021904733031988144
maximum O 0 0.027126476168632507
GENEHUNTER O 1 0.9943761825561523
- O 1 0.953272819519043
PLUS O 0 0.04436211660504341
nonparametric O 0 0.06997351348400116
linkage O 0 0.03754705190658569
score O 0 0.017050566151738167
= O 0 0.021693967282772064
3 O 0 0.01124248281121254
. O 0 0.007358666975051165
29 O 0 0.015744207426905632
, O 0 0.01318709272891283
P O 0 0.17551949620246887
= O 0 0.019490456208586693
2 O 0 0.010901623405516148
. O 0 0.006475206930190325
57 O 0 0.016020357608795166
x O 0 0.018550045788288116
10 O 0 0.012936683371663094
( O 0 0.01572142355144024
- O 0 0.09394553303718567
3 O 0 0.013569430448114872
) O 0 0.011823317036032677
; O 0 0.01148898433893919
SIBPAL O 0 0.14696255326271057
Pempirical O 0 0.05689352750778198
value O 0 0.013844091445207596
< O 0 0.040035612881183624
1 O 0 0.012979583814740181
x O 0 0.017349354922771454
10 O 0 0.010782246477901936
( O 0 0.01467407587915659
- O 1 0.5386955738067627
3 O 0 0.0127403037622571
) O 0 0.00925528071820736
) O 0 0.007153360638767481
that O 0 0.0048164795152843
are O 0 0.005549311172217131
linked O 0 0.025039177387952805
to O 0 0.023905472829937935
mental O 1 0.9999897480010986
health O 1 0.9999643564224243
wellness O 1 0.9999949932098389
. O 0 0.16110415756702423

These O 0 0.02043842151761055
findings O 0 0.01883731409907341
are O 0 0.007755727972835302
consistent O 0 0.012329768389463425
with O 0 0.0084258196875453
the O 0 0.011284423060715199
hypothesis O 0 0.01523580215871334
that O 0 0.005731099750846624
certain O 0 0.008108478039503098
alleles O 0 0.02047915942966938
could O 0 0.00890461914241314
prevent O 0 0.01764511689543724
or O 0 0.009949129074811935
modify O 0 0.018749350681900978
the O 0 0.014284147880971432
clinical O 1 0.9132266640663147
manifestations O 1 0.9994034767150879
of O 1 0.9929532408714294
BPAD B-Disease 1 0.9999996423721313
and O 0 0.43594634532928467
perhaps O 0 0.23541919887065887
other O 0 0.03016013652086258
related O 1 0.9961793422698975
affective B-Disease 1 0.999998927116394
disorders I-Disease 1 0.9999991655349731
. O 1 0.7696191072463989

Segregation O 1 0.9903809428215027
distortion O 1 0.9977042078971863
in O 1 0.9480711221694946
myotonic B-Disease 1 0.999998927116394
dystrophy I-Disease 1 0.9999995231628418
. O 1 0.7635555863380432

Myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.999951958656311
DM B-Disease 1 0.9999998807907104
) O 0 0.04225652292370796
is O 0 0.016777735203504562
an O 0 0.2764241695404053
autosomal B-Disease 1 0.9999977350234985
dominant I-Disease 1 0.999993085861206
disease I-Disease 1 0.9999992847442627
which O 0 0.09684959053993225
, O 0 0.011135072447359562
in O 0 0.0071767596527934074
the O 0 0.010955030098557472
typical O 0 0.09711995720863342
pedigree O 0 0.15380169451236725
, O 0 0.009516941383481026
shows O 0 0.00958335679024458
a O 0 0.012694330886006355
three O 0 0.014553889632225037
generation O 1 0.5275318622589111
anticipation O 0 0.4658004641532898
cascade O 1 0.9437868595123291
. O 0 0.044705525040626526

This O 0 0.01893928460776806
results O 0 0.01798633299767971
in O 0 0.02138516679406166
infertility B-Disease 1 0.9999969005584717
and O 1 0.9999903440475464
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999983310699463
CDM B-Disease 1 0.9999995231628418
) O 0 0.01859869807958603
with O 0 0.01049699354916811
the O 0 0.013858616352081299
disappearance O 1 0.5148649215698242
of O 1 0.7127277851104736
DM B-Disease 1 0.9999995231628418
in O 0 0.02200896479189396
that O 0 0.019062360748648643
pedigree O 0 0.35867583751678467
. O 0 0.03492517024278641

The O 0 0.03145124018192291
concept O 0 0.02898513898253441
of O 0 0.02709454484283924
segregation O 1 0.9990791082382202
distortion O 1 0.9984431862831116
, O 0 0.01655370369553566
where O 0 0.010386530309915543
there O 0 0.007453048136085272
is O 0 0.00819213967770338
preferential O 0 0.0369236096739769
transmission O 0 0.015261071734130383
of O 0 0.008157224394381046
the O 0 0.009661389514803886
larger O 0 0.011043334379792213
allele O 0 0.0208148080855608
at O 0 0.015363682061433792
the O 0 0.4670394957065582
DM B-Disease 1 0.9999998807907104
locus O 1 0.9965481162071228
, O 0 0.013412469998002052
has O 0 0.0076185171492397785
been O 0 0.007091208826750517
put O 0 0.010189250111579895
forward O 0 0.01027433667331934
to O 0 0.007184714078903198
explain O 0 0.01155624259263277
partially O 0 0.016781453043222427
the O 0 0.01282073650509119
maintenance O 1 0.9171291589736938
of O 1 0.6338822841644287
DM B-Disease 1 0.9999996423721313
in O 0 0.01872424967586994
the O 0 0.024322381243109703
population O 0 0.026157235726714134
. O 0 0.03255344554781914

In O 0 0.02592676505446434
a O 0 0.025740686804056168
survey O 0 0.029278626665472984
of O 0 0.03189047798514366
DM B-Disease 1 0.9999934434890747
in O 0 0.018409129232168198
Northern O 0 0.02692394331097603
Ireland O 0 0.03001185692846775
, O 0 0.022570310160517693
59 O 0 0.04591982811689377
pedigrees O 0 0.0805707648396492
were O 0 0.029044440016150475
ascertained O 0 0.0724787712097168
. O 0 0.042114753276109695

Sibships O 1 0.5487406253814697
where O 0 0.02259279042482376
the O 0 0.014346170239150524
status O 0 0.015752768144011497
of O 0 0.008506319485604763
all O 0 0.006970261223614216
the O 0 0.008739760145545006
members O 0 0.00908800307661295
had O 0 0.008312531746923923
been O 0 0.0058933584950864315
identified O 0 0.007384599652141333
were O 0 0.005078827030956745
examined O 0 0.009316871874034405
to O 0 0.005054285749793053
determine O 0 0.0060302033089101315
the O 0 0.007246362045407295
transmission O 0 0.014484217390418053
of O 0 0.011945143342018127
the O 1 0.6286405920982361
DM B-Disease 1 0.9999998807907104
expansion O 0 0.36868321895599365
from O 0 0.01650850847363472
affected O 0 0.02104989066720009
parents O 0 0.017234068363904953
to O 0 0.014188483357429504
their O 0 0.0174404326826334
offspring O 0 0.07279004156589508
. O 0 0.03530353680253029

Where O 0 0.0402841679751873
the O 0 0.03451237455010414
transmitting O 1 0.896060585975647
parent O 1 0.9200040698051453
was O 0 0.11772990971803665
male O 0 0.18737342953681946
, O 0 0.029910603538155556
58 O 0 0.06455397605895996
. O 0 0.04134384170174599

3 O 0 0.034124523401260376
% O 0 0.018226006999611855
of O 0 0.014031622558832169
the O 0 0.016258491203188896
offspring O 0 0.08987575769424438
were O 0 0.00980663113296032
affected O 0 0.015182117000222206
, O 0 0.008498908951878548
and O 0 0.006521260365843773
in O 0 0.005731208249926567
the O 0 0.007682912517338991
case O 0 0.008995557203888893
of O 0 0.009574223309755325
a O 0 0.02841903083026409
female O 1 0.943790078163147
transmitting O 1 0.9912393689155579
parent O 1 0.945059597492218
, O 0 0.026204774156212807
68 O 0 0.06549155712127686
. O 0 0.03645671531558037

7 O 0 0.07139069586992264
% O 0 0.03796771913766861
were O 0 0.026647720485925674
affected O 0 0.048066072165966034
. O 0 0.04209413006901741

Studies O 0 0.03239899501204491
on O 0 0.03024037554860115
meiotic O 1 0.9985309839248657
drive O 1 0.7902318835258484
in O 0 0.21858657896518707
DM B-Disease 1 0.9999992847442627
have O 0 0.011476177722215652
shown O 0 0.011156663298606873
increased O 0 0.012113035656511784
transmission O 0 0.017071444541215897
of O 0 0.009405066259205341
the O 0 0.01063601952046156
larger O 0 0.012810524553060532
allele O 0 0.022811274975538254
at O 0 0.014277221634984016
the O 0 0.021986864507198334
DM B-Disease 1 0.9999970197677612
locus O 0 0.42637670040130615
in O 0 0.02149791270494461
non O 1 0.9987169504165649
- O 1 0.9999964237213135
DM O 1 0.9999996423721313
heterozygotes O 1 0.9967480897903442
for O 0 0.045877691358327866
CTGn O 1 0.9897510409355164
. O 0 0.04849893972277641

This O 0 0.02567472495138645
study O 0 0.01934274286031723
provides O 0 0.016557641327381134
further O 0 0.01020184438675642
evidence O 0 0.010009062476456165
that O 0 0.009625060483813286
the O 0 0.21439321339130402
DM B-Disease 1 0.9999998807907104
expansion O 1 0.7392725944519043
tends O 0 0.03601476177573204
to O 0 0.017406409606337547
be O 0 0.017660463228821754
transmitted O 0 0.04896893724799156
preferentially O 0 0.06201525405049324
. O 0 0.03840060532093048

Diagnosis O 1 0.9995469450950623
of O 1 0.9611061215400696
hemochromatosis B-Disease 1 0.9999958276748657
. O 1 0.6859277486801147

If O 0 0.0671185702085495
untreated O 1 0.9999483823776245
, O 1 0.9987452030181885
hemochromatosis B-Disease 1 1.0
can O 1 0.9832700490951538
cause O 1 0.9999544620513916
serious O 1 0.9999927282333374
illness O 1 0.9999996423721313
and O 1 0.9160206913948059
early B-Disease 1 0.8782427906990051
death I-Disease 1 0.9983741044998169
, O 0 0.016809817403554916
but O 0 0.0076154675334692
the O 0 0.139263316988945
disease O 1 0.9999704360961914
is O 0 0.022869691252708435
still O 0 0.016159214079380035
substantially O 0 0.06835372745990753
under O 1 0.9548510313034058
- O 1 0.9999914169311523
diagnosed O 1 0.9999842643737793
. O 0 0.05137982219457626

The O 0 0.04298115149140358
cornerstone O 1 0.9849013686180115
of O 0 0.058473505079746246
screening O 1 0.9271019697189331
and O 0 0.019282342866063118
case O 0 0.055062197148799896
detection O 0 0.1233174204826355
is O 0 0.010192492976784706
the O 0 0.011727887205779552
measurement O 0 0.02256876416504383
of O 0 0.021282196044921875
serum O 1 0.9993182420730591
transferrin O 1 0.9991552829742432
saturation O 0 0.4217014014720917
and O 0 0.021151069551706314
the O 0 0.05088081583380699
serum O 1 0.9996746778488159
ferritin O 1 0.9986557960510254
level O 0 0.05708853527903557
. O 0 0.041674137115478516

Once O 0 0.057141076773405075
the O 0 0.04935183748602867
diagnosis O 1 0.9998369216918945
is O 0 0.02491319179534912
suspected O 0 0.3227553367614746
, O 0 0.01774785667657852
physicians O 0 0.1815255582332611
must O 0 0.014046921394765377
use O 0 0.01589484140276909
serum O 1 0.9991169571876526
ferritin O 1 0.9990014433860779
levels O 0 0.0299209151417017
and O 0 0.03181919828057289
hepatic O 1 0.9999921321868896
iron O 1 0.9997232556343079
stores O 0 0.10664033889770508
on O 0 0.2678346633911133
liver O 1 0.9999923706054688
biopsy O 1 0.999703586101532
specimens O 0 0.02536928281188011
to O 0 0.015590355731546879
assess O 0 0.0502135194838047
patients O 0 0.13049320876598358
for O 0 0.01067139208316803
the O 0 0.017098968848586082
presence O 0 0.13034352660179138
of O 1 0.7901612520217896
iron B-Disease 1 0.9999915361404419
overload I-Disease 1 0.9999878406524658
. O 0 0.0701044499874115

Liver O 1 0.9999988079071045
biopsy O 1 0.9999701976776123
is O 0 0.033945389091968536
also O 0 0.011401745490729809
used O 0 0.006659675855189562
to O 0 0.00616344902664423
establish O 0 0.009844579733908176
the O 0 0.008101249113678932
presence O 0 0.011553933843970299
or O 0 0.008363348431885242
absence O 0 0.2388017475605011
of O 1 0.9356657266616821
cirrhosis B-Disease 1 1.0
, O 1 0.6420523524284363
which O 0 0.01494561042636633
can O 0 0.013124488294124603
affect O 0 0.04660740867257118
prognosis O 1 0.9998880624771118
and O 0 0.03377500921487808
management O 0 0.28047236800193787
. O 0 0.03595462068915367

A O 0 0.053876932710409164
DNA O 0 0.03595276549458504
- O 0 0.10115302354097366
based O 0 0.012800336815416813
test O 0 0.012609729543328285
for O 0 0.010118836537003517
the O 0 0.021914232522249222
HFE O 1 0.9999905824661255
gene O 0 0.023713769391179085
is O 0 0.00991425383836031
commercially O 0 0.012445474043488503
available O 0 0.0059982482343912125
, O 0 0.005232019815593958
but O 0 0.004165753722190857
its O 0 0.0051257857121527195
place O 0 0.0074141789227724075
in O 0 0.007056504487991333
the O 0 0.01702059991657734
diagnosis O 1 0.999970555305481
of O 1 0.9993434548377991
hemochromatosis B-Disease 1 1.0
is O 1 0.9665690064430237
still O 0 0.05550677701830864
being O 0 0.02786996401846409
evaluated O 0 0.045655522495508194
. O 0 0.03373606130480766

Currently O 0 0.033993832767009735
, O 0 0.017110928893089294
the O 0 0.013762875460088253
most O 0 0.00952128879725933
useful O 0 0.01071903109550476
role O 0 0.01178984809666872
for O 0 0.007343795616179705
this O 0 0.005470895208418369
test O 0 0.009431404992938042
is O 0 0.005956611596047878
in O 0 0.005280832760035992
the O 0 0.008612753823399544
detection O 0 0.10668223351240158
of O 0 0.28154897689819336
hemochromatosis B-Disease 1 0.9999996423721313
in O 0 0.011366311460733414
the O 0 0.014270619489252567
family O 0 0.06072581186890602
members O 0 0.01000239234417677
of O 0 0.01638353429734707
patients O 1 0.9650481939315796
with O 0 0.010674534365534782
a O 0 0.026926329359412193
proven O 0 0.3192484676837921
case O 0 0.027525436133146286
of O 0 0.028446732088923454
the O 1 0.9589293003082275
disease O 1 0.999992847442627
. O 0 0.19201748073101044

It O 0 0.024117188528180122
is O 0 0.01850619539618492
crucial O 0 0.028341110795736313
to O 0 0.02914074994623661
diagnose O 1 0.9999940395355225
hemochromatosis B-Disease 1 0.9999998807907104
before O 1 0.9999078512191772
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999977350234985
because O 1 0.9996978044509888
phlebotomy O 1 0.9999998807907104
therapy O 1 0.9999983310699463
can O 1 0.8507834076881409
avert O 1 0.9999958276748657
serious O 1 0.9999998807907104
chronic O 1 1.0
disease O 1 1.0
and O 1 0.99921715259552
can O 0 0.052080970257520676
even O 0 0.011359416879713535
lead O 0 0.02059813402593136
to O 0 0.012376228347420692
normal O 0 0.023653315380215645
life O 0 0.0562615841627121
expectancy O 1 0.9148222208023071
. O 0 0.02256033942103386
. O 0 0.02981509454548359

Prevalence O 1 0.5363265872001648
of O 0 0.03402579203248024
the O 0 0.26837587356567383
I1307K O 1 0.9999724626541138
APC B-Disease 1 0.9999659061431885
gene O 0 0.03343167155981064
variant O 0 0.021827181801199913
in O 0 0.0090975072234869
Israeli O 0 0.01466735452413559
Jews O 0 0.01369448658078909
of O 0 0.00898790080100298
differing O 0 0.0094628119841218
ethnic O 0 0.012488205917179585
origin O 0 0.011533182114362717
and O 0 0.01825590617954731
risk O 1 0.9979161620140076
for O 1 0.9997795224189758
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9754334688186646

BACKGROUND O 0 0.25368767976760864
& O 1 0.8036059737205505
AIMS O 0 0.05831899121403694
Israeli O 0 0.025788431987166405
Jews O 0 0.020945843309164047
of O 0 0.013769801706075668
European O 0 0.016387246549129486
birth O 1 0.6455699801445007
, O 0 0.013825017027556896
i O 0 0.015927767381072044
. O 0 0.008329774253070354
e O 0 0.017630139365792274
. O 0 0.006758691743016243
, O 0 0.00824461318552494
Ashkenazim O 0 0.04065106809139252
, O 0 0.007608331274241209
have O 0 0.005523096304386854
the O 0 0.01553406473249197
highest O 1 0.9999731779098511
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999977350234985
of O 1 0.9477394819259644
any O 0 0.09738679230213165
Israeli O 0 0.46567800641059875
ethnic O 0 0.09494557976722717
group O 0 0.10124458372592926
. O 0 0.03678083047270775

The O 0 0.06758458912372589
I1307K O 1 0.998149037361145
APC B-Disease 1 0.9998044371604919
gene O 0 0.05028087645769119
variant O 0 0.039153143763542175
was O 0 0.023458123207092285
found O 0 0.013768533244729042
in O 0 0.016584808006882668
6 O 0 0.039901044219732285
. O 0 0.03351420536637306

1 O 0 0.04124222323298454
% O 0 0.020663538947701454
of O 0 0.014095477759838104
American O 0 0.017804456874728203
Jews O 0 0.01772082969546318
, O 0 0.010516580194234848
28 O 0 0.01327709760516882
% O 0 0.009586417116224766
of O 0 0.011527524329721928
their O 0 0.38092032074928284
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9998573064804077
, O 1 0.5741040706634521
but O 0 0.008647593669593334
not O 0 0.007152148522436619
in O 0 0.009961170144379139
non O 0 0.34202149510383606
- O 1 0.9944412112236023
Jews O 0 0.04991532489657402
. O 0 0.03388902172446251

We O 0 0.028232654556632042
assessed O 0 0.03352600708603859
the O 0 0.025948798283934593
I1307K O 1 0.9931061863899231
prevalence O 1 0.9799171090126038
in O 0 0.01294775865972042
Israeli O 0 0.018858589231967926
Jews O 0 0.01771407388150692
of O 0 0.010420650243759155
differing O 0 0.010271554812788963
ethnic O 0 0.012834570370614529
origin O 0 0.010979292914271355
and O 0 0.01697256788611412
risk O 1 0.9961697459220886
for O 1 0.9997149109840393
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9873929619789124

METHODS O 0 0.03857114538550377
DNA O 0 0.025066981092095375
samples O 0 0.016277682036161423
from O 0 0.011395351961255074
500 O 0 0.01799309439957142
unrelated O 0 0.015378115698695183
Jews O 0 0.014185789972543716
of O 0 0.00916509609669447
European O 0 0.011470694094896317
or O 0 0.010676180943846703
non O 1 0.7192320823669434
- O 1 0.9911162853240967
European O 0 0.00968641322106123
origin O 0 0.006150313187390566
, O 0 0.005499913357198238
with O 0 0.004847226198762655
or O 0 0.005780084524303675
without O 0 0.006033857353031635
a O 0 0.010972019284963608
personal O 0 0.10674343258142471
and O 0 0.030330907553434372
/ O 1 0.9982753992080688
or O 0 0.00812762975692749
family O 0 0.013622218742966652
history O 0 0.013113727793097496
of O 0 0.29181063175201416
neoplasia B-Disease 1 0.999991774559021
, O 0 0.012371391989290714
were O 0 0.007803052663803101
examined O 0 0.012796529568731785
for O 0 0.008405646309256554
the O 0 0.011987702921032906
I1307K O 1 0.6382032036781311
variant O 0 0.018190450966358185
by O 0 0.008898884057998657
the O 0 0.016126468777656555
allele O 0 0.17091597616672516
- O 1 0.9455040097236633
specific O 0 0.019538171589374542
oligonucleotide O 1 0.9031102061271667
( O 0 0.15858983993530273
ASO O 1 0.9996452331542969
) O 0 0.03328249230980873
method O 0 0.033028457313776016
. O 0 0.03558502718806267

RESULTS O 0 0.028077298775315285
In O 0 0.01518306601792574
persons O 0 0.01664760895073414
at O 0 0.015263751149177551
average O 0 0.02051149122416973
risk O 1 0.915372371673584
for O 1 0.987561047077179
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9981538653373718
I1307K O 1 0.9999161958694458
was O 0 0.23605912923812866
found O 0 0.013658100739121437
in O 0 0.013936641626060009
5 O 0 0.028815502300858498
. O 0 0.02843082882463932

0 O 0 0.05463884398341179
% O 0 0.0244827289134264
of O 0 0.02087085321545601
120 O 0 0.03132998198270798
European O 0 0.021761298179626465
and O 0 0.021235182881355286
1 O 0 0.03902236372232437
. O 0 0.037442561239004135

6 O 0 0.04157528653740883
% O 0 0.02155276946723461
of O 0 0.01893817074596882
188 O 0 0.04914095997810364
non O 0 0.06644386798143387
- O 1 0.7325537800788879
European O 0 0.019674932584166527
Jews O 0 0.036720097064971924
( O 0 0.041795991361141205
P O 1 0.9123066663742065
= O 0 0.04556754231452942
0 O 0 0.034195367246866226
. O 0 0.02404828742146492
08 O 0 0.07506308704614639
) O 0 0.034030165523290634
. O 0 0.037361934781074524

It O 0 0.03480745851993561
occurred O 0 0.03600577265024185
in O 0 0.025191079825162888
15 O 0 0.04522555321455002
. O 0 0.041652120649814606

4 O 0 0.03603622317314148
% O 0 0.019278354942798615
of O 0 0.016888750717043877
52 O 0 0.030080560594797134
Ashkenazi O 0 0.14549124240875244
Israelis O 0 0.0276495311409235
with O 0 0.060038600116968155
familial O 1 0.9999980926513672
cancer B-Disease 1 0.9999997615814209
( O 1 0.9978618025779724
P O 1 0.9996558427810669
= O 0 0.06940095126628876
0 O 0 0.02182832360267639
. O 0 0.012798577547073364
02 O 1 0.9185882210731506
) O 0 0.011025871150195599
and O 0 0.007987318560481071
was O 0 0.009796611964702606
not O 0 0.0056000808253884315
detected O 0 0.010264546610414982
in O 0 0.006767939776182175
51 O 0 0.01805436983704567
non O 0 0.037735361605882645
- O 1 0.7752392888069153
European O 0 0.013506367802619934
Jews O 0 0.027284979820251465
at O 0 0.152617946267128
increased O 1 0.8731979727745056
cancer B-Disease 1 0.9999862909317017
risk O 1 0.9864908456802368
. O 0 0.04429192841053009

Colorectal B-Disease 1 0.9999994039535522
neoplasia I-Disease 1 0.9999953508377075
occurred O 1 0.8989359736442566
personally O 1 0.8160706162452698
or O 0 0.012164387851953506
in O 0 0.0070894574746489525
the O 0 0.007709138561040163
families O 0 0.008521336130797863
of O 0 0.007221384905278683
13 O 0 0.011345363222062588
of O 0 0.011125783436000347
20 O 0 0.016585741192102432
Ashkenazi O 1 0.9867997169494629
I1307K O 1 0.9816375374794006
carriers O 0 0.024887939915060997
, O 0 0.009826227091252804
8 O 0 0.011614597402513027
of O 0 0.008201372809708118
whom O 0 0.01435769721865654
also O 0 0.008446089923381805
had O 0 0.009854169562458992
a O 0 0.011852243915200233
personal O 0 0.018706202507019043
or O 0 0.011940618976950645
family O 0 0.019766006618738174
history O 0 0.02136744000017643
of O 0 0.3800942003726959
noncolonic O 1 0.9999608993530273
neoplasia B-Disease 1 0.9999605417251587
. O 0 0.061020877212285995

CONCLUSIONS O 0 0.06494855880737305
The O 0 0.047930262982845306
I1307K O 1 0.9993797540664673
APC O 1 0.9997491240501404
variant O 0 0.06261193752288818
may O 0 0.012739441357553005
represent O 0 0.010847123339772224
a O 0 0.017263829708099365
susceptibility O 1 0.9989293217658997
gene O 0 0.13112418353557587
for O 0 0.14355924725532532
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 0.030406977981328964
or I-Disease 0 0.009580641984939575
other I-Disease 0 0.007255169562995434
, I-Disease 0 0.014413733035326004
cancers I-Disease 1 0.9711717963218689
in O 0 0.011224379763007164
Ashkenazi O 1 0.9964134097099304
Jews O 0 0.11534006148576736
, O 0 0.011763432994484901
and O 0 0.01003132201731205
partially O 0 0.02514101006090641
explains O 0 0.013934386894106865
the O 0 0.009896998293697834
higher O 0 0.015516776591539383
incidence O 1 0.999914288520813
of O 1 0.9999347925186157
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.6482905745506287
European O 0 0.31715598702430725
Israelis O 0 0.18627174198627472
. O 0 0.03585211932659149

Systematic O 0 0.06347543746232986
analysis O 0 0.024611379951238632
of O 0 0.031929973512887955
coproporphyrinogen O 1 0.9998753070831299
oxidase O 1 0.9999468326568604
gene O 1 0.683071494102478
defects O 1 0.9967496395111084
in O 0 0.029871929436922073
hereditary B-Disease 1 0.9999932050704956
coproporphyria I-Disease 1 0.9999823570251465
and O 1 0.8657966256141663
mutation O 1 0.9932564496994019
update O 0 0.3600260019302368
. O 0 0.03859834745526314

Hereditary B-Disease 1 0.9999452829360962
coproporphyria I-Disease 1 0.999945878982544
( O 1 0.9860281944274902
HC B-Disease 1 0.9999860525131226
) O 0 0.030638419091701508
is O 0 0.020011331886053085
an O 1 0.6370367407798767
acute O 1 0.9999998807907104
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999881982803345
autosomal O 1 1.0
dominant O 1 0.9999970197677612
inheritance O 1 0.9999926090240479
caused O 1 0.9999042749404907
by O 1 0.7962725758552551
deficient B-Disease 1 0.9997038245201111
activity I-Disease 0 0.023074153810739517
of I-Disease 0 0.3057703673839569
coproporphyrinogen I-Disease 1 0.9999910593032837
III I-Disease 1 0.9999985694885254
oxidase I-Disease 1 0.9999817609786987
( O 1 0.6472723484039307
CPO O 1 0.9884517192840576
) O 0 0.040153007954359055
. O 0 0.03995431959629059

Clinical O 1 0.91680908203125
manifestations O 1 0.9963898062705994
of O 1 0.7071084976196289
the O 1 0.9994146823883057
disease O 1 0.9999994039535522
are O 0 0.017979776486754417
characterized O 1 0.9955665469169617
by O 1 0.7670775055885315
acute O 1 0.9999998807907104
attacks O 1 0.9994930028915405
of O 1 0.9999873638153076
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9960021376609802
precipitated O 1 0.9999847412109375
by O 0 0.3070901036262512
drugs O 1 0.9776439070701599
, O 0 0.04040969908237457
fasting O 1 0.9894696474075317
, O 0 0.19294002652168274
cyclical O 1 0.9998551607131958
hormonal O 1 0.999919056892395
changes O 0 0.04059344530105591
, O 1 0.7575188279151917
or O 1 0.9959208965301514
infectious B-Disease 1 0.9999997615814209
diseases I-Disease 1 0.9999994039535522
. O 1 0.8344581127166748

Skin O 1 0.9999938011169434
photosensitivity O 1 0.9999876022338867
may O 0 0.33578771352767944
also O 0 0.02259335294365883
be O 0 0.01815919764339924
present O 0 0.028214266523718834
. O 0 0.033794302493333817

The O 0 0.036452509462833405
seven O 0 0.032909661531448364
exons O 0 0.048800043761730194
, O 0 0.019635792821645737
the O 0 0.025641383603215218
exon O 1 0.9070769548416138
/ O 1 0.9945230484008789
intron O 1 0.7621371150016785
boundaries O 0 0.016788605600595474
and O 0 0.0103249317035079
part O 0 0.012377173639833927
of O 0 0.011654993519186974
3 O 0 0.016956638544797897
noncoding O 0 0.029809700325131416
sequence O 0 0.009681707248091698
of O 0 0.010284192860126495
the O 0 0.01472176518291235
CPO O 1 0.9465873837471008
gene O 0 0.012152641080319881
were O 0 0.007594166323542595
systematically O 0 0.013840746134519577
analyzed O 0 0.009409086778759956
by O 0 0.007279347162693739
an O 0 0.009550174698233604
exon O 0 0.1213289126753807
- O 0 0.29361194372177124
by O 0 0.016888529062271118
- O 1 0.9519931674003601
exon O 0 0.2721337676048279
denaturing O 1 0.9873794317245483
gradient O 1 0.966292679309845
gel O 1 0.9983079433441162
electrophoresis O 1 0.9785047769546509
( O 0 0.39632484316825867
DGGE O 1 0.999549925327301
) O 0 0.016706936061382294
strategy O 0 0.01621728204190731
followed O 0 0.010933227837085724
by O 0 0.008125584572553635
direct O 0 0.01030123420059681
sequencing O 0 0.013581759296357632
in O 0 0.009117052890360355
seven O 0 0.01595483161509037
unrelated O 0 0.07282754778862
heterozygous O 1 0.945587694644928
HC B-Disease 1 0.9999971389770508
patients O 1 0.9907200336456299
from O 0 0.021968413144350052
France O 0 0.4155455231666565
, O 0 0.02351837418973446
Holland O 1 0.5443940162658691
, O 0 0.020079070702195168
and O 0 0.019612664356827736
Czech O 0 0.0885641872882843
Republic O 0 0.05897548794746399
. O 0 0.039226435124874115

Seven O 0 0.05374498292803764
novel O 0 0.06027970463037491
mutations O 0 0.0316082127392292
and O 0 0.01662294939160347
two O 0 0.01448243297636509
new O 0 0.026616767048835754
polymorphisms O 0 0.20300641655921936
were O 0 0.023651760071516037
detected O 0 0.04341128095984459
. O 0 0.03528431057929993

Among O 0 0.03455497696995735
these O 0 0.014503591693937778
mutations O 0 0.01660894975066185
two O 0 0.009004802443087101
are O 0 0.008776428177952766
missense O 0 0.14485463500022888
( O 0 0.02804403193295002
G197W O 1 0.971899688243866
, O 0 0.01682824268937111
W427R O 1 0.8712387084960938
) O 0 0.009916913695633411
, O 0 0.006185630802065134
two O 0 0.005041047465056181
are O 0 0.005346411839127541
nonsense O 0 0.11490490287542343
( O 0 0.03638242930173874
Q306X O 1 0.9927776455879211
, O 0 0.017304036766290665
Q385X O 1 0.95679771900177
) O 0 0.009909885004162788
, O 0 0.006454765796661377
two O 0 0.0047701941803097725
are O 0 0.004122574348002672
small O 0 0.009404625743627548
deletions O 0 0.033264610916376114
( O 0 0.023570973426103592
662de14bp O 1 0.8124717473983765
; O 0 0.01568065769970417
1168del3bp O 0 0.2687681317329407
removing O 0 0.026953719556331635
a O 0 0.015360711142420769
glycine O 0 0.03382808342576027
at O 0 0.01309777982532978
position O 0 0.014496076852083206
390 O 0 0.08465208113193512
) O 0 0.010150264948606491
, O 0 0.006918552331626415
and O 0 0.0054753730073571205
one O 0 0.0059549263678491116
is O 0 0.0061179110780358315
a O 0 0.009444708935916424
splicing O 0 0.01660887338221073
mutation O 0 0.017122456803917885
( O 0 0.01785138063132763
IVS1 O 1 0.9977918863296509
- O 1 0.9984297156333923
15c O 1 0.9992043375968933
- O 1 0.9999003410339355
- O 1 0.9998705387115479
> O 1 0.981222927570343
g O 0 0.043939538300037384
) O 0 0.01223691739141941
which O 0 0.009372509084641933
creates O 0 0.018299832940101624
a O 0 0.016938406974077225
new O 0 0.028657998889684677
acceptor O 1 0.768412709236145
splice O 0 0.10915767401456833
site O 0 0.04381757974624634
. O 0 0.03563233092427254

The O 0 0.041032858192920685
pathological O 0 0.09450063854455948
significance O 0 0.022638387978076935
of O 0 0.015226554125547409
the O 0 0.017764506861567497
point O 0 0.024610746651887894
mutations O 0 0.040159016847610474
G197W O 1 0.9896724224090576
, O 0 0.016956718638539314
W427R O 1 0.7690006494522095
, O 0 0.008481492288410664
and O 0 0.00635336060076952
the O 0 0.008335746824741364
in O 0 0.01064460352063179
- O 1 0.9987398982048035
frame O 1 0.6643782258033752
deletion O 0 0.23116543889045715
390delGly O 0 0.2740406394004822
were O 0 0.008609628304839134
assessed O 0 0.01221269927918911
by O 0 0.00723624974489212
their O 0 0.00614195317029953
respective O 0 0.011946568265557289
expression O 0 0.010563807561993599
in O 0 0.007304724305868149
a O 0 0.013465127907693386
prokaryotic O 0 0.0352579765021801
system O 0 0.01654685288667679
using O 0 0.012661724351346493
site O 0 0.029970018193125725
- O 1 0.7446420192718506
directed O 0 0.0405728742480278
mutagenesis O 0 0.09262421727180481
. O 0 0.04034065827727318

These O 0 0.023077771067619324
mutations O 0 0.02850446105003357
resulted O 0 0.020507797598838806
in O 0 0.011392688378691673
the O 0 0.01748899556696415
absence O 0 0.45452553033828735
or O 0 0.014772001653909683
a O 0 0.019846424460411072
dramatic O 0 0.06367480009794235
decrease O 0 0.05219510570168495
of O 0 0.17075112462043762
CPO O 1 0.9997443556785583
activity O 0 0.056407466530799866
. O 0 0.038223810493946075

The O 0 0.029068343341350555
two O 0 0.018640004098415375
polymorphisms O 0 0.04223690927028656
were O 0 0.012400755658745766
localized O 0 0.0278072077780962
in O 0 0.011180213652551174
noncoding O 0 0.028533469885587692
part O 0 0.013192172162234783
of O 0 0.008666918613016605
the O 0 0.01055226568132639
gene O 0 0.010916939936578274
1 O 0 0.010720547288656235
) O 0 0.008547473698854446
a O 0 0.014522061683237553
C O 1 0.9841383099555969
/ O 1 0.9966084957122803
G O 0 0.17038963735103607
polymorphism O 0 0.022652840241789818
in O 0 0.00938912108540535
the O 0 0.014876864850521088
promotor O 1 0.9956172704696655
region O 0 0.02047027461230755
, O 0 0.013575667515397072
142 O 0 0.0338749960064888
bp O 0 0.02623927593231201
upstream O 0 0.015457273460924625
from O 0 0.008144645020365715
the O 0 0.010747997090220451
transcriptional O 0 0.02607281506061554
initiation O 0 0.031309958547353745
site O 0 0.02070169895887375
( O 0 0.026640363037586212
- O 1 0.9993139505386353
142C O 1 0.9998461008071899
/ O 1 0.9999263286590576
G O 1 0.9621357917785645
) O 0 0.010569162666797638
, O 0 0.006728882435709238
and O 0 0.006667430512607098
2 O 0 0.010491040535271168
) O 0 0.007596599403768778
a O 0 0.009816406294703484
6 O 0 0.016222991049289703
bp O 0 0.028436487540602684
deletion O 0 0.022733774036169052
polymorphism O 0 0.01848829723894596
in O 0 0.007752392441034317
the O 0 0.009545738808810711
3 O 0 0.012955286540091038
noncoding O 0 0.025206100195646286
part O 0 0.01136702299118042
of O 0 0.010684498585760593
the O 0 0.016518164426088333
CPO O 1 0.9825513958930969
gene O 0 0.019077463075518608
, O 0 0.015040348283946514
574 O 0 0.4921068251132965
bp O 0 0.030300337821245193
downstream O 0 0.015464941039681435
of O 0 0.007733587641268969
the O 0 0.00835387408733368
last O 0 0.00914900191128254
base O 0 0.011907321400940418
of O 0 0.008024548180401325
the O 0 0.012010281905531883
normal O 0 0.022287162020802498
termination O 1 0.9900582432746887
codon O 1 0.8918133974075317
( O 0 0.23243187367916107
+ O 1 0.8786962032318115
574 O 1 0.9863682389259338
delATTCTT O 1 0.9863359928131104
) O 0 0.03983084112405777
. O 0 0.03932799771428108

Five O 0 0.050402700901031494
intragenic O 1 0.9966307282447815
dimorphisms O 1 0.9818220138549805
are O 0 0.012321757152676582
now O 0 0.013655278831720352
well O 0 0.011274080723524094
characterized O 0 0.01841953583061695
and O 0 0.008509974926710129
the O 0 0.010740116238594055
high O 0 0.020336922258138657
degree O 0 0.015084178186953068
of O 0 0.027088122442364693
allelic O 1 0.999612033367157
heterogeneity O 1 0.9982317090034485
in O 0 0.1031397134065628
HC B-Disease 1 0.9999963045120239
is O 0 0.016417916864156723
demonstrated O 0 0.012542970478534698
with O 0 0.006525976583361626
seven O 0 0.00855895783752203
new O 0 0.007638479117304087
different O 0 0.0043778992258012295
mutations O 0 0.007611885201185942
making O 0 0.006156167946755886
a O 0 0.006983816158026457
total O 0 0.009065676480531693
of O 0 0.014233408495783806
nineteen O 1 0.9627872109413147
CPO O 1 0.999941349029541
gene B-Disease 1 0.7822877168655396
defects I-Disease 1 0.9886667728424072
reported O 0 0.020772654563188553
so O 0 0.015041753649711609
far O 0 0.01850435882806778
. O 0 0.019913356751203537
. O 0 0.0282159261405468

Coincidence O 0 0.056329626590013504
of O 0 0.024003835394978523
two O 0 0.017689986154437065
novel O 0 0.042777616530656815
arylsulfatase O 1 0.9602299332618713
A O 0 0.06221586465835571
alleles O 0 0.04054279625415802
and O 0 0.021009454503655434
mutation O 1 0.542946994304657
459 O 1 0.9994440674781799
+ O 1 0.9979641437530518
1G O 1 0.9989297986030579
> O 0 0.04717181250452995
A O 0 0.017372481524944305
within O 0 0.01137301605194807
a O 0 0.014777004718780518
family O 0 0.028166795149445534
with O 0 0.09321511536836624
metachromatic B-Disease 1 0.9999958276748657
leukodystrophy I-Disease 1 0.9999977350234985
: O 0 0.0334884412586689
molecular O 0 0.021108228713274002
basis O 0 0.015914423391222954
of O 0 0.021671108901500702
phenotypic O 0 0.0965331420302391
heterogeneity O 1 0.8806336522102356
. O 0 0.05464408919215202

In O 0 0.02377759851515293
a O 0 0.020521437749266624
family O 0 0.02040654607117176
with O 0 0.011030828580260277
three O 0 0.012895921245217323
siblings O 0 0.12578673660755157
, O 0 0.011236675083637238
one O 0 0.010165520943701267
developed O 0 0.013660760596394539
classical O 0 0.020075872540473938
late O 0 0.2275112271308899
infantile O 1 0.9999994039535522
metachromatic B-Disease 1 0.9999996423721313
leukodystrophy I-Disease 1 1.0
( O 1 0.9997966885566711
MLD B-Disease 1 0.9999995231628418
) O 0 0.029081478714942932
, O 0 0.016434727236628532
fatal O 1 0.7868098020553589
at O 0 0.014535648748278618
age O 0 0.013681032694876194
5 O 0 0.011125910095870495
years O 0 0.0076246545650064945
, O 0 0.008298344910144806
with O 0 0.01177883055061102
deficient O 1 0.9984560012817383
arylsulfatase O 1 0.9996631145477295
A O 1 0.9753104448318481
( O 1 0.8206311464309692
ARSA O 1 0.999861478805542
) O 0 0.017043031752109528
activity O 0 0.013580674305558205
and O 0 0.012957688421010971
increased O 0 0.026068203151226044
galactosylsulfatide O 1 0.9998074173927307
( O 1 0.9860053062438965
GS O 1 0.9999936819076538
) O 0 0.05761387199163437
excretion O 1 0.8610475063323975
. O 0 0.04887750372290611

The O 0 0.02513428032398224
two O 0 0.012981170788407326
other O 0 0.011208366602659225
siblings O 0 0.06278061866760254
, O 0 0.013869541697204113
apparently O 0 0.016382597386837006
healthy O 0 0.023951588198542595
at O 0 0.01149226725101471
12 O 0 0.013124019838869572
( O 0 0.015532094985246658
1 O 0 0.0215532798320055
/ O 1 0.946509599685669
2 O 0 0.011927030049264431
) O 0 0.007174022030085325
and O 0 0.005493128206580877
15 O 0 0.008217750117182732
years O 0 0.0066711073741316795
, O 0 0.007528331596404314
respectively O 0 0.009147018194198608
, O 0 0.006820704322308302
and O 0 0.005884286481887102
their O 0 0.006454552058130503
father O 1 0.6711333990097046
, O 0 0.016171153634786606
apparently O 0 0.015656180679798126
healthy O 0 0.019307248294353485
as O 0 0.007638738490641117
well O 0 0.007915539667010307
, O 0 0.010313939303159714
presented O 0 0.03296373412013054
ARSA O 1 0.9999586343765259
and O 0 0.02857135608792305
GS O 1 0.9998723268508911
values O 0 0.014459616504609585
within O 0 0.009875388815999031
the O 0 0.012784102000296116
range O 0 0.0225051399320364
of O 1 0.5536194443702698
MLD B-Disease 1 0.9999996423721313
patients O 1 0.9998779296875
. O 0 0.061673834919929504

Mutation O 0 0.2591839134693146
screening O 0 0.05817607045173645
and O 0 0.01658777892589569
sequence O 0 0.014617360197007656
analysis O 0 0.01013033464550972
disclosed O 0 0.014024321921169758
the O 0 0.008871514350175858
involvement O 0 0.016606347635388374
of O 0 0.010243655182421207
three O 0 0.010700548999011517
different O 0 0.010856760665774345
ARSA O 1 0.9998717308044434
mutations O 0 0.020696183666586876
being O 0 0.011433209292590618
the O 0 0.012113535776734352
molecular O 0 0.014342933893203735
basis O 0 0.0119601059705019
of O 0 0.024722211062908173
intrafamilial O 1 0.9957475066184998
phenotypic O 0 0.23874323070049286
heterogeneity O 1 0.8638111352920532
. O 0 0.051271308213472366

The O 0 0.053885944187641144
late O 1 0.8081964254379272
infantile O 1 0.9999982118606567
patient O 1 0.9999850988388062
inherited O 1 0.9998332262039185
from O 0 0.04102972894906998
his O 1 0.734427273273468
mother O 1 0.997728168964386
the O 0 0.03454035893082619
frequent O 0 0.3779710829257965
0 O 0 0.05613338202238083
- O 1 0.9753133654594421
type O 0 0.04556230828166008
mutation O 0 0.11611481010913849
459 O 1 0.9983396530151367
+ O 1 0.9967954754829407
1G O 1 0.9997531771659851
> O 0 0.3332843780517578
A O 0 0.016942156478762627
, O 0 0.009286276064813137
and O 0 0.007504974491894245
from O 0 0.007746214512735605
his O 0 0.012365031987428665
father O 0 0.13961757719516754
a O 0 0.01822267472743988
novel O 0 0.02794630266726017
, O 0 0.012630620039999485
single O 0 0.025219839066267014
basepair O 1 0.9579648375511169
microdeletion O 1 0.7373572587966919
of O 0 0.01794891245663166
guanine O 0 0.04144668951630592
at O 0 0.013133946806192398
nucleotide O 0 0.018361372873187065
7 O 0 0.014611329883337021
in O 0 0.010283359326422215
exon O 0 0.04738976061344147
1 O 0 0.029348112642765045
( O 0 0.03626835718750954
7delG O 0 0.4988430440425873
) O 0 0.03466271236538887
. O 0 0.03516451641917229

The O 0 0.044414591044187546
two O 0 0.031589508056640625
clinically O 1 0.8363158702850342
unaffected O 0 0.19514068961143494
siblings O 0 0.05405808240175247
carried O 0 0.0266074538230896
the O 0 0.025887608528137207
maternal O 1 0.9962485432624817
mutation O 1 0.9794124364852905
459 O 1 0.9999326467514038
+ O 1 0.9998694658279419
1G O 1 0.9999129772186279
> O 1 0.6610855460166931
A O 0 0.02155890315771103
and O 0 0.011301812715828419
, O 0 0.00952953938394785
on O 0 0.009761901572346687
their O 0 0.010309569537639618
paternal O 1 0.771542489528656
allele O 0 0.042413897812366486
, O 0 0.012405602261424065
a O 0 0.01547673624008894
novel O 0 0.027797697111964226
cytosine O 0 0.04256533458828926
to O 0 0.016041141003370285
thymidine O 0 0.05055734142661095
transition O 0 0.026034686714410782
at O 0 0.018218277022242546
nucleotide O 0 0.03158463537693024
2435 O 0 0.49205318093299866
in O 0 0.015094077214598656
exon O 0 0.04486731439828873
8 O 0 0.01758325658738613
, O 0 0.011211907491087914
resulting O 0 0.012308475561439991
in O 0 0.009478829801082611
substitution O 0 0.021586310118436813
of O 0 0.01939471997320652
alanine O 1 0.9195916652679443
464 O 1 0.9815071821212769
by O 0 0.044893957674503326
valine O 1 0.9994375109672546
( O 0 0.3603023588657379
A464V O 1 0.9753512740135193
) O 0 0.04278324544429779
. O 0 0.03858255222439766

The O 0 0.052381373941898346
fathers O 0 0.22703319787979126
genotype O 1 0.7899487018585205
thus O 0 0.0325465202331543
was O 0 0.15496139228343964
7delG O 1 0.9995821118354797
/ O 1 0.9993114471435547
A464V O 1 0.9795844554901123
. O 0 0.057162702083587646

Mutation O 0 0.36052754521369934
A464V O 1 0.5589169263839722
was O 0 0.027256356552243233
not O 0 0.010962926782667637
found O 0 0.010050417855381966
in O 0 0.011137657798826694
18 O 0 0.029868461191654205
unrelated O 1 0.9951633214950562
MLD B-Disease 1 0.9999994039535522
patients O 1 0.9995511174201965
and O 0 0.038624733686447144
50 O 0 0.04131666198372841
controls O 0 0.05715302750468254
. O 0 0.038568541407585144

A464V O 1 0.6649446487426758
, O 0 0.030263414606451988
although O 0 0.019582614302635193
clearly O 0 0.026340294629335403
modifying O 0 0.17170211672782898
ARSA O 1 0.9999278783798218
and O 0 0.4743809998035431
GS O 1 0.999992847442627
levels O 0 0.03299972042441368
, O 0 0.014676571823656559
apparently O 0 0.016268866136670113
bears O 0 0.015321028418838978
little O 0 0.012212262488901615
significance O 0 0.013621489517390728
for O 0 0.011847693473100662
clinical O 1 0.9732996821403503
manifestation O 1 0.9999399185180664
of O 1 0.9976404905319214
MLD B-Disease 1 0.9999998807907104
, O 0 0.4306458830833435
mimicking O 1 0.9756922721862793
the O 0 0.0753626674413681
frequent O 1 0.980909526348114
ARSA O 1 0.9999706745147705
pseudodeficiency O 1 0.9996957778930664
allele O 1 0.7260183691978455
. O 0 0.05167869105935097

Our O 0 0.03832113742828369
results O 0 0.018584400415420532
demonstrate O 0 0.01855551265180111
that O 0 0.007615452632308006
in O 0 0.008296689949929714
certain O 0 0.010446822270751
genetic O 0 0.023483991622924805
conditions O 1 0.9391690492630005
MLD B-Disease 1 0.9999997615814209
- O 1 0.9999804496765137
like O 1 0.8792802691459656
ARSA O 1 0.9999879598617554
and O 0 0.27956774830818176
GS O 1 0.9999709129333496
values O 0 0.01657760888338089
need O 0 0.010065743699669838
not O 0 0.005744956899434328
be O 0 0.006456581875681877
paralleled O 0 0.02388179302215576
by O 0 0.018663588911294937
clinical O 1 0.999839186668396
disease O 1 0.999993085861206
, O 0 0.12655428051948547
a O 0 0.08530908077955246
finding O 0 0.050816766917705536
with O 0 0.08379244804382324
serious O 1 0.9995334148406982
diagnostic O 1 0.9997484087944031
and O 1 0.8769419193267822
prognostic O 1 0.999954342842102
implications O 1 0.8640615940093994
. O 0 0.05258406698703766

Moreover O 0 0.059265099465847015
, O 0 0.03169873729348183
further O 0 0.03269879147410393
ARSA O 1 0.9997929930686951
alleles O 0 0.18338268995285034
functionally O 0 0.055571336299180984
similar O 0 0.016309117898344994
to O 0 0.015498539432883263
A464V O 1 0.923451840877533
might O 0 0.011968595907092094
exist O 0 0.007600206416100264
which O 0 0.004824833013117313
, O 0 0.005381450988352299
together O 0 0.00652099447324872
with O 0 0.008521449752151966
0 O 0 0.07979044318199158
- O 1 0.9990021586418152
type O 0 0.20872390270233154
mutations O 0 0.014841889031231403
, O 0 0.009782415814697742
may O 0 0.012336455285549164
cause O 0 0.4325202703475952
pathological O 1 0.9998457431793213
ARSA O 1 0.9999994039535522
and O 1 0.9897359609603882
GS O 1 0.9999992847442627
levels O 0 0.021002942696213722
, O 0 0.009018473327159882
but O 0 0.006886473391205072
not O 0 0.007729673758149147
clinical O 1 0.5190502405166626
outbreak O 1 0.9982478618621826
of O 1 0.8411768674850464
the O 1 0.998752236366272
disease O 1 0.9999991655349731
. O 0 0.2301734983921051
. O 0 0.03999888151884079

Human O 1 0.9808366894721985
MLH1 O 1 0.9999901056289673
deficiency O 1 0.9999996423721313
predisposes O 1 0.9999654293060303
to O 1 0.9591428637504578
hematological B-Disease 1 0.9999992847442627
malignancy I-Disease 1 0.9999998807907104
and O 1 0.9998761415481567
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 1 0.9996563196182251
1 I-Disease 0 0.29596275091171265
. O 0 0.044183582067489624

Heterozygous O 1 0.7192989587783813
germ O 1 0.9994609951972961
- O 1 0.9977933168411255
line O 0 0.04126477986574173
mutations O 0 0.019778035581111908
in O 0 0.01004093885421753
the O 0 0.015228250063955784
DNA O 0 0.03127538785338402
mismatch O 1 0.9915285110473633
repair O 1 0.9547558426856995
genes O 0 0.020365813747048378
lead O 0 0.02797241508960724
to O 0 0.032373566180467606
hereditary B-Disease 1 0.9999980926513672
nonpolyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.9405713677406311

The O 1 0.9442534446716309
disease O 1 0.9999918937683105
susceptibility O 1 0.9997493624687195
of O 1 0.6130528450012207
individuals O 0 0.34849512577056885
who O 0 0.3297019600868225
constitutionally O 1 0.9432960152626038
lack O 0 0.07565208524465561
both O 0 0.015602742321789265
wild O 1 0.869691789150238
- O 1 0.999958872795105
type O 1 0.9745314717292786
alleles O 0 0.1779399812221527
is O 0 0.02159813977777958
unknown O 0 0.030871085822582245
. O 0 0.03115912340581417

We O 0 0.020935015752911568
have O 0 0.009829957969486713
identified O 0 0.011046496219933033
three O 0 0.007429388351738453
offspring O 0 0.01750478334724903
in O 0 0.010847615078091621
a O 0 0.09625483304262161
hereditary B-Disease 1 0.9999997615814209
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999884366989136
who O 1 0.9997087121009827
developed O 1 0.9999122619628906
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 0.9999998807907104
at O 1 0.5690025091171265
a O 0 0.018361186608672142
very O 0 0.00778179569169879
early O 0 0.00953969918191433
age O 0 0.023444730788469315
, O 0 0.006648307200521231
and O 0 0.00510758999735117
at O 0 0.005857386160641909
least O 0 0.004433011636137962
two O 0 0.003823317587375641
of O 0 0.005452777724713087
them O 0 0.005942043848335743
displayed O 0 0.014446025714278221
signs O 0 0.03890419378876686
of O 1 0.7015406489372253
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 1 0.9993126392364502
1 I-Disease 1 0.9158753156661987
( O 1 0.5923338532447815
NF1 B-Disease 1 0.9990543723106384
) O 0 0.03253048658370972
. O 0 0.03151262179017067

DNA O 0 0.03874789550900459
sequence O 0 0.021569862961769104
analysis O 0 0.014421985484659672
and O 0 0.01527295634150505
allele O 0 0.06950678676366806
- O 1 0.7308323979377747
specific O 0 0.012927894480526447
amplification O 0 0.023367682471871376
in O 0 0.007973355241119862
two O 0 0.009289263747632504
siblings O 0 0.02607487328350544
revealed O 0 0.021383199840784073
a O 0 0.019900640472769737
homozygous O 0 0.13787610828876495
MLH1 O 1 0.9996309280395508
mutation O 0 0.4281424880027771
( O 0 0.09276323020458221
C676T O 1 0.9995922446250916
- O 1 0.9999648332595825
- O 1 0.9999451637268066
> O 1 0.9969742298126221
Arg226Stop O 1 0.9875593781471252
) O 0 0.03775656223297119
. O 0 0.03311729431152344

Thus O 0 0.029057886451482773
, O 0 0.018733272328972816
a O 0 0.022334519773721695
homozygous O 0 0.2054208517074585
germ O 1 0.9997093081474304
- O 1 0.9994809031486511
line O 1 0.6441282033920288
MLH1 O 1 0.9999122619628906
mutation O 0 0.21078862249851227
and O 0 0.03224394842982292
consequent O 1 0.9999871253967285
mismatch O 1 0.9999995231628418
repair O 1 0.9999991655349731
deficiency O 1 0.9999996423721313
results O 0 0.01856236532330513
in O 0 0.012988883070647717
a O 0 0.2868320941925049
mutator O 1 0.9999935626983643
phenotype O 1 0.9975402355194092
characterized O 1 0.8242994546890259
by O 1 0.6022142171859741
leukemia B-Disease 1 1.0
and O 1 0.9998064637184143
/ O 1 0.9999995231628418
or O 1 0.9997122883796692
lymphoma B-Disease 1 1.0
associated O 1 0.9912468791007996
with O 1 0.9988225102424622
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9990063309669495
1 I-Disease 0 0.06315156072378159
. O 0 0.02285253256559372
. O 0 0.03009628690779209

Missense O 0 0.48157405853271484
mutations O 0 0.03661975637078285
in O 0 0.013222000561654568
the O 0 0.012698161415755749
most O 0 0.009974746964871883
ancient O 0 0.015176927670836449
residues O 0 0.016767973080277443
of O 0 0.013643711805343628
the O 0 0.02689078263938427
PAX6 O 1 0.999977707862854
paired O 1 0.7660438418388367
domain O 0 0.03464408963918686
underlie O 0 0.12043914198875427
a O 0 0.02009875513613224
spectrum O 0 0.13922151923179626
of O 1 0.8765613436698914
human O 1 0.9999685287475586
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999998807907104
malformations I-Disease 1 0.9999997615814209
. O 1 0.9777267575263977

Mutations O 0 0.04161315783858299
of O 0 0.01864699274301529
the O 0 0.020906522870063782
human O 0 0.12567010521888733
PAX6 O 1 0.9999970197677612
gene O 1 0.9693092703819275
underlie O 1 0.9999659061431885
aniridia B-Disease 1 0.9999995231628418
( O 1 0.9996893405914307
congenital B-Disease 1 0.9999998807907104
absence I-Disease 1 0.9889100193977356
of I-Disease 1 0.8037692904472351
the I-Disease 1 0.9922040700912476
iris I-Disease 1 0.9999861717224121
) O 0 0.021897858008742332
, O 0 0.01099239382892847
a O 0 0.015906885266304016
rare O 1 0.5626193881034851
dominant O 1 0.9992468357086182
malformation B-Disease 1 0.9999980926513672
of I-Disease 1 0.9778247475624084
the I-Disease 1 0.9978442192077637
eye I-Disease 1 0.9999655485153198
. O 0 0.09192002564668655

The O 0 0.03595471754670143
spectrum O 0 0.04233705624938011
of O 0 0.043015364557504654
PAX6 O 1 0.9999878406524658
mutations O 1 0.736178994178772
in O 0 0.11623760312795639
aniridia B-Disease 1 0.9999954700469971
patients O 1 0.9985277652740479
is O 0 0.01654512621462345
highly O 0 0.01882072724401951
biased O 0 0.020198866724967957
, O 0 0.00839314330369234
with O 0 0.007123937364667654
92 O 0 0.02075297012925148
% O 0 0.007829183712601662
of O 0 0.00698879174888134
all O 0 0.007039855699986219
reported O 0 0.012603817507624626
mutations O 0 0.012979265302419662
leading O 0 0.014173399657011032
to O 0 0.010339105501770973
premature O 0 0.10948009043931961
truncation O 0 0.03976460546255112
of O 0 0.012177212163805962
the O 0 0.019537096843123436
protein O 0 0.01472094189375639
( O 0 0.012681732885539532
nonsense O 0 0.03221028670668602
, O 0 0.010429125279188156
splicing O 0 0.016140440478920937
, O 0 0.010515389032661915
insertions O 0 0.03369187191128731
and O 0 0.011722858995199203
deletions O 0 0.02664065733551979
) O 0 0.009140887297689915
and O 0 0.007097832392901182
just O 0 0.008239269256591797
2 O 0 0.01066023763269186
% O 0 0.007751725614070892
leading O 0 0.010585930198431015
to O 0 0.007743657100945711
substitution O 0 0.013553806580603123
of O 0 0.009322832338511944
one O 0 0.011711648665368557
amino O 0 0.015268267132341862
acid O 0 0.018342819064855576
by O 0 0.010974220000207424
another O 0 0.026003025472164154
( O 0 0.04250107333064079
missense O 1 0.6411638259887695
) O 0 0.030843054875731468
. O 0 0.033369697630405426

The O 0 0.034520599991083145
extraordinary O 0 0.03412831202149391
conservation O 0 0.02615157514810562
of O 0 0.01713845692574978
the O 0 0.06865450739860535
PAX6 O 1 0.9999827146530151
protein O 0 0.017241129651665688
at O 0 0.012162772007286549
the O 0 0.012350505217909813
amino O 0 0.016675278544425964
acid O 0 0.02109178714454174
level O 0 0.013223756104707718
amongst O 0 0.022215621545910835
vertebrates O 0 0.030825724825263023
predicts O 0 0.03305439651012421
that O 0 0.010607847012579441
pathological O 1 0.9438332915306091
missense O 1 0.9736895561218262
mutations O 0 0.023966148495674133
should O 0 0.008465000428259373
in O 0 0.006556679029017687
fact O 0 0.007768117822706699
be O 0 0.005487889517098665
common O 0 0.007376376073807478
even O 0 0.005811980459839106
though O 0 0.0050988770090043545
they O 0 0.004158705938607454
are O 0 0.004667138215154409
hardly O 0 0.01431984268128872
ever O 0 0.014500049874186516
seen O 0 0.019301053136587143
in O 0 0.022859890013933182
aniridia B-Disease 1 0.9999198913574219
patients O 1 0.9959701299667358
. O 0 0.05028533935546875

This O 0 0.024812066927552223
indicates O 0 0.02402769774198532
that O 0 0.008404111489653587
there O 0 0.007440220098942518
is O 0 0.008979108184576035
a O 0 0.014313969761133194
heavy O 1 0.6391717791557312
ascertainment O 1 0.9996777772903442
bias O 0 0.037108082324266434
in O 0 0.008027216419577599
the O 0 0.010295527055859566
selection O 0 0.014547878876328468
of O 0 0.02584104612469673
patients O 1 0.9986475110054016
for O 1 0.5706269145011902
PAX6 O 1 0.9999992847442627
mutation O 1 0.5098263621330261
analysis O 0 0.010089948773384094
and O 0 0.007525239139795303
that O 0 0.006269352976232767
the O 0 0.012452132999897003
missing O 0 0.07111753523349762
PAX6 O 1 0.9999518394470215
missense O 1 0.9956276416778564
mutations O 0 0.10233785957098007
frequently O 0 0.025499535724520683
may O 0 0.023155180737376213
underlie O 1 0.8224093317985535
phenotypes O 0 0.37944191694259644
distinct O 0 0.027657216414809227
from O 0 0.03315276652574539
textbook O 1 0.9958550333976746
aniridia B-Disease 1 0.9998152852058411
. O 0 0.062434203922748566

Here O 0 0.027773216366767883
we O 0 0.013808020390570164
present O 0 0.014945450238883495
four O 0 0.015861311927437782
novel O 0 0.09195148199796677
PAX6 O 1 0.9999775886535645
missense O 1 0.9809312224388123
mutations O 0 0.02649708464741707
, O 0 0.010313590057194233
two O 0 0.0072334278374910355
in O 0 0.00811926182359457
association O 0 0.01762719824910164
with O 0 0.016781186684966087
atypical O 1 0.999975323677063
phenotypes O 1 0.9994770884513855
ectopia B-Disease 1 0.9999779462814331
pupillae I-Disease 1 0.9999501705169678
( O 0 0.36057940125465393
displaced B-Disease 1 0.6103403568267822
pupils I-Disease 1 0.9386788606643677
) O 0 0.042045511305332184
and O 1 0.8151638507843018
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999995231628418
( O 1 0.973261833190918
searching B-Disease 1 0.881938636302948
gaze I-Disease 1 0.9979594945907593
) O 0 0.01384778879582882
, O 0 0.007675529457628727
and O 0 0.0061888969503343105
two O 0 0.006136884912848473
in O 0 0.007681306451559067
association O 0 0.015278378501534462
with O 0 0.012708102352917194
more O 0 0.016075678169727325
recognizable O 1 0.9733563661575317
aniridia B-Disease 1 0.9998975992202759
phenotypes O 1 0.9481271505355835
. O 0 0.05519133433699608

Strikingly O 0 0.0732259526848793
, O 0 0.021721288561820984
all O 0 0.011887636035680771
four O 0 0.011493208818137646
mutations O 0 0.013257227838039398
are O 0 0.00534773338586092
located O 0 0.011679120361804962
within O 0 0.009611493907868862
the O 0 0.018609248101711273
PAX6 O 1 0.9999809265136719
paired O 1 0.9007726311683655
domain O 0 0.022270211949944496
and O 0 0.011186708696186543
affect O 0 0.01258306298404932
amino O 0 0.012112167663872242
acids O 0 0.01006346382200718
which O 0 0.005544193554669619
are O 0 0.004267387092113495
highly O 0 0.009764187037944794
conserved O 0 0.010763516649603844
in O 0 0.007554319221526384
all O 0 0.010375086218118668
known O 0 0.0253871139138937
paired O 0 0.20419715344905853
domain O 0 0.04018243029713631
proteins O 0 0.03263204172253609
. O 0 0.031156491488218307

Our O 0 0.03429292142391205
results O 0 0.015255509875714779
support O 0 0.014777282252907753
the O 0 0.012594497762620449
hypothesis O 0 0.014017947018146515
that O 0 0.0055340128019452095
the O 0 0.007581199984997511
under O 0 0.012770532630383968
- O 0 0.20426632463932037
representation O 0 0.012318450957536697
of O 0 0.01390755083411932
missense O 1 0.9733929634094238
mutations O 0 0.03678378090262413
is O 0 0.01137722097337246
caused O 0 0.14645960927009583
by O 0 0.024103179574012756
ascertainment O 1 0.9999932050704956
bias O 1 0.9251446723937988
and O 0 0.01283655222505331
suggest O 0 0.009446363896131516
that O 0 0.0049282549880445
a O 0 0.008097134530544281
substantial O 0 0.012388520874083042
burden O 1 0.8416422009468079
of O 1 0.9648153185844421
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
related I-Disease 1 0.9998248219490051
disease I-Disease 1 0.9999986886978149
remains O 1 0.9756202101707458
to O 0 0.01514190249145031
be O 0 0.011825371533632278
uncovered O 0 0.03446998819708824
. O 0 0.01977061852812767
. O 0 0.028165841475129128

The O 0 0.038711775094270706
chromosomal O 0 0.10783319175243378
order O 0 0.01903129369020462
of O 0 0.015062380582094193
genes O 0 0.014417106285691261
controlling O 0 0.04315066710114479
the O 0 0.029464296996593475
major O 1 0.9693995714187622
histocompatibility O 1 0.9999995231628418
complex O 1 0.8393994569778442
, O 0 0.03963683545589447
properdin O 1 0.9997300505638123
factor O 1 0.8716211915016174
B O 1 0.9927813410758972
, O 0 0.01667146570980549
and O 0 0.02493033930659294
deficiency B-Disease 1 0.9999914169311523
of I-Disease 0 0.021548498421907425
the I-Disease 0 0.05973738059401512
second I-Disease 1 0.5904255509376526
component I-Disease 1 0.5163994431495667
of I-Disease 0 0.03274138271808624
complement I-Disease 1 0.5207990407943726
. O 0 0.03940166160464287

The O 0 0.03456944227218628
relationship O 0 0.028869275003671646
of O 0 0.01924852654337883
the O 0 0.021920807659626007
genes O 0 0.02104756236076355
coding O 0 0.030438732355833054
for O 0 0.017194755375385284
HLA O 1 0.9997249245643616
to O 0 0.012292267754673958
those O 0 0.009090740233659744
coding O 0 0.017031103372573853
for O 0 0.010484281927347183
properdin O 1 0.9913700819015503
Factor O 1 0.6891506314277649
B O 1 0.9992653727531433
allotypes O 1 0.9960820078849792
and O 0 0.014240038581192493
for O 0 0.020563175901770592
deficiency B-Disease 1 0.9999756813049316
of I-Disease 0 0.012322130613029003
the I-Disease 0 0.013996819965541363
second I-Disease 0 0.029451370239257812
component I-Disease 0 0.04093003273010254
of I-Disease 0 0.02172969840466976
complement I-Disease 1 0.9894779324531555
( O 1 0.897821843624115
C2 O 1 0.9999545812606812
) O 0 0.010364468209445477
was O 0 0.009716006927192211
studied O 0 0.008101907558739185
in O 0 0.006202503573149443
families O 0 0.010876565240323544
of O 0 0.03711283579468727
patients O 1 0.9999556541442871
with O 1 0.9998214840888977
connective O 1 1.0
tissue O 1 0.9999997615814209
disorders O 1 0.9999997615814209
. O 1 0.9750186204910278

Patients O 1 0.5953660607337952
were O 0 0.01753852888941765
selected O 0 0.020014703273773193
because O 0 0.010332003235816956
they O 0 0.006716134026646614
were O 0 0.009375980123877525
heterozygous O 0 0.027447853237390518
or O 0 0.019871419295668602
homozygous O 1 0.9281520843505859
for O 1 0.9737468361854553
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
. O 1 0.5266818404197693

12 O 0 0.04336164891719818
families O 0 0.031096763908863068
with O 0 0.019437603652477264
15 O 0 0.03110494837164879
matings O 1 0.529079794883728
informative O 1 0.8023759722709656
for O 1 0.9922838807106018
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.08039850741624832
found O 0 0.039718013256788254
. O 0 0.03828950598835945

Of O 0 0.04016350209712982
57 O 0 0.05799681320786476
informative O 0 0.05902127921581268
meioses O 1 0.5060771703720093
, O 0 0.013236136175692081
two O 0 0.009081589989364147
crossovers O 0 0.020499246194958687
were O 0 0.006967991124838591
noted O 0 0.009150886908173561
between O 0 0.01189330592751503
the O 1 0.7235283255577087
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
gene O 0 0.03578934073448181
and O 0 0.015235194936394691
the O 1 0.9388280510902405
HLA O 1 1.0
- O 1 0.9999942779541016
B O 1 0.9996216297149658
gene O 0 0.014537177048623562
, O 0 0.008439632132649422
with O 0 0.008116780780255795
a O 0 0.014915497042238712
recombinant O 0 0.03182685002684593
fraction O 0 0.02357759140431881
of O 0 0.02204001136124134
0 O 0 0.04576438292860985
. O 0 0.03495745733380318

035 O 1 0.9323016405105591
. O 0 0.12292645871639252

A O 0 0.07485304027795792
lod O 1 0.7765659689903259
score O 0 0.024445435032248497
of O 0 0.016216369345784187
13 O 0 0.017337163910269737
was O 0 0.014655527658760548
calculated O 0 0.012367564253509045
for O 0 0.010471169836819172
linkage O 0 0.34010377526283264
between O 1 0.7511142492294312
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.999944806098938
HLA O 1 1.0
- O 1 0.9999992847442627
B O 1 0.9998550415039062
at O 0 0.01261096354573965
a O 0 0.009880229830741882
maximum O 0 0.011292885057628155
likelihood O 0 0.01117306761443615
value O 0 0.005876600742340088
of O 0 0.007941555231809616
the O 0 0.013314382173120975
recombinant O 0 0.03784982115030289
fraction O 0 0.02329849824309349
of O 0 0.02201170101761818
0 O 0 0.04646145924925804
. O 0 0.034737952053546906

04 O 1 0.6653367877006531
. O 0 0.1095675677061081

18 O 0 0.03988562524318695
families O 0 0.029860006645321846
with O 0 0.017462583258748055
21 O 0 0.031113529577851295
informative O 0 0.038755446672439575
matings O 0 0.046059057116508484
for O 0 0.014684214256703854
both O 0 0.016047853976488113
properdin O 1 0.9652329683303833
Factor O 0 0.16980062425136566
B O 1 0.9831200838088989
allotype O 1 0.9950031638145447
and O 1 0.5258978605270386
HLA O 1 0.9999992847442627
- O 1 0.999945878982544
B O 1 0.9955475330352783
were O 0 0.020918671041727066
found O 0 0.02545732632279396
. O 0 0.03160182759165764

Of O 0 0.048713237047195435
72 O 0 0.06499511003494263
informative O 0 0.06411560624837875
meioses O 1 0.8576304912567139
, O 0 0.01718737557530403
three O 0 0.013739677146077156
recombinants O 1 0.7761808633804321
were O 0 0.01103774830698967
found O 0 0.00881722941994667
, O 0 0.009195075370371342
giving O 0 0.01252565998584032
a O 0 0.01492986548691988
recombinant O 0 0.03723638504743576
fraction O 0 0.02549402043223381
of O 0 0.024943511933088303
0 O 0 0.04873614385724068
. O 0 0.04122253507375717

042 O 1 0.7326539754867554
. O 0 0.12087202072143555

A O 0 0.06447335332632065
lod O 0 0.14523375034332275
score O 0 0.024996869266033173
of O 0 0.01719384640455246
16 O 0 0.022073594853281975
between O 0 0.03493882715702057
HLA O 1 0.9999979734420776
- O 1 0.9998937845230103
B O 1 0.996457040309906
and O 0 0.018693802878260612
Factor O 1 0.6539294719696045
B O 1 0.9972730278968811
allotypes O 1 0.979007363319397
was O 0 0.01616152748465538
calculated O 0 0.01047088298946619
at O 0 0.008285947144031525
a O 0 0.008790913037955761
maximum O 0 0.00961359590291977
likelihood O 0 0.011075220070779324
value O 0 0.006677259691059589
of O 0 0.009012937545776367
the O 0 0.014034551568329334
recombinant O 0 0.07737128436565399
fraction O 0 0.025573519989848137
of O 0 0.02338014356791973
0 O 0 0.04601152241230011
. O 0 0.039175815880298615

04 O 1 0.7024986743927002
. O 0 0.11234330385923386

A O 0 0.06450200825929642
crossover O 0 0.07233919203281403
was O 0 0.026798546314239502
shown O 0 0.014157329685986042
to O 0 0.009127517230808735
have O 0 0.007167007774114609
occurred O 0 0.009991887025535107
between O 0 0.008138161152601242
genes O 0 0.008564255200326443
for O 0 0.009116828441619873
Factor O 0 0.026535609737038612
B O 1 0.9736065864562988
and O 0 0.13741327822208405
HLA O 1 0.9999995231628418
- O 1 0.999943733215332
D O 1 0.989044189453125
, O 0 0.009992226958274841
in O 0 0.008813249878585339
which O 0 0.014385410584509373
HLA O 1 0.999995231628418
- O 1 0.9998189806938171
D O 1 0.9989840388298035
segregared O 1 0.983250081539154
with O 0 0.19206863641738892
HLA O 1 0.9999988079071045
- O 1 0.9996230602264404
A O 0 0.4296732246875763
and O 0 0.037044256925582886
B O 1 0.9652779698371887
. O 0 0.03827773034572601

These O 0 0.019282883033156395
studies O 0 0.015002692118287086
suggest O 0 0.010410977527499199
that O 0 0.006382872816175222
the O 0 0.008023795671761036
genes O 0 0.008884063921868801
for O 0 0.010241454467177391
Factor O 1 0.7513118982315063
B O 1 0.9999619722366333
and O 1 0.9989460110664368
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.008959594182670116
located O 0 0.015416856855154037
outside O 0 0.01162320002913475
those O 0 0.008094594813883305
for O 0 0.015420367009937763
HLA O 1 0.9999887943267822
, O 0 0.008716652169823647
that O 0 0.004459737800061703
the O 0 0.005769478622823954
order O 0 0.008292453363537788
of O 0 0.010979696176946163
genese O 1 0.9980218410491943
is O 0 0.10146986693143845
HLA O 1 0.9999973773956299
- O 1 0.9878041744232178
A O 0 0.025789774954319
, O 0 0.013247968629002571
- O 1 0.97797691822052
B O 1 0.8722729682922363
, O 0 0.01637260429561138
- O 1 0.9953116774559021
D O 1 0.8979625105857849
, O 0 0.012539846822619438
Factor O 0 0.027858400717377663
B O 1 0.995677649974823
allotype O 1 0.9995854496955872
, O 1 0.9927506446838379
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
, O 0 0.014936711639165878
that O 0 0.006703606341034174
the O 0 0.010330813936889172
genes O 0 0.013116801157593727
coding O 0 0.034887105226516724
for O 0 0.4830069839954376
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.7822135090827942
Factor O 1 0.9962762594223022
B O 1 0.9986068606376648
allotypes O 0 0.2426387220621109
are O 0 0.005091545637696981
approximately O 0 0.008653523400425911
3 O 0 0.014319749549031258
- O 1 0.7480524182319641
- O 0 0.18815471231937408
5 O 0 0.012281399220228195
centimorgans O 0 0.029924733564257622
from O 0 0.008796095848083496
the O 0 0.01634545810520649
HLA O 1 0.9999792575836182
- O 1 0.9612685441970825
A O 0 0.12301464378833771
and O 1 0.8157587051391602
HLA O 1 0.9999998807907104
- O 1 0.9999984502792358
B O 1 0.9999760389328003
loci O 0 0.4157889187335968
, O 0 0.009650263004004955
and O 0 0.00724372873082757
that O 0 0.0050569334998726845
the O 0 0.00842976476997137
apparent O 0 0.02007749117910862
lack O 0 0.014093788340687752
of O 0 0.01269453950226307
recombinants O 1 0.9496448636054993
between O 0 0.01099866908043623
the O 0 0.014131930656731129
Factor O 1 0.6915072798728943
B O 1 0.9995180368423462
gene O 1 0.53985995054245
and O 1 0.9691577553749084
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.5971906185150146
suggests O 0 0.015558423474431038
that O 0 0.005830447655171156
these O 0 0.004878650419414043
two O 0 0.007408608216792345
genes O 0 0.011216413229703903
lie O 0 0.018319910392165184
in O 0 0.010156486183404922
close O 0 0.017173003405332565
proximity O 0 0.022543244063854218
to O 0 0.014221281744539738
one O 0 0.016492437571287155
another O 0 0.02783030830323696
. O 0 0.03364865481853485

Distribution O 0 0.04091786965727806
of O 0 0.033608630299568176
emerin O 1 0.9942336678504944
and O 0 0.03317821025848389
lamins O 1 0.9967221617698669
in O 0 0.016583843156695366
the O 0 0.028178006410598755
heart O 1 0.9987277388572693
and O 0 0.01770486682653427
implications O 0 0.22178208827972412
for O 0 0.24664516746997833
Emery B-Disease 1 0.9999953508377075
- I-Disease 1 0.9999996423721313
Dreifuss I-Disease 1 0.9999997615814209
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999996423721313
. O 1 0.7936387658119202

Emerin O 1 0.6503220796585083
is O 0 0.026868820190429688
a O 0 0.023568077012896538
nuclear O 0 0.03635412082076073
membrane O 0 0.043550021946430206
protein O 0 0.011990336701273918
which O 0 0.006852153688669205
is O 0 0.007818544283509254
missing O 0 0.012950561009347439
or O 0 0.010870667174458504
defective O 0 0.3556634187698364
in O 0 0.017129117622971535
Emery B-Disease 1 0.9997977614402771
- I-Disease 1 0.9999977350234985
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999775886535645
EDMD B-Disease 1 0.9999991655349731
) O 0 0.10692622512578964
. O 0 0.03929504379630089

It O 0 0.021302610635757446
is O 0 0.015345328487455845
one O 0 0.010065303184092045
member O 0 0.0127091184258461
of O 0 0.009459387511014938
a O 0 0.012614336796104908
family O 0 0.024438999593257904
of O 0 0.47548991441726685
lamina O 1 0.9999986886978149
- O 1 0.9998204112052917
associated O 0 0.016862919554114342
proteins O 0 0.010018959641456604
which O 0 0.008862321265041828
includes O 0 0.014770438894629478
LAP1 O 1 0.9474750757217407
, O 0 0.021956736221909523
LAP2 O 1 0.9975925087928772
and O 0 0.04023256525397301
lamin O 1 0.9999477863311768
B O 1 0.9999294281005859
receptor O 1 0.9918279647827148
( O 0 0.15489846467971802
LBR O 1 0.9952162504196167
) O 0 0.045799367129802704
. O 0 0.04735551029443741

A O 0 0.04207364469766617
panel O 0 0.03315693885087967
of O 0 0.022341342642903328
16 O 0 0.08962895721197128
monoclonal O 1 0.9998180270195007
antibodies O 1 0.9975517392158508
( O 1 0.6321907043457031
mAbs O 1 0.9985394477844238
) O 0 0.01644543744623661
has O 0 0.01007587555795908
been O 0 0.009275766089558601
mapped O 0 0.014485047198832035
to O 0 0.006942443083971739
six O 0 0.008663535118103027
specific O 0 0.0067525296472013
sites O 0 0.00793966930359602
throughout O 0 0.007259628269821405
the O 0 0.0105165746062994
emerin O 0 0.4916313886642456
molecule O 0 0.018760688602924347
using O 0 0.011441944167017937
phage O 1 0.9982761144638062
- O 1 0.9937762022018433
displayed O 0 0.0573701485991478
peptide O 0 0.06519618630409241
libraries O 0 0.013147222809493542
and O 0 0.008535674773156643
has O 0 0.007797126192599535
been O 0 0.006865458097308874
used O 0 0.006635408382862806
to O 0 0.010598802007734776
localize O 0 0.1937294900417328
emerin O 1 0.6928859353065491
in O 0 0.01493915356695652
human O 0 0.025783460587263107
and O 0 0.12286616861820221
rabbit O 1 0.9996621608734131
heart O 1 0.9997976422309875
. O 0 0.05732118338346481

Several O 0 0.0422290600836277
mAbs O 0 0.17388196289539337
against O 0 0.03244177997112274
different O 0 0.01818809285759926
emerin O 1 0.9882104396820068
epitopes O 1 0.757362425327301
did O 0 0.014366153627634048
not O 0 0.009336336515843868
recognize O 0 0.02308531478047371
intercalated O 1 0.9896798729896545
discs O 0 0.06606130301952362
in O 0 0.010423119179904461
the O 0 0.05965879186987877
heart O 1 0.9995421171188354
, O 0 0.010911225341260433
though O 0 0.008540679700672626
they O 0 0.006393174175173044
recognized O 0 0.018390189856290817
cardiomyocyte O 1 0.9880490899085999
nuclei O 0 0.032986968755722046
strongly O 0 0.012306076474487782
, O 0 0.007667336612939835
both O 0 0.006660263054072857
at O 0 0.009983113035559654
the O 0 0.012859715148806572
rim O 0 0.09808319807052612
and O 0 0.013139115646481514
in O 0 0.016264738515019417
intranuclear O 1 0.9948673248291016
spots O 0 0.09885521978139877
or O 0 0.023699983954429626
channels O 0 0.03142081946134567
. O 0 0.03528623655438423

A O 0 0.20392996072769165
polyclonal O 1 0.9985734224319458
rabbit O 1 0.9939925074577332
antiserum O 1 0.9896892309188843
against O 0 0.08191919326782227
emerin O 1 0.9818654656410217
did O 0 0.018747830763459206
recognize O 0 0.018389610573649406
both O 0 0.0113029470667243
nuclear O 0 0.029796186834573746
membrane O 0 0.0803774818778038
and O 0 0.015477069653570652
intercalated O 1 0.995179295539856
discs O 0 0.034508876502513885
but O 0 0.008794071152806282
, O 0 0.009422303177416325
after O 0 0.012126348912715912
affinity O 0 0.019913407042622566
purification O 0 0.1616443246603012
against O 0 0.01500761229544878
a O 0 0.01837346889078617
pure O 0 0.262364000082016
- O 1 0.9979143738746643
emerin O 1 0.8403569459915161
band O 0 0.02158111333847046
on O 0 0.009767969138920307
a O 0 0.011319538578391075
western O 0 0.016078799962997437
blot O 1 0.6900278329849243
, O 0 0.013043347746133804
it O 0 0.010322807356715202
stained O 1 0.9457163214683533
only O 0 0.012327794916927814
the O 0 0.019559016451239586
nuclear O 0 0.044268421828746796
membrane O 0 0.05444849282503128
. O 0 0.03162821754813194

These O 0 0.020905472338199615
results O 0 0.013928283005952835
would O 0 0.009348013438284397
not O 0 0.006305346731096506
be O 0 0.006582764443010092
expected O 0 0.009477830491960049
if O 0 0.01069021224975586
immunostaining O 1 0.9481453895568848
at O 0 0.030047761276364326
intercalated O 1 0.9927399754524231
discs O 0 0.027231328189373016
were O 0 0.0082877017557621
due O 0 0.008067668415606022
to O 0 0.005770080257207155
a O 0 0.00734237814322114
product O 0 0.0072301412001252174
of O 0 0.0070600672625005245
the O 0 0.023904237896203995
emerin O 1 0.9999568462371826
gene O 0 0.024212835356593132
and O 0 0.008898952975869179
, O 0 0.008782519027590752
therefore O 0 0.007084913086146116
, O 0 0.006838817149400711
cast O 0 0.008198883384466171
some O 0 0.004429746884852648
doubt O 0 0.010142544284462929
upon O 0 0.009044068865478039
the O 0 0.009703168645501137
hypothesis O 0 0.031110724434256554
that O 0 0.015029367059469223
cardiac B-Disease 1 0.9999988079071045
defects I-Disease 1 0.9999847412109375
in O 0 0.34185683727264404
EDMD B-Disease 1 0.9999973773956299
are O 0 0.01052815280854702
caused O 0 0.026303021237254143
by O 0 0.011725720018148422
absence O 0 0.3889493942260742
of O 0 0.43931493163108826
emerin O 1 0.9999276399612427
from O 1 0.5471732020378113
intercalated O 1 0.9998239874839783
discs O 1 0.8840891122817993
. O 0 0.04188781604170799

Although O 0 0.04038306325674057
emerin O 1 0.8585842251777649
was O 0 0.024731017649173737
abundant O 0 0.020723000168800354
in O 0 0.010036731138825417
the O 0 0.013804242014884949
membranes O 0 0.16989140212535858
of O 0 0.06398122757673264
cardiomyocyte O 1 0.999946117401123
nuclei O 0 0.3594213128089905
, O 0 0.009426016360521317
it O 0 0.005233059637248516
was O 0 0.00909492839127779
absent O 0 0.012953316792845726
from O 0 0.006293193902820349
many O 0 0.007339508272707462
non O 1 0.9746977090835571
- O 1 0.9999910593032837
myocyte O 1 0.9999957084655762
cells O 0 0.06968631595373154
in O 0 0.01604592800140381
the O 0 0.03328768536448479
heart O 1 0.9990442395210266
. O 0 0.04786834120750427

This O 0 0.017547378316521645
distribution O 0 0.018684612587094307
of O 0 0.019525811076164246
emerin O 1 0.986218273639679
was O 0 0.018917974084615707
similar O 0 0.007354183588176966
to O 0 0.006742335390299559
that O 0 0.005093425512313843
of O 0 0.01065828651189804
lamin O 1 0.9993576407432556
A O 0 0.08481835573911667
, O 0 0.00979999266564846
a O 0 0.011641916818916798
candidate O 0 0.017186451703310013
gene O 0 0.011852791532874107
for O 0 0.009428991004824638
an O 0 0.015666265040636063
autosomal O 1 0.9796513915061951
form O 0 0.03684091940522194
of O 1 0.835528552532196
EDMD B-Disease 1 0.9999945163726807
. O 0 0.09224376082420349

In O 0 0.03548727557063103
contrast O 0 0.0452357679605484
, O 0 0.04488057643175125
lamin O 1 0.9998974800109863
B1 O 1 0.9999467134475708
was O 0 0.03630044683814049
absent O 0 0.043548036366701126
from O 0 0.019594719633460045
cardiomyocyte O 1 0.994530975818634
nuclei O 0 0.04065801948308945
, O 0 0.013924223370850086
showing O 0 0.019892968237400055
that O 0 0.018840454518795013
lamin O 1 0.9999850988388062
B1 O 1 0.9999915361404419
is O 0 0.012878761626780033
not O 0 0.007648703176528215
essential O 0 0.013677127659320831
for O 0 0.009574083611369133
localization O 0 0.03076554462313652
of O 0 0.018134677782654762
emerin O 1 0.9461345672607422
to O 0 0.019502878189086914
the O 0 0.03119427151978016
nuclear O 0 0.1647217720746994
lamina O 1 0.9972825050354004
. O 0 0.05104503408074379

Lamin O 1 0.9999390840530396
B1 O 1 0.9999722242355347
is O 0 0.027917390689253807
also O 0 0.016856960952281952
almost O 0 0.014526169747114182
completely O 0 0.02756613865494728
absent O 0 0.3573397099971771
from O 0 0.32333874702453613
skeletal O 1 0.9999849796295166
muscle O 1 0.9999467134475708
nuclei O 1 0.9802200794219971
. O 0 0.05858960375189781

In O 0 0.043958332389593124
EDMD B-Disease 1 0.9980008006095886
, O 0 0.017902297899127007
the O 0 0.012701678089797497
additional O 0 0.012566165998578072
absence O 0 0.0282131414860487
of O 1 0.5548896193504333
lamin O 1 0.9999990463256836
B1 O 1 0.9999996423721313
from O 1 0.9226046204566956
heart O 1 0.9999983310699463
and O 1 0.9971611499786377
skeletal O 1 0.9999996423721313
muscle O 1 0.9999899864196777
nuclei O 1 0.9953141212463379
which O 0 0.012156534940004349
already O 0 0.014332002960145473
lack O 0 0.0854250118136406
emerin O 1 0.9963635802268982
may O 0 0.009464357979595661
offer O 0 0.008644798770546913
an O 0 0.006650893483310938
alternative O 0 0.009200851432979107
explanation O 0 0.009099200367927551
of O 0 0.008402729406952858
why O 0 0.014185816049575806
these O 0 0.007911182940006256
tissues O 0 0.21438267827033997
are O 0 0.008626552298665047
particularly O 0 0.01952538453042507
affected O 0 0.027809040620923042
. O 0 0.022457614541053772
. O 0 0.032970573753118515

Genetic O 0 0.05252150818705559
mapping O 0 0.03492976725101471
of O 0 0.023299001157283783
the O 0 0.03292682021856308
copper B-Disease 1 0.995980978012085
toxicosis I-Disease 1 0.9998799562454224
locus O 1 0.6040540337562561
in O 0 0.021983442828059196
Bedlington O 1 0.9977834820747375
terriers O 1 0.5934361815452576
to O 0 0.019264470785856247
dog O 1 0.6640171408653259
chromosome O 0 0.02554975263774395
10 O 0 0.01144417654722929
, O 0 0.008952242322266102
in O 0 0.007827508263289928
a O 0 0.01223048660904169
region O 0 0.020073629915714264
syntenic O 0 0.3761337101459503
to O 0 0.01479374524205923
human O 0 0.02037104032933712
chromosome O 0 0.052493512630462646
region O 0 0.048969000577926636
2p13 O 1 0.9991476535797119
- O 1 0.9996289014816284
p16 O 1 0.9534873366355896
. O 0 0.047074154019355774

Abnormal O 1 0.9999063014984131
hepatic B-Disease 1 0.9999982118606567
copper I-Disease 1 0.9997324347496033
accumulation I-Disease 1 0.9967689514160156
is O 0 0.01804708130657673
recognized O 0 0.020426273345947266
as O 0 0.017739150673151016
an O 1 0.9483919143676758
inherited B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999998807907104
in O 1 0.9452518224716187
man O 1 0.9998051524162292
, O 1 0.612861156463623
mouse O 1 0.9695823192596436
, O 0 0.04271521046757698
rat O 1 0.994113028049469
and O 0 0.025211235508322716
dog O 1 0.5454148650169373
. O 0 0.038187120109796524

The O 0 0.03248489648103714
major O 0 0.046666838228702545
cause O 1 0.9738287925720215
of O 1 0.9988459348678589
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999974966049194
accumulation I-Disease 1 0.9999306201934814
in O 0 0.020522138103842735
man O 1 0.7061014175415039
is O 0 0.010571436025202274
a O 0 0.019089505076408386
dysfunctional O 1 0.9994977712631226
ATP7B O 1 0.9998751878738403
gene O 0 0.030406847596168518
, O 0 0.022086702287197113
causing O 1 0.9906345009803772
Wilson B-Disease 1 0.9999732971191406
disease I-Disease 1 0.9999996423721313
( O 1 0.9998569488525391
WD B-Disease 1 0.999995231628418
) O 0 0.048780057579278946
. O 0 0.03976784273982048

Mutations O 0 0.04564165696501732
in O 0 0.01880233734846115
the O 0 0.026989396661520004
ATP7B O 1 0.9995853304862976
genes O 0 0.015808653086423874
have O 0 0.007060474716126919
also O 0 0.007892054505646229
been O 0 0.008333051577210426
demonstrated O 0 0.016688238829374313
in O 0 0.014076048508286476
mouse O 1 0.5308617949485779
and O 0 0.031792063266038895
rat O 1 0.9728472828865051
. O 0 0.0434633307158947

The O 0 0.0614386647939682
ATP7B O 1 0.9997997879981995
gene O 0 0.028494300320744514
has O 0 0.012394449673593044
been O 0 0.009884484112262726
excluded O 0 0.014425095170736313
in O 0 0.007233920972794294
the O 0 0.009053248912096024
much O 0 0.011795621365308762
rarer O 1 0.804747462272644
human O 1 0.5365033745765686
copper B-Disease 1 0.9999027252197266
overload I-Disease 1 0.9999955892562866
disease O 1 0.9999953508377075
non B-Disease 1 0.9998760223388672
- I-Disease 1 0.9999852180480957
Indian I-Disease 1 0.9930897355079651
childhood I-Disease 1 0.9999983310699463
cirrhosis I-Disease 1 1.0
, O 1 0.9824714064598083
indicating O 1 0.9684615731239319
genetic O 1 0.6482333540916443
heterogeneity O 1 0.9663543701171875
. O 0 0.04579649865627289

By O 0 0.032662950456142426
investigating O 0 0.03895566985011101
the O 0 0.03063979558646679
common O 0 0.41305384039878845
autosomal O 1 0.9999734163284302
recessive O 1 0.999998927116394
copper B-Disease 1 0.9999988079071045
toxicosis I-Disease 1 0.9999998807907104
( O 1 0.999612033367157
CT B-Disease 1 0.9999655485153198
) O 0 0.01739536039531231
in O 0 0.013954765163362026
Bedlington O 1 0.998344898223877
terriers O 0 0.3742711842060089
, O 0 0.010778652504086494
we O 0 0.006233278661966324
have O 0 0.0044885845854878426
identified O 0 0.007079357281327248
a O 0 0.00801088660955429
new O 0 0.011658662930130959
locus O 0 0.2791501581668854
involved O 0 0.019949469715356827
in O 1 0.5339100956916809
progressive O 1 0.9999992847442627
liver B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 1 0.9829612374305725

We O 0 0.027757791802287102
examined O 0 0.03242938965559006
whether O 0 0.017102567479014397
the O 0 0.024418117478489876
WD B-Disease 1 0.9999425411224365
gene O 0 0.0355856791138649
ATP7B O 1 0.9896758198738098
was O 0 0.028207534924149513
also O 0 0.014875013381242752
causative O 1 0.9444212913513184
for O 0 0.012257302179932594
CT B-Disease 1 0.9886200428009033
by O 0 0.009584788233041763
investigating O 0 0.01571098528802395
the O 0 0.01497356966137886
chromosomal O 1 0.9636210203170776
co O 1 0.9906778335571289
- O 1 0.9968079924583435
localization O 0 0.05951383337378502
of O 0 0.02248036488890648
ATP7B O 1 0.9993982315063477
and O 0 0.021447233855724335
C04107 O 1 0.8361518979072571
, O 0 0.014150451868772507
using O 0 0.011127887293696404
fluorescence O 0 0.027229083701968193
in O 0 0.0183092150837183
situ O 1 0.8387936353683472
hybridization O 0 0.04598348215222359
( O 0 0.03382638841867447
FISH O 0 0.03625962510704994
) O 0 0.0301361046731472
. O 0 0.03093450702726841

C04107 O 0 0.49629268050193787
is O 0 0.03595142811536789
an O 0 0.03162770718336105
anonymous O 0 0.06993389874696732
microsatellite O 1 0.9176297783851624
marker O 1 0.5289205312728882
closely O 0 0.034034255892038345
linked O 0 0.053803883492946625
to O 0 0.036917828023433685
CT B-Disease 1 0.9973539113998413
. O 0 0.04438566789031029

However O 0 0.0422152616083622
, O 0 0.04210934415459633
BAC O 1 0.9974658489227295
clones O 1 0.6596319675445557
containing O 0 0.042953696101903915
ATP7B O 1 0.970934271812439
and O 0 0.024654602631926537
C04107 O 0 0.240968719124794
mapped O 0 0.028025619685649872
to O 0 0.012001197785139084
the O 0 0.01749156042933464
canine O 1 0.9872080683708191
chromosome O 0 0.06073935702443123
regions O 0 0.02129686065018177
CFA22q11 O 1 0.9537547826766968
and O 0 0.020443148910999298
CFA10q26 O 1 0.9616087079048157
, O 0 0.014798993244767189
respectively O 0 0.014664342626929283
, O 0 0.012334972620010376
demonstrating O 0 0.024875076487660408
that O 0 0.014103458262979984
WD B-Disease 1 0.9999229907989502
cannot O 0 0.018104085698723793
be O 0 0.013296114280819893
homologous O 0 0.041481319814920425
to O 0 0.029406683519482613
CT B-Disease 1 0.9872815012931824
. O 0 0.04485535994172096

The O 0 0.04782434552907944
copper O 0 0.37812647223472595
transport O 0 0.052257440984249115
genes O 0 0.03059200569987297
CTR1 O 1 0.9972984194755554
and O 0 0.021707482635974884
CTR2 O 1 0.9937142729759216
were O 0 0.010909544304013252
also O 0 0.00932344887405634
excluded O 0 0.01588079333305359
as O 0 0.008672491647303104
candidate O 0 0.013968287967145443
genes O 0 0.010497835464775562
for O 0 0.011091579683125019
CT B-Disease 1 0.983290433883667
since O 0 0.010206415317952633
they O 0 0.0060699800960719585
both O 0 0.008786357007920742
mapped O 0 0.02380743809044361
to O 0 0.018900923430919647
canine O 1 0.9991366267204285
chromosome O 0 0.24505504965782166
region O 0 0.0518975704908371
CFA11q22 O 1 0.9657743573188782
. O 0 0.05171792581677437

2 O 0 0.09639105200767517
- O 1 0.8966224789619446
22 O 0 0.06890121847391129
. O 0 0.052309300750494

5 O 0 0.12032868713140488
. O 0 0.08328600972890854

A O 0 0.052943289279937744
transcribed O 0 0.03978259861469269
sequence O 0 0.0168051365762949
identified O 0 0.014404868707060814
from O 0 0.01024673879146576
the O 0 0.015887495130300522
C04107 O 1 0.9967437982559204
- O 1 0.9991256594657898
containing O 0 0.08949608355760574
BAC O 1 0.9994415640830994
was O 0 0.017433838918805122
found O 0 0.008024334907531738
to O 0 0.00703557999804616
be O 0 0.006115215364843607
homologous O 0 0.014541400596499443
to O 0 0.007477539591491222
a O 0 0.009820837527513504
gene O 0 0.009738761931657791
expressed O 0 0.008960715495049953
from O 0 0.00822521187365055
human O 0 0.01530236005783081
chromosome O 1 0.5345039963722229
2p13 O 1 0.9996492862701416
- O 1 0.9998961687088013
p16 O 1 0.9422343969345093
, O 0 0.012140362523496151
a O 0 0.013067574240267277
region O 0 0.015999166294932365
devoid O 0 0.02821427956223488
of O 0 0.015100856311619282
any O 0 0.017326168715953827
positional O 1 0.5301524996757507
candidate O 0 0.05334630236029625
genes O 0 0.0336296372115612
. O 0 0.03587251529097557

Molecular O 0 0.03422164544463158
analysis O 0 0.013029107823967934
of O 0 0.012728315778076649
the O 0 0.019416289404034615
APC B-Disease 1 0.994105339050293
gene O 0 0.01588873378932476
in O 0 0.009230434894561768
205 O 0 0.029569730162620544
families O 0 0.01624106615781784
: O 0 0.015180214308202267
extended O 0 0.02637520618736744
genotype O 1 0.9911110997200012
- O 1 0.9994076490402222
phenotype O 1 0.8043912649154663
correlations O 0 0.039359502494335175
in O 0 0.017082203179597855
FAP B-Disease 1 0.999937891960144
and O 0 0.012194281443953514
evidence O 0 0.008542480878531933
for O 0 0.006662165746092796
the O 0 0.010058804415166378
role O 0 0.01669917441904545
of O 0 0.027716010808944702
APC B-Disease 1 0.9999344348907471
amino O 0 0.03189624473452568
acid O 0 0.058625172823667526
changes O 0 0.02233283221721649
in O 1 0.7856663465499878
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
predisposition O 1 0.999997615814209
. O 1 0.7689485549926758

BACKGROUND O 1 0.624987781047821
/ O 1 0.9651188850402832
AIMS O 0 0.05040644481778145
The O 0 0.021871043369174004
development O 0 0.2718285024166107
of O 1 0.999728262424469
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8810315728187561
a O 0 0.3298000693321228
variable O 0 0.01666518859565258
range O 0 0.010300339199602604
of O 0 0.012991635128855705
extracolonic O 1 0.9756136536598206
manifestations O 1 0.9955548644065857
in O 0 0.4553515911102295
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999996423721313
FAP B-Disease 1 1.0
) O 0 0.14129874110221863
is O 0 0.008108969777822495
the O 0 0.0065697054378688335
result O 0 0.005873465444892645
of O 0 0.006541984621435404
the O 0 0.01070162933319807
dominant O 0 0.35504835844039917
inheritance O 1 0.9587569832801819
of O 1 0.9992073178291321
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999934434890747
APC B-Disease 1 0.9999992847442627
) O 1 0.5392481088638306
gene O 0 0.03959011286497116
mutations O 0 0.038934919983148575
. O 0 0.032490406185388565

In O 0 0.022477399557828903
this O 0 0.012871766462922096
study O 0 0.013783368282020092
, O 0 0.011232299730181694
direct O 0 0.012478136457502842
mutation O 0 0.014773408882319927
analysis O 0 0.007255959790199995
of O 0 0.008918201550841331
the O 0 0.02071821689605713
APC B-Disease 1 0.9998780488967896
gene O 0 0.0153823746368289
was O 0 0.011256059631705284
performed O 0 0.011694134213030338
to O 0 0.009107803925871849
determine O 0 0.014068664982914925
genotype O 1 0.968105137348175
- O 1 0.9952357411384583
phenotype O 0 0.043490611016750336
correlations O 0 0.018852273002266884
for O 0 0.010108521208167076
nine O 0 0.02128198929131031
extracolonic O 1 0.9981672763824463
manifestations O 1 0.9000797271728516
and O 0 0.011670241132378578
to O 0 0.010419419035315514
investigate O 0 0.018511809408664703
the O 0 0.013536859303712845
incidence O 1 0.9759865999221802
of O 0 0.07663091272115707
APC B-Disease 1 0.9998223185539246
mutations O 0 0.0298041682690382
in O 0 0.01960557885468006
non O 1 0.999845027923584
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.8603953719139099

METHODS O 0 0.050258930772542953
The O 0 0.03889087587594986
APC B-Disease 1 0.9867653846740723
gene O 0 0.02507520094513893
was O 0 0.0196420568972826
analysed O 0 0.021247677505016327
in O 0 0.011257164180278778
190 O 0 0.028764238581061363
unrelated O 0 0.03131270408630371
FAP B-Disease 1 0.9997493624687195
and O 0 0.0173938125371933
15 O 0 0.02970917336642742
non O 1 0.9993273019790649
- O 1 0.9999997615814209
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999586343765259
using O 0 0.13322965800762177
denaturing O 1 0.9999544620513916
gradient O 1 0.999473512172699
gel O 1 0.9977717995643616
electrophoresis O 0 0.12272786349058151
, O 0 0.0159286055713892
the O 0 0.01694251224398613
protein O 0 0.02055039443075657
truncation O 0 0.04924293980002403
test O 0 0.022520199418067932
, O 0 0.01700288988649845
and O 0 0.016230158507823944
direct O 0 0.028375575318932533
sequencing O 0 0.042704589664936066
. O 0 0.0385114885866642

RESULTS O 0 0.04768623784184456
Chain O 0 0.13138218224048615
terminating O 0 0.2027948647737503
signals O 0 0.020098740234971046
were O 0 0.008546535857021809
only O 0 0.007908481173217297
identified O 0 0.010574848391115665
in O 0 0.007822155952453613
patients O 0 0.028491269797086716
belonging O 0 0.01822981983423233
to O 0 0.011135881766676903
the O 0 0.07268348336219788
FAP B-Disease 1 0.9999991655349731
group O 1 0.9502173662185669
( O 1 0.5274498462677002
105 O 1 0.8684948086738586
patients O 1 0.9671273231506348
) O 0 0.033473532646894455
. O 0 0.0337345190346241

Amino O 0 0.058199696242809296
acid O 0 0.03878162428736687
changes O 0 0.011077758856117725
were O 0 0.008028237149119377
identified O 0 0.010515973903238773
in O 0 0.007098599337041378
four O 0 0.010702760890126228
patients O 0 0.37154585123062134
, O 0 0.008425413630902767
three O 0 0.0068773613311350346
of O 0 0.009689424186944962
whom O 0 0.015311550348997116
belonged O 0 0.016884174197912216
to O 0 0.007593994494527578
the O 0 0.011236515827476978
non O 1 0.8438528776168823
- O 1 0.9999628067016602
FAP O 1 0.9999985694885254
group O 1 0.9958586096763611
of O 1 0.9999545812606812
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999961853027344
. O 1 0.746726930141449

Genotype O 1 0.999160647392273
- O 1 0.9998736381530762
phenotype O 1 0.9778059720993042
correlations O 0 0.05472690612077713
identified O 0 0.017201069742441177
significant O 0 0.009948743507266045
differences O 0 0.009148871526122093
in O 0 0.007070530671626329
the O 0 0.008686072193086147
nature O 0 0.010435409843921661
of O 0 0.010662848129868507
certain O 0 0.015616906806826591
extracolonic O 1 0.999923825263977
manifestations O 1 0.9999364614486694
in O 1 0.9650301933288574
FAP B-Disease 1 0.9999998807907104
patients O 1 0.9989676475524902
belonging O 0 0.05501708760857582
to O 0 0.015304744243621826
three O 0 0.020357681438326836
mutation O 0 0.1320507526397705
subgroups O 0 0.300615519285202
. O 0 0.04146295040845871

CONCLUSIONS O 0 0.06406404823064804
Extended O 0 0.07322774082422256
genotype O 1 0.9950931072235107
- O 1 0.9996254444122314
phenotype O 1 0.8562068939208984
correlations O 0 0.03232733532786369
made O 0 0.012323255650699139
in O 0 0.007820360362529755
this O 0 0.0064598554745316505
study O 0 0.008579508401453495
may O 0 0.006710251327604055
have O 0 0.004413960967212915
the O 0 0.006462564691901207
potential O 0 0.008068609982728958
to O 0 0.005900651682168245
determine O 0 0.006319739855825901
the O 0 0.006385948043316603
most O 0 0.006346747279167175
appropriate O 0 0.01196212973445654
surveillance O 0 0.027227725833654404
and O 0 0.02569250389933586
prophylactic O 1 0.9999904632568359
treatment O 1 0.9999867677688599
regimens O 1 0.9999406337738037
for O 0 0.02053881622850895
those O 0 0.013441388495266438
patients O 1 0.9750987887382507
with O 0 0.0298923347145319
mutations O 0 0.146428182721138
associated O 0 0.018090156838297844
with O 0 0.017268327996134758
life O 1 0.7806499004364014
threatening O 1 0.9970846772193909
conditions O 1 0.8591405749320984
. O 0 0.05057613551616669

This O 0 0.024194344878196716
study O 0 0.01930907927453518
also O 0 0.011691312305629253
provided O 0 0.012053721584379673
evidence O 0 0.008579167537391186
for O 0 0.008097091689705849
the O 0 0.012904694303870201
pathological O 1 0.774735689163208
nature O 0 0.017091093584895134
of O 0 0.01630341075360775
amino O 0 0.022561760619282722
acid O 0 0.025146467611193657
changes O 0 0.009472026489675045
in O 0 0.009972726926207542
APC O 1 0.9829549193382263
associated O 0 0.008577593602240086
with O 0 0.007107763085514307
both O 0 0.010552807711064816
FAP B-Disease 1 0.9999829530715942
and O 0 0.3724329471588135
non O 1 0.9999810457229614
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999996542930603
. O 0 0.19846972823143005
. O 0 0.044508468359708786

Inherited B-Disease 1 0.9999958276748657
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.999981164932251
cancer B-Disease 1 0.9999998807907104
risk O 1 0.9997451901435852
of O 1 0.9851498603820801
the O 1 0.9992019534111023
APC O 1 0.9999977350234985
I1307K O 1 0.9996684789657593
polymorphism O 1 0.7297312021255493
. O 0 0.05320638045668602

Germ O 1 0.9992642998695374
- O 1 0.9946063160896301
line O 0 0.04772462323307991
and O 0 0.02334688790142536
somatic O 0 0.24672919511795044
truncating O 1 0.7710373401641846
mutations O 0 0.022248759865760803
of O 0 0.015127872116863728
the O 0 0.10300836712121964
APC B-Disease 1 0.9998860359191895
gene O 0 0.01358526200056076
are O 0 0.005231320392340422
thought O 0 0.009312489069998264
to O 0 0.010450276546180248
initiate O 1 0.8831453919410706
colorectal B-Disease 1 0.9999997615814209
tumor I-Disease 1 0.999993085861206
formation O 1 0.9992033839225769
in O 1 0.9920318126678467
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999978542327881
sporadic O 1 0.9999998807907104
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 1 0.99155592918396
respectively O 0 0.31460151076316833
. O 0 0.040345143526792526

Recently O 0 0.04886958375573158
, O 0 0.025922955945134163
an O 0 0.02733253873884678
isoleucine O 1 0.9996548891067505
- O 1 0.9999573230743408
- O 1 0.9998387098312378
> O 1 0.8256661295890808
lysine O 0 0.05431797355413437
polymorphism O 0 0.03863394632935524
at O 0 0.02114170975983143
codon O 0 0.05241447314620018
1307 O 1 0.5861290097236633
( O 0 0.02252282202243805
I1307K O 0 0.05051320046186447
) O 0 0.010233358480036259
of O 0 0.009342893026769161
the O 0 0.01847461238503456
APC B-Disease 1 0.9998742341995239
gene O 0 0.013243281282484531
has O 0 0.006659707520157099
been O 0 0.005911444313824177
identified O 0 0.006739222444593906
in O 0 0.005850204266607761
6 O 0 0.013957427814602852
% O 0 0.011037960648536682
- O 0 0.19662651419639587
7 O 0 0.013739987276494503
% O 0 0.008403444662690163
of O 0 0.009912644512951374
the O 0 0.01856585592031479
Ashkenazi O 1 0.9255527853965759
Jewish O 0 0.04792118817567825
population O 0 0.029609108343720436
. O 0 0.035101570188999176

To O 0 0.03142648935317993
assess O 0 0.03350844234228134
the O 0 0.016063101589679718
risk O 0 0.01689906232059002
of O 0 0.011684437282383442
this O 0 0.009992869570851326
common O 0 0.10300146788358688
APC B-Disease 1 0.9999557733535767
allelic O 1 0.9996778964996338
variant O 1 0.9888701438903809
in O 1 0.8724003434181213
colorectal O 1 1.0
carcinogenesis O 1 0.999997615814209
, O 0 0.025068825110793114
we O 0 0.008433767594397068
have O 0 0.005647017154842615
analyzed O 0 0.008658737875521183
a O 0 0.008885965682566166
large O 0 0.01043039932847023
cohort O 0 0.05885443463921547
of O 0 0.01915827766060829
unselected O 1 0.9862494468688965
Ashkenazi O 1 0.9477614164352417
Jewish O 0 0.04344508424401283
subjects O 0 0.035585422068834305
with O 0 0.39186081290245056
adenomatous B-Disease 1 0.9999998807907104
polyps I-Disease 1 0.9999961853027344
and O 1 0.778073787689209
. O 1 0.8416556119918823
or O 1 0.9998636245727539
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, I-Disease 1 0.6101316213607788
for O 0 0.028831038624048233
the O 1 0.7403557896614075
APC O 1 0.999945878982544
I1307K O 1 0.9975409507751465
polymorphism O 0 0.46661779284477234
. O 0 0.04943498969078064

The O 0 0.06632456928491592
APC O 1 0.9983978867530823
I1307K O 1 0.987014889717102
allele O 0 0.07049636542797089
was O 0 0.022421563044190407
identified O 0 0.013754462823271751
in O 0 0.009021456353366375
48 O 0 0.016508765518665314
( O 0 0.012546384707093239
10 O 0 0.009806645102798939
. O 0 0.008094009011983871
1 O 0 0.013045944273471832
% O 0 0.012654215097427368
) O 0 0.014652922749519348
of O 0 0.022010231390595436
476 O 1 0.9588137865066528
patients O 1 0.9373210072517395
. O 0 0.051312100142240524

Compared O 0 0.02766147069633007
with O 0 0.014134163036942482
the O 0 0.012872142717242241
frequency O 0 0.010778484866023064
in O 0 0.006563366390764713
two O 0 0.005299712531268597
separate O 0 0.007614320144057274
population O 0 0.006735290866345167
control O 0 0.009573151357471943
groups O 0 0.00671897828578949
, O 0 0.007767754606902599
the O 0 0.014954528771340847
APC O 1 0.999969482421875
I1307K O 1 0.9997743964195251
allele O 0 0.3180384039878845
is O 0 0.00935312919318676
associated O 0 0.008208280429244041
with O 0 0.006800726056098938
an O 0 0.009182572364807129
estimated O 0 0.012609954923391342
relative O 0 0.020184174180030823
risk O 0 0.026931816712021828
of O 0 0.02318807691335678
1 O 0 0.043527185916900635
. O 0 0.03543481603264809

5 O 0 0.08993543684482574
- O 1 0.8787413239479065
1 O 0 0.0620298907160759
. O 0 0.049046095460653305

7 O 0 0.0676291212439537
for O 0 0.38890400528907776
colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9999988079071045
( O 1 0.819963812828064
both O 0 0.062403809279203415
P O 1 0.9996544122695923
= O 1 0.5000618100166321
. O 0 0.02816227823495865
01 O 1 0.9723811745643616
) O 0 0.03650273382663727
. O 0 0.03605164960026741

Furthermore O 0 0.04885489493608475
, O 0 0.019144630059599876
compared O 0 0.017187030985951424
with O 0 0.01683940179646015
noncarriers O 1 0.9976629018783569
, O 0 0.10082578659057617
APC O 1 0.999809205532074
I1307K O 1 0.9906215667724609
carriers O 0 0.026421673595905304
had O 0 0.01132043357938528
increased O 0 0.010134480893611908
numbers O 0 0.008434453047811985
of O 0 0.017075520008802414
adenomas B-Disease 1 0.9999864101409912
and O 1 0.9468901753425598
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999972581863403
per O 1 0.7038974761962891
patient O 1 0.9999737739562988
( O 1 0.9517224431037903
P O 1 0.9993810653686523
= O 0 0.2547786235809326
. O 0 0.012908315286040306
03 O 1 0.849938154220581
) O 0 0.010328894481062889
, O 0 0.00724290544167161
as O 0 0.006213702727109194
well O 0 0.006596267689019442
as O 0 0.008394317701458931
a O 0 0.016863148659467697
younger O 0 0.4822152256965637
age O 1 0.5580983757972717
at O 1 0.8146558403968811
diagnosis O 1 0.9997658133506775
. O 0 0.04576427489519119

We O 0 0.030217686668038368
conclude O 0 0.03549594432115555
that O 0 0.014436987228691578
the O 0 0.02428581193089485
APC O 1 0.9989301562309265
I1307K O 1 0.9773942232131958
variant O 0 0.04164562001824379
leads O 0 0.029606927186250687
to O 0 0.017384883016347885
increased O 1 0.6002398133277893
adenoma B-Disease 1 0.9999996423721313
formation O 1 0.9308610558509827
and O 0 0.014190124347805977
directly O 0 0.011963306926190853
contributes O 0 0.01716693863272667
to O 0 0.008150742389261723
3 O 0 0.012031360529363155
% O 0 0.010967668145895004
- O 0 0.024551721289753914
4 O 0 0.01079501025378704
% O 0 0.008034251630306244
of O 0 0.009134105406701565
all O 0 0.015357495285570621
Ashkenazi O 1 0.9992597699165344
Jewish O 1 0.9998387098312378
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 1 0.8497468829154968

The O 0 0.036696333438158035
estimated O 0 0.029105426743626595
relative O 0 0.03240503743290901
risk O 0 0.06667088717222214
for O 0 0.01703997142612934
carriers O 0 0.16764992475509644
may O 0 0.01565510779619217
justify O 0 0.023924557492136955
specific O 0 0.011642399244010448
clinical O 0 0.31305497884750366
screening O 0 0.05574023723602295
for O 0 0.010181082412600517
the O 0 0.01346474140882492
360 O 0 0.02559235692024231
, O 0 0.009981035254895687
000 O 0 0.01524442620575428
Americans O 0 0.009305848740041256
expected O 0 0.008277996443212032
to O 0 0.00830342061817646
harbor O 0 0.040509387850761414
this O 0 0.008741502650082111
allele O 0 0.020683379843831062
, O 0 0.007894781418144703
and O 0 0.0071599544025957584
genetic O 0 0.009364507161080837
testing O 0 0.007609009277075529
in O 0 0.004788320045918226
the O 0 0.006741872522979975
setting O 0 0.00944498460739851
of O 0 0.009225403890013695
long O 0 0.40211284160614014
- O 1 0.9997391104698181
term O 0 0.07324132323265076
- O 1 0.9319698214530945
outcome O 0 0.010206622071564198
studies O 0 0.007268500979989767
may O 0 0.007521629333496094
impact O 0 0.0114439120516181
significantly O 0 0.019638048484921455
on O 1 0.9408363699913025
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999983310699463
in O 0 0.182843878865242
this O 0 0.019192803651094437
population O 0 0.024231858551502228
. O 0 0.031076475977897644

Localization O 0 0.09365814179182053
of O 0 0.03015275113284588
human O 0 0.18492646515369415
BRCA1 O 1 0.9845812916755676
and O 0 0.011527270078659058
its O 0 0.009899886325001717
loss O 0 0.014577028341591358
in O 0 0.009302640333771706
high O 0 0.3219156861305237
- O 1 0.9993926286697388
grade O 1 0.8629961013793945
, O 0 0.022054262459278107
non B-Disease 1 0.9968844056129456
- I-Disease 1 0.9999967813491821
inherited I-Disease 1 0.9999970197677612
breast I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.999998927116394
. O 0 0.2925906777381897

Although O 0 0.025270022451877594
the O 0 0.01799384132027626
link O 0 0.020954838022589684
between O 0 0.012988394126296043
the O 0 0.057058706879615784
BRCA1 O 1 0.9999953508377075
tumour B-Disease 1 1.0
- O 1 0.9999958276748657
suppressor O 1 0.9998797178268433
gene O 0 0.022264264523983
and O 0 0.02069760300219059
hereditary B-Disease 1 0.9999991655349731
breast I-Disease 1 1.0
and I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9741839170455933
established O 1 0.7332245707511902
, O 0 0.009643711149692535
the O 0 0.009197838604450226
role O 0 0.01371604111045599
, O 0 0.006388301961123943
if O 0 0.004511107690632343
any O 0 0.004660915117710829
, O 0 0.005680345464497805
of O 0 0.009829196147620678
BRCA1 O 1 0.9860059022903442
in O 0 0.016540784388780594
non B-Disease 1 0.9995871186256409
- I-Disease 1 0.9999990463256836
familial I-Disease 1 0.9999996423721313
cancers I-Disease 1 0.9999961853027344
is O 0 0.09869924932718277
unclear O 0 0.03838100656867027
. O 0 0.034660182893276215

BRCA1 O 1 0.9988580942153931
mutations O 0 0.040038079023361206
are O 0 0.010177062824368477
rare O 0 0.019451379776000977
in O 0 0.01582551933825016
sporadic B-Disease 1 0.9980342984199524
cancers I-Disease 1 0.9999637603759766
, O 0 0.016825072467327118
but O 0 0.007683204021304846
loss O 0 0.09766991436481476
of O 0 0.24658054113388062
BRCA1 O 1 0.9998739957809448
resulting O 0 0.021771084517240524
from O 0 0.010815550573170185
reduced O 0 0.01759500801563263
expression O 0 0.01702314428985119
or O 0 0.012158314697444439
incorrect O 0 0.02499435842037201
subcellular O 0 0.09292114526033401
localization O 0 0.04542550444602966
is O 0 0.00963963195681572
postulated O 0 0.015977216884493828
to O 0 0.006308389361947775
be O 0 0.004420748911798
important O 0 0.0053390259854495525
in O 0 0.007689954247325659
non B-Disease 1 0.9791989922523499
- I-Disease 1 0.9999979734420776
familial I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 0.9999960660934448
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
. O 1 0.8593673706054688

Epigenetic O 1 0.5905834436416626
loss O 1 0.5190687775611877
, O 0 0.020697789266705513
however O 0 0.011141214519739151
, O 0 0.009756822139024734
has O 0 0.007418970577418804
not O 0 0.005789672490209341
received O 0 0.01051634643226862
general O 0 0.014320192858576775
acceptance O 0 0.057478781789541245
due O 0 0.01088437158614397
to O 0 0.008486575447022915
controversy O 0 0.016012301668524742
regarding O 0 0.012197556905448437
the O 0 0.012129799462854862
subcellular O 0 0.089585080742836
localization O 0 0.22846180200576782
of O 0 0.18279144167900085
BRCA1 O 1 0.999811589717865
proteins O 0 0.012558537535369396
, O 0 0.007523715030401945
reports O 0 0.006413565017282963
of O 0 0.006735065020620823
which O 0 0.005968298297375441
have O 0 0.006001644767820835
ranged O 0 0.013192468322813511
from O 0 0.008292625658214092
exclusively O 0 0.01147189550101757
nuclear O 0 0.013701246120035648
, O 0 0.007586469873785973
to O 0 0.008056818507611752
conditionally O 0 0.025861689820885658
nuclear O 0 0.014044015668332577
, O 0 0.007890334352850914
to O 0 0.008475917391479015
the O 0 0.02522219344973564
ER O 1 0.9999934434890747
/ O 1 0.9999096393585205
golgi O 1 0.9828590750694275
, O 0 0.01735125482082367
to O 0 0.018556782975792885
cytoplasmic O 0 0.07609070092439651
invaginations O 0 0.4410824179649353
into O 0 0.023054994642734528
the O 0 0.0297184307128191
nucleus O 0 0.08246944844722748
. O 0 0.03985927253961563

In O 0 0.027614204213023186
an O 0 0.020440608263015747
attempt O 0 0.02873636782169342
to O 0 0.015456345863640308
resolve O 0 0.03584524989128113
this O 0 0.010135356336832047
issue O 0 0.013224600814282894
, O 0 0.008676629513502121
we O 0 0.007998604327440262
have O 0 0.008218865841627121
comprehensively O 0 0.038747332990169525
characterized O 0 0.04244198277592659
19 O 0 0.05455122888088226
anti O 1 0.9997541308403015
- O 1 0.9999889135360718
BRCA1 O 1 0.9996300935745239
antibodies O 1 0.6626600027084351
. O 0 0.04491853341460228

These O 0 0.030545173212885857
reagents O 0 0.06316252797842026
detect O 0 0.03722570464015007
a O 0 0.024027451872825623
220 O 0 0.05323309451341629
- O 1 0.9994615912437439
kD O 1 0.999444305896759
protein O 0 0.02214914932847023
localized O 0 0.021875666454434395
in O 0 0.008685468696057796
discrete O 0 0.017300548031926155
nuclear O 0 0.019982008263468742
foci O 0 0.16444721817970276
in O 0 0.010180800221860409
all O 0 0.015293379314243793
epithelial O 1 0.9998922348022461
cell O 0 0.3424438238143921
lines O 0 0.015776297077536583
, O 0 0.010039066895842552
including O 0 0.009060408920049667
those O 0 0.01083634328097105
derived O 0 0.019505467265844345
from O 0 0.0335044264793396
breast B-Disease 1 0.9999704360961914
malignancies I-Disease 1 0.9997779726982117
. O 0 0.07763534784317017

Immunohistochemical O 1 0.996039867401123
staining O 1 0.9591168761253357
of O 0 0.04790714755654335
human O 1 0.9160845279693604
breast O 1 0.9999876022338867
specimens O 0 0.15108977258205414
also O 0 0.01893743686378002
revealed O 0 0.10277494043111801
BRCA1 O 1 0.990658164024353
nuclear O 0 0.03361613675951958
foci O 1 0.862281858921051
in O 0 0.02575208991765976
benign O 1 0.9999822378158569
breast O 1 0.9999982118606567
, O 1 0.9960182309150696
invasive B-Disease 1 0.9999996423721313
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999978542327881
and O 1 0.9580532312393188
low B-Disease 1 0.9999305009841919
- I-Disease 1 0.9999991655349731
grade I-Disease 1 0.9999909400939941
ductal I-Disease 1 0.9999997615814209
carcinomas I-Disease 1 0.9999970197677612
. O 0 0.08409302681684494

Conversely O 0 0.20934754610061646
, O 0 0.042349472641944885
BRCA1 O 1 0.9972475171089172
expression O 0 0.026890365406870842
was O 0 0.024765128269791603
reduced O 0 0.020560497418045998
or O 0 0.013614507392048836
undetectable O 0 0.4482942223548889
in O 0 0.0065940432250499725
the O 0 0.007427111268043518
majority O 0 0.008832715451717377
of O 0 0.010880643501877785
high O 1 0.933199405670166
- O 1 0.9999765157699585
grade O 1 0.9998121857643127
, O 1 0.9885482788085938
ductal B-Disease 1 1.0
carcinomas I-Disease 1 0.9999995231628418
, O 0 0.018299447372555733
suggesting O 0 0.013350410386919975
that O 0 0.006549626123160124
absence O 0 0.06812085956335068
of O 0 0.3866582214832306
BRCA1 O 1 0.9999580383300781
may O 0 0.014382070861756802
contribute O 0 0.014279321767389774
to O 0 0.008632984012365341
the O 0 0.01164896972477436
pathogenesis O 1 0.9702031016349792
of O 0 0.01027112640440464
a O 0 0.011744466610252857
significant O 0 0.010492496192455292
percentage O 0 0.014769266359508038
of O 0 0.12187008559703827
sporadic B-Disease 1 0.9999817609786987
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999983310699463
. O 0 0.11013936996459961
. O 0 0.03720280900597572

